Citrus Sinensis ID: 013750

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------
Protein Sequence
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR
Secondary Structure (PSIPRED)
cEEEEEEccccEEEEcccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEEEHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEEccccccHHHHHHccccccccccHHHHHHHHHHHHHHHHcccccccccEEEccccccccccccccccccccccccccccccccEEEcccccccccccHHHHccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccccHHHHHHccccHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEccccccEccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHccccHcHcccHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEEEEccccc
Coil and Loop (DISEMBL)
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLIltgsskkpkigIIVGIVGGLIVLISGGLLFFLckgrhkgykrevFVDVAGEVDRRIAFGQLKRYSWRELQLATdnfseknvlgqggfgkvyrgvladGTKVAVKRLtdfespggdaaFQREVEMISVAVHRNLLRLIgfcttpterllvyPFMQNLSVAYRLreikpgepvldwVTRKRVALGAARGLEYlhehcnpkiihRDVKAANVLldedfeavvgdfGLAKLVDVrktnvttqvrgtmghiapeylstgkssertdvFGYGIMLLELVTGqraidfsrleeeDDVLLLDHVKKLEREKRLDAIVDRnlnknyniQEVETMIQVALLCtqaspedrpaMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRfdwgedsvyNQEAIELSGGR
Flexible Loop (DISEMBL)
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILtgsskkpkIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDnfseknvlgqggfGKVYRGVLADGTKVAVKRLTDfespggdaafQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIkpgepvldwvtRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDfglaklvdvrktnvttqvrgtmghiapeylstgksseRTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLdhvkklerekrldaivdrnlnknynIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGlaerweewqhvEVTRRQEYERLqrrfdwgedsvynqeaielsggr
Low Complexity Region (SEG)
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTgsskkpkigiivgivgglivlisgglLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRleeeddvllldhvkkleREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR
Disordered region (IsUnstruct)
**QVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQ***********VVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVY***********
Disordered Region (DISOPRED)
MIQVAWLDVGSAFILWKMFSRVEPLNLLG*********************IVGIVGGLIVLISGGLLFFLCKG***********************GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT******GD*AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG**************************************IELS***
Disordered Region (DISEMBL)
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR
Disordered Region (DISPRO)
MIQVAWLDVGSAFILWKMFSRVEPLN******************KPKIGIIVGIVGGLIVLISGGLLFFLCKGRHK*******VDVA****RRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE*L********************************YNQE**E*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIQVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	437	2.2.26 [Sep-21-2011]
C0LGT1	613	Probable LRR receptor-lik	yes	no	0.910	0.649	0.876	0.0
C0LGX1	607	Probable LRR receptor-lik	no	no	0.894	0.644	0.851	0.0
Q8W4S5	614	Probable LRR receptor-lik	no	no	0.908	0.646	0.657	1e-145
Q94AG2	625	Somatic embryogenesis rec	no	no	0.816	0.571	0.680	1e-141
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.819	0.570	0.670	1e-137
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.745	0.530	0.705	1e-132
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.739	0.520	0.678	1e-125
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.892	0.614	0.563	1e-122
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.739	0.537	0.656	1e-120
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.819	0.566	0.570	1e-117

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  708 bits (1827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/398 (87%), Positives = 372/398 (93%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           +G S KPK GII G+V G+ V++ G LLF  CK RHKGY+R+VFVDVAGEVDRRIAFGQL
Sbjct: 216 SGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQL 275

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           KR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDAAFQRE
Sbjct: 276 KRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQRE 335

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW TRKR+A
Sbjct: 336 VEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIA 395

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRG
Sbjct: 396 LGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRG 455

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 456 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 515

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL AIVD+NL+  Y  +EVE MIQVALLCTQ SPEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 516 EKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEE 575

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 576 WQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/391 (85%), Positives = 367/391 (93%)

Query: 47  KIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRE 106
           K GII G+V G+ V++ G   FF CK +HKGYKR+VFVDVAGEVDRRIAFGQL+R++WRE
Sbjct: 217 KTGIIAGVVSGIAVILLGFFFFFFCKDKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRE 276

Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           LQLATD FSEKNVLGQGGFGKVY+G+L+DGTKVAVKRLTDFE PGGD AFQREVEMISVA
Sbjct: 277 LQLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVA 336

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
           VHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LREIKPG+PVLDW  RK++ALGAARGL
Sbjct: 337 VHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGL 396

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAP
Sbjct: 397 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAP 456

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
           E +STGKSSE+TDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL+ I
Sbjct: 457 ECISTGKSSEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDI 516

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT 406
           VD+ L+++Y  +EVE MIQVALLCTQA+PE+RPAMSEVVRMLEGEGLAERWEEWQ++EVT
Sbjct: 517 VDKKLDEDYIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVT 576

Query: 407 RRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           R++E++RLQRRFDWGEDS+ NQ+AIELSGGR
Sbjct: 577 RQEEFQRLQRRFDWGEDSINNQDAIELSGGR 607

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1

 Score =  516 bits (1328), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 267/406 (65%), Positives = 327/406 (80%), Gaps = 9/406 (2%)

Query: 37  LILTGSSKKPK-IGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIA 95
           L +T S KK + I +    V  +I+ +   +++   + R   Y  ++F DVAGE DR+I+
Sbjct: 213 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKY--DIFFDVAGEDDRKIS 270

Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA 155
           FGQLKR+S RE+QLATD+F+E N++GQGGFGKVYRG+L D TKVAVKRL D+ SPGG+AA
Sbjct: 271 FGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAA 330

Query: 156 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
           FQRE+++ISVAVH+NLLRLIGFCTT +ER+LVYP+M+NLSVAYRLR++K GE  LDW TR
Sbjct: 331 FQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTR 390

Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           KRVA G+A GLEYLHEHCNPKIIHRD+KAAN+LLD +FE V+GDFGLAKLVD   T+VTT
Sbjct: 391 KRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTT 450

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 335
           QVRGTMGHIAPEYL TGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+++LLLDH+K
Sbjct: 451 QVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIK 510

Query: 336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE-GLA 394
           KL RE+RL  IVD NL   Y+ +EVET++QVALLCTQ SPEDRPAMSEVV+ML+G  GLA
Sbjct: 511 KLLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLA 569

Query: 395 ERWEEWQHVEVTRRQE---YERLQRRFDWGEDSVYNQEAIELSGGR 437
           E+W EW+ +E  R +E      L   +D  E++  +QE+I LS  R
Sbjct: 570 EKWTEWEQLEEVRNKEALLLPTLPATWD-EEETTVDQESIRLSTAR 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  501 bits (1290), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 243/357 (68%), Positives = 288/357 (80%)

Query: 81  EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 140
           ++F DV  E D  +  GQLKR+S RELQ+A+D FS KN+LG+GGFGKVY+G LADGT VA
Sbjct: 269 DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVA 328

Query: 141 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 200
           VKRL +  +PGG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  L
Sbjct: 329 VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 388

Query: 201 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 260
           RE  P +P LDW TRKR+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 389 RERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 448

Query: 261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D +
Sbjct: 449 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 508

Query: 321 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 380
           RL  +DDV+LLD VK L +EK+L+ +VD +L  NY  +E+E +IQVALLCTQ SP +RP 
Sbjct: 509 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPK 568

Query: 381 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           MSEVVRMLEG+GLAE+W+EWQ VE+ R +         DW  DS YN  A+ELSG R
Sbjct: 569 MSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  487 bits (1254), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 240/358 (67%), Positives = 286/358 (79%)

Query: 80  REVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV 139
           +E F DV  E D  +  GQLKR+S RELQ+ATD+FS KN+LG+GGFGKVY+G LADGT V
Sbjct: 271 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLV 330

Query: 140 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYR 199
           AVKRL +  +PGG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  
Sbjct: 331 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 390

Query: 200 LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 259
           LRE  P +  L W  R+++ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct: 391 LRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 450

Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 319
           FGLA+L+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D 
Sbjct: 451 FGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 510

Query: 320 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 379
           +RL  +DDV+LLD VK L +EK+L+ +VD +L  NY   EVE +IQVALLCTQ+SP +RP
Sbjct: 511 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERP 570

Query: 380 AMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
            MSEVVRMLEG+GLAE+W+EWQ VEV R++         DW  DS  N  A+ELSG R
Sbjct: 571 KMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  473 bits (1218), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 230/326 (70%), Positives = 272/326 (83%)

Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F DV  E D  +  GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVK
Sbjct: 258 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 317

Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 318 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 377

Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
               +P LDW  R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 378 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 437

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           AKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL
Sbjct: 438 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 497

Query: 323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
             +DDV+LLD VK L +EK+L+A+VD +L  NY  +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 498 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 557

Query: 383 EVVRMLEGEGLAERWEEWQHVEVTRR 408
           EVVRMLEG+GLAERWEEWQ  E+ R+
Sbjct: 558 EVVRMLEGDGLAERWEEWQKEEMFRQ 583

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  449 bits (1155), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/323 (67%), Positives = 262/323 (81%)

Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F DV  E D  +  GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG  VAVK
Sbjct: 263 FFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVK 322

Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 323 RLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 382

Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
              G P LDW  RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 383 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGL 442

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           AKL++   ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +RL
Sbjct: 443 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 502

Query: 323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
             +DD++LLD VK++ +EK+L+++VD  L   Y   EVE +IQ+ALLCTQ+S  +RP MS
Sbjct: 503 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 562

Query: 383 EVVRMLEGEGLAERWEEWQHVEV 405
           EVVRMLEG+GLAERWEEWQ  E+
Sbjct: 563 EVVRMLEGDGLAERWEEWQKEEM 585

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  437 bits (1125), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 227/403 (56%), Positives = 292/403 (72%), Gaps = 13/403 (3%)

Query: 41  GSSKKPKIGIIVGIVGGLIVLISGGLLFFLC-KGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           G +K  KI ++ G+    + L+  G  F L  + RH   K+ +F D+  +    +  G L
Sbjct: 240 GGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHN--KQVLFFDINEQNKEEMCLGNL 297

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           +R++++ELQ AT NFS KN++G+GGFG VY+G L DG+ +AVKRL D  + GG+  FQ E
Sbjct: 298 RRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTE 357

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           +EMIS+AVHRNLLRL GFCTT +ERLLVYP+M N SVA RL+     +PVLDW TRKR+A
Sbjct: 358 LEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK----AKPVLDWGTRKRIA 413

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGA RGL YLHE C+PKIIHRDVKAAN+LLD+ FEAVVGDFGLAKL+D  +++VTT VRG
Sbjct: 414 LGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRG 473

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           T+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +   +    +LD VKKL++
Sbjct: 474 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGA-ILDWVKKLQQ 532

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWE- 398
           EK+L+ IVD++L  NY+  EVE M+QVALLCTQ  P  RP MSEVVRMLEG+GL E+WE 
Sbjct: 533 EKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKWEA 592

Query: 399 EWQHVEVTRR----QEYERLQRRFDWGEDSVYNQEAIELSGGR 437
             Q  E  R      E+   +R  D  +DS    +A+ELSG R
Sbjct: 593 SSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQAMELSGPR 635

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  433 bits (1114), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 212/323 (65%), Positives = 259/323 (80%)

Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F+DV  E D  +  GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD T VAVK
Sbjct: 244 FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVK 303

Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 304 RLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 363

Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
              G P LDW  RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAVVGDFGL
Sbjct: 364 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGL 423

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           AKL++   ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +RL
Sbjct: 424 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 483

Query: 323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
             +DD++LLD VK++ +EK+L+++VD  L   Y   EVE +IQ+ALLCTQ+S  +RP MS
Sbjct: 484 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 543

Query: 383 EVVRMLEGEGLAERWEEWQHVEV 405
           EVVRMLEG+GLAERWEEWQ  E+
Sbjct: 544 EVVRMLEGDGLAERWEEWQKEEM 566

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  421 bits (1081), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 210/368 (57%), Positives = 276/368 (75%), Gaps = 10/368 (2%)

Query: 79  KREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK 138
            +++F DV  + D  ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L DGT 
Sbjct: 266 NKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTL 325

Query: 139 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 198
           VAVKRL D    GG+  FQ EVE IS+A+HRNLLRL GFC++  ER+LVYP+M N SVA 
Sbjct: 326 VAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVAS 385

Query: 199 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 258
           RL++   GEP LDW  RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEAVVG
Sbjct: 386 RLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 445

Query: 259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           DFGLAKL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+A+D
Sbjct: 446 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD 505

Query: 319 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 378
           F R   +  V +LD VKKL +E +L  ++D++LN  ++  E+E ++QVALLCTQ +P  R
Sbjct: 506 FGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHR 564

Query: 379 PAMSEVVRMLEGEGLAERWEEWQH---------VEVTRRQEYERLQRRFDWGEDSVYNQE 429
           P MSEV++MLEG+GLAERWE  Q+         +         R++   D+ ++S    E
Sbjct: 565 PKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVE 624

Query: 430 AIELSGGR 437
           AIELSG R
Sbjct: 625 AIELSGPR 632

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	437
356512695	610	PREDICTED: probable LRR receptor-like se	0.908	0.650	0.932	0.0
356525465	610	PREDICTED: probable LRR receptor-like se	0.908	0.650	0.929	0.0
224093748	611	predicted protein [Populus trichocarpa]	0.910	0.651	0.922	0.0
118486735	611	unknown [Populus trichocarpa]	0.910	0.651	0.919	0.0
449458289	612	PREDICTED: probable LRR receptor-like se	0.908	0.648	0.897	0.0
297811131	613	leucine-rich repeat family protein [Arab	0.910	0.649	0.876	0.0
224081132	606	predicted protein [Populus trichocarpa]	0.842	0.607	0.937	0.0
22326703	613	putative LRR receptor-like serine/threon	0.910	0.649	0.876	0.0
8953410	605	protein serine/threonine kinase-like pro	0.910	0.657	0.876	0.0
20260260	613	protein serine/threonine kinase-like pro	0.910	0.649	0.874	0.0

>gi|356512695|ref|XP_003525052.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max]

 Score =  763 bits (1971), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/398 (93%), Positives = 384/398 (96%), Gaps = 1/398 (0%)

Query: 41  GSSKKPKIGIIVGIVGGLIV-LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           GSS KPK G+IVGIV GL+V L  GGLLFF CKGRHK Y+REVFVDVAGEVDRRIAFGQL
Sbjct: 213 GSSHKPKTGLIVGIVIGLVVILFLGGLLFFWCKGRHKSYRREVFVDVAGEVDRRIAFGQL 272

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           +R++WRELQ+ATDNFSEKNVLGQGGFGKVY+GVLAD TKVAVKRLTD+ESPGGDAAFQRE
Sbjct: 273 RRFAWRELQIATDNFSEKNVLGQGGFGKVYKGVLADNTKVAVKRLTDYESPGGDAAFQRE 332

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE+KPGEPVLDW TRKRVA
Sbjct: 333 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRELKPGEPVLDWPTRKRVA 392

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LG ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG
Sbjct: 393 LGTARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 452

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 453 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 512

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL+AIVDRNLNKNYNIQEVE MIQVALLCTQA+PEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 513 EKRLEAIVDRNLNKNYNIQEVEMMIQVALLCTQATPEDRPPMSEVVRMLEGEGLAERWEE 572

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQHVEV RRQEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 573 WQHVEVNRRQEYERLQRRFDWGEDSVYNQDAIELSGGR 610

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356525465|ref|XP_003531345.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max]

 Score =  761 bits (1964), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/398 (92%), Positives = 384/398 (96%), Gaps = 1/398 (0%)

Query: 41  GSSKKPKIGIIVGIVGGLIV-LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           GSS KPK G+IVGIV GL+V L  GGL+FF CKGRHKGY+REVFVDVAGEVDRRIAFGQL
Sbjct: 213 GSSHKPKTGLIVGIVIGLVVILFLGGLMFFGCKGRHKGYRREVFVDVAGEVDRRIAFGQL 272

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           +R++WRELQ+ATDNFSEKNVLGQGGFGKVY+GVLAD TKVAVKRLTD+ESPGGDAAFQRE
Sbjct: 273 RRFAWRELQIATDNFSEKNVLGQGGFGKVYKGVLADNTKVAVKRLTDYESPGGDAAFQRE 332

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW TRK+VA
Sbjct: 333 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWPTRKQVA 392

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LG ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG
Sbjct: 393 LGTARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 452

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 453 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 512

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRLDAIVD NLNKNYNIQEVE MI+VALLCTQA+PEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 513 EKRLDAIVDHNLNKNYNIQEVEMMIKVALLCTQATPEDRPPMSEVVRMLEGEGLAERWEE 572

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQHVEV RRQEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 573 WQHVEVNRRQEYERLQRRFDWGEDSVYNQDAIELSGGR 610

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093748|ref|XP_002309974.1| predicted protein [Populus trichocarpa] gi|222852877|gb|EEE90424.1| predicted protein [Populus trichocarpa]

 Score =  745 bits (1923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/399 (92%), Positives = 379/399 (94%), Gaps = 1/399 (0%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LCKGRHKGYKREVFVDVAGEVDRRIAFGQ 98
           +G S K K GII+G+VGG  VL   G L F +CKGRHKGYKREVFVDVAGEVD+RIAFGQ
Sbjct: 213 SGGSHKSKTGIIIGVVGGFTVLFLFGGLLFFVCKGRHKGYKREVFVDVAGEVDQRIAFGQ 272

Query: 99  LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 158
           LKR+SWRELQLATDNFSEKN+LGQGGFGKVY+GVLAD TK+AVKRLTDFESPGGDAAFQR
Sbjct: 273 LKRFSWRELQLATDNFSEKNILGQGGFGKVYKGVLADNTKIAVKRLTDFESPGGDAAFQR 332

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
           EVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LRE KP EPVLDW TRKRV
Sbjct: 333 EVEMISVAVHRNLLRLIGFCTTTTERLLVYPFMQNLSVAYCLRERKPEEPVLDWTTRKRV 392

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR
Sbjct: 393 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 452

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
           GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE
Sbjct: 453 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 512

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWE 398
           REKRLDAIVDRNLNKNYNIQEVE MIQVALLCTQASPE+RPAMSEVVRMLEGEGLAERWE
Sbjct: 513 REKRLDAIVDRNLNKNYNIQEVEMMIQVALLCTQASPENRPAMSEVVRMLEGEGLAERWE 572

Query: 399 EWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           EWQHVEVTR QEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 573 EWQHVEVTRMQEYERLQRRFDWGEDSVYNQDAIELSGGR 611

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|118486735|gb|ABK95203.1| unknown [Populus trichocarpa]

 Score =  742 bits (1915), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/399 (91%), Positives = 378/399 (94%), Gaps = 1/399 (0%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LCKGRHKGYKREVFVDVAGEVDRRIAFGQ 98
           +G S K K GII+G+VGG  VL   G L F +CKGRHKGYKREVFVDVAGEVD+RIAFGQ
Sbjct: 213 SGGSHKSKTGIIIGVVGGFTVLFLFGGLLFFVCKGRHKGYKREVFVDVAGEVDQRIAFGQ 272

Query: 99  LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 158
           LKR+SWRELQLATDNFSEKN+LGQGGFGKVY+GVLAD TK+AVKRLTD ESPGGDAAFQR
Sbjct: 273 LKRFSWRELQLATDNFSEKNILGQGGFGKVYKGVLADNTKIAVKRLTDVESPGGDAAFQR 332

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
           EVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LRE KP EPVLDW TRKRV
Sbjct: 333 EVEMISVAVHRNLLRLIGFCTTTTERLLVYPFMQNLSVAYCLRERKPEEPVLDWTTRKRV 392

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR
Sbjct: 393 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 452

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
           GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE
Sbjct: 453 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 512

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWE 398
           REKRLDAIVDRNLNKNYNIQEVE MIQVALLCTQASPE+RPAMSEVVRMLEGEGLAERWE
Sbjct: 513 REKRLDAIVDRNLNKNYNIQEVEMMIQVALLCTQASPENRPAMSEVVRMLEGEGLAERWE 572

Query: 399 EWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           EWQHVEVTR QEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 573 EWQHVEVTRMQEYERLQRRFDWGEDSVYNQDAIELSGGR 611

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449458289|ref|XP_004146880.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus] gi|449519138|ref|XP_004166592.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus]

 Score =  723 bits (1865), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/399 (89%), Positives = 380/399 (95%), Gaps = 2/399 (0%)

Query: 40  TGSSKKPKIGIIVGIVGGLIV-LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQ 98
           +GSS KPK+G+IVGI+ G  V L+  G+LFFL KGR+K YKREVFVDVAGEVDRRIAFGQ
Sbjct: 215 SGSSNKPKVGLIVGIIAGFTVALLLVGVLFFLSKGRYKSYKREVFVDVAGEVDRRIAFGQ 274

Query: 99  LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 158
           LKR++WRELQLAT+NFSEKNVLGQGGFGKVY+GVLADGTKVAVKRLTD+ESPGGDAAFQR
Sbjct: 275 LKRFAWRELQLATENFSEKNVLGQGGFGKVYKGVLADGTKVAVKRLTDYESPGGDAAFQR 334

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
           EVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAYRLRE+KPGE VLDW TRKRV
Sbjct: 335 EVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYRLRELKPGEAVLDWPTRKRV 394

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           ALG ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ+R
Sbjct: 395 ALGTARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQIR 454

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
           GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE
Sbjct: 455 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 514

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWE 398
           REKRLDAIVDRNLN NYNIQEVE MIQVALLCTQ   +DRPAMS+VVRMLEGEGLAERWE
Sbjct: 515 REKRLDAIVDRNLN-NYNIQEVEMMIQVALLCTQPCSDDRPAMSQVVRMLEGEGLAERWE 573

Query: 399 EWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           EWQH+EVTRRQEYERLQRRF+WGEDS++ Q+AI+LSGGR
Sbjct: 574 EWQHLEVTRRQEYERLQRRFEWGEDSIHRQDAIQLSGGR 612

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297811131|ref|XP_002873449.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297319286|gb|EFH49708.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  722 bits (1863), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/398 (87%), Positives = 372/398 (93%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           +G S KPK GII G+V G+ V++ G LLF  CK RHKGY+R+VFVDVAGEVDRRIAFGQL
Sbjct: 216 SGDSSKPKTGIIAGVVAGVTVILFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQL 275

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           KR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDAAFQRE
Sbjct: 276 KRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQRE 335

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW TRKR+A
Sbjct: 336 VEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIA 395

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRG
Sbjct: 396 LGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRG 455

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 456 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 515

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL AIVD+NL+  Y  +EVE MIQVALLCTQ SPEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 516 EKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEE 575

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 576 WQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081132|ref|XP_002306304.1| predicted protein [Populus trichocarpa] gi|222855753|gb|EEE93300.1| predicted protein [Populus trichocarpa]

 Score =  716 bits (1847), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/368 (93%), Positives = 359/368 (97%)

Query: 70  LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 129
           +CKGR KGY+RE+FVDVAGEVDRRIAFGQLKR++WRELQLATDNFSE+N+LGQGGFGKVY
Sbjct: 239 VCKGRRKGYRREIFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEENILGQGGFGKVY 298

Query: 130 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 189
           +GVLAD TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 299 KGVLADNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLVYP 358

Query: 190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 249
           FMQNLSVAYRLRE KP EPVLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL
Sbjct: 359 FMQNLSVAYRLRERKPEEPVLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 418

Query: 250 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 309
           DEDFEAVVGDFGLAKL+DVRKTNVTTQVRGTMGHIAPEYLSTGKSS RTDVFGYGIMLLE
Sbjct: 419 DEDFEAVVGDFGLAKLMDVRKTNVTTQVRGTMGHIAPEYLSTGKSSGRTDVFGYGIMLLE 478

Query: 310 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL 369
           LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MI+VALL
Sbjct: 479 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIKVALL 538

Query: 370 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 429
           CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR+EY RLQRRFD+GEDS+YNQ+
Sbjct: 539 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRREEYSRLQRRFDFGEDSLYNQD 598

Query: 430 AIELSGGR 437
           AIELSGGR
Sbjct: 599 AIELSGGR 606

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22326703|ref|NP_196591.2| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|264664527|sp|C0LGT1.1|Y5129_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g10290; Flags: Precursor gi|224589669|gb|ACN59366.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332004134|gb|AED91517.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana]

 Score =  708 bits (1827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/398 (87%), Positives = 372/398 (93%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           +G S KPK GII G+V G+ V++ G LLF  CK RHKGY+R+VFVDVAGEVDRRIAFGQL
Sbjct: 216 SGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQL 275

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           KR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDAAFQRE
Sbjct: 276 KRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQRE 335

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW TRKR+A
Sbjct: 336 VEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIA 395

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRG
Sbjct: 396 LGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRG 455

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 456 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 515

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL AIVD+NL+  Y  +EVE MIQVALLCTQ SPEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 516 EKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEE 575

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 576 WQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|8953410|emb|CAB96685.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana]

 Score =  707 bits (1826), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/398 (87%), Positives = 372/398 (93%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           +G S KPK GII G+V G+ V++ G LLF  CK RHKGY+R+VFVDVAGEVDRRIAFGQL
Sbjct: 208 SGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQL 267

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           KR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDAAFQRE
Sbjct: 268 KRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQRE 327

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW TRKR+A
Sbjct: 328 VEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIA 387

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRG
Sbjct: 388 LGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRG 447

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 448 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 507

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL AIVD+NL+  Y  +EVE MIQVALLCTQ SPEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 508 EKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEE 567

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 568 WQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 605

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20260260|gb|AAM13028.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana]

 Score =  704 bits (1818), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/398 (87%), Positives = 371/398 (93%)

Query: 40  TGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQL 99
           +G S KPK GII G+V G+ V++ G LLF  CK RHKGY+R+VFVDVAGEVDRRIAFGQL
Sbjct: 216 SGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQL 275

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           KR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDAAFQRE
Sbjct: 276 KRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQRE 335

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           VEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW TRKR+A
Sbjct: 336 VEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIA 395

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           LGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRG
Sbjct: 396 LGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRG 455

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
           TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER
Sbjct: 456 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 515

Query: 340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEE 399
           EKRL AIVD+NL+  Y  +EV  MIQVALLCTQ SPEDRP MSEVVRMLEGEGLAERWEE
Sbjct: 516 EKRLGAIVDKNLDGEYIKEEVGMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEE 575

Query: 400 WQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
           WQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 576 WQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	437
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.848	0.605	0.857	7.4e-169
TAIR|locus:2160644	614	AT5G63710 [Arabidopsis thalian	0.819	0.583	0.679	2.3e-126
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.816	0.571	0.652	2.8e-121
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.816	0.568	0.649	8.8e-118
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.739	0.520	0.653	1.9e-108
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.739	0.537	0.631	2e-104
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.821	0.568	0.552	2.3e-101
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.830	0.568	0.557	4.4e-100
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.684	0.471	0.605	4.8e-94
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.677	0.456	0.614	2.1e-93

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1642 (583.1 bits), Expect = 7.4e-169, P = 7.4e-169
 Identities = 318/371 (85%), Positives = 336/371 (90%)

Query:    67 LFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFG 126
             LF  CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFG
Sbjct:   243 LFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFG 302

Query:   127 KVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 186
             KVY+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLL
Sbjct:   303 KVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLL 362

Query:   187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 246
             VYPFMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAAN
Sbjct:   363 VYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAAN 422

Query:   247 VLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 306
             VLLDEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM
Sbjct:   423 VLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 482

Query:   307 LLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQV 366
             LLELVTGQRAIDFSR                 REKRL AIVD+NL+  Y  +EVE MIQV
Sbjct:   483 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQV 542

Query:   367 ALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVY 426
             ALLCTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++
Sbjct:   543 ALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMH 602

Query:   427 NQEAIELSGGR 437
             NQ+AIELSGGR
Sbjct:   603 NQDAIELSGGR 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1241 (441.9 bits), Expect = 2.3e-126, P = 2.3e-126
 Identities = 246/362 (67%), Positives = 291/362 (80%)

Query:    79 KREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK 138
             K ++F DVAGE DR+I+FGQLKR+S RE+QLATD+F+E N++GQGGFGKVYRG+L D TK
Sbjct:   254 KYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTK 313

Query:   139 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 198
             VAVKRL D+ SPGG+AAFQRE+++ISVAVH+NLLRLIGFCTT +ER+LVYP+M+NLSVAY
Sbjct:   314 VAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAY 373

Query:   199 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 258
             RLR++K GE  LDW TRKRVA G+A GLEYLHEHCNPKIIHRD+KAAN+LLD +FE V+G
Sbjct:   374 RLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLG 433

Query:   259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             DFGLAKLVD   T+VTTQVRGTMGHIAPEYL TGKSSE+TDVFGYGI LLELVTGQRAID
Sbjct:   434 DFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAID 493

Query:   319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 378
             FSR                 RE+RL  IVD NL   Y+ +EVET++QVALLCTQ SPEDR
Sbjct:   494 FSRLEEEENILLLDHIKKLLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSPEDR 552

Query:   379 PAMSEVVRMLEGEG-LAERWEEWQHVEVTRRQEYERLQRR-FDWGED-SVYNQEAIELSG 435
             PAMSEVV+ML+G G LAE+W EW+ +E  R +E   L      W E+ +  +QE+I LS 
Sbjct:   553 PAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLST 612

Query:   436 GR 437
              R
Sbjct:   613 AR 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
 Identities = 233/357 (65%), Positives = 276/357 (77%)

Query:    81 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 140
             ++F DV  E D  +  GQLKR+S RELQ+A+D FS KN+LG+GGFGKVY+G LADGT VA
Sbjct:   269 DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVA 328

Query:   141 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 200
             VKRL +  +PGG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  L
Sbjct:   329 VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 388

Query:   201 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 260
             RE  P +P LDW TRKR+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct:   389 RERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 448

Query:   261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
             GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D +
Sbjct:   449 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 508

Query:   321 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 380
             R                 +EK+L+ +VD +L  NY  +E+E +IQVALLCTQ SP +RP 
Sbjct:   509 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPK 568

Query:   381 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 437
             MSEVVRMLEG+GLAE+W+EWQ VE+ R +         DW  DS YN  A+ELSG R
Sbjct:   569 MSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
 Identities = 233/359 (64%), Positives = 275/359 (76%)

Query:    80 REVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV 139
             +E F DV  E D  +  GQLKR+S RELQ+ATD+FS KN+LG+GGFGKVY+G LADGT V
Sbjct:   271 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLV 330

Query:   140 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYR 199
             AVKRL +  +PGG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  
Sbjct:   331 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 390

Query:   200 LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 259
             LRE  P +  L W  R+++ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct:   391 LRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 450

Query:   260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 319
             FGLA+L+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D 
Sbjct:   451 FGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 510

Query:   320 SRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 379
             +R                 +EK+L+ +VD +L  NY   EVE +IQVALLCTQ+SP +RP
Sbjct:   511 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERP 570

Query:   380 AMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQR-RFDWGEDSVYNQEAIELSGGR 437
              MSEVVRMLEG+GLAE+W+EWQ VEV R QE E       DW  DS  N  A+ELSG R
Sbjct:   571 KMSEVVRMLEGDGLAEKWDEWQKVEVLR-QEVELSSHPTSDWILDSTDNLHAMELSGPR 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
 Identities = 211/323 (65%), Positives = 249/323 (77%)

Query:    83 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
             F DV  E D  +  GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG  VAVK
Sbjct:   263 FFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVK 322

Query:   143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
             RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct:   323 RLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 382

Query:   203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                G P LDW  RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct:   383 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGL 442

Query:   263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
             AKL++   ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R 
Sbjct:   443 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 502

Query:   323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                             +EK+L+++VD  L   Y   EVE +IQ+ALLCTQ+S  +RP MS
Sbjct:   503 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 562

Query:   383 EVVRMLEGEGLAERWEEWQHVEV 405
             EVVRMLEG+GLAERWEEWQ  E+
Sbjct:   563 EVVRMLEGDGLAERWEEWQKEEM 585

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1034 (369.0 bits), Expect = 2.0e-104, P = 2.0e-104
 Identities = 204/323 (63%), Positives = 246/323 (76%)

Query:    83 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
             F+DV  E D  +  GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD T VAVK
Sbjct:   244 FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVK 303

Query:   143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
             RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct:   304 RLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 363

Query:   203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                G P LDW  RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAVVGDFGL
Sbjct:   364 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGL 423

Query:   263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
             AKL++   ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R 
Sbjct:   424 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 483

Query:   323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                             +EK+L+++VD  L   Y   EVE +IQ+ALLCTQ+S  +RP MS
Sbjct:   484 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 543

Query:   383 EVVRMLEGEGLAERWEEWQHVEV 405
             EVVRMLEG+GLAERWEEWQ  E+
Sbjct:   544 EVVRMLEGDGLAERWEEWQKEEM 566

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 205/371 (55%), Positives = 269/371 (72%)

Query:    78 YKR--EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD 135
             Y+R  ++F DV  + D  ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L D
Sbjct:   263 YRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLND 322

Query:   136 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 195
             GT VAVKRL D    GG+  FQ EVE IS+A+HRNLLRL GFC++  ER+LVYP+M N S
Sbjct:   323 GTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGS 382

Query:   196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 255
             VA RL++   GEP LDW  RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEA
Sbjct:   383 VASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEA 442

Query:   256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
             VVGDFGLAKL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+
Sbjct:   443 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query:   316 AIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP 375
             A+DF R                 +E +L  ++D++LN  ++  E+E ++QVALLCTQ +P
Sbjct:   503 ALDFGRSAHQKGVMLDWVKKLH-QEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNP 561

Query:   376 EDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR---------QEYERLQRRFDWGEDSVY 426
               RP MSEV++MLEG+GLAERWE  Q+     +             R++   D+ ++S  
Sbjct:   562 SHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSL 621

Query:   427 NQEAIELSGGR 437
               EAIELSG R
Sbjct:   622 VVEAIELSGPR 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
 Identities = 212/380 (55%), Positives = 268/380 (70%)

Query:    67 LFFLCKGRHKGYKREVFVDVA-GEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGF 125
             LF   + RH    +  F DV  G     ++ G L+R+ +RELQ+AT+NFS KN+LG+GG+
Sbjct:   267 LFLWWRQRHN---QNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGY 323

Query:   126 GKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 185
             G VY+G+L D T VAVKRL D  + GG+  FQ EVEMIS+AVHRNLLRL GFC T TE+L
Sbjct:   324 GNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKL 383

Query:   186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 245
             LVYP+M N SVA R++     +PVLDW  RKR+A+GAARGL YLHE C+PKIIHRDVKAA
Sbjct:   384 LVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAA 439

Query:   246 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGI 305
             N+LLD+  EAVVGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI
Sbjct:   440 NILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 499

Query:   306 MLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNL--NKNYNIQEVETM 363
             +LLELVTGQRA +F +                 +EK+L+ +VD+ L   K+Y+  E++ M
Sbjct:   500 LLLELVTGQRAFEFGKAANQKGVMLDWVKKIH-QEKKLELLVDKELLKKKSYDEIELDEM 558

Query:   364 IQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT-----RRQEYERLQRRF 418
             ++VALLCTQ  P  RP MSEVVRMLEG+GLAE+WE  Q  +       R  E      R+
Sbjct:   559 VRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRY 618

Query:   419 -DWGEDSVYNQEAIELSGGR 437
              D  +DS    +A+ELSG R
Sbjct:   619 SDLTDDSSLLVQAMELSGPR 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
 Identities = 184/304 (60%), Positives = 230/304 (75%)

Query:    94 IAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD 153
             +  G L+ +++REL +ATD FS K++LG GGFG VYRG   DGT VAVKRL D     G+
Sbjct:   279 LGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGN 338

Query:   154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
             + F+ E+EMIS+AVHRNLLRLIG+C + +ERLLVYP+M N SVA RL+     +P LDW 
Sbjct:   339 SQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWN 394

Query:   214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
             TRK++A+GAARGL YLHE C+PKIIHRDVKAAN+LLDE FEAVVGDFGLAKL++   ++V
Sbjct:   395 TRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHV 454

Query:   274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXX 333
             TT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +            
Sbjct:   455 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514

Query:   334 XXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 393
                  +E +++ +VDR L   Y+  EV  M+QVALLCTQ  P  RP MSEVV+MLEG+GL
Sbjct:   515 RKLH-KEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGL 573

Query:   394 AERW 397
             AERW
Sbjct:   574 AERW 577

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 930 (332.4 bits), Expect = 2.1e-93, P = 2.1e-93
 Identities = 185/301 (61%), Positives = 226/301 (75%)

Query:    97 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF 156
             G L+ +++REL + TD FS KN+LG GGFG VYRG L DGT VAVKRL D     GD+ F
Sbjct:   286 GNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQF 345

Query:   157 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 216
             + E+EMIS+AVH+NLLRLIG+C T  ERLLVYP+M N SVA +L+     +P LDW  RK
Sbjct:   346 RMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS----KPALDWNMRK 401

Query:   217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
             R+A+GAARGL YLHE C+PKIIHRDVKAAN+LLDE FEAVVGDFGLAKL++   ++VTT 
Sbjct:   402 RIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTA 461

Query:   277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXX 336
             VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +               
Sbjct:   462 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKL 521

Query:   337 XXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAER 396
                E +++ ++DR L  NY+  EV  M+QVALLCTQ  P  RP MSEVV MLEG+GLAER
Sbjct:   522 H-EEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAER 580

Query:   397 W 397
             W
Sbjct:   581 W 581

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGT1	Y5129_ARATH	2, ., 7, ., 1, 1, ., 1	0.8768	0.9107	0.6492	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_VII0470 SubName- Full=Putative uncharacterized protein; (611 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	437
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (401), Expect = 2e-45
 Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 42/288 (14%)

Query: 118 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
             LG+G FG+VY+G L       T+VAVK L +  S      F +E  ++    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 174 LIGFCTTPTERLLVYPFMQN---LSV--AYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L+G CT      LV  +M+    L      R     P +  L        A+  A+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---A 285
           L      K +HRD+ A N L+ ED    + DFGL++ V            G    I   A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK---LEREK 341
           PE L  G  + ++DV+ +G++L E+ T G      +      +  +L++++K   L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGA-----TPYPGLSNEEVLEYLRKGYRLPKPE 230

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                              + + ++ L C Q  PEDRP  SE+V  LE
Sbjct: 231 YCP----------------DELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (390), Expect = 6e-44
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 29/276 (10%)

Query: 119 VLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
            LG+G FG+VY+G L         +VAVK L +  S      F RE  ++    H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L+G CT     ++V  +M    +   LR  K     L        AL  ARG+EYL    
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
               IHRD+ A N L+ E+    + DFGL++ +           +  +  +APE L  GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 294 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 352
            + ++DV+ +G++L E+ T G+    +  +   +   +L+++KK  R  +          
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEE--PYPGMSNAE---VLEYLKKGYRLPKPPNCPPE--- 232

Query: 353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                     + ++ L C    PEDRP  SE+V +L
Sbjct: 233 ----------LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  151 bits (383), Expect = 2e-43
 Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 10/194 (5%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           LG+GGFG VY       G KVA+K +   +S        RE+E++    H N+++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
                  LV  + +  S+   L+E +     L      R+ L    GLEYLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114

Query: 239 HRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 296
           HRD+K  N+LLD D  +  + DFGL+KL+     ++   + GT  ++APE L   G  SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 297 RTDVFGYGIMLLEL 310
           ++D++  G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  152 bits (386), Expect = 3e-43
 Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 32/279 (11%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              LG+G FG+VY+G L         +VAVK L +  S      F RE  ++    H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++L+G CT      +V  +M+       L   ++   P L        AL  ARG+EYL 
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGD----LLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
                  IHRD+ A N L+ E+    + DFGL++ +           +  +  +APE L 
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 291 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
            GK + ++DV+ +G++L E+ T G++   +  +  E+   +L+++K   R  +       
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ--PYPGMSNEE---VLEYLKNGYRLPQPPNCPPE 231

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                        +  + L C    PEDRP  SE+V +L
Sbjct: 232 -------------LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (385), Expect = 4e-43
 Identities = 71/199 (35%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
            LG G FG VY+      G  VAVK L    E    D   +RE+ ++    H N++RLI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                    LV  + +   +   L         L     K++AL   RGLEYLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS 295
           IIHRD+K  N+LLDE+    + DFGLAK +    +++TT V GT  ++APE L  G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 296 ERTDVFGYGIMLLELVTGQ 314
            + DV+  G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (379), Expect = 3e-42
 Identities = 87/285 (30%), Positives = 130/285 (45%), Gaps = 47/285 (16%)

Query: 119 VLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
            LG+G FG+VY+G L        TKVAVK L +  S      F  E  ++    H N++R
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L+G CT      +V  +M    +   LR  K GE  L      ++AL  A+G+EYL    
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEK-LTLKDLLQMALQIAKGMEYLESK- 121

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLS 290
               +HRD+ A N L+ E+    + DFGL++  D+ + +   +  G    I   APE L 
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 291 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVLLLDHVKKLEREKRLDAIVD 348
            GK + ++DV+ +G++L E+ T         L E+    +   + ++ LE   RL     
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT---------LGEQPYPGMSNEEVLELLEDGYRLPR--- 225

Query: 349 RNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               +N     Y +     M    L C    PEDRP  SE+V  L
Sbjct: 226 ---PENCPDELYEL-----M----LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (346), Expect = 2e-37
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           +     LG+G FGKVY       G  VA+K +   +         RE++++    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL        +  LV  + +   +   L++       L     +         LEYLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK 116

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
               I+HRD+K  N+LLDED    + DFGLA+ +D     +TT V GT  ++APE L   
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171

Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
              +  D++  G++L EL+TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (300), Expect = 6e-31
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 16/219 (7%)

Query: 118 NVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
            +LG+G FG VY  +  D G  +AVK +    +S     A +RE+ ++S   H N++R  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 176 GFCTTPTER-LLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEH 232
           G      +  L ++  ++   S++  L++     EPV+     ++       GL YLH +
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTRQILEGLAYLHSN 120

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLST 291
               I+HRD+K AN+L+D D    + DFG AK + D+     T  VRGT   +APE +  
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 330
            +     D++  G  ++E+ TG+    +S L      L 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (287), Expect = 2e-28
 Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 24/285 (8%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAA-FQREVE-MISVAVHR 169
           ++     LG+G FG+VY     D   VA+K L    ES   +   F RE++ + S+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L  F        LV  ++   S+   L++I    P+ +      +       LEYL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYL 117

Query: 230 HEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVR-----GTMGH 283
           H      IIHRD+K  N+LLD D     + DFGLAKL+    +  +         GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 284 IAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 340
           +APE L   S   +S  +D++  GI L EL+TG    +  +         L  + +L   
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233

Query: 341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
                     L+ +      +    +        P++R + S  +
Sbjct: 234 SLA-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 12/203 (5%)

Query: 114 FSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           F     +G+GGFG+VY+      G +VA+K +   ES         E++++    H N++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +  G      E  +V  F    S    L+++ K     L       V     +GLEYLH 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
           +    IIHRD+KAAN+LL  D E  + DFGL+  +   K   T    GT   +APE ++ 
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVING 171

Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
                + D++  GI  +EL  G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-27
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 37/277 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              +G+G FG V  G    G KVAVK L D +S    A F  E  +++   H NL++L+G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQA-FLAEASVMTTLRHPNLVQLLG 67

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                    +V  +M   S+   LR    G  V+    +   AL    G+EYL E     
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---N 122

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            +HRD+ A NVL+ ED  A V DFGLAK     + +    V+ T    APE L   K S 
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 356
           ++DV+ +GI+L E+ +  R   + R+  +D   ++ HV+                 K Y 
Sbjct: 179 KSDVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVE-----------------KGYR 217

Query: 357 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
           ++  E     + +V   C +  P  RP   ++   L 
Sbjct: 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  107 bits (270), Expect = 9e-27
 Identities = 89/284 (31%), Positives = 135/284 (47%), Gaps = 39/284 (13%)

Query: 118 NVLGQGGFGKVYRGVLADG----TKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRN 170
            V+G+G FG VY G L D        AVK   R+TD E       F +E  ++    H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57

Query: 171 LLRLIGFCTTPTE--RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           +L L+G C  P+E   L+V P+M++  +   +R       V D +      L  A+G+EY
Sbjct: 58  VLSLLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEY 113

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHIA 285
           L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
            E L T K + ++DV+ +G++L EL+T + A  +       DV   D    L + +RL  
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP------DVDSFDITVYLLQGRRL-- 221

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                L   Y     + + +V L C    PE RP  SE+V  +E
Sbjct: 222 -----LQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 1e-24
 Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 40/283 (14%)

Query: 118 NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
            V+G G FG+V RG L    K    VA+K L    S      F  E  ++    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G  T     +++  +M+N S+   LRE    +          +  G A G++YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRGTMGHIAPEY 288
               +HRD+ A N+L++ +    V DFGL++ ++  +   TT+     +R T    APE 
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179

Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
           ++  K +  +DV+ +GI++ E+++ G+R   D S      DV+     K +E   RL   
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPPP 230

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +D              + Q+ L C Q    +RP  S++V  L+
Sbjct: 231 MDCP----------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 38/291 (13%)

Query: 118 NVLGQGGFGKVYRG---VLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
             LG+G FGKV       L D T  +VAVK L         + F+RE+E++    H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 173 RLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +  G C  P  R   L+  ++ + S+   L+  +     ++       +    +G++YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPEY 288
                + IHRD+ A N+L++ +    + DFGLAK++   K     +  G   +   APE 
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAI-----DFSRL--EEEDDVLLLDHVKKLEREK 341
           L T K S  +DV+ +G+ L EL T          +F R+    +  +++   ++ L+  +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 342 RL---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           RL    +  D          EV  +++   LC +A P+DRP+ ++++ +++
Sbjct: 244 RLPRPPSCPD----------EVYDLMK---LCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G FG VY+GVL   T+VAVK  R T    P     F +E E++    H N+++LIG 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
           C       +V   +   S+   LR+ K    V   +   +++L AA G+EYL        
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL---QMSLDAAAGMEYLESKN---C 114

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 292
           IHRD+ A N L+ E+    + DFG+++     +      V   +  I     APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 293 KSSERTDVFGYGIMLLELVTG 313
           + +  +DV+ YGI+L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 5e-24
 Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 22/210 (10%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 170
           N+   +++G+G FG VY+G+ L  G  VA+K+++  +       +  +E++++    H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-----VLDWVTRKRVALGAARG 225
           +++ IG   T     ++  + +N S+    + IK   P     V  +V +        +G
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLR---QIIKKFGPFPESLVAVYVYQ------VLQG 111

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHI 284
           L YLHE     +IHRD+KAAN+L  +D    + DFG+A KL DV K      V GT   +
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           APE +    +S  +D++  G  ++EL+TG 
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  103 bits (259), Expect = 1e-23
 Identities = 69/279 (24%), Positives = 138/279 (49%), Gaps = 28/279 (10%)

Query: 116 EKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLR 173
           E+NV+ +G  G  Y+G  + +G +  VK + D  S P  + A   +++      H N+++
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVK 747

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           LIG C +     L++ +++       L E+      L W  R+++A+G A+ L +LH  C
Sbjct: 748 LIGLCRSEKGAYLIHEYIE----GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRC 800

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
           +P ++  ++    +++D   E  +    L  L+        +       ++APE   T  
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKD 854

Query: 294 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 353
            +E++D++G+G++L+EL+TG+   D    E      +++  +    +  LD  +D ++  
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 354 NYNIQE---VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + ++ +   VE M  +AL CT   P  RP  ++V++ LE
Sbjct: 912 DVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 43/240 (17%)

Query: 119 VLGQGGFGKVYRGV---LADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           VLG G FG VY+GV     +  K  VA+K L +  SP  +     E  +++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 223
           L+G C +     L+   M             P   +LD+V   +  +G+          A
Sbjct: 74  LLGICLSSQ-VQLITQLM-------------PLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
           +G+ YL E    +++HRD+ A NVL+       + DFGLAKL+DV +        G    
Sbjct: 120 KGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVP 174

Query: 284 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 339
           I   A E +     + ++DV+ YG+ + EL+T G +  +     E     + D ++K ER
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGER 229

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 15/203 (7%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLL 172
           F+ +  LG G FG+V+ G+  +  +VA+K L +D      D  FQ+EV+ +    H++L+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L   C+      ++   M+  S+   LR   P   VL   +   +A   A G+ YL E 
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTT-QVRGTMGHIAPEYL 289
                IHRD+ A N+L+ ED    V DFGLA+L+  DV  ++      + T    APE  
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176

Query: 290 STGKSSERTDVFGYGIMLLELVT 312
           S G  S ++DV+ +GI+L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 51/285 (17%)

Query: 120 LGQGGFGKVYRGV--LADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           LG G FG V +GV  +  G   +VAVK L       G   F RE  +++   H  ++RLI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------VALGAARGL 226
           G C          P M        + E+ P  P+L ++ ++R         +A   A G+
Sbjct: 63  GVCKGE-------PLML-------VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGHI 284
            YL        +HRD+ A NVLL    +A + DFG+++ +         TT  R  +   
Sbjct: 109 AYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
           APE ++ GK S ++DV+ YG+ L E  + G +   +  ++  + + +L+  ++L R +  
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEEC 223

Query: 344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                            + +  + L C +  PEDRP  SE+    
Sbjct: 224 P----------------QEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 39/286 (13%)

Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G+          T+VA+K + +  S      F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE---PVLDWVTRKRV---ALGAARGLE 227
           L+G  +T    L+V   M    +   LR  +P     P L   T ++    A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL      K +HRD+ A N ++ ED    +GDFG+ +  D+ +T+   +    +  +   
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
           APE L  G  + ++DV+ +G++L E+ T         L E+         + L  E+ L 
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSNEEVLK 232

Query: 345 AIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            ++D   L+   N  +   ++++  +C Q +P+ RP   E+V  L+
Sbjct: 233 FVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 87/295 (29%), Positives = 136/295 (46%), Gaps = 52/295 (17%)

Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQ-- 157
            WR+ +L          LG G FG VY G+ L DG   AVK   L D    G +A  Q  
Sbjct: 1   RWRKGEL----------LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE 50

Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLREIKP-GEPVLDWV 213
           +E+ ++S   H N+++ +G   T  E   +Y F++ +   S+A  L++     EPV+   
Sbjct: 51  QEIALLSKLQHPNIVQYLG---TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY 107

Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
           TR+ +      GLEYLH   +   +HRD+K AN+L+D +    + DFG+AK V       
Sbjct: 108 TRQILL-----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFS 156

Query: 274 TTQ-VRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 331
             +  +G+   +APE +   G      D++  G  +LE+ TG+    +S+LE    V   
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF-- 212

Query: 332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
               K+ R K L  I D   ++  +           L C Q  P  RP  +E++ 
Sbjct: 213 ----KIGRSKELPPIPDHLSDEAKDF---------ILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 19/217 (8%)

Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           N +G G FGKVY  V L  G  +AVK  R+ D   P        E++++ +  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G       R  VY FM+  S    L E+     +LD    +   L    GL YLH H  
Sbjct: 65  YG---VEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---HIAPEYLST 291
             I+HRD+K AN+ LD +    +GDFG A  +    T +  +V+   G   ++APE ++ 
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 292 GKSSER---TDVFGYGIMLLELVTGQRAIDFSRLEEE 325
           GK        D++  G ++LE+ TG+R   +S L+ E
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.9 bits (232), Expect = 2e-21
 Identities = 66/292 (22%), Positives = 128/292 (43%), Gaps = 54/292 (18%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHR 169
            +     +G+G FGKVY     +DG    +K   L++      + A   EV+++    H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEP-----VLDWVTRKRVALGAA 223
           N+++         +  +V  +     ++ ++++  K G+P     +LDW  +  + L   
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA-- 115

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             L+YLH     KI+HRD+K  N+ L  +    +GDFG++K++     ++   V GT  +
Sbjct: 116 --LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYY 169

Query: 284 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 340
           ++PE L   K  + ++D++  G +L EL T +   +   L E     L   + K +    
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQYPPI 223

Query: 341 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
                  L  +V   L K+                    PE+RP+++++++ 
Sbjct: 224 PSQYSSELRNLVSSLLQKD--------------------PEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 39/281 (13%)

Query: 117 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           K+ LG G +G+VY GV       VAVK L +      +  F +E  ++    H NL++L+
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
           G CT      ++  FM   ++   LRE       ++ V    +A   +  +EYL +    
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK--- 123

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 292
             IHRD+ A N L+ E+    V DFGL++L+     +  T   G    I   APE L+  
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 293 KSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
           K S ++DV+ +G++L E+ T G      ID S++ E     LL+   ++ER +     V 
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKGYRMERPEGCPPKV- 234

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                       E M      C Q +P DRP+ +E+ +  E
Sbjct: 235 -----------YELMRA----CWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 119 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           VLGQG  G VY+      G   A+K++             RE++ +       +++  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                E  +V  +M   S+A  L+++    EPVL ++ R+       +GL+YLH      
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHT--KRH 120

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           IIHRD+K +N+L++   E  + DFG++K+++       T V GT+ +++PE +     S 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179

Query: 297 RTDVFGYGIMLLELVTGQ 314
             D++  G+ LLE   G+
Sbjct: 180 AADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           D    K  LG+G FGKV+ G         D   VAVK L +  S      F+RE E+++ 
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------IKPGEPV--LDWVTR 215
             H N+++  G CT     ++V+ +M++  +   LR           P  P+  L     
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
            ++A+  A G+ YL        +HRD+   N L+  D    +GDFG+++  DV  T+   
Sbjct: 125 LQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDY-Y 178

Query: 276 QVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
           +V G TM  I    PE +   K +  +DV+ +G++L E+ T
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 21/200 (10%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G     TKVAVK L     PG     AF +E +++    H  L++L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 178 CTTPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGA--ARGLEYLHEH 232
           C+      +V  +M   S+   L+     K   P L       V + A  A G+ YL   
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-------VDMAAQIAEGMAYLESR 122

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
                IHRD+ A N+L+ E+    + DFGLA+L++  +       +  +   APE  + G
Sbjct: 123 ---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179

Query: 293 KSSERTDVFGYGIMLLELVT 312
           + + ++DV+ +GI+L E+VT
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 69/293 (23%)

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +LG+G FG+V++G L D T VAVK   +         F  E  ++    H N+++LIG C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----------RVALGAARGLEY 228
              T+R  +Y  M          E+ PG   L ++ +K          + AL AA G+ Y
Sbjct: 62  ---TQRQPIYIVM----------ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108

Query: 229 LH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIA 285
           L  ++C    IHRD+ A N L+ E+    + DFG+++  D  +  ++   Q+   +   A
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTA 162

Query: 286 PEYLSTGKSSERTDVFGYGIMLLEL----------VTGQRAIDFSRLEEEDDVLLLDHVK 335
           PE L+ G+ S  +DV+ YGI+L E           +T Q+A                   
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------------------- 203

Query: 336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
              RE+     V++    +   +  + + +V   C    PE+RP  SE+ + L
Sbjct: 204 ---REQ-----VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 82/279 (29%), Positives = 121/279 (43%), Gaps = 32/279 (11%)

Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLLRLI 175
            V+G G    VY  + L +  KVA+KR+ D E         ++EV+ +S   H N+++  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                  E  LV P++   S+   ++   P    LD      V     +GLEYLH +   
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN--- 121

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
             IHRD+KA N+LL ED    + DFG    LA   D  +    T V GT   +APE +  
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVMEQ 180

Query: 292 GKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL---DHVKKLEREKRLDAIV 347
                 + D++ +GI  +EL TG  A  +S+      VL+L   +    LE         
Sbjct: 181 VHGYDFKADIWSFGITAIELATG--AAPYSKYPPM-KVLMLTLQNDPPSLETGAD----- 232

Query: 348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                K Y+ +    MI    LC Q  P  RP   E+++
Sbjct: 233 ----YKKYS-KSFRKMIS---LCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 11/195 (5%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G+  + T VAVK L     PG      F  E +++    H  L++L   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
           CT      +V   M+  S+   L+        L       +A   A G+ YL        
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGR--ALKLPQLIDMAAQVASGMAYLEAQ---NY 124

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           IHRD+ A NVL+ E+    V DFGLA+++           +  +   APE     + S +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 298 TDVFGYGIMLLELVT 312
           +DV+ +GI+L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 18/197 (9%)

Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G FG+V+ G L AD T VAVK   +   P   A F +E  ++    H N++RLIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKI 237
              T++  +Y  M+ +     L  ++   P L      ++   AA G+EYL  +HC    
Sbjct: 63  ---TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 292
           IHRD+ A N L+ E     + DFG+++     + +      G M  I     APE L+ G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 293 KSSERTDVFGYGIMLLE 309
           + S  +DV+ +GI+L E
Sbjct: 172 RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G+VY+      G  VA+K++  + E  G      RE++++    H N++RL   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 178 CTTPTER--LLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            T+  +    +V+ +M + L+      E+K  E  +     K        GL+YLH +  
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI-----KCYMKQLLEGLQYLHSN-- 119

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 292
             I+HRD+K +N+L++ D    + DFGLA+    R +   T    T+ +  PE L  +T 
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT- 177

Query: 293 KSSERTDVFGYGIMLLELVTG 313
           +     D++  G +L EL  G
Sbjct: 178 RYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 33/273 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K  T  E    +  F  E +++    H  L++L G CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
             +   LV+ FM++  ++  LR  +         T   + L    G+ YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  K S ++D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 300 VFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQE 359
           V+ +G+++ E+        FS               K   E R ++ V   +N  + + +
Sbjct: 184 VWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRLYK 222

Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRML 388
                +++ ++   C +  PEDRP+ S ++  L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA------FQREVEMISVAVHRNL 171
            VLG+G +G VY G+   G  +AVK++ + ++    AA       Q EV+++    H N+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 230
           ++ +G C       +   F+   S++  L    P  EPV    T++ +      G+ YLH
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIA 285
            +C   ++HRD+K  NV+L  +    + DFG A+ +         +N+   + GT   +A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           PE ++      ++D++  G  + E+ TG+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)

Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 172
           LG+G FG+V +            + VAVK L D  +    +    E+EM+  +  H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE----PVLDWVTRKRV--------AL 220
            L+G CT      +V  +  + ++   LR  +P      P       + +        A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQV 277
             ARG+E+L      K IHRD+ A NVL+ ED    + DFGLA+  D+   +    TT  
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 336
           R  +  +APE L     + ++DV+ +G++L E+ T G        +EE     L   +K+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----LFKLLKE 249

Query: 337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             R       +++  N     QE+  ++     C    P  RP   ++V  L+
Sbjct: 250 GYR-------MEKPQNCT---QELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 40/278 (14%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G   + TKVAVK L     PG  +  AF  E  ++    H  L+RL   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            T      ++  +M   S+   L+  + G+ +L     K +   A  A G+ Y+      
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK--- 122

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHRD++AANVL+ E     + DFGLA++++  +       +  +   APE ++ G  +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 296 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 355
            ++DV+ +GI+L E+VT                       K+      ++ V   L + Y
Sbjct: 183 IKSDVWSFGILLYEIVT---------------------YGKIPYPGMSNSDVMSALQRGY 221

Query: 356 NIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
            +  +E     +  +   C +   E+RP    +  +L+
Sbjct: 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 39/298 (13%)

Query: 108 QLATDNFSEKNVLGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVE 161
           ++  D+ +    LG G FG+VY    RG   D  +  VAVK L +  S   ++ F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP--GEP-VLDWVTRKRV 218
           ++S   H+N++RLIG       R ++   M    +   LRE +P    P  L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTT 275
           A   A+G +YL E+     IHRD+ A N LL        A + DFG+A+  D+ + +   
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYR 176

Query: 276 QVRGTMGHIA---PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 332
           +    M  I    PE    G  + +TDV+ +G++L E+ +        R  +E  V+   
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEF- 233

Query: 333 HVKKLEREKRLDAIVDRNL-NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               +    RLD    +      Y I     M      C Q +PEDRP  + ++  ++
Sbjct: 234 ----VTGGGRLDP--PKGCPGPVYRI-----MTD----CWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 39/277 (14%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVA+K L   +      AF  E  ++    H  L+RL    T
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK--QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 180 T-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNPK 236
             P    ++  +M+N S+   L+        +     K + + A  A G+ ++       
Sbjct: 72  QEPI--YIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAEGMAFIERK---N 122

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHRD++AAN+L+ E     + DFGLA+L++  +       +  +   APE ++ G  + 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 356
           ++DV+ +GI+L E+VT  R I +  +   +                    V +NL + Y 
Sbjct: 183 KSDVWSFGILLTEIVTYGR-IPYPGMTNPE--------------------VIQNLERGYR 221

Query: 357 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   +     + ++  LC +  PE+RP    +  +LE
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNL 171
           F+    +G+G FG+VY+ +       VA+K + D E    +    Q+E++ +S      +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +  G     ++  ++  +    S    L+  K  E  + ++ R+ +      GLEYLHE
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHE 116

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+KAAN+LL E+ +  + DFG++  +    +   T V GT   +APE +  
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172

Query: 292 GKSSERTDVFGYGIMLLELVTG 313
               E+ D++  GI  +EL  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 37/275 (13%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V+ G       VA+K +   E    +  F  E +++    H NL++L G CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 180 TPTERLLVYPFMQNLSVAYRLREIK---PGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                 +V  +M N  +   LRE K     E +LD      +       +EYL  +    
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG--- 120

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHRD+ A N L+ ED    V DFGLA+ V   +   +   +  +    PE     + S 
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK---KLEREKRLDAIVDRNLNK 353
           ++DV+ +G+++ E+ +  + + + R    +   +++ V    +L R K            
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYRPK------------ 224

Query: 354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                    +  +   C    PEDRPA  +++  L
Sbjct: 225 ----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 52/240 (21%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +F    V+G+G FGKV      D  K+ A+K +            Q+ VE  SV   RN+
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK----------QKCVEKGSV---RNV 47

Query: 172 LRLIGFCTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVA 219
           L          ER ++    +PF+ NL  +++  E        +  G+  L +   ++V 
Sbjct: 48  LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD--LRYHLSQKVK 96

Query: 220 LGAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
               +           LEYLH      IIHRD+K  N+LLDE     + DF +A    V 
Sbjct: 97  FSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA--TKVT 151

Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
              +TT   GT G++APE L     S   D +  G+   E + G+R          D + 
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 16/201 (7%)

Query: 120 LGQGGFGKVYRGVLADGTKV-AVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+GGFG+V    +    K+ A K+L     +   G+     E +++     R ++ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 233
              T  +  LV   M    + Y +  +  GEP        R    AA+   GLE+LH+  
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFP---EARAIFYAAQIICGLEHLHQR- 114

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
             +I++RD+K  NVLLD+     + D GLA  V+++         GT G++APE L    
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170

Query: 294 SSERTDVFGYGIMLLELVTGQ 314
                D F  G  L E++ G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 82.7 bits (204), Expect = 6e-18
 Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           ++G+G FG V +G    G KVAVK +  D  +     AF  E  +++   H+NL+RL+G 
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLG- 66

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                   +V   M   ++   LR    G  ++  +   + +L  A G+EYL    + K+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKL 121

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N+L+ ED  A V DFGLA++  +   N    V+ T    APE L   K S +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177

Query: 298 TDVFGYGIMLLELVTGQRA 316
           +DV+ YG++L E+ +  RA
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 56/296 (18%)

Query: 119 VLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVE-MISVAV------ 167
           +LG+G FG V  G L+  DG+  KVAVK +        D     E+E  +S A       
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK------LDIHTYSEIEEFLSEAACMKDFD 59

Query: 168 HRNLLRLIGFCTTPTER------LLVYPFMQNLSV-AYRLREIKPGEPV-LDWVTRKRVA 219
           H N+++LIG C   +        +++ PFM++  + ++ L     G P  L   T  +  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTT 275
           +  A G+EYL    N   IHRD+ A N +L ED    V DFGL+K +      R+  +  
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA- 175

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 334
             +  +  IA E L+    + ++DV+ +G+ + E+ T GQ    +  +E  +    L H 
Sbjct: 176 --KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHG 231

Query: 335 KKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            +L++ E  LD + D              M      C +A P+DRP  +++  +LE
Sbjct: 232 NRLKQPEDCLDELYD-------------LMYS----CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 35/284 (12%)

Query: 115 SEKNVLGQGGFGKVYRGVL-ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           +++ V+G G FG+V+RG+L   G K   VA+K L    +      F  E  ++    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYL 229
           ++RL G  T     +++  +M+N ++   LR+   GE      V   R   G A G++YL
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIAAGMKYL 123

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPE 287
            +      +HRD+ A N+L++ + E  V DFGL++++  D   T  T+  +  +   APE
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 288 YLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDA 345
            ++  K +  +DV+ +GI++ E+++ G+R   D S  E          +K +    RL A
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---------MKAINDGFRLPA 231

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            +D              + Q+ L C Q     RP   ++V +L+
Sbjct: 232 PMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 28/221 (12%)

Query: 119 VLGQGGFGKVYRGVLAD-GTKVAVKR--LTDFESPGGD-------AAFQREVEMISVAVH 168
           ++G+G +G+VY  +    G  +AVK+  L    +   D        A + E+E +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARG 225
            N+++ +GF TT     +   ++   S+   LR    G   E ++ + T + +      G
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVL-----EG 120

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHI 284
           L YLH   +  I+HRD+KA N+L+D D    + DFG++K   D+   +    ++G++  +
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 285 APEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLE 323
           APE + +     S + D++  G ++LE+  G+R   +S  E
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 18/209 (8%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGD---AAFQREVEMISVAV 167
           N+    +LGQG FG+VY     D G ++AVK++  D +SP       A + E++++    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 225
           H    R++ +     +   +  FM+ +       ++K    + + VTRK  R  L    G
Sbjct: 63  HE---RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EG 116

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 283
           +EYLH +    I+HRD+K AN+L D      +GDFG +K +    ++ T    V GT   
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           ++PE +S      + DV+  G  ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)

Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-------VRGT 280
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+   +       VR  
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW- 187

Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 340
              +APE L  G  +  +D++ +G++L E+         + L E+         + L  E
Sbjct: 188 ---MAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNE 228

Query: 341 KRLDAIVDRN-LNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + L  ++D   L++  N  E V  +++   +C Q +P+ RP   E+V +L+
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
            + +     +G+G  G+VY+    A G +VA+K++        +     E+ ++    H 
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR--EIKPGEPVLDWVTRKRVALGAARGLE 227
           N++          E  +V  +M   S+   +    ++  EP + +V R+ +     +GLE
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLE 130

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH      +IHRD+K+ N+LL +D    + DFG A  +   K+   + V GT   +APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +       + D++  GIM +E+  G+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 31/214 (14%)

Query: 119 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDA-----------AFQREVEMISVA 166
           ++G G FG VY G+ A  G  +AVK++   E P   A           A  RE+ ++   
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV---ELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 167 VHRNLLRLIGFCTTPTERLLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 224
            H N+++ +G  +   + L ++  ++   SVA  L       E ++    R+ +     +
Sbjct: 64  QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----K 117

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRG 279
           GL YLH   N  IIHRD+K AN+L+D      + DFG++K ++    +  T      ++G
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++  +APE +     + + D++  G +++E++TG
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           F     LG+G +G VY+ +    G  VA+K +             +E+ ++       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  +V   M+          +K     L       +     +GLEYLH +
Sbjct: 62  KYYGSYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVRGTMGHIAPEYLS 290
              K IHRD+KA N+LL+E+ +A + DFG++ +L D + K N    V GT   +APE + 
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQ 172

Query: 291 TGKSSERTDVFGYGIMLLELVTG 313
               + + D++  GI  +E+  G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 159
           E+ L+   F E+  LG+G FGKVY+G L         T VA+K L +   P     F++E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------- 209
            E++S   H N++ L+G CT      +++ ++ +  +   L    P   V          
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 210 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 266
             LD      +A+  A G+EYL  H     +HRD+ A N L+ E     + DFGL++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 267 --DVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
             D  +  +     VR     + PE +  GK +  +D++ +G++L E+
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 20/221 (9%)

Query: 119 VLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           VLG G FG VY+G+ + +G  V    A+K L +   P  +  F  E  +++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 174 LIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           L+G C +PT +L+  + P    L   +  ++    + +L+W  +       A+G+ YL E
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 289
               +++HRD+ A NVL+       + DFGLA+L+  D ++ N     +  +  +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECI 183

Query: 290 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 329
              K + ++DV+ YG+ + EL+T G +  D     E  D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 30/276 (10%)

Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           LG G FG V RG           VAVK L   +       F +E  ++    H NL+RL 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
           G   T    ++V       S+  RLR  K         T    A+  A G+ YL      
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEYLSTGK 293
           + IHRD+ A N+LL  D +  +GDFGL + +   + +   +  ++      APE L T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 294 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 352
            S  +DV+ +G+ L E+ T G+    ++ L     +  +D  K+ ER +R +A       
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKKID--KEGERLERPEACPQD--- 229

Query: 353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
             YN+     M+Q    C   +P DRP  + +   L
Sbjct: 230 -IYNV-----MLQ----CWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 49/297 (16%)

Query: 120 LGQGGFGKVYR----GVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           +GQG FG+V++    G+L     T VAVK L +  S    A FQRE  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 174 LIGFCTTPTERLLVYPFM----------------QNLSVAYRLREIKPGEPVLDWVTRKR 217
           L+G C       L++ +M                Q           K G   L     ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 218 VALGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTN 272
           + +    A G+ YL E    K +HRD+   N L+ E+    + DFGL++     D  K +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 332
               +   +  + PE +   + +  +DV+ YG++L E+ +      +    EE       
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------- 240

Query: 333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            V    R+  + +  D    + YN+           LC    P DRP+ + + R+L+
Sbjct: 241 -VIYYVRDGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 73/231 (31%), Positives = 110/231 (47%), Gaps = 27/231 (11%)

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA---AFQREVEMISVAVHRNLLRLI 175
            +G+G FG V  G    G KVAVK + +      DA   AF  E  +++   H NL++L+
Sbjct: 13  TIGKGEFGDVMLGDY-RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 176 GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
           G        L +V  +M   S+   LR    G  VL      + +L     +EYL  +  
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 294
              +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K 
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176

Query: 295 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           S ++DV+ +GI+L E+ +  R + + R+       L D V ++E+  ++DA
Sbjct: 177 STKSDVWSFGILLWEIYSFGR-VPYPRIP------LKDVVPRVEKGYKMDA 220

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 42/294 (14%)

Query: 113 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           N  E   LG+G FG+V+             T V VK L   +     + F+RE++M    
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 167 VHRNLLRLIGFC--TTPTERLLVYPFMQNLS---VAYRLREIKPGEPVLDWVTRKRVALG 221
            H+N++RL+G C    P   +L Y  + +L     A + ++ K   P L    +  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            A G+++L    N + +HRD+ A N L+    E  V    L+K V   +          +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 340
             +APE +     S ++DV+ +G+++ E+ T Q  + F  L +E +VL      KLE   
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-EVLNRLQAGKLELPV 240

Query: 341 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                 RL  ++ R                    C   +P+DRP+ SE+V  L 
Sbjct: 241 PEGCPSRLYKLMTR--------------------CWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 33/219 (15%)

Query: 120 LGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 167
           LG+G FG+V   V+A+              VAVK L D  +    +    E+EM+  +  
Sbjct: 20  LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 168 HRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG-----------EPVLDWVT 214
           H+N++ L+G CT   P   L+ Y    NL    R R   PG           E  L +  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLPEEQLTFKD 135

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNV 273
               A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA+ V ++     
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 9e-17
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 39/283 (13%)

Query: 119 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V RG L    K    VA+K L    +      F  E  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     +++  FM+N ++   LR+      V+  V   R   G A G++YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHI-----APEY 288
              +HRD+ A N+L++ +    V DFGL++ ++   ++ T T   G  G I     APE 
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEA 182

Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
           ++  K +  +DV+ YGI++ E+++ G+R   D S           D +  +E++ RL   
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDVINAIEQDYRLPPP 233

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +D              + Q+ L C Q     RP   ++V  L+
Sbjct: 234 MDCP----------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 33/275 (12%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH---RNLLR 173
           ++G+G +G VYRG  +  G  VA+K + + ++P  D +  QREV ++S        N+ +
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
             G         ++  + +  SV   ++     E  +  + R+ +       L+Y+H+  
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
              +IHRD+KAAN+L+       + DFG+A L++   +  +T V GT   +APE ++ GK
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177

Query: 294 SSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 352
             + + D++  GI + E+ TG     +S ++    ++L+   K      RL+   D   +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLE---DNGYS 228

Query: 353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
           K         + +    C    P++R +  E+++ 
Sbjct: 229 K--------LLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)

Query: 118 NVLGQGGFGKVYRG----VLADGT---KVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           N LG G FG+VY G    +L  G+   +VAVK L    +      F +E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 171 LLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           +++L+G C     + ++   M+    LS     R  + G P+L       + L  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 228 YLHEHCNPKIIHRDVKAANVLLDE---DFEAVV--GDFGLAKLVDVRKTNVTTQVRGT-- 280
           YL +      IHRD+ A N L+ E   D + VV  GDFGLA+  D+ K++   +  G   
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYY-RKEGEGL 174

Query: 281 --MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             +  +APE L  GK + ++DV+ +G+++ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 33/274 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+       TKVAVK +     PG  +  AF  E  ++    H  L++L   
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
             T     ++  FM   S+   L+  +  +  L     K +   A  A G+ ++ +    
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR--- 121

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHRD++AAN+L+       + DFGLA++++  +       +  +   APE ++ G  +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 296 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 355
            ++DV+ +GI+L+E+VT  R I +  +   + +  L+   ++ R +              
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229

Query: 356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E +  + + C +  PE+RP    +  +L+
Sbjct: 230 -----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 40/111 (36%), Positives = 66/111 (59%), Gaps = 14/111 (12%)

Query: 206 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-K 264
            E +L      ++A+   +GL YLHE    KIIHRDVK +N+L++   +  + DFG++ +
Sbjct: 98  PERIL-----GKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150

Query: 265 LVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           LV+ + KT V     GT  ++APE +     S ++D++  G+ L+EL TG+
Sbjct: 151 LVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 38/230 (16%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREV 160
           W +++        ++V+G+G FG+V +  +  DG ++  A+KR+ ++ S      F  E+
Sbjct: 6   WNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58

Query: 161 EMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKR 217
           E++  +  H N++ L+G C       L   +    NL    R   +   +P         
Sbjct: 59  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118

Query: 218 VALGA----------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
             L +          ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 268 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           V        V+ TMG +     A E L+    +  +DV+ YG++L E+V+
Sbjct: 176 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 31/273 (11%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G     TKVAVK L     PG     +F  E +++    H  L++L   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            +       +Y   + +S    L  +K GE   L       +A   A G+ Y+ E  N  
Sbjct: 70  VS----EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN-- 122

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHRD+++AN+L+ +     + DFGLA+L++  +       +  +   APE    G+ + 
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 356
           ++DV+ +GI+L ELVT  R + +  +    +VL     +++ER  R+    D  ++ +  
Sbjct: 183 KSDVWSFGILLTELVTKGR-VPYPGMNNR-EVL-----EQVERGYRMPCPQDCPISLH-- 233

Query: 357 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               E M+Q    C +  PE+RP    +   LE
Sbjct: 234 ----ELMLQ----CWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 74/285 (25%), Positives = 136/285 (47%), Gaps = 45/285 (15%)

Query: 120 LGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           LGQG FG VY G+ A G       T+VA+K + +  S      F  E  ++      +++
Sbjct: 14  LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGA---ARGL 226
           RL+G  +     L++   M    +   LR ++P     PV    + K++   A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---- 282
            YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+ +T+     +G  G    
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPV 185

Query: 283 -HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 341
             ++PE L  G  +  +DV+ +G++L E+ T         L E+         + +  E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP-------YQGMSNEQ 229

Query: 342 RLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
            L  +++   L+K  N  ++  + ++  +C Q +P+ RP+  E++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 51/292 (17%)

Query: 120 LGQGGFGKVYRGVLADGT---KVAVKRL-------TDFESPGGDAAFQREVEMISVAVHR 169
           LG+G FG V  G L       KVAVK +       ++ E    +A   +E +      H 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HP 60

Query: 170 NLLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA- 222
           N++RLIG C    E       +++ PFM++  +   L   + G+      T+  V     
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 223 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVR 278
            A G+EYL    +   IHRD+ A N +L+E+    V DFGL+K +   D  +     ++ 
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM- 176

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 337
             +  IA E L+    + ++DV+ +G+ + E+ T GQ    +  +E  +   + D++++ 
Sbjct: 177 -PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQG 230

Query: 338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            R K+    +D              +  +   C   +P+DRP+   +   LE
Sbjct: 231 NRLKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 42/232 (18%)

Query: 119 VLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVE-MISVAV--HRN 170
           +LG G FG V++G+ + +G      VA+K + D     G   FQ   + M+++    H  
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------- 222
           ++RL+G C   + +L+               ++ P   +LD V + R +L          
Sbjct: 71  IVRLLGICPGASLQLVT--------------QLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116

Query: 223 --ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVR 278
             A+G+ YL EH    ++HR++ A N+LL  D    + DFG+A L+  D +K    ++ +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY-FYSEHK 172

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 329
             +  +A E +  G+ + ++DV+ YG+ + E+++ G       R  E  D+L
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAF-QREVEMISVAV 167
           +++     +G G +G VY+   +A G  VA+K  +L     PG D    Q+E+ M+    
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECR 58

Query: 168 HRNLLRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
           H N++   G      +  +V  +    +L   Y++      E  + +V R+       +G
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKG 113

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTM 281
           L YLHE      IHRD+K AN+LL ED +  + DFG++  +      RK+ +     GT 
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTP 165

Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 314
             +APE       G    + D++  GI  +EL   Q
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 119 VLGQGGFGKV--YRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           VLG+G FGKV  Y    A DGT   VAVK L         + +++E+ ++    H N+++
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARG 225
             G C+    + L             + E  P   + D++ + ++ L            G
Sbjct: 71  YKGCCSEQGGKGLQL-----------IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEG 119

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGH 283
           + YLH       IHRD+ A NVLLD D    +GDFGLAK V        V       +  
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            A E L   K S  +DV+ +G+ L EL+T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G K    VA+K L +  SP  +     E  ++
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGT 280
            A+G+ YL E    +++HRD+ A NVL+       + DFGLAKL+    K       +  
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           +  +A E +     + ++DV+ YG+ + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 23/204 (11%)

Query: 120 LGQGGFGKVYRGV--LADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLI 175
           LG+G FGKV   V     G   A+K L   +            E  ++S   H  +++L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 176 -GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLH 230
             F T   E+L LV  +     +   L +    E        +R    AA     LEYLH
Sbjct: 60  YAFQTE--EKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYLH 110

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
                 II+RD+K  N+LLD D    + DFGLAK +    +   T   GT  ++APE L 
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166

Query: 291 TGKSSERTDVFGYGIMLLELVTGQ 314
                +  D +  G++L E++TG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G VY+      G  VA+K++   FES G      RE++++    H N+++L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 178 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                +  LV+ FM  +L      + IK  +  L     K       +GL + H H    
Sbjct: 67  FRHKGDLYLVFEFMDTDL-----YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-S 295
           I+HRD+K  N+L++ +    + DFGLA+         T  V  T  + APE L   K  S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177

Query: 296 ERTDVFGYGIMLLELVTGQ 314
              D++  G +  EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 52/284 (18%)

Query: 119 VLGQGGFGKVYRGVLA-DGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           VLG G FG VY+G+   DG      VA+K L +  SP  +     E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 223
           L+G C T T +L+               ++ P   +LD+V   +  +G+          A
Sbjct: 74  LLGICLTSTVQLVT--------------QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA 119

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMG 282
           +G+ YL E    +++HRD+ A NVL+       + DFGLA+L+D+ +T       +  + 
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 341
            +A E +   + + ++DV+ YG+ + EL+T G +  D     E  D+L     +K ER  
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-----EKGER-- 229

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
                    L +         MI V   C     E RP   E+V
Sbjct: 230 ---------LPQPPICTIDVYMIMVK--CWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLL 172
           LG+G FGKV+           D   VAVK L +  ES   D  FQRE E+++V  H++++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 222
           R  G CT     L+V+ +M++  +   LR   P   +L     + VA G           
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA--GGEDVAPGQLTLGQMLAIA 128

Query: 223 ---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
              A G+ YL    +   +HRD+   N L+ +     +GDFG+++  D+  T+       
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGR 183

Query: 280 TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
           TM  I    PE +   K +  +D++ +G++L E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 37/233 (15%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           ++  D       LG+G FG+V   V+A+            TKVAVK L    +    +  
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL 70

Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG------- 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG       
Sbjct: 71  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYCYNP 129

Query: 207 --EPVLDWVTRKRV--ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
              P      +  V  A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGL
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 186

Query: 263 AK---LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           A+    +D  K   TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 187 ARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67

Query: 178 CTTPTERL-LVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCN 234
                E + +V  +M   S    L +   GE    L       +A   A G+ Y+ E  N
Sbjct: 68  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 294
              +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ 
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 295 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 354
           + ++DV+ +GI+L EL T  R      +  E    +LD V   ER  R+    +      
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV---ERGYRMPCPPECP---- 229

Query: 355 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                 E++  +   C +  PE+RP    +   LE
Sbjct: 230 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 47/298 (15%)

Query: 119 VLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
            LG+G FGKV +         A  T VAVK L +  S         E  ++    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------------PGEPVLDW 212
           +L G C+     LL+  + +  S+   LRE +                    P E  L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 A   +RG++YL E    K++HRD+ A NVL+ E  +  + DFGL++ V    + 
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 273 VT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 331
           V  ++ R  +  +A E L     + ++DV+ +G++L E+VT      +  +  E    LL
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNLL 242

Query: 332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               ++ER +                   E M  + L C +  P+ RP  +++ + LE
Sbjct: 243 KTGYRMERPENCS----------------EEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 16/209 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 167
           N+    +LGQG FG+VY    AD G ++AVK++  D ESP       A + E++++   +
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 225
           H  +++  G    P ER L   FM+++       ++K    + + VTRK  R  L    G
Sbjct: 63  HERIVQYYGCLRDPMERTLSI-FMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EG 118

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 283
           + YLH +    I+HRD+K AN+L D      +GDFG +K +     + T    V GT   
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           ++PE +S      + D++  G  ++E++T
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 18/213 (8%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ----REVEMISVAVH 168
           +F   N +G+G FG V++ V     +V   +  D      +   +     E  +++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDS 58

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRVALGAARG 225
             ++R         +  +V  + +N  +   L+  + G P+ +   W    R  +    G
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVW----RFFIQILLG 113

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L +LH     KI+HRD+K+ N+ LD      +GD G+AKL+    TN    + GT  +++
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLS 169

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           PE       +E++DV+  G++L E  TG+   D
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 120 LGQGGFGKVYR----GVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRN 170
           LG+G FG+V R    G+          VAVK L D  +    A    E+E++ +   H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRK-----------RV 218
           ++ L+G CT      ++  +    ++   LR  +P  P   + +T+              
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQV 277
           A   ARG+EYL      + IHRD+ A NVL+ ED    + DFGLA+ V D+     T+  
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           R  +  +APE L     + ++DV+ +GI++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 57/230 (24%)

Query: 117 KNVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 172
           ++V+G+G FG+V R ++  DG K+  A+K L +F S      F  E+E++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 218
            L+G C             +N    Y   E  P   +LD++ + RV              
Sbjct: 67  NLLGAC-------------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113

Query: 219 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                      A   A G++YL E    + IHRD+ A NVL+ E+  + + DFGL++  +
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE 170

Query: 268 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           V        V+ TMG +     A E L+    + ++DV+ +G++L E+V+
Sbjct: 171 V-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     KV   ++ D E    +    Q+E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++   M+ L     L  ++PG   LD      +     +GL+YLH  
Sbjct: 66  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 286
              K IHRD+KAANVLL E  E  + DFG+A +L D       TQ++     GT   +AP
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAP 170

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E +       + D++  GI  +EL  G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 74/284 (26%), Positives = 114/284 (40%), Gaps = 34/284 (11%)

Query: 120 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           +G G FGKV  G    G   A   VK L    +P     F +EV+      H N+L+ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 177 FCTTPTERLLVYPF--MQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
            C      LLV  F  + +L    R  R +            +R+A   A GL +LH+  
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA--QKDVLQRMACEVASGLLWLHQA- 119

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIAPEY--- 288
               IH D+   N  L  D    +GD+GLA L    +    T       +  +APE    
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 289 ----LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
               L     +++++++  G+ + EL T      +  L +E    +L  V + E++ +L 
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAA-DQPYPDLSDEQ---VLKQVVR-EQDIKLP 231

Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                 L+  Y+ +  E M    L      PE RP   EV  +L
Sbjct: 232 ---KPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     TKVA+K L     PG     AF +E +++    H  L+ L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            +       +Y   + +     L  +K G+   L       +A   A G+ Y+ E  N  
Sbjct: 70  VSEEP----IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN-- 122

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHRD++AAN+L+ ++    + DFGLA+L++  +       +  +   APE    G+ + 
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 297 RTDVFGYGIMLLELVTGQR 315
           ++DV+ +GI+L ELVT  R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 52/296 (17%)

Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR--------- 224
            G C +   R L            RL  E  P   + D++ + R  L   +         
Sbjct: 71  KGVCYSAGRRNL------------RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 225 -GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--M 281
            G+EYL      + +HRD+   N+L++ +    +GDFGL K++   K     +  G   +
Sbjct: 119 KGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-----GQRAIDFSRL--EEEDDVLLLDH- 333
              APE L+  K S  +DV+ +G++L EL T          +F R+   ++   +++ H 
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235

Query: 334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           ++ L+   RL A             E+  ++     C    P  RP+ SE+   +E
Sbjct: 236 IELLKNNGRLPAPPGCP-------AEIYAIM---KECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 34/224 (15%)

Query: 114 FSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRL-------TDFESPGGDAAFQREVEM 162
           F+   +LG+G FG V    L   DG+  KVAVK L       +D E    +AA  +E + 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD- 59

Query: 163 ISVAVHRNLLRLIGFC--TTPTERL----LVYPFMQNLSVAYRLREIKPGE-PV-LDWVT 214
                H N+++LIG    +    RL    ++ PFM++  +   L   + GE P  L   T
Sbjct: 60  -----HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKT 271
             R  +  A G+EYL    +   IHRD+ A N +L+E+    V DFGL+K +   D  + 
Sbjct: 115 LVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQ 314
              +++   +  +A E L+    +  +DV+ +G+ + E++T GQ
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREV 160
           EL L+   F E+  LG+  FGK+Y+G L          VA+K L D  +P     FQ+E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV----------- 209
            +++   H N++ L+G  T      +++ ++    +   L    P   V           
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 210 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LV 266
             LD      +A+  A G+EYL  H     +H+D+ A N+L+ E     + D GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
                 V  +    +  + PE +  GK S  +D++ +G++L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 119 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     ++V  +M+N S+   LR+      V+  V   R   G A G++YL +   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
              +HRD+ A N+L++ +    V DFGL++++  D      T   +  +   APE ++  
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 293 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
           K +  +DV+ YGI++ E+++ G+R   +  +  +      D +K +E   RL A +D   
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ------DVIKAIEEGYRLPAPMDCPA 236

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                      + Q+ L C Q    +RP   ++V +L+
Sbjct: 237 ----------ALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 57/229 (24%)

Query: 118 NVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLR 173
           +V+G+G FG+V +  +  DG ++  A+KR+ ++ S      F  E+E++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV--------------- 218
           L+G C             ++    Y   E  P   +LD++ + RV               
Sbjct: 61  LLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 107

Query: 219 ----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
                     A   ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +V
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164

Query: 269 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
                   V+ TMG +     A E L+    +  +DV+ YG++L E+V+
Sbjct: 165 -------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           +   E + LG+G  G V +  L +   + A+K +T   +P       RE+E+        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 171 LLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAA 223
           +++  G     +   +     + +  S+    +++K      GE VL      ++A    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMG 282
           +GL YLH     KIIHRD+K +N+LL    +  + DFG++ +LV+      T    GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE +     S  +DV+  G+ LLE+   
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 172
           F++   +G+G FG+VY+G+     +V   ++ D E    +    Q+E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYL 229
           R  G     T+  ++   M+ L     L  +KPG   E  +  + R+ +     +GL+YL
Sbjct: 66  RYYGSYLKGTKLWII---MEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYL 117

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H     + IHRD+KAANVLL E  +  + DFG+A  +   +    T V GT   +APE +
Sbjct: 118 HSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173

Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
                  + D++  GI  +EL  G+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 35/275 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
                 +V  +M N  +   LRE     +P       K V      G+ YL      + I
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC----EGMAYLESK---QFI 122

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQ--VRGTMGHIAPEYLSTGKS 294
           HRD+ A N L+D+     V DFGL++ V  D   ++V ++  VR +     PE L   K 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKF 178

Query: 295 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 354
           S ++DV+ +G+++ E+ +  + + + R    + V  +    +L R               
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPH------------- 224

Query: 355 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                 E +  +   C     E+RP   +++  +E
Sbjct: 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAV 167
            T  F    V+G+G +GKVY+      G  VA+K + D      +   + E  ++   + 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDII-EDEEEEIKEEYNILRKYSN 61

Query: 168 HRNLLRLIG--FCTTPT----ERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTRK 216
           H N+    G      P     +  LV       SV       R +  +  E  + ++ R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR- 120

Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVT 274
                  RGL YLHE+   K+IHRD+K  N+LL ++ E  + DFG++  +D  + + N  
Sbjct: 121 ----ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173

Query: 275 TQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 314
               GT   +APE ++  +  +     R+DV+  GI  +EL  G+
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           D  +  ++L +G FG+++ G+L D       +V VK + D  S        +E  ++   
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 167 VHRNLLRLIGFCTTPTERLLV-YPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGA- 222
            H+N+L ++  C    E   V YP+M   NL +  +   +          T++ V +   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 223 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---------LVDVRKTN 272
            A G+ YLH+     +IH+D+ A N ++DE+ +  + D  L++         L D    N
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----N 178

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
               V+     +A E L   + S  +DV+ +G++L EL+T
Sbjct: 179 ENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 48/283 (16%)

Query: 119 VLGQGGFGK--VYRGVLADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           VLG+G FG+  +YR    D + V  K   LT         A   E+ ++S+  H N++  
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAY 64

Query: 175 IG-FCTTPTERLLV---YPFMQNLS--VAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
              F    T  LL+   Y     L   +  +  ++   E VL ++ +   A+       Y
Sbjct: 65  YNHFMDDNT--LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS------Y 116

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           +H+     I+HRD+K  N+ L +     +GDFG++K++    +   T V GT  +++PE 
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPEL 172

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
               K + ++D++  G +L EL+T +R  D +                         +V 
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVV 211

Query: 349 RNLNKNYN-IQEVET--MIQVALLCTQASPEDRPAMSEVVRML 388
           + +  NY  +  V +  +I +     Q  PE RP   EV+   
Sbjct: 212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 17/179 (9%)

Query: 134 ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI-GFCTTPTERLLVYPFMQ 192
               KV VK +T  ++PG      RE++++    HR ++ LI  +    T  +++  +  
Sbjct: 117 EQRKKVIVKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 252
           +L   +   +     P+   +T +R  L A   L YLH      IIHRDVK  N+ LDE 
Sbjct: 171 DL---FTYVDRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLDEP 221

Query: 253 FEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
             AV+GDFG A KL     T       GT+   +PE L+      +TD++  G++L E+
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 26/203 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FGKVY+    +    A  ++   ES      F  E++++S   H N++ L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
              +  ++  F    ++   + E++ G  EP + +V R+ +       L +LH H   K+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---KV 124

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVTTQVR----GTMGHIAPEYLSTG 292
           IHRD+KA N+LL  D +  + DFG+ AK         T Q R    GT   +APE ++  
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKS------TLQKRDTFIGTPYWMAPEVVACE 178

Query: 293 KSSE-----RTDVFGYGIMLLEL 310
              +     + D++  GI L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 114 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 168
           F++   +G G FG VY  R V  +   VA+K+++ +     +  +Q   +EV  +    H
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 226
            N +   G         LV  +   L  A  + E+  KP    L  V    +  GA +GL
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYC--LGSASDILEVHKKP----LQEVEIAAICHGALQGL 128

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
            YLH H     IHRD+KA N+LL E     + DFG A LV    + V     GT   +AP
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180

Query: 287 EY---LSTGKSSERTDVFGYGIMLLEL 310
           E    +  G+   + DV+  GI  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           + + D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIK-----------P 205
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R              P
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 206 GEPVL--DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
            E +   D V+        ARG+EYL    + K IHRD+ A NVL+ E+    + DFGLA
Sbjct: 131 DEQMTFKDLVS---CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184

Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + V ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)

Query: 113 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDA-----AFQREVEMISV 165
            + +   LG G F   Y  R V   GT +AVK++T   +   +      A ++E+ +++ 
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 224
             H +++R++G     +   L   +M   SV++ L +     E V+   T +       R
Sbjct: 60  LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-----LLR 114

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNV---TTQVRGT 280
           GL YLHE+   +IIHRDVK AN+L+D   + + + DFG A  +  + T       Q+ GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 281 MGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 314
           +  +APE L     G+S    DV+  G +++E+ T +
Sbjct: 172 IAFMAPEVLRGEQYGRSC---DVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 24/189 (12%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG-DAAFQREVEM---ISVAVH 168
           + E   +G+G +G VY+   L  G  VA+K++    S  G   +  RE+ +   +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 169 RNLLRLIGFCTTP-TER----LLVYPFM-QNLSVAYRLREIKPG--EPVLDWVTRKRVAL 220
            N++RL+  C  P T+R     LV+  + Q+L+  Y  +  KPG     +  + R+ +  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT-YLSKCPKPGLPPETIKDLMRQLL-- 117

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
              RG+++LH H    I+HRD+K  N+L+  D +  + DFGLA++    +  +T+ V  T
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-T 169

Query: 281 MGHIAPEYL 289
           + + APE L
Sbjct: 170 LWYRAPEVL 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 34/225 (15%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF----QREV 160
           E +   D   E+ VLG+G +G VY    L+   ++A+K     E P  D+ +      E+
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEI 56

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLRE----IKPGEPVLDWV 213
            + S   HRN+++ +G  +   E      FM+ +   S++  LR     +K  E  + + 
Sbjct: 57  ALHSYLKHRNIVQYLGSDS---ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113

Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKT 271
           T++ +      GL+YLH++   +I+HRD+K  NVL++  +  VV   DFG +K +     
Sbjct: 114 TKQIL-----EGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGIN 163

Query: 272 NVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQ 314
             T    GT+ ++APE +  G        D++  G  ++E+ TG+
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 70.2 bits (173), Expect = 2e-13
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 171
           + +   LG+G +G VY+      G  VA+K++  D E  G  +   RE+ ++    H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++L+    T  +  LV+ +         L++ +      L     K +     RGL Y H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL- 289
            H   +I+HRD+K  N+L++ D    + DFGLA+   +     T +V  T+ + APE L 
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILL 171

Query: 290 -----STGKSSERTDVFGYGIMLLELVTGQ 314
                ST       D++  G +  E++TG+
Sbjct: 172 GSKHYSTA-----VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISVAVHRNLLR 173
           LG+G +  VY+      G  VA+K++   E           A  RE++++    H N++ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66

Query: 174 LIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           L+      +   LV+ FM+ +L        IK    VL     K   L   RGLEYLH +
Sbjct: 67  LLDVFGHKSNINLVFEFMETDLEKV-----IKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
               I+HRD+K  N+L+  D    + DFGLA+        +T QV  T  + APE L
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 113 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           N   K  LG+G FGKV+           D   VAVK L D  S      F RE E+++  
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNL 64

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRK--R 217
            H ++++  G C      ++V+ +M++  +   LR   P       G    +    +   
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
           +A   A G+ YL    +   +HRD+   N L+ E+    +GDFG+++  DV  T+     
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVG 179

Query: 278 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
             TM  I    PE +   K +  +DV+  G++L E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 33/273 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V+ G      KVA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNP 235
                 +V  FM+N  +   LR+ + G         K + L   +    G+EYL  +   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ-RQG------KLSKDMLLSMCQDVCEGMEYLERN--- 119

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHRD+ A N L+       V DFG+ + V   +   ++  +  +    PE  +  K S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 296 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 355
            ++DV+ +G+++ E+ T  + + F +    + V ++    +L R K     V        
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKLASMTV-------- 230

Query: 356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                    +V   C    PE RP  +E++R +
Sbjct: 231 --------YEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           NF +   LG+G +  VY+G     G  VA+K +      G  +   RE+ ++    H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 172 LRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +RL     T  + +LV+ +M ++L    +  +       LD  T K       +G+ + H
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLK---KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
           E+   +++HRD+K  N+L+++  E  + DFGLA+   +     + +V  T+ + AP+ L 
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 291 TGKS-SERTDVFGYGIMLLELVTG 313
             ++ S   D++  G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 61/278 (21%), Positives = 121/278 (43%), Gaps = 22/278 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 169
           NF  +  +G+G F +VYR   L DG  VA+K++  F+     A     +E++++    H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++         E  +V        ++  ++  K  + ++   T  +  +     LE++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H     +++HRD+K ANV +       +GD GL +     KT     + GT  +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
                + ++D++  G +L E+   Q           D + L    KK+E+          
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEQCDY------P 226

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
            L  ++  +E+  ++    +C    PE RP ++ V  +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 120 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 173
           +G+G +GKV+  R +   G  VA+KR+       G   +  REV ++       H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 174 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L   CT       T+  LV+  +      Y  +  +PG P     T K +     RGL++
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H   +++HRD+K  N+L+    +  + DFGLA++   +     T V  T+ + APE 
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180

Query: 289 LSTGKSSERTDVFGYGIMLLEL 310
           L     +   D++  G +  E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 35/178 (19%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRN 170
               K  LG+G FG+VY+   +  G  VA+K++    E  G      RE++++    H N
Sbjct: 11  EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68

Query: 171 LLRLI--------GFCTTPTERLLVYPFM--------QNLSVAYRLREIKPGEPVLDWVT 214
           ++ LI                  +V P+M        +N SV     +IK          
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK---------- 118

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                L    G+ YLHE+    I+HRD+KAAN+L+D      + DFGLA+  D    N
Sbjct: 119 --CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 48/222 (21%)

Query: 117 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLR 173
              +G G +G V   V    G KVA+K++++      DA     RE++++    H N++ 
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIG 63

Query: 174 LIGFCTTPTERL------LVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRV------AL 220
           L+     P          +V   M+ +L   +++  IK  +P+    T   +       L
Sbjct: 64  LLDI-LRPPSPEDFNDVYIVTELMETDL---HKV--IKSPQPL----TDDHIQYFLYQIL 113

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQV 277
              RGL+YLH   N  +IHRD+K +N+L++ + +  + DFGLA+ VD     K  +T  V
Sbjct: 114 ---RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 278 -----RGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 313
                R      APE  LS+ + ++  D++  G +  EL+T 
Sbjct: 168 VTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 31/148 (20%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-------TTQV 277
            LEYLH +    IIHRD+K  N+L+D +    + DFGL+K+  VR+            ++
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-----------------QRAIDFS 320
            GT  +IAPE +     S+  D +  G +L E + G                    I++ 
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221

Query: 321 RLEEEDDVLLLDHVKKL---EREKRLDA 345
              E  D   +D + KL   + EKRL A
Sbjct: 222 EDVEVSDE-AIDLISKLLVPDPEKRLGA 248

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.6 bits (167), Expect = 5e-13
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 167
           N+    +LGQG FG+VY     D G ++A K++  D ESP      +A + E++++    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 225
           H  +++  G      E+ L   FM+ +       ++K    + + VTRK  R  L    G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTI-FMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EG 118

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 283
           + YLH +    I+HRD+K AN+L D      +GDFG +K +     + T    V GT   
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           ++PE +S      + DV+  G  ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 47/226 (20%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMIS 164
           +N S    LG G FGKV     A G        KVAVK L          A   E++++S
Sbjct: 35  NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 165 -VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL- 220
            +  H N++ L+G CT   P   +  Y    +L               L+++ RKR +  
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDL---------------LNFLRRKRESFL 138

Query: 221 ----------GAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
                       A+G+ +L  ++C    IHRD+ A NVLL       + DFGLA+  D+ 
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR--DIM 192

Query: 270 KTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             +   V    R  +  +APE +     +  +DV+ YGI+L E+ +
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 50/220 (22%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV----- 167
           +     +G+G FG V +    +DG  +  K + D+ +       ++E + +   V     
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMT-----EKEKQQLVSEVNILRE 55

Query: 168 --HRNLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRK 216
             H N++R        + + L Y  M         Q +    + R+    E +       
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------ 108

Query: 217 RVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           R+       L   H        ++HRD+K AN+ LD +    +GDFGLAK++    +   
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           T V GT  +++PE L+     E++D++  G ++ EL    
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 120 LGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           +G G FGKV  G +  G    +V VK L    S      F  E +      H NLL+ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARGLEYLHEHCNP 235
            CT  T  LLV  F     +   LR  +  E +  D  T +R+A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKS 294
             IH D+   N LL  D    +GD+GL+         VT  Q+   +  IAPE +     
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 295 -------SERTDVFGYGIMLLEL 310
                  ++ ++V+  G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVH 168
           T+ + +   +G G FG V        G  VA+K++   F +P       RE++++    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
            N++ L     +P E +     +    +  RL   +P E        +       RGL+Y
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLKY 123

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           +H   +  ++HRD+K +N+L++E+ +  + DFGLA++ D + T   +    T  + APE 
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEI 176

Query: 289 LST-GKSSERTDVFGYGIMLLELVTGQ 314
           + T  K     D++  G +  E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 83/290 (28%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAF----------QREV 160
           D+F    ++G+G F  V          + A+K L        D             + E 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--------DKRQLIKEKKVKYVKIEK 52

Query: 161 EMIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           E+++ +  H  +++L  + T          F Q+    Y + E  P   +L ++ RK  +
Sbjct: 53  EVLTRLNGHPGIIKL--YYT----------F-QDEENLYFVLEYAPNGELLQYI-RKYGS 98

Query: 220 LG-------AAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
           L        AA     LEYLH      IIHRD+K  N+LLD+D    + DFG AK++D  
Sbjct: 99  LDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155

Query: 270 KTNVTTQVR-------------------GTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            +  + +                     GT  +++PE L+   + + +D++  G ++ ++
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215

Query: 311 VTG-----------------QRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
           +TG                 +    F      D   L++ +  L+ + RL
Sbjct: 216 LTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 64/203 (31%), Positives = 89/203 (43%), Gaps = 23/203 (11%)

Query: 120 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLL 172
           LG+GGFG+V        G L    K+  KRL   +   G    +R    I   VH R ++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR----ILAKVHSRFIV 56

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYL 229
            L     T T+  LV   M    + Y +  +    P        R     A+   GLE+L
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHL 113

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEY 288
           H+    +II+RD+K  NVLLD D    + D GLA +L D    + T    GT G +APE 
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPEL 168

Query: 289 LSTGKSSERTDVFGYGIMLLELV 311
           L   +     D F  G+ L E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 36/191 (18%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +GQG FG+V++         VA+K+ L + E  G      RE++++ +  H N++ LI  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 178 CTTPTER--------LLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           C T             LV+ F        + N +V + L EIK            +V   
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK------------KVMKM 127

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 278
              GL Y+H +   KI+HRD+KAAN+L+ +D    + DFGLA+   + K    N  T   
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 279 GTMGHIAPEYL 289
            T+ +  PE L
Sbjct: 185 VTLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 89/342 (26%), Positives = 140/342 (40%), Gaps = 97/342 (28%)

Query: 119 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 171
            LG+G FGKV +       K      VAVK L +  +     A   E++ +I +  H N+
Sbjct: 14  PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73

Query: 172 LRLIGFCTTPTERLLV---YPFMQNLSVAY----------------RLREIKPGEPV--- 209
           + L+G CT P   L+V   Y    NLS  Y                R RE+K  E     
Sbjct: 74  VNLLGACTKPGGPLMVIVEYCKFGNLS-NYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 210 LD------------WVTRKRV-------------------------ALGAARGLEYLHEH 232
           LD            ++  K +                         +   ARG+E+L   
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPE 287
            + K IHRD+ A N+LL E+    + DFGLA+ +      VRK +     R  +  +APE
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----ARLPLKWMAPE 245

Query: 288 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
            +     + ++DV+ +G++L E+ + G       +++EE         ++L+   R+ A 
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FCRRLKEGTRMRA- 297

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                   Y   E   +  + L C   +PEDRP  SE+V +L
Sbjct: 298 ------PEYATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 44/299 (14%)

Query: 117 KNVLGQGGFGKVYRG------VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           K  LG+G FGKV+           D   VAVK L D  +      FQRE E+++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 68

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPV-----LDWVTRKRV 218
           +++  G C      ++V+ +M++  +   LR   P       G+P      L       +
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A   A G+ YL    +   +HRD+   N L+  +    +GDFG+++  DV  T+      
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 183

Query: 279 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 335
            TM  I    PE +   K +  +DV+ +G++L E+ T  +   F +L   + +  +   +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECITQGR 242

Query: 336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 394
            LER +     V       Y+I          L C Q  P+ R  + E+ ++L   G A
Sbjct: 243 VLERPRVCPKEV-------YDIM---------LGCWQREPQQRLNIKEIYKILHALGKA 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 37/290 (12%)

Query: 119 VLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRL 174
           ++G+G +G V +    + G  VA+K+    ES       +   RE+ M+    H NL+ L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
           I          LV+ F+ +      L +++     LD    ++      RG+E+ H H  
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGK 293
             IIHRD+K  N+L+ +     + DFG A+ +       T  V  T  + APE L    K
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTK 177

Query: 294 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--EREKRLDAIVDRN- 350
                D++  G ++ E++TG+          + D+  L H+ K       R   I  +N 
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 351 ---LNKNYNIQEVETM-----------IQVALLCTQASPEDRPAMSEVVR 386
                +   ++E+E +           + +A  C +  P+DRP+ S+++ 
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 15/210 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRN 170
           NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 171 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVALGAARGLEY 228
           +++L+    T  +  LV+ F+ Q+L    +  +  P   + L  +  K       +GL +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLSGIPLPLI--KSYLFQLLQGLAF 115

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
            H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE 
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI 171

Query: 289 LSTGK-SSERTDVFGYGIMLLELVTGQRAI 317
           L   K  S   D++  G +  E+VT +RA+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)

Query: 119 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMI-----SVAVHRNLL 172
           VLG+G FGKV    L    +  A+K            A +++V +         V R +L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49

Query: 173 RLIG--------FCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
            L          FCT  T+  L  V  ++    + + ++     +         R    A
Sbjct: 50  ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-------EARARFYA 102

Query: 223 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           A    GL++LH+     II+RD+K  NVLLD+D    + DFG+ K     +   +T   G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-G 158

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           T  +IAPE L   K +E  D + +G++L E++ GQ
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     +V   ++ D E    +    Q+E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++  ++   S    LR   P +        K +     +GL+YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI----LKGLDYLHSE 120

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDV---RKTNVTTQVRGTMGHIAPEY 288
              K IHRD+KAANVLL E  +  + DFG+A +L D    R T V     GT   +APE 
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEV 172

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQ 314
           +       + D++  GI  +EL  G+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 16/202 (7%)

Query: 119 VLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIG 176
           V+G+G +G V +    A G  VA+K+  + E          REV+++    H N++ L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                    LV+ +++  ++   L     G   L     +       + + Y H H    
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---N 120

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----STG 292
           IIHRD+K  N+L+ E     + DFG A+ +  R  +  T    T  + APE L    + G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
           K     DV+  G ++ EL+ G+
Sbjct: 181 KP---VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 50/226 (22%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHR 169
           D +   + +G G +G+V        G KVA+K+L+  F+S        RE+ ++    H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 170 NLLRLIGFCTTPTERL-------LVYPFM----------QNLS---VAYRLREIKPGEPV 209
           N++ L+    TP   L       LV   M          Q LS   + + + +I      
Sbjct: 75  NVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI------ 127

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
                         RGL+Y+H   +  IIHRD+K +N+ ++ED E  + DFGLA+  D  
Sbjct: 128 -------------LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-- 169

Query: 270 KTNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 314
              +T  V  T  + APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 170 -DEMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 52/287 (18%)

Query: 113 NFSEKNVLGQGGFGKVYR-GVLADGTKVAVKR-----LTDFESPGGDAAFQREVEMISVA 166
           +F     LG+G +G VY+   L+D    A+K      ++  E    DA    E+ +++  
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAV--NEIRILASV 56

Query: 167 VHRNLLR-----LIG--FCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKR 217
            H N++      L G   C      ++ Y    +LS A   R+   K       W    R
Sbjct: 57  NHPNIISYKEAFLDGNKLCI-----VMEYAPFGDLSKAISKRKKKRKLIPEQEIW----R 107

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
           + +   RGL+ LHE    KI+HRD+K+AN+LL  +    +GD G++K++   K N+    
Sbjct: 108 IFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQ 161

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 337
            GT  ++APE       S ++D++  G +L E+ T     +   +++             
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------------- 208

Query: 338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
            R K         +   Y+    + +        Q  P+ RP   ++
Sbjct: 209 LRYKVQRGKYPP-IPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FGKVY+    +   +A  ++ D +S      +  E+++++   H N+++L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                 ++  F    +V   + E++    EP +  V ++ +       L YLHE+   KI
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN---KI 124

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 293
           IHRD+KA N+L   D +  + DFG++      K   T Q R    GT   +APE +    
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 294 SSER-----TDVFGYGIMLLEL 310
           S +R      DV+  GI L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)

Query: 114 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 170
           F +  VLG+GGFG+V    V A G   A KRL     +   G++    E +++     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 227
           ++ L     T     LV   M    + + +  +  G P  +    +R    AA    GLE
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
            LH       ++RD+K  N+LLD+     + D GLA  V + +        GT+G++APE
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE 171

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
            L+  + +   D +G G ++ E++ GQ      R  +E        VK+ E ++R+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKE-------KVKREEVDRRV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 120 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG+G FGKV        G    G +VAVK L         A  ++E+E++    H N+++
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 174 LIGFCTTPTER--LLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 230
             G CT        L+  F+ + S    L+E  P  +  ++   + + A+   +G++YL 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY 288
                + +HRD+ A NVL++ + +  +GDFGL K ++  K   T +  +   +   APE 
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 289 LSTGKSSERTDVFGYGIMLLELVT 312
           L   K    +DV+ +G+ L EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 172
           F    V+G G +G+VY+G      ++A  ++ D  +   +   + E+ M+   + HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 173 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
              G     +      +  LV  F    SV   ++  K      DW+    +     RGL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
            +LH H   K+IHRD+K  NVLL E+ E  + DFG++  +D R         GT   +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 190

Query: 287 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 313
           E ++  ++ +     R+D++  GI  +E+  G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 172
           F    ++G G +G+VY+G      ++A  ++ D  +   +   ++E+ M+   + HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 173 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
              G            +  LV  F    SV   ++  K      +W+    +     RGL
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
            +LH+H   K+IHRD+K  NVLL E+ E  + DFG++  +D R         GT   +AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 180

Query: 287 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 313
           E ++  ++ +     ++D++  GI  +E+  G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 53/218 (24%), Positives = 105/218 (48%), Gaps = 20/218 (9%)

Query: 113 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
            + +  V+G+G FG V+  R   AD   V +K++  +  +     A Q E +++ +  H 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVA----YRLREIKPGEPVLDWVTRKRVALGAARG 225
           N++            ++V  +    ++A     R   +   + +L +  +  +AL     
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL----- 114

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
             ++H      I+HRD+K  N+LLD+    V +GDFG++K++  +    T  V GT  +I
Sbjct: 115 -HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           +PE       ++++D++  G +L EL + +RA + + L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 170
            F + N +G+G +G VYR      G  VA+K++  D E  G   +  RE+ ++    H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 171 LLRL---------------IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
           ++ L               + +C      LL      N+   +   ++K           
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKC---------- 112

Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
             + L   RGL+YLHE+    IIHRD+K +N+LL +     + DFGLA+   +    +T 
Sbjct: 113 --LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 276 QVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           +V  T+ + APE L      +   D++  G +L EL+  +
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 20/226 (8%)

Query: 120 LGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+GGFG+V    V   G   A K+L     +   G+     E E++       ++ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 233
              + T   LV   M    + Y +  +  GE  L+    +RV   +A+   G+ +LH   
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHLHSM- 114

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
              I++RD+K  NVLLD+     + D GLA  V+++     TQ  GT G++APE L    
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 294 SSERTDVFGYGIMLLELVTGQRAI-DFSRLEEEDDVL---LLDHVK 335
            S   D F  G  + E+V G+    D      ++++    L D VK
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT----DFESPGGDAAFQREVEMISVAV 167
           N+    +LG+G FG+VY    AD G ++AVK++       E+     A + E++++    
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 168 HRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
           H  +++  G    P E+ L     +M   S+  +L   K    + + VTR R      +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYTRQILQG 118

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 283
           + YLH +    I+HRD+K AN+L D      +GDFG +K +     + T    V GT   
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           ++PE +S      + DV+     ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN-----LSVAYRLREIKPGEPVLDWV 213
           E  ++    H ++++L G  T      L+ P  +      L+    +        + D +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNI-------AICDIL 185

Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTN 272
             +R  L   R ++YLHE+   +IIHRD+KA N+ ++   +  +GDFG A   VD+   N
Sbjct: 186 AIERSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                 GT+   APE L+        D++  GI+L E+ T   ++
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 175
           ++G+GGFG+VY    AD  K+   +  D    +   G+     E  M+S+    +   ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 176 GFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
                  TP +   +   M    + Y L +      V      +  A     GLE++H  
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMH-- 114

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
            N  +++RD+K AN+LLDE     + D GLA     +K + +    GT G++APE L  G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170

Query: 293 KSSERT-DVFGYGIMLLELVTGQ 314
            + + + D F  G ML +L+ G 
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 114 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 170
           F +  VLG+GGFG+V    V A G   A K+L     +   G++    E +++     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 227
           ++ L     T     LV   M    + + +  +  GE   +     R    AA    GLE
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICCGLE 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
            LH+    +I++RD+K  N+LLD+     + D GLA  V V +        GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +   + +   D +  G +L E++ GQ
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 36/208 (17%)

Query: 120 LGQGGFGKVYR------GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FGKVY+      G LA    +  K   + E       +  E+E+++   H  +++
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED------YMVEIEILATCNHPYIVK 73

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHE 231
           L+G      +  ++  F    +V   + E+  G  EP +  + R+ +       L+YLH 
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLH- 127

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPE 287
             + KIIHRD+KA NVLL  D +  + DFG++      K   T Q R    GT   +APE
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMAPE 180

Query: 288 YL--STGKSSE---RTDVFGYGIMLLEL 310
            +   T K +    + D++  GI L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 23/177 (12%)

Query: 217 RVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNV 273
           ++A+    GL YL+  H   +I+HRD+K +N+L++   +  + DFG++ +L++ +  T V
Sbjct: 107 KIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 333
                GT  +++PE +  GK + ++DV+  GI ++EL  G+    FS     DD    D 
Sbjct: 164 -----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS---NIDDDGQDDP 215

Query: 334 VKKLEREKRLDAIVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
           +  L+    L  IV      L  +   +++   +   LL     P +RP   ++  M
Sbjct: 216 MGILD---LLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 114 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 168
           FS+   +G G FG VY  R V      VA+K+++ +     +  +Q   +EV  +    H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 226
            N ++  G         LV  +   L  A  L E+  KP    L  V    V  GA +GL
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAVTHGALQGL 128

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
            YLH H    +IHRDVKA N+LL E     +GDFG A ++      V     GT   +AP
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180

Query: 287 EY---LSTGKSSERTDVFGYGIMLLEL 310
           E    +  G+   + DV+  GI  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 22/277 (7%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV 167
             NF  +  +G+G F  VY+ + L DG  VA+K++  FE           +E++++    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++ +       E  +V        ++  ++  K  + ++   T  +  +     LE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           ++H     +I+HRD+K ANV +       +GD GL +    + T   + V GT  +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 347
            +     + ++D++  G +L E+   Q           D + L    KK+E+        
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEKCDY----- 225

Query: 348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
              L  ++  +E+  ++     C    PE RP +S V
Sbjct: 226 -PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 72/238 (30%), Positives = 113/238 (47%), Gaps = 45/238 (18%)

Query: 119 VLGQGGFGKVYRGVLADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           VLG+G FGKV   +LA+  K     A+K L       GD   + EVE  S+   + +   
Sbjct: 6   VLGRGHFGKV---LLAEYKKTGELYAIKALKK-----GDIIARDEVE--SLMCEKRI--- 52

Query: 175 IGFCTTPTERLLVYPFMQNL-------SVAYRLREIKPGEPVL-----DWVTRKRVALGA 222
             F T  +ER   +PF+ NL            + E   G  ++     D  +  R    A
Sbjct: 53  --FETANSER---HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA 107

Query: 223 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           A    GL+YLHE+   KI++RD+K  N+LLD +    + DFGL K   +   + T+   G
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCG 163

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK 335
           T   +APE L+    +   D +G G+++ E++ G+    F   +EE+  D ++ D V+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDSIVNDEVR 219

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 41/276 (14%)

Query: 120 LGQGGFGKVYRGVLADGTK-VAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRLI 175
           +G G FG VY    +   + VAVK+++ +     +  +Q   +EV+ +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           G         LV  +   L  A  L E+  KP    L  V    +  GA +GL YLH H 
Sbjct: 88  GCYLKEHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN 141

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY---LS 290
              +IHRD+KA N+LL E  +  + DFG A       + V     GT   +APE    + 
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193

Query: 291 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 350
            G+   + DV+  GI  +EL   +       L   + +  L H+ + +            
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNDSP---------T 239

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
           L  N   +  ++       C Q  P++RPA +E++R
Sbjct: 240 LQSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 175
           ++G+GGFG+VY    AD  K+   +  D    +   G+     E  M+S+    +   ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 176 GFC---TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
                  TP +   +   M    + Y L +      V      +  A     GLE++H  
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMH-- 114

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
            N  +++RD+K AN+LLDE     + D GLA   D  K      V GT G++APE L  G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKG 170

Query: 293 KSSERT-DVFGYGIMLLELVTGQ 314
            + + + D F  G ML +L+ G 
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 45/278 (16%)

Query: 120 LGQGGFGKVYRGVLA--DGTK-VAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           LG G FG V +G+       K VAVK L  D   P       RE  ++    +  ++R+I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARGLEYL 229
           G C             ++  +   L E+ P    L     VT K +       + G++YL
Sbjct: 63  GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPE 287
            E      +HRD+ A NVLL     A + DFGL+K +   +     +  G   +   APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168

Query: 288 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
            ++  K S ++DV+ +G+++ E  + GQ+   +  ++  +   +++  +++E  +R    
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIESGERMECPQRCPPE 226

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           +       Y++ +         LC     ++RP  + V
Sbjct: 227 M-------YDLMK---------LCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA+K++   + P  +     E+ ++    H N++  +   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 137

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 5/88 (5%)

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            GL YLH     +IIHRDVK  N+ +++  +  +GD G A+   V    +   + GT+  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELV 311
            APE L+  K + + D++  GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)

Query: 120 LGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIGF 177
           +G+G  G V++      G  VA+K++      GG      RE++ +    H  +++L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 178 CTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
               +  +LV  +M  +LS   R  E    E  +     K       +G+ Y+H +    
Sbjct: 68  FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQV-----KSYMRMLLKGVAYMHAN---G 119

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSS 295
           I+HRD+K AN+L+  D    + DFGLA+L    +  + +    T  + APE L    K  
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 296 ERTDVFGYGIMLLELVTGQ 314
              D++  G +  EL+ G 
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 46/217 (21%)

Query: 119 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           VLG+G FGKV    L   G   AVK            A +++V +I   V          
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40

Query: 178 CTTPTERLLVY----PFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 224
           CT   +R+L      PF+ +L   ++ +E        +  G+ +     + R  L  A  
Sbjct: 41  CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100

Query: 225 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                  GL++LH      II+RD+K  NV+LD D    + DFG+ K  +V   N  +  
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTF 156

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            GT  +IAPE L   K +   D + +G++L E++ GQ
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 7/104 (6%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           GL++LHE     II+RD+K  NVLLD +    + DFG+ K   +     T+   GT  +I
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYI 163

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 328
           APE LS        D +  G++L E++ GQ   +    ++ED++
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 62.9 bits (154), Expect = 4e-11
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 38/217 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D+F     LG G FG+V         K  A+K L             ++VE   V   + 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVE--HVLNEKR 53

Query: 171 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 224
           +L+ I   F        L   F  + ++ Y + E  PG  +   + +  R     AR   
Sbjct: 54  ILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107

Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
                 LEYLH   +  I++RD+K  N+LLD D    + DFG AK V  R    T  + G
Sbjct: 108 AQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCG 160

Query: 280 TMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTG 313
           T  ++APE + +   GK+    D +  GI++ E++ G
Sbjct: 161 TPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 22/205 (10%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRN 170
           F++   +G G FG VY        +V   +   +     +  +Q   +EV+ +    H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEY 228
            +   G         LV  +   L  A  L E+  KP    L  V    +  GA +GL Y
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAY 140

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H    +IHRD+KA N+LL E  +  + DFG A +     + V     GT   +APE 
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192

Query: 289 ---LSTGKSSERTDVFGYGIMLLEL 310
              +  G+   + DV+  GI  +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 41/223 (18%)

Query: 113 NFSEKNVLGQGGFGKVY----RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 168
           NF    VLG G +GKV+     G    G   A+K L            Q+          
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA------TIVQKAKTAEHTRTE 54

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYR--------LREIKPGEPVLDWVTRKRVAL 220
           R +L  +  C          PF+  L  A++        L  +  GE       R+    
Sbjct: 55  RQVLEAVRRC----------PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104

Query: 221 GAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
              R         L++LH+     II+RD+K  N+LLD +   V+ DFGL+K     +  
Sbjct: 105 SEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Query: 273 VTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 313
                 GT+ ++APE +  G     +  D +  G++  EL+TG
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 51/253 (20%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQRE-VEMISVAV 167
           +F+   VLG+G FGKV   +LA+  GT    A+K L        D   Q + VE     V
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVIIQDDDVE--CTMV 49

Query: 168 HRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRK 216
            + +L L G          C    +RL  V  ++    + Y ++++ K  EP   +    
Sbjct: 50  EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--- 106

Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
             A   A GL +LH   +  II+RD+K  NV+LD +    + DFG+ K  ++     T  
Sbjct: 107 --AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT 160

Query: 277 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LL 331
             GT  +IAPE   Y   GKS    D + +G++L E++ GQ   D    E+ED++   ++
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFDG---EDEDELFQSIM 214

Query: 332 DHV----KKLERE 340
           +H     K L +E
Sbjct: 215 EHNVSYPKSLSKE 227

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 36/118 (30%), Positives = 64/118 (54%), Gaps = 15/118 (12%)

Query: 201 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 260
           + +   E +L      ++A+   + LEYLH      +IHRDVK +NVL++ + +  + DF
Sbjct: 96  KGLTIPEDIL-----GKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF 148

Query: 261 GLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE----RTDVFGYGIMLLELVTG 313
           G++  LVD   +   T   G   ++APE ++   + +    ++DV+  GI ++EL TG
Sbjct: 149 GISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)

Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D++ +   LG+G +  VY+G    +G  VA+K +   E  G      RE  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++ L     T     LV+ ++      Y  +   PG    + V  K       RGL Y+H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHPENV--KLFLFQLLRGLSYIH 120

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 289
           +     I+HRD+K  N+L+ +  E  + DFGLA+   V     + +V  T+ +  P+  L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRA 316
            + + S   D++G G + +E++ G  A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 10/103 (9%)

Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTT 275
           ++ +   + L YL E     +IHRDVK +N+LLD      + DFG++ +LVD +     T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKT 172

Query: 276 QVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQ 314
           +  G   ++APE +       K   R DV+  GI L+EL TGQ
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA+K++   + P  +     E+ ++    + N++  +   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + L++LH +   ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALDFLHSN---QVI 137

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           D + +   +G G +G V   +    G KVA+K+L   F+S        RE+ ++    H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 170 NLLRLIGFCTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           N++ L+    TP   L       LV PFM    +   ++  K  E  + ++  + +    
Sbjct: 75  NVIGLLD-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML---- 128

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
            +GL+Y+H      IIHRD+K  N+ ++ED E  + DFGLA+  D   T        T  
Sbjct: 129 -KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRW 180

Query: 283 HIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 314
           + APE  L+    ++  D++  G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 12/209 (5%)

Query: 120 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           LG+G +  VY+G   L D   VA+K +      G      REV ++    H N++ L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
             T     LV+ ++      Y    +      ++    K       RGL Y H     K+
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 296
           +HRD+K  N+L++E  E  + DFGLA+   +     + +V  T+ +  P+  L +   S 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
           + D++G G +  E+ TG+     S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 169
           NF  +  +G+G F +VYR   L D   VA+K++  FE     A     +E++++    H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++ +       E  +V        ++  ++  K  + ++   T  +  +     +E++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H     +++HRD+K ANV +       +GD GL +     KT     + GT  +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178

Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
                + ++D++  G +L E+   Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE---MISVA 166
           TD +     +G+G +GKVY+     DG+  AVK L     P  D   + E E   + S+ 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL----DPISDVDEEIEAEYNILQSLP 76

Query: 167 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
            H N+++  G      + +     LV       SV   ++ +      LD      +  G
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
           A  GL++LH   N +IIHRDVK  N+LL  +    + DFG++  +   +    T V GT 
Sbjct: 137 ALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 192

Query: 282 GHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTG 313
             +APE ++  +  +     R DV+  GI  +EL  G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 33/212 (15%)

Query: 120 LGQGGFGKVYRGVLADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG G FG V +GV     K   VA+K L +           RE E++    +  ++R+IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----------GL 226
            C    E L++            + E+  G P+  +++ K+  +  +           G+
Sbjct: 63  VCEA--EALML------------VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGM 108

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHI 284
           +YL        +HRD+ A NVLL     A + DFGL+K +    +    +  G   +   
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
           APE ++  K S R+DV+ YGI + E  + GQ+
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)

Query: 120 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           +G G FGKV    +   T VA   VK L    S      F ++ +   +  H N+L+ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 177 FCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            C      LLV+ +  + +L       +          +  +R+A   A G+ ++H+H  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS--QLLLLQRMACEIAAGVTHMHKH-- 118

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY---- 288
              +H D+   N  L  D    VGD+G+      ++  + T+      +  +APE     
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 289 ---LSTGKSSERTDVFGYGIMLLELV--TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
              L T + ++ ++V+  G+ L EL     Q     S  E      +L+HV K +++ +L
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL 229

Query: 344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                  L   Y+    E   +V   C   SPE R    EV R+L
Sbjct: 230 ---FKPQLELPYS----ERWYEVLQFC-WLSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 10/208 (4%)

Query: 120 LGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           LG+G +  V++G        VA+K +      G      REV ++    H N++ L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
            T     LV+ ++ +    Y    +     ++     K       RGL Y H+    KI+
Sbjct: 73  HTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSER 297
           HRD+K  N+L++E  E  + DFGLA+   V     + +V  T+ +  P+  L + + S  
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 298 TDVFGYGIMLLELVTGQRAIDFSRLEEE 325
            D++G G +L E+ TG+     S ++EE
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---VRKTNVTTQVRGT 280
           RGL+Y+H      +IHRD+K +N+L++ED E  +GDFG+A+ +           T+   T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 281 MGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
             + APE  LS  + +   D++  G +  E++ G+R +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 55/285 (19%)

Query: 119 VLGQGGFGKV----YRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 173
           V+G+G +G+V    +R    DG +  +K+L     S     A ++E +++S   H N++ 
Sbjct: 7   VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 174 LIGFCTTPTERL-LVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEY 228
                      L +V  F +   + ++L+E K    P   V++W  +       A  L+Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LHE     I+HRD+K  NV L       VGD G+A++++ +    +T + GT  +++PE 
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
            S    + ++DV+  G  + E+ T + A +                      K ++++V 
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN---------------------AKDMNSLVY 212

Query: 349 R-------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
           R        + K+Y+ +  E +I   +L  +  PE RP++  ++R
Sbjct: 213 RIIEGKLPPMPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G V+  + +A G +VA+K++   + P  +     E+ ++    + N++  +   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE-----CLQALEFLHAN---QVI 137

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ NVLL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 32/230 (13%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVL---ADGTK---VAVKRLTDFESPGGDAAFQRE 159
           E+ L+T  F E+  LG+  FGKVY+G L   A G +   VA+K L D         F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 160 VEMISVAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR----------EIKPGE 207
             M S   H N++ L+G  T   P   +  Y    +L     +R          + K  +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 266
             L+      +    A G+E+L  H    ++H+D+   NVL+ +     + D GL + V 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 267 --DVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             D  K   N    +R     ++PE +  GK S  +D++ YG++L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 45/304 (14%)

Query: 113 NFSEKNVLGQGGFGKVY----------------RGVLADGTK-VAVKRLTDFESPGGDAA 155
           NF EK  LG+G FG+V+                    AD    VAVK L    S      
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 156 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEP 208
           F +EV+++S     N+ RL+G CT      ++  +M+N  +   L++             
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
            L + T   +A   A G+ YL        +HRD+   N L+ +++   + DFG+++ +  
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180

Query: 269 RKTNVTTQVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 324
             ++   +V+G     I   A E +  GK + ++DV+ +G+ L E++T  R   +  L +
Sbjct: 181 -YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239

Query: 325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           +    ++++     R+      + R  N   +I E+  M++    C +   EDRP   E+
Sbjct: 240 QQ---VIENAGHFFRDDGRQIYLPRPPNCPKDIYEL--MLE----CWRRDEEDRPTFREI 290

Query: 385 VRML 388
              L
Sbjct: 291 HLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V   +    G KVA+K+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 178 CTTPT------ERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
            T+        +  LV P+MQ +L    ++      E  + ++  + +      GL+Y+H
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQML-----CGLKYIH 134

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEY 288
                 IIHRD+K  N+ ++ED E  + DFGLA+  D   T   VT   R      APE 
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR------APEV 185

Query: 289 -LSTGKSSERTDVFGYGIMLLELVTGQ 314
            L+    ++  D++  G ++ E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 12/209 (5%)

Query: 120 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           LG+G +  V++G   L +   VA+K +      G      REV ++    H N++ L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
             T     LV+ ++      Y    +     ++     K       RGL Y H     K+
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 296
           +HRD+K  N+L++E  E  + DFGLA+   V     + +V  T+ +  P+  L + + S 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
           + D++G G +  E+ +G+     S +E+E
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDE 213

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)

Query: 114 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 170
           F    VLG+GGFG+V    V A G   A K+L     +   G+A    E  ++     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 227
           ++ L     T     LV   M    + + +  +  G P  D    +R    AA    GLE
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
            L      +I++RD+K  N+LLD+     + D GLA  V + +        GT+G++APE
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPE 171

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            ++  K +   D +G G ++ E++ GQ
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 136 GTKVAVKRLTDFESPGGD---AAFQREVEMISVAVHRNLLRLIGFCTTPTERLL-VYPFM 191
           G +VA+K L   ++P  +   A F+RE  + +   H N++ L+     P   L  V+ ++
Sbjct: 3   GHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-- 249
              +    LRE+   +  L      R+ L     L   H   N  I+HRD+K  N+++  
Sbjct: 62  PGRT----LREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114

Query: 250 -DEDFEAVVGDFGLAKL------VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFG 302
                 A V DFG+  L       DV     TT+V GT  + APE L     +  +D++ 
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 303 YGIMLLELVTGQRAIDFSRLEE 324
           +G++ LE +TGQR +  + + E
Sbjct: 175 WGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 114 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 170
           F    VLG+GGFG+V    V A G   A K+L     +   G+A    E +++     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 227
           ++ L     T     LV   M    + + +  +  G P  D    +R    AA    GLE
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFD---EERAVFYAAEITCGLE 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
            LH     +I++RD+K  N+LLD+     + D GLA  V++ +        GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +   + +   D +G G ++ E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +L  D+F + + LG G  G V++        +  ++L   E              I  A+
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--------------IKPAI 46

Query: 168 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
              ++R   ++  C +P        F  +  ++  +  +  G   LD V +K        
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 104

Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 273
             +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    ++
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 158

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)

Query: 119 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 171
           VLG G FGKV         K      VAVK L +  +     A   E++ +I +  H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 172 LRLIGFCTTPTERLLV---YPFMQNLS----------VAYRLREIKPGEPVLDWVT---- 214
           + L+G CT P   L+V   +    NLS            YR +  K        V     
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133

Query: 215 RKRVALGAARGLEYLH-----EHCNP---------------------------------- 235
            +R+  G A  L            NP                                  
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPEYLS 290
           K IHRD+ A N+LL E+    + DFGLA+ +      VRK +     R  +  +APE + 
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS----ARLPLKWMAPESIF 249

Query: 291 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
               + ++DV+ +G++L E+ + G       ++ EE         ++L+   R+ A    
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRA---- 298

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAER 396
                    E+    ++ L C Q  P++RP  S +V +L G+ L E 
Sbjct: 299 ---PENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 49/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197

Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 44/224 (19%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
             +   + +G+G +G V        G KVA+K+++ FE         RE++++    H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 171 LLRLIGFCTTPT-----ERLLVYPFM----------QNLS---VAYRLREIKPGEPVLDW 212
           ++ ++     P+     +  +V   M          Q+LS   + Y L +I         
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI--------- 115

Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-- 270
                      RGL+Y+H   N  ++HRD+K +N+LL+ + +  + DFGLA++ D     
Sbjct: 116 ----------LRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 271 TNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTG 313
           T   T+   T  + APE +   K  ++  D++  G +L E+++ 
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 16/210 (7%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           NF    VLG G +GKV+      G      +L   +     A  Q+   +      RN+L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTG--KLYAMKVLQKAALVQKAKTVEHTRTERNVL 58

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-------- 224
             +    +P    L Y F     +   L  +  GE       R   +    R        
Sbjct: 59  EHVR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            LE+LH+     I++RD+K  N+LLD +   V+ DFGL+K     +   T    GT+ ++
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 285 APEYL-STGKSSERTDVFGYGIMLLELVTG 313
           APE +   G   +  D +  GI++ EL+TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 16/214 (7%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA 166
           +L  D+F   + LG G  G V +        +  ++L   E  P       RE++++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAAR 224
               ++   G   +  E  +    M   S+   L+E K  P E +       +V++   R
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL------GKVSIAVLR 114

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGH 283
           GL YL E    +I+HRDVK +N+L++   E  + DFG++ +L+D    ++     GT  +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           ++PE L     S ++D++  G+ L+EL  G+  I
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 37/283 (13%)

Query: 112 DNFSEK--NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISV 165
           DN S K   +LG G FG++ RG L   +K    VA+  L    S      F  E   +  
Sbjct: 3   DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
             H N++RL G  T     ++V  +M N ++   LR+    E  L       +  G A G
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASG 119

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI- 284
           ++YL E      +H+ + A  VL++ D    +  F   +L + +   + T + G    + 
Sbjct: 120 MKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLW 174

Query: 285 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREK 341
            APE +     S  +DV+ +GI++ E+++ G+R   D S           D +K +E   
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---------QDVIKAVEDGF 225

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           RL A          N   +  + Q+ L C Q    +RP  S++
Sbjct: 226 RLPAPR--------NCPNL--LHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 15/215 (6%)

Query: 119 VLGQGGFGKVYRGVL-ADGTKVAVKRLT-DFESPGGDA-AFQREVEMISVAVHRNLLRLI 175
           VLG+G FGKV    L   G   AVK L  D      D      E  ++S+A +   L  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 176 GFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
             C    +RL  V  F+    + + +++ +      D    +  A      L +LH+   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK-- 115

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 294
             II+RD+K  NVLLD +    + DFG+ K   +     T+   GT  +IAPE L     
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 295 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
               D +  G++L E++ G    +    E EDD+ 
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRN 170
            +     +G+G FGK+Y       ++  V +  D          A ++EV +++   H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAA 223
           +   + F  +  E   ++  M+       ++ I          + +L W  +  ++LG  
Sbjct: 61  I---VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG-- 113

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
             L+++H+    KI+HRD+K+ N+ L ++   A +GDFG+A+ ++     +     GT  
Sbjct: 114 --LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPY 167

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           +++PE       + +TD++  G +L EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 36/119 (30%), Positives = 65/119 (54%), Gaps = 17/119 (14%)

Query: 210 LDWVTRK----------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 259
           LD V +K          ++++   RGL YL E    KI+HRDVK +N+L++   E  + D
Sbjct: 86  LDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 143

Query: 260 FGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           FG++ +L+D    ++     GT  +++PE L     + ++D++  G+ L+E+  G+  I
Sbjct: 144 FGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 62/262 (23%), Positives = 116/262 (44%), Gaps = 52/262 (19%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGD------AAFQREVEMIS-------V 165
           LG+G FG VY  ++ D   VA +RL    E P G+          +E +++S       V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVA 219
             H + L    FC       ++  + +   +  +L E+K          V +W  +  + 
Sbjct: 66  KFHASFLERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
                G+ Y+H+    +I+HRD+KA N+ L  +    +GDFG+++L+ +   ++ T   G
Sbjct: 118 -----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTG 167

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS-------RLEEEDDVLLLD 332
           T  +++PE L       ++D++  G +L E+     A +         R+ E     L +
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE 227

Query: 333 HVKKLEREKRLDAIVDRNLNKN 354
                   ++L++I+   LNK+
Sbjct: 228 TY-----SRQLNSIMQSMLNKD 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 20/216 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREV---EMISVA 166
           D + +   +G+G +GKVY+      G  VA+K+   + +  G      RE+   +M+S +
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 167 VHRNLLRLIGFCTTPTER-----LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           ++  ++RL+       +       LV+ ++  +L          PG P L   T K    
Sbjct: 61  IY--IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMY 117

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRG 279
              +G+ + H+H    ++HRD+K  N+L+D+    + + D GL +   +   + T ++  
Sbjct: 118 QLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173

Query: 280 TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           T+ + APE L      S   D++  G +  E+   Q
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 11/101 (10%)

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTT 275
           +A+   + L YL E    KIIHRDVK +N+LLD +    + DFG++ +LVD + K    T
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----T 165

Query: 276 QVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTG 313
           +  G   ++APE +          R+DV+  GI L E+ TG
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 54/232 (23%)

Query: 119 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +LG+G FGKV+   L       A+K            A +++V ++   V          
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40

Query: 178 CTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 224
           CT   +R+L     +PF+ +L   ++ +E        +  G+ +    +  +  L  A  
Sbjct: 41  CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100

Query: 225 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVT 274
                  GL++LH   +  I++RD+K  N+LLD D    + DFG+ K   L D +    T
Sbjct: 101 YAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 326
               GT  +IAPE L   K +   D + +G++L E++ GQ    F   +EE+
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 40/225 (17%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKR----LTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           +G+GG G+VY         +VA+K+    L++         F RE ++ +  +H  ++ +
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL--KKRFLREAKIAADLIHPGIVPV 67

Query: 175 IGFCTTPTERLLVY---PFMQNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAAR 224
              C+   +   VY   P+++  ++   L+ +   E +   +  K        +      
Sbjct: 68  YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----------VDVRKTNVT 274
            +EY+H      ++HRD+K  N+LL    E V+ D+G A            +DV + N+ 
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 275 T-------QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
                   ++ GT  ++APE L    +SE TD++  G++L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 25/181 (13%)

Query: 207 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KL 265
           E VL      R+A+   +GL YL    + KI+HRDVK +N+L++   +  + DFG++ +L
Sbjct: 94  EHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145

Query: 266 VD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 324
           V+ + KT V     GT  ++APE +S  +    +DV+  GI  +EL  G+    + ++++
Sbjct: 146 VNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR--FPYPQIQK 198

Query: 325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
               L+   +        L  IVD +       Q  E  +     C +  P++RPA   +
Sbjct: 199 NQGSLMPLQL--------LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250

Query: 385 V 385
           +
Sbjct: 251 M 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGT--KVAVKRLTDFESPGGDAAFQREVEM 162
           R+ ++  ++F+    LG G FG+V      +     VA+KR   FE     +   ++ ++
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR---FEK----SKIIKQKQV 75

Query: 163 ISVAVHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--- 217
             V   R +L  I   FC        +Y   ++ S  Y + E   G     ++ R +   
Sbjct: 76  DHVFSERKILNYINHPFCVN------LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129

Query: 218 --VALGAARGLEYLHEHCNP-KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
             V    A  +  + E+     I++RD+K  N+LLD+D    + DFG AK+VD R    T
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             + GT  +IAPE L      +  D +  GI + E++ G
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 30/164 (18%)

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV------DVRKTNVTTQVRGTMGH 283
           H H +  +IHRD+K+AN+LL  +    +GDFG +K+       DV +T       GT  +
Sbjct: 158 HVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYY 211

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
           +APE       S++ D+F  G++L EL+T +R  D   +EE         V       R 
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------VMHKTLAGRY 262

Query: 344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
           D +         +I      I  ALL +   P+ RP+ S+++ M
Sbjct: 263 DPLPP-------SISPEMQEIVTALLSSD--PKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 176
           LG G FG VY       G  VA+K++   F S   +    REV+ +  +  H N+++L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 177 FCTTPTERLLVYPFM-QNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCN 234
                 E   V+ +M  NL    + R+ KP  E V+     + +     +GL ++H+H  
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVI-----RSIIYQILQGLAHIHKH-- 118

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 292
               HRD+K  N+L+       + DFGLA+ +  R    T  V  T  + APE L  ST 
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDYV-STRWYRAPEILLRSTS 175

Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
            SS   D++  G ++ EL T +
Sbjct: 176 YSSP-VDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G V++    + G  VA+K+  + E  P       RE+ M+    H NL+ LI  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                +  LV+ +  + +V   L E++     +     K++     + + + H+H     
Sbjct: 69  FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           IHRDVK  N+L+ +  +  + DFG A+++     + T  V  T  + APE L  G +   
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQYG 179

Query: 298 T--DVFGYGIMLLELVTGQ 314
              DV+  G +  EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 34/191 (17%)

Query: 136 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 195
           G +VAVK++   +    +  F  EV ++    H N++ +        E  +V  F++   
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE--- 99

Query: 196 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 247
                     G  + D VT  R        V L   + L +LH      +IHRD+K+ ++
Sbjct: 100 ----------GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146

Query: 248 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 303
           LL  D    + DFG    ++K V  RK+ V     GT   +APE +S        D++  
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 201

Query: 304 GIMLLELVTGQ 314
           GIM++E+V G+
Sbjct: 202 GIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 35/224 (15%)

Query: 119 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQR--------EVEMISVAVHR 169
           VLG+G FGKV    L    +V A+K L        D   Q         E  ++++A   
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAKH 55

Query: 170 NLLRLIGFCTTPTERLL-VYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR--- 224
             L  +  C    +RL  V  ++    + +++ R  K  EP        R    AA    
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP--------RSRFYAAEVTL 107

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L +LH H    +I+RD+K  N+LLD +    + DFG+ K   +     TT   GT  +I
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYI 163

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 328
           APE L   +     D +  G+++ E++ GQ   +    + EDD+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ---------REVEMISVAVHR 169
           +G G FG V+      DG +VA+K++ +         FQ         RE++M+    H 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFKHD 59

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-------IKPGEPVLDWVTRKRVALGA 222
           N+L  +     P     + PF + + V   L +       + P     D V  K      
Sbjct: 60  NVLSALDILQPP----HIDPF-EEIYVVTELMQSDLHKIIVSPQPLSSDHV--KVFLYQI 112

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
            RGL+YLH   +  I+HRD+K  N+L++ +    + DFGLA++ +  ++   TQ   T  
Sbjct: 113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 283 HIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDF 319
           + APE L   +  +   D++  G +  EL+   R I F
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 20/191 (10%)

Query: 136 GTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 193
           GT V V R+TD E+   +   A Q EV +     H N++      TT +   ++ PFM  
Sbjct: 25  GTLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 253
            S    L+   P E + + +    +  GA RGL YLH++     IHR++KA+++L+  D 
Sbjct: 84  GSANSLLKTYFP-EGMSEALIGN-ILFGALRGLNYLHQN---GYIHRNIKASHILISGD- 137

Query: 254 EAVVGDFGLAKLVDVRKTNVTTQV--------RGTMGHIAPEYLSTGKS--SERTDVFGY 303
             +V   GL+ L  + +     +V           +  ++PE L       + ++D++  
Sbjct: 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196

Query: 304 GIMLLELVTGQ 314
           GI   EL TG+
Sbjct: 197 GITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 120 LGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR----- 173
           +G+G FG+VY+    D  ++ A+K L+  E          + E+      RN+L      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-------IVAKKEVAHTIGERNILVRTLLD 53

Query: 174 ----LIGF---CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-- 224
               ++G      T ++  LV  +M    + + L+  K G       +  R     A   
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGR-----FSEDRAKFYIAELV 106

Query: 225 -GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             LE+LH++    I++RD+K  N+LLD      + DFGL+K  ++     T    GT  +
Sbjct: 107 LALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEY 162

Query: 284 IAPEYLSTGKS-SERTDVFGYGIMLLELVTG 313
           +APE L   K  ++  D +  G+++ E+  G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 48/251 (19%)

Query: 114 FSEKNVLGQGGFGKVY----------------------RGVLADGTKVAVKRLTDFESPG 151
           F EK  LG+G FG+V+                      R +L     VAVK L    +  
Sbjct: 9   FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL-----VAVKILRPDANKN 61

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 205
               F +EV+++S     N++RL+G C       ++  +M+N      LS  +   + + 
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 206 GE---------PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 256
           G          P + + +   VAL  A G++YL    +   +HRD+   N L+ E+    
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIK 178

Query: 257 VGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           + DFG+++ L       +  +    +  +A E +  GK +  +DV+ +G+ L E++   +
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238

Query: 316 AIDFSRLEEED 326
              +  L +E 
Sbjct: 239 EQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 21/163 (12%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L YLH+    +I+HRD+   N++L ED +  + DFGLAK    +  +  T V GT+ +  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           PE +      E+ DV+ +G +L ++ T Q    +S      ++L L         K ++A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-YS-----TNMLSL-------ATKIVEA 228

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
           + +  L +    ++V  +I     C     E RP + +V  M+
Sbjct: 229 VYE-PLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)

Query: 119 VLGQGGFGKVY--RGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLR 173
           VLGQG FGKV+  R +     G   A+K L        D    +    I   V H  +++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR---GLEYL 229
           L     T  +  L+  F++   +  RL +E+          T + V    A     L++L
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--------FTEEDVKFYLAELALALDHL 114

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 288
           H   +  II+RD+K  N+LLDE+    + DFGL+K  +D  K        GT+ ++APE 
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEV 169

Query: 289 LSTGKSSERTDVFGYGIMLLELVTG 313
           ++    ++  D + +G+++ E++TG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 15/116 (12%)

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVR-G 279
           + GL +LH      II+RD+K  NV+LD +    + DFG+ K  +VD     VTT+   G
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD----GVTTRTFCG 163

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLDH 333
           T  +IAPE ++     +  D + YG++L E++ GQ   D    E+ED++   +++H
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           LG+G +  VY+G+   +G  VA+K ++     G      RE  ++    H N++ L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
            T      V+ +M      Y ++   PG   L     +       RGL Y+H      I+
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQH--PGG--LHPYNVRLFMFQLLRGLAYIHGQ---HIL 125

Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSSE 296
           HRD+K  N+L+    E  + DFGLA+   +     +++V  T+ +  P+ L  +T  SS 
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184

Query: 297 RTDVFGYGIMLLELVTGQ 314
             D++G G + +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 31/237 (13%)

Query: 114 FSEKNVLGQGGFGKVYRGVLADGTK----------------VAVKRLTDFESPGGDAAFQ 157
             EK  LG+G FG+V+    A+G                  VAVK L    +      F 
Sbjct: 9   LKEK--LGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65

Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN--LSVAYRLREIKP------GEPV 209
           +E++++S   + N++RL+G C +     ++  +M+N  L+     REI+         P 
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDV 268
           +       +A+  A G++YL    +   +HRD+   N L+   +   + DFG+++ L   
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
               +  +    +  +A E +  GK +  +DV+ +G+ L E+ T  +   +S L +E
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G V++    +    VA+KR+  D +  G  ++  RE+ ++    H+N++RL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 178 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
             +  +  LV+ +  Q+L    +  +   G+   D    K       +GL + H H    
Sbjct: 68  LHSDKKLTLVFEYCDQDLK---KYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAK 264
           ++HRD+K  N+L++++ E  + DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 25/215 (11%)

Query: 113 NFSEKNVLGQGGFGKVY--RGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 168
           NF    VLG G +GKV+  R V     G   A+K L            Q+          
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK------ATIVQKAKTTEHTRTE 54

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---- 224
           R +L  I    +P    L Y F  +  +   L  I  GE       R+R      +    
Sbjct: 55  RQVLEHIR--QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112

Query: 225 ----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
                LE+LH+     II+RD+K  N+LLD +   V+ DFGL+K     +        GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 281 MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 313
           + ++AP+ +  G     +  D +  G+++ EL+TG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 32/223 (14%)

Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
             LG+G +GKV +      G  VA+K++   E        ++ V M    +H   LR + 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM--CGIHFTTLRELK 72

Query: 177 FCTT---PTERLLVYPFMQ----NLSV---AYRLREIKPGEPVLDWVTRKRVALGAARGL 226
                       LV  +++    NL +   A  L+++   +  L     K + L    GL
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK------LVDV--------RKTN 272
             LH       +HRD+  AN+ ++      + DFGLA+        D         R+  
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 273 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           +T++V  T+ + APE L    K     D++  G +  EL+TG+
Sbjct: 190 MTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 36/224 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFESPGGDAAFQREVE---MISV 165
           +D +     +G+G +GKV++ VL   +G+K AVK L     P  D   + E E   + ++
Sbjct: 17  SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKAL 71

Query: 166 AVHRNLLRLIGF-----CTTPTERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTR 215
           + H N+++  G           +  LV       SV      +  R  +  EP++ ++  
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131

Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVT 274
           +     A  GL++LH +   K IHRDVK  N+LL  +    + DFG+ A+L   R    T
Sbjct: 132 E-----ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183

Query: 275 TQVRGTMGHIAPEYLSTGKS-----SERTDVFGYGIMLLELVTG 313
           +   GT   +APE ++  +        R DV+  GI  +EL  G
Sbjct: 184 SV--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAV---HRNLLR 173
           +G G +G VY+      G  VA+K  R+   E  G   +  REV ++       H N++R
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 174 LIGFCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L+  C T      T+  LV+  +      Y  +   PG P     T K +     RGL++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA---ETIKDLMRQFLRGLDF 123

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH +C   I+HRD+K  N+L+    +  + DFGLA++   +     T V  T+ + APE 
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEV 178

Query: 289 LSTGKSSERTDVFGYGIMLLEL 310
           L     +   D++  G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 30/172 (17%)

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQV 277
           A+G+E+L    + K IHRD+ A N+LL E+    + DFGLA+ +      VRK +     
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----A 241

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 336
           R  +  +APE +     + ++DV+ +G++L E+ + G       +++EE         ++
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294

Query: 337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
           L+   R+ A        +Y   E   M Q  L C    P  RP  SE+V  L
Sbjct: 295 LKEGTRMRA-------PDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 10/106 (9%)

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
            DW   K+       G+E LH+     IIHRD+K  N+L+D+     + DFGL++     
Sbjct: 96  EDWA--KQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           K  V     GT  ++APE +      + +D +  G ++ E + G  
Sbjct: 151 KKFV-----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 40/120 (33%), Positives = 65/120 (54%), Gaps = 21/120 (17%)

Query: 202 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           E  P E VL     +R+     +GL++L E  N  IIHRDVK  NVL++ + +  + DFG
Sbjct: 97  EGIP-EDVL-----RRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148

Query: 262 LA-KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG 313
           ++  LV  + KTN+     G   ++APE + +G  ++       +DV+  G+ +LE+  G
Sbjct: 149 VSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G VY+G     G  VA+K++  + E  G  +   RE+ ++    H N++ L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
               +   L++ F+  + +   L  +  G+  +D    K       +G+ + H     ++
Sbjct: 68  LMQESRLYLIFEFLS-MDLKKYLDSLPKGQ-YMDAELVKSYLYQILQGILFCHSR---RV 122

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTNVTTQVRGTMGHIAPEYL-STGKS 294
           +HRD+K  N+L+D      + DFGLA+   + VR   V T    T+ + APE L  + + 
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLWYRAPEVLLGSPRY 179

Query: 295 SERTDVFGYGIMLLELVT 312
           S   D++  G +  E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 66/282 (23%), Positives = 118/282 (41%), Gaps = 40/282 (14%)

Query: 120 LGQGGFGKVYRGV---LADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           LGQG F K+++G+   + D      T+V +K L D        +F     M+S   H++L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL-DKSHRNYSESFFEAASMMSQLSHKHL 61

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +   G C    E ++V  +++  S+   L++ K    +  W  +  VA   A  L +L +
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLED 118

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH----IAPE 287
                + H +V A NVLL  + +   G+    KL D    ++T   +  +      + PE
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD-PGISITVLPKEILLERIPWVPPE 174

Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
            +   ++ S   D + +G  L E+ +G           +  +  LD  KKL+  +     
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYE----- 219

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
            DR+        E+  +I     C    P+ RP+   ++R L
Sbjct: 220 -DRHQLPAPKWTELANLINQ---CMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 36/211 (17%)

Query: 119 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR- 173
           V+G+G FGKV    LA    DG   AVK L          A  ++ E   +   RN+L  
Sbjct: 2   VIGKGSFGKVL---LAKHKADGKFYAVKVLQK-------KAILKKKEQKHIMAERNVLLK 51

Query: 174 ------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGA 222
                 L+G  +     ++L  V  ++    + + L RE    EP      R R  A   
Sbjct: 52  NVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEI 105

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A  L YLH      II+RD+K  N+LLD     V+ DFGL K   +  +  T+   GT  
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPE 161

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE L         D +  G +L E++ G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 4/88 (4%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           LE LH+     +I+RD+K  N+LLD      + DFGL KL +++  + T    GT  ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTG 313
           PE L     ++  D +  G++L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 34/191 (17%)

Query: 136 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 195
           G +VAVK++ D            EV ++    H N++ +        E  +V  F++   
Sbjct: 47  GKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE--- 102

Query: 196 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 247
                     G  + D VT  R        V L   R L YLH   N  +IHRD+K+ ++
Sbjct: 103 ----------GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSI 149

Query: 248 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 303
           LL  D    + DFG    ++K V  RK+ V     GT   +APE +S        D++  
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 204

Query: 304 GIMLLELVTGQ 314
           GIM++E++ G+
Sbjct: 205 GIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 31/224 (13%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           R+LQ+  +++    V+G+G FG+V         KV A+K L+ FE       A F  E +
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +++ A    +++L  FC    ++ L           Y + E  PG  +++ ++   V   
Sbjct: 96  IMAFANSPWVVQL--FCAFQDDKYL-----------YMVMEYMPGGDLVNLMSNYDVPEK 142

Query: 222 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
            A+         L+ +H      +IHRDVK  N+LLD+     + DFG    +D      
Sbjct: 143 WAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199

Query: 274 TTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 313
                GT  +I+PE L +    G      D +  G+ L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 37/219 (16%)

Query: 120 LGQGGFGKVY--------------RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMI 163
           L  G FGK++              RGV +         + +      G  AA Q E E++
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215

Query: 164 SVAV--HRNLLRLIGFCTTPTERLLV--------YPFMQNLSVAYRLREIKPGEPVLDWV 213
           ++    H N+L++     +     ++        Y FM + +  ++ R      P+L   
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR------PLL-KQ 268

Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
           TR  +       +EY+H+    K+IHRD+K  N+ L+ D + V+GDFG A   +  +   
Sbjct: 269 TR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
                GT+   +PE L+     E TD++  G++LL++++
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 169
           D + + N + +G +G VYR      G  VA+K+L  + E  G      RE+ ++    H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 170 NLLRL--IGFCTTPTERLLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
           N++ +  +   +   +  +V  +        M+ +   +   E+K             + 
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC------------LM 112

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
           L    G+ +LH++    I+HRD+K +N+LL+      + DFGLA+         T  V  
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 280 TMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 313
           T+ + APE  L   + S   D++  G +  EL+T 
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L YLH      +++RD+K  N++LD+D    + DFGL K   +          GT  ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           PE L         D +G G+++ E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 169
           + +   + +G G +G V        G +VAVK+L+  F+S        RE+ ++    H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 170 NLLRLIGFCTTPT---ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
           N++ L+   T      E   VY  + +L  A     +K  +   D V  + +     RGL
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTDDHV--QFLIYQILRGL 133

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           +Y+H   +  IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + AP
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAP 186

Query: 287 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           E  L+    ++  D++  G ++ EL+TG+     +           DH+ +L+   RL  
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----------DHIDQLKLILRLVG 235

Query: 346 IVDRNLNKNYNIQEVETMIQ 365
                L K  + +     IQ
Sbjct: 236 TPGAELLKKISSESARNYIQ 255

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
            EYLH      II+RD+K  N+LLD +    + DFG AK +       T    GT  ++A
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVA 160

Query: 286 PEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           PE +   K  + + D +  GI+L EL+TG
Sbjct: 161 PEIIL-NKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYLH   +  II+RD+K  N+LLD      V DFG AK V  R    T  + GT  ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAP 184

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTG 313
           E + +    +  D +  G++L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 44/239 (18%)

Query: 99  LKRY-----SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PG 151
           L RY        +L++  ++F    V+G+G FG+V         +V A+K L+ FE    
Sbjct: 25  LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
            D+AF  E   I           +    +     L Y F Q+    Y + E  PG  +++
Sbjct: 85  SDSAFFWEERDI-----------MAHANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVN 132

Query: 212 WVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
            ++   +    AR         L+ +H   +   IHRDVK  N+LLD+     + DFG  
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189

Query: 264 KLVDVRKTNVTTQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 313
                 K +    VR     GT  +I+PE L +    G      D +  G+ L E++ G
Sbjct: 190 M-----KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 4/119 (3%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +I
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
           APE L         D +  G+++ E++ G+   D     +  D    D++ ++  EK++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 50/208 (24%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++ +    +G+G FG VY+GV      +   VAVK   +  SP     F +E  ++
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGA 222
               H ++++LIG  T       V+  M+ L+    LR  ++  +  LD  +    +   
Sbjct: 62  RQFDHPHIVKLIGVITENP----VWIVME-LAPLGELRSYLQVNKYSLDLASLILYSYQL 116

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +  L YL    + + +HRD+ A NVL+       +GDFGL++ ++       ++ +  + 
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            +APE ++  + +  +DV+ +G+ + E+
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 44/215 (20%)

Query: 119 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREV-----EMISVAVHR 169
           V+G+G FGKV   +LA    DG   AVK L            Q+++     E   +   R
Sbjct: 2   VIGKGSFGKV---LLAKRKLDGKCYAVKVL------------QKKIVLNRKEQKHIMAER 46

Query: 170 NLLR-------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV 218
           N+L        L+G  +    TE+L  V  F+    + + L RE    EP       +  
Sbjct: 47  NVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFY 101

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A   A  L YLH   +  I++RD+K  N+LLD     V+ DFGL K   + +++ TT   
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC 157

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           GT  ++APE +         D +  G +L E++ G
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 162
           R+L++  +++    V+G+G FG+V         KV A+K L+ FE     D+AF  E   
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--- 92

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
                 R+++    F  +P    L Y F Q+    Y + E  PG  +++ ++   V    
Sbjct: 93  -----ERDIM---AFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 143

Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L+ +H       IHRDVK  N+LLD+     + DFG        K N  
Sbjct: 144 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-----KMNKE 195

Query: 275 TQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 313
             VR     GT  +I+PE L +    G      D +  G+ L E++ G
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 4/94 (4%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L +LHE     II+RD+K  NVLLD D    + D+G+ K   +   + T+   GT  +I
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYI 163

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           APE L   +     D +  G+++ E++ G+   D
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)

Query: 116 EKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 173
           EK  +G+G +G VY+      G  VA+K++  + E  G  +   RE+ ++    H N++R
Sbjct: 5   EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L+    +  +  LV+ F+ +L +   +         LD    K       +G+ Y H H 
Sbjct: 63  LLDVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
             +++HRD+K  N+L+D +    + DFGLA+   V     T +V  T+ + APE L   +
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 294 S-SERTDVFGYGIMLLELVTGQ 314
             S   D++  G +  E+V  +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 38/216 (17%)

Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 125

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK+ V     
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----- 177

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 45/241 (18%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+   VLG+G FGKV   +LA+  GT    A+K L        D   Q + ++    V 
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVVIQDD-DVECTMVE 50

Query: 169 RNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKR 217
           + +L L G          C    +RL  V  ++    + Y+++++ +  EP   +     
Sbjct: 51  KRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY---- 106

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTT 275
            A   A GL +LH   +  II+RD+K  NV+LD +    + DFG+ K  + D     VTT
Sbjct: 107 -AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----GVTT 158

Query: 276 QVR-GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLD 332
           +   GT  +IAPE ++     +  D + +G++L E++ GQ   +    E+ED++   +++
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIME 215

Query: 333 H 333
           H
Sbjct: 216 H 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 47/250 (18%), Positives = 112/250 (44%), Gaps = 30/250 (12%)

Query: 128 VYRGVLADGTKVAVKRLTDFESPGGDA---AFQREVEMISVAVHRNLLRLIGFCTTPTER 184
           +Y+G+  +  +V ++    F   G        + E++ +      N+L++ GF     + 
Sbjct: 36  IYKGIF-NNKEVIIRTFKKF-HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 244
           L     +        LRE+   E  L + T+  +A+   +GL  L+++ N    ++++ +
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151

Query: 245 ANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGHIAPEYLST--GKSSERTD 299
            + L+ E+++  +   GL K++     +  N        M + + + L+    + + + D
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVN-------FMVYFSYKMLNDIFSEYTIKDD 204

Query: 300 VFGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK-KLERE--KRLDAIVDRNLNKN 354
           ++  G++L E+ TG+  I F  L  ++  D+++  +   KL  +    +  IV+   + +
Sbjct: 205 IYSLGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262

Query: 355 Y----NIQEV 360
                NI+E+
Sbjct: 263 SIKRPNIKEI 272

Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           D F     +G+G +G+VY+    D G  VA+K++  D E  G      RE++++    HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 170 NLLRLIGFCTTPTERL----------LVYPFM--------QNLSVAYRLREIKP-GEPVL 210
           N++ L    T   + L          LV+ +M        ++  V +    IK   + +L
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           +             GL Y H       +HRD+K +N+LL+   +  + DFGLA+L +  +
Sbjct: 127 E-------------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 271 TNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVT 312
           +   T    T+ +  PE  L   +     DV+  G +L EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 4/102 (3%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L +LHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 327
           PE L         D +  G+++ E++ G+   D   + +  D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 48/217 (22%)

Query: 119 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G+G FGKV   +LA    DG+  AVK L             ++ E   +   RN+L  
Sbjct: 2   VIGKGSFGKV---LLAKRKSDGSFYAVKVLQK-------KTILKKKEQNHIMAERNVLL- 50

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT---------RKRV------- 218
                    + L +PF+  L  +++  E      VLD+V          R+R        
Sbjct: 51  ---------KNLKHPFLVGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRAR 99

Query: 219 --ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
             A   A  + YLH      II+RD+K  N+LLD     V+ DFGL K   V     T+ 
Sbjct: 100 FYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTST 155

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             GT  ++APE L         D +  G +L E++ G
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 49/203 (24%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 119 VLGQGGFGK--VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           V+G+G FG+  + + V +D  K A+K +   +S       ++E  +++   H N+   + 
Sbjct: 7   VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI---VA 62

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAARGLEYL 229
           F  +      +Y  M+       +++IK       P + +L W  +         G++++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHI 116

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           HE    +++HRD+K+ N+ L ++ +  +GDFG A+L+        T V GT  ++ PE  
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172

Query: 290 STGKSSERTDVFGYGIMLLELVT 312
                + ++D++  G +L EL T
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 32/238 (13%)

Query: 114 FSEKNVLGQGGFGKVY----RGVLADGTK-------------VAVKRLTDFESPGGDAAF 156
           F EK  LG+G FG+V+     G+     K             VAVK L +  +      F
Sbjct: 9   FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66

Query: 157 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD----- 211
            +E++++S     N++RL+  C T     ++  +M+N  +   L   +P E         
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 212 --WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
             + T   +A   A G++YL    +   +HRD+   N L+ +++   + DFG+++ +   
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YS 182

Query: 270 KTNVTTQVRGTMG--HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
                 Q R  +    ++ E +  GK +  +DV+ +G+ L E++T  +   +S+L +E
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 32/214 (14%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           D+      +G G FG+V+           A+K +   +      +     E  ++    H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV-TRKRVALGAAR--- 224
             ++RL  F T   +R L           Y L E  PG  +  ++    R +        
Sbjct: 61  PFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFYA 107

Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
                 LEYLH     +I++RD+K  N+LLD++    + DFG AK +  R    T  + G
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCG 160

Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T  ++APE + +   ++  D +  GI++ E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 170
           ++F     +G G +G VY+    +  ++A  ++   E PG D A  Q+E+ M+    H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSN 67

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYL 229
           ++   G      +  +   F    S+        P  E  + +V+R+ +     +GL YL
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYL 122

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIA 285
           H   +   +HRD+K AN+LL ++    + DFG++  +      RK+ +     GT   +A
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174

Query: 286 PEYLST---GKSSERTDVFGYGIMLLEL 310
           PE  +    G  ++  D++  GI  +EL
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 35/232 (15%)

Query: 119 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 172
           +LG+G FGKV   +L    A G   A+K L            ++EV +    V   L   
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKIL------------KKEVIIAKDEVAHTLTES 46

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-------LGA--A 223
           R++     P    L Y F     + + +  +  GE     ++R+RV         GA   
Sbjct: 47  RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIV 105

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             L+YLH   + KI++RD+K  N++LD+D    + DFGL K   +          GT  +
Sbjct: 106 SALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEY 161

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 335
           +APE L         D +G G+++ E++ G+        E+  +++L++ +K
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +  VY+G     G  VA+K +      G      RE  ++    H N++ L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
             T     LV+ ++      Y   +   G   L     +       RGL Y H+    ++
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYM--DDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSS 295
           +HRD+K  N+L+ E  E  + DFGLA+   V     + +V  T+ +  P+ L  ST  S+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 296 ERTDVFGYGIMLLELVTGQ 314
              D++G G +  E+ TG+
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V          KVAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA--------LGAARGLEYL 229
            T  T        ++N +  Y +  +  G  + + V  ++++            RGL+Y+
Sbjct: 83  FTPATS-------IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-Y 288
           H   +  IIHRD+K +NV ++ED E  + DFGLA+  D   T        T  + APE  
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIM 187

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQ 314
           L+    ++  D++  G ++ EL+ G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 20/131 (15%)

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVD--------VRKTNVT 274
           RGL+Y+H   +  ++HRD+K ANV ++ ED    +GDFGLA++VD        + +  VT
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 275 TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 333
              R      +P   LS    ++  D++  G +  E++TG+     +  E E   L+L+ 
Sbjct: 182 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILES 234

Query: 334 VKKLEREKRLD 344
           V  +  E R +
Sbjct: 235 VPVVREEDRNE 245

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 23/200 (11%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGFC 178
           +G G +G VY+       ++A  ++   E PG D +  Q+E+ M+    H N++   G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
            +  +  +   +    S+        P  E  + +V R+ +     +GL YLH       
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 293
           +HRD+K AN+LL ++ +  + DFG+A      K   T   R    GT   +APE  +  K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 294 S---SERTDVFGYGIMLLEL 310
           +   ++  D++  GI  +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 77/268 (28%), Positives = 113/268 (42%), Gaps = 49/268 (18%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR---- 173
           V+G+G FGKV      A+    AVK L          A  ++ E   +   RN+L     
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQK-------KAILKKKEEKHIMSERNVLLKNVK 54

Query: 174 ---LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGAARG 225
              L+G  F     ++L  V  ++    + Y L RE    EP      R R  A   A  
Sbjct: 55  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 108

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L YLH   +  I++RD+K  N+LLD     V+ DFGL K  ++     T+   GT  ++A
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLA 164

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVL-------------- 329
           PE L         D +  G +L E++ G     +SR   E  D++L              
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITNSA 223

Query: 330 --LLDHVKKLEREKRLDAIVDRNLNKNY 355
             LL+ + + +R KRL A  D    KN+
Sbjct: 224 RHLLEGLLQKDRTKRLGAKDDFMEIKNH 251

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 33/118 (27%), Positives = 66/118 (55%), Gaps = 18/118 (15%)

Query: 205 PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 264
           P + +LDW  +  +AL      +++H+    KI+HRD+K+ N+ L +D    +GDFG+A+
Sbjct: 99  PEDQILDWFVQICLAL------KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149

Query: 265 L----VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           +    V++ +T +     GT  +++PE       + ++D++  G +L E+ T + A +
Sbjct: 150 VLNSTVELARTCI-----GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 17/144 (11%)

Query: 176 GFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPV--LDWVTRKRVALGAARGLEYL-HE 231
           GF +  ++  + + P   + S +   ++ +  E    LD     R +   A+G+++L  +
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK 231

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNVTTQVRGTMGHIAP 286
           +C    IHRDV A NVLL +   A + DFGLA+ +      V K N    V+     +AP
Sbjct: 232 NC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK----WMAP 283

Query: 287 EYLSTGKSSERTDVFGYGIMLLEL 310
           E +     + ++DV+ YGI+L E+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           V+G+G +G V   +    G KVA+K++ D FE         RE++++ +  H +++ +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLRE------IKPGEPVLDWVTRKRVAL---GAARGLE 227
               P+ R       +++ V + L E      IK      D +T +          R L+
Sbjct: 67  IMLPPSRREF-----KDIYVVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALK 117

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVRGTMGHIA 285
           Y+H      + HRD+K  N+L + D +  + DFGLA+    D       T    T  + A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 286 PEYLST--GKSSERTDVFGYGIMLLELVTGQ 314
           PE   +   K +   D++  G +  E++TG+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
           RGL+Y+H   +  ++HRD+K +N+LL+ + +  + DFGLA+    +   +T  V  T  +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 284 IAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 314
            APE L     SE T   DV+  G +  EL+  +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 26/207 (12%)

Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFE------SPGG--DAAFQREVEMISVAVHRN 170
           LGQG F  +Y+GVL        V    +                AF     ++S   H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           L++L G C    E ++V  +++   +   L   +     L W  +  VA   A  L YL 
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHR-EKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 231 EHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVD--VRKTNVTTQVR-GTMGHIA 285
           +    K++H +V   N+L+      E  V      KL D  +  T ++ + R   +  IA
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPF---IKLSDPGIPITVLSREERVERIPWIA 172

Query: 286 PEYLSTGKSSERT--DVFGYGIMLLEL 310
           PE +  G++S     D + +G  LLE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)

Query: 136 GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 194
           G  VAVK+L+  F++        RE+ ++    H+N++ L+    TP + L  +   Q++
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKSLEEF---QDV 101

Query: 195 SVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDE 251
            +   L +    + +   +  +R++    +   G+++LH   +  IIHRD+K +N+++  
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158

Query: 252 DFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
           D    + DFGLA+      TN + T    T  + APE +      E  D++  G ++ EL
Sbjct: 159 DCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 311 VTG 313
           V G
Sbjct: 216 VKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)

Query: 108 QLATDNFSE---KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
             A  + SE    N +G G  G VY+ +    G   A+K +             RE+E++
Sbjct: 67  PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126

Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGA 222
               H N+++         E  ++  FM   S+    + +    E  L  V R+ ++   
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILS--- 179

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
             G+ YLH      I+HRD+K +N+L++      + DFG    LA+ +D   ++V     
Sbjct: 180 --GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----- 229

Query: 279 GTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLELVTGQ 314
           GT+ +++PE ++T  +         D++  G+ +LE   G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 19/200 (9%)

Query: 120 LGQGGFGKVYRG-VLADGTKVAVKRLTD-FESPGGDAAFQREVE-MISVAVHRNLLRLIG 176
           +G+G F +V +      G   A+K +   F+S        RE++ +  ++ H N+LRLI 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65

Query: 177 FC-TTPTERL-LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
                 T RL LV+  M  NL   Y L  IK  +  L     K       + L+++H + 
Sbjct: 66  VLFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTG 292
              I HRD+K  N+L+ +D    + DFG  + +  +     T+   T  + APE  L+ G
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG 174

Query: 293 KSSERTDVFGYGIMLLELVT 312
               + D++  G +  E+++
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 30/166 (18%)

Query: 121 GQGGFGKVYRGVL---ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLL 172
           G+G +G+VY+       DG + A+K+   F+       G   +  RE+ ++    H N++
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 173 RLIGFCTTPTERL--LVYPFMQNLSVAYRLREI-----KPGEPVLDWVTRKRVALGAARG 225
            L+       ++   L++ + +     + L +I     +     +     K +      G
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAE-----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 226 LEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVD 267
           + YLH +    ++HRD+K AN+L+  +     VV  GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 55/217 (25%), Positives = 107/217 (49%), Gaps = 43/217 (19%)

Query: 120 LGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQ---------REVEMIS-VA 166
           LG+G +G V++ +  D      VA+K++ D        AF+         RE+  +  + 
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELG 64

Query: 167 VHRNLLRLIGFCTTPTER--LLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
            H N+++L+       ++   LV+ +M+ +L        I+    +L+ V ++ +     
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAV-----IRAN--ILEDVHKRYIMYQLL 117

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTTQVRG 279
           + L+Y+H   +  +IHRD+K +N+LL+ D    + DFGLA+ +    +  +  V T    
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 280 TMGHIAPEYL--STGKSSERTDVFGYGIMLLELVTGQ 314
           T  + APE L  ST + ++  D++  G +L E++ G+
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHI 284
           L+ +H      ++HRD+K+AN+ L       +GDFG +K   D    +V +   GT  ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           APE     + S++ D++  G++L EL+T  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 18/183 (9%)

Query: 136 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 195
           G +VAVK + D            EV ++    H+N++ +        E  ++  F+Q  +
Sbjct: 46  GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 255
           +   + + +  E  +       V     + L YLH      +IHRD+K+ ++LL  D   
Sbjct: 105 LTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRV 156

Query: 256 VVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
            + DFG    ++K V  RK+ V     GT   +APE +S        D++  GIM++E+V
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 312 TGQ 314
            G+
Sbjct: 212 DGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            +F  K+++G+G FG+V      A G   A+K +        +     E E       R+
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE-------RD 53

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +L +     +P    L Y F    ++ Y + E +PG  +L  + R            YL 
Sbjct: 54  ILSI---SNSPWIPQLQYAFQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA 109

Query: 231 E-----HCNPKI--IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
           E     H   ++  +HRD+K  NVL+D      + DFG A  +   K   +    GT  +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169

Query: 284 IAPEYLST----GKSSE--RTDVFGYGIMLLELVTGQ 314
           IAPE L+T    GK +     D +  G++  E++ G+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 20/143 (13%)

Query: 188 YPFMQNLSVAYRLR-------EIKPGEPVLDWVTRKRVA-------LGA--ARGLEYLHE 231
           +PF+  L  A++         E   G  +   ++R+RV         GA     LEYLH 
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 113

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                +++RD+K  N++LD+D    + DFGL K        + T   GT  ++APE L  
Sbjct: 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 169

Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
                  D +G G+++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 169
           D + +   +G+G +G VY+         +A+K++  + E  G  +   RE+ ++    H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR--KRVALGAARGLE 227
           N++RL     +     LV+ ++        L++     P      R  K       RG+ 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           Y H H   +++HRD+K  N+L+D    A+ + DFGLA+   +     T +V  T+ + AP
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172

Query: 287 EYLSTGKS-SERTDVFGYGIMLLELVT 312
           E L   +  S   D++  G +  E+V 
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++         GT  ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           APE L         D +G G+++ E++ G+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           LE+LH+     II+RD+K  N+LLD      + DFGL K   + +  VT    GT+ ++A
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMA 168

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           PE L      +  D +  G ++ +++TG 
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 62/304 (20%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGF 177
                   + +      T VAVK+  + +S   +     Q+E+       H N+L  +  
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLH-EHC 233
               +E  +V P M   S    L+   P    E  + ++ +          L+Y+H +  
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKGF 122

Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-----RKTNVTTQVRGTMGHI---A 285
               IHR VKA+++LL  D + V+   GL   V +     R+  V    + ++ ++   +
Sbjct: 123 ----IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 286 PEYLSTGKS--SERTDVFGYGI-------------------MLLELVTG--QRAIDFSRL 322
           PE L       +E++D++  GI                   MLLE V G     +D S  
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236

Query: 323 EEEDDVLLLDHVKKLERE---KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 379
              +D +        E       +D    R  +++++        Q   LC Q  PE RP
Sbjct: 237 PLYEDSMS-QSRSSNEHPNNRDSVDHPYTRTFSEHFH--------QFVELCLQRDPESRP 287

Query: 380 AMSE 383
           + S+
Sbjct: 288 SASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--------EPVLDWVTRKRVA 219
           + N ++L    TT    +L+   M      Y    IK G        E  L     K++ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLI---MD-----Y----IKDGDLFDLLKKEGKLSEAEVKKII 115

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQV- 277
                 L  LH+H    IIH D+K  NVL D   + + + D+GL K++       T    
Sbjct: 116 RQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCY 166

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 337
            GT+ + +PE +         D +  G++  EL+TG+        E+ED+ L    ++ L
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK----EDEDEEL---DLESL 219

Query: 338 EREKRLDAIVDRNLNKN 354
            + ++      +N++KN
Sbjct: 220 LKRQQKKLPFIKNVSKN 236

Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 10/92 (10%)

Query: 223 ARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVR 278
           A+G+ +L  ++C    IHRD+ A N+LL       + DFGLA+  D+R  +   V    R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNYVVKGNAR 277

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
             +  +APE +     +  +DV+ YGI+L E+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 12/110 (10%)

Query: 208 PVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 266
           P L ++     +   A G+E+L  ++C    +HRD+ A NVL+ E     + DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289

Query: 267 DVRKTNVTTQVRGT----MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            +R +N  +  +G+    +  +APE +     +  +DV+ +GI+L E+ T
Sbjct: 290 -MRDSNYIS--KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 51/223 (22%)

Query: 120 LGQGGFGKV----YRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVE-MISV 165
           LGQG +G V         ++   VA+K++T+         F          RE++ +   
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITN--------VFSKKILAKRALRELKLLRHF 58

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA-- 223
             H+N+  L           +   F  N +  Y   E    E  L  + R    L  A  
Sbjct: 59  RGHKNITCLYD---------MDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHF 107

Query: 224 --------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT- 274
                    GL+Y+H   +  ++HRD+K  N+L++ D E  + DFGLA+           
Sbjct: 108 QSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164

Query: 275 --TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 314
             T+   T  + APE  LS    ++  DV+  G +L EL+  +
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 10/126 (7%)

Query: 186 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 244
           LV P  ++    Y    ++P G   +  V R+   L A   ++Y+H      IIHRD+K 
Sbjct: 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ--LLSA---IDYIHGE---GIIHRDIKT 288

Query: 245 ANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 303
            NVL++   +  +GDFG A        T     + GT+   APE L+    +   D++  
Sbjct: 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348

Query: 304 GIMLLE 309
           G+++ E
Sbjct: 349 GLVIFE 354

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 41/167 (24%)

Query: 122 QGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMIS------VAVHRNLLRL 174
           +G FGKVY G   + +K+ AVK +             ++ +MI+      V   R+ L L
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVV-------------KKADMINKNMVHQVQAERDALAL 60

Query: 175 IG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------LDWVTRKRVALGAA 223
               F         +Y  +Q+ +  Y + E   G  V          D     +     A
Sbjct: 61  SKSPFIVH------LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             L+YLH H    IIHRD+K  N+L+  +    + DFGL+K V + +
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-- 280
           ARG+E+L    +   +HRD+ A NVLL +     + DFGLA+  D+   +       T  
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFL 301

Query: 281 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            +  +APE +     +  +DV+ YGI+L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 19/103 (18%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL---------------VDVRK 270
           LEYLH   N  I+HRD+K  N+L+       + DFGL+K+                D R+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             +  QV GT  +IAPE +      +  D +  GI+L E + G
Sbjct: 171 F-LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)

Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 154
           F  LKRY          N        QG     Y  VL     VA+K+L+  F++     
Sbjct: 13  FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAK 61

Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 214
              RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   + 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLN-VFTPQKSLEEF---QDVYLVMELMDANLCQVIQMELD 117

Query: 215 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
            +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      +
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
            + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)

Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 154
           F  LKRY          N        QG     Y  +L     VA+K+L+  F++     
Sbjct: 20  FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK 68

Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 214
              RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   + 
Sbjct: 69  RAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLCQVIQMELD 124

Query: 215 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
            +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      +
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 179

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            + T    T  + APE +      E  D++  G ++ E++ G 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 32/217 (14%)

Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQGG+G+V+     D G  VA+KR+         +   +  E+  V   R++L      
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKK-------SLLFKLNEVRHVLTERDIL-----T 56

Query: 179 TTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAAR--------GLE 227
           TT +E L  L+Y F Q+    Y   E  PG      +    V +   AR         ++
Sbjct: 57  TTKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
            LHE      IHRD+K  N L+D      + DFGL+K + V   N    V G+  ++APE
Sbjct: 116 ALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPE 168

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 324
            L         D +  G ML E + G      S   E
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 41/152 (26%), Positives = 61/152 (40%), Gaps = 48/152 (31%)

Query: 198 YRLREIKPGEPVLDWVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLL 249
           +RL + +PG         K ++   AR         LEYLH      I++RD+K  N+LL
Sbjct: 89  FRLLQRQPG---------KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILL 136

Query: 250 DEDFEAVVGDFGLAKLVDVRKTNVTTQVR----------------------------GTM 281
            E    ++ DF L+K  DV    V+  +R                            GT 
Sbjct: 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +IAPE +S        D +  GI+L E++ G
Sbjct: 197 EYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 16/208 (7%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G+G +G VY+    DG       L   E  G   +  RE+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 180 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           + ++R   L++ + ++    +   +R  +       L     K +      G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 234 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 287
              ++HRD+K AN+L+     E     + D G A+L +  ++       V  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTGQ 314
            L   +  ++  D++  G +  EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 16/208 (7%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G+G +G VY+    DG       L   E  G   +  RE+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 180 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           +  +R   L++ + ++    +   +R  +       L     K +      G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 234 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 287
              ++HRD+K AN+L+     E     + D G A+L +  ++       V  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTGQ 314
            L   +  ++  D++  G +  EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 9e-04
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 11/93 (11%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG---TM 281
           G+++LH   +  IIHRD+K +N+++  D    + DFGLA     R    +  +     T 
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPYVVTR 181

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            + APE +      E  D++  G ++ E++ G 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 11/206 (5%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 169
           + F    V+G+G +G V +    +  + VA+K+  D E +        RE++M+      
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++ L        +  LV+ +++  ++   L E+  G P  + V  +       + + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKV--RSYIYQLIKAIHWC 116

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 288
           H++    I+HRD+K  N+L+  +    + DFG A+ L +    N T  V  T  + +PE 
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQ 314
           L      +  D++  G +L EL  GQ
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 168
           ++F    V+G+G FG+V    L +  KV A+K L  +E       A F+ E +++    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
           + +  L           LV  +      L++  +  +  P +    ++    +A+ +   
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVDVRKTNVTTQVRGTMGHI 284
           L Y         +HRD+K  N+L+D +    + DFG   KL++      +  V GT  +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170

Query: 285 APEYLST-----GKSSERTDVFGYGIMLLELVTGQ 314
           +PE L       GK     D +  G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 118 NVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRNLLRLI 175
           N++G G FG VY  +  D + KVA+K++        D  ++ RE+ ++    H N++ L 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLK 125

Query: 176 GFCTTPTER-----LLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
            +  T   +     + +   M+ +  +V   ++        L     K  +    R L Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           +H      I HRD+K  N+L+D +   + + DFG AK +   + +V+     +  + APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPE 240

Query: 288 -YLSTGKSSERTDVFGYGIMLLELV------TGQRAID 318
             L     +   D++  G ++ E++      +GQ ++D
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Length = 440

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 168
           D+F    V+G+G FG+V    +    ++ A+K L  +E       A F+ E         
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--------- 51

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           RN+L + G C   T   L Y F Q+ +  Y + +   G  +L  +++    L       Y
Sbjct: 52  RNVL-VNGDCQWITT--LHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 229 LHEHC-------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
           + E             +HRD+K  NVLLD +    + DFG    ++   T  ++   GT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 282 GHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 314
            +I+PE L       GK     D +  G+ + E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 28/164 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           ++F    V+G+G FG+V R V     G   A+K L   E       F+++ ++  V   R
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSE------MFKKD-QLAHVKAER 52

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW----------VTRKRVA 219
           ++L       +P    L Y F Q+    Y + E  PG  ++            VTR  +A
Sbjct: 53  DVL---AESDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
                 +E +H+      IHRD+K  N+L+D      + DFGL+
Sbjct: 109 -ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 45/131 (34%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL----------------------- 262
           +E +H       IHRD+K  N+L+D D    + DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 263 ------------AKLVDVRKTNVTTQVR-------GTMGHIAPEYLSTGKSSERTDVFGY 303
                        +L  + +       R       GT  +IAPE L     ++  D +  
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 304 GIMLLELVTGQ 314
           G++L E++ GQ
Sbjct: 231 GVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	437
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
smart00090	237	RIO RIO-like kinase.	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
COG4248	637	Uncharacterized protein with protein kinase and he	98.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.67
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.63
PRK09902	216	hypothetical protein; Provisional	98.52
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.19
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.15
PLN02876	822	acyl-CoA dehydrogenase	98.11
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.07
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.02
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89
PRK10593	297	hypothetical protein; Provisional	97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.79
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.68
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.66
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.53
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.53
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.33
PRK05231	319	homoserine kinase; Provisional	97.3
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.12
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.92
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.81
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.68
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.63
PLN02236	344	choline kinase	96.52
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.45
KOG2270	520	consensus Serine/threonine protein kinase involved	96.43
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.17
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	95.98
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.92
PLN02756	418	S-methyl-5-thioribose kinase	95.78
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.76
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.64
COG2334	331	Putative homoserine kinase type II (protein kinase	95.61
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.57
PRK11768	325	serine/threonine protein kinase; Provisional	95.38
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.34
PRK06148	1013	hypothetical protein; Provisional	95.04
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.84
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.8
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.6
PTZ00384	383	choline kinase; Provisional	94.48

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-60  Score=461.40  Aligned_cols=288  Identities=51%  Similarity=0.848  Sum_probs=253.1

Q ss_pred             CccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeee
Q 013750           98 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF  177 (437)
Q Consensus        98 ~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~  177 (437)
                      ..+.|+++|+..||++|+..+.||+|+||.||+|.+++|..||||++....... ..+|.+|++++++++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            567899999999999999999999999999999999999999999887644332 5679999999999999999999999


Q ss_pred             eecCC-eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          178 CTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       178 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      |.+.+ +.+||||||++|+|.++|+.....  +++|.+|++||.++|+||+|||+.+.|+|+||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99999 599999999999999999875433  689999999999999999999999999999999999999999999999


Q ss_pred             EeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          257 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |+|||+|+..........+...||.+|+|||++..+..+.|+|||||||+++||+||+.+.+.....  ....+..|...
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHHH
Confidence            9999999765431111111117999999999999999999999999999999999999988765422  22337888888


Q ss_pred             HHhccchhhhcccccc-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLN-KNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....+.+.+++|+.+. ..+.. .+...+..++.+|++.+|.+||+|.||+++|+.
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            8888899999999987 56664 688999999999999999999999999999955

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-51  Score=395.50  Aligned_cols=255  Identities=33%  Similarity=0.504  Sum_probs=211.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCC-eeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~  190 (437)
                      ++...+.||+|+||+||+|.+++...||||++..... ....++|.+|+.+|.+++|||||+++|+|.++. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3344566999999999999997444499999975432 222679999999999999999999999999988 79999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eEecCCCCCCeeecCCC-cEEEeecCCceeccc
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDV  268 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~  268 (437)
                      +++|+|..+++..  ....+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++....
T Consensus       122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999874  345599999999999999999999999   7 99999999999999997 999999999986653


Q ss_pred             CCCccccccccccccccccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLS--TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .. ...+...||..|||||++.  ...|+.|+||||||+++|||+||+.||.....        ...         ...+
T Consensus       197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~---------~~~v  258 (362)
T KOG0192|consen  197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQV---------ASAV  258 (362)
T ss_pred             cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHH---------HHHH
Confidence            22 3334467999999999999  56899999999999999999999999974322        011         1122


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      +....+...+..++..+..++..||+.||+.||++.+++..|+.
T Consensus       259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            22333344444567799999999999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=400.35  Aligned_cols=255  Identities=30%  Similarity=0.438  Sum_probs=216.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .+.+...+.||+|.||.||.|.+++...||+|.++..  ....++|.+|+++|++++|+|||+++|+|......+|||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            3344456789999999999999987889999999864  34567899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |++|+|.+||+.  .+...+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+|||+|+....+.
T Consensus       283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            999999999987  2445588999999999999999999999   99999999999999999999999999999554444


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...        ...+.+..+.++.        
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~le~Gy--------  421 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELLERGY--------  421 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHHhccC--------
Confidence            334444455779999999999999999999999999999999 77776532        2334444444443        


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        +...|..|+..++++|..||+.+|++|||++.+...|+.
T Consensus       422 --Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  422 --RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             --cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence              334466788899999999999999999999999988876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-50  Score=410.19  Aligned_cols=262  Identities=26%  Similarity=0.433  Sum_probs=219.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      +....+....+.||+|.||+||+|...      +.+.||||.+++..+.+..++|.+|+++++.++|||||+|+|+|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            334555666788999999999999853      35679999999877777889999999999999999999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPG----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE  251 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~  251 (437)
                      +..++|+|||..|+|.+||....+.          ..+|+..+.+.||.|||.||.||.++   .++||||.++|+|+.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            9999999999999999999765321          23488999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhh
Q 013750          252 DFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       252 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~  329 (437)
                      +..+||+|||+++..-..+... .....-+.+|||||.+..++||.+||||||||+|||++| |+.|+.....++     
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence            9999999999998553333222 212334679999999999999999999999999999999 888886433221     


Q ss_pred             HHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .+         ..+-++.+ -+.+.+++..+++||..||+.+|.+||+++||-..|+.
T Consensus       714 ---VI---------e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  714 ---VI---------ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             ---HH---------HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence               11         11222233 34567788999999999999999999999999999987

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=361.91  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=210.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-eeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~  190 (437)
                      +++..+.||+|..|+|||+.++ ++..+|+|++.....+...++..+|++++.+.+|||||.++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445688999999999999986 688999999965555667788999999999999999999999999888 59999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++|||+..+....    .+++...-+++.+|++||.|||+ +   +||||||||+|||++..|++||||||.++.+...
T Consensus       160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999998653    37888999999999999999996 6   8999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                         ....++||..|||||.+++..|+.++||||||+.++|+.+|+.|+............+.            ..+++.
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~  297 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDE  297 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcC
Confidence               34557899999999999999999999999999999999999999976522222222222            222221


Q ss_pred             cccCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          350 NLNKNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       350 ~l~~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .. ...+. ..+.++.+++..|+++||.+||++.|+++.
T Consensus       298 pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 PP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11 11122 356789999999999999999999999853

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=354.59  Aligned_cols=202  Identities=24%  Similarity=0.405  Sum_probs=181.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+.+|++++|||||.|++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457778888999999999999975 58999999997543 3556777889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC------CcEEEeecCC
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED------FEAVVGDFGL  262 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~------~~~kl~Dfgl  262 (437)
                      |||.+|+|..|++...    .++..+...++.|+|.||++||++   +||||||||+||||+..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            9999999999999764    389999999999999999999999   99999999999999765      5689999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR  321 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~  321 (437)
                      |+.+.  ........+|++-|||||++..++|+.|+|+||+|+++||+++|+.||+..+
T Consensus       162 AR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  162 ARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99876  3334455789999999999999999999999999999999999999998543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=386.31  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=225.6

Q ss_pred             ccCHHHHHHHhcCC---------CCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcc
Q 013750          101 RYSWRELQLATDNF---------SEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV  167 (437)
Q Consensus       101 ~~~~~e~~~~~~~~---------~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~  167 (437)
                      .++|++...|...|         .+.++||.|.||.|++|.++-    ...||||.++...+.+...+|+.|..+|.++.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            45666655554444         456899999999999999852    45799999998887888899999999999999


Q ss_pred             cccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       168 H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      ||||++|.|+.+..+..++|+|||+||+|+.||+...   ..+.+.+...+..+||.||+||.++   +++||||.++||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI  762 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI  762 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence            9999999999999999999999999999999998743   3389999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCcccccc--cccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      |++.+...|++|||+++.+..+....++..  .-+.+|.|||.+..+++|.+|||||||+++||.++ |.+|+=.     
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd-----  837 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-----  837 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc-----
Confidence            999999999999999998876654443332  34679999999999999999999999999999888 9998731     


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         +.-.+.+...+.+.+          -..+.+|+..+.+||+.||++|-.+||.+.+|+..|++
T Consensus       838 ---mSNQdVIkaIe~gyR----------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  838 ---MSNQDVIKAIEQGYR----------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             ---cchHHHHHHHHhccC----------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence               112233334333333          34467788999999999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-46  Score=368.79  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=211.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..|...++||+|+|+.||.++. .+|+.||+|++.+.  ......+...+|+++-++++|||||++++++++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688889999999999999997 78999999999652  23556778899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      |+|++++|..+++..+    ++++..+..+..||+.||.|||++   +|+|||||..|+||+++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999988543    489999999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      +. ......+||+.|+|||++.....+..+||||+||++|-|+.|++||+.....+        -........       
T Consensus       171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~-------  234 (592)
T KOG0575|consen  171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNE-------  234 (592)
T ss_pred             cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcC-------
Confidence            43 34455789999999999999999999999999999999999999998543221        111111000       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          -.+|...+....+|+.++|+.||.+|||+.+|+.
T Consensus       235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                0112344567889999999999999999999994

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.3e-46  Score=339.37  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      +.|+...++|+|+||+|||++++ +|+.||||++.+..+ +.-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999986 599999999986554 3334556799999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||+.--|++ |+....+   ++.....+++.|+++|+.|+|++   +++||||||+|||++.++.+||||||+|+.+.. 
T Consensus        82 ~~dhTvL~e-Le~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHTVLHE-LERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchHHHHH-HHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            998855544 4443322   78888999999999999999999   999999999999999999999999999998764 


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------  339 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  339 (437)
                      ....++..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|...+     +++.+..+.....         
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-----DiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-----DIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-----hHHHHHHHHHHHcccCHHHHHH
Confidence            5556777889999999999987 679999999999999999999999886533     2333333322111         


Q ss_pred             ---c-----cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 ---E-----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ---~-----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         .     -.+++.-++.......+..+.-+.+++..|++.||++|++.++++.
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1     1111111111112223444567899999999999999999999984

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-46  Score=351.71  Aligned_cols=256  Identities=24%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCc------chHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG------GDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ..+.|...+.||+|+||.|-+|..+ +|+.||||++++.....      ......+|+++|++++|||||++.+++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4566788899999999999999964 69999999997533211      1223469999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEEee
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGD  259 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~D  259 (437)
                      ..|+|+||+++|.|.+++-...    .+.......++.|++.|+.|||+.   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999987543    266667788999999999999999   99999999999999766   8899999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      ||+|+..+  ....+...+||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.....+..    +.     
T Consensus       323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----l~-----  391 (475)
T KOG0615|consen  323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----LK-----  391 (475)
T ss_pred             cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----HH-----
Confidence            99999765  445566789999999999997654   34588999999999999999999975433221    11     


Q ss_pred             HHhccchhhhccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLNK--NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             +.+...+..-  .......++..+|+.+|+..||++|||+.|+++.-..
T Consensus       392 -------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  392 -------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             -------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence                   1111222111  1123456789999999999999999999999875544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-47  Score=342.06  Aligned_cols=259  Identities=21%  Similarity=0.345  Sum_probs=211.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecc-CCCCcchHHHHHHHHHHHhcccccceeeee-eeecCCe-eEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIG-FCTTPTE-RLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv  187 (437)
                      .+|.+.+.||.|.||+|||+. ..+|..+|.|.++- .-+.+..++...|+.+|++++|||||+.++ -+...++ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            346667889999999999998 46899999999872 123455678889999999999999999998 3444444 8999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP-KIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||..|+|...+...+.+...++....++++.|++.||..+|+.... -++||||||.||+|+.+|.+||+|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999999888888899999999999999999999995332 2999999999999999999999999999988


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      +.. .......+||+.||+||.+....|+.+|||||+||++|||+.-+.||...+        +.......... ...  
T Consensus       179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qg-d~~--  246 (375)
T KOG0591|consen  179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQG-DYP--  246 (375)
T ss_pred             cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcC-CCC--
Confidence            643 334455789999999999999999999999999999999999999997542        22222222111 111  


Q ss_pred             ccccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          347 VDRNLNKNYN-IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       347 ~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                             ..+ ...+.++.+|+..|+..||+.||+.-.+++.+.
T Consensus       247 -------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 -------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                   112 456789999999999999999999555554443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-45  Score=353.78  Aligned_cols=266  Identities=20%  Similarity=0.334  Sum_probs=216.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .+.+.+.+.++||+|.||.|.++...++..||||+++.........+|.+|+++|.+++||||+.|+|+|..++.+++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            34556677899999999999999998889999999998777777789999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      |||++|+|..|+.......  ++-....+|+.|||.||+||.+.   +++||||.++|+|+|.++++||+|||+++.+-.
T Consensus       615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999998754322  45566678999999999999999   999999999999999999999999999995533


Q ss_pred             CCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          269 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       269 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .+. ......+-+.+|||||.+..+++|.+||||+||+.+||+++  ...|+.....     ....+....+.+.+....
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~  764 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQV  764 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcce
Confidence            322 22333456789999999999999999999999999999876  5667642111     112222222222222211


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      +      ...++-++..+++++..||..+..+||+++++...|..
T Consensus       765 ~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  765 V------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             e------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            1      12245567799999999999999999999999998875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=338.57  Aligned_cols=244  Identities=25%  Similarity=0.286  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..++|++.++||+|+||+||.++.+ +++.+|+|++++..  .....+....|..+|.+++||.||++.-.+++...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4678999999999999999999964 58999999997533  33456778899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |+||+.||.|..+|.+..    .++...+.-++..|+.||.|||++   +|+||||||+|||||++|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999998533    378888889999999999999999   9999999999999999999999999999854


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      - .....+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+..        ..........     
T Consensus       176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k-----  241 (357)
T KOG0598|consen  176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGK-----  241 (357)
T ss_pred             c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCc-----
Confidence            3 2333444579999999999999999999999999999999999999999754321        1222222211     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP  379 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  379 (437)
                           ....+.-......+++...++.||++|-
T Consensus       242 -----~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                 0111222345788999999999999995

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-44  Score=352.73  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=205.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      ...++|.+.+.||+|+||.||+|.+      .++..||+|++.........+.+.+|+.++..+ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3457788899999999999999974      235689999997544444556799999999999 899999999998765


Q ss_pred             C-eeEEEEecccCchhhhhhhhcCCC------------------------------------------------------
Q 013750          182 T-ERLLVYPFMQNLSVAYRLREIKPG------------------------------------------------------  206 (437)
Q Consensus       182 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  206 (437)
                      + ..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 578999999999999998753210                                                      


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-cccccccc
Q 013750          207 ----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTM  281 (437)
Q Consensus       207 ----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~  281 (437)
                          ...+++.....++.||++||+|||++   +++||||||+|||++.++.+||+|||+++......... .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                13478889999999999999999999   99999999999999999999999999998653322211 12234567


Q ss_pred             cccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHH
Q 013750          282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEV  360 (437)
Q Consensus       282 ~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  360 (437)
                      .|+|||.+.+..++.++||||||+++|||++ |..||.......    ..   .........          ...+...+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~---~~~~~~~~~----------~~~~~~~~  303 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EF---CQRLKDGTR----------MRAPENAT  303 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HH---HHHHhcCCC----------CCCCCCCC
Confidence            8999999999999999999999999999997 999986432211    01   111111100          11122334


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          361 ETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       361 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            578999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=380.10  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--C----CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD--G----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++.+..+.||+|.||.||.|...+  |    ..||||.+.+..+.+...+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455667899999999999999643  3    359999999888888899999999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          185 LLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ++++|||++|+|..||++..+   +...++..+.+.++.|||+|+.||+++   ++|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998643   245688899999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCccccc-ccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          262 LAKLVDVRKTNVTTQ-VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       262 la~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +|+............ ..-...|||||.+..+.+|.|+|||||||++||++| |..||...+..        +.......
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------~v~~~~~~  919 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------EVLLDVLE  919 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------HHHHHHHh
Confidence            999443322222111 233569999999999999999999999999999999 77777533211        11111112


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ++          +-..+..|++.++++|..||+.+|++||++..+++.++.
T Consensus       920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence            22          334467788899999999999999999999999998765

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=353.34  Aligned_cols=264  Identities=28%  Similarity=0.462  Sum_probs=213.7

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      .++++...+++.....||+|.||+||+|.|.  -.||||+++... ++...+.|.+|+.++++-+|.||+-+.|||.++.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4677777788888999999999999999995  469999997433 4557789999999999999999999999999988


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      . .+|+.||++.+|+.+++...   ..++..+.+.|+.|||+||.|||.+   +|||||||+.||+|.+++.+||+|||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            7 99999999999999998744   3488899999999999999999999   999999999999999999999999999


Q ss_pred             ceecccC-CCcccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          263 AKLVDVR-KTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       263 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      +..-... .........|...|||||++..   .+|+.+|||||||+++|||+||..||.. +....  +.     ...-
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq--Ii-----fmVG  606 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ--II-----FMVG  606 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh--eE-----EEec
Confidence            9754432 2222334557889999999964   3689999999999999999999999972 22111  00     0000


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ++....+.      .....+++.++.+|+..||..++++||.+.+|+..|+.
T Consensus       607 rG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~  652 (678)
T KOG0193|consen  607 RGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE  652 (678)
T ss_pred             ccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence            11001111      11234566789999999999999999999999998876

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-45  Score=353.66  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=226.7

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ++++....+....++||.|.||.||.|+|+. ...||||.+++.  ....++|++|..+|+.++|||+|+|+|+|+....
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            6777777888889999999999999999975 678999999863  4568899999999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+|+|||..|+|.+||++...  ..+.-...+.++.||+.||.||..+   ++|||||.++|+|+.++..+|++|||++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence            9999999999999999998743  3366677889999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      +++..+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+...+        +..          
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSq----------  474 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQ----------  474 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHH----------
Confidence            9887655544444445779999999999999999999999999999998 888875322        211          


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...++....+.+-+..|+..+++||+.||+++|.+||++.|+-+.+|.
T Consensus       475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            234455555666677888999999999999999999999999999987

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=384.75  Aligned_cols=259  Identities=26%  Similarity=0.513  Sum_probs=212.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ...|...+.||+|+||.||+|+. .++..||||++.....     ....|++.+++++|||||+++|+|.+.+..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            35677889999999999999997 4789999999864321     12356889999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.++++.       ++|..+.+++.|+|+||+|||+.+.++++||||||+||+++.++.+++. ||........
T Consensus       764 y~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        764 YIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             CCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999863       7899999999999999999997777799999999999999999988875 6665432211


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                           ....++..|+|||++.+..++.++|||||||++|||+||+.|++.....   ......|.+............|+
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHhcCccchhheeCc
Confidence                 1235789999999999999999999999999999999999998643222   22244555544444445566666


Q ss_pred             cccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNK--NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .+..  ..+.++..++.+++.+||+.||++||||.|+++.|+.
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  950 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES  950 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence            6543  3356677889999999999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-44  Score=336.66  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC--eeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv  187 (437)
                      ..++...+.||+|+||+||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+.+|......  .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            3456667899999999999999754 8999999986543222 667899999999999999999999855544  58899


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceec
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLV  266 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~  266 (437)
                      |||+++|+|.+++.....   .++...+.++..||++||+|||++   +++|+||||+|||++. ++.+||+|||+++..
T Consensus        95 mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            999999999999987542   489999999999999999999999   9999999999999999 799999999999876


Q ss_pred             cc--CCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DV--RKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..  ..........||+.|||||++..+. ...++|||||||++.||+||+.||... ..      ...+.-.....   
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~------~~~~~~~ig~~---  238 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE------EAEALLLIGRE---  238 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc------hHHHHHHHhcc---
Confidence            53  2223344578999999999998643 345999999999999999999998632 00      01111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                            .....++...+.+..+++..|++.||++|||+.++++..
T Consensus       239 ------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  239 ------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                  111244555667899999999999999999999999754

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=352.92  Aligned_cols=260  Identities=28%  Similarity=0.417  Sum_probs=212.0

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC--C--CE-EEEEEecc--CCCCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD--G--TK-VAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~-vAvK~l~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      .++...++....++||+|+||.||+|.+..  +  .. ||||..+.  ........+|.+|.+++..++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345556666777999999999999999743  2  23 89999874  23456678999999999999999999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      ......++|||+|+||+|.++|.....   .++..++..++.+.|.||+|||++   +++||||.++|+|++.+..+||+
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence            999999999999999999999987542   489999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCcccc-cccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 013750          259 DFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |||+++...  ...... ...-+..|+|||.+..+.|+.++|||||||++||+++ |..|+......        +... 
T Consensus       305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~-  373 (474)
T KOG0194|consen  305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKA-  373 (474)
T ss_pred             ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHH-
Confidence            999988543  111111 1235679999999999999999999999999999999 78888643221        1111 


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              .+.....+...+...+..+..++.+||..+|++||+|.++.+.|+.
T Consensus       374 --------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~  419 (474)
T KOG0194|consen  374 --------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA  419 (474)
T ss_pred             --------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence                    1112222333344566788899999999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.3e-43  Score=336.80  Aligned_cols=265  Identities=22%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-----------------CCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR  173 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  173 (437)
                      .++|...+.||+|+||.||++.+++                 +..||+|.+..........+|.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3567888999999999999998642                 33699999876444445568999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCchhhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 013750          174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKII  238 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii  238 (437)
                      +++++...+..++||||+++|+|.+++.....               ....++|....+++.||+.||.|||+.   +++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999999865321               123478899999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhC--CC
Q 013750          239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG--QR  315 (437)
Q Consensus       239 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg--~~  315 (437)
                      ||||||+|||+++++.+||+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865432221 12223457889999999988999999999999999999975  44


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          316 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       316 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      |+.....  .   ...............      ......++.++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       241 p~~~~~~--~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTD--E---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCH--H---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5542211  1   111111111111000      0001112234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-42  Score=331.92  Aligned_cols=260  Identities=15%  Similarity=0.253  Sum_probs=203.8

Q ss_pred             CccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc--chHHHHHHHHHHHhcccccceeee
Q 013750           98 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLI  175 (437)
Q Consensus        98 ~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~  175 (437)
                      +.+..+.+++     +......||+|++|.||+|.+ +|+.||||++.......  ..+.|.+|+.++.+++||||++++
T Consensus        11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             cceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            3444555555     222336799999999999999 68999999997533211  146788999999999999999999


Q ss_pred             eeeec----CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC
Q 013750          176 GFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE  251 (437)
Q Consensus       176 g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~  251 (437)
                      |++.+    ....++||||+++|+|.+++...    ..+++....+++.+++.||.|||+..  +++||||||+|||+++
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~  158 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE  158 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence            99876    34678999999999999998753    24889999999999999999999742  6789999999999999


Q ss_pred             CCcEEEeecCCceecccCCCcccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh
Q 013750          252 DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       252 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  329 (437)
                      ++.+||+|||+++......    ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||......     .
T Consensus       159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~  229 (283)
T PHA02988        159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----E  229 (283)
T ss_pred             CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----H
Confidence            9999999999998653221    22457889999999976  67999999999999999999999999743211     1


Q ss_pred             HHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...   ..         .........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       230 ~~~---~i---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        230 IYD---LI---------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHH---HH---------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            111   11         11111112223456689999999999999999999999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.5e-43  Score=329.86  Aligned_cols=256  Identities=24%  Similarity=0.310  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++..........|.+|+.++.+++||||++++|++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888899999999999999863    3568999999865444555689999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999987532   3488999999999999999999999   9999999999999999999999999987653


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ............++..|+|||.+.+..++.++|||||||++||+++ |+.||......        .........     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~-----  224 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDG-----  224 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCC-----
Confidence            2222111112335678999999999999999999999999999875 99998643211        111111111     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           .....+..++..+.+++..||+.+|++||++.++.+.|++
T Consensus       225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                 0111233455689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.5e-43  Score=347.51  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=206.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  180 (437)
                      ....++|+..+.||+|+||.||+|+.      .++..||||++.........+.+.+|+.++..+ +||||++++++|..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            33456788899999999999999974      235689999997544444566789999999999 89999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCC-------------------------------------------------------
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKP-------------------------------------------------------  205 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  205 (437)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999999864321                                                       


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          206 ----------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       206 ----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                                      ....+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                            112478899999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          270 KTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       270 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......    .......    ..      
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~----~~------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIK----EG------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHH----hC------
Confidence            2211 112234568999999999999999999999999999998 888875322111    1111111    10      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .....+...+.++.+++.+||+.||++||++.|+++.|+.
T Consensus       334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               0011111224578999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=346.05  Aligned_cols=248  Identities=24%  Similarity=0.408  Sum_probs=206.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++..+.....+-||+|+-|.||+|++. ++.||||+++...        ..+++-|++++||||+.+.|+|.....+|+|
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            333444455678999999999999995 7999999886422        3578889999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||||+.|-|.+.|+...    ++.-.....+..+||.||.|||.+   .|||||||+-||||+.+..+||+|||-++...
T Consensus       191 MEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            99999999999998643    266677788999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .....++||..|||||++.+.+.++|+|||||||+||||+||..|+......                 ..+--+-
T Consensus       264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------------AIIwGVG  324 (904)
T KOG4721|consen  264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------------AIIWGVG  324 (904)
T ss_pred             hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------------eeEEecc
Confidence            32  3345688999999999999999999999999999999999999998521110                 0011111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...|.-..+..++..+.-|+++||+..|.+||++.+++..|+-
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            2223344567788899999999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-43  Score=335.53  Aligned_cols=264  Identities=23%  Similarity=0.304  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  186 (437)
                      .+.|+..++||+|+||.||+|+. .+|+.||+|++.-.. .+....-..+||.+|++++||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45677788999999999999995 579999999987433 344555667999999999999999999999877  68999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |+|||++ +|.-++...   ...++..++..++.|++.||+|+|++   +++|||||.+|||||.+|.+||+|||||+++
T Consensus       196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999987 677776642   33488999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH-------
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-------  338 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  338 (437)
                      ........+..+-|.+|.|||.+.+. .|+.+.|+||.|||+.||++|++.++......     .+..+-.+-       
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-----Ql~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-----QLHKIFKLCGSPTEDY  343 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-----HHHHHHHHhCCCChhc
Confidence            87777767778889999999999876 59999999999999999999999987654322     222221110       


Q ss_pred             -hccchhhhccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          339 -REKRLDAIVDRNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       339 -~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ....+.....-.....+.       ...+...++|+..+|..||++|.|+.++++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             000111000000001111       122356788999999999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-44  Score=339.26  Aligned_cols=262  Identities=21%  Similarity=0.278  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCC-eeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT-ERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv  187 (437)
                      -++|...+.||.|+||.||+|+. .+|..||||+++..--.-+.-.=++|++.|.+++ ||||++|.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            46677789999999999999995 4689999999975332222223458999999999 999999999998888 89999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||||+. +|..++++.   ...++...+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+...
T Consensus        89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999975 888888764   56699999999999999999999999   99999999999999999999999999999664


Q ss_pred             cCCCccccccccccccccccccc-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc----
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR----  342 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  342 (437)
                        .....+..+.|.+|.|||++. .+.|+.+.|+|++||+++|+.+-++.|.+.+..     +.+..+........    
T Consensus       162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-----DQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-----HHHHHHHHHhCCCccccc
Confidence              334466778999999999885 567999999999999999999999988754322     22222222111111    


Q ss_pred             -----hhhhcc--------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 -----LDAIVD--------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 -----~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           +...+.        ..+. ..-+..+.+..+++.+|+++||++|||+.|.++.
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                 111111        1111 1123367789999999999999999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-42  Score=307.23  Aligned_cols=266  Identities=22%  Similarity=0.302  Sum_probs=209.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|...+.||+|.||.||+|++ ++|+.||||+++... ..+-....++|++.|+.++|+||+.|++++...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4567788999999999999995 579999999997533 23445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||+. +|+..+++   ....++-.++..++.++.+|++|||++   .|+||||||+|+|+++++.+||+|||+++.+...
T Consensus        82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 78888876   445688899999999999999999999   8999999999999999999999999999988754


Q ss_pred             CCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh----
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD----  344 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  344 (437)
                      .... +..+.|-+|.|||.+.+. .|+...||||.||++.||+.|.+-|.+.+     ++.....+-........+    
T Consensus       155 ~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-----DidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  155 NRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-----DIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             Cccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-----hHHHHHHHHHHcCCCCcccCcc
Confidence            4333 333679999999988765 59999999999999999999887765433     222222222211111111    


Q ss_pred             --hhc--------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 --AIV--------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 --~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        .+.        ........-+.++.+..+|+..++..||.+|+++.|++++=-.
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf  284 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF  284 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence              111        1111122344556788999999999999999999999976544

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=327.78  Aligned_cols=249  Identities=27%  Similarity=0.469  Sum_probs=194.9

Q ss_pred             CCeeeecCcEEEEEEEEC-----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          117 KNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .+.||.|.||.||+|.+.     .+..|+||.+.........+.|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999986     257899999976444445789999999999999999999999999888899999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++|+|.+++...  ....+++..+..++.||++||.|||++   +++|+||+++||++++++.+||+|||++........
T Consensus        84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999875  234489999999999999999999999   999999999999999999999999999987632222


Q ss_pred             -cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          272 -NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       272 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                       ...........|+|||.+....++.++||||||+++|||++ |+.|+....        .............       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~~~~~-------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLKQGQR-------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHHTTEE-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccc-------
Confidence             12222346779999999999899999999999999999999 677765321        1111222211111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                         ...+..++..+.+++..||+.+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               111223445899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=336.00  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=209.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCe
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  183 (437)
                      .....+|...+.||+|+|++|++|+.. +++.||||++.+..  .....+-...|-++|.+| .||.|++|+-.+.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445678999999999999999999964 68999999986422  233344566788889988 89999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      +|+|+||+++|+|.+++.....    ++....+.++.+|+.||+|||++   |||||||||+|||||+|+++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999997654    88899999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc----------cc--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          264 KLVDVRKTN----------VT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       264 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      +.+......          ..  ..++||..|.+||++.....+..+|+|+|||+||+|+.|.+||...+     +....
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliF  296 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIF  296 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHH
Confidence            987542211          11  44789999999999999999999999999999999999999997533     22222


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +.+..+          +    -.+++.-++.+.+|+.+.|..||.+|++.++|-+.
T Consensus       297 qkI~~l----------~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  297 QKIQAL----------D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHh----------c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            222111          1    12233334688899999999999999999777643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=324.76  Aligned_cols=264  Identities=24%  Similarity=0.361  Sum_probs=210.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ...++|+....||.|..++||+|+. +.++.||||++.-.......+.+.+|+..++.++||||++.+..|..+..+++|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            3467899999999999999999995 568999999997545555578899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |+||.+||+.+.+...-+..  ++...+..|..++++||.|||.+   |.||||||+.||||+++|.+||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999998765444  88999999999999999999999   99999999999999999999999999877654


Q ss_pred             cCCCccc---ccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          268 VRKTNVT---TQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       268 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .......   ...+||++|||||++..  ..|+.|+||||||+...||.+|..||....  . .++.    ...+  ...
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--P-mkvL----l~tL--qn~  248 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--P-MKVL----LLTL--QND  248 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--h-HHHH----HHHh--cCC
Confidence            4332221   34689999999999543  459999999999999999999999986321  1 0111    1111  111


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ........+..+-.......+.+++-.|+++||++|||++++++
T Consensus       249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11111111111112233458899999999999999999999984

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-42  Score=342.39  Aligned_cols=263  Identities=25%  Similarity=0.378  Sum_probs=205.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  180 (437)
                      ....++|+..+.||+|+||.||+++..      ++..||+|++.........+.+.+|+++++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344567888999999999999998842      34579999997544444556788999999999 89999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCC-------------------------------------------------------
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKP-------------------------------------------------------  205 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  205 (437)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999998854210                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-
Q 013750          206 -----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-  273 (437)
Q Consensus       206 -----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  273 (437)
                                 ....+++...++++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++......... 
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       112478889999999999999999999   99999999999999999999999999998653322111 


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      .....++..|+|||++....++.++||||||+++|||++ |+.||.......    ...    ......         ..
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~----~~~~~~---------~~  333 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFY----KMVKRG---------YQ  333 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHH----HHHHcc---------cC
Confidence            112234568999999998899999999999999999997 999986432111    000    110000         01


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11111123578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.6e-42  Score=325.21  Aligned_cols=258  Identities=24%  Similarity=0.424  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|+..+.||+|+||.||+|...+      ...||+|.+...........|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467788999999999999998643      25799999875444445667999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          186 LVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      ++|||+++++|.+++......            ...+++...+.++.|++.||+|||++   +++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999998754221            14578899999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 013750          254 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  331 (437)
                      .++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......     ...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----~~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----EVI  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            999999999986533221 12223446788999999998899999999999999999998 99998643211     011


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..             +........+...+..+.+|+.+||+.||++||++.||++.|+.
T Consensus       237 ~~-------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EM-------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH-------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11             11111112234456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-41  Score=318.66  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++|+..+.||+|+||.||++.++++..+|+|.+...  ....++|.+|++++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            557778999999999999999988889999988642  233567899999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++|+|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||.++.......
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            9999999887532   2478999999999999999999999   999999999999999999999999999986533222


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .   ............       
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~---~~~~~i~~~~~~-------  220 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----Y---EVVEMISRGFRL-------  220 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----H---HHHHHHHCCCCC-------
Confidence            22222335668999999998889999999999999999999 8888853321     1   111111111100       


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                         ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               001112357899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=319.12  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..++|+..+.||+|++|.||+|.+.++..||+|.+....  ...++|.+|+.++++++|||++++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            456788889999999999999998778899999987532  345678999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++.....++.|++.|+.|||++   +++|+||||+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999987543  23479999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ..........+..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .....   .....        
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~---~~~~~--------  220 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQ---QVDQG--------  220 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH---HHHcC--------
Confidence            2211112223458999999999999999999999999999999 9988863221     01111   11100        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        .....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 --YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              0111122345689999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-41  Score=319.47  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|+..+.||+|+||.||+|...++..||+|.+...  ....+.+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4678888999999999999999888889999988642  23457899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99999999987542  23478889999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........++..|+|||.+....++.++||||||+++|||+| |..||......     .....   .....        
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~---~~~~~--------  221 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSA---LQRGY--------  221 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----HHHHH---HHcCC--------
Confidence            222223345678999999998889999999999999999998 99998532211     11111   11110        


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ........+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              001112234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-41  Score=337.63  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=207.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeec
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  180 (437)
                      ....++|.+.+.||+|+||.||+|++.      .+..||||++.........+.|.+|+++++++. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344678888999999999999999853      134799999975444445678999999999996 9999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCC-------------------------------------------------------
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKP-------------------------------------------------------  205 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  205 (437)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998864310                                                       


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          206 -------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       206 -------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                                                           ....+++..+..++.|++.||+|||+.   +++|+||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                 012478888999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED  326 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~  326 (437)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            999999999999999865432221 1122346778999999998899999999999999999997 888886322110  


Q ss_pred             hhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ...   ... ..         ......+...+..+.+++.+||+.||++||++.+|.++|+.
T Consensus       348 --~~~---~~~-~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 --TFY---NKI-KS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             --HHH---HHH-hc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence              000   000 00         01111223345689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-41  Score=323.10  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |...+.||+|+||.||++.. .+|+.||+|.+....  .......+.+|++++.+++|+|++++.+++...+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66678999999999999996 478999999986422  123345678999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|..++....  ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.++|+|||++...... 
T Consensus        82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            99999988876532  23478999999999999999999999   9999999999999999999999999999865322 


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       .......||..|+|||.+.+..++.++|||||||++|||++|+.||.........     ......        +..  
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-----~~~~~~--------~~~--  219 (285)
T cd05631         156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-----EEVDRR--------VKE--  219 (285)
T ss_pred             -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-----HHHHHH--------hhc--
Confidence             1223456899999999999999999999999999999999999999753321100     000000        000  


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                      ....++...+..+.+|+.+||+.||++||+     ++++++
T Consensus       220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            001122234457899999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-41  Score=329.83  Aligned_cols=264  Identities=23%  Similarity=0.282  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||.||+++.. +|..+|+|.+.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478889999999999999999975 5889999998754334445679999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+..  +++|+||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999987533    3788999999999999999999862  5999999999999999999999999998755322


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-HHhc--------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-LERE--------  340 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~--------  340 (437)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......     +...... ....        
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  229 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSI  229 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccCCcccc
Confidence               1233468999999999999999999999999999999999999986432110     0000000 0000        


Q ss_pred             ---------------------cchhhhcc----ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          341 ---------------------KRLDAIVD----RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       341 ---------------------~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                                           ....++.+    ...........+.++.+++.+||+.||++|||+.|+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                 00000000    0000000112456789999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=322.79  Aligned_cols=261  Identities=24%  Similarity=0.403  Sum_probs=205.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ...++|+..+.||+|+||.||+|.+.      ++..||+|++..........+|.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999853      256799999865433344567899999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      ..++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998754321      23468889999999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 013750          257 VGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      |+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||......     ...   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~~---  231 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVL---  231 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH---
Confidence            99999987543222111 112235678999999998899999999999999999999 68887543211     011   


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .... .....         ..+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       232 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RFVM-EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1110 11000         1122234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-41  Score=319.38  Aligned_cols=255  Identities=28%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..+|+..+.||+|+||.||+|..+ +++.||+|.+...  .....++.+|++++..++||||+++++++......+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            345777899999999999999975 5889999998642  3345678999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++..++.++.|+++||+|||++   +++|+||||+||++++++.+||+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999986532  23479999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |..|+......        ........         
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~---------  220 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEK---------  220 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHC---------
Confidence            2221122234568999999999999999999999999999998 88888643211        11111111         


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       ......+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       221 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         221 -GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             11112223345689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.9e-41  Score=321.09  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999986 57899999987532 23345678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++++++..+...    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999877655432    23478899999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH-----------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-----------  338 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  338 (437)
                      .........|+..|+|||.+.+..++.++|||||||++|||++|+.||.......     .........           
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-----QLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhhCCCCHHHHHhh
Confidence            3323334568999999999998889999999999999999999999997532211     000011000           


Q ss_pred             -hccchhhhcccccc------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          339 -REKRLDAIVDRNLN------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       339 -~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ..........+...      .......+..+.+++.+|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             00000000000000      0001123457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=302.99  Aligned_cols=265  Identities=25%  Similarity=0.337  Sum_probs=215.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-----
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----  181 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  181 (437)
                      -...++|.+.+.||+|||+-||+++ ..++..||+|++.-.. .+..+..++|++..++++|||++++++++..+     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            3456789999999999999999999 5679999999987433 56677889999999999999999999988443     


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      .+.|++++|...|+|.+.+...+.+...++..+.+.++.++++||++||+. .|+++||||||.|||+++.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            358999999999999999998887777899999999999999999999998 3469999999999999999999999999


Q ss_pred             CceecccCCCcc--------ccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhH
Q 013750          262 LAKLVDVRKTNV--------TTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL  330 (437)
Q Consensus       262 la~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~  330 (437)
                      .++.....-...        -.....|..|.|||.+.   +...++++|||||||++|+|+.|..||+....        
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------  246 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------  246 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence            988653211111        11134689999999985   45679999999999999999999999974322        


Q ss_pred             HHHHHHHHhccch-hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          331 LDHVKKLEREKRL-DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       331 ~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              .++.+ -.+..+.+.-.-....++.+.+++.+|++.||.+||+..+++..++.
T Consensus       247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                    12222 12333333322223367899999999999999999999999998875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-41  Score=317.79  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|+..+.||+|+||.||+|.++.    ...||+|.+...........|.+|+.++.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4578889999999999999999742    457999998755445556789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      +|||+++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||++++++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999987532   2489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......     ....   ......   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~---~~~~~~---  225 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIK---AVEDGY---  225 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHH---HHHcCC---
Confidence            5222221 122335678999999998899999999999999999998 98887532110     1111   111100   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ....+..++..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       226 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 -------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                   011122345688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-41  Score=327.64  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ..+|+..+.||+|+||.||+|++. ++.    .||+|++.........++|.+|+.+++.++||||++++|+|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356888999999999999999864 333    48999987544445567899999999999999999999999765 567


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +++||+++|+|.+++....   ..+++...++++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            9999999999999987632   3478899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCccc-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|++.....        ..........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~--  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGE--  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCC--
Confidence            653322211 12234678999999999999999999999999999998 99998642111        0111111110  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ....+..+...+.+++..||+.+|++||++.+++..|..
T Consensus       229 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         229 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                    011112234578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=305.66  Aligned_cols=238  Identities=23%  Similarity=0.295  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..  .....+...+|-.+|+.+.||+++++.+.+.+.+..++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457788899999999999999975 68999999997532  334456677899999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||.++|.|..+++....    ++...++-++.+|+.||+|||++   .|++|||||+|||||.+|.+||+|||.|+...
T Consensus       123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999987544    88899999999999999999999   99999999999999999999999999999765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..    +...+||+.|+|||.++...|+.++|+|||||++|||+.|..||...+.     +..            ...++
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~i------------Y~KI~  254 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQI------------YEKIL  254 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHH------------HHHHH
Confidence            32    4557899999999999999999999999999999999999999975443     111            12222


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDR  378 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R  378 (437)
                      ...+  .++.....++.+|+...++.|-.+|
T Consensus       255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            2222  2234444588899999999999999

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.9e-41  Score=316.04  Aligned_cols=261  Identities=20%  Similarity=0.352  Sum_probs=210.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+++++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999964 68999999875422  2334557889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++.........++......++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998876544455678899999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......      ............       
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~-------  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCD-------  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCC-------
Confidence            221 122345788999999998888999999999999999999999998532211      111111111100       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                        .........+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              01111223456899999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-41  Score=320.25  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+.........+.|.+|+++++.++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3457778999999999999998643      4789999987654444567899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          185 LLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      +++|||+++++|.+++.....          ....+++.....++.|++.|+.|||++   +++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            999999999999999976421          234578999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          255 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......     ....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~~~~  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIE  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH
Confidence            99999999975432221 11122345778999999999999999999999999999999 99998533211     1111


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ...    .+.         ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       236 ~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 CIT----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHH----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111    110         11112234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=319.67  Aligned_cols=269  Identities=28%  Similarity=0.383  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHh--cccccceeeeeeeecCC----ee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFCTTPT----ER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~  184 (437)
                      ....+..+++|+|.||.||||.+. ++.||||++.    ....+.|..|-++++.  ++|+||+++++.-....    ++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            344555688999999999999995 6999999986    4557889999988774  58999999998875555    78


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceEecCCCCCCeeecCCCcEEEe
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH------CNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      .||++|.++|+|.+||....     ++|....+|+..+++||+|||+.      .+|+|+|||||++|||+.+|++..|+
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999999999998643     89999999999999999999974      36789999999999999999999999


Q ss_pred             ecCCceecccCCCcc-cccccccccccccccccCCC-CC-----CchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          259 DFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGK-SS-----ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       259 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      |||+|..+....... .-..+||.+|||||++.+.- +.     .+.||||+|.++|||++.-...+.... .+..+-+-
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v-p~Yqlpfe  437 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV-PEYQLPFE  437 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC-CcccCchh
Confidence            999999886543322 22367999999999997643 22     368999999999999997654432111 11111111


Q ss_pred             HHHHHHHhccchhh-hccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDA-IVDRNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~-~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+..-..-+.+++ ++..+.+..++     ...+..+.+.+..||..||+-|-|+.=+-+++..
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            01111000111111 11222222221     2345688999999999999999999888877755

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=329.01  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC---CC-cchHHHHHHHHHHHhcc-cccceeeeeeeecCC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE---SP-GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT  182 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  182 (437)
                      ...+.|...+.||+|+||+|+.|... ++..||+|++....   .. ...+...+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34678889999999999999999864 68999999765421   11 33456668999999999 999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFG  261 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg  261 (437)
                      ..++||||+.+|+|.+++.+..    .+......+++.|++.|++|+|++   +|+||||||+|||+|.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999998732    377799999999999999999999   99999999999999999 999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCC-CC-CchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+..     .+..   ..  
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-----~l~~---ki--  235 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-----NLYR---KI--  235 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-----HHHH---HH--
Confidence            999764 2333445578999999999999877 75 8999999999999999999999852211     1111   11  


Q ss_pred             ccchhhhccccccCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 EKRLDAIVDRNLNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                             .....  .++... +..+..|+.+|+..||.+|+++.+++..
T Consensus       236 -------~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  236 -------RKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -------hcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                   11000  111222 5689999999999999999999999943

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=334.01  Aligned_cols=258  Identities=22%  Similarity=0.377  Sum_probs=217.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC---C--CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLAD---G--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      +...+.....++||+|.||.||+|..-+   |  -.||||..+...+++..+.|++|..+|+.++||||++|+|+|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3344455567899999999999999632   3  369999998777788899999999999999999999999999764 


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++|||.++-|.|..||...+   ..++......++.||+.||+|||+.   +++||||..+|||+....-+||+|||+
T Consensus       464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence            5779999999999999998743   4488888899999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.+..+.....+...-+..|||||.+...++|.+||||.|||.+||+++ |..||.+-....                 
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------  600 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------  600 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------
Confidence            99887666655555556789999999999999999999999999999987 999997533211                 


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .--.+...-+...++.|+..++.|+.+||..+|.+||.+.|+...|..
T Consensus       601 -VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  601 -VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             -eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence             111112222344577888899999999999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=329.95  Aligned_cols=249  Identities=20%  Similarity=0.313  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ..|.....||+|..|.||.+.. .+++.||||++.... ....+-.++|+.+|+..+|+|||+++..+...++++.||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4577778999999999999985 468899999997533 45566788999999999999999999999888999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |++|+|.+.+....     +++.++..|+.++++||+|||.+   +|+|||||.+|||++.++.+||+|||++..+....
T Consensus       352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999886543     88999999999999999999999   99999999999999999999999999999876554


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .. .+..+||+.|||||++....|+.+.||||||++++||+-|++||=..+     .   +.........+        .
T Consensus       424 ~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----P---lrAlyLIa~ng--------~  486 (550)
T KOG0578|consen  424 SK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----P---LRALYLIATNG--------T  486 (550)
T ss_pred             Cc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----h---HHHHHHHhhcC--------C
Confidence            43 344579999999999999999999999999999999999999984211     1   11111111111        1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..-..+...+..+.++..+||+.|+++||++.|+|+
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            111223445678999999999999999999999995

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-40  Score=318.81  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||+|..+ ++..||+|++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888899999999999999975 68899999987544344456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++ +|..++...   ...+++.....++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            985 888887653   23478889999999999999999999   99999999999999999999999999997643222


Q ss_pred             CcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh----------
Q 013750          271 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER----------  339 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  339 (437)
                      . ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........     .........          
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-----LHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCCChHHhhcc
Confidence            1 1223457899999998865 5689999999999999999999999965432211     111111000          


Q ss_pred             --ccchhhhccccccCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 --EKRLDAIVDRNLNKN----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 --~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        .........+.....    ..+....+..+++.+|++.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              000000010110000    01122357789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-40  Score=311.61  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=199.9

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhh
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA  197 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  197 (437)
                      ++||+|+||.||+|..+++..+|+|.+...........|.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999875443444557899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccc
Q 013750          198 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV  277 (437)
Q Consensus       198 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  277 (437)
                      +++....   ..+++..+..++.+++.||.|||++   +++|+||||+||++++++.++|+|||++..............
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9886532   3478999999999999999999999   999999999999999999999999999875432221111122


Q ss_pred             cccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       278 ~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      .++..|+|||++.+..++.++||||||+++||+++ |..||......        .........          .....+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~----------~~~~~~  216 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKG----------YRMSCP  216 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC----------CCCCCC
Confidence            34568999999998899999999999999999998 88898643211        111111111          111122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=330.52  Aligned_cols=254  Identities=20%  Similarity=0.254  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999976 58999999986432  1234567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....    .+++.....++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999987532    378889999999999999999999   999999999999999999999999999985532


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                          ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ....+...   .   ....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~---~---~~~~  218 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----TWENLKYW---K---ETLQ  218 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----HHHHHHhc---c---cccc
Confidence                2234568999999999999999999999999999999999999997432211     11111110   0   0010


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...........+..+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000012335678899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.8e-41  Score=317.99  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      +..+|+..+.||+|+||.||+|...++..+|+|.+.... ......+..|+.+++.++|||++++++++......++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            445688889999999999999999889999999987532 3345678999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999997643  23479999999999999999999999   9999999999999999999999999999765332


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      . .......++..|+|||.+....++.++||||||+++|+|++ |+.||.....     ........             
T Consensus       158 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~-------------  218 (261)
T cd05148         158 V-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYDQIT-------------  218 (261)
T ss_pred             c-ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHH-------------
Confidence            1 11223345678999999998899999999999999999998 8888864321     11111111             


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .......+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            111112233445689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-41  Score=328.08  Aligned_cols=202  Identities=24%  Similarity=0.341  Sum_probs=175.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|+..+.||+|+||.||++.+. ++..+|+|.+.........+.+.+|++++++++||||++++++|...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3578999999999999999999976 588899998865433444567899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....    .+++.....++.+++.||.|||+..  +++|+||||+|||+++++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999987532    3788889999999999999999752  699999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      .   ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1   122346889999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-41  Score=313.96  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .+|++.+.||+|+||.||++.++++..+|+|.+...  ......|.+|+++++.++||||+++++++...+..++|+||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            357778999999999999999887789999998642  223457889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....   ..+++...+.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            9999999987532   2489999999999999999999999   999999999999999999999999999986532211


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     ..   .......          
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~---~~~~~~~----------  217 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EV---VESVSAG----------  217 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HH---HHHHHcC----------
Confidence            11111223457999999999999999999999999999999 78888642211     01   1111100          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      .....+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            01111223456899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.7e-41  Score=314.33  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++|...+.||+|+||+||+|..+++..+|+|.+...  ....+.|.+|+.++.+++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            456778899999999999999877778999988643  233567999999999999999999999999888999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|||.++.......
T Consensus        82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999999987532   2489999999999999999999999   999999999999999999999999999886543322


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......     ......   .....        
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~---~~~~~--------  219 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKV---SQGLR--------  219 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHH---hcCCC--------
Confidence            22222335678999999998889999999999999999999 99888633211     011111   11100        


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                        ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              0111123468899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-41  Score=318.46  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             CCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV  187 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  187 (437)
                      ...+.||+|+||+||++..     .++..||+|.+...........|.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7789999999999988653     357899999987543334567888999999999999999999998654  357899


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...     .+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||+++...
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998652     289999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          268 VRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       268 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ......  .....++..|+|||.+....++.++||||||+++|||+||..|+.........   ...............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  235 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIE  235 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhh
Confidence            322211  11223566799999998888999999999999999999999997543211000   0000000000111122


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+.......+...+..+.+++..||+.+|++|||+++++++|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            222222222333455789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.9e-41  Score=328.84  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=203.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      ...++|.+.+.||+|+||.||+|...      +++.||+|++.........+.+.+|+.++.++ +|+||++++++|...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34567888999999999999999742      25789999987543344456788999999999 899999999988654


Q ss_pred             -CeeEEEEecccCchhhhhhhhcCCC------------------------------------------------------
Q 013750          182 -TERLLVYPFMQNLSVAYRLREIKPG------------------------------------------------------  206 (437)
Q Consensus       182 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  206 (437)
                       ...++++||+++++|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5678999999999999988542210                                                      


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-ccccccccc
Q 013750          207 ---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMG  282 (437)
Q Consensus       207 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~  282 (437)
                         ...++|..+..++.||+.||+|||++   +|+||||||+||++++++.++|+|||++.......... .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12589999999999999999999999   99999999999999999999999999998654322211 122345678


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHH
Q 013750          283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE  361 (437)
Q Consensus       283 y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  361 (437)
                      |+|||++.+..++.++|||||||++|||++ |..||.......    .+.   .... ..         .....+...+.
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~---~~~~-~~---------~~~~~~~~~~~  303 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFC---RRLK-EG---------TRMRAPEYATP  303 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHH---HHHh-cc---------CCCCCCccCCH
Confidence            999999999999999999999999999998 999986432111    010   1111 00         01111222345


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          362 TMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       362 ~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .+.+++.+||+.+|++||++.|+++.|+.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            78999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.6e-41  Score=318.54  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|+..+.||+|+||.||+|.+     .++..||+|.+...........|.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567789999999999999985     24678999999754444445678999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          187 VYPFMQNLSVAYRLREIKP-------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      +|||+++++|.+++.....             ....+++...+.++.|++.||+|||++   +++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999854321             123478899999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 013750          254 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  331 (437)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......     ...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            999999999986533221 11222345678999999988889999999999999999998 88888532210     011


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...   . ....         ...+...+..+.+++.+||+.||++||++.++++.|..
T Consensus       237 ~~~---~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMV---R-KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH---H-cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111   1 1000         01122234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.6e-41  Score=334.23  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=207.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeee
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT  179 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~  179 (437)
                      ++...++|...+.||+|+||.||+|++.      ++..||+|++.........+.+.+|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4555667888899999999999999864      246899999975443444567899999999997 999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCC------------------------------------------------------
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------  205 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  205 (437)
                      .....++|+||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 013750          206 ----------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA  245 (437)
Q Consensus       206 ----------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~  245 (437)
                                                              ....+++.....++.|++.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    113478888899999999999999998   9999999999


Q ss_pred             CeeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 013750          246 NVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE  323 (437)
Q Consensus       246 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~  323 (437)
                      |||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986532221 11122346788999999998889999999999999999998 88887532211


Q ss_pred             ccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .        .....         +........+...+..+.+++..||+.+|++||++.+|++.|++
T Consensus       349 ~--------~~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 E--------QFYNA---------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             H--------HHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            0        00010         01111111222344689999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-41  Score=327.72  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|...+.||+|.||.||||+-+ +.+.||+|.+.+.. ..++.+.+.+|++++++++||||+.+++++++..+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777788999999999999965 57899999987644 34456789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+.+ +|..++....    .++......++.++..||.|||++   +|+|||+||+|||++.++.+|++|||+|+..+. 
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 9999987643    389999999999999999999999   999999999999999999999999999997764 


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .....+.+.||+-|||||...++.|+..+|.||+||++||+++|++||...+        +...++....+.-       
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v-------  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPV-------  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCC-------
Confidence            3344566789999999999999999999999999999999999999995321        2222322211110       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ..+...+..+..++...+.+||.+|.+..+++.
T Consensus       218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                113355678899999999999999999999884

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=342.56  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=212.8

Q ss_pred             CCCeeeecCcEEEEEEEE-CCC----CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          116 EKNVLGQGGFGKVYRGVL-ADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~-~~g----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ..++||+|+||+||+|.+ ..|    -+||+|++.+....+..+++++|+-.|++++|||+++|+|+|.... ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            458899999999999996 334    4799999988877888899999999999999999999999998776 8899999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |+.|+|.+|++..+   ..+.....+.+..|||+||.|||++   +++||||.++|||+.+-..+||+|||+++....+.
T Consensus       779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999998743   3477888899999999999999999   99999999999999999999999999999887665


Q ss_pred             Cccccc-ccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          271 TNVTTQ-VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       271 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ...... ..-.+.|||-|.+....|+.+||||||||.+||++| |..|++....+                  .+.+++.
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------------eI~dlle  914 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------------EIPDLLE  914 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------------HhhHHHh
Confidence            554433 334578999999999999999999999999999999 88887643221                  1233333


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+-..++-++.+++-++.+||..|++.||+++++...+..
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            333344567788899999999999999999999999988765

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-41  Score=321.01  Aligned_cols=246  Identities=20%  Similarity=0.207  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++... +++.||+|++....  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999975 68999999986321  1234557889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999987533    378889999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .    .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   ......         
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~---~~~i~~---------  212 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GI---YEKILA---------  212 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHh---------
Confidence            1    12346899999999999888999999999999999999999998643211     01   111110         


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  387 (437)
                      ..  ..++......+.+++.+||+.||.+||+     +.++++.
T Consensus       213 ~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         213 GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            00  0112223457889999999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-40  Score=317.42  Aligned_cols=264  Identities=23%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467889999999999999999975 6899999998754433444567899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++ ++|.+++...   ...++...+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 5677776542   23378888999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR------  342 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  342 (437)
                      . .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......    ..............      
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ----DQLERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhCCCChhhccc
Confidence            2 12233457899999998865 458899999999999999999999997432110    01111100000000      


Q ss_pred             ---hhhhccccccC--CCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 ---LDAIVDRNLNK--NYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ---~~~~~d~~l~~--~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...........  ...       ...+..+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               00000000000  000       011246789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-40  Score=311.11  Aligned_cols=248  Identities=28%  Similarity=0.403  Sum_probs=197.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      +.||+|+||.||+|.+. +++.||+|.............|.+|++++++++||||++++++|......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999974 68999999886544344566799999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc-c
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-T  275 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~  275 (437)
                      .+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998643   23478999999999999999999999   999999999999999999999999999875432111111 1


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC
Q 013750          276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN  354 (437)
Q Consensus       276 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  354 (437)
                      ....+..|+|||.+.++.++.++||||||+++|||++ |..|+......     ..   ...          ........
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~---~~~----------~~~~~~~~  216 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QT---REA----------IEQGVRLP  216 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HH---HHH----------HHcCCCCC
Confidence            1123457999999999999999999999999999998 88887532110     00   000          00111112


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          355 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       355 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      .+...+..+.+++.+|++.+|++|||+.+++++|+
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=318.34  Aligned_cols=257  Identities=28%  Similarity=0.400  Sum_probs=203.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +|...+.||+|+||.||+|...      +...+|+|.+.........+++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999863      2357899988754444445689999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          187 VYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      ++||+++++|.+++.....                    ....+++...+.++.|++.||+|||+.   +++|+||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999864321                    123478999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      |++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            999999999999999998653322211 122345678999999988889999999999999999999 99888543211 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .+...             .........+...+..+.+++..||+.+|++||++.|+++.|+.
T Consensus       237 ----~~~~~-------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         237 ----RLFNL-------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             ----HHHHH-------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                01111             11111111222344688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.9e-40  Score=310.31  Aligned_cols=259  Identities=22%  Similarity=0.364  Sum_probs=211.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..  ......+.+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999986 7899999988632  22334668899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|..++.........+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999876554555689999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......      ..........         
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---------  222 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEK---------  222 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhc---------
Confidence            2221 22345788999999999888999999999999999999999998533211      1111111110         


Q ss_pred             ccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYN-IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       ......+ ...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       223 -~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         223 -CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             -CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence             0011112 2445688999999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.5e-41  Score=320.81  Aligned_cols=263  Identities=28%  Similarity=0.415  Sum_probs=208.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      +....++|+..+.||+|+||.||++...+      ...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            44556778888999999999999998642      3689999987544444556788999999999 7999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      .....+++|||+++|+|..++....            .....+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            9999999999999999999987532            2234589999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE  325 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~  325 (437)
                      ++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......  
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  241 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  241 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence            9999999999999999865432211 1122234678999999988899999999999999999998 88887532211  


Q ss_pred             chhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .......          .......+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       242 ------~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         242 ------ELFKLLK----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ------HHHHHHH----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence                  1111111          111111223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-40  Score=318.56  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhc---ccccceeeeeeee-----c
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCT-----T  180 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~  180 (437)
                      ++|...+.||+|+||.||+|...  +++.||+|++.... .......+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  46889999986432 222344567788777665   6999999999985     2


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      ....++|+||++ ++|..++....  ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            345789999997 58888886532  23478999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh-
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-  339 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  339 (437)
                      |+++.....  .......||..|+|||.+.+..++.++|||||||++|||++|+.||.......     ....+..... 
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-----~~~~i~~~~~~  227 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVIGL  227 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHHHHHhCC
Confidence            999865432  22334568999999999988899999999999999999999999997533211     1111111100 


Q ss_pred             --ccch-------hhhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 --EKRL-------DAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 --~~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        ....       .........   ....+.....+.+++.+|++.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              0000       000000000   0011223457789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-40  Score=317.47  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTE  183 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  183 (437)
                      ..++|...+.||+|+||.||+|.+.+     +..|++|++.........+.+.+|+.++++++|||++++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45778889999999999999999765     688999998755445556788999999999999999999999876 467


Q ss_pred             eEEEEecccCchhhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEee
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD  259 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D  259 (437)
                      .+++++|+++++|.+++......    ...+++..++.++.|++.||+|||++   +++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998765332    25689999999999999999999999   999999999999999999999999


Q ss_pred             cCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHH
Q 013750          260 FGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       260 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      ||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....     .......   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~---  232 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAYL---  232 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHHH---
Confidence            99998653322211 122345678999999988889999999999999999999 9999864321     1111111   


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....          ......++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       233 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         233 KDGYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             HcCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            11110          01112234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=333.44  Aligned_cols=244  Identities=26%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCe
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  183 (437)
                      ....++|...++||+|.||+|+++..+ +++.+|||++++..  ..++.+....|-+++... +||.+++|+.++.+.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456678999999999999999999986 57899999998644  456677888888888766 59999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+||||..+|++..+.+     ...++...+.-++..|+.||.|||++   +||+||||.+|||||.+|++||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence            999999999999433322     23489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      +..- .....++.++||+.|||||++.+..|+.++|+|||||++||||.|..||...+.                     
T Consensus       516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---------------------  573 (694)
T KOG0694|consen  516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---------------------  573 (694)
T ss_pred             cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---------------------
Confidence            8532 234456678999999999999999999999999999999999999999975432                     


Q ss_pred             hhhccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          344 DAIVDRNLNK--NYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       344 ~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ++++|..+..  .++...+.+...++.+.+.++|++|--+
T Consensus       574 ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  574 EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2333333322  3456677899999999999999999776

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-40  Score=312.02  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|++.+.||+|+||.||++..+++..+|+|.+....  ...+.|.+|+.++++++|+|++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            45678889999999999999998888899999987532  23467999999999999999999999875 4568899999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++..++.++.+++.||+|||++   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999987532  23478999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....     ...   .......         
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~---~~~~~~~---------  219 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REV---LEQVERG---------  219 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHH---HHHHHcC---------
Confidence            222222335668999999988889999999999999999999 8888853221     111   1111110         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1111223345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.7e-41  Score=326.07  Aligned_cols=242  Identities=22%  Similarity=0.249  Sum_probs=195.9

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.||+|+||.||++..+ +|+.||+|++....  .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999974 68999999987422  2334457889999999999999999999999999999999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT  274 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  274 (437)
                      +|..++...    ..+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~  152 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcc
Confidence            999888753    2478999999999999999999999   999999999999999999999999999875322 12223


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC
Q 013750          275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN  354 (437)
Q Consensus       275 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  354 (437)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..     ....   .....       +    ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~---~~~~~-------~----~~  213 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFE---LILME-------E----IR  213 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHH---HHHcC-------C----CC
Confidence            3456899999999999999999999999999999999999998643211     0111   11000       0    11


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          355 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       355 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                      ++...+..+.+++.+||+.||++||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2223445788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=327.51  Aligned_cols=249  Identities=20%  Similarity=0.312  Sum_probs=194.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|+||.||++.+. +++.||||++.........+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            44566788999999999999975 68999999996544344556789999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|....        ..+......++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++......
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986432        245677788999999999999999   99999999999999999999999999998654321


Q ss_pred             CcccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                       .......||..|+|||.+..     ...+.++|||||||++|||++|+.||.......     ...........     
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~-----  291 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMS-----  291 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhcc-----
Confidence             11233468999999998743     234568999999999999999999997322111     00011000000     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           ............+.+++.+||+.||++||++.|+++.
T Consensus       292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011122344678999999999999999999999864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-40  Score=315.76  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|...+.||+|+||+||+|.+. +++    .+++|.+..........++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46777899999999999999974 344    4788887543333344677888889999999999999998864 45778


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ++||+++|+|.+++....   ..+++.....++.||+.||+|||++   +++|+||||+||++++++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            999999999999997532   3489999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ...... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.......     ..+..    ..+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~----~~~~~-  229 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLL----EKGER-  229 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH----HCCCc-
Confidence            433221 2223456778999999998999999999999999999998 999886432110     11111    11100 


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ...+..+...+.+++.+||+.||++|||+.|+++.|..
T Consensus       230 --------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         230 --------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                    00111133477889999999999999999999998876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-40  Score=316.41  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      .+++|...+.||+|+||.||+|.+.+      +..||+|.............|.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678889999999999999999753      568999988654444455679999999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---cEEE
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVV  257 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl  257 (437)
                      .++||||+++++|.+++......   ...+++..+++++.||+.||+|||++   +++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            99999999999999999765421   23589999999999999999999999   999999999999998754   5999


Q ss_pred             eecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 013750          258 GDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +|||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||+.....     ....   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~---  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVME---  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH---
Confidence            9999998653221111 111223568999999999999999999999999999997 98888643211     0111   


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ....          ......+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       233 ~~~~----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTG----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHc----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1110          1111122334568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=316.98  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ..++|...+.||+|+||.||+|...+      +..||+|.+...........+.+|+.+++.++|||++++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            35678888999999999999998642      368999998754434445678899999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEE
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV  257 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl  257 (437)
                      .++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence            99999999999999998754322      23478999999999999999999999   9999999999999999999999


Q ss_pred             eecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 013750          258 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       258 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +|||+++....... .......++..|+|||.+.++.++.++||||||+++||++| |..||......     ....   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~---  232 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EVLK---  232 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----HHHH---
Confidence            99999876543221 11223346789999999988889999999999999999998 88888532211     1111   


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ... ...         ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVI-DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHh-cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111 110         01112223568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-40  Score=311.81  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=205.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..++|...+.||+|+||.||+|..++++.||+|.+...  ....+.|.+|+.++++++|+|++++++++. .+..++++|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            34678888999999999999999988999999998743  234568999999999999999999999864 556899999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++.....++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999886532  23478999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .........++..|+|||.+....++.++||||||+++|||++ |+.||......        .........        
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~--------  219 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERG--------  219 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcC--------
Confidence            2222222345678999999998899999999999999999999 99998643211        111111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        .....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 --YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              0011122234579999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-40  Score=324.54  Aligned_cols=247  Identities=22%  Similarity=0.243  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            356888899999999999999975 58899999986422  223456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999987532    378888889999999999999999   99999999999999999999999999998653


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .......         
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~---------  228 (329)
T PTZ00263        170 DR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKIL---------  228 (329)
T ss_pred             CC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHh---------
Confidence            22    12346899999999999999999999999999999999999998632210        1111111         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  387 (437)
                      ...+  .++......+.+++.+||+.||.+||+     +.++++.
T Consensus       229 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        229 AGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             cCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1110  111122347889999999999999997     5666643

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.9e-40  Score=310.92  Aligned_cols=254  Identities=26%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|.+.+.||+|+||.||+|.++++..||+|++...  ....+.|.+|++++..++||||+++++++. ....++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            4568889999999999999999877778999998742  223567899999999999999999999875 4557899999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999999997532  23478999999999999999999999   99999999999999999999999999998664333


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........++..|+|||...+..++.++||||||+++|||+| |..||......     ..   .......         
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~---~~~~~~~---------  219 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EV---LDQVERG---------  219 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HH---HHHHhcC---------
Confidence            222223345678999999988899999999999999999999 78787532211     01   0111000         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence             0011123455688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-40  Score=318.07  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-C--CEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-G--TKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++........+.|.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578888999999999999999753 3  357888887544444556789999999999 799999999999999999999


Q ss_pred             EecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          188 YPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                      +||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++|+||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999865321            113488999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ||+|||++......  ........+..|+|||.+.+..++.++|||||||++|||++ |..||......        ...
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------~~~  228 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELY  228 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99999998643211  11111223557999999998899999999999999999998 99998643211        111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....          .......+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       229 ~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         229 EKLP----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             HHHh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1110          111111222344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-40  Score=317.92  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +|...+.||+|+||.||+|...+      +..||+|++.........+.|.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            45567889999999999998632      478999999754433345678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          187 VYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      ++||+++++|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            9999999999999853211            123478889999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          255 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+.....        ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~  234 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD  234 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            99999999886532221 11122345779999999988899999999999999999998 7777753211        11


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .........          ....+.+.+..+.+++..||+.+|++||++.+|+..|+.
T Consensus       235 ~~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111111          111223455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-40  Score=327.81  Aligned_cols=262  Identities=20%  Similarity=0.251  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||++... +++.||+|...       ...+.+|++++++++||||+++++++......++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            467999999999999999999974 68899999653       2346799999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ++. ++|..++....    .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            985 67877776432    378999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc---hhhHHHHHHHHHh-------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED---DVLLLDHVKKLER-------  339 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~-------  339 (437)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.|+-........   ...+.........       
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            222333457999999999999999999999999999999999999876432111100   0001001100000       


Q ss_pred             --ccchhhhc----c-----ccccCC--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 --EKRLDAIV----D-----RNLNKN--YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 --~~~~~~~~----d-----~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        ........    .     +..+..  .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              00000000    0     000000  011235678999999999999999999999853

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=317.55  Aligned_cols=265  Identities=21%  Similarity=0.350  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC---------------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD---------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI  175 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~  175 (437)
                      .++|.+.+.||+|+||.||++...+               ...||+|.+...........|.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578888999999999999987632               2358999987544444556799999999999999999999


Q ss_pred             eeeecCCeeEEEEecccCchhhhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          176 GFCTTPTERLLVYPFMQNLSVAYRLREIKP--------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       176 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      +++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999865321        113478899999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCcccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEE  324 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt--g~~p~~~~~~~~  324 (437)
                      ++++++.+||+|||++......... ......++..|+|||.+.++.++.++||||||+++|||++  |..||...... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            9999999999999999755322211 1122335678999999998899999999999999999998  44555432111 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                          ..............      .......+...+..+.+++.+||+.||++|||+.+|++.|+
T Consensus       240 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 ----QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ----HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                11111111111000      00001112223458999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-40  Score=316.34  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ...++|++.+.||+|+||.||+|..++      +..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999997532      45899998865443444557889999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      ..++||||+++|+|.+++.....      +....++.....++.|++.||.|||++   +++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975432      224467788899999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 013750          257 VGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      |+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......        +..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~~  231 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QVL  231 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence            9999998854322211 1122235678999999998899999999999999999999 77787532211        111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCC
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG  392 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  392 (437)
                      ........          ...+...+..+.+++.+|++.||++|||+.++++.|+...
T Consensus       232 ~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11110000          0111223468999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.4e-40  Score=315.71  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      ..+|.+.+.||+|+||+||++...      ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            356788899999999999999852      24568999886532 34466799999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          185 LLVYPFMQNLSVAYRLREIKP---------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                      ++||||+++++|.+++.....         ....+++..++.++.|++.||+|||++   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999999875431         223489999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHH
Q 013750          256 VVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  333 (437)
                      +|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......        ..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EV  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence            9999999985532221 11222345778999999998899999999999999999999 88887533211        01


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..... .+...         ..+...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       232 ~~~i~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         232 IECIT-QGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HHHHH-cCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            11111 11100         0111233578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-40  Score=323.30  Aligned_cols=262  Identities=20%  Similarity=0.330  Sum_probs=194.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----eeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  185 (437)
                      +|+..+.||+|+||.||+|... +|..||||++.... .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4777899999999999999965 68999999986422 2233457889999999999999999999885432     479


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+. ++|..++...    ..+++..+..++.|+++||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 5788877643    2388999999999999999999999   999999999999999999999999999985


Q ss_pred             cccCCC--cccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh--
Q 013750          266 VDVRKT--NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--  339 (437)
Q Consensus       266 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  339 (437)
                      ......  .......||..|+|||.+.+  ..++.++|||||||++|||++|+.||.......     ..........  
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~  227 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-----QLDLITDLLGTP  227 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHHHHhCCC
Confidence            432211  11233568999999999865  678999999999999999999999996433211     0000000000  


Q ss_pred             ---------ccchhhhcc---ccccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 ---------EKRLDAIVD---RNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ---------~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                               .........   .......   .+.....+.+++.+||+.||++|||+.|+++.
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     000000000   0000000   01123567899999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4e-40  Score=313.64  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||+||+|.+. +|.    .||+|++.........+.+.+|+.++..++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            456788899999999999999853 444    48999987544455567889999999999999999999999754 577


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +++||+++|+|.+++...   ...+++...+.++.|++.||+|||++   +++|+||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999998753   23488999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||+....     ........    .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~----~---  226 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLE----K---  226 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH----C---
Confidence            65332221 112234678999999998899999999999999999998 8888863221     11111111    0   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            ......+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         227 ------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             ------CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                  00111122344578999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.5e-40  Score=315.77  Aligned_cols=265  Identities=23%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-----------------CCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR  173 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  173 (437)
                      ..+|++.+.||+|+||.||++...+                 +..||+|.+.........+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578889999999999999998642                 24689999876544455678999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCchhhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      +++++......++++||+++++|..++.....       ....+++...+.++.|++.||+|||++   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999876542       123589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE  323 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt--g~~p~~~~~~~  323 (437)
                      |+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++  |..|+....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999976532221 11223346778999999988889999999999999999998  556654221  


Q ss_pred             ccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                         ..................      .....+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       239 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 ---DQQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---hHHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               111111111111111100      001112233468999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.4e-40  Score=307.83  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++|...+.||+|++|.||++.++++..+|+|.+...  ....+.|.+|+++++.++|||++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            457788899999999999999887778999988643  233567899999999999999999999875 45688999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999987532  23478999999999999999999999   999999999999999999999999999986543322


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++..|+|||...+..++.++||||||+++|||++ |..||......     ....   .....          
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~---~~~~~----------  219 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVLE---QVERG----------  219 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHHcC----------
Confidence            22222345678999999998899999999999999999999 88888632211     0111   11110          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111123345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6e-40  Score=308.88  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=195.7

Q ss_pred             eeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||.||+|.+.   ++..||+|++.........+.|.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999864   355799999875443444567999999999999999999999885 4568899999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc--c
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--T  274 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~  274 (437)
                      .+++...   ...+++..+++++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++..........  .
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9988642   23489999999999999999999999   99999999999999999999999999998654332211  1


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       275 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      ....++..|+|||.+.+..++.++||||||+++||+++ |..||......        .......          .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~----------~~~~~  217 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIE----------QGKRL  217 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHH----------CCCCC
Confidence            11233578999999988889999999999999999996 99998632211        1111111          11111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+..++.++.+++..||+.+|++||++.+|.+.|+.
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2233445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=322.49  Aligned_cols=242  Identities=21%  Similarity=0.234  Sum_probs=193.4

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||.||++... ++..||+|++....  .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 57899999986421  234456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||+++...... .....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            9998753    2378999999999999999999999   99999999999999999999999999997543222 22334


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ........         ..  ..++
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~---------~~--~~~~  213 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQ---------EP--LRFP  213 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHc---------CC--CCCC
Confidence            56899999999999999999999999999999999999999643211        11111111         00  1112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      ......+.+++.+||+.||++||++..+.+.|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            23345788999999999999998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.6e-40  Score=314.39  Aligned_cols=248  Identities=25%  Similarity=0.313  Sum_probs=196.8

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||+||++... +++.||+|.+....  .....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999975 68899999986422  122335678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      ..++.........+++..+..++.||+.||.|||++   +++||||||+||++++++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865444445689999999999999999999999   999999999999999999999999999976543222 2233


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..||..|+|||.+.+..++.++||||||+++|||++|+.||..........    ....         .+....  ...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~----~~~~---------~~~~~~--~~~~  221 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK----ELKQ---------RILNDS--VTYP  221 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH----HHHH---------hhcccC--CCCc
Confidence            468999999999999999999999999999999999999996432211100    0000         011110  1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                      ...+..+.+++.+||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            33456889999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-40  Score=322.87  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=198.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      +|++.+.||+|+||.||+++.    .++..||+|++.+..   .....+.+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999985    357899999986421   223345678899999999 599999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|..++....    .+++.....++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999987532    378899999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............||..|+|||.+.+. .++.++|||||||++|||++|+.||..........    ........    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~~~~~~~~----  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS----EVSRRILK----  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH----HHHHHHhc----
Confidence            6543333333345789999999999765 47899999999999999999999996432211110    11111100    


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                         .++    ..+...+..+.+++.+||+.||++||     +++++++.
T Consensus       226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence               011    11222345788999999999999999     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6e-40  Score=308.61  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=195.4

Q ss_pred             eeeecCcEEEEEEEEC---CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          119 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      .||+|+||.||+|.++   ++..+|+|++.... .....+++..|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57899999986432 2334567899999999999999999999885 45678999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-  273 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  273 (437)
                      +|.+++....    .+++.....++.|++.||+|||++   +++|+||||.||++++++.+||+|||++.......... 
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999986532    378999999999999999999999   99999999999999999999999999998654332211 


Q ss_pred             -cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          274 -TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       274 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                       .....++..|+|||.+....++.++||||||+++|||++ |..||......     ..   ...... .         .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~---~~~i~~-~---------~  215 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EV---TQMIES-G---------E  215 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH---HHHHHC-C---------C
Confidence             112234578999999988889999999999999999998 99998642211     11   111111 1         1


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....+...+..+.+++.+||+.||++||++.+|.+.|++
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            111223345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-40  Score=338.98  Aligned_cols=260  Identities=22%  Similarity=0.266  Sum_probs=206.5

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC--
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--  182 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--  182 (437)
                      .....++|.+.+.||+|+||+||++.. .+|+.||||++.... +......+.+|+..+..++|+|++++.+.+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344467899999999999999999986 468999999986432 2344567889999999999999999987764332  


Q ss_pred             ------eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          183 ------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       183 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                            ..++||||+++|+|.+++.........+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence                  36799999999999999976544445689999999999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCC-CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          257 VGDFGLAKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       257 l~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      |+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~  255 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMH  255 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHH
Confidence            99999998654322 12223456899999999999999999999999999999999999999643211        1111


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .... ..         ....+...+..+.+++..||+.||++||++.++++.
T Consensus       256 ~~~~-~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLA-GR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhc-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1110 00         011223345678999999999999999999999864

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.3e-40  Score=315.12  Aligned_cols=265  Identities=21%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-----------------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-----------------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR  173 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  173 (437)
                      .++|++.+.||+|+||.||++...                 ++..+|+|++...........|.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            456888999999999999998642                 234699999875443445678999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCchhhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG-------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      +++++...+..+++|||+++++|.+++......       ...+++.....++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       13478889999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE  323 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt--g~~p~~~~~~~  323 (437)
                      |+++.++.++|+|||+++......... .....++..|+|||....+.++.++|||||||++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999997653322111 112234678999999888899999999999999999998  66666432111


Q ss_pred             ccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                           .................      ....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 -----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 -----QVIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -----HHHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                 01111111110000000      00112234468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-40  Score=308.73  Aligned_cols=257  Identities=27%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ...++|.+.+.||+|+||.||++..+++..+|+|.+...  ....+++.+|+.++++++|+|++++++++......+++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            345788899999999999999999888889999998743  234567999999999999999999999999989999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....  ...+++..+..++.+++.|+.|||++   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999987632  23489999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......     ....   .....       
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~---~~~~~-------  220 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLE---QVERG-------  220 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHHcC-------
Confidence            22111222234568999999998889999999999999999999 99988532210     0111   11100       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .....+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ---YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               0111122234578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.5e-40  Score=309.65  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|+..+.||+|+||.||+|.... +   ..+|+|.+.........+.+.+|++++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4577888999999999999999752 3   37999998754334456789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|..++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999998653   23479999999999999999999999   9999999999999999999999999999866


Q ss_pred             ccCCCcccc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DVRKTNVTT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .........  ....+..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .   ..........  
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~---~~~~~i~~~~--  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----H---EVMKAINDGF--  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----H---HHHHHHhcCC--
Confidence            432222111  1223457999999998889999999999999999998 9999853221     0   1111111110  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ......+.+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       228 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         228 --------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                    111122344688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-40  Score=336.11  Aligned_cols=252  Identities=17%  Similarity=0.227  Sum_probs=202.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-C-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .|...+.||+|+||.||++... + +..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3778899999999999999864 3 578888876432 234455678899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|.+++.........+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999998876444445688999999999999999999999   99999999999999999999999999998764322


Q ss_pred             C-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||......        ......... ..      
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~-~~------  288 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYG-KY------  288 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CC------
Confidence            2 1233456899999999999999999999999999999999999998642211        111111100 00      


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...+...+..+.+++..||+.||++||++.+++.
T Consensus       289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0112223457899999999999999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=303.68  Aligned_cols=264  Identities=24%  Similarity=0.282  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeee--cCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l  186 (437)
                      .++|+..+.|++|+||.||+|+++ +++.||+|+++-.. ..+---.-++|+.+|.+.+|||||.+..+..  +-+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            456778899999999999999975 68899999997422 2233345689999999999999999998875  3457899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |||||++ +|...++...   ..+...+..-+..|+++|++|||++   -|+|||||++|+|++..|.+||+|||+|+.+
T Consensus       155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999987 7888887654   3477888888999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc---cc
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE---KR  342 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  342 (437)
                      +.. ....+..+-|.+|.|||.+.+.+ |+...|+||+|||+.||+++++.|.+.....     .++.+-.+...   ..
T Consensus       228 gsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-----Ql~~If~llGtPte~i  301 (419)
T KOG0663|consen  228 GSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-----QLDKIFKLLGTPSEAI  301 (419)
T ss_pred             cCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-----HHHHHHHHhCCCcccc
Confidence            643 34456677899999999998765 8999999999999999999999887544322     22222111110   00


Q ss_pred             hhhhcc--------------ccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 LDAIVD--------------RNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 ~~~~~d--------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.+..              ..++..+... ..+.-++|+...+..||.+|-|+.|.++.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000000              0111112111 34677899999999999999999998864

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.6e-40  Score=316.19  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      ...++|.+.+.||+|+||.||++...        ++..||+|.+.........+.+.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567888899999999999999741        24579999987543344567789999999999 8999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      .....+++|||+++++|.+++......            ...+++..+..++.||+.||+|||++   +++|+||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            999999999999999999999764321            23578899999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE  325 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~  325 (437)
                      ++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence            99999999999999998664322221 222345678999999988889999999999999999998 7777753211   


Q ss_pred             chhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           ...........          ....+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       246 -----~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         246 -----EELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             -----HHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                 11111111111          111122345688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.4e-40  Score=309.82  Aligned_cols=260  Identities=22%  Similarity=0.363  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++.. .++..+|||.+....  .....+++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999996 478999999886422  2234467889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++.........+++...+.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999876544455689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ... ......++..|+|||.+.+..++.++|+||||+++|||++|..||......      .........      ....
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~------~~~~  225 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE------QCDY  225 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh------cCCC
Confidence            222 122345788999999999888999999999999999999999998532211      111111111      0000


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      +.   ......+..+.+++.+||+.||++||||.+|+++++.
T Consensus       226 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         226 PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            11   1112345689999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-40  Score=317.39  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC--EEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|++.+.||+|+||.||+|.++ ++.  .+|+|.+...........+.+|++++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357788899999999999999974 344  46888776544444566888999999999 89999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          187 VYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      |+||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999875431            123578999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHH
Q 013750          255 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  333 (437)
                      +||+|||++......  .......++..|+|||.+.+..++.++||||||+++|||+| |..||......        ..
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~  232 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL  232 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------HH
Confidence            999999998632211  11111234568999999988889999999999999999998 99998533211        11


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......          ......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       233 ~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         233 YEKLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HHHHhc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111110          00111112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-40  Score=323.04  Aligned_cols=247  Identities=24%  Similarity=0.243  Sum_probs=200.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|...+.||+|+||.||+|.+++  +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4678889999999999999998643  3689999986421  23345678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999987533    378899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   .....        
T Consensus       182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~---~~~i~--------  241 (340)
T PTZ00426        182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LI---YQKIL--------  241 (340)
T ss_pred             CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HH---HHHHh--------
Confidence            422    22356899999999999888999999999999999999999999643211     11   11111        


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                       ....  .++......+.+++.+|++.||++|+     +++++++.
T Consensus       242 -~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 -EGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -cCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             1000  11222234678999999999999995     88888754

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.3e-40  Score=320.02  Aligned_cols=246  Identities=22%  Similarity=0.253  Sum_probs=191.1

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||++..+ +++.||+|++....  .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999987432  223345677888888776 799999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~  152 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  152 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence            99988876532    388999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||...............+........        .  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~--~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q--I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------C--C
Confidence            23356899999999999999999999999999999999999999632211111111111111111110        0  1


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      .++...+..+.+++.+||+.||++||++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1223344578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.2e-40  Score=316.90  Aligned_cols=259  Identities=29%  Similarity=0.405  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+...........+..|++++..+ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467888999999999999999852        23579999987543344456788999999999 799999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      ...++||||+++|+|.+++....+.            ...+++..+++++.|++.||+|||++   +++|+||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            9999999999999999999764321            23489999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 013750          250 DEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDD  327 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~  327 (437)
                      +.++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            999999999999987553211111 112234568999999998889999999999999999998 88887532211    


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          ....... .         ......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       250 ----~~~~~~~-~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         250 ----ELFKLLK-E---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             ----HHHHHHH-c---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence                1111111 0         01111223345688899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-39  Score=309.22  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=197.8

Q ss_pred             CCCCCeeeecCcEEEEEEEECCC-C--EEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC------Ce
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADG-T--KVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE  183 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g-~--~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  183 (437)
                      |.+.+.||+|+||.||+|.+.++ .  .+|+|.+.... +....+.|.+|+++++.++||||++++++|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34568899999999999997543 2  69999886432 334466788999999999999999999988432      24


Q ss_pred             eEEEEecccCchhhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          184 RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      .++++||+++|+|..++....  .....+++.....++.|++.||+|||++   +++||||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874322  2234589999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          262 LAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       262 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .....   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~---~~~~  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYD---YLRQ  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---HHHc
Confidence            998654322111 112235678999999999999999999999999999999 7888853211     11111   1111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...          ...+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       230 ~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            110          01122344578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.1e-40  Score=321.20  Aligned_cols=243  Identities=23%  Similarity=0.257  Sum_probs=196.1

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.||+|+||.||++... +|+.||+|++....  .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68999999997432  2334567889999999999999999999999999999999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT  274 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  274 (437)
                      +|..++...    ..+++.....++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            998888653    2488999999999999999999999   9999999999999999999999999998753221 1222


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC
Q 013750          275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN  354 (437)
Q Consensus       275 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  354 (437)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .........       +.    .
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~-------~~----~  213 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILME-------DI----K  213 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccC-------Cc----c
Confidence            3356899999999999889999999999999999999999999643211        011111000       00    1


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          355 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       355 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                      ++...+..+.+++.+||+.||++||     ++.++++.
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1222345788999999999999997     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-40  Score=321.04  Aligned_cols=243  Identities=22%  Similarity=0.253  Sum_probs=195.1

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.||+|+||.||++... +|..||+|++....  .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999986422  2334556788999999999999999999999999999999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT  274 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  274 (437)
                      +|..++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~  152 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence            9988886532    378999999999999999999999   9999999999999999999999999998753221 1222


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC
Q 013750          275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN  354 (437)
Q Consensus       275 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  354 (437)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     .   ......         ..  ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~---~~~~~~---------~~--~~  213 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----L---FELILM---------EE--IR  213 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----H---HHHHhc---------CC--CC
Confidence            33568999999999999999999999999999999999999986432110     0   111100         00  01


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          355 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       355 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                      ++...+..+.+++.+||+.||++||     ++.++++.
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1223345788999999999999998     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.7e-40  Score=317.12  Aligned_cols=260  Identities=26%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      ...++|...+.||+|+||.||++...      ++..||+|++.........+.+.+|+++++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            44567888999999999999999742      24579999987544344456789999999999 799999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      +..+++|||+++|+|.+++....  ...+++.+...++.|++.||+|||++   +++|+||||+||+++.++.++++|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999987532  23379999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          262 LAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       262 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......    ..    .....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~----~~~~~  258 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KF----YKLIK  258 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HH----HHHHH
Confidence            99865432211 1112345678999999999899999999999999999998 999886432110    00    01111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .         ......+...+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       259 ~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         259 E---------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             c---------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            1         11111112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.1e-40  Score=309.48  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-C---CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-D---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..+|.+.+.||+|+||.||+|.+. +   +..+|+|.+.........+.|.+|+.++..++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            356778899999999999999864 2   347999998754434456789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++....   ..+++...+.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999987532   3478999999999999999999999   9999999999999999999999999999866


Q ss_pred             ccCCCcccc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DVRKTNVTT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .........  ...++..|+|||.+.+..++.++|+||||+++||+++ |..||......        ..........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~--  226 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEEGY--  226 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhCCC--
Confidence            543222211  1223568999999998899999999999999999887 99998532211        1111111110  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ....+...+..+.+++.+|++.+|++||+|.++++.|+.
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                    011122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-40  Score=320.48  Aligned_cols=255  Identities=20%  Similarity=0.239  Sum_probs=203.8

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      ....++|+....||+|+||.||+++-+ +|..+|+|++++..  .....+..+.|-++|....+|+||+|+-.+.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            346788999999999999999999965 69999999998644  344567788999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ||||||++||++..+|....    .|+......++.+++-|+.-||..   |+|||||||+|+|||..|++||+||||+.
T Consensus       217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999998643    488888999999999999999999   99999999999999999999999999985


Q ss_pred             eccc--------------------CC-C-c-----cc-------------------ccccccccccccccccCCCCCCch
Q 013750          265 LVDV--------------------RK-T-N-----VT-------------------TQVRGTMGHIAPEYLSTGKSSERT  298 (437)
Q Consensus       265 ~~~~--------------------~~-~-~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~s  298 (437)
                      -+..                    .. . .     ..                   ...+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3311                    00 0 0     00                   114699999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 013750          299 DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR  378 (437)
Q Consensus       299 Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R  378 (437)
                      |+||+|||+||||.|-+||....+...-. .+..|...+..+              .......+..+||.+|+. ||++|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~r-kI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYR-KIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999999998655432111 111121111111              111223588899999998 99999


Q ss_pred             CC---HHHHH
Q 013750          379 PA---MSEVV  385 (437)
Q Consensus       379 Ps---~~evl  385 (437)
                      --   ++||-
T Consensus       434 LG~~G~~EIK  443 (550)
T KOG0605|consen  434 LGSKGAEEIK  443 (550)
T ss_pred             cCcccHHHHh
Confidence            65   55544

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.8e-40  Score=313.69  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .+|...+.||+|+||.||++...      ++..+++|.+.... ....+.+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45777889999999999999852      34568999886432 334567899999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          186 LVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +++|+||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999975432            123489999999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 013750          254 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  331 (437)
                      .++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |..||......        
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------  232 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------  232 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            999999999975433221 11223346788999999999999999999999999999999 99987543211        


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...... ......         ..+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       233 ~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~  281 (291)
T cd05094         233 EVIECI-TQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA  281 (291)
T ss_pred             HHHHHH-hCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            011111 111110         1122234678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.7e-40  Score=314.01  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|+..+.||+|+||.||++..+      ++..||+|.+...........|.+|+.++++++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            567888999999999999999864      46789999987544444556799999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          185 LLVYPFMQNLSVAYRLREIKP------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      ++++||+++++|.+++.....                  ....+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  123478889999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      |++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999998754322211 1112234667999999998899999999999999999998 87787532111 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ....... .....         ..+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       240 -------~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -------EVIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   1111111 11110         1122334689999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=319.40  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=208.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ...|+..+.||+|.||.||+|.+. .++.||+|++.-.......++..+|+.++++++++||.+.+|.+..+..+.++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            345667789999999999999964 6889999999865666778899999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||.+|++.+.+.....    ++.....-+..++..|+.|||++   +.+|||||+.|||+..++.+||+|||.+......
T Consensus        92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999875332    35555666788999999999999   9999999999999999999999999999877644


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..  -            ...+..-..|
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--v------------lflIpk~~PP  229 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--V------------LFLIPKSAPP  229 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--E------------EEeccCCCCC
Confidence            4333 56789999999999998899999999999999999999999986322110  0            0011111122


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~--~L~~  390 (437)
                      .+.+    +.+..+.+++..|+++||+.||++.++++  +++.
T Consensus       230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            2222    34457999999999999999999999994  3444

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.6e-40  Score=319.44  Aligned_cols=251  Identities=21%  Similarity=0.265  Sum_probs=195.0

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||++... +++.||+|++....  .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 58899999997422  223345678899999888 799999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++...    ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.... ....
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCc
Confidence            9998888643    2389999999999999999999999   999999999999999999999999999874221 1122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||+..............+.....        .....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCCC--
Confidence            23456899999999999999999999999999999999999999743222111111111111111        11111  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPA------MSEVVR  386 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs------~~evl~  386 (437)
                      ..+...+..+.+++.+|++.||.+||+      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            112223457889999999999999998      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-40  Score=328.30  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=202.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      ....++|+..+.||+|+||.||+++.. ++..||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345678899999999999999999975 58899999986421  223345678899999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|..++...     .++......++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999988653     267778888999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ..............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......        .........
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~  262 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDH  262 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcC
Confidence            6543322222345689999999998653    4789999999999999999999999643211        111111110


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM  387 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  387 (437)
                      ..       .+.-......+..+.+++..|++.+|++  ||++.++++.
T Consensus       263 ~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00       0000111123568889999999999988  9999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=327.27  Aligned_cols=253  Identities=24%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|.+.+.||+|+||+||+|... +|+.||+|++....  .......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999999975 68999999986422  2244567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++...    ..++...+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998764    3478899999999999999999998   999999999999999999999999999986543


Q ss_pred             CC----------------------------CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          269 RK----------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       269 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      ..                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            01122346899999999999999999999999999999999999999643


Q ss_pred             cccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 013750          321 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRM  387 (437)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~~  387 (437)
                      ...        ..........       ..+........+..+.+++..|++ ||.+||+ +.++++.
T Consensus       234 ~~~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQ--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHH--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            311        0111111000       000000011134678899999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=307.27  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=200.6

Q ss_pred             CCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe-----
Q 013750          114 FSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  183 (437)
                      |.+.+.||+|+||.||+|....    +..||+|++.... .......+.+|++.++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999999642    3679999987432 23345678999999999999999999999866554     


Q ss_pred             -eEEEEecccCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          184 -RLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       184 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                       .++++||+++++|..++.....  ....+++.....++.|++.||+|||+.   +++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7899999999999999865432  224589999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHH
Q 013750          261 GLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       261 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......     ....   ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~---~~~  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYD---YLR  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHH
Confidence            9998654332211 111234678999999988889999999999999999999 88887532211     1111   111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...          ....+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       230 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         230 HGN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             cCC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            110          111223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=308.00  Aligned_cols=250  Identities=25%  Similarity=0.431  Sum_probs=196.2

Q ss_pred             CeeeecCcEEEEEEEECC-CC--EEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|.+++ +.  .+|+|.+.........+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 43  57888887544445566889999999999 799999999999999999999999999


Q ss_pred             chhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          194 LSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       194 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ++|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999875431            123478999999999999999999998   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ++......  ........+..|+|||++....++.++||||||+++|||++ |..||......        .........
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQG  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhCC
Confidence            98632211  11111223567999999988889999999999999999997 99998532211        111111110


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                                .....+...+..+.+++.+||+.+|.+|||+.+++..|+.
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 ----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                      0111122234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-39  Score=309.47  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|+||.||+|.. .++..||+|.+.........+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999996 468899999986543344556789999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..+.        .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        267888889999999999999999   9999999999999999999999999999765322 


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .........         .+..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~---------~~~~  216 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCI---------VDED  216 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHH---------hccC
Confidence              2233468899999999998899999999999999999999999986422111110 000111110         0000


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      .........+.++.+++.+|++.+|++||++.|+++..
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            00000112335788999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-39  Score=309.48  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--Cee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  184 (437)
                      .+|.+.+.||+|+||.||++..+     ++..||+|.+.... ....+.|.+|+++++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46778899999999999999853     57899999986532 34456889999999999999999999987543  467


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+++++|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            89999999999999986532   3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh-c-
Q 013750          265 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-E-  340 (437)
Q Consensus       265 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~-  340 (437)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||++|..++......      .......... . 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~  230 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQM  230 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhccccccccc
Confidence            664332211  11122345699999999888999999999999999999987765322110      0000000000 0 


Q ss_pred             --cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 --KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 --~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ..+.+.+............+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence              00001111111111122345689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-40  Score=318.55  Aligned_cols=243  Identities=23%  Similarity=0.284  Sum_probs=194.5

Q ss_pred             CeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          118 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.||+|+||.||+++.    .+++.||+|++....   .......+..|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357899999986421   123345678899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..++....    .+.+.....++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999886532    367888888999999999999999   99999999999999999999999999987543222


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .......         ...
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~---------~~~  216 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKIL---------KGK  216 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHH---------cCC
Confidence             2223356899999999999888999999999999999999999999643211        1111111         111


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                        ...+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              111223345788999999999999999     78887653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-39  Score=308.43  Aligned_cols=255  Identities=28%  Similarity=0.374  Sum_probs=193.1

Q ss_pred             CeeeecCcEEEEEEEECC---CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.||+|+||.||+|...+   +..+|+|.+...........|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45799998875444444567889999999999999999999999999999999999999


Q ss_pred             hhhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          195 SVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       195 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++|+||||+||+++.+++++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975432 223467788889999999999999999   99999999999999999999999999987543222111


Q ss_pred             -cccccccccccccccccCC-------CCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          274 -TTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       274 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||.......     .....   .. ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~~---~~-~~~~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTYT---VR-EQQL  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHH---hh-cccC
Confidence             1223467889999998642       35789999999999999996 999986432111     10000   00 0111


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ...++.+.    ......+.+++..|| .+|++|||+.||+..|+
T Consensus       229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111    122346788999999 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-40  Score=325.62  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=205.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      -|...+.||.|+-|.|-+|++ .+|+.+|||++.+..  +........+|+-+|+.+.|||+++|++++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            356678899999999999996 479999999996532  23334567899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|-|.+++....+    +......+++.||..|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-.. 
T Consensus        93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999986543    88899999999999999999999   999999999999999999999999999986432 


Q ss_pred             CCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                       .......+|.++|.|||++.+.+| +.++||||.|||||.|+||+.||+..+.        ........++ .      
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G-~------  228 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRG-V------  228 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcC-c------
Confidence             233445689999999999999998 6899999999999999999999984321        1111111111 0      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          -+.+...+.+..+|+.+|+..||++|.|++||++.
T Consensus       229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                11233445689999999999999999999999975

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=305.39  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC----CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|...+.||+|++|.||++... ++..||+|.+.....    ....+.+.+|++++.+++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999964 689999998864321    1224568899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ++||+++++|.+++....    .++......++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999887533    378888999999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCccc--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+..     ..   .....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~---~~~~~------  220 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA---IFKIA------  220 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH---HHHHh------
Confidence            43221111  2345778999999999988999999999999999999999998532110     00   01110      


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         ........+......+.+++..||+.+|++|||+.++++.
T Consensus       221 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 ---TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               0111112233345578999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-39  Score=315.91  Aligned_cols=261  Identities=28%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      ...++|.+.+.||+|+||.||++...        .+..+|+|.+...........+.+|+++++++ +||||++++++|.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            33467788999999999999999752        24579999987544444566788999999999 6999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      .....++++||+++|+|.+++.....            ....+++.....++.|++.||.|||++   +++|+||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            98999999999999999999976432            124589999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE  325 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~  325 (437)
                      ++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999998654322111 112234567999999998889999999999999999999 88887532211  


Q ss_pred             chhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .........          .....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       244 ------~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         244 ------ELFKLLREG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             ------HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                  111111110          0111223344578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-40  Score=322.46  Aligned_cols=253  Identities=18%  Similarity=0.214  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|...+.||+|+||+||++... +|+.||+|++....  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999975 68999999997432  1234557889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....   ..+++.....++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999987642   3488999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccccccc------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ..........||..|+|||.+.      ...++.++|||||||++|||++|+.||......        ...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~  226 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR  226 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            3333333356899999999986      456789999999999999999999999643211        11111111100


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...       -...+..+..+.+++..|++ +|++||++.++++
T Consensus       227 ~~~-------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLK-------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccC-------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000       00111234578889999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=311.11  Aligned_cols=249  Identities=19%  Similarity=0.314  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      -+|++.+.||+|.||+|-+++. ..|+.||||.+.+..  +.+..-.+.+|+++|+.++||||+.++.+|.+.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4567778899999999999995 679999999997543  3344456789999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||..+|.|.+|+.+...    |+.....+++.||..|+.|+|.+   +++|||||.+|||||.|+++||+|||++.++. 
T Consensus       133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~-  204 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA-  204 (668)
T ss_pred             EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence            99999999999987654    89999999999999999999999   99999999999999999999999999998765 


Q ss_pred             CCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                       +......++|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||+..+.        ...++...++.      
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~Ga------  269 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGA------  269 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhccc------
Confidence             3344556889999999999999887 6899999999999999999999985432        12222222111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                         .+   .+..+....-|+++|+-.||++|.|+.+|.....
T Consensus       270 ---Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  270 ---YR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ---cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence               11   2223447788999999999999999999987654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-39  Score=303.12  Aligned_cols=250  Identities=23%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|++|.||++..+ ++..|++|.+.... .....+.+.+|+++++.++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999975 68999999986422 244567889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++.....++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999987642  23588999999999999999999999   99999999999999999999999999998664332


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      . ......++..|+|||++.+..++.++|+||||+++|||++|+.||.....     ...   ...... .         
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~---~~~~~~-~---------  216 (256)
T cd08529         156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GAL---ILKIIR-G---------  216 (256)
T ss_pred             c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHH---HHHHHc-C---------
Confidence            2 22334578899999999999999999999999999999999999864321     001   111100 0         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+...+..+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            011122234568999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=310.92  Aligned_cols=253  Identities=24%  Similarity=0.323  Sum_probs=200.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .|+..+.||+|+||+||++... +++.||+|++....  .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999974 68999999986422  12234567889999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999998886532  23488999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......     ........        +.  
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~--------~~--  218 (285)
T cd05605         156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERR--------VK--  218 (285)
T ss_pred             C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHH--------hh--
Confidence            2  1223468999999999998899999999999999999999999997432211     00000000        00  


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                      .....++...+..+.+++..||+.||++||     ++.++++.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            001122333456789999999999999999     77787643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=304.28  Aligned_cols=247  Identities=27%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|.+..    +..+|+|.+.........+++.+|+++++.+.|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    36899999875443345668999999999999999999999876 4567999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|.+++....    .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997543    479999999999999999999999   99999999999999999999999999998664333222


Q ss_pred             ccc--ccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          274 TTQ--VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       274 ~~~--~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      ...  ..++..|+|||.+.+..++.++||||||+++|||++ |..||.....     .........   ..         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~~---~~---------  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLES---GE---------  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHc---CC---------
Confidence            111  223468999999998999999999999999999998 9999864321     111111111   10         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       ....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       216 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         216 -RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             011122334588999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-39  Score=322.78  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----eeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  185 (437)
                      +|+..+.||+|+||.||++... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 68999999986422 2234567889999999999999999999998776     789


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +|+||+. ++|..++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 467666643    23488999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch-
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL-  343 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  343 (437)
                      .............++..|+|||.+.+. .++.++|||||||++|||++|+.||.......     ....+......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~g~~~~~  227 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-----QLDLITDLLGTPSLE  227 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHHHcCCCCHH
Confidence            554333333445678999999998764 47999999999999999999999997543211     11111110000000 


Q ss_pred             ----------hhhccccccC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          344 ----------DAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       344 ----------~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                ..+.......       .........+.+++.+|++.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      0000000000       0111224578899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-39  Score=304.02  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .+|+..+.||+|+||.||++.+.++..+|+|.+...  .....+|.+|++++.+++|||++++++++......++++||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467778999999999999999877889999988643  233567999999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....   ..+++..+..++.+++.|++|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999999887532   3478999999999999999999999   999999999999999999999999999876533222


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++.+|+|||.+.++.++.++||||||+++|||++ |..||......        ..........   ....  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~---~~~~--  222 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGF---RLYK--  222 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCC---CCCC--
Confidence            11222234678999999998899999999999999999998 89888632211        1111111110   0011  


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                           +...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 1112358999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.7e-40  Score=311.87  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--Cee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  184 (437)
                      ..|...+.||+|+||.||++.+     .++..||+|.+...........+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467789999999999999984     247889999987544445567899999999999999999999998765  567


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999998653   23479999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccc-------cchhhHHHHHH
Q 013750          265 LVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDHVK  335 (437)
Q Consensus       265 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~-------~~~~~~~~~~~  335 (437)
                      ........  ......++..|+|||.+.+..++.++||||||+++|||++++.|........       ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            65432221  1123446778999999988889999999999999999999877643211000       00000111111


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...          .......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       238 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLE----------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHH----------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            110          000111122345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=302.95  Aligned_cols=250  Identities=29%  Similarity=0.421  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|...+.||+|+||.||++... |+.||+|.+.....  ..+.+.+|+.++++++|+|++++++++......++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            457888899999999999999985 89999999975332  467899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++.....  ..+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.++......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            999999999876432  2489999999999999999999999   99999999999999999999999999998653221


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .    ....+..|+|||.+..+.++.++||||||+++|||++ |..||......     .+.   ......         
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~---~~~~~~---------  215 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVV---PHVEKG---------  215 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHH---HHHhcC---------
Confidence            1    2234668999999998899999999999999999997 99888532211     011   111110         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             0111122335688999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-40  Score=324.27  Aligned_cols=257  Identities=21%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ++....++|+..+.||+|+||.||++... +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34455678999999999999999999975 57899999986421  2233456889999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+++|+|.+++...     .++......++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999998643     267888899999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      +...............||+.|+|||.+...    .++.++|||||||++|||++|+.||......        .....  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~--  258 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSK--  258 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHH--
Confidence            986643322222345699999999998654    3789999999999999999999999643211        11111  


Q ss_pred             hccchhhhccccccCCC--CHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013750          339 REKRLDAIVDRNLNKNY--NIQEVETMIQVALLCTQASPED--RPAMSEVVRM  387 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  387 (437)
                             +.+......+  ....+..+.+++..|++.++.+  ||++.|+++.
T Consensus       259 -------i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 -------IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -------HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                   1111100011  1123457788889999765544  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-39  Score=307.51  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..|...+.||+|+||.||+|.+.. +   ..||+|.+.........++|..|+.+++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            346678999999999999999753 3   369999987544444567899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....   ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999987532   3478999999999999999999999   99999999999999999999999999987654


Q ss_pred             cCCCcc--ccccc--ccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          268 VRKTNV--TTQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       268 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ......  .....  .+..|+|||.+.+..++.++||||||+++||+++ |..||......     .....+   ...  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i---~~~--  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAI---EQD--  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHH---HcC--
Confidence            322211  11111  2457999999999999999999999999999987 99998532211     111111   100  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              .....+.+.+..+.+++..||+.+|++||++.+++..|+.
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         228 --------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                    0111123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-39  Score=309.26  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|...+.||+|+||.||++...      ++..+|+|.+.... ....+.|.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46677899999999999999742      35689999886532 445668999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          186 LVYPFMQNLSVAYRLREIKPG-----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      +++||+++++|.+++....+.           ...+++..++.++.|++.|++|||+.   +++|+||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            999999999999998754321           13478999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          255 AVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      ++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......        .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~  232 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------E  232 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------H
Confidence            999999999755322211 1112235678999999999999999999999999999998 88887532111        0


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      .........          ....+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       233 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 AIECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            111111000          01112233457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=302.72  Aligned_cols=251  Identities=32%  Similarity=0.491  Sum_probs=204.5

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||++...+    +..||+|.+.........+.+.+|++++..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999754    7899999997644333467899999999999999999999999999999999999999


Q ss_pred             chhhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          194 LSVAYRLREIKPG-----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       194 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ++|.+++......     ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875322     35589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          269 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       269 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..||......        ........       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~-------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRK-------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc-------
Confidence            321 11223457889999999988899999999999999999999 58888643211        11111111       


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                         ......+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               0111223334568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-39  Score=304.73  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..++|...+.||+|+||.||++...++..+|+|.+...  ....+.|.+|++++++++|+|++++.+++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            34678889999999999999999877888999988642  2345678999999999999999999999877 77899999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999987532  23478899999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .........++..|+|||.+....++.++|+||||+++|++++ |+.||......     ....   ... ..       
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~---~~~-~~-------  219 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR---ALE-RG-------  219 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHH---HHh-CC-------
Confidence            2222222345678999999998889999999999999999999 88888632211     0111   110 00       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        .........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              0011122334578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-39  Score=307.63  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|...+.||+|+||.||+|..+      +...|++|.+.........+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999964      246799998865332324568999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKPGE-----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      +||||+++++|.+++.......     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987654221     2589999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     .   ....... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~---~~~~~~~-  232 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----E---EVLNRLQ-  232 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----H---HHHHHHH-
Confidence            9987543222222233346778999999988889999999999999999999 7778753211     0   1111111 


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ..        .+....+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       233 ~~--------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AG--------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cC--------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            00        1111112233458999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-39  Score=318.68  Aligned_cols=261  Identities=27%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC-
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP-  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-  181 (437)
                      ..++|...+.||+|+||.||+|..      .+++.||||++...........+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346788899999999999999974      246789999997544344456788999999999 689999999988654 


Q ss_pred             CeeEEEEecccCchhhhhhhhcCC--------------------------------------------------------
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKP--------------------------------------------------------  205 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  205 (437)
                      ...++++||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            467899999999999999864211                                                        


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-cccc
Q 013750          206 -------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQV  277 (437)
Q Consensus       206 -------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~  277 (437)
                             ....+++.....++.|+++||+|||++   +++||||||+||++++++.+||+|||++.......... ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   012368888899999999999999999   99999999999999999999999999998653222111 1123


Q ss_pred             cccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       278 ~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..|+.......    ..   .........          ...+
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~---~~~~~~~~~----------~~~~  304 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EF---CRRLKEGTR----------MRAP  304 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HH---HHHHhccCC----------CCCC
Confidence            35678999999988899999999999999999997 888875422110    01   111111100          0011


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......+.+++..||+.+|++|||+.|+++.|+.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1123478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-39  Score=324.09  Aligned_cols=253  Identities=20%  Similarity=0.249  Sum_probs=194.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .|...+.||+|+||+||+|... +++.||+|++....  .....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999964 58899999996422  22345678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999987533    378888889999999999999999   9999999999999999999999999997643110


Q ss_pred             CC----------------------------------------------cccccccccccccccccccCCCCCCchhhHHH
Q 013750          270 KT----------------------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY  303 (437)
Q Consensus       270 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~  303 (437)
                      ..                                              .......||..|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00122468999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHH--hccCCCCCCCCH
Q 013750          304 GIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL--CTQASPEDRPAM  381 (437)
Q Consensus       304 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPs~  381 (437)
                      ||++|||++|+.||.......     ..   .......       ..+........+.++.+++.+  |+..+|..||++
T Consensus       235 G~il~elltG~~Pf~~~~~~~-----~~---~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTE-----TQ---LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHH-----HH---HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            999999999999996432211     00   0000000       000000011123456677766  666677779999


Q ss_pred             HHHHHH
Q 013750          382 SEVVRM  387 (437)
Q Consensus       382 ~evl~~  387 (437)
                      .++++.
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=329.03  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=194.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-------
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-------  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------  181 (437)
                      ..++|...+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3467999999999999999999974 68899999885321     2345799999999999999999876332       


Q ss_pred             -CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEee
Q 013750          182 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGD  259 (437)
Q Consensus       182 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~D  259 (437)
                       ...++||||+++ +|..++.........+++.....++.||+.||+|||++   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             235689999985 67776655443445689999999999999999999999   999999999999999664 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      ||+++......  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||........    +........
T Consensus       215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~~~~  288 (440)
T PTZ00036        215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQVLG  288 (440)
T ss_pred             cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhC
Confidence            99998654322  22334689999999998654 689999999999999999999999965332110    111111100


Q ss_pred             hcc--------------chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          339 REK--------------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       339 ~~~--------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...              ....+....+...++...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000              0000000111111222344688999999999999999999999843

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=333.52  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=210.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCC-CEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeee-ee---c-
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-TKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGF-CT---T-  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~---~-  180 (437)
                      .+...+.++.++|.+|||+.||.+.+..+ ..||+|++-.. +....+...+|+++|++|. |+|||.+++. ..   . 
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            34455667789999999999999998765 99999999754 4667788999999999997 9999999993 21   1 


Q ss_pred             --CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          181 --PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       181 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                        .-+.+|.||||.+|.|-+++.......  |+..++++|+.++++|+++||.. .|+|||||||-+||||+.+++.|||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence              236789999999999999998765444  89999999999999999999987 6789999999999999999999999


Q ss_pred             ecCCceecccCCCcccc--------ccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 013750          259 DFGLAKLVDVRKTNVTT--------QVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD  327 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~  327 (437)
                      |||.+.-..........        ...-|+.|.|||.+.   +..+++|+|||+|||+||-|+....||+...      
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------  262 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------  262 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence            99998744332211100        012488999999884   6678999999999999999999999997431      


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                                     ...+++....-...+.++..+.+||..||+.||++||++-+|++.+-.
T Consensus       263 ---------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  263 ---------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ---------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                           123444444444456788899999999999999999999999988765

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=300.61  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=198.7

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhh
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA  197 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  197 (437)
                      +.||+|+||.||++.+.+++.||+|.+.........+.|.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999999875443335668999999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc-cc
Q 013750          198 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQ  276 (437)
Q Consensus       198 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~  276 (437)
                      +++....   ..+++.....++.+++.||+|||++   +++|+||||+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9986532   2478899999999999999999999   999999999999999999999999999975432111111 11


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY  355 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  355 (437)
                      ...+..|+|||.+.++.++.++|+||||+++|||+| |..||.......     .....             ........
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~-------------~~~~~~~~  216 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERI-------------ESGYRMPA  216 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHH-------------hcCCCCCC
Confidence            223567999999998899999999999999999999 788875332110     11110             00001111


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       356 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      +...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.9e-39  Score=304.61  Aligned_cols=255  Identities=21%  Similarity=0.278  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            45788899999999999999996 468899999986432 3344567899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999988643    2378999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .. ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+........        ......    ...
T Consensus       160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~~~----~~~  226 (267)
T cd06646         160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMSK----SNF  226 (267)
T ss_pred             cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heeeec----CCC
Confidence            11 122345788999999884   34578899999999999999999999853211100        000000    000


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      ..+...  .....+..+.+++.+||+.+|++||+++++++.|
T Consensus       227 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000010  0112346889999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-39  Score=316.72  Aligned_cols=245  Identities=24%  Similarity=0.318  Sum_probs=192.8

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHH---HhcccccceeeeeeeecCCeeEEE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMI---SVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      |.+.+.||+|+||.||++... +++.||||++....  .....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556789999999999999975 58999999996422  223345666776655   567899999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|..++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887753     2389999999999999999999999   99999999999999999999999999987432


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......        .........       
T Consensus       153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-------  216 (324)
T cd05589         153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVND-------  216 (324)
T ss_pred             CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------
Confidence            21 12223456899999999999999999999999999999999999998643211        011111110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                        .  ...+...+..+.+++.+||+.||++||+     +.++++
T Consensus       217 --~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 --E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              0  0112223457889999999999999994     566554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-39  Score=303.63  Aligned_cols=249  Identities=29%  Similarity=0.393  Sum_probs=199.2

Q ss_pred             CeeeecCcEEEEEEEECC--C--CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLAD--G--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|++|.||+|.+.+  +  ..||+|.+.........+.|.+|+.++++++||||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999743  3  36999998764433556789999999999999999999999988 889999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|.+++.....  ..+++.....++.|++.||+|||++   +++|+||+|+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999876432  4589999999999999999999999   99999999999999999999999999998764422211


Q ss_pred             --cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          274 --TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       274 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......        ..........         
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~---------  217 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEG---------  217 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcC---------
Confidence              112446789999999998899999999999999999999 99998532211        1111111000         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      .....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            001112233468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-39  Score=314.77  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHh-cccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|... +++.||+|++....  .....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986422  22334556677777765 4899999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .++......++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            99998887532    378889999999999999999999   99999999999999999999999999998543222 22


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   .......           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~---~~~i~~~-----------~~  213 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----EL---FDSILND-----------RP  213 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHcC-----------CC
Confidence            33456899999999999989999999999999999999999999643211     01   1111000           01


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV  385 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl  385 (437)
                      .++...+..+.+++..||+.||++||++. +++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12222345788999999999999999975 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-40  Score=319.51  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=212.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe-eEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-RLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~  188 (437)
                      ++|...+++|+|+||.++..+.+ ++..+++|.+.-.. +....+...+|+.++++++|||||...+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888899999999999999865 57899999986322 33344577899999999999999999999988888 89999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      +|++||++...+...+  ...++...+++++.|++.|+.|||++   .|+|||||+.||+++.+..++|+|||+|+....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998755  34588999999999999999999998   999999999999999999999999999998875


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ... ......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+...        .+...         ..
T Consensus       159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki---------~~  220 (426)
T KOG0589|consen  159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKI---------NR  220 (426)
T ss_pred             chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHH---------hh
Confidence            542 3455679999999999999999999999999999999999999997544321        11111         11


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ......+...+.++..++..|++.+|+.||++.+++..
T Consensus       221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             11223355667799999999999999999999999976

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=320.28  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||+||++... +|+.||||++....  .......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999975 58999999996421  1234456788999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999987532    388999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc-------------------------------------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 013750          269 RKTN-------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV  311 (437)
Q Consensus       269 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ell  311 (437)
                      ....                                     ......||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     001235899999999999999999999999999999999


Q ss_pred             hCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 013750          312 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVVRM  387 (437)
Q Consensus       312 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~  387 (437)
                      +|..||......        ..........       ..+........+..+.+++.+|+. +|.+|++   +.++++.
T Consensus       234 ~G~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQ--------ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHH--------HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999999643211        0111111000       000000011123577888888986 9999998   8888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-39  Score=316.43  Aligned_cols=263  Identities=28%  Similarity=0.392  Sum_probs=206.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC--------CCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeee
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC  178 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~  178 (437)
                      +....+|.+.+.||+|+||.||++...+        +..||+|.+.........+++.+|++++.++ +||||++++++|
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3445578889999999999999997421        2368999887543344567899999999999 799999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      ......++++||+++|+|.+++....+            ....+++..++.++.|++.||+|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            999999999999999999999875432            123588999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      |+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999999865432211 1122234568999999999999999999999999999998 8888753221  


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                            ..........          .....+...+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus       243 ------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         243 ------EELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             ------HHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                  1111111111          11111223345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4e-39  Score=302.45  Aligned_cols=251  Identities=18%  Similarity=0.277  Sum_probs=203.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      +|+..+.||+|+||.||++... ++..+|+|.+.........+.+.+|+.+++.++|+|++++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999975 688999999864333445678889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....  ...++....+.++.|++.||.|||++   +++|+||||+||++++++.++++|||++....... 
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            9999999886532  23478889999999999999999999   99999999999999999999999999998654322 


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......        ....... ....        
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~--------  217 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVC-QGSY--------  217 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHh-cCCC--------
Confidence            2223356888999999999888999999999999999999999998643211        0111111 0111        


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ...+...+..+.+++.+||+.||++||++.+++..
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             11122334578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=326.63  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=206.2

Q ss_pred             CCCCeeeecCcEEEEEEEECC--CC--EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          115 SEKNVLGQGGFGKVYRGVLAD--GT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~--g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ...++||+|.||.|++|.|..  |+  .||||.+..........+|++|+.+|.+++|||+++|+|+..+ ....+|+|+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            334789999999999999853  43  6999999876655578899999999999999999999999987 778999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      ++.|+|.+.|+..  ....+-......++.|||.||.||.++   ++|||||.++|+||..--.+||+|||+.+-+....
T Consensus       192 aplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999872  334577788899999999999999999   99999999999999998899999999999876544


Q ss_pred             Ccccc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          271 TNVTT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       271 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .....  ...-...|.|||.+....++.+||||+|||.||||+| |+.||....     ...             +.+.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~q-------------IL~~i  328 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQ-------------ILKNI  328 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHH-------------HHHhc
Confidence            43322  2234668999999999999999999999999999999 777875432     111             22233


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      |.+-+-.-+..|+++++++++.||..+|++|||+..+.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            333333446778999999999999999999999999973

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-39  Score=313.60  Aligned_cols=263  Identities=22%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||+|+.+ ++..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999975 57889999987544344455788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++ +|..++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            985 777776543   23478889999999999999999999   99999999999999999999999999997543322


Q ss_pred             CcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc--------
Q 013750          271 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------  341 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  341 (437)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........     ...........        
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-----LHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCCHHHHhhh
Confidence            1 1223457889999998865 4689999999999999999999999965432211     01111100000        


Q ss_pred             ----chhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 ----RLDAIVDRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ----~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          .......+....    ...+..+..+.+++.+|++.||.+|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence                000000000000    0011234577899999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-39  Score=305.56  Aligned_cols=251  Identities=27%  Similarity=0.455  Sum_probs=198.9

Q ss_pred             CeeeecCcEEEEEEEECC-------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          118 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.||+|+||.||+|+..+       +..+|+|.+...........|.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998643       2579999886543344567899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-----cEEEeecCC
Q 013750          191 MQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-----EAVVGDFGL  262 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-----~~kl~Dfgl  262 (437)
                      +++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975432   224478999999999999999999999   999999999999999887     899999999


Q ss_pred             ceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          263 AKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       263 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      +......... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||.....     ......   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~~~~~---~~~~  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVLQH---VTAG  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HHHHHH---HhcC
Confidence            8755322111 1112235678999999999999999999999999999998 9999863221     111111   1100


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                                .....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       230 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 ----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                      111122334568899999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.9e-39  Score=311.53  Aligned_cols=263  Identities=21%  Similarity=0.292  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|++++.+++||||+++++++..++..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999975 57889999886433333456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...    ..+++.....++.|+++||.|||+.+  +++|+||||+|||++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998754    23788899999999999999999832  8999999999999999999999999998754321 


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc---------
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---------  341 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  341 (437)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......     ............         
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccc
Confidence              1223467899999999988889999999999999999999999986432111     000000000000         


Q ss_pred             -----------chhhhccccc---cCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          342 -----------RLDAIVDRNL---NKNYN-IQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       342 -----------~~~~~~d~~l---~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                                 ...+..+...   ....+ ......+.+++.+||+.+|++||++.++++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                       0000000000   00000 11345789999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-39  Score=301.75  Aligned_cols=248  Identities=28%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee-cCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||++... |..||+|.+...   ...+.|.+|+.++++++|+|++++++++. ..+..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            56788899999999999999875 888999988642   33567899999999999999999999764 55678999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++...+.++.|++.||+|||++   +++|+||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999987532  23478999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                          .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+.....        ..........         
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~---------  215 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKG---------  215 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcC---------
Confidence                12234568999999998889999999999999999998 8888753211        1111111111         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             1111222345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-39  Score=320.85  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=204.4

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ..++....++|+..+.||+|+||.||++..+ +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4556667789999999999999999999975 57899999986321  22334567889999999999999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      .+..++||||+++|+|..++...     .++...+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999988653     267788888999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |++...............||+.|+|||.+...    .++.++|||||||++|||++|+.||......        .....
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~  258 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK  258 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence            99987643332223345699999999998654    3789999999999999999999999743211        11111


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~~  390 (437)
                      .......       +........+..+.+++..|++.++.+  ||++.++++....
T Consensus       259 i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         259 IMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            1110000       000011234457888999999844443  7899998876543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.9e-39  Score=317.40  Aligned_cols=201  Identities=20%  Similarity=0.275  Sum_probs=173.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||+||++... +++.||+|++....  .......+..|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999875 58899999986422  1233456788999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999998753    2388999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC
Q 013750          269 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ  314 (437)
Q Consensus       269 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~  314 (437)
                      ...                                  .......||+.|+|||.+.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 013750          315 RAIDF  319 (437)
Q Consensus       315 ~p~~~  319 (437)
                      .||..
T Consensus       234 ~Pf~~  238 (363)
T cd05628         234 PPFCS  238 (363)
T ss_pred             CCCCC
Confidence            99964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.8e-39  Score=304.59  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|...+.||+|+||.||+|.+.+    ...||+|...........+.|.+|+.+++.++|||++++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4567788999999999999998643    246899988654434456689999999999999999999998875 45789


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++....   ..+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            999999999999997532   2479999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ............++..|+|||.+....++.++||||||+++||+++ |..||.......     .   ..........  
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~---~~~~~~~~~~--  227 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----V---IGRIENGERL--  227 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----H---HHHHHcCCcC--
Confidence            4332222222334568999999988889999999999999999996 999986432210     1   1111111100  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ..+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    1122345689999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.8e-39  Score=306.83  Aligned_cols=250  Identities=24%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||.||++..+ +|+.||+|.+....  .......+..|++++.+++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999975 58999999986422  122334566799999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++......  .....
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~  153 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQ  153 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeec
Confidence            98886532  23478999999999999999999999   9999999999999999999999999998865432  12233


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||........    ........         ....... ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~---------~~~~~~~-~~  219 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRT---------LEDEVKF-EH  219 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHh---------hcccccc-cc
Confidence            4688999999999988899999999999999999999999864321111    00111110         0000000 01


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+.++.+++..||+.||++||++.|+++.+..
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            1234578999999999999999999887755544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-39  Score=313.50  Aligned_cols=237  Identities=25%  Similarity=0.338  Sum_probs=190.6

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||++..+ +++.||+|++....  .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999986421  233456777888888876 699999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .++...+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            99998887532    378899999999999999999999   99999999999999999999999999987542221 22


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .........         .  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~---------~--~  213 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND---------E--V  213 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC---------C--C
Confidence            23356899999999999989999999999999999999999999743211        111111100         0  0


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ..+...+..+.+++.+|++.||++||++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1112234578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.9e-40  Score=318.42  Aligned_cols=243  Identities=21%  Similarity=0.247  Sum_probs=194.6

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.||+|+||.||++... +|..||+|++....  .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999986422  2234557788999999999999999999999999999999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      +|..++...    ..+++..+..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            998888653    248899999999999999999997 6   89999999999999999999999999987532221 12


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||.......     .   ...... .      .    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~---~~~i~~-~------~----~  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----L---FELILM-E------E----I  213 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----H---HHHHhc-C------C----C
Confidence            233468999999999999999999999999999999999999996432110     1   011000 0      0    0


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                      .++...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11122345788999999999999996     89998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.5e-39  Score=312.97  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|+.. +++.||+|++....  .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 47899999986422  233455677899988865 799999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|..++....    .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...... ...
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~  152 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVT  152 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccc
Confidence            99998886532    378899999999999999999999   9999999999999999999999999998754322 222


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||......     ..   ........         .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~---~~~i~~~~---------~--  213 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DL---FESILHDD---------V--  213 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HH---HHHHHcCC---------C--
Confidence            33456899999999999989999999999999999999999999743211     11   11111100         0  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRP-------AMSEVVRM  387 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-------s~~evl~~  387 (437)
                      ..+...+..+.+++..|++.||++||       ++.++++.
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            01112335788999999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-39  Score=307.60  Aligned_cols=270  Identities=24%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec--CCee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  184 (437)
                      +.|...+.||+|+||.||++.+.     ++..+|+|.+.........+.|.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45667789999999999999864     3678999999754322346789999999999999999999999877  5578


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      +++|||+++++|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999987533   2489999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............   .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~  234 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI---AQGQMIVTR  234 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc---ccccccHHH
Confidence            765322211  112234567999999988899999999999999999999999875422111000000   000000000


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+.+........+..++..+.+++.+||+.+|++|||+.||+++|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            011111111112223345689999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-39  Score=313.68  Aligned_cols=242  Identities=25%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||++... ++..||+|++....  .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 47899999987422  233455677888888877 699999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .+++.....++.|++.||.|||++   +++||||||+||++++++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~  152 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT  152 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence            99998886532    389999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......     ..   .....         ...  .
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~---~~~i~---------~~~--~  213 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----EL---FQSIL---------EDE--V  213 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HH---HHHHH---------cCC--C
Confidence            23346899999999999999999999999999999999999999643211     11   11111         000  0


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAM-----SEVVR  386 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~  386 (437)
                      .++...+..+.+++.+||+.||++||++     .++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1122334578999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.6e-39  Score=315.05  Aligned_cols=242  Identities=23%  Similarity=0.293  Sum_probs=193.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccc-cceeeeeeeecCCeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  188 (437)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....  .....+.+..|.+++..+.|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999975 47899999986422  234456788899999999765 5888999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998886532    378899999999999999999999   999999999999999999999999999874322


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .. .......||..|+|||.+.+..++.++|||||||++|||+||+.||......     ...   ....         .
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~---~~i~---------~  215 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELF---QSIM---------E  215 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHH---HHHH---------c
Confidence            11 1223356899999999999999999999999999999999999999643211     111   1111         0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      .  ...++...+..+.+++.+||+.||.+||+.
T Consensus       216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         216 H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            0  011122234578899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.5e-39  Score=301.76  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=197.6

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcc-hHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGG-DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      |+..+.||+|+||+||++...+ ++.||+|.+........ .....+|+.++++++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4457899999999999999864 56899999975432221 223456999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++...    ..+++..+..++.|+++||.+||++   +++|+||||+||++++++.++|+|||.+.... ...
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            999999999832    2389999999999999999999999   99999999999999999999999999998642 222


Q ss_pred             ccccccccccccccccccc-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .......++..|+|||.+. +..++.++||||+|+++|+|++|..|+.......     ...................  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~--  225 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-----QLEIIEKILKRPLPSSSQQ--  225 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-----HHHHHHHHHHTHHHHHTTS--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchh-----hhhhhhhcccccccccccc--
Confidence            3334456899999999998 8889999999999999999999999987441111     1111111110000000000  


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           .......+.+++..||+.||++||++.++++
T Consensus       226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0001258999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=308.27  Aligned_cols=260  Identities=25%  Similarity=0.314  Sum_probs=206.6

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-------------CcchHHHHHHHHHHHhcccccce
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------------PGGDAAFQREVEMISVAVHRNLL  172 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~~E~~~l~~l~H~niv  172 (437)
                      -..-.++|++.+.||+|.||.|-+|+.. +++.||||++.+...             ....+...+|+.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3445688999999999999999999964 689999999965221             11235788999999999999999


Q ss_pred             eeeeeeecC--CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec
Q 013750          173 RLIGFCTTP--TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD  250 (437)
Q Consensus       173 ~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~  250 (437)
                      +|+.+..++  +..|||+|||..|.+.+.-    .....++..++++++.++..||+|||.+   +|+||||||.|+||+
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            999998765  4689999999988865432    2222389999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecCCceecccCC----CcccccccccccccccccccCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          251 EDFEAVVGDFGLAKLVDVRK----TNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       251 ~~~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      +++++||+|||.+..+....    .......+||+.|+|||...++.    .+.+-||||+||.||.|+.|+.||-....
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            99999999999998763221    11223367999999999997743    36788999999999999999999953211


Q ss_pred             cccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           ..            ....++...+.-...++..+.+.+|++++|.+||++|.+..+|......
T Consensus       325 -----~~------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  325 -----LE------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             -----HH------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                 11            1233444444444445667899999999999999999999999877654

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.9e-39  Score=302.37  Aligned_cols=249  Identities=30%  Similarity=0.428  Sum_probs=191.8

Q ss_pred             CeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCeeEEEEeccc
Q 013750          118 NVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFMQ  192 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~  192 (437)
                      +.||+|+||.||+|.+.    ++..||+|++.........+.+.+|+.+++.++|||+++++++|.. +...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    2457999998654334456788899999999999999999998764 456789999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC-
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-  271 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  271 (437)
                      +++|.+++....   ..+++.....++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999987532   2357778889999999999999999   999999999999999999999999999975432111 


Q ss_pred             --cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          272 --NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       272 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                        .......++..|+|||.+.+..++.++||||||+++|||++|. .|+....     ....   .........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~---~~~~~~~~~------  220 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDI---TVYLLQGRR------  220 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHH---HHHHhcCCC------
Confidence              1111234567899999998889999999999999999999954 4554211     1111   111111100      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          ...+...+..+.+++..||+.+|++||++.++++.|+.
T Consensus       221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                01111224578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=321.95  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|...+.||+|+||+||++... +++.||||++....  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888899999999999999864 68999999986421  2334567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999987532    378888889999999999999999   999999999999999999999999999863321


Q ss_pred             CCCc----------------------------------------------ccccccccccccccccccCCCCCCchhhHH
Q 013750          269 RKTN----------------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFG  302 (437)
Q Consensus       269 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s  302 (437)
                      ....                                              ......||+.|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                              001245899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC---C
Q 013750          303 YGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---P  379 (437)
Q Consensus       303 ~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---P  379 (437)
                      |||++|||++|+.||......     ..   .........       .+.-......+..+.+++.+|+. +|.+|   |
T Consensus       234 lGvil~elltG~~Pf~~~~~~-----~~---~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH-----ET---YRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH-----HH---HHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            999999999999999643211     01   111110000       00000011223578889999997 66665   5


Q ss_pred             CHHHHHHH
Q 013750          380 AMSEVVRM  387 (437)
Q Consensus       380 s~~evl~~  387 (437)
                      ++.|+++.
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99998865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7e-39  Score=303.40  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=189.8

Q ss_pred             eeeecCcEEEEEEEECCC---CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          119 VLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .||+|+||.||+|...++   ..+++|.+.........+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985443   34667766544334456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC-ccc
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVT  274 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~  274 (437)
                      |.+++..........++.....++.||+.||+|||+.   +++|+||||+|||++.++.++|+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976543334467777889999999999999999   999999999999999999999999999864321111 112


Q ss_pred             ccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          275 TQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       275 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.....     .   ......... ....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~---~~~~~~~~~-~~~~~  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----R---EVLNHVIKD-QQVKL  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHHhh-ccccc
Confidence            23457889999998753       2457899999999999999974 566643211     1   111111111 11122


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      .++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22222222    3357788899999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.1e-39  Score=305.14  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=198.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC-----
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP-----  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-----  181 (437)
                      .+.+.|+..+.||+|+||.||+|... +++.||+|.+...  ......+.+|+.++.++ +|||++++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35677888899999999999999975 5889999998643  33456788999999998 699999999998653     


Q ss_pred             -CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          182 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       182 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                       ...+++|||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence             45789999999999999987632  23488999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      |++....... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||......        ....
T Consensus       156 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--------~~~~  226 (272)
T cd06637         156 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--------RALF  226 (272)
T ss_pred             CCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH--------HHHH
Confidence            9998653322 1223356889999999986     345788999999999999999999998532110        0000


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..... .     ..   .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       227 ~~~~~-~-----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 LIPRN-P-----AP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHhcC-C-----CC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00000 0     00   0111123457899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-38  Score=305.00  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  188 (437)
                      ++|...+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777899999999999999975 58899999987544344567799999999999999999999998643  4679999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++.........++......++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998765444445588899999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ..   .....++..|+|||.+.+..++.++||||||+++|||++|+.|++..............+....    ....+.+
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  230 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD  230 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhcc
Confidence            21   1234578899999999999999999999999999999999999975432111222122221110    0011110


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      . .  ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0 0  0011234678999999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.5e-39  Score=302.98  Aligned_cols=256  Identities=22%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccCC---------CCcchHHHHHHHHHHHh-cccccceeeeeeeec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE---------SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTT  180 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~---------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  180 (437)
                      +|+..+.||+|+||.||+|..+.  +..+|+|.+....         ......++.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999764  6889999875321         12234567788888765 799999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+..  +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988654444456899999999999999999999631  7999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||......        .......  
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~--  226 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIV--  226 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHh--
Confidence            9998654332  233456888999999999888999999999999999999999998633211        1111111  


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                             +...........+..+.+++.+||+.||++||++.|+..+++
T Consensus       227 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 -------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   010000001123357889999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=316.88  Aligned_cols=239  Identities=22%  Similarity=0.262  Sum_probs=192.3

Q ss_pred             CeeeecCcEEEEEEEE----CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          118 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      +.||+|+||.||++..    .+|+.||+|++.... .......+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    358899999987432 12234567789999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +|+|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++...... .
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            99999988643    2389999999999999999999999   99999999999999999999999999997643321 2


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......     ..   ......         ..  
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~---~~~i~~---------~~--  214 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ET---MTMILK---------AK--  214 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HH---HHHHHc---------CC--
Confidence            223456899999999999888999999999999999999999998643211     01   111110         00  


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSE  383 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~e  383 (437)
                      ...+...+..+.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0112223457889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=305.06  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-CC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-GT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .+|...+.||+|+||.||+|.+++ |.    .+|+|.+...........+.+|+.++++++|||+++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567778999999999999999643 33    6899988754444456788999999999999999999999987 78899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |+||+++|+|.+++....   ..+++.....++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999987532   2389999999999999999999998   9999999999999999999999999999866


Q ss_pred             ccCCCccc-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ........ ....++..|+|||.+....++.++|+||||+++||+++ |+.||......        ..........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~---  228 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGE---  228 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCC---
Confidence            43222111 11223568999999988899999999999999999999 99998643211        1111111110   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ....+..+...+.+++.+||..+|++||++.++++.|+.
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                   011112233578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.6e-39  Score=311.43  Aligned_cols=244  Identities=22%  Similarity=0.247  Sum_probs=191.3

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||++... +++.||+|++....  .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999997432  123345678899998888 699999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            99988876432    389999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..........  .........        ....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~--------~~~~--~  220 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVI--------LEKP--I  220 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHH--------HhCC--C
Confidence            234568999999999999999999999999999999999999996432221111  111111111        0110  0


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ..+...+..+.+++.+|++.||++||++
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1122234578899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-38  Score=301.25  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=190.4

Q ss_pred             eeeecCcEEEEEEEECC---CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          119 VLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .||+|+||.||+|...+   ...+|+|.+...........|.+|+..++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999998543   357888887654434445678899999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc-
Q 013750          196 VAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-  273 (437)
Q Consensus       196 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  273 (437)
                      |.+++...... ....++.....++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999765422 23356788889999999999999999   99999999999999999999999999987533221111 


Q ss_pred             cccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          274 TTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......     ..   ........ ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~---~~~~~~~~-~~~  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QV---LKQVVREQ-DIK  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HH---HHHHhhcc-Ccc
Confidence            122345678999998743       356889999999999999999 77777532110     01   11111111 011


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      +.++.    .+...+..+.+++..|| .||++|||+++|++.|.
T Consensus       230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111    12233456778888898 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-39  Score=306.98  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||+||++... +|..||+|++.........+.+.+|++++..++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            356777789999999999999965 5889999988654444456789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|..++....    .+++.....++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998886532    3789999999999999999999732  7999999999999999999999999998654221


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch---hhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD---VLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  346 (437)
                         ......++..|+|||.+.+..++.++|||||||++|||++|+.||+.........   ............       
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  227 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-------  227 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-------
Confidence               1123468899999999988899999999999999999999999997543221100   001111111110       


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                        ...........+..+.+++.+||+.||++|||+.|+++...
T Consensus       228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         228 --EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             --ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence              00000001124457899999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-40  Score=288.42  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=207.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +.++|++.+.||+|.||.||.|+.+ ++..||+|++.+..  ..+...++.+|+++-+.++||||+++++++.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3578899999999999999999965 67899999997532  23345678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ++||.++|++...|.+...  ..++......++.|+|.|+.|+|.+   +++||||||+|+|++.++..||+|||-+...
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            9999999999999985432  2367777888999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .   ....+..+||..|++||...+..++..+|+|++|++.||++.|.+||+.....   +  ....+...       + 
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---e--tYkrI~k~-------~-  238 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---E--TYKRIRKV-------D-  238 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---H--HHHHHHHc-------c-
Confidence            3   33345568999999999999999999999999999999999999999743311   1  11111110       1 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                            -.++...+....+++.+|+..+|.+|.+..|+++.
T Consensus       239 ------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 ------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  11223344588999999999999999999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-39  Score=299.79  Aligned_cols=266  Identities=23%  Similarity=0.266  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhccccc-ceeeeeeeecCC------
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRN-LLRLIGFCTTPT------  182 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------  182 (437)
                      ..|...++||+|+||+||+|+.+ +|+.||+|++.-... .+.-....+|+.++++++|+| ||+|.+++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555677999999999999964 689999999974332 334456679999999999999 999999998877      


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++|+||++. +|..++.........++-..++.+..|++.||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78999999965 89999987653323356688999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      |+..... ....+..++|.+|.|||++.+. .|+...||||+||++.||++++..|...+.     ......+-......
T Consensus       167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTP  240 (323)
T ss_pred             HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCC
Confidence            9965532 2335566789999999999877 699999999999999999999998875443     22222222221111


Q ss_pred             ---chhhhc---ccc--ccCCC-C----HHH---HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 ---RLDAIV---DRN--LNKNY-N----IQE---VETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ---~~~~~~---d~~--l~~~~-~----~~~---~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         ..+.+.   +-.  ..... +    ...   .....+++.+|++.+|.+|.|+...++.
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               111111   111  00000 1    111   1378899999999999999999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-39  Score=313.67  Aligned_cols=242  Identities=23%  Similarity=0.287  Sum_probs=193.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +|...+.||+|+||.||+|... ++..||+|++....  .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777899999999999999975 57899999987432  123344567788888776 5899999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++....    .+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998886532    378899999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......     .....+.            .
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~~i~------------~  215 (323)
T cd05616         154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIM------------E  215 (323)
T ss_pred             CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHHHHH------------h
Confidence            21 2223456899999999999999999999999999999999999999643211     1111111            1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ..  ..++...+..+.+++.+|++.||++|++.
T Consensus       216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            00  11122344578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6e-39  Score=311.36  Aligned_cols=241  Identities=24%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHh-cccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|... +++.||+|++....  .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 47899999987432  12334566778888875 4899999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++....    .+++.....++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            99999987532    378899999999999999999999   99999999999999999999999999987532211 12


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||......     .....+   ...       .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~i---~~~-------~~----  213 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----ELFQSI---RMD-------NP----  213 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHH---HhC-------CC----
Confidence            23356899999999999989999999999999999999999999643211     111111   100       00    


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV  385 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl  385 (437)
                      .++......+.+++.+||+.||++||++. ++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            11122335788999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-40  Score=304.87  Aligned_cols=258  Identities=24%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----eeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l  186 (437)
                      .|...+++|.|+||.||+|... ++..||||+......     ---+|+.+|+++.|||||+|.-++....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4556789999999999999975 478999999864332     1137899999999999999998874332     2348


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCCcee
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKL  265 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~  265 (437)
                      |||||+. +|...++.+...+..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ +.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 89999987655555677778888999999999999998   99999999999999976 8999999999998


Q ss_pred             cccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .......  .....|-.|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..     +.+..+-.+......+
T Consensus       176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-----dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-----DQLVEIIKVLGTPTRE  248 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-----HHHHHHHHHhCCCCHH
Confidence            7654433  344568899999999775 5999999999999999999999999754322     1222222221111111


Q ss_pred             hh----------ccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          345 AI----------VDRNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       345 ~~----------~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ++          -.+.+..     -+......+..+++.++++.+|.+|.++.|++.
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11          1111111     123345568899999999999999999999884

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-38  Score=305.91  Aligned_cols=250  Identities=19%  Similarity=0.298  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .+|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++|||++++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            57788899999999999999964 68899999987533 33456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...     .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999988642     268889999999999999999999   99999999999999999999999999987543322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      . ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......        .........        .
T Consensus       171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--------~~~~~~~~~--------~  233 (296)
T cd06654         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNG--------T  233 (296)
T ss_pred             c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--------hHHHHhcCC--------C
Confidence            1 1223457889999999998889999999999999999999999986432110        000000000        0


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....+......+.+++.+||..+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0011122344578899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=302.46  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+|++++.+++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999975 58899999987544344566788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...     .+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998753     489999999999999999999999   99999999999999999999999999998765332


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       .......++..|+|||.+.+..++.++||||||+++|||+||+.||......     ..   ..... .....      
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~---~~~~~-~~~~~------  216 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RV---LFLIP-KNNPP------  216 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HH---HHHhh-hcCCC------
Confidence             1223345788999999999888999999999999999999999998643210     01   01100 00011      


Q ss_pred             ccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          351 LNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       351 l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         ..... .+..+.+++.+||+.+|++||+++++++.
T Consensus       217 ---~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         217 ---SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ---CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               11111 34578899999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-38  Score=298.40  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||.||+|...+ +..+|+|.+....   ..+++.+|++++++++|||++++++++......++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            3678889999999999999999864 7899999986432   26789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...   ...+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999998652   23489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........        .... ..       ..
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~-~~-------~~  215 (256)
T cd06612         153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMI-PN-------KP  215 (256)
T ss_pred             cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhh-cc-------CC
Confidence            21 22234478899999999988999999999999999999999999864321110        0000 00       00


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ......+......+.+++.+||+.||++|||+.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0001112234467899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-38  Score=300.45  Aligned_cols=258  Identities=21%  Similarity=0.293  Sum_probs=200.7

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++.+++++.....||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            4556777777889999999999999965 57889999886533 344568899999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCce
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK  264 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~  264 (437)
                      +++||+++++|.+++..... ....++..+..++.|++.||+|||++   +++|+||||+||+++. ++.++|+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999875321 11127788889999999999999999   9999999999999986 6799999999987


Q ss_pred             ecccCCCcccccccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ....... ......++..|+|||.+....  ++.++||||||+++|+|++|+.|+........     ..+....     
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~-----  226 (268)
T cd06624         158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGM-----  226 (268)
T ss_pred             ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhh-----
Confidence            6532221 122345788999999986644  78999999999999999999999853211100     0000000     


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            .......+......+.+++.+||+.+|++|||+.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 ------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                  00011223334467899999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.6e-39  Score=308.76  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||.||+|.+. +|.    .||+|.+...........+.+|+.+++.++||||++++|+|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356777889999999999999864 343    57999887544344455788999999999999999999998754 467


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            999999999999998753   23478899999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......     ......   ..... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~~---~~~~~-  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDLL---EKGER-  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH---HCCCC-
Confidence            54322211 112335678999999998899999999999999999998 88888532110     011111   11100 


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                               ...+..++..+.+++..||..+|++||++.++++.|+.
T Consensus       230 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         230 ---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                     01112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-38  Score=300.94  Aligned_cols=240  Identities=23%  Similarity=0.346  Sum_probs=187.0

Q ss_pred             CeeeecCcEEEEEEEECC-------------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          118 NVLGQGGFGKVYRGVLAD-------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      +.||+|+||.||+|+..+             ...||+|.+.... ......|.+|+.++..++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999998532             2358899876532 34456788999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc-------EEE
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-------AVV  257 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-------~kl  257 (437)
                      +++|||+++++|..++...   ...+++..+.+++.||++||+|||++   +++||||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999998887642   23478999999999999999999999   9999999999999987654       899


Q ss_pred             eecCCceecccCCCccccccccccccccccccc-CCCCCCchhhHHHHHHHHHHH-hCCCCCCCCcccccchhhHHHHHH
Q 013750          258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +|||++......     ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+.......         ..
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~  219 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KE  219 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HH
Confidence            999998754321     1234778899999886 466899999999999999998 5777765322110         00


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ......         ..  ........+.+|+.+||+.||++||++.++++.++
T Consensus       220 ~~~~~~---------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYEGQ---------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHhcC---------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000000         00  01112347889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-38  Score=304.06  Aligned_cols=264  Identities=20%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|++|.||+|+.. ++..||+|++.... .....+.+.+|+.++.+++|||++++++++..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999975 68999999986432 223346788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      ++ ++|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 588888765432 34589999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh----------
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER----------  339 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  339 (437)
                       .......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........    ..........          
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ----LFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhcch
Confidence             122233568899999988654 578999999999999999999999864322110    0000000000          


Q ss_pred             -ccchhhhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 -EKRLDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 -~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ........+....   .......+.++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000000000   0001123457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-38  Score=320.77  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ..|.+.+.||+|+||.||++.+. +++.||||...       ...+.+|++++++++|+|||++++++......++|||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46888899999999999999976 47889999642       22467899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +. ++|..++...   ...++|..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6888777542   23489999999999999999999999   99999999999999999999999999998654322


Q ss_pred             Cc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc---hhhHHHHHHHHHhc-cchhh
Q 013750          271 TN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED---DVLLLDHVKKLERE-KRLDA  345 (437)
Q Consensus       271 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~  345 (437)
                      .. ......||..|+|||++.+..++.++|||||||++|||++|..|+-........   ...+...+...... .....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21 122356899999999999999999999999999999999988654221111110   11111111111000 00000


Q ss_pred             -----h----cc---ccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 -----I----VD---RNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 -----~----~d---~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           +    ..   ........       ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 0    00   00000000       0122368899999999999999999999864

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-38  Score=297.49  Aligned_cols=252  Identities=29%  Similarity=0.472  Sum_probs=201.9

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      |++.+.||.|+||.||++...+     +..||+|.+.........+.+..|+.++..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999754     38899999975443335678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++......  .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999998753321  179999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..........++..|+|||.+.+..++.++||||+|++++||++ |..|+.....     ...   ........      
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~---~~~~~~~~------  221 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEV---LEYLKKGY------  221 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHHHhcCC------
Confidence            32222222336789999999988889999999999999999998 7777753211     111   11111111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                          ....+...+..+.+++.+|++.+|++|||+.++++.|
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                1111222456899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-39  Score=322.26  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=195.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....  .....+.+.+|++++.+++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999965 58999999986421  1233566889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .++......++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999987532    378888888999999999999999   999999999999999999999999999753210


Q ss_pred             CC------------------------------------------CcccccccccccccccccccCCCCCCchhhHHHHHH
Q 013750          269 RK------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM  306 (437)
Q Consensus       269 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~  306 (437)
                      ..                                          ........||+.|+|||.+.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHH
Q 013750          307 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP---AMSE  383 (437)
Q Consensus       307 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---s~~e  383 (437)
                      +|||++|+.||.......     .   .........       .+........+..+.+++.+|+ .+|.+|+   ++.+
T Consensus       234 lyell~G~~Pf~~~~~~~-----~---~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE-----T---QLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             eeehhhCCCCCCCCCHHH-----H---HHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            999999999997433211     0   011100000       0000001122345667777766 5999999   8888


Q ss_pred             HHHH
Q 013750          384 VVRM  387 (437)
Q Consensus       384 vl~~  387 (437)
                      +++.
T Consensus       298 ll~h  301 (376)
T cd05598         298 IKAH  301 (376)
T ss_pred             HhCC
Confidence            8754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.1e-39  Score=311.33  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=190.7

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHh-cccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+++.+ +|..||+|.+....  .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 58899999987422  12334566778888775 4899999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||+++..... ...
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            9999888653    2378889999999999999999999   9999999999999999999999999998743221 122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||......     ....   .....       .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~~~---~~~~~-------~~----  213 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFE---SIRVD-------TP----  213 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH---HHHhC-------CC----
Confidence            33456899999999999999999999999999999999999999643211     1111   11000       01    


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV  385 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl  385 (437)
                      ..+......+.+++.+||+.||++||++. ++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11112345788999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.8e-38  Score=300.64  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=203.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4666788999999999999975 588999999875443455678899999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++...     .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999988642     378888899999999999999999   999999999999999999999999999976543221


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|..|+.......     .   ..          ......
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~---~~----------~~~~~~  217 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----V---LF----------LIPKNN  217 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----H---hh----------hhhcCC
Confidence             2223457889999999988889999999999999999999999986432110     0   00          001111


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ........+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            122344566789999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-38  Score=304.45  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566789999999999999975 688999999864321  22235677899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999886532  23478899999999999999999999   99999999999999999999999999987653222


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........     .........  .       
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----~~~~~~~~~--~-------  220 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----EEVERLVKE--V-------  220 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----HHHHhhhhh--h-------
Confidence              122346899999999999999999999999999999999999999743221100     000110000  0       


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                       ....+......+.+++..||+.||++|||     +.|+++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 -QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             00112223357889999999999999999     778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.3e-39  Score=305.05  Aligned_cols=247  Identities=25%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      |+..+.||+|+||.||+|.+. ++..||+|.+.........+.+.+|++++++++||||+++++++...+..++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445577999999999999864 5789999988744434455678999999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|.+++..     ..+++..+..++.|+++|+.|||++   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999988753     2378999999999999999999999   999999999999999999999999999976543221 


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......     ..   ..          ......
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~---~~----------~~~~~~  218 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VL---FL----------IPKNSP  218 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HH---hh----------hhcCCC
Confidence            1222457889999999998889999999999999999999999975322110     00   00          000011


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .......+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11222345678999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-39  Score=306.46  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=204.1

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee-
Q 013750          103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT-  179 (437)
Q Consensus       103 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-  179 (437)
                      .++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+...  ......+.+|+.++.++ +|||++++++++. 
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34556667899999999999999999999974 5789999987642  23346788999999999 6999999999884 


Q ss_pred             ----cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          180 ----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       180 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                          .++..++||||+++++|.+++.........+++..+..++.|+++||.|||+.   +++|+||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34568999999999999998875443445588999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL  330 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~  330 (437)
                      +|+|||++........ ......|+..|+|||.+..     ..++.++|||||||++|||++|+.|+.......      
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------  236 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------  236 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------
Confidence            9999999986543221 1223458899999998853     457899999999999999999999986432110      


Q ss_pred             HHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       331 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                        ........ ......+       +......+.+++.+||+.||++|||+.|+++.+
T Consensus       237 --~~~~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 --ALFKIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --HHhhcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              00000000 0000001       111234788999999999999999999998743

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-38  Score=336.19  Aligned_cols=260  Identities=21%  Similarity=0.311  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....  ....+.|.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999975 589999999864321  233567999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          189 PFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ||+++++|.+++.....       ....+++...+.++.||++||+|||++   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999865321       123356778899999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCC-----------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 013750          262 LAKLVDVRKT-----------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE  324 (437)
Q Consensus       262 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~  324 (437)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986621110                 0011246899999999999999999999999999999999999998642211 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~  390 (437)
                        ...   ...         ...++. ......+.+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus       238 --ki~---~~~---------~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 --KIS---YRD---------VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             --hhh---hhh---------hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              000   000         000000 0000123345788999999999999995 57777777765

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-39  Score=320.80  Aligned_cols=201  Identities=22%  Similarity=0.271  Sum_probs=171.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .|+..+.||+|+||+||+|... +++.||+|++....  .....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5778899999999999999974 58899999986422  12345578899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++....    .++......++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999887532    378888889999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------CcccccccccccccccccccCCCCCCchhhHHH
Q 013750          270 K----------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY  303 (437)
Q Consensus       270 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~  303 (437)
                      .                                              ........||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000112468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCC
Q 013750          304 GIMLLELVTGQRAIDFS  320 (437)
Q Consensus       304 Gv~l~elltg~~p~~~~  320 (437)
                      ||++|||++|+.||...
T Consensus       235 Gvil~elltG~~Pf~~~  251 (382)
T cd05625         235 GVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             hHHHHHHHhCCCCCCCC
Confidence            99999999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.7e-39  Score=313.06  Aligned_cols=238  Identities=24%  Similarity=0.264  Sum_probs=188.4

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHH-HHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||+|... +|+.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986422  1223345555655 46789999999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++...    ..+++.....++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++.... ....
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKT  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCc
Confidence            9999888653    2378889999999999999999999   999999999999999999999999999875322 1222


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ......         .....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i---------~~~~~--  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNI---------LNKPL--  213 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHH---------HcCCC--
Confidence            33456899999999999999999999999999999999999998643211        111111         11110  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      ...+..+..+.+++.+|++.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11122345789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-38  Score=299.33  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=199.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC-----CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....     ......+.+|++++++++|+||+++.+++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677899999999999999988899999998863221     12234688999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999987532    378889999999999999999999   99999999999999999999999999987543


Q ss_pred             cCC-----CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          268 VRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       268 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ...     ........++..|+|||.+.+..++.++||||||+++|||++|..||...+...        ......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~-  224 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHR-  224 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhcc-
Confidence            211     111223457889999999998889999999999999999999999986322110        000000000 


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             ......+......+.+++.+||+.+|++||++.++++
T Consensus       225 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 -------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   0011122234457899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-38  Score=312.48  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  182 (437)
                      ..++|...+.||+|+||.||++... +|..||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999974 58999999986432 2344567889999999999999999999986443     


Q ss_pred             -eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          183 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       183 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                       ..++||||+++ +|...+..      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999976 45444432      267888889999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch----------hhHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD----------VLLL  331 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~----------~~~~  331 (437)
                      +++....  ........+|..|+|||.+.+..++.++|||||||++|||++|+.||...+......          ....
T Consensus       169 ~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             Ccccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            9975432  222334568999999999999999999999999999999999999997442211000          0000


Q ss_pred             H----HHHHHHhc-c-----chhhhccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          332 D----HVKKLERE-K-----RLDAIVDRNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       332 ~----~~~~~~~~-~-----~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .    ........ .     ...+......   ...........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    00000000 0     0000000000   000111124578899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-38  Score=298.14  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++|.+.+.||+|+||.||++.. +++.||+|.+...   ...+.+.+|+.++..++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578889999999999999986 6888999998642   2356789999999999999999999988654 579999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            9999999987542  23478999999999999999999999   9999999999999999999999999998754321  


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......        ........          .
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~----------~  213 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECVEK----------G  213 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhC----------C
Confidence              112234568999999998899999999999999999998 89888643211        11111111          1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1111122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-38  Score=304.10  Aligned_cols=262  Identities=23%  Similarity=0.298  Sum_probs=192.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhc---ccccceeeeeeeec-----CC
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTT-----PT  182 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  182 (437)
                      +|+..+.||+|+||+||+|... +++.||+|.+..... ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777899999999999999975 688999999864321 22234566777777655   69999999998854     23


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..+++|||+++ +|..++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999985 7888776532  23478999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--  340 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  340 (437)
                      +.......  ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......    .+..........  
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~  228 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPE  228 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCCh
Confidence            98654221  2233457899999999998899999999999999999999999986432111    011111100000  


Q ss_pred             cchh-------hhccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KRLD-------AIVDRNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~~~-------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....       ....+..   .....+.....+.+++.+|++.||++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000       0000000   00111233467889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=299.90  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|+||.||++.++ +++.+|+|.+.........+.+.+|++++++++||||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999986 58999999987644445567889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      +++++|.+++....   ..++......++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999987642   347888999999999999999999 7   9999999999999999999999999998755322


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.........   ...........         
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~---------  219 (265)
T cd06605         155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNE---------  219 (265)
T ss_pred             Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcC---------
Confidence            11   1156788999999999889999999999999999999999998643221111   11111111110         


Q ss_pred             cccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          350 NLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       350 ~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      . ....+.. .+..+.+++.+||..+|++|||+.+++..
T Consensus       220 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 P-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             C-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            0 0111111 45678999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=301.09  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHH--hcccccceeeeeeeecCC--
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS--VAVHRNLLRLIGFCTTPT--  182 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~--  182 (437)
                      ......+....+.||+|.||.||+|.++ |..||||++..    .+++.+.+|.++..  .++|+||+.+++.-..++  
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            3445567788899999999999999996 99999999963    34567888888876  569999999988664443  


Q ss_pred             --eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEecCCCCCCeeecCCCcE
Q 013750          183 --ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       183 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                        +++||++|.++|||.+||.+.     .++....++++..+|.||++||-     +.+|.|.|||||+.|||+..++..
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence              578999999999999999863     38899999999999999999995     357899999999999999999999


Q ss_pred             EEeecCCceecccCCCcc---cccccccccccccccccCCC------CCCchhhHHHHHHHHHHHhCC----------CC
Q 013750          256 VVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQ----------RA  316 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~Gv~l~elltg~----------~p  316 (437)
                      .|+|+|+|..........   ....+||.+|||||++...-      .-..+||||||.++||+.-..          .|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            999999998765443222   22357999999999996431      124689999999999997632          33


Q ss_pred             CCCCcccccchhhHHHHHHHHHhccchhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          317 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      |..-.+....   .         +.....+...++++..     +.+++..+.+||+.||..+|.-|-|+--+-+.|..
T Consensus       436 yyd~Vp~DPs---~---------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  436 YYDVVPSDPS---F---------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             cccCCCCCCC---H---------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence            3211111000   0         0111223334444443     35677899999999999999999999888877765

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=308.40  Aligned_cols=256  Identities=20%  Similarity=0.236  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...  ......+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999975 5899999998642  12334556889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++...   ...++...+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999998653   22378888999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..........||+.|+|||.+..     ..++.++|||||||++|||++|+.||......        ............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~  226 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH  226 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence            33222233468999999999863     45788999999999999999999998643211        111111110000


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQAS--PEDRPAMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d--p~~RPs~~evl~~  387 (437)
                      ..     + .......+..+.+++.+|+..+  +..||++.++++.
T Consensus       227 ~~-----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQ-----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cc-----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00     0 0001123456777887776543  3347899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-38  Score=302.62  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|+||.||++..+ ++..||+|.+...........+.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36778899999999999999976 68999999886433334456889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..++.... ....+++..+..++.+++.||.|||+.+  +++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999998887532 1235899999999999999999999732  8999999999999999999999999998754321 


Q ss_pred             CcccccccccccccccccccCC------CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                        ......++..|+|||.+.+.      .++.++|+|||||++|||++|+.||.......     ......         
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~---------  220 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLS---------  220 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHH---------
Confidence              22234578899999998544      35889999999999999999999986422110     111111         


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.+.. ....+......+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         221 AIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            111110 112233456688999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-38  Score=306.02  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||+|..+ ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999975 57899999986544344455778999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      ++ ++|..++...   ...+++.....++.|+++||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888877653   23478899999999999999999999   99999999999999999999999999997543222


Q ss_pred             CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---ccchhhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---EKRLDAI  346 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  346 (437)
                      . ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......     ..........   ......+
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCChhhchhh
Confidence            1 12223468899999988654 47899999999999999999999997543211     1111111000   0000000


Q ss_pred             cc---------ccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          347 VD---------RNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       347 ~d---------~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      .+         +....    ......+..+.+++.+|++.||.+|||+.|+++.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~  287 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP  287 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            00         00000    00112345788999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-38  Score=301.04  Aligned_cols=254  Identities=21%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHH-HHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|++.+.||+|+||.||++... +|..||+|++...........+..|+.. ++..+|||++++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999975 6899999998754333344566667775 566789999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++ ++|..++.........+++..++.++.|++.||+|||+++  +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6888887664434456899999999999999999999854  7999999999999999999999999999865321


Q ss_pred             CCcccccccccccccccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                        .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||......    .   ......... ..  
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~---~~~~~~~~~-~~--  225 (283)
T cd06617         158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F---QQLKQVVEE-PS--  225 (283)
T ss_pred             --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H---HHHHHHHhc-CC--
Confidence              11223457889999998864    45688999999999999999999998532110    0   011110000 00  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         +.+   .....+..+.+++.+||+.+|++||++.++++
T Consensus       226 ---~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 ---PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000   01123467899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=298.32  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEec-cCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-----CC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-----PT  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~-~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~  182 (437)
                      ....|...+.||+|+||.|+.+... +|..||||++. .+......++-.+|+++|+.++|+||+.+.+++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4455666789999999999999974 68999999997 34445566778899999999999999999998855     45


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..|+|+|+|+ -+|...++.    +..++......+..|+++||+|+|+.   +++||||||.|+|++.+...||+|||+
T Consensus       100 DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            6899999994 477777764    33388888999999999999999999   999999999999999999999999999


Q ss_pred             ceecccC-CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          263 AKLVDVR-KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       263 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |+..... .....+..+.|.+|.|||.+.. ..||.+.||||.||++.||++|++.|.+.+.-....     .+......
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~-----lI~~~lGt  246 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ-----LILELLGT  246 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH-----HHHHhcCC
Confidence            9977543 1223466788999999998864 569999999999999999999999997654332211     11111100


Q ss_pred             c---chhh--------hccc---ccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 K---RLDA--------IVDR---NLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ~---~~~~--------~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .   .+..        .+..   ...   ...-++.....++|+.+|+..||.+|+|++|.++.
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0   0000        0000   000   01112334578899999999999999999999854

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-38  Score=295.48  Aligned_cols=252  Identities=22%  Similarity=0.297  Sum_probs=204.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||.|+||.||.+... ++..+++|.+.... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999998854 58899999886432 344566789999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987643  34478999999999999999999999   99999999999999999999999999998664433


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      . ......++..|+|||.+.+..++.++||||||+++|||++|..||......        ........         ..
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~---------~~  217 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQ---------GN  217 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc---------CC
Confidence            2 223345889999999998888999999999999999999999998643211        11111110         11


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      .. ......+..+.+++.+||+.+|++||++.++++.+
T Consensus       218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            10 11123345788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-38  Score=302.14  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=194.8

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |+..+.||+|+||+||++... +++.||+|.+....  .......+.+|++++..++|+|++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556688999999999999974 68899999986422  122345678899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..++....  ...+++.....++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999998886532  23489999999999999999999999   99999999999999999999999999997643221


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|..||........    ......... ..  .      
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~-~~--~------  221 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVL-ET--E------  221 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhh-cc--c------
Confidence              12234689999999999988999999999999999999999999964321110    000000000 00  0      


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                        ..+....+..+.+++..|++.||++||++.
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             --cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence              011222345788999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-38  Score=304.12  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++..... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999986 589999999864332 2245678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|..+....    ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999988776532    2389999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--cch---
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRL---  343 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~---  343 (437)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......     ............  ...   
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-----HHHHHHHHHhCCCchhhHHH
Confidence            2 22233457889999999875 45788999999999999999999988643211     110010000000  000   


Q ss_pred             ---hhhccccccCC---------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 ---DAIVDRNLNKN---------YNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ---~~~~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ....+......         ..+..+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               00000000000         01233567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.2e-38  Score=302.97  Aligned_cols=198  Identities=22%  Similarity=0.340  Sum_probs=160.4

Q ss_pred             CCeeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec--CCeeEEEEecc
Q 013750          117 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVYPFM  191 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  191 (437)
                      .+.||+|+||+||+|...   ++..||+|.+...   .....+.+|++++++++||||+++++++..  ....++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999964   4678999998642   234567899999999999999999998854  45678999998


Q ss_pred             cCchhhhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee----cCCCcEEEeecCC
Q 013750          192 QNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL  262 (437)
Q Consensus       192 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgl  262 (437)
                      .+ +|..++.....     ....+++..+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 67776653221     123478889999999999999999999   99999999999999    4567899999999


Q ss_pred             ceecccCCC--cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCc
Q 013750          263 AKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSR  321 (437)
Q Consensus       263 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~  321 (437)
                      ++.......  .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            986643221  112345689999999998764 58999999999999999999999996433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.9e-38  Score=302.93  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            46788899999999999999996 468999999986433 3345678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999988642     378889999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........        .....        .
T Consensus       169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~~~~--------~  231 (297)
T cd06656         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATN--------G  231 (297)
T ss_pred             ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------eeccC--------C
Confidence            221 223457889999999999889999999999999999999999996432211000        00000        0


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000112233457889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.8e-38  Score=298.83  Aligned_cols=262  Identities=21%  Similarity=0.290  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ....+.+.+|+++++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999976 589999999864332 2334568899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|..+....    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999888776532    2389999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------  339 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  339 (437)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........     .........         
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-----LYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCChHHhhh
Confidence            21 1223457889999999876 4578999999999999999999999864332110     000000000         


Q ss_pred             ---ccchhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 ---EKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ---~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         .........+......     ....+..+.+++.+||+.+|++||++.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               0000000000000000     0122467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-38  Score=311.46  Aligned_cols=262  Identities=20%  Similarity=0.248  Sum_probs=196.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC------
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  181 (437)
                      ..++|...+.||+|+||.||++... .++.||+|++.... .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 58899999986432 233456788999999999999999999988543      


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ...++||||+++ ++...+..      .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346899999976 55555532      278888999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH----
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL----  337 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  337 (437)
                      +++....  ........+|..|+|||.+.+..++.++|||||||++|||++|+.||........    ........    
T Consensus       165 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~  238 (355)
T cd07874         165 LARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ----WNKVIEQLGTPC  238 (355)
T ss_pred             ccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCC
Confidence            9985432  2222345689999999999998999999999999999999999999964332110    00000000    


Q ss_pred             --------------H-hccchhhhcccc-----c---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          338 --------------E-REKRLDAIVDRN-----L---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       338 --------------~-~~~~~~~~~d~~-----l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                    . .......+..+.     +   ...........+.+++.+|++.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                          0 000000000000     0   001111234578999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-38  Score=294.38  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=199.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec-CCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e  189 (437)
                      +|+..+.||+|++|.||++..+ +++.||+|++.... .....+.+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999975 57899999986432 23345678899999999999999999988764 446789999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....  ...+++.++..++.+++.|++|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999987632  23479999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      . .......+++.|+|||.+.+..++.++||||||++++||++|+.||......        ........ +..      
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~-~~~------  219 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIE-GKL------  219 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHh-cCC------
Confidence            2 2223345788999999999999999999999999999999999998643211        11111111 101      


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...+...+..+.+++.+|++.+|++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               1122334568999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-38  Score=309.05  Aligned_cols=242  Identities=24%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +|+..+.||+|+||+||++... +|+.||+|++....  .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667889999999999999975 68899999986422  2334456788999888886 577888999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++....    .+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999886532    388999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .. .......||..|+|||.+.+..++.++|||||||++|||++|+.||......     ...   ....         .
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~---~~i~---------~  215 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELF---QSIM---------E  215 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHH---HHHH---------h
Confidence            21 1223356899999999999989999999999999999999999999643211     111   1111         1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ..  ..++...+..+.+++.+|++.+|.+|++.
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            00  11122334578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-38  Score=310.03  Aligned_cols=256  Identities=19%  Similarity=0.225  Sum_probs=196.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999975 57899999986421  2233456788999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++....   ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999997632   2478888999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCcccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..........||+.|+|||.+.+     +.++.++||||||+++|||++|+.||......        ............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence            33322333568999999999875     56789999999999999999999999643211        111111110000


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  387 (437)
                      .     .+ .....+.+..+.+++.+|+..++++  |+++.++++.
T Consensus       227 ~-----~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 F-----QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             c-----cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0     00 0001123457888899988865544  4677777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-38  Score=296.26  Aligned_cols=253  Identities=20%  Similarity=0.303  Sum_probs=203.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec--CCeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  188 (437)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... .....+.+..|+++++.++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4777899999999999999864 68899999986432 23445678899999999999999999998754  44578999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-----EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-----~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      ||+++++|.+++.........+++...+.++.|++.||.|||     +.   +++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999775444556899999999999999999999     66   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........ ......++..|+|||.+....++.++|+||||+++|+|++|..|+......        ....... .   
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~---  224 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIK-E---  224 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHh-c---
Confidence            87653322 122346889999999999888999999999999999999999998743211        1111110 1   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                            ......+...+..+.+++.+|++.+|++||++.+|++.
T Consensus       225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  11112233455689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-38  Score=308.42  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=164.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ....+|.+.+.||+|+||.||+|... ++..||+|.....       ....|+.++++++||||+++++++......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            44567999999999999999999975 4678999975421       235689999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +||+. ++|..++...   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99995 5787777642   33489999999999999999999999   99999999999999999999999999997533


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      ..  .......||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus       209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            21  1223356899999999999999999999999999999999966554

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-38  Score=296.28  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=194.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC----CCcchHHHHHHHHHHHhcccccceeeeeeeec--CCee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  184 (437)
                      .+|...+.||+|+||.||++... ++..||+|++....    .....+.+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999974 58999999886322    11234568889999999999999999998865  3567


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++++||+++++|.+++....    .+++...+.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999999987532    378888999999999999999998   99999999999999999999999999987


Q ss_pred             ecccCC--CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ......  ........++..|+|||.+.+..++.++||||||+++|||++|+.||.....        .........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~---  223 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIAT---  223 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhc---
Confidence            553211  1111224578899999999988899999999999999999999999863211        011111100   


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            .......+......+.+++ .||..+|++||+++|+++
T Consensus       224 ------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 ------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                  0011122233344566666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-38  Score=297.02  Aligned_cols=249  Identities=22%  Similarity=0.390  Sum_probs=199.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCc--------chHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG--------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      +|...+.||+|+||.||+|... +++.+|+|.+.......        ..+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999864 58899999886432211        12468899999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++++||+++++|..++....    .+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999997542    378888999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc-----ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          264 KLVDVRKTN-----VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       264 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      +........     ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .   .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~---~~~~~~~  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----L---QAIFKIG  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----H---HHHHHHh
Confidence            866422111     11123578899999999988899999999999999999999999864211     0   0111100


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            .    ......+...+..+.+++.+||+.||++||++.++++
T Consensus       226 ------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 ------E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  0    1111223344568899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=333.81  Aligned_cols=265  Identities=25%  Similarity=0.366  Sum_probs=214.6

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC----C----CCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----D----GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIG  176 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g  176 (437)
                      .++...+++.+.+.||+|.||.|++|...    .    ...||||.+++.....+.+.+..|+++++.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45555666667779999999999999853    1    4579999998776667788999999999988 5999999999


Q ss_pred             eeecCCeeEEEEecccCchhhhhhhhcC---C--CC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC
Q 013750          177 FCTTPTERLLVYPFMQNLSVAYRLREIK---P--GE-------PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA  244 (437)
Q Consensus       177 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~--~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~  244 (437)
                      +|......++|.||+..|+|..+++..+   .  ..       ..+.....+.++.|||.||+||++.   +++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998765   0  01       2488899999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEeecCCceecccCCCccccccc--ccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCc
Q 013750          245 ANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR  321 (437)
Q Consensus       245 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~  321 (437)
                      +|||+.++..+||+|||+++..........+...  -+..|||||.+....|+.+|||||||+++|||+| |..|+....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999965444433323223  2457999999999999999999999999999999 667764311


Q ss_pred             ccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          322 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .       .......          +...-+...+..+..+++++|+.||+.+|++||++.++++.++.
T Consensus       527 ~-------~~~l~~~----------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 P-------TEELLEF----------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             c-------HHHHHHH----------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            0       0011111          12222233355567799999999999999999999999999987

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-38  Score=299.15  Aligned_cols=239  Identities=23%  Similarity=0.310  Sum_probs=185.3

Q ss_pred             eeeecCcEEEEEEEECC-------------------------CCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee
Q 013750          119 VLGQGGFGKVYRGVLAD-------------------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR  173 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~  173 (437)
                      .||+|+||.||+|.+..                         ...||+|++.... ......|.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999998521                         1358999886432 333457889999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      ++++|......++||||+++|+|..++...   ...+++..+..++.|+++||+|||++   +++||||||+||+++.++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            999999999999999999999999888652   23478899999999999999999999   999999999999997643


Q ss_pred             -------cEEEeecCCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHH-hCCCCCCCCcccc
Q 013750          254 -------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEE  324 (437)
Q Consensus       254 -------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~ell-tg~~p~~~~~~~~  324 (437)
                             .++++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3799999988643211     12346788999998865 56899999999999999995 6888886432111


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                           ......   ...        .    .+......+.+++.+||+.+|++|||+.++++.|.
T Consensus       230 -----~~~~~~---~~~--------~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 -----KERFYE---KKH--------R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----HHHHHH---hcc--------C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 001000   000        0    01111236889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-38  Score=310.02  Aligned_cols=256  Identities=19%  Similarity=0.228  Sum_probs=196.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|...+.||+|+||.||++..+ +++.+|+|++.+..  .......|..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888899999999999999976 47889999986321  2233446888999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....   ..+++.....++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999997532   2478889999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||......        ............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKER  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCcc
Confidence            3332233356899999999986     346889999999999999999999999643211        111111111000


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  387 (437)
                      ..     . .......+..+.+++.+|+..++++  ||++.|+++.
T Consensus       227 ~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00     0 0011223457788888887654444  6889888755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-38  Score=308.73  Aligned_cols=257  Identities=19%  Similarity=0.242  Sum_probs=192.7

Q ss_pred             CCCeeeec--CcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          116 EKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       116 ~~~~lG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ..++||+|  +||+||++..+ +|+.||+|++..... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35779999  78999999864 689999999864322 233456778999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++|+|.+++.....  ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999865322  2378999999999999999999999   999999999999999999999999986543321111


Q ss_pred             c------ccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          272 N------VTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       272 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........    .....     ....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~-----~~~~  227 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKL-----NGTV  227 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHh-----cCCc
Confidence            0      0112346778999999976  4589999999999999999999999964221110    00000     0000


Q ss_pred             hhhcc------------------------------------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVD------------------------------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d------------------------------------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....+                                    ..............+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000                                    00000112233457899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-38  Score=310.08  Aligned_cols=238  Identities=22%  Similarity=0.254  Sum_probs=187.4

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHH-HHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+++.. +++.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999986421  1223345556655 57889999999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|..++...    ..++......++.||+.||.|||++   +++||||||+||+++.++.+||+|||+++.... ....
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEET  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCc
Confidence            9998887643    2377888889999999999999999   999999999999999999999999999875322 1222


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..        ......         ....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i---------~~~~--~  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNI---------LHKP--L  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHH---------hcCC--C
Confidence            33456899999999999889999999999999999999999999643211        111111         1111  1


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      ..+......+.+++.+|++.||.+||+..
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12223345789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.1e-38  Score=301.58  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      ++..++..++++|+..+.||+|+||.||++... +++.+|+|.+...  ......+.+|+.++.++ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            445566667899999999999999999999974 6889999998643  23346778899999988 8999999999986


Q ss_pred             cC-----CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          180 TP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       180 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      ..     ...++|+||+++++|.+++.........+++..++.++.|++.||+|||+.   +++|+||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            54     357999999999999998875443445589999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCCcccccccccccccccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh
Q 013750          255 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  329 (437)
                      ++|+|||++........ ......++..|+|||.+...     .++.++|||||||++|||++|+.|+......      
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------  239 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------  239 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence            99999999876542221 11224578899999998643     3689999999999999999999998632210      


Q ss_pred             HHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        ......... ....+       ..+......+.+++.+||+.+|++||++.|+++
T Consensus       240 --~~~~~~~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 --KTLFKIPRN-PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             --HHHHHHhcC-CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              001111000 00001       112223457899999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-38  Score=294.69  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=199.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC----CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      +|...+.||+|+||.||+|... ++..|++|.+.....    ....+.+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999986 789999998864221    22456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +||+++++|.+++....    .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999987532    378999999999999999999999   99999999999999999999999999988654


Q ss_pred             cCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....     .   ............   
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~---~~~~~~~~~~~~---  220 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----V---AAVFKIGRSKEL---  220 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----H---HHHHHHHhcccC---
Confidence            322  223455788999999997776 89999999999999999999999864321     0   111111110011   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            ...+......+.+++.+||+.+|++||++.++++
T Consensus       221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  1112223457889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.2e-39  Score=311.64  Aligned_cols=245  Identities=23%  Similarity=0.261  Sum_probs=191.5

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHH-HHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||++... +|+.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999964 68999999986421  1233445666665 46779999999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++...    ..+++.....++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence            9998887643    2378999999999999999999999   9999999999999999999999999998743221 122


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||..|+|||.+.+..++.++|||||||++|||++|..||......        .......         ...+  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~---------~~~~--  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNIL---------HKPL--  213 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHH---------cCCc--
Confidence            33456899999999999999999999999999999999999998643211        1111111         1010  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ...+..+..+.+++..|++.+|.+||++.+.++.+.
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~  249 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ  249 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence            011223457889999999999999999875554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.7e-38  Score=304.00  Aligned_cols=250  Identities=20%  Similarity=0.314  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .+|+..+.||.|++|.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4578889999999999999986 468999999986433 34467788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..++...     .+++..+..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999988642     378999999999999999999999   99999999999999999999999999987654322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...        ......... ...     
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~~~-~~~-----  234 (296)
T cd06655         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPE-----  234 (296)
T ss_pred             cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC-Ccc-----
Confidence            21 223457889999999998889999999999999999999999986432210        000110000 000     


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        ...+...+..+.+++.+||+.||++||++.++++.
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              01122234578899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.2e-37  Score=298.53  Aligned_cols=252  Identities=22%  Similarity=0.280  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .+.|++.+.||.|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++|||++++++++..+...++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            466888899999999999999975 4889999998653 24456778899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|..++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        90 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          90 FCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            999999988876432   2488999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      . .......++..|+|||.+.     ...++.++|||||||++|||++|+.|+......        .......... ..
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-~~  233 (292)
T cd06644         164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSE-PP  233 (292)
T ss_pred             c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCC-Cc
Confidence            1 1122345788999999984     345788999999999999999999998532210        0111111000 00


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .       ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       234 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 T-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             c-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0       0112233457889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-38  Score=297.14  Aligned_cols=238  Identities=24%  Similarity=0.388  Sum_probs=188.4

Q ss_pred             CeeeecCcEEEEEEEECCCC-----------EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          118 NVLGQGGFGKVYRGVLADGT-----------KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +.||+|+||.||+|.+.+..           .+++|.+.....  ....|.+|+.++++++|||++++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999986433           578887764321  26789999999999999999999999988 77899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-------cEEEee
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-------EAVVGD  259 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-------~~kl~D  259 (437)
                      |+||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +++|+||||+||+++.++       .++|+|
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999999876432   478999999999999999999999   999999999999999888       799999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCC--CCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      ||++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+.......        ....
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~~  218 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KERF  218 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHHH
Confidence            999986432     1223467789999999876  78999999999999999999 466665332110        0000


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ......        .    +......+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 ~~~~~~--------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQHR--------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcCCC--------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000000        0    0001158899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=334.82  Aligned_cols=262  Identities=17%  Similarity=0.260  Sum_probs=201.8

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec--
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--  180 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--  180 (437)
                      .+.....++|.+.+.||+|+||+||++... ++..+|+|.+.... .......|..|+.++..++|||||++++++..  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            344455678999999999999999999975 47789999886432 23345678999999999999999999998854  


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceEecCCCCCCeeecCC----
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN----PKIIHRDVKAANVLLDED----  252 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~iiH~dlk~~NIll~~~----  252 (437)
                      ....++||||+++++|..++.........+++..++.|+.||+.||.|||+...    .+|+|+||||+||||+.+    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            456899999999999999997654344558999999999999999999998521    259999999999999643    


Q ss_pred             -------------CcEEEeecCCceecccCCCcccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          253 -------------FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       253 -------------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                                   ..+||+|||++.......  ......||+.|+|||.+.+  ..++.++|||||||++|||+||+.||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                         348999999998654322  2233468999999999854  45899999999999999999999999


Q ss_pred             CCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          318 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....       .......+.....        +.   ....+..+.+|+..||+.+|.+||++.|++.
T Consensus       244 ~~~~~-------~~qli~~lk~~p~--------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        244 HKANN-------FSQLISELKRGPD--------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcCCc-------HHHHHHHHhcCCC--------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            63221       1111111111100        00   0112457899999999999999999999983

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-38  Score=308.67  Aligned_cols=246  Identities=22%  Similarity=0.246  Sum_probs=190.9

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHH-HHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||++... +++.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 57889999986421  1222334455544 56788999999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|..++....    .+.......++.||+.||.|||++   +++||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~  152 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT  152 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence            99999887532    367788888999999999999999   9999999999999999999999999999753221 222


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ........         ...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~---------~~~--  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILN---------KPL--  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHh---------CCc--
Confidence            33456899999999999999999999999999999999999999643211        11111110         000  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+..+..+.+++.+|++.||.+||++.+.+..+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~  250 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN  250 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence            1122334578899999999999999998765554444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9e-38  Score=309.09  Aligned_cols=266  Identities=20%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC------
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  181 (437)
                      ..++|...+.||+|+||.||++... .++.||||++.... .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 58899999986432 233456788999999999999999999987543      


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ...++||||+++ +|..++..      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999976 56555532      267888999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhH-------HHHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LDHV  334 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~-------~~~~  334 (437)
                      +++.....  .......+|..|+|||.+.+..++.++|||||||++|||++|+.||............+       ....
T Consensus       172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99865322  22234568999999999999999999999999999999999999996433211000000       0000


Q ss_pred             HHHH--------hccc-----hhhhccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          335 KKLE--------REKR-----LDAIVDRNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~--------~~~~-----~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ....        ....     ...+....+   ...........+.+++.+|++.||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000        0000     000000000   000111123578899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-38  Score=314.56  Aligned_cols=263  Identities=22%  Similarity=0.279  Sum_probs=198.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ...+|.+.+.||+|+||.||++...   .+..||+|.+...      ..+.+|++++++++||||+++++++......++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            3457999999999999999999853   3578999987642      235689999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      +||++. ++|..++..    ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++..
T Consensus       164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999996 577777743    23489999999999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc-h-
Q 013750          267 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR-L-  343 (437)
Q Consensus       267 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-  343 (437)
                      ...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+......+..... . 
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS-SSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc-HHHHHHHHHHhccCccccC
Confidence            432221 22345689999999999999999999999999999999999999865433221 1111111111100000 0 


Q ss_pred             --------hhh--ccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          344 --------DAI--VDRNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       344 --------~~~--~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                              ...  .....+..+.       .....++.+++.+|++.||++|||+.|++..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    000  0000000000       1123467889999999999999999999865

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-38  Score=296.54  Aligned_cols=257  Identities=26%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||.|+||+||+|... ++..+|+|++.........+.+.+|++.++.++|+|++++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999964 57899999987544344667899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....+ ...+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976433 23478999999999999999999999   99999999999999999999999999987665432


Q ss_pred             Cc---ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          271 TN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       271 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..   ......++..|+|||.+... .++.++|+||||+++|||++|+.||.......    ......    ..      
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~----~~------  222 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL----QN------  222 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHh----cC------
Confidence            22   12234578899999998877 78999999999999999999999986332110    010100    00      


Q ss_pred             ccccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..+.+.... ....+..+.+++..||+.||++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            001111111 1234567899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-38  Score=299.63  Aligned_cols=260  Identities=24%  Similarity=0.316  Sum_probs=202.2

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      .++.++..+.+.|+..+.||+|+||.||+|... +++.+|+|.+...  ......+..|+.++.++ +|+|++++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            355666677889999999999999999999974 5889999988542  23446788899999988 6999999999985


Q ss_pred             c------CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          180 T------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       180 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      .      ....+++|||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            3      4567999999999999999876432  3377888899999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          254 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      .++|+|||++........ ......++..|+|||.+.     ...++.++||||||+++|||++|..||........   
T Consensus       159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---  234 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---  234 (282)
T ss_pred             CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---
Confidence            999999999875532211 122345888999999886     34578899999999999999999999853221100   


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           ....         .............+..+.+++.+||+.||.+||++.|+++
T Consensus       235 -----~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 -----LFLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -----hhhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                 0000         0000001111234468999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-38  Score=299.56  Aligned_cols=240  Identities=22%  Similarity=0.352  Sum_probs=187.9

Q ss_pred             CeeeecCcEEEEEEEECC--------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          118 NVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      +.||+|+||.||+|..+.        ...+|+|.+.... ....+.+.+|+.+++.+.|||++++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999998642        2348888875422 3445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc--------EEEeecC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--------AVVGDFG  261 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--------~kl~Dfg  261 (437)
                      |+++|+|..++....   ..+++..++.++.||+.||+|||++   +++||||||+||+++.++.        ++++|||
T Consensus        80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            999999999987532   2478999999999999999999999   9999999999999987765        5999999


Q ss_pred             CceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCC-CCCCCCcccccchhhHHHHHHHHHh
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ++.....     .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+......        ........
T Consensus       154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~  220 (258)
T cd05078         154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFYED  220 (258)
T ss_pred             cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHHHc
Confidence            8864432     1224578899999999864 5799999999999999999995 444321110        00000000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                                  ....+.....++.+++.+||+.||++|||++++++.|+
T Consensus       221 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                        01112222357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-38  Score=314.74  Aligned_cols=202  Identities=21%  Similarity=0.286  Sum_probs=173.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++... +++.||+|++....  .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999975 58999999986422  2334567888999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .++......++.|++.||+|||++   +++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999987532    378899999999999999999999   999999999999999999999999999875421


Q ss_pred             CCC----------------------------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC
Q 013750          269 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ  314 (437)
Q Consensus       269 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~  314 (437)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                  0011346899999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 013750          315 RAIDFS  320 (437)
Q Consensus       315 ~p~~~~  320 (437)
                      .||...
T Consensus       234 ~Pf~~~  239 (360)
T cd05627         234 PPFCSE  239 (360)
T ss_pred             CCCCCC
Confidence            999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=300.96  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++.... .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788899999999999999976 58899999886432 23345678999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++++.+..+....    ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99988777655432    2378999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------  339 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  339 (437)
                      .........++..|+|||.+.+. .++.++||||||+++|+|++|+.||......     ...........         
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQEL  228 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhh
Confidence            33233345678899999999888 7899999999999999999999998643211     01111000000         


Q ss_pred             ---ccc-----hhhhcccc-ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 ---EKR-----LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ---~~~-----~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...     ..+..+.. ....++...+..+.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               000     00000000 000111223578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.3e-38  Score=303.08  Aligned_cols=197  Identities=22%  Similarity=0.339  Sum_probs=159.4

Q ss_pred             CCeeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee--cCCeeEEEEecc
Q 013750          117 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLLVYPFM  191 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lv~e~~  191 (437)
                      ...||+|+||.||+|+..   ++..||+|.+...   .....+.+|++++++++||||+++++++.  .....++|+||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            367999999999999965   3578999988642   23456789999999999999999999885  345678999998


Q ss_pred             cCchhhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee----cCCCcEEEeecCC
Q 013750          192 QNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL  262 (437)
Q Consensus       192 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgl  262 (437)
                      ++ +|..++....     .....+++..+..++.|++.||.|||+.   +++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 6666654321     1223478899999999999999999999   99999999999999    5667899999999


Q ss_pred             ceecccCCCc--ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          263 AKLVDVRKTN--VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       263 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      ++........  ......+|..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9866432221  12334678999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.1e-38  Score=297.86  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=196.8

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      |+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            456788999999999999976 47788999886432 3456678999999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|..++...   ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++....... .
T Consensus        86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~  158 (282)
T cd06643          86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  158 (282)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence            99998887642   23489999999999999999999999   99999999999999999999999999987543221 1


Q ss_pred             cccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          273 VTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.||......        .......... ...  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~-~~~--  227 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSE-PPT--  227 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcC-CCC--
Confidence            122345889999999984     345788999999999999999999998632210        0011110000 000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                           ...+...+..+.+++.+||+.+|++||++.++++.-
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         228 -----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                 011222345789999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-38  Score=299.38  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367888899999999999999975 6899999998754333334567789999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++ +|.+++....   ..+++.....++.|+++||.|||+.   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9985 8888876532   2478999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---ccchhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---EKRLDA  345 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  345 (437)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .   ..........   ......
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-D---QLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-H---HHHHHHHhcCCCChhhhhh
Confidence            111 122346789999998865 458999999999999999999999986433110 0   0000000000   000000


Q ss_pred             hc--------------cccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IV--------------DRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~--------------d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..              ...+.... .......+.+++.+|++.+|++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00              00000000 0011257789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.1e-38  Score=320.25  Aligned_cols=264  Identities=17%  Similarity=0.217  Sum_probs=192.5

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc------cceeeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR------NLLRLIGF  177 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~  177 (437)
                      +++...+++|.+.+.||+|+||+||+|.+. +++.||||++...  ......+..|+.++.+++|.      ++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            344556788999999999999999999974 5788999998642  22344566788887777654      58889998


Q ss_pred             eecC-CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---
Q 013750          178 CTTP-TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---  253 (437)
Q Consensus       178 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---  253 (437)
                      +... ...++|||++ +++|.+++...    ..+++..+..++.||+.||.|||+++  +|+||||||+|||++.++   
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccc
Confidence            8754 4678999988 66788777653    23889999999999999999999732  899999999999998765   


Q ss_pred             -------------cEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          254 -------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       254 -------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                                   .+||+|||.+....    .......||..|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         49999999886322    2233457899999999999999999999999999999999999999754


Q ss_pred             cccccchhhHHHHHHHHHh-----------ccchhhhccc--cccCCCC---------------HHHHHHHHHHHHHhcc
Q 013750          321 RLEEEDDVLLLDHVKKLER-----------EKRLDAIVDR--NLNKNYN---------------IQEVETMIQVALLCTQ  372 (437)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d~--~l~~~~~---------------~~~~~~l~~l~~~Cl~  372 (437)
                      ....     ....+.....           .....++.+.  .+.....               ......+.+|+..||+
T Consensus       349 ~~~~-----~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  423 (467)
T PTZ00284        349 DNLE-----HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH  423 (467)
T ss_pred             ChHH-----HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence            3211     1111100000           0000000000  0000000               0113467899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 013750          373 ASPEDRPAMSEVVR  386 (437)
Q Consensus       373 ~dp~~RPs~~evl~  386 (437)
                      .||++|||+.|+++
T Consensus       424 ~dP~~R~ta~e~L~  437 (467)
T PTZ00284        424 YDRQKRLNARQMTT  437 (467)
T ss_pred             cChhhCCCHHHHhc
Confidence            99999999999986

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-37  Score=293.05  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|++|.||++... ++..||+|++...........+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46788899999999999999986 48999999987544334567899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      +++++|.+++...    ..++......++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999754    348999999999999999999999 8   9999999999999999999999999999866433


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ... .....++..|+|||.+....++.++|+||||+++|||++|+.|+......  .   .........         ..
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~~~~~---------~~  218 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELMQAIC---------DG  218 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHHHHHh---------cC
Confidence            222 12345788999999999989999999999999999999999998643320  0   111111111         00


Q ss_pred             cccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          350 NLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       350 ~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       .....+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 -PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             01111222 45689999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.6e-38  Score=293.44  Aligned_cols=250  Identities=20%  Similarity=0.324  Sum_probs=201.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|+||.||++... +|+.||+|++.... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999964 68899999986422 233456889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....  ...+++...+.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999887532  22478889999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      . ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+......        ..........         
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~---------  217 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRGS---------  217 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcCC---------
Confidence            1 122345788999999999888999999999999999999999998632211        1111111000         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ....+......+.+++.+||+.+|++||++.+|++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             01112334567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-37  Score=295.23  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=200.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      -|+..+.||+|+||.||+|... ++..||+|...........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3566788999999999999864 688999998864433445567889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|..++..     ..+++.....++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999988864     2378999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....     .   ....... ..         .
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~---~~~~~~~-~~---------~  217 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----M---KVLFLIP-KN---------N  217 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----H---HHHHHHh-cC---------C
Confidence             12234578899999999888899999999999999999999999853211     0   0111110 00         0


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ........+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111222344678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.7e-37  Score=293.10  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-C---CcchHHHHHHHHHHHhcccccceeeeeeeecC--Cee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-S---PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  184 (437)
                      ++|...+.||+|+||.||+|... ++..||+|.+.... .   ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999975 58999999875321 1   12345788899999999999999999988654  457


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      +++|||+++++|.+++....    .+++...++++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999987532    278888899999999999999999   99999999999999999999999999987


Q ss_pred             ecccCCC--cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .......  .......++..|+|||.+.+..++.++||||||+++|||++|+.||......        ......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~-----  221 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKI-----  221 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------HHHHHH-----
Confidence            5432111  1122345788999999998888999999999999999999999998532110        000111     


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          .........+......+.+++.+|+. +|++||+++++++
T Consensus       222 ----~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ----ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ----hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                00111122344555678889999984 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-38  Score=299.52  Aligned_cols=262  Identities=20%  Similarity=0.279  Sum_probs=195.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|+||.||+|... +|..||+|++.... .......+.+|++++++++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4677889999999999999975 68999999986422 223345678899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++ +|..++...   ...+++...+.++.||++||.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            974 677766542   23489999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc------h
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR------L  343 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~  343 (437)
                      . ......++..|+|||.+.+.. ++.++|||||||++|||+||..|+.......    ..............      .
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH----HHHHHHHHHhCCCChHHhHHh
Confidence            1 122345788999999987654 7899999999999999999998864222110    01111100000000      0


Q ss_pred             hhhccccc----c-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNL----N-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l----~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....+...    .     ....+..+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000    0     0111223467889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=291.26  Aligned_cols=254  Identities=21%  Similarity=0.292  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|||++++++++......+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            367888899999999999999974 57889999987533 3356788999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...   ...++......++.|++.||+|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999988753   13378899999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .. ......++..|+|||.+...   .++.++||||||+++|||++|+.|+.......        .........    .
T Consensus       155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~~----~  221 (262)
T cd06613         155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKSN----F  221 (262)
T ss_pred             hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcc----C
Confidence            11 12234578899999999776   78999999999999999999999986322110        000000000    0


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....  .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000  1112344567999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-37  Score=295.56  Aligned_cols=256  Identities=27%  Similarity=0.369  Sum_probs=197.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      |.+.+.||+|+||.||+|.+.    ++..||||++.... .....+++.+|++++++++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999863    36889999986432 2344567889999999999999999999886543      


Q ss_pred             eeEEEEecccCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      ..+++++|+++|+|..++.....  ....+++...+.++.|++.||+|||++   +++|+||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            23788999999999988754321  223478899999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHH
Q 013750          261 GLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       261 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      |+++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+.....     ........   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~---  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNYLI---  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHHHH---
Confidence            999865432211 1122345678999999988889999999999999999999 8888753221     11111111   


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....          ..++..+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       230 ~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         230 KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            11000          1112334689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.6e-38  Score=295.79  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            46667788999999999999964 58899999986432 33445688999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++....    .+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999886532    378999999999999999999999   99999999999999999999999999987654321


Q ss_pred             Cccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          271 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                       .......|+..|+|||.+.   ...++.++|||||||++|||++|..|+.......  .      ........    ..
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~------~~~~~~~~----~~  227 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A------LFLMTKSN----FQ  227 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h------HHhhhccC----CC
Confidence             1223346889999999874   4568899999999999999999999975322110  0      00000000    00


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .+....  ....+..+.+++.+|++.+|++||++.++++
T Consensus       228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000000  0122346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-37  Score=295.15  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=197.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--C-------cchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--P-------GGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      +|...+.||+|+||.||+|... +|+.||+|.+.....  .       ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999864 689999998753111  0       11346788999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++|+||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998764    3478889999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCc-ccccccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          263 AKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       263 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +......... ......++..|+|||.+....  ++.++|+||||+++||+++|..|+......        ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLGN  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhhc
Confidence            9754322111 122345788999999987654  789999999999999999999998532110        00000000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      . ..    ............+..+.+++..||+.+|++||++.++++
T Consensus       227 ~-~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 K-RS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             c-cc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0 00    011111122234568899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-37  Score=292.63  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=201.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCC-----CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +|+..+.||+|++|.||++.. .+++.||+|.+.....     ....+.+.+|++++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999986 4689999999864221     1134678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCcee
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL  265 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~  265 (437)
                      |+||+++++|.+++....    .+++.....++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999987533    378899999999999999999999   999999999999998775 599999999876


Q ss_pred             cccCCCc---ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          266 VDVRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       266 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .......   ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.........     .....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~------  222 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-----ALIFK------  222 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----HHHHH------
Confidence            6432111   112245788999999998888999999999999999999999998643221110     00100      


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ..........+......+.+++.+|++.+|++||++.++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 ---IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               00011112334445568999999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=294.86  Aligned_cols=255  Identities=25%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCC-----
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT-----  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----  182 (437)
                      ++++|+..+.||+|+||.||+|..+ +++.+++|++...  ....+.+.+|+.+++++ .|+|++++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4688999999999999999999975 5789999998643  23456789999999998 6999999999996644     


Q ss_pred             -eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          183 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       183 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                       ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999876543345589999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      ++....... .......++..|+|||.+..     ..++.++||||||+++|+|++|..||......        .....
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~  229 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFK  229 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHH
Confidence            987653222 12223458889999998753     34688999999999999999999998632110        00011


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .... ..     +  ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~-~~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRN-PP-----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhcc-CC-----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1000 00     0  01112234568899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-37  Score=294.67  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=201.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|...+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999975 689999999875332 33456899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      + +++|.+++....   ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999887532   4489999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc--------
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------  341 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  341 (437)
                      ........++..|+|||.+.+. .++.++||||+|+++|||++|..+|.....     ..............        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-----IEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-----HHHHHHHHHHcCCCChHHHhhc
Confidence            2223345688999999998654 468999999999999999999777753221     11111111100000        


Q ss_pred             -c---hhhhccccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 -R---LDAIVDRNL----NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 -~---~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       .   ...+..+.-    ..+..++....+.+++.+|++.+|++||+++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0   000000000    000112234788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=294.34  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc---cccceeeeeeeecCCeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .|+..+.||+|+||.||+|.+ .++..||+|.+.........+++.+|++++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 4689999999875444455677889999999987   999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++...     .+++...+.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999887642     488999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......        .....      ....
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~------~~~~  218 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMMLI------PKSK  218 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhcc------ccCC
Confidence            3321 2234688899999998754 46899999999999999999999986432110        00000      0000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.+...   ..+..+.+++.+||+.||++||++.++++.
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0111110   134578999999999999999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=296.69  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=200.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||.||++... ++..+|+|.+... .....+.|.+|++++++++|||++++++++......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            456888899999999999999975 5889999998643 24455679999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....   ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            999999999987532   3488999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .. ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......        .......... . 
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~-  225 (280)
T cd06611         157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSE-P-  225 (280)
T ss_pred             cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCC-C-
Confidence            21 222345888999999875     344678999999999999999999998643211        1111111100 0 


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          +.  ...+...+..+.+++..||+.+|++||++.++++.
T Consensus       226 ----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 ----PT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                00  01122334578899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=300.93  Aligned_cols=253  Identities=25%  Similarity=0.274  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC--cchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++... ++..||+|.+......  ...+.+..|++++..++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999975 4899999998753322  24567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+.+++|.+++....  ...+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999887432  23488899999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc----------------------------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          269 RKTN----------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       269 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      ....                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            011235788999999999888999999999999999999999998643


Q ss_pred             cccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 013750          321 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA----MSEVVR  386 (437)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----~~evl~  386 (437)
                      ....    ..             ..+.+...........+..+.+++.+||+.||++||+    +.|++.
T Consensus       236 ~~~~----~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE----TF-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH----HH-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2210    00             0111111111111124568999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-37  Score=296.89  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=196.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|++|.||+|+.. +|..||||++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999975 68999999886432 233345788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +. ++|..++....  ...+++.....++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 57888876532  23488999999999999999999999   99999999999999999999999999987554322


Q ss_pred             CcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc--------
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------  341 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  341 (437)
                      . ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......    .............        
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhhh
Confidence            1 122234678999999887644 6889999999999999999999986432211    0111111100000        


Q ss_pred             -------chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          342 -------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       342 -------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             .........+ ....+.....+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   0000000000 0001122356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-37  Score=291.84  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|...+.||+|+||.||+|... ++..||+|.+..... ....+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999965 689999999875332 23567889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...    ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999998753    2378889999999999999999999   99999999999999999999999999998764433


Q ss_pred             Ccccc---cccccccccccccccCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          271 TNVTT---QVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       271 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .....   ...++..|+|||.+....   ++.++||||||+++||+++|+.||.....    .........    ...  
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~~~~~----~~~--  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFHVG----AGH--  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHHHHHh----cCC--
Confidence            22211   245788999999998766   89999999999999999999999863321    100100000    000  


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         .+.+.  ........+.+++.+||+.+|++||++.+++.
T Consensus       224 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 ---KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000  01112457889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=304.67  Aligned_cols=259  Identities=23%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC-----
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  181 (437)
                      ...++|...+.||+|+||.||++... ++..||||++.... .....+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34678999999999999999999964 68899999986422 123345677999999999999999999987543     


Q ss_pred             -CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          182 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       182 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                       ...+++++++ +++|..++..     ..+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3468999988 6788777653     2388999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      |+++.....    .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......     ..........
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~  233 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-----QLKRIMEVVG  233 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHHhC
Confidence            999865422    233468999999999876 568999999999999999999999986432211     1111100000


Q ss_pred             ccc-----------hhhhccccccCCCC--------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 EKR-----------LDAIVDRNLNKNYN--------IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ~~~-----------~~~~~d~~l~~~~~--------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...           ...... .+ ...+        ......+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQ-SL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhh-cc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000           000000 00 0000        0112357899999999999999999999954

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-38  Score=293.97  Aligned_cols=250  Identities=23%  Similarity=0.228  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..++|...+.||.|.-|+||++.+++ +..+|+|++.+..  +.....+.+.|-++|+.++||.+..|++.+.+++..|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            34566677899999999999999874 5899999997533  23344567789999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      +||||+||+|....+...  ...++...++-++..++-||+|||-.   |||.|||||+||||-++|++.|+||.++...
T Consensus       155 ~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999887643  34488889999999999999999999   9999999999999999999999999986533


Q ss_pred             cc---------------------------------CCC----------------------cccccccccccccccccccC
Q 013750          267 DV---------------------------------RKT----------------------NVTTQVRGTMGHIAPEYLST  291 (437)
Q Consensus       267 ~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~  291 (437)
                      ..                                 ...                      ..+..++||..|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 000                      01123579999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhc
Q 013750          292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT  371 (437)
Q Consensus       292 ~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  371 (437)
                      ...+.++|+|+|||++|||+.|..||.+.+...                 .+..++...+.-...+..+..+.+||++.|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            999999999999999999999999998654322                 223333333332223355678999999999


Q ss_pred             cCCCCCCCCH
Q 013750          372 QASPEDRPAM  381 (437)
Q Consensus       372 ~~dp~~RPs~  381 (437)
                      .+||.+|--.
T Consensus       373 vKdP~kRlg~  382 (459)
T KOG0610|consen  373 VKDPSKRLGS  382 (459)
T ss_pred             ccChhhhhcc
Confidence            9999999883

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=303.79  Aligned_cols=251  Identities=22%  Similarity=0.288  Sum_probs=211.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCC--cchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESP--GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  185 (437)
                      ..+.|+..+.||.|.||.||+++.+. |+.+|+|.+.+....  ...+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            35678888999999999999999765 999999999754422  23468899999999998 999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC----CcEEEeecC
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFG  261 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfg  261 (437)
                      +|||++.+|.|.+.+...    . ++......++.|++.++.|||+.   +++||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999875    2 88999999999999999999999   99999999999999643    479999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....  .......+||+.|+|||.+....|+..+||||+|+++|.|++|..||........    ..          
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~----------  248 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FL----------  248 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HH----------
Confidence            9998765  4445567899999999999999999999999999999999999999975432211    00          


Q ss_pred             chhhhccc--cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 RLDAIVDR--NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~~~~~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         .+...  ..........+..+.+++..|+..||.+|+|+.++++.
T Consensus       249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence               11111  22233345557789999999999999999999999985

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.5e-37  Score=296.22  Aligned_cols=266  Identities=22%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++++|...+.||+|+||.||+|... +|..||+|++...........+.+|+++++.++|+||+++.+++......++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578888999999999999999864 688999999865443444457789999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+. +++..++...   ...+.+.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 5666665432   22367888889999999999999999   999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH----------
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL----------  337 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------  337 (437)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++|..||+.......   .+.......          
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE---QLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHHHHHcCCCChhhhhh
Confidence            211 12223468899999998764 578899999999999999999999874322110   000000000          


Q ss_pred             -Hh-ccchhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          338 -ER-EKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       338 -~~-~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       .. ................     .......+.+++.+|++.||++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             00 0000000000000000     0012357889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.7e-37  Score=297.21  Aligned_cols=256  Identities=20%  Similarity=0.230  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888899999999999999975 478999999865321  233457889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....    .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999986532    378899999999999999999999   999999999999999999999999999874211


Q ss_pred             CCC--------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          269 RKT--------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       269 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ...              .......++..|+|||.+....++.++|+||||+++|||++|..||......        ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            000              0111234678999999998888999999999999999999999998632211        111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .......    ...+.    .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~----~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDD----IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcc----cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1111000    00000    011234578999999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-37  Score=289.45  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... .....+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999974 68899999986432 334567889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~  269 (437)
                      +++++|.+++....  ...+++..+.+++.++++||+|||++   +++|+||+|+||+++++ ..++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997632  23478999999999999999999999   99999999999999854 46899999999866432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+..+...     .   ....... ..      
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~---~~~~~~~-~~------  218 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----L---VLKIMSG-TF------  218 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----H---HHHHHhc-CC------
Confidence            2  1223457889999999998889999999999999999999999986432210     1   1111000 00      


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...+...+..+.+++..||+.+|++|||+.|+++
T Consensus       219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               0111223457899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-37  Score=297.63  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999975 589999999875443445667889999999996 99999999999999999999999


Q ss_pred             ccCchhhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      +.. ++..+.... ......+++.....++.+++.||+|||+..  +++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 444433211 112245889999999999999999999743  8999999999999999999999999999755322


Q ss_pred             CCcccccccccccccccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .  ......++..|+|||.+...   .++.++||||||+++|||++|+.||.....       ...........      
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~------  226 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKG------  226 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCC------
Confidence            1  11223578899999999776   689999999999999999999999863220       11111111000      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..+.+....+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01112222223355689999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-37  Score=294.19  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=200.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      +|+..+.||.|++|.||+|+.. +|..||+|.+.........+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999985 588999999875444445567889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 78887765432 34589999999999999999999999   999999999999999999999999999975543211


Q ss_pred             cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--cchhhhcc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLDAIVD  348 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d  348 (437)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.||........    ...........  .....+.+
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ----LLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhHHHHhc
Confidence             12223468899999988654 578999999999999999999999875432211    00000000000  00000000


Q ss_pred             -cccc-----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          349 -RNLN-----------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       349 -~~l~-----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       +.+.           ....+..+..+.+++..|++.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             0000           0111233567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-38  Score=281.83  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC---cc----hHHHHHHHHHHHhc-ccccceeeeeee
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP---GG----DAAFQREVEMISVA-VHRNLLRLIGFC  178 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~----~~~~~~E~~~l~~l-~H~niv~l~g~~  178 (437)
                      ...-++|...+.||.|..++|-++..+ +|..+|+|++......   ..    .++-.+|+.+|+++ .||||+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            334567788899999999999998864 6889999998643321   11    23445799999987 599999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      .++...++|+|.|+.|.|.++|...    ..++.....+|+.|+.+|++|||.+   +|+||||||+|||+|++.+++|+
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence            9999999999999999999999754    3489999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCcccccccccccccccccccC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  332 (437)
                      |||.++.+..  .......+||++|+|||.+..      ..|+..+|+|+.||++|.|+.|.+||-..     ..+..+.
T Consensus       166 DFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQmlMLR  238 (411)
T KOG0599|consen  166 DFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQMLMLR  238 (411)
T ss_pred             ccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHHHHH
Confidence            9999997753  344556789999999999853      34788999999999999999999998421     1111111


Q ss_pred             HHHHHHhccchhhhcccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 HVKKLEREKRLDAIVDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                  .++.....  ..--.+.+..+.+|+.+|++.||.+|.|++|++.
T Consensus       239 ------------~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 ------------MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ------------HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                        12222211  1112345668999999999999999999999985

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-37  Score=296.19  Aligned_cols=248  Identities=26%  Similarity=0.339  Sum_probs=195.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +.|...+.||+|+||+||+|... +++.||+|.+....  .....+++.+|+++++.++|||++++.++|...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778899999999999999975 68999999886322  2233457889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||++ |++.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 4666665432   22489999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .     ....++..|+|||.+.   ...++.++||||||+++|||+||+.|+......     ..   .......     
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~---~~~~~~~-----  229 (307)
T cd06607         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA---LYHIAQN-----  229 (307)
T ss_pred             C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HH---HHHHhcC-----
Confidence            2     2235788999999874   456889999999999999999999998532211     00   0000000     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                          ..........+..+.+++.+||+.+|++||++.+++...
T Consensus       230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 ----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             ----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                000011223456789999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=292.93  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=197.8

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEEEe
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVYP  189 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  189 (437)
                      |++.+.||+|+||.||+|... +++.+|+|++.... .......+.+|++++++++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999976 48899999997543 233456788999999999999999999999888  88999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++ +|..++...   ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 787777543   13589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc---cchhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE---KRLDA  345 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  345 (437)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ...........   .....
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-----QLEKIFELCGSPTDENWPG  228 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCchhhccc
Confidence            3222333456788999998764 457999999999999999999999986433211     11111110000   00000


Q ss_pred             --------------hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 --------------IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 --------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                    .....+.......++..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                          00000000011112568899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.5e-37  Score=294.21  Aligned_cols=262  Identities=23%  Similarity=0.261  Sum_probs=198.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC----cchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      +|+..+.||+|+||.||+|... +|+.||+|.+......    .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999975 6899999999753321    2244677899999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+ +++|..++....   ..+++..+..++.|+++||.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999987532   3589999999999999999999999   99999999999999999999999999998664


Q ss_pred             cCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc-----
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-----  341 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  341 (437)
                      .... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|......     .............     
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-----DQLGKIFEALGTPTEENW  227 (298)
T ss_pred             CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-----HHHHHHHHHcCCCchhhh
Confidence            3221 2222346788999998854 45789999999999999999997777532211     1111110000000     


Q ss_pred             ----chhhhccccccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 ----RLDAIVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ----~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          .............     .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                0000000000001     112235688999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.6e-37  Score=295.33  Aligned_cols=262  Identities=23%  Similarity=0.281  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  187 (437)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.+.... .......+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            56888899999999999999976 58899999986432 122334677899999999999999999998877  889999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +||+++ +|.+++....   ..+++.....++.|++.||+|||++   +++|+||||+||++++++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 8888876532   2589999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh-------
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-------  339 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  339 (437)
                      .... ......++..|+|||.+.+.. ++.++|+||||+++|||++|..||.......     ..........       
T Consensus       158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-----~~~~~~~~~~~~~~~~~  231 (293)
T cd07843         158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTPTEKIW  231 (293)
T ss_pred             CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCchHHH
Confidence            3221 122344688999999987544 6899999999999999999999986432211     1111100000       


Q ss_pred             ----------ccchhhhccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 ----------EKRLDAIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ----------~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                ...........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                      0000000111111122221 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-37  Score=299.08  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=195.5

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      ...||+|+||.||++... ++..||||.+.... ....+.+.+|+.++..++|+|++++++.+...+..++||||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            456999999999999974 58899999986432 3445678899999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccc
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT  275 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  275 (437)
                      |.+++...     .+++.....++.||+.||+|||++   +++|+||||+||++++++.++|+|||++........ ...
T Consensus       106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~  176 (292)
T cd06658         106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK  176 (292)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence            99987532     378899999999999999999999   999999999999999999999999999875432221 122


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCC
Q 013750          276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY  355 (437)
Q Consensus       276 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  355 (437)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......     ..   .....      ....+.+..  
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~---~~~~~------~~~~~~~~~--  240 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QA---MRRIR------DNLPPRVKD--  240 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHH------hcCCCcccc--
Confidence            345788999999998888999999999999999999999998632211     01   11110      001111110  


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       356 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .......+.+++..||+.||++|||++++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11234578899999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-37  Score=295.60  Aligned_cols=245  Identities=21%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      ...||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++..++|||++++++++..++..++++||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            456999999999999974 68999999986432 3445678899999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccc
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT  275 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  275 (437)
                      |..++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........ ...
T Consensus       105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~  175 (297)
T cd06659         105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK  175 (297)
T ss_pred             HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence            9887754     2378999999999999999999999   999999999999999999999999999875433221 122


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCC
Q 013750          276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY  355 (437)
Q Consensus       276 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  355 (437)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......        .......... ..     ..  ..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-~~-----~~--~~  239 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDSP-PP-----KL--KN  239 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhccC-CC-----Cc--cc
Confidence            345889999999999888999999999999999999999998632211        1111111100 00     00  00


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       356 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11223578899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.1e-37  Score=294.10  Aligned_cols=250  Identities=20%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            67888899999999999999864 67899999986432 34456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...     .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999988642     268889999999999999999999   99999999999999999999999999987554322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      . ......++..|+|||.+....++.++||||||+++||+++|+.||...+.....        ......        +.
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--------~~~~~~--------~~  232 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATN--------GT  232 (293)
T ss_pred             c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--------eehhcC--------CC
Confidence            2 122345788999999998888999999999999999999999999643221100        000000        00


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011122234578899999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.3e-37  Score=288.20  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=204.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... .......+.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999864 68899999986432 234456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|..++.........+++.....++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876544445689999999999999999999999   9999999999999999999999999999866433 


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......     ...   .. ..         .
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~---~~-~~---------~  216 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRY---KV-QR---------G  216 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH---HH-hc---------C
Confidence              2223457889999999998889999999999999999999999986432110     100   00 00         1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+.....++.+++.+|++.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111223345568999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=292.98  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      |+..+.||+|++|.||+|... +|..||+|++.... .....+.+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999975 69999999986432 2233457889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 688888865431  3489999999999999999999999   999999999999999999999999999976543221


Q ss_pred             cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc--------c
Q 013750          272 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------R  342 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~  342 (437)
                      . .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.......    .............        .
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID----QLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHHhhhhhh
Confidence            1 1223468899999988654 57899999999999999999999986432211    0111111000000        0


Q ss_pred             hhhhccc------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDR------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..+....      .......+..+..+.+++.+|++.+|++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000      0000111223357889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=304.02  Aligned_cols=241  Identities=22%  Similarity=0.231  Sum_probs=184.9

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc---ccccceeeeeeeecCCeeEEEEecccC
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      ||+|+||+||+|... +++.||+|++....  .......+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 58999999986321  122233455677776655   699999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.++|+|||++....... ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            9999888653    2378999999999999999999999   99999999999999999999999999987532221 22


Q ss_pred             cccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          274 TTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......        ......... .      ..+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~-~------~~~~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFG-K------VRFP  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcC-C------CCCC
Confidence            2345689999999998765 4899999999999999999999998643211        111111100 0      0000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPA----MSEVVR  386 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----~~evl~  386 (437)
                      .   ...+..+.+++.+||+.||++||+    +.++++
T Consensus       218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0   112347789999999999999985    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.1e-37  Score=293.49  Aligned_cols=245  Identities=23%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|+..+.||+|+||.||++... +++.||+|.+....  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46788899999999999999975 58999999986422  2234567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++...    ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999998754    2378899999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .    .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......        .......         .
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~---------~  212 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKIL---------E  212 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh---------c
Confidence            3    22345889999999998888999999999999999999999998643210        0001100         0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                      ..  ...+......+.+++.+||+.||++||     +++|+++
T Consensus       213 ~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         213 GK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            00  011222345888999999999999998     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-36  Score=290.89  Aligned_cols=266  Identities=20%  Similarity=0.257  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCe-----
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  183 (437)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.+++.++ |||++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999975 68999999876432 2233457889999999995 6999999999876665     


Q ss_pred             eEEEEecccCchhhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecC
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFG  261 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg  261 (437)
                      .++||||+++ +|..++...... ...+++..++.++.||+.||.|||++   +++|+||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 788877654322 34589999999999999999999999   9999999999999998 8999999999


Q ss_pred             CceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||........    ...........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence            99865332221 222346788999998865 4579999999999999999999999864321110    11111100000


Q ss_pred             cc--hhhhc---c----cccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KR--LDAIV---D----RNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~--~~~~~---d----~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..  .....   +    +...    ....+.....+.+++.+||+.||++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00  00000   0    0000    0011224567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.4e-37  Score=292.17  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++.|+..+.||+|++|.||++.++ ++..+|+|++.....  ..+.+.+|+++++.++|+|++++++++......++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4667888899999999999999986 688999999875332  4677899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999998643   3589999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......     ..   ...... ......  
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~---~~~~~~-~~~~~~--  236 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RA---LFLITT-KGIPPL--  236 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHh-cCCCCC--
Confidence            221 122234778999999998888999999999999999999999998632211     00   011000 000000  


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 -----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 0112234678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.7e-37  Score=288.07  Aligned_cols=243  Identities=23%  Similarity=0.286  Sum_probs=195.7

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||.|+||.||+++.. ++..||+|++....  .....+.+.+|+++++.++||||+++++++..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 48999999986432  223456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++....    .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            99987532    378889999999999999999998   99999999999999999999999999998664322  2223


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..++..|+|||.+....++.++|+||||+++|||++|..|+.....+   ..   ....         ...+......++
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~---------~~~~~~~~~~~~  216 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PM---EIYN---------DILKGNGKLEFP  216 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HH---HHHH---------HHhccCCCCCCC
Confidence            45788999999998888999999999999999999999998644321   11   1111         111111112223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                      ...+..+.+++.+||+.+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            333568999999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-37  Score=290.89  Aligned_cols=248  Identities=24%  Similarity=0.280  Sum_probs=201.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      +|+..+.||.|+||.||++... ++..||+|.+....  .....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999975 58999999986422  22456789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...    ..++......++.|+++||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998753    3478999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .  ......++..|+|||.+....++.++|+||||+++|+|++|..|+........      .........         
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~---------  216 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR------DQIRAKQET---------  216 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH------HHHHHHhcc---------
Confidence            2  22234578899999999888899999999999999999999999875432210      111111000         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAM--SEVV  385 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~--~evl  385 (437)
                       .....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             1112223344688999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=294.36  Aligned_cols=270  Identities=20%  Similarity=0.284  Sum_probs=196.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC---CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  185 (437)
                      .|...+.||+|+||.||+|...   ++..||+|.+....  .....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999975   47899999987522  133346678899999999999999999999888  7899


Q ss_pred             EEEecccCchhhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC----CCcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----DFEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~----~~~~kl~Df  260 (437)
                      +||||+++ ++..++..... ....++......++.|++.||.|||+.   +++|+||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 55555543322 233688899999999999999999999   9999999999999999    999999999


Q ss_pred             CCceecccCCCc--ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch-----hhHHH
Q 013750          261 GLAKLVDVRKTN--VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-----VLLLD  332 (437)
Q Consensus       261 gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~-----~~~~~  332 (437)
                      |++.........  ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..........     ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999865432221  12234578899999988664 57899999999999999999999997544332100     00111


Q ss_pred             HHHHHHhc-----------cchhhhccccccCCCC---------H--HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 HVKKLERE-----------KRLDAIVDRNLNKNYN---------I--QEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ~~~~~~~~-----------~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....+...           .......+......++         .  .....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11100000           0000000000000000         0  23357899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.3e-37  Score=287.93  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=199.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|+||.||++..+ +|..+|+|.+.... .....+.+.+|+.+++.++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999975 58899999986432 223456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  269 (437)
                      +++++|.+++....  ...+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999987532  23478999999999999999999999   999999999999999885 4699999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .. ......|+..|+|||.+.+..++.++|+||||+++|||++|..|+.....        .........         .
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~---------~  217 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQ---------G  217 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhc---------c
Confidence            22 22234578899999999888899999999999999999999999863321        111111110         0


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .. ....+..+..+.+++.+||+.+|++|||+.++++
T Consensus       218 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            00 1112233457899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-36  Score=282.39  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      +|+..+.||+|++|.||++... ++..+++|++..... ...+.+.+|+++++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4677889999999999999985 688999999975432 45678999999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999999887642   3489999999999999999999998   999999999999999999999999999986654322


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                        .....++..|+|||.+....++.++||||||+++|+|++|+.|+......        ........ ........   
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~---  219 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIAT-NGPPGLRN---  219 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHh-cCCCCcCc---
Confidence              23345788999999999888999999999999999999999998643211        00001000 11111110   


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ....+..+.+++.+||+.||++|||+.++++
T Consensus       220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1112457999999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-36  Score=283.10  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY  188 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  188 (437)
                      +|...+.||+|++|.||+|... ++..|++|++.... .....+.+.+|++++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4667789999999999999986 68999999986432 124567889999999999999999999999888  8899999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999987643    589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......++..|+|||.+.....+.++||||||+++++|++|..||.....       ........         .
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~---------~  217 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKI---------G  217 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhc---------c
Confidence            3321 12234578899999999888899999999999999999999999874431       01111111         1


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ........+...+..+.+++.+|++.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111112223334578999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-36  Score=291.03  Aligned_cols=266  Identities=22%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC---
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT---  182 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---  182 (437)
                      +...++|++.+.||+|+||.||+|..+ +|+.||+|++.... .......+.+|+++++.++|||++++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999985 58899999986432 2333457788999999999999999999987655   


Q ss_pred             -------eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          183 -------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       183 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                             ..++|+||+++ ++..++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                   78999999986 565555432   23489999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......     .....+
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-----~~~~~~  230 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-----AQLELI  230 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHH
Confidence            999999998664433222222345778999998864 45789999999999999999999998643211     111111


Q ss_pred             HHHHhcc---chhhhccc--------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          335 KKLEREK---RLDAIVDR--------------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       335 ~~~~~~~---~~~~~~d~--------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .......   ....+...              ..... ....+..+.+++..||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111000   00000000              00000 0112467899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-36  Score=287.17  Aligned_cols=258  Identities=18%  Similarity=0.228  Sum_probs=192.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecC--CeeEEEEe
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP--TERLLVYP  189 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e  189 (437)
                      |...+.||+|+||.||+|... +++.||+|++.............+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999964 689999999875433333345567899898885 99999999999877  88999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 4777776542   23489999999999999999999999   9999999999999999 99999999999865432


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--------  340 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  340 (437)
                      ..  .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+...     ...........        
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-----QIAKIHDVLGTPDAEVLKK  225 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-----HHHHHHHHcCCCCHHHHHh
Confidence            21  223457889999997644 557899999999999999999999996433211     11111111000        


Q ss_pred             ---cchhhhcccccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 ---KRLDAIVDRNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ---~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ........+...    .......+..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence               000000000000    0011234678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=282.74  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|++.+.||+|.|+.|+++... +|+.+|+|++... -+....+++.+|+.+-..++|||||+|...+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            466777788999999999998864 6899999988521 23446778899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~  265 (437)
                      |+|.+++|..-+-..    ..++....-..+.||+++|.|+|.+   +|+|||+||+|+||..   ..-+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999998766543    3367778888999999999999999   9999999999999953   34589999999998


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ++  +.......+||++|||||++...+|+..+|||+-||+||-|+.|..||...+..     .+...+..   ..    
T Consensus       163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~I~~---g~----  228 (355)
T KOG0033|consen  163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQIKA---GA----  228 (355)
T ss_pred             eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHHHhc---cc----
Confidence            76  444455578999999999999999999999999999999999999999642111     11111110   00    


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       .|  ..+..-+...+...+|+++|+..||.+|.|+.|.++.
T Consensus       229 -yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  229 -YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             -cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence             00  0111122334578899999999999999999998854

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-36  Score=284.10  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=205.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|...+.||.|+||.||++... ++..+|+|++..... ....+.+.+|+++++.++|||++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999975 589999999875332 24566788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++.........+++.....++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987543345689999999999999999999999   99999999999999999999999999998664432


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       .......+++.|+|||......++.++|+||+|+++++|++|..|+......        ........ ..        
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~--------  219 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILK-GQ--------  219 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhc-CC--------
Confidence             1222345788999999998888999999999999999999999998643211        11111110 00        


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ....+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             11112234468899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-37  Score=298.79  Aligned_cols=263  Identities=20%  Similarity=0.333  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----ee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  184 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 689999999875443445567889999999999999999999875443     57


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++++||+++ +|...+..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 66666543     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCc--ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc-
Q 013750          265 LVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-  340 (437)
Q Consensus       265 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  340 (437)
                      ........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~  229 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTP  229 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCC
Confidence            65432211  1123457889999998754 468999999999999999999999986432111     01111100000 


Q ss_pred             --cchhhhcccc---------ccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 --KRLDAIVDRN---------LNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 --~~~~~~~d~~---------l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        .....+.+..         ....     ..+..+..+.+++.+||+.+|++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000000         0000     011234578999999999999999999999975

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-36  Score=291.03  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=197.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      |...+.||+|++|.||++... +++.+|+|++.... ....+.+.+|+.++..++|||++++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            444578999999999999964 68899999886422 3345668899999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|.+++..     ..+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999998875     2378899999999999999999999   999999999999999999999999998875443221 


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....     .   ......... .     .+.+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~---~~~~~~~~~-~-----~~~~~  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---QAMKRIRDN-L-----PPKLK  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----H---HHHHHHHhc-C-----CCCCc
Confidence            12234588999999999888899999999999999999999999853221     1   111111111 0     00000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        .....+..+.+++.+||+.+|++||++.++++
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              01123458999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-38  Score=308.06  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEE---EEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe--eEEEEec
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE--RLLVYPF  190 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vA---vK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~  190 (437)
                      ..+||+|+|-+||||.+. +|..||   ||.-....++...+.|..|+.+|+.|+||||++++.++.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999974 477776   3332223345667899999999999999999999999876665  6789999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~  269 (437)
                      |..|+|..|..+.+.    .+......++.||++||.|||++ .|+|+|||||-+||+|+. .|.+||+|+|||......
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999987654    67788999999999999999998 678999999999999986 489999999999976532


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .   .+...|||.|||||... ..|++.+||||||+.++||.|+..|+..-..+    ..+...+-...++..+..+-| 
T Consensus       200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKKV~SGiKP~sl~kV~d-  270 (632)
T KOG0584|consen  200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKKVTSGIKPAALSKVKD-  270 (632)
T ss_pred             c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHHHHcCCCHHHhhccCC-
Confidence            2   23478999999999987 78999999999999999999999998643321    122223322223333333333 


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                 .++.++|.+|+.. ..+|||+.|+|+
T Consensus       271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       2789999999998 999999999994

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-36  Score=292.32  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=195.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|+..+.||+|+||.||+|.+++ ++.||||.+...........+..|+.++.+.. ||||++++++|......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34677888999999999999999864 89999999975443445566778888776665 99999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+.+ ++..+.....   ..+++..+..++.|++.||+|||+.+  +++|+||+|+||++++++.++|+|||++....
T Consensus        93 ~e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999864 6666654422   25899999999999999999999732  89999999999999999999999999987653


Q ss_pred             cCCCcccccccccccccccccccCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ...  ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||......    .   .......... .
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~---~~~~~~~~~~-~  236 (296)
T cd06618         167 DSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----F---EVLTKILQEE-P  236 (296)
T ss_pred             CCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----H---HHHHHHhcCC-C
Confidence            221  122234778999999987554    789999999999999999999998532110    0   0111110000 0


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      ..     .  ......+..+.+++.+||+.||++||++.++++..
T Consensus       237 ~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 PS-----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CC-----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00     0  00112345789999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=289.85  Aligned_cols=260  Identities=17%  Similarity=0.198  Sum_probs=181.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCC----CEEEEEEeccCCCCcchH----------HHHHHHHHHHhcccccceeeee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDA----------AFQREVEMISVAVHRNLLRLIG  176 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vAvK~l~~~~~~~~~~----------~~~~E~~~l~~l~H~niv~l~g  176 (437)
                      .++|.+.+.||+|+||+||+|...++    ..+|+|+..........+          ....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46788999999999999999997543    456666543211111011          1122333455678999999999


Q ss_pred             eeecCC----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          177 FCTTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       177 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ++....    ..+++++++.. ++.+.+....    ..++.....++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            775443    33667777643 4545444321    246777889999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCceecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 013750          253 FEAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED  326 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~  326 (437)
                      +.++|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ 
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-  241 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-  241 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-
Confidence            99999999999866432211      11224689999999999999999999999999999999999999974322111 


Q ss_pred             hhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                         .......    .....+..+...   ....+..+.+++..|++.+|++||++.++.+.|+
T Consensus       242 ---~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 ---LIHAAKC----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             ---HHHHhHH----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence               1110000    000111111110   1123467899999999999999999999998764

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=284.98  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC----CCcchHHHHHHHHHHHhcccccceeeeeeeecC--Cee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  184 (437)
                      .+|...+.||+|+||.||+|... ++..||+|.+....    .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57888999999999999999974 58999999875321    223445788999999999999999999998664  457


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++++||+++++|.+++....    .+++....+++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999887532    378888999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCC--CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ......  ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......        .....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~------  220 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFK------  220 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHH------
Confidence            653211  11122345788999999999888999999999999999999999998632110        00111      


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ..........+......+.+++.+||+ +|..||+..+++.
T Consensus       221 ---~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 ---IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               111111122344455689999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-37  Score=315.29  Aligned_cols=273  Identities=18%  Similarity=0.236  Sum_probs=188.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEE--------------ecc--CCCCcchHHHHHHHHHHHhccccc
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKR--------------LTD--FESPGGDAAFQREVEMISVAVHRN  170 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~--------------l~~--~~~~~~~~~~~~E~~~l~~l~H~n  170 (437)
                      ...++|.+.+.||+|+||+||++..+.  +...+.|.              +.+  .........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987542  22222221              110  011223456889999999999999


Q ss_pred             ceeeeeeeecCCeeEEEEecccCchhhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       171 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      |+++++++...+..+++++++.. +|..++..... ............++.|++.||.|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99999999999999999999864 56666543221 112233556778999999999999999   99999999999999


Q ss_pred             cCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCcccccchh
Q 013750          250 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI-DFSRLEEEDDV  328 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~-~~~~~~~~~~~  328 (437)
                      +.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|..++ .......  ..
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~--~~  378 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP--GK  378 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH--HH
Confidence            99999999999999876543333333457999999999999999999999999999999999987543 2211111  01


Q ss_pred             hHHHHHHHHHh-----cc---chhhhcccc-cc---CCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          329 LLLDHVKKLER-----EK---RLDAIVDRN-LN---KNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       329 ~~~~~~~~~~~-----~~---~~~~~~d~~-l~---~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.........     ..   ...+.++.. ..   ...+     ......+.+++.+|++.||.+|||+.|+++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111111000     00   000000000 00   0000     0122457788999999999999999999864

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-36  Score=287.13  Aligned_cols=242  Identities=25%  Similarity=0.328  Sum_probs=190.8

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||+||++... +|+.||+|.+....  .....+.+..|+++++.++|||++++++++...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 68999999986422  223345678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++.....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.....  ......
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence            999876432  3488999999999999999999999   999999999999999999999999999876543  222223


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||..........     .....        ...  .....+
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~--------~~~--~~~~~~  218 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-----ELKRR--------TLE--MAVEYP  218 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-----HHHhc--------ccc--ccccCC
Confidence            457889999999988889999999999999999999999986443211110     00000        000  011122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSE  383 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~e  383 (437)
                      ...+..+.+++.+||+.||++||+..+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            233557899999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.4e-36  Score=293.55  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=197.1

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCe
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTE  183 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  183 (437)
                      +...+++|+..+.||.|+||.||++... +++.||+|++... ......+.+.+|++++..++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3446788999999999999999999965 6899999988642 223345678899999999999999999998865 557


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++++||+ +++|..++...     .+++.....++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 45787776532     267888888999999999999999   9999999999999999999999999998


Q ss_pred             eecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH--------HH
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD--------HV  334 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~~  334 (437)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ....        +.
T Consensus       156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~-~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS-IITDLLGTPPDDVI  230 (328)
T ss_pred             cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHH
Confidence            754321    122356889999998866 568999999999999999999999986433211000 0000        00


Q ss_pred             HHHHhccchhhhcc-ccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          335 KKLEREKRLDAIVD-RNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~~~~~~~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ....... ..++.. -......+     +.....+.+++.+|++.+|++||++.+++..
T Consensus       231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             Hhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000 000000 00001111     1234688999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.7e-36  Score=286.58  Aligned_cols=244  Identities=25%  Similarity=0.318  Sum_probs=187.3

Q ss_pred             eeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHH---hcccccceeeeeeeecCCeeEEEEeccc
Q 013750          119 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMIS---VAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      .||+|+||.||++... +++.+|+|.+.....  ......+.+|..++.   ..+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999974 589999998864321  122233445544433   4479999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|.+++....    .+++.....++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999998887532    389999999999999999999999   99999999999999999999999999987543221  


Q ss_pred             ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          273 VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                       .....|+..|+|||.+.. ..++.++|||||||++|||++|..||.........      .......          ..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~----------~~  214 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTL----------TV  214 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhh----------cC
Confidence             122458999999999864 55899999999999999999999999643221110      0111000          00


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRML  388 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L  388 (437)
                      ....+...+..+.+++..|++.||++||     +++|+++..
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            1112333456889999999999999999     598887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-36  Score=290.49  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=193.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe-----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  183 (437)
                      .++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|++++++++||||++++++|.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457888999999999999999975 58999999886432 22234456789999999999999999999876543     


Q ss_pred             ---eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          184 ---RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       184 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                         .++||||+.+ +|..++...   ...+++...+.++.|++.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               4999999975 677766542   23479999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCc---ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          261 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       261 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......     .......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-----~~~~~~~  238 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-----QLTLISQ  238 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Confidence            999866432221   11223467889999988664 47889999999999999999999986433211     1111111


Q ss_pred             HHhc---cch-----hhhccc-cccCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          337 LERE---KRL-----DAIVDR-NLNKNY---------NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       337 ~~~~---~~~-----~~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....   ...     .+..+. ......         .......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1000   000     000000 000000         0001246779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=293.11  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=208.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .-|...+.||+|.|..|-++++ -+|..||||++.+..- ......+.+|++-|+.++|||||+||.+..+...+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466678899999999999984 3799999999976442 2334578899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceeccc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~  268 (437)
                      +-++|+|.+|+.....+   +......+++.||+.|+.|+|..   .++||||||+||.+.+ -|-+||+|||++..+.+
T Consensus        98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999765433   78889999999999999999999   8999999999998765 57899999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                        ....+..+|...|-|||++.+..|+ +++|||||||+||.|++|+.||+..+..                 ..+..++
T Consensus       172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm  232 (864)
T KOG4717|consen  172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM  232 (864)
T ss_pred             --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence              3344556899999999999999885 7899999999999999999999743321                 1233444


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      |...  ..+...+.+..+|+..|+..||.+|.+.+||+..
T Consensus       233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            5332  3456677899999999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=301.18  Aligned_cols=197  Identities=24%  Similarity=0.295  Sum_probs=170.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-c-----ccceeeeeeeecCCeeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-H-----RNLLRLIGFCTTPTERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~  185 (437)
                      +|.+.+.||+|+||.|.+|.+ ++++.||||++++.  ..-..+-..|+.+|..++ |     -|+|++++++...++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            788899999999999999996 46999999999853  334556678999999987 4     38999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC--CcEEEeecCCc
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLA  263 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfgla  263 (437)
                      ||+|.+. -+|.++++.....  .++......++.||+.||.+||+.   +|||+||||+||||.+.  ..+||+|||.+
T Consensus       265 iVfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999995 4999999876543  388999999999999999999999   99999999999999653  47999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR  321 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~  321 (437)
                      +.....-   . ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|...+
T Consensus       339 c~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  339 CFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            9764322   1 4456789999999999999999999999999999999988886544

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5e-36  Score=290.99  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=194.6

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |...+.||+|+||.||+++.. ++..||+|.+....  .......+.+|++++++++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566788999999999999964 68899999986432  223345788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++ ++.+.+...   ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....  
T Consensus       107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            975 676666432   23489999999999999999999999   999999999999999999999999999875432  


Q ss_pred             Cccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          271 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                         .....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+.....     ...   .......       
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~---~~~~~~~-------  239 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA---LYHIAQN-------  239 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHH---HHHHHhc-------
Confidence               12235788999999974   45689999999999999999999999753211     001   1111100       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ..........+..+.+++.+||+.+|.+||++.++++.+..
T Consensus       240 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         240 --ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             --cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence              00011122334578999999999999999999999986544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=287.45  Aligned_cols=265  Identities=22%  Similarity=0.256  Sum_probs=195.9

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      |.+.+.||+|++|+||+|... +++.||+|++.............+|+..+.+++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999985 478999999875332233345567999999999 999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                       +++|.+++....  ...+++..+..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             788988886543  23489999999999999999999999   99999999999999999999999999998654322 


Q ss_pred             ccccccccccccccccccc-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh--------HHHHHHHHHhccc
Q 013750          272 NVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--------LLDHVKKLEREKR  342 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~  342 (437)
                       ......++..|+|||.+. ...++.++|+||||++++||++|+.||............        ...+.........
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             122345788999999875 445799999999999999999999998644321100000        0000000000000


Q ss_pred             hhhhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..........   ....+.....+.+++.+||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   0001112467999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-36  Score=285.30  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=196.2

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||.||+++.. +|+.+|+|.+....  .....+.+.+|++++.+++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 48999999986432  123456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC-----
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-----  271 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----  271 (437)
                      .+++....    .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99987643    489999999999999999999999   999999999999999999999999999875433211     


Q ss_pred             --cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          272 --NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       272 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                        .......++..|+|||.......+.++||||||+++|||++|..||......        ........ .        
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~--------  216 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILN-G--------  216 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc-C--------
Confidence              1122345788999999998888999999999999999999999998643211        11111110 0        


Q ss_pred             cccCCCCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQ--EVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~--~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..  ..+..  .+..+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       217 ~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         217 KI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             Cc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00  01111  24688999999999999999999777666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=284.33  Aligned_cols=260  Identities=20%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      |...+.||+|++|.||++... +++.+|+|++..... ......+.+|++++++++|+|++++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999975 688999999864332 234567889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++ ++..++....   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 7777776532   3489999999999999999999999   99999999999999999999999999998765433 


Q ss_pred             cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH-Hhc--cchhhhc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL-ERE--KRLDAIV  347 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~  347 (437)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+...     ........ ...  .......
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-----QLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCchHhcccch
Confidence            122234577899999998876 78999999999999999999999986433211     11111000 000  0000000


Q ss_pred             c-----------c--cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 D-----------R--NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d-----------~--~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +           .  .......+..+..+.+++..||+.||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0           0  0001112345678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.2e-36  Score=294.75  Aligned_cols=266  Identities=19%  Similarity=0.269  Sum_probs=197.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeecC------
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  181 (437)
                      ..++|+..+.||+|+||.||++... +|+.||+|.+... ........+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999964 6899999998642 2233445678899999999999999999988543      


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ...++||||+.+ +|...+...      ++......++.|++.||+|||++   +++|+||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            346999999964 777766431      78888899999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh----------hHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV----------LLL  331 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~----------~~~  331 (437)
                      +++.....  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......          .+.
T Consensus       164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99865432  122334578899999999999999999999999999999999999864322110000          000


Q ss_pred             HHHH----HHHhc------cchhhhccccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          332 DHVK----KLERE------KRLDAIVDRNL----NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       332 ~~~~----~~~~~------~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ....    .....      .....+....+    ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000    00000      00000100000    000112345678899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.7e-36  Score=294.35  Aligned_cols=264  Identities=21%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC-CCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC--Cee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~  184 (437)
                      ..++|+..+.||+|+||.||+|.+. +|+.+|+|++... ........+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888899999999999999975 5889999988542 2233445677899999999 999999999998643  467


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||++ ++|..++...     .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 4888877542     478999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCc----ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH-
Q 013750          265 LVDVRKTN----VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-  338 (437)
Q Consensus       265 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  338 (437)
                      ........    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........     ........ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-----~~~~~~~~~  230 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-----LEKIIEVIG  230 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhC
Confidence            65433221    2223457889999998765 4578999999999999999999999864322110     00000000 


Q ss_pred             ----------hccchhhhccccc------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          339 ----------REKRLDAIVDRNL------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       339 ----------~~~~~~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                .......+++...      .....+..+..+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                      0000001111000      001111235678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-36  Score=289.50  Aligned_cols=264  Identities=20%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|+..+.||+|++|+||+|..+ +|+.||+|.+.... .....+.+.+|++++++++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888899999999999999975 68899999886432 22334678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceeccc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~  268 (437)
                      |++ ++|..++....  ...+++.....++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 47777765432  22357888889999999999999999   9999999999999985 56799999999976543


Q ss_pred             CCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--c----
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--K----  341 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----  341 (437)
                      .. ...+...++..|+|||.+.+. .++.++||||||+++|+|+||+.||........    ...........  .    
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFKIFRILGTPNEETWPG  230 (294)
T ss_pred             Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhhccc
Confidence            21 112234568899999988664 578999999999999999999999864322110    00000000000  0    


Q ss_pred             --chhhhcc--ccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          342 --RLDAIVD--RNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       342 --~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        .+.....  +....    ...+..+..+.+++.+|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000000  00000    011223457889999999999999999999986

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7e-36  Score=288.77  Aligned_cols=264  Identities=25%  Similarity=0.297  Sum_probs=196.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  186 (437)
                      .++|+..+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++.+++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467888999999999999999975 58999999986422 122234567899999999999999999998654  46899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+.+ +|.+++....   ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 7877776532   3489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc---c
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---R  342 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  342 (437)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..     .............   .
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESI  232 (309)
T ss_pred             CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhh
Confidence            43321 1222345788999999865 45799999999999999999999998643221     1111111110000   0


Q ss_pred             hhhhccc------cccCC----C---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 LDAIVDR------NLNKN----Y---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 ~~~~~d~------~l~~~----~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...+.+.      .+...    .   ....+..+.+++.+|++.||++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000      00000    0   01124577899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=304.71  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCC-EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.|.+..-||.|+||.||+++.++.. ..|.|++. ..+....++|+-|+++|+.+.||+||+|++.+.-.+.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            34556677999999999999987544 44566664 34567788999999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |.||-....+-+..   .+|...++..++.|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+.... ..
T Consensus       111 C~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST  183 (1187)
T ss_pred             cCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hH
Confidence            99999988876642   3488999999999999999999999   99999999999999999999999999986422 12


Q ss_pred             Cccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ......+.||+.|||||+..     ..+|++++||||||+.|.||..+.+|-...        .....+-.. .....+.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVllKi-aKSePPT  254 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKI-AKSEPPT  254 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHHHH-hhcCCCc
Confidence            22334578999999999875     467999999999999999999999885321        111111111 1111111


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAER  396 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  396 (437)
                      ++.       +......+.+++..|+.+||..||++.++++.--....+.+
T Consensus       255 Llq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  255 LLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            221       34455689999999999999999999999975443333333

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-37  Score=296.62  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=202.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEec-cCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~-~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  185 (437)
                      .+....|++.++||+||.+.||++...+.+.||+|++. ...+.+...-|.+|+..|.+++ |.+|+.|++|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34456788999999999999999998888889988775 3345667788999999999995 999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||-+ -+|...|......  ...| .++.+..||+.++.++|.+   +|||.||||.|+|+-. |.+||+|||+|..
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~a  508 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANA  508 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence            9999964 4888888765432  2345 6778899999999999999   9999999999999965 5899999999998


Q ss_pred             cccCCCcc-cccccccccccccccccCC-----------CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          266 VDVRKTNV-TTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       266 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      +..+.... ....+||..||+||.+...           +.+++|||||+||+||+|+.|+.||..          ....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----------~~n~  578 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----------IINQ  578 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----------HHHH
Confidence            76655443 3346799999999998532           246899999999999999999999852          1111


Q ss_pred             HHHHHhccchhhhccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .      ..+..+.|+...-+++.- ...++.++|+.||..||.+||+..|+++
T Consensus       579 ~------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  579 I------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1      123455555433333211 1123999999999999999999999985

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.1e-36  Score=288.12  Aligned_cols=256  Identities=20%  Similarity=0.254  Sum_probs=199.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      +|+..+.||+|+||.||++..    .++..||||.+....   .....+.+.+|++++.++ +|||++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999985    257889999986421   123345688999999999 599999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++++|..++...    ..+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999988642    2378889999999999999999999   99999999999999999999999999988


Q ss_pred             ecccCCCcccccccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ..............++..|+|||.+.+..  .+.++||||||+++|||++|..||........    ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~--  227 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHcc--
Confidence            65443322223345788999999987665  78899999999999999999999853221110    01111111100  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           .    ...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 -----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 0    11122233578899999999999999999999888776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.6e-36  Score=286.66  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=195.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      +|+..+.||+|+||.||++..    .+|..||+|++....   .....+.+.+|++++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999986    368999999986422   123346788899999999 599999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+++++|.+++....    .+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999987532    378888889999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ..............|+..|+|||.+...  .++.++||||||+++|+|++|..|+........    ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~--  227 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS--  227 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhcc--
Confidence            6543332223335588899999998753  468899999999999999999999864221111    11111111000  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                           .    ..++......+.+++.+||+.||++||     +..+++.
T Consensus       228 -----~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -----E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 0    111223345788999999999999997     5566654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=282.31  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=214.0

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      .++....+++....++.+|.||.||.|.+.      +.+.|-+|.++...++-....|+.|--++..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            456666777888889999999999999764      34567889888777777788899999999999999999999999


Q ss_pred             ecC-CeeEEEEecccCchhhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          179 TTP-TERLLVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       179 ~~~-~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      .+. ...+.+|.++.-|+|..||...+    .....+.-.+...++.|++.|++|||.+   +++|.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence            654 45688899999999999998443    2334577788889999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCCccc-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 013750          254 EAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~  331 (437)
                      .+||+|=.+++-+-+.+.+.. ...-.+..||+||.+....|+.++|||||||++|||+| |+.|+...++        .
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------f  505 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------F  505 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------H
Confidence            999999999986654443322 22235679999999999999999999999999999999 8888753221        1


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....+.++.++          ..+.+|+.+++.+|..||...|++||++++++.-|..
T Consensus       506 Em~~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  506 EMEHYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHHHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            111222222222          2356688899999999999999999999999987754

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=301.57  Aligned_cols=246  Identities=27%  Similarity=0.357  Sum_probs=197.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .|+..+-||.|+||.||-+++ .+...||||++.-..  +....+++++|+..|.+++|||++...|++......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            356678899999999999996 468899999996322  23445688999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||- ||-.+.+.-.   ..++....+..|..+.+.||+|||++   +.||||||+.||||++.+.+||+|||.|....+.
T Consensus       107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            995 4666766543   23478888899999999999999999   9999999999999999999999999999866532


Q ss_pred             CCccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                           ..++||+.|||||++.   .+.|+-++||||+|+...||...++|.--     .+.++-+.++.         ..
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-----MNAMSALYHIA---------QN  240 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----MNAMSALYHIA---------QN  240 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-----chHHHHHHHHH---------hc
Confidence                 2467999999999884   67899999999999999999998888521     11221111111         11


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      -.|.|.   ..+-+..+..++..|+++-|.+|||.++++..
T Consensus       241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            111121   34566789999999999999999999998853

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-35  Score=290.08  Aligned_cols=261  Identities=23%  Similarity=0.288  Sum_probs=192.3

Q ss_pred             Ceeeec--CcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      ..||+|  +||+||++... +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999974 69999999986432 233456788999999999999999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      +++.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999876532  2378889999999999999999999   99999999999999999999999998654322111110


Q ss_pred             ------cccccccccccccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH---------
Q 013750          274 ------TTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK---------  336 (437)
Q Consensus       274 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  336 (437)
                            .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........    .......         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCcccc
Confidence                  0011245679999999764  478999999999999999999999864321100    0000000         


Q ss_pred             -------HHh----------------ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          337 -------LER----------------EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       337 -------~~~----------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                             ...                ........+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   000                000000111111222234456789999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=303.18  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=199.7

Q ss_pred             CeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          118 NVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      -+||+|.||+||-|++.+ ...+|||.+.... ....+-+..|+.+-+.++|.|||+.+|.|.++...-+.||-.++|+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            479999999999999754 5679999987644 34456678999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceecccCCCcccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTT  275 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~  275 (437)
                      ..+|+..- +.-.-...+.-.+..||++||.|||++   .|+|||||-+|||++. .|.+||+|||-++.+.. -...+.
T Consensus       660 SsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE  734 (1226)
T ss_pred             HHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence            99998643 121125667777899999999999999   9999999999999975 68899999999986642 223345


Q ss_pred             cccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          276 QVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       276 ~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .+.||..|||||++..++  |+.++|||||||.+.||.||++||-....+.          ..+.+-+.      -+..+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------AAMFkVGm------yKvHP  798 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------AAMFKVGM------YKVHP  798 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----------Hhhhhhcc------eecCC
Confidence            577999999999998765  8899999999999999999999995221110          01111111      12235


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +++.+.+.+...++++|+..||.+||+++++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            567788889999999999999999999999984

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-36  Score=289.68  Aligned_cols=260  Identities=22%  Similarity=0.270  Sum_probs=191.0

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      +.+|.|+++.||++.. +++.||+|++... ......+.+.+|+++++.++||||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555555 6899999998753 2344567899999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC-----
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-----  271 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----  271 (437)
                      .+++.....  ..+++.....++.|++.||+|||++   +|+|+||||+||+++.++.++|+|||.+........     
T Consensus        87 ~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999876432  2378888899999999999999999   999999999999999999999999998875432111     


Q ss_pred             -cccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH----h-----
Q 013750          272 -NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE----R-----  339 (437)
Q Consensus       272 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~-----  339 (437)
                       .......++..|+|||.+..  ..++.++||||||+++|||++|+.||.......    ..........    .     
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCccccccCchh
Confidence             11122346778999999875  358899999999999999999999986432110    0111000000    0     


Q ss_pred             --ccchhh----hcccc----ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 --EKRLDA----IVDRN----LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 --~~~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        ......    ..++.    ...........++.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              000000    00000    0111223345678999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=276.27  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|+..+.||+|++|.||++... ++..||+|.+..... ....+.+.+|++++.+++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999875 578999999975432 13556889999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998754    3489999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      .. .....++..|+|||...+..++.++||||+|+++|+|++|+.|+.....       .... ..... .         
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~-~~~~~-~---------  214 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAAL-FRIVQ-D---------  214 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHH-HHHhc-c---------
Confidence            21 2234578899999999888889999999999999999999999863221       0000 01000 0         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            001112233468889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.4e-36  Score=294.35  Aligned_cols=265  Identities=20%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec----CCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  184 (437)
                      .++|+..+.||+|+||.||+|... +|..||+|++.... .......+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378888999999999999999965 58999999987432 23345677889999999999999999988753    3467


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+. ++|..++...    ..+++.....++.|++.||+|||++   +++|+||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 5888877542    2389999999999999999999999   99999999999999999999999999997


Q ss_pred             ecccCCCc---ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh-
Q 013750          265 LVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-  339 (437)
Q Consensus       265 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  339 (437)
                      ........   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......     .......... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~g~  230 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-----QLKLILSVLGS  230 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-----HHHHHHHHhCC
Confidence            65432211   1123468889999999865 458999999999999999999999996432211     0011110000 


Q ss_pred             ----------ccchhhhcccc-ccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          340 ----------EKRLDAIVDRN-LNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       340 ----------~~~~~~~~d~~-l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                                ........+.. ....     ..+..+..+.+++.+||+.+|++||++.+++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                      00000011000 0001     1123457899999999999999999999998743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-36  Score=288.04  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=194.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ..||+|+||.||++..+ ++..||+|++... .......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            56999999999999874 6899999988542 234566788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++...     .+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++....... .....
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~  175 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  175 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence            9877532     378899999999999999999999   99999999999999999999999999987554322 11223


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..||......     ..   ......      .....+..  .
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~---~~~~~~------~~~~~~~~--~  239 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KA---MKMIRD------NLPPKLKN--L  239 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHh------hCCcccCC--c
Confidence            45788999999998888999999999999999999999998632211     01   111100      00011100  1


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...+..+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            123346788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=280.02  Aligned_cols=261  Identities=24%  Similarity=0.339  Sum_probs=194.3

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhc---ccccceeeeeeeecCCe-----
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  183 (437)
                      |++.+.||+|+||.||+|..+ +++.||+|++..... ......+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            556789999999999999986 489999999974322 22234566788777665   59999999999987776     


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .+++|||+.+ +|.+++.....  ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999974 78888765332  2489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|||++|..||.......    ...............
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  228 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFDVIGLPSEE  228 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHHHcCCCChH
Confidence            86543221  122347889999999999899999999999999999999998886432211    011111110000000


Q ss_pred             ---------hhhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 ---------DAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                               .........   ....++....+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     000000000   1111234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.5e-36  Score=281.93  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=197.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCC----CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      +|.+.+.||+|+||.||++.... +..+++|.++...    .......+..|+.+++.++|||++++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999998753 4556666654321    223344677899999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876544455689999999999999999999999   9999999999999986 469999999987653


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....        ........         
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~---------  218 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIV---------  218 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHH---------
Confidence            322 122234578899999999888899999999999999999999999853211        01111110         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      . ......+...+..+.+++.+||+.+|++||++.|+++
T Consensus       219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            0 0111123345568899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.6e-35  Score=277.96  Aligned_cols=248  Identities=21%  Similarity=0.238  Sum_probs=190.6

Q ss_pred             HHHHHhcCCCCCCee--eecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          106 ELQLATDNFSEKNVL--GQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       106 e~~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      +.....++|++.+.+  |+|+||.||++..+ ++..+|+|.+......    .  .|+.....+ +|||++++++++...
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~--~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A--IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            344445677776666  99999999999964 6888999988642211    1  122222222 799999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeec
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDF  260 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Df  260 (437)
                      +..++||||+++++|.+++....    .+++..+..++.|+++||.|||+.   +++|+||||+||+++.++ .++|+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            99999999999999999987532    489999999999999999999999   999999999999999998 9999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++......     ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .....+....   
T Consensus       155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~---  223 (267)
T PHA03390        155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ---  223 (267)
T ss_pred             ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh---
Confidence            998765422     12357889999999999899999999999999999999999997332211   1111111111   


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~  386 (437)
                             ...  .......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       224 -------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -------QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -------ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                   000  0112234568899999999999999996 688874

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-36  Score=281.34  Aligned_cols=245  Identities=19%  Similarity=0.228  Sum_probs=188.9

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHH-HhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|... +|+.||+|++.....  ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999974 589999999864321  12223445555544 455899999999999999999999999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      ++|..++....    .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999987532    378888999999999999999999   999999999999999999999999999875432     


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..||......     ..   ....... ..      ....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~---~~~~~~~-~~------~~~~  214 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AV---FDNILSR-RI------NWPE  214 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HH---HHHHHhc-cc------CCCC
Confidence            22345788999999998888999999999999999999999998643211     01   1111000 00      0011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ......+..+.+++.+||+.+|++||++.++.+.|.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            112234568899999999999999998876665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.7e-36  Score=284.97  Aligned_cols=249  Identities=23%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|...+.||+|+||.||++... +|..||+|++....  .....+.+.+|++++.+++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999975 68999999986422  2334567889999999998 99999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999987643    489999999999999999999999   99999999999999999999999999988654


Q ss_pred             cCCC-------------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          268 VRKT-------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       268 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      ....                   .......++..|+|||......++.++|+||||++++++++|+.|+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            3221                   1122345788999999998888999999999999999999999998743210     


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM----SEVVR  386 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~----~evl~  386 (437)
                         .......           ......+...+..+.+++.+||+.+|++||++    +++++
T Consensus       229 ---~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ---LTFQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               0011110           01112223335688999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=289.00  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=200.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCC-----eeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  185 (437)
                      +|.+.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777899999999999999975 489999999875332 344567899999999999999999999997775     789


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ++|||+++ +|..++....    .+++..+..++.+++.||+|||++   +++|+||||.||+++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 7887776432    589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCC--cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--
Q 013750          266 VDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--  340 (437)
Q Consensus       266 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  340 (437)
                      ......  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......     ....+......  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~  227 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-----QLNLIVEVLGTPS  227 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHHHHhcCCCC
Confidence            654321  122334578899999999887 78999999999999999999999986543211     01111110000  


Q ss_pred             ---------cchhhhccc-ccc-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 ---------KRLDAIVDR-NLN-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ---------~~~~~~~d~-~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                               ......+.. ...     ....+..+..+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     000000000 000     00112245678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-35  Score=287.32  Aligned_cols=248  Identities=27%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |+..+.||+|+||.||+|... ++..+|+|.+...  ......+++.+|+++++.++|+|++++.+++......++|+||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555688999999999999975 5789999988632  2223345788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +. |++.+.+...   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus        97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            97 5777766532   23478899999999999999999999   9999999999999999999999999998765422 


Q ss_pred             Cccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          271 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                          ....++..|+|||.+.   ...++.++|||||||++|||++|..|+......     ..   ....... ..    
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~---~~~~~~~-~~----  231 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA---LYHIAQN-ES----  231 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HH---HHHHhhc-CC----
Confidence                2345788999999974   356788999999999999999999997532110     00   0000000 00    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       +   ..........+.+++.+||+.+|++||++.++++....
T Consensus       232 -~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         232 -P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             -C---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence             0   00112344578899999999999999999999976554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-36  Score=294.75  Aligned_cols=262  Identities=20%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC-----Ce
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  183 (437)
                      .++|...+.||+|+||+||++... ++..||||.+.... .......+.+|+.++..++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999964 68999999986422 233345677899999999999999999988644     34


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++++||+. ++|..++...    ..+++.....++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 6787777542    2388999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--  340 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  340 (437)
                      ....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+...     ...........  
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~  229 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-----QLKLITELLGSPS  229 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHHHHhCCCC
Confidence            8654322 22233457889999998865 468999999999999999999999986432111     00000000000  


Q ss_pred             ---------cchhhhc-------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 ---------KRLDAIV-------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ---------~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                               .......       +... ....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                     0000000       0000 00112345678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-35  Score=285.86  Aligned_cols=264  Identities=25%  Similarity=0.319  Sum_probs=192.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      .++|+..+.||+|+||.||+|... +++.+|+|++..... ......+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578889999999999999999975 589999999864322 223446789999999999999999999875433      


Q ss_pred             --eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          183 --ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       183 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                        ..++|+||+.. ++...+...   ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46899999975 555555432   23489999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcc----------cccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh
Q 013750          261 GLAKLVDVRKTNV----------TTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       261 gla~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  329 (437)
                      |++..........          .+...++..|+|||.+.+. .++.++||||||+++|||++|+.||.......     
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-----  234 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-----  234 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            9997654322111          1223467889999987654 57899999999999999999999986433211     


Q ss_pred             HHHHHHHHHhc---------cchhhhccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          330 LLDHVKKLERE---------KRLDAIVDRNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       330 ~~~~~~~~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...........         .......+.......+       ......+.+++.+|++.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11111110000         0000000000000000       112257889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.6e-36  Score=314.51  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=189.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-----
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----  181 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  181 (437)
                      ..-.++|++.++||+||||.|||++++ ||+.||||++.-..+........+|+.++++++|||||+++....+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            445678888999999999999999976 89999999997544455566788999999999999999886322100     


Q ss_pred             --------------------------------------------------------------------------------
Q 013750          182 --------------------------------------------------------------------------------  181 (437)
Q Consensus       182 --------------------------------------------------------------------------------  181 (437)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 013750          182 ----------------------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE  227 (437)
Q Consensus       182 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~  227 (437)
                                                        ..+|+-||||+.-++.+++++.....   .-...++++.+|++||+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence                                              11356678887777777776543211   35567889999999999


Q ss_pred             HHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc-----------------cCCCccccccccccccccccccc
Q 013750          228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----------------VRKTNVTTQVRGTMGHIAPEYLS  290 (437)
Q Consensus       228 yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~  290 (437)
                      |+|+.   ++|||||||.||+||++..+||+|||+|+...                 .......+..+||.-|+|||.+.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998721                 00111234567999999999997


Q ss_pred             CC---CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc--CCCCHHHHHHHHH
Q 013750          291 TG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN--KNYNIQEVETMIQ  365 (437)
Q Consensus       291 ~~---~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~  365 (437)
                      +.   +|+.|+|+||+|++++||+.   ||+....                +...+..+-++.+.  ..+..+....=.+
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----------------RASILTNLRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHH----------------HHHHHHhcccCCCCCCcccccccchHHHH
Confidence            65   49999999999999999986   4543221                11111222222221  1223334445678


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 013750          366 VALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       366 l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ++.++++.||++|||+.|++.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999974

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.3e-35  Score=279.89  Aligned_cols=243  Identities=25%  Similarity=0.323  Sum_probs=186.7

Q ss_pred             eeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHH---HHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          119 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEM---ISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      .||+|+||.||++... +++.||+|.+.....  ......+..|..+   ++...|||++.+.+++...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999999864321  1222234445443   444579999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|..++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999888643    3489999999999999999999999   99999999999999999999999999987543221  


Q ss_pred             ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                       .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||..........      .......      ..   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~------~~---  215 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRMTLT------MA---  215 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH------HHHHhhc------cC---
Confidence             1234589999999999754 58999999999999999999999986432211100      0000000      01   


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                       ...+...+..+.+++.+|++.+|.+||     ++.++++.
T Consensus       216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             111222346899999999999999999     99999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.4e-35  Score=283.85  Aligned_cols=245  Identities=26%  Similarity=0.359  Sum_probs=191.0

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |...+.||+|+||+||+|+.. +|..||+|.+....  .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999974 58899999986422  123345788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +. +++.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 4666666542   23488999999999999999999999   999999999999999999999999999864321  


Q ss_pred             Cccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          271 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                         .....++..|+|||.+.   ...++.++||||||+++|||++|..|+.....     ...   ........ ..   
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~---~~~~~~~~-~~---  238 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA---LYHIAQND-SP---  238 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHH---HHHHHhcC-CC---
Confidence               12345788999999984   45688999999999999999999999853221     111   11111100 00   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           .......+..+.+++.+||+.+|++||++.+++..
T Consensus       239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00111223468899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-36  Score=294.64  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=208.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .-...|.+...||+|.|++|.++++. ++..||||.+.+... ....+.+.+|+++|+.++|||||+++.+..+...+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34577888999999999999999964 699999999976442 3334568899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+.+|.+.+|+.....    ........++.|+..|++|||++   .|+|||||++||||+.+.++||+|||++..+
T Consensus       133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            9999999999999986543    45577888999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .  ........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+......-.                 +.
T Consensus       206 ~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~r  266 (596)
T KOG0586|consen  206 D--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PR  266 (596)
T ss_pred             c--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------ch
Confidence            6  3334455789999999999998876 68999999999999999999999854432211                 11


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ++...++  ++.-...++.+++++++-.+|.+|++++++-+-
T Consensus       267 vl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            2222222  123344578889999999999999999998754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=282.82  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=204.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      |.+..+||+|+||.||++.++ +|+.+|||.+..   ....++..+|+.++.+...|++|+.+|.+.....+++|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            556788999999999999975 699999999864   3457889999999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      .|+..+.++.   ...+++...+-.++...++||+|||..   .=+|||||+.||||+.+|.+||+|||.+..+......
T Consensus       112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            9999999876   345689999999999999999999999   8899999999999999999999999999866432222


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                       .....||+.|||||++..-.|+.++||||+|+...||..|++|+...-+-.              .--.+..  .+...
T Consensus       186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIFMIPT--~PPPT  248 (502)
T KOG0574|consen  186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIFMIPT--KPPPT  248 (502)
T ss_pred             -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeEeccC--CCCCC
Confidence             223579999999999999999999999999999999999999985321100              0000000  11111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      -..+..-+.++.++++.|+-++|++|-|+.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            12244556789999999999999999999998864

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-35  Score=289.62  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      .++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999964 68999999986422 2333456889999999999999999999986543      


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++|+||+.. +|..+..      ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999964 5555432      2378899999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ............
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~  234 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVP  234 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCC
Confidence            8754321    123457889999999876 468999999999999999999999997532211     111111000000


Q ss_pred             -----------chhhhccc--c-ccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 -----------RLDAIVDR--N-LNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 -----------~~~~~~d~--~-l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                 ........  . .....   .+.....+.+++.+||+.||++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       00000000  0 00000   01223568899999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=278.50  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+.... .....+.+..|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999976 48999999987543 2334567889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      + ++|.+++....   ..+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 58999887642   3489999999999999999999999   999999999999999999999999999986543222


Q ss_pred             cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc---chhhh-
Q 013750          272 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---RLDAI-  346 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  346 (437)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......     ............   ..... 
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-----QLFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHHHhCCCcHHHHHhhc
Confidence             22233457789999998776 78999999999999999999999886433111     111111100000   00000 


Q ss_pred             ----cccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 ----VDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ----~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          .+....       ....+.....+.+++..||+.+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                000000       0001122467999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=267.41  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEeccc
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      .....||+|+.|.|+++..+ +|...|||.+.......+.++.+..++++.+.+ .|+||+.+||+..+....+-||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34566999999999999976 589999999987666667778888888776654 9999999999999999999999985


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      . .++.++....   .++++...-++...+.+||.||.+++  +|+|||+||+|||+|+.|++|+||||++..+-.  +.
T Consensus       175 ~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk  246 (391)
T KOG0983|consen  175 T-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK  246 (391)
T ss_pred             H-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence            3 4555555432   33677777788999999999999886  899999999999999999999999999986643  33


Q ss_pred             cccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          273 VTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ..+...|.+.|||||.+.   ...|+.++||||||+.++||.||+.||.....+    ......+..     ...    +
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~ltkvln-----~eP----P  313 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEVLTKVLN-----EEP----P  313 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHHHHHHHh-----cCC----C
Confidence            445567899999999985   446899999999999999999999999753322    111111111     011    1


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .|...  ..-+..++++...|+++|+.+||...++++
T Consensus       314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11111  113458999999999999999999999885

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-35  Score=286.29  Aligned_cols=266  Identities=23%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      ..++...+++|...+.||+|+||.||++.. .+++.||+|++.... +....+.+.+|+.++.+++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            456777889999999999999999999986 468999999986432 223346788999999999999999999988543


Q ss_pred             ------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          182 ------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       182 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                            ...+++++++ +++|.+++...     .+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  3467888876 67887776532     378999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      +|+|||++.....    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     .....
T Consensus       160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-----~~~~~  230 (345)
T cd07877         160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLI  230 (345)
T ss_pred             EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH
Confidence            9999999875432    1223457889999998866 468899999999999999999999986432111     00000


Q ss_pred             HHHHh---ccchhhh-----------ccccccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          335 KKLER---EKRLDAI-----------VDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~~---~~~~~~~-----------~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....   ......+           ........+   .......+.+++..|++.||++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00000   0000000           000000000   00124568899999999999999999999854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.4e-35  Score=285.33  Aligned_cols=263  Identities=22%  Similarity=0.249  Sum_probs=194.1

Q ss_pred             cCCC-CCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCc-------------chHHHHHHHHHHHhcccccceeeee
Q 013750          112 DNFS-EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG-------------GDAAFQREVEMISVAVHRNLLRLIG  176 (437)
Q Consensus       112 ~~~~-~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-------------~~~~~~~E~~~l~~l~H~niv~l~g  176 (437)
                      ++|. ..+.||+|+||+||+|... +++.||+|.+.......             ....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 3577999999999999965 68999999986432111             1125779999999999999999999


Q ss_pred             eeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       177 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      ++...+..+++|||++ ++|.+++...    ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999997 5888887642    2378899999999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCC-------------CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          257 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       257 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      |+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|..||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654111             1111123467889999998764 468999999999999999999999864332


Q ss_pred             cccchhhHHHHHHHHHhccc---hhhhcc------------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          323 EEEDDVLLLDHVKKLEREKR---LDAIVD------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~---~~~~~d------------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .     .....+........   .....+            ... .......+..+.+++..|++.+|++||++.|++..
T Consensus       240 ~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 I-----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H-----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1     11111111100000   000000            000 00011234678899999999999999999999964


Q ss_pred             H
Q 013750          388 L  388 (437)
Q Consensus       388 L  388 (437)
                      -
T Consensus       314 ~  314 (335)
T PTZ00024        314 E  314 (335)
T ss_pred             c
Confidence            3

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=297.44  Aligned_cols=203  Identities=27%  Similarity=0.337  Sum_probs=175.9

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC------eeEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ERLLV  187 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv  187 (437)
                      ...+.||+|+||.||+|+++ +|+.||||.+.+.......+...+|++++++++|||||+++++-.+..      ...++
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            44578999999999999964 699999999987666777888999999999999999999998765544      56899


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec--C--CCcEEEeecCCc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--E--DFEAVVGDFGLA  263 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~--~--~~~~kl~Dfgla  263 (437)
                      ||||.+|||...|+...+ ..-|+....+.+..+++.||.|||++   +|+||||||.||++-  +  .-.-||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999988764 34489999999999999999999999   999999999999993  2  234699999999


Q ss_pred             eecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCccc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLE  323 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~  323 (437)
                      +..+.  .......+||..|++||.... +.|+..+|.|||||++||..||..||.....+
T Consensus       172 rel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            96653  346667889999999999984 88999999999999999999999999754443

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=284.09  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             CHHHHHHHh-cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          103 SWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       103 ~~~e~~~~~-~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      .|-|.+..+ +.|..-++||+|+||.||-++.+ +|.-+|.|++.+..  ..+.....+.|-.+|.+++.+.||.+--.+
T Consensus       175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            334444433 45777899999999999999865 69999999885422  233445677899999999999999999889


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      .+.+.+++|+..|.+|+|..++.+..  .+.++....+-++.+|+-||++||..   +|+.|||||+|||||+.|+++|+
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEee
Confidence            99999999999999999999998764  35689999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      |.|+|..+...  ......+||.+|||||++.++.|+...|+||+||+||||+.|+.||........          .  
T Consensus       330 DLGLAvei~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------~--  395 (591)
T KOG0986|consen  330 DLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------R--  395 (591)
T ss_pred             ccceEEecCCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------H--
Confidence            99999976533  333444799999999999999999999999999999999999999963221110          0  


Q ss_pred             hccchhhhccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          339 REKRLDAIVDRNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       339 ~~~~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                            +-+|.+.   ...++..-+++..+|....+++||.+|--..
T Consensus       396 ------eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  396 ------EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ------HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                  0111111   1123344456778888888999999986443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=283.13  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC----
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----  182 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  182 (437)
                      ...++|+..+.||+|+||.||++... ++..||||++.... .....+.+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999864 68999999985422 2233456889999999999999999999886553    


Q ss_pred             --eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          183 --ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       183 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                        ..++||||+ +++|..++..     ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence              458999998 6688877653     2378999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh-------HHH
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL-------LLD  332 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-------~~~  332 (437)
                      |++......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............       ...
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999754321    123356889999999876 45889999999999999999999998643221000000       000


Q ss_pred             HHHHHHhccchhhhcc--cccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 HVKKLEREKRLDAIVD--RNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +...... ........  +...    ..........+.+++.+|++.||++|||+.+++.
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000 00000000  0000    0011123446889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.2e-35  Score=286.93  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC---------
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP---------  181 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------  181 (437)
                      .+|...+.||.|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            67888899999999999999974 58899999986533 34556788999999999999999999776543         


Q ss_pred             -----CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CCCcE
Q 013750          182 -----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEA  255 (437)
Q Consensus       182 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~  255 (437)
                           ...++|+||++ ++|..++...     .+++...+.++.||+.||.|||+.   +++||||||+||+++ +++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 4887776532     378899999999999999999999   999999999999997 45678


Q ss_pred             EEeecCCceecccCCCc--ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 013750          256 VVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  332 (437)
                      +|+|||++.........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........    ..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~----~~  230 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM----QL  230 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH
Confidence            99999999865322111  1122357889999998754 45789999999999999999999999643221110    00


Q ss_pred             HHHHHHh------cc---chhhhcc-ccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 HVKKLER------EK---RLDAIVD-RNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ~~~~~~~------~~---~~~~~~d-~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .......      ..   ....... .....     ...+.....+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000000      00   0000000 00000     001123357889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-34  Score=283.26  Aligned_cols=266  Identities=20%  Similarity=0.234  Sum_probs=189.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-C--CCEEEEEEeccCC-CCcchHHHHHHHHHHHhc-ccccceeeeeeeecC----Ce
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-D--GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP----TE  183 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  183 (437)
                      +|...+.||+|+||.||++... +  +..||+|++.... .....+.+.+|+.++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999975 3  6799999986422 223356788999999999 599999999876432    45


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .+++++|+. ++|..++...    ..+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678888886 5788877542    3488999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc---ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh-------HHH
Q 013750          264 KLVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL-------LLD  332 (437)
Q Consensus       264 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-------~~~  332 (437)
                      .........   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||............       ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            865432211   1223468899999998765 46899999999999999999999998643311000000       000


Q ss_pred             HHHHHHhccchh--hhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 HVKKLEREKRLD--AIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ~~~~~~~~~~~~--~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ............  ........   ....+.....+.+++.+|++.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000  00000000   0001112457899999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=317.69  Aligned_cols=253  Identities=26%  Similarity=0.337  Sum_probs=200.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +-++.....||.|.||.||.|.. ++|...|+|-+.-.. .........+|++++..++|||+|+.+|+-...+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34566778999999999999995 579999999875322 2344567789999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      |||++|+|.+.+.....    .+......+..|++.|++|||++   +||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999876432    56666667889999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc---cccccccccccccccccCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          269 RKTNV---TTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       269 ~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .....   .....||+.|||||.+.+.+   ...+.||||+||++.||+||++||.--+    +...+...+    ..+.
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----ne~aIMy~V----~~gh 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----NEWAIMYHV----AAGH 1458 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----chhHHHhHH----hccC
Confidence            43221   12357999999999997654   4678999999999999999999985221    111111111    1111


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .         +.+|...+.+-.+++..|+..||.+|-++.|+++.
T Consensus      1459 ~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 K---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         22344456678899999999999999888777653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=269.96  Aligned_cols=237  Identities=24%  Similarity=0.241  Sum_probs=192.2

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      ||+|+||.||++... +++.+|+|.+.....  ......+..|++++++++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999975 489999999865332  22456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccc
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ  276 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  276 (437)
                      .+++....    .+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            99987543    378999999999999999999998   99999999999999999999999999998654322 12233


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       277 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      ..++..|+|||...+...+.++|+||||+++||+++|..||.....     .   ........         .  ....+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~---~~~~~~~~---------~--~~~~~  213 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----K---EIYEKILK---------D--PLRFP  213 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---HHHHHHhc---------C--CCCCC
Confidence            4578899999999888899999999999999999999999864321     0   01111110         0  01122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSE  383 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~e  383 (437)
                      ...+..+.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            222468899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=274.08  Aligned_cols=243  Identities=23%  Similarity=0.280  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      --++|+..++||+|.||+|-+++-+ +|+.+|+|++++..  ..+....-+.|-++|...+||.+..|.-.+.+.+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467888999999999999999965 68999999997532  23344556688999999999999999888999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||..+|.|..+|.+.    ..++.....-+...|..||.|||+.   +|+.||||.+|.|||.+|++||+|||+++.-
T Consensus       246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999998763    3377778888899999999999999   9999999999999999999999999999853


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                       ......++.++||+.|+|||++....|+.++|+|.+||++|||++|+.||...+.+.     +...+            
T Consensus       319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LFeLI------------  380 (516)
T KOG0690|consen  319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LFELI------------  380 (516)
T ss_pred             -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HHHHH------------
Confidence             234445667899999999999999999999999999999999999999996432211     11110            


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP  379 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  379 (437)
                      +-..  -.++...+.+...|....+.+||.+|-
T Consensus       381 l~ed--~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMED--LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             Hhhh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            0000  112333445677788889999999994

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-34  Score=284.37  Aligned_cols=260  Identities=24%  Similarity=0.304  Sum_probs=195.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe----
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----  183 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  183 (437)
                      ..++|+..+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678889999999999999999975 57899999886422 22334567789999999999999999988766554    


Q ss_pred             --eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          184 --RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       184 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                        .++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 5688888764     2389999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ...........
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-----~~~~i~~~~~~  234 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-----QLKRIMNLVGT  234 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHhcCC
Confidence            99865322    223457889999999865 367899999999999999999999986432211     11111010000


Q ss_pred             -----------cchhhhccccc---cCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 -----------KRLDAIVDRNL---NKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 -----------~~~~~~~d~~l---~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                 ......+....   ...   .....+..+.+++.+|++.+|++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                       00000000000   000   001225688999999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.1e-34  Score=296.83  Aligned_cols=261  Identities=18%  Similarity=0.230  Sum_probs=170.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-C----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeee------e
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-D----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF------C  178 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~  178 (437)
                      ..++|+..+.||+|+||.||+|++. +    +..||+|++....   ..+.+..+  .+....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            5678999999999999999999975 4    6899999886422   12222221  1111122222222111      3


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPG----------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV  242 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl  242 (437)
                      ......++||||+++++|.+++......                ........+..++.|++.||+|||++   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            4567889999999999999988643210                01112334567899999999999999   9999999


Q ss_pred             CCCCeeecC-CCcEEEeecCCceecccCCCcccccccccccccccccccCC----------------------CCCCchh
Q 013750          243 KAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----------------------KSSERTD  299 (437)
Q Consensus       243 k~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  299 (437)
                      ||+|||+++ ++.+||+|||+++..............+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 57999999999986544333344456789999999965322                      2345679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc-h---hhhccccccCC----C--CHHHHHHHHHHHHH
Q 013750          300 VFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR-L---DAIVDRNLNKN----Y--NIQEVETMIQVALL  369 (437)
Q Consensus       300 v~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~d~~l~~~----~--~~~~~~~l~~l~~~  369 (437)
                      ||||||++|||+++..+.+..         .......+...+. .   .....+....+    +  .........+|+.+
T Consensus       362 VwSlGviL~el~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            999999999999976654311         1111111111100 0   01111110000    0  00011245589999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 013750          370 CTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       370 Cl~~dp~~RPs~~evl~~  387 (437)
                      |++.||++|||+.++++.
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999974

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.2e-34  Score=264.66  Aligned_cols=220  Identities=20%  Similarity=0.164  Sum_probs=175.8

Q ss_pred             cCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhhhhhh
Q 013750          123 GGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR  201 (437)
Q Consensus       123 G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~  201 (437)
                      |.||.||++... +++.||+|++....      .+.+|...+....|||++++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            889999999974 68999999986432      23445555666679999999999999999999999999999999886


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccc
Q 013750          202 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM  281 (437)
Q Consensus       202 ~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~  281 (437)
                      ...    .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+......    .....++.
T Consensus        78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~  146 (237)
T cd05576          78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN  146 (237)
T ss_pred             Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence            532    388999999999999999999999   9999999999999999999999999987654321    12234567


Q ss_pred             cccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHH
Q 013750          282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE  361 (437)
Q Consensus       282 ~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  361 (437)
                      .|+|||.+....++.++||||+|+++|||++|+.|+........                       .......+.....
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~  203 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------------THTTLNIPEWVSE  203 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------------cccccCCcccCCH
Confidence            89999999888899999999999999999999987642211000                       0000011222345


Q ss_pred             HHHHHHHHhccCCCCCCCCHH
Q 013750          362 TMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       362 ~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      .+.+++.+|++.||++||++.
T Consensus       204 ~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCCC
Confidence            788999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-33  Score=296.60  Aligned_cols=147  Identities=26%  Similarity=0.346  Sum_probs=130.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....  .......+..|+.+++.++||||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367888899999999999999976 68999999986422  123346788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |||+++++|..++....    .+++...+.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987533    378888999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-34  Score=261.37  Aligned_cols=275  Identities=19%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeec-CC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PT  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~  182 (437)
                      ....|+....||+|.||.||++.-++     ...+|+|+++...+ .+-.....+|+.++++++|||++.|..++.+ +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            34678888999999999999997432     23799999974322 2345567899999999999999999999877 77


Q ss_pred             eeEEEEecccCchhhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC----CcEEE
Q 013750          183 ERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVV  257 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~----~~~kl  257 (437)
                      ..++++||.++ +|...++... .....++-.....|+.||+.|+.|||++   =++||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            88999999987 5655554332 2224578888999999999999999999   69999999999999887    99999


Q ss_pred             eecCCceecccCCCc--ccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccch-hhHHHH
Q 013750          258 GDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-VLLLDH  333 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~-~~~~~~  333 (437)
                      +|+|+++.+...-..  .....+-|.+|.|||.+.+.. ||.+.|||+.||++.||+|-++.|.......... ....+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987643222  223456799999999998765 8999999999999999999988886543332221 111111


Q ss_pred             HHHHHh------ccchhh----------hcccc--ccCCCC-HH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          334 VKKLER------EKRLDA----------IVDRN--LNKNYN-IQ-------EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       334 ~~~~~~------~~~~~~----------~~d~~--l~~~~~-~~-------~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..+...      ....+.          +-+-+  ...+.. ..       -....++|...+++.||.+|.|+++.++.
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            111110      000000          00000  000000 00       01236789999999999999999998864


Q ss_pred             H
Q 013750          388 L  388 (437)
Q Consensus       388 L  388 (437)
                      .
T Consensus       338 ~  338 (438)
T KOG0666|consen  338 P  338 (438)
T ss_pred             c
Confidence            3

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=265.77  Aligned_cols=256  Identities=21%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHH-HHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++....||.|+||+|+|-.++ .|+..|||++.......+.++|+.|.+. ++.-+.||||+++|.+......++-||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            334567999999999999875 6999999999876656777889999996 55668999999999999999999999999


Q ss_pred             cCchhhhhhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          192 QNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       192 ~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +- ||..+... +.-.+..++....-+|..-..+||.||-...  .|||||+||+||||+..|.+||||||++..+.  +
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~  220 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--D  220 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH--H
Confidence            54 55544322 1223344777777788888899999998775  89999999999999999999999999997653  2


Q ss_pred             CcccccccccccccccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      +...+..+|...|||||.+...  .|+.+|||||||+.|||+.||..|+...+.       ..+.+.....+. .     
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gd-p-----  287 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGD-P-----  287 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCC-C-----
Confidence            3334556788899999999633  489999999999999999999999863211       222222221111 1     


Q ss_pred             ccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          349 RNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       349 ~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +.+..+. ..+.+..+..++..|+-+|..+||+..++.++
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1111111 23355689999999999999999999998753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.5e-33  Score=258.36  Aligned_cols=238  Identities=27%  Similarity=0.324  Sum_probs=192.1

Q ss_pred             CcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhhhhhhh
Q 013750          124 GFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE  202 (437)
Q Consensus       124 ~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~  202 (437)
                      +||.||+|... +|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999997544332267899999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccccccccccc
Q 013750          203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG  282 (437)
Q Consensus       203 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~  282 (437)
                      ...    +++.....++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..
T Consensus        81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            432    78899999999999999999999   99999999999999999999999999998765432  2234457889


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCH-HHHH
Q 013750          283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-QEVE  361 (437)
Q Consensus       283 y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~  361 (437)
                      |++||.+....++.++||||||+++++|++|..|+.....    ....   ......         ......... ..+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~---~~~~~~---------~~~~~~~~~~~~~~  215 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLEL---FKKIGK---------PKPPFPPPEWKISP  215 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHH---HHHHhc---------cCCCCccccccCCH
Confidence            9999999988899999999999999999999999864211    0001   111110         000000000 0446


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          362 TMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       362 ~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .+.+++.+|++.+|++||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            8999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=300.06  Aligned_cols=258  Identities=22%  Similarity=0.281  Sum_probs=209.1

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ..++....++|.+.++||+|+||.|..++.+ +++.||+|++.+..  .......|..|-++|.--+.+=|++|.-.+.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4677788899999999999999999999975 58899999997622  13345678899999999999999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      .+++|+|||||+||+|-.++..+.    .++...+..++..|.-||.-||+.   |+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998754    377888888999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCccccccccccccccccccc----C-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLS----T-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      |.+-.+..+..-.....+|||.|++||++.    + +.|+..+|+||+||++|||+.|..||...+...        -. 
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY-  290 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TY-  290 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HH-
Confidence            999888776666666788999999999985    3 679999999999999999999999997432211        11 


Q ss_pred             HHHhccchhhhccccccCCCC--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYN--IQEVETMIQVALLCTQASPEDRPA---MSEVVR  386 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~  386 (437)
                              ..+++..-.-.+|  .+.++...+||++-+. +|+.|-.   ++++-.
T Consensus       291 --------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  291 --------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             --------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                    1111111111222  2345677778776663 7888877   766653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=268.01  Aligned_cols=244  Identities=24%  Similarity=0.312  Sum_probs=195.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ....+|....+||+|+||.|.++.-++ .+.+|||++++..  ..+..+--..|-++|+.. +-|.++.|..++.+-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            344678889999999999999998764 5789999997633  122333344566677755 578899999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |+||||+.+|+|-.++.+...    +....+.-+|..||-||-|||++   +|+.||||.+||+||.+|++||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence            999999999999999987654    66777888999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .-- -....+..++||+.|+|||++..++|+..+|+|||||+||||+.|++||+..+.++     +.            .
T Consensus       499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----lF------------~  560 (683)
T KOG0696|consen  499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LF------------Q  560 (683)
T ss_pred             ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HH------------H
Confidence            432 23334556899999999999999999999999999999999999999998643221     11            1


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP  379 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  379 (437)
                      .+.+..  -.++...+.+...+...-+.+.|.+|-
T Consensus       561 aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 AIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            122211  123455566778888888999999994

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=253.23  Aligned_cols=264  Identities=20%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecC
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP  181 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  181 (437)
                      +.+.-..|+     +.||+|+|+.|--++ ..+|.+||||++.+.. ........+|++++...+ |+||+.|++++.++
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            345554554     579999999999988 5789999999998753 556778889999999885 99999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEe
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVG  258 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~  258 (437)
                      ...|||||-|.+|+|..++...+-    ++...+.++..+|+.||.|||.+   +|.||||||+|||-.+...   +||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            999999999999999999986543    88899999999999999999999   9999999999999965443   7999


Q ss_pred             ecCCceecccC--CCcc----ccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc-
Q 013750          259 DFGLAKLVDVR--KTNV----TTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-  326 (437)
Q Consensus       259 Dfgla~~~~~~--~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~-  326 (437)
                      ||.+.......  -+..    ....+|+..|||||+..     ...|+.++|.|||||++|-|++|-.||.......-. 
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            99987643221  1111    12356888999999874     345889999999999999999999999765432110 


Q ss_pred             -hhhHHHHHHHHHhccchhhhccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          327 -DVLLLDHVKKLEREKRLDAIVDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       327 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ........+..    ....+-+..  -+++.    ..+.+..+++...+-.|+.+|-++.++++
T Consensus       302 drGe~Cr~CQ~~----LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNK----LFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHH----HHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             00001111110    001111111  12232    23456678888888899999999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=278.42  Aligned_cols=240  Identities=21%  Similarity=0.270  Sum_probs=192.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|++.+..     .+-.+|+.++... +|||++++.+.+.+..+.++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            56788888899999999999986 468899999997542     1223566655544 7999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee-cCCCcEEEeecCCceecc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll-~~~~~~kl~Dfgla~~~~  267 (437)
                      |++.++-+.+.+.....    .. ..+..|+.+|+.|+.|||++   +++||||||+|||+ ++.++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999988877765332    22 66778999999999999999   99999999999999 588999999999998765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .+    ....+-|..|.|||+.....|++++||||||++||+|++|+.||......    .                ++.
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~----------------ei~  523 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----I----------------EIH  523 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----H----------------HHH
Confidence            44    22335688999999999999999999999999999999999999743221    0                111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....+.+....+....+|+.+|++.||.+||+|.++...
T Consensus       524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            1111122234455688999999999999999999999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=277.33  Aligned_cols=263  Identities=20%  Similarity=0.210  Sum_probs=181.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-----------------CCCCEEEEEEeccCCCCcchHH--------------HHH
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-----------------ADGTKVAVKRLTDFESPGGDAA--------------FQR  158 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~~--------------~~~  158 (437)
                      ..++|++.++||+|+||+||+|.+                 .+++.||||++.... ....++              +..
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence            477899999999999999999974                 235689999986422 222223              334


Q ss_pred             HHHHHHhcccccc-----eeeeeeeec--------CCeeEEEEecccCchhhhhhhhcCC--------------------
Q 013750          159 EVEMISVAVHRNL-----LRLIGFCTT--------PTERLLVYPFMQNLSVAYRLREIKP--------------------  205 (437)
Q Consensus       159 E~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------  205 (437)
                      |+.++.+++|.|+     ++++++|..        ....+|||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777776654     677888753        3467999999999999999874211                    


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccc
Q 013750          206 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA  285 (437)
Q Consensus       206 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a  285 (437)
                      ....++|..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            112357788899999999999999999   99999999999999999999999999997543322222222335789999


Q ss_pred             cccccCCCC----------------------CCchhhHHHHHHHHHHHhCCC-CCCCCccccc----chhhHHHHHHHHH
Q 013750          286 PEYLSTGKS----------------------SERTDVFGYGIMLLELVTGQR-AIDFSRLEEE----DDVLLLDHVKKLE  338 (437)
Q Consensus       286 PE~~~~~~~----------------------~~~sDv~s~Gv~l~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~  338 (437)
                      ||.+.....                      ..+.||||+||++|||++|.. |+.....-..    .......|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            998754321                      234799999999999999875 5532110000    0000000100  0


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP---EDRPAMSEVVR  386 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPs~~evl~  386 (437)
                      ..        ....-...........+++.+++..+|   .+|+|+.|+++
T Consensus       457 ~~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KG--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cc--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00        001111112234578899999999766   68999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=262.73  Aligned_cols=265  Identities=20%  Similarity=0.226  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc--c----cceeeeeeeecCC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--R----NLLRLIGFCTTPT  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~  182 (437)
                      .+++|.+...+|+|.||.|-.+.+. .+..||+|+++..  ..-.+.-+-|++++.++.+  |    -+|.+.+|+.-.+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            3788999999999999999999865 4789999999753  2334566789999999843  2    2678889999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec------------
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD------------  250 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~------------  250 (437)
                      +.|+|+|.+ +-|+.+++.+.  +..+++...+..|+.|++++++|||+.   +++|.||||+|||+.            
T Consensus       165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            999999998 45889998763  345588889999999999999999999   999999999999993            


Q ss_pred             --------CCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          251 --------EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       251 --------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                              .+..++++|||.|++-...    .+..+.|-.|.|||++.+-.++..+||||+||||.|+.||...|+..+.
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                    2445899999999865432    2456789999999999999999999999999999999999999987663


Q ss_pred             cccchhhH-------HHHH-----HHHHhccch-----------hhhccccc----cCCCCHHHHHHHHHHHHHhccCCC
Q 013750          323 EEEDDVLL-------LDHV-----KKLEREKRL-----------DAIVDRNL----NKNYNIQEVETMIQVALLCTQASP  375 (437)
Q Consensus       323 ~~~~~~~~-------~~~~-----~~~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp  375 (437)
                      .+...+..       ...+     ......+.+           ..+.++..    .......+..++++|+..++..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            32211110       0000     000000000           01111100    011123455689999999999999


Q ss_pred             CCCCCHHHHHH
Q 013750          376 EDRPAMSEVVR  386 (437)
Q Consensus       376 ~~RPs~~evl~  386 (437)
                      .+|+|+.|+++
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=267.41  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccC--CCCcc----hHHHHHHHHHHHhcccccceeeeeeee-cC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGG----DAAFQREVEMISVAVHRNLLRLIGFCT-TP  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~-~~  181 (437)
                      ..++|-..++||+|+|+.||++.+ ...+-||||+-.-.  .....    .+...+|.++-+.+.||.||++++|+. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            345566678999999999999985 45788999986422  21222    224558999999999999999999996 44


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEe
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVG  258 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~  258 (437)
                      +..|-|.|||++.+|..||...+    .++...+..|++||+.||.||.+. +|+|||-||||.||||-+   -|.+||+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            56789999999999999998654    389999999999999999999987 678999999999999954   4789999


Q ss_pred             ecCCceecccCCC------cccccccccccccccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          259 DFGLAKLVDVRKT------NVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       259 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      |||+++.+..+..      ..+++..||.+|++||.+.-+    +++.++||||.||++|+.+.|+.||.......  + 
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--d-  692 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--D-  692 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--H-
Confidence            9999998865433      235567899999999988543    47899999999999999999999997432111  1 


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                       ++.      ....+.   .....-...+..+.+...++++|++..-++|....++.
T Consensus       693 -ILq------eNTIlk---AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 -ILQ------ENTILK---ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -HHh------hhchhc---ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             100      000000   00111111233445788999999999999999877765

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=251.55  Aligned_cols=254  Identities=23%  Similarity=0.269  Sum_probs=194.2

Q ss_pred             HhcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHH-HHhcccccceeeeeeeec----CC
Q 013750          110 ATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTT----PT  182 (437)
Q Consensus       110 ~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~----~~  182 (437)
                      .+++|++. ++||-|-.|.|..+..+ +|+.+|+|++.+.      ....+|+++ +..-.|||||.+++++.+    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            35566543 67999999999999975 6899999999742      234678876 344479999999999854    34


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec---CCCcEEEee
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGD  259 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~D  259 (437)
                      .+++|||.|++|.|...+.+.  +...+...++-.|..||+.|+.|||+.   +|.||||||+|+|.+   .|...||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            567899999999999998875  455688999999999999999999999   999999999999996   456789999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ||+|+....  .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......     +....+...+
T Consensus       208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----ispgMk~rI~  280 (400)
T KOG0604|consen  208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKRRIR  280 (400)
T ss_pred             cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----CChhHHhHhh
Confidence            999986432  223344567999999999999999999999999999999999999996422211     1111111111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.. ++     ...--.+.++...++++..+..+|.+|-|+.++.+.
T Consensus       281 ~gqy-~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  281 TGQY-EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCc-cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            1100 00     011113456788999999999999999999999854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=277.26  Aligned_cols=258  Identities=25%  Similarity=0.325  Sum_probs=206.1

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee----
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT----  179 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----  179 (437)
                      .+-..++-|++.+.||.|.+|.||+++. ++++..|+|++...  .+..++...|.++++.. .|||++.++|++.    
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3344567788899999999999999995 57999999998754  34456677888888876 6999999999984    


Q ss_pred             -cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          180 -TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       180 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                       .++.++||||||.+||..++.++..  ...++|..+..|+..++.|+.+||.+   .++|||+|-.|||++.++.+||+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence             4567899999999999999999877  45589999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCcccccccccccccccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      |||++..+...-.. .....||+.|||||++...     .|+..+|+||||++..||--|.+|+-..-+           
T Consensus       166 DFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------  233 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------  233 (953)
T ss_pred             eeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------
Confidence            99999876533222 2335699999999999643     478899999999999999999998742110           


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.+..   +.  -.|+...--+..-..++.+++..|+.+|-++||++.++++.
T Consensus       234 mraLF~---Ip--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  234 MRALFL---IP--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhhhcc---CC--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            111110   00  11222222245567899999999999999999999998853

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=230.60  Aligned_cols=262  Identities=21%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +|...++||+|.||+||+|+.. +++.||+|++.-. .+.+.....++|+-+++.++|+|||+++++...++..-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455678999999999999965 5889999998632 3344456788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |. .+|..+.....   ..++-.....++.|+.+||.|+|++   ++.|||+||.|.||+.+|+.|++|||+++.++.. 
T Consensus        83 cd-qdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-  154 (292)
T ss_pred             hh-HHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence            95 47777776532   2378888999999999999999999   9999999999999999999999999999977642 


Q ss_pred             CcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHH--Hhc---cch
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKL--ERE---KRL  343 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~--~~~---~~~  343 (437)
                      ....+..+-|.+|.+|.++.+.+ |+...|+||-||++.|+... ++.|...+....    +....+.+  ..+   ..+
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq----lkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH----HHHHHHHhCCCccccCCcc
Confidence            22344456799999999998776 78999999999999999984 444543322211    11111111  011   112


Q ss_pred             hhhccccccCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYN---------IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..+.|-..-..++         +.....=.++....+.-+|.+|.++++.++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2222322222221         112223345555666668999999988765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-33  Score=266.64  Aligned_cols=246  Identities=22%  Similarity=0.310  Sum_probs=193.6

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCc
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      .++||+|.||+||-|.++ +|+.||||++.+.. .......+.+|+.+|..+.||.||.|.-.|++++..+.|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999974 79999999997533 3445578889999999999999999999999999999999999654


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEEeecCCceecccCCC
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~  271 (437)
                      -|+-.|..   ....++......++.||+-||.|||.+   +|+|.||||+||||.+.   -.+||||||.|+..+.  .
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k  720 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K  720 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence            44444432   233477777788999999999999999   99999999999999654   4589999999998763  2


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                      ......+||+.|+|||++.+..|...-|+||.||++|--++|.-||.....       +.+.++...       .+-   
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNAa-------FMy---  783 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNAA-------FMY---  783 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhccc-------ccc---
Confidence            334557899999999999999999999999999999999999999963221       111221110       000   


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..+.-.+.....++|+...++..-.+|-|...-+..
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            011122334577889999999999999998876654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=5.5e-34  Score=251.66  Aligned_cols=268  Identities=25%  Similarity=0.369  Sum_probs=194.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEec-cCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--------
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--------  181 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~-~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------  181 (437)
                      +.|....++|+|.||.||+++.+ +|+.||+|+.. +....+--...++|+++|..+.|+|++.++..|.+.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999975 47888988753 222344455678999999999999999999998432        


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ...|+||++|++ +|.-.|.+.   ...++...+.++..++..||.|+|..   .|+|||+|+.|+||+.++.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            237899999986 677777653   23488899999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcc---cccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-
Q 013750          262 LAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-  336 (437)
Q Consensus       262 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-  336 (437)
                      +++.++......   .+..+-|.+|.+||.+.+. .|+.+.|||.-||++.||.||.+-++.......  ..+.+.... 
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~LcGs  247 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQLCGS  247 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHHHhcc
Confidence            998776543322   3344569999999998765 589999999999999999999988765432211  111111100 


Q ss_pred             ----HHhccc----hhhhccccccCCCC---HHHH------HHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          337 ----LEREKR----LDAIVDRNLNKNYN---IQEV------ETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       337 ----~~~~~~----~~~~~d~~l~~~~~---~~~~------~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                          .+++-.    ...+--+.+.....   .+..      ...++|+..++..||.+||.+.+++..-
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence                000000    00000011111100   1111      2567889999999999999999998643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=232.74  Aligned_cols=208  Identities=22%  Similarity=0.324  Sum_probs=173.7

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHH-hcccccceeeeeeeecCCee
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~  184 (437)
                      ++...+.+.....||+|++|.|-+-++ .+|+..|+|++......+..+..+.|+++.. ....|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444555566667899999999988886 4799999999986555667778889999765 45799999999999888899


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++-||.|+. ||..+..+.......++....-+|+..+.+||.|||++-  .++|||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999964 787777665555566888888999999999999999985  79999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDF  319 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~Gv~l~elltg~~p~~~  319 (437)
                      .+..  +-..+...|...|||||.+..    ..|+.+|||||||+.+.||.+++.|++.
T Consensus       198 ~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            6642  223333568889999998853    3689999999999999999999999863

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=244.78  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=196.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ...++|...++||+|+|.+|..++++ +.+.+|+|++++.  .......=...|-.++.+. +||.+|-|..++.+...+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            34567899999999999999999975 5788999998642  1122222334565566544 799999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|.||.++|+|-.++.+..    .++...+.-+...|.-||.|||+.   +|+.||||.+|||+|..+++||+|||+++
T Consensus       327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence            99999999999988887543    388888888999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .- ..+...++.++||+.|.|||.+.+..|...+|+|++||+++||+.|+.||+.-..+..+ ....++.-        +
T Consensus       400 e~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylf--------q  469 (593)
T KOG0695|consen  400 EG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLF--------Q  469 (593)
T ss_pred             cC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHH--------H
Confidence            53 34455566789999999999999999999999999999999999999999853322111 11111111        1


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA  380 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  380 (437)
                      -++.+.++  ++...+.....+.+.-+++||.+|--
T Consensus       470 vilekqir--iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 VILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence            22222221  23444556777888899999999843

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=274.45  Aligned_cols=247  Identities=26%  Similarity=0.354  Sum_probs=186.6

Q ss_pred             CCCCCCeeeecCcEE-EEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGK-VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      -|...+++|.|+.|+ ||+|.. +|+.||||++..    ....-..+|+..+..- +|||||+.++.-.+.+..|+..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            355567899998875 699999 589999999863    2234556899998876 699999999888888999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-----CCcEEEeecCCcee
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLAKL  265 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla~~  265 (437)
                      |. .+|.++++..........-...+.+..|+++||++||+.   +|+||||||.||||+.     ...++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            95 499999986411111111134567889999999999998   9999999999999975     35799999999998


Q ss_pred             cccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          266 VDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       266 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ........  .....||.+|+|||.+.....+.++||||+||++|..++| .+||...-....+   +      +.....
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---I------l~~~~~  731 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---I------LTGNYT  731 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---h------hcCccc
Confidence            87654433  3346799999999999999989999999999999999996 8999643221111   0      000111


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +..+       ....++  ...+|+.+|++.+|..||++.+|+.
T Consensus       732 L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1100       001112  6789999999999999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.8e-30  Score=230.08  Aligned_cols=211  Identities=34%  Similarity=0.507  Sum_probs=183.3

Q ss_pred             eeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhhh
Q 013750          120 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY  198 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  198 (437)
                      ||+|.+|.||++...+ ++.+++|++.........+.+.+|++.++.++|++++++++++......++++||+++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999998753322235789999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceecccCCCcccccc
Q 013750          199 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQV  277 (437)
Q Consensus       199 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  277 (437)
                      ++....   ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987642   3478999999999999999999999   9999999999999999 89999999999986643321 12234


Q ss_pred             cccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC
Q 013750          278 RGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN  356 (437)
Q Consensus       278 ~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  356 (437)
                      .+...|++||..... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            577899999999877 789999999999999998                                              


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          357 IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       357 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                278889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=259.17  Aligned_cols=245  Identities=22%  Similarity=0.248  Sum_probs=197.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCC-EEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ...++.....||-|+||.|=+...++.. .+|+|.+++..  .....+....|-.+|.+.+.|.||+|+-.+.+.+..|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            3445566678999999999999876433 48999887532  34556678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      +||-|-+|.|-..|+....    ++..+..-++..+.+|++|||++   +||.|||||+|.+||.+|-+||.|||+|+.+
T Consensus       498 LmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999886543    77778888999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ....  .+-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-.     ....+-..     +.  
T Consensus       571 ~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-----tYn~ILkG-----id--  636 (732)
T KOG0614|consen  571 GSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-----TYNLILKG-----ID--  636 (732)
T ss_pred             ccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-----HHHHHHhh-----hh--
Confidence            6433  3345789999999999999999999999999999999999999998654321     11111110     00  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA  380 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  380 (437)
                           .-.+|........+|+++.+..+|.+|--
T Consensus       637 -----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 -----KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                 11223334456778888888999999965

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.8e-30  Score=253.10  Aligned_cols=205  Identities=21%  Similarity=0.280  Sum_probs=171.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ...-|..++.||-|+||.|.++.- ++...||.|.+.+.+  ..........|-++|++-.++=||+|+-.|.+.+.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            345577789999999999999984 456789999987532  12334456789999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||+|+++|++-.+|-...    .+.+..+..++..++-|+++.|..   |+|||||||+|||||.+|++||+||||+.-+
T Consensus       707 VMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence            999999999998887543    377888888899999999999999   9999999999999999999999999998644


Q ss_pred             c---------cCCCc-------------c-------------------cccccccccccccccccCCCCCCchhhHHHHH
Q 013750          267 D---------VRKTN-------------V-------------------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGI  305 (437)
Q Consensus       267 ~---------~~~~~-------------~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv  305 (437)
                      .         ..+..             .                   ....+||..|+|||++....|+.-+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         00000             0                   01146899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCc
Q 013750          306 MLLELVTGQRAIDFSR  321 (437)
Q Consensus       306 ~l~elltg~~p~~~~~  321 (437)
                      +||||+.|+.||-...
T Consensus       860 il~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHHHhhCCCCccCCC
Confidence            9999999999996443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=238.30  Aligned_cols=268  Identities=21%  Similarity=0.243  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-----c---ccceeeeeeee--
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----H---RNLLRLIGFCT--  179 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~--  179 (437)
                      ..+|...++||-|.|++||++.+ .+.+.||+|+.+..  ..-.+..+.|+++|++++     |   .+||+|++.|.  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            36788899999999999999996 45789999998742  344566789999999884     3   36999999984  


Q ss_pred             --cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-----
Q 013750          180 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-----  252 (437)
Q Consensus       180 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-----  252 (437)
                        ++.+.|+|+|++ +.+|..++....-  .-++.....+|+.||+.||.|||.+|  +|||.||||+|||+..+     
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence              456899999999 5578788765432  33788999999999999999999999  99999999999999200     


Q ss_pred             --------------------------------------------------------------------------------
Q 013750          253 --------------------------------------------------------------------------------  252 (437)
Q Consensus       253 --------------------------------------------------------------------------------  252 (437)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013750          253 --------------------------------------------------------------------------------  252 (437)
Q Consensus       253 --------------------------------------------------------------------------------  252 (437)
                                                                                                      
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                                                                            


Q ss_pred             -CcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc--hhh
Q 013750          253 -FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DVL  329 (437)
Q Consensus       253 -~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~--~~~  329 (437)
                       ..+||+|||-|+-..    ...+....|..|.|||++.+..|+..+||||++|+++||.||...|+..+.+...  +..
T Consensus       390 di~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             ceeEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence             013444444443221    1122334578899999999999999999999999999999999999876554322  212


Q ss_pred             HHHHHHHH--------Hhccchhhhcccc--------c---------c--CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          330 LLDHVKKL--------EREKRLDAIVDRN--------L---------N--KNYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       330 ~~~~~~~~--------~~~~~~~~~~d~~--------l---------~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      +...+.-+        ..+...+++++++        |         .  -.++.++..++.+++.-||+.+|++|||+.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            21111111        1122233333322        1         1  135677888999999999999999999999


Q ss_pred             HHHHHHh
Q 013750          383 EVVRMLE  389 (437)
Q Consensus       383 evl~~L~  389 (437)
                      +.++.-.
T Consensus       546 ~cl~hPw  552 (590)
T KOG1290|consen  546 QCLKHPW  552 (590)
T ss_pred             HHhcCcc
Confidence            9986543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-31  Score=234.72  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=194.8

Q ss_pred             CCCCeeeecCcEEEEEEEE-CCCCEEEEEEecc-CCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-----eeEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERLLV  187 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  187 (437)
                      +..+-||-|+||.||..++ ++|+.||.|++.. ..+-..-+.+.+|++++..++|.|++..+++..-+.     +.|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999986 4799999999864 222344567889999999999999999998775543     45677


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +|.|.. +|+..+-    +...++-....-+..||++||+|||+.   +|.||||||.|.|++.|...||+|||+++...
T Consensus       136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            787753 4554443    344577777788899999999999999   99999999999999999999999999999888


Q ss_pred             cCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc------
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE------  340 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  340 (437)
                      .+.....++.+-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|+...+....+     .+..+...      
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~-----lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ-----MIIDLLGTPSQEAM  282 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH-----HHHHHhCCCcHHHH
Confidence            7777778888889999999999876 48999999999999999999888887554433222     11111111      


Q ss_pred             -----cchhhhccccccCC-C--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          341 -----KRLDAIVDRNLNKN-Y--------NIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       341 -----~~~~~~~d~~l~~~-~--------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                           +....++....... +        +...-.....+.+.++..||++|.+..+.+..+
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                 11112222221110 0        111122455677788999999999998887554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.2e-28  Score=225.75  Aligned_cols=200  Identities=30%  Similarity=0.422  Sum_probs=171.9

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      |...+.||+|++|.||++...+ +..+|+|.+.........+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999865 899999999754322256788999999999999999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +++|.+++......   +++.....++.+++.++.|||+.   +++|+|++|.||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999998764321   78899999999999999999999   9999999999999999999999999999876543211


Q ss_pred             ccccccccccccccccc-cCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013750          273 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDF  319 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gv~l~elltg~~p~~~  319 (437)
                      ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334577899999998 667788899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=7.7e-29  Score=216.35  Aligned_cols=261  Identities=19%  Similarity=0.292  Sum_probs=191.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCC--eeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--ERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~  185 (437)
                      ..++|++.+.+|+|.++.||.|.. .++++++||++++    -..+...+|+++|..+. ||||+.|+++..++.  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            357788889999999999999984 5788999999984    34667889999999997 999999999997665  457


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCCce
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAK  264 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~  264 (437)
                      ||+||..+.+.......       ++...+...+.++++||.|+|+.   ||+|||+||.|++||.. -..+|+|+|+|.
T Consensus       112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            99999998776554432       67778888999999999999999   99999999999999964 568999999999


Q ss_pred             ecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh---------HHHHH
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL---------LLDHV  334 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~---------~~~~~  334 (437)
                      +..+.....  -.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-........-+.         +..++
T Consensus       182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            887544322  1234567888998854 56889999999999999999999998432221111111         11111


Q ss_pred             HHHH--hccchhhhccccccC-------CCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          335 KKLE--REKRLDAIVDRNLNK-------NYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       335 ~~~~--~~~~~~~~~d~~l~~-------~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....  -......++....+.       .-+.. ...+..+++...+..|-.+|||+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1100  011122222211111       00111 1257788999999999999999999763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-29  Score=240.57  Aligned_cols=197  Identities=23%  Similarity=0.346  Sum_probs=165.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-------CcchHHHHHHHHHHHhcc---cccceeeeeeeec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAV---HRNLLRLIGFCTT  180 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  180 (437)
                      .+|+..+.+|+|+||.|+.+.++ +...|+||.+.+..-       ....-..-.|+.+|+.++   |+||+++++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45788899999999999999986 467899998864210       011112336999999997   9999999999999


Q ss_pred             CCeeEEEEecc-cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEee
Q 013750          181 PTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD  259 (437)
Q Consensus       181 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D  259 (437)
                      .+.+||+||-. ++.+|.++++..    +.++......|+.||+.|+++||+.   +|+|||||-+||.++.+|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999986 566788887753    3489999999999999999999999   999999999999999999999999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCC
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAID  318 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~  318 (437)
                      ||.+....   +.....++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99987543   233445789999999999999887 567899999999999999888874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=222.45  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=191.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc-CCCCcchHHHHHHHHHHHhcccccceeeeeeeecC------C
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  182 (437)
                      ..+|...+.+|.|.- .|..+.+. .++.||+|++.. .......+...+|..++..++|+|+++++.+++-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            345666677888876 55555532 589999998752 22233455677999999999999999999988543      3


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      +.|+|||||. .+|...+...      ++-.+...+..|++.|++|||+.   +|+||||||+||++..+...||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            5689999995 4787776621      56778889999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch----------h----
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD----------V----  328 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~----------~----  328 (437)
                      ++.....  ...+..+.|-.|.|||++.+..+.+.+||||.||++.||++|..-|.+......-.          .    
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9865432  45667788999999999998889999999999999999999998876432211100          0    


Q ss_pred             hHHHHHHHHHhc------cchhhhc-ccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          329 LLLDHVKKLERE------KRLDAIV-DRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       329 ~~~~~~~~~~~~------~~~~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+...++...+.      ....+++ |....  .+.++-......+++.+|+-.||++|.|.+++++.
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            001111111110      0000111 11111  11122334577899999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.2e-28  Score=236.95  Aligned_cols=212  Identities=22%  Similarity=0.209  Sum_probs=176.5

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc------ccccee
Q 013750          101 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV------HRNLLR  173 (437)
Q Consensus       101 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~------H~niv~  173 (437)
                      .|.+.-.+..-..|.+....|+|-|++|.+|... -|..||||++...  ....+.=+.|+++|++|+      --|+++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            3445556667788999999999999999999975 4889999999753  334556678999999996      237999


Q ss_pred             eeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-
Q 013750          174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-  252 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-  252 (437)
                      |+..|...+++|||+|-+. .+|.+.|..+.. ..-|.......++.|+.-||..|-..   +++|.||||+|||+++. 
T Consensus       499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            9999999999999999884 589999987753 33478888999999999999999988   99999999999999875 


Q ss_pred             CcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          253 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      ..+||||||.|...+.+.   .+.+.-+-.|.|||++.+-.|+..-|+||.||.||||.||+..|.+...
T Consensus       574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            567999999998665332   2333345689999999999999999999999999999999999876543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=8.8e-28  Score=260.11  Aligned_cols=196  Identities=15%  Similarity=0.163  Sum_probs=138.0

Q ss_pred             hccc-ccceeeeeee-------ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 013750          165 VAVH-RNLLRLIGFC-------TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK  236 (437)
Q Consensus       165 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  236 (437)
                      .++| +||++++++|       ......+.++||+ +++|.+++...   ...+++..++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3455 5888888887       2334567778887 55999999742   23489999999999999999999999   9


Q ss_pred             eEecCCCCCCeeecC-------------------CCcEEEeecCCceecccCCC---------------ccccccccccc
Q 013750          237 IIHRDVKAANVLLDE-------------------DFEAVVGDFGLAKLVDVRKT---------------NVTTQVRGTMG  282 (437)
Q Consensus       237 iiH~dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~  282 (437)
                      |+||||||+||||+.                   ++.+|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44556666666653211000               00011357888


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHH
Q 013750          283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVET  362 (437)
Q Consensus       283 y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  362 (437)
                      |||||++.+..++.++|||||||++|||++|..|+....          ........     ....+.     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~-----~~~~~~-----~~~~~~~  240 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH-----RVLPPQ-----ILLNWPK  240 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH-----hhcChh-----hhhcCHH
Confidence            999999999999999999999999999999887754110          00000000     001110     0111234


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          363 MIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       363 l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...++.+||+.+|.+||+|.|+++.
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhhc
Confidence            5678889999999999999999863

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=212.94  Aligned_cols=254  Identities=20%  Similarity=0.278  Sum_probs=183.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeee-eecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGF-CTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~l  186 (437)
                      ..+.|.+.+.||+|.||.+-++.++ +.+.+++|-+...  ....++|.+|..---.+ .|.||+.-+++ +.+.+.+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            3467888999999999999999986 4678999988642  34567899998854444 69999987765 466677889


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec--CCCcEEEeecCCce
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAK  264 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~  264 (437)
                      ++||++.|+|...+....     +......+++.|++.|+.|+|++   +++|||||.+|||+-  +...+||||||+.+
T Consensus       100 ~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             eeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            999999999988775422     67778889999999999999999   999999999999993  34689999999998


Q ss_pred             ecccCCCcccccccccccccccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ..+..-    ....-+..|.+||....-     ...+.+|||.||+++|.++||..||+......   .....|.....+
T Consensus       172 k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  172 KVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKR  244 (378)
T ss_pred             ccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcc
Confidence            543211    112245679999977432     34778999999999999999999997322211   112222221111


Q ss_pred             -ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          340 -EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       340 -~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                       ...++..+.     .    .++.+..+.++-+..+|++|-...++-++-.
T Consensus       245 k~~~~P~~F~-----~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  245 KNPALPKKFN-----P----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             cCccCchhhc-----c----cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence             111111111     1    2246677778889999999966666655543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.5e-28  Score=239.30  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=196.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+....+|+|+||.|||+++. +++..|+|+++-.. .....-..+|+-+++..+||||+.++|-+...+...+.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            467888899999999999999964 68999999987432 3344556789999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||.+|+|++-.+-.    .+++..++-.+.....+|++|||+.   +=+|||||-.|||+++.+.+|++|||.+-.+.. 
T Consensus        93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-  164 (829)
T ss_pred             ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence            99999998876543    3488888889999999999999999   889999999999999999999999999876542 


Q ss_pred             CCcccccccccccccccccc---cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .....+.+.||+.|||||+.   ..+.|...+|||+.|+...|+-.-++|.-.        ....+....+.     ...
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--------lhpmr~l~LmT-----kS~  231 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--------LHPMRALFLMT-----KSG  231 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--------cchHHHHHHhh-----ccC
Confidence            12234557899999999987   356789999999999999998776665321        11111111111     111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .++.-..+ ...-.+.+.++++.|+.++|.+||+++.++.
T Consensus       232 ~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 FQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11111111 1223457899999999999999999987764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=214.15  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=192.5

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccC-CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      ..+|.+...|..|+|+++ |..+++|++... .+....++|..|.-.|+.+.||||++++|.|..+....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            456888999999999996 556666877632 234456689999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccc
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT  275 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  275 (437)
                      |...+++.  .....+-.++.+++.+||+|++|||+. .|-|.---|.+..|++|++.+++|+- +-+++.-..     .
T Consensus       274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe-----~  344 (448)
T KOG0195|consen  274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE-----V  344 (448)
T ss_pred             HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec-----c
Confidence            99999874  345678889999999999999999997 33455567899999999999988752 111111111     1


Q ss_pred             cccccccccccccccCCCC---CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          276 QVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       276 ~~~gt~~y~aPE~~~~~~~---~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                      ...-.+.||+||.++..+.   -.++|+|||++++|||.|...||....+-+. +                -.+.-..++
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-g----------------mkialeglr  407 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-G----------------MKIALEGLR  407 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-h----------------hhhhhcccc
Confidence            1123678999999987654   3589999999999999999999964322110 0                011123455


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                      ..+++..+..+.+|+.-|++.||.+||.+..++-.||++
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            566777778999999999999999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.7e-26  Score=203.10  Aligned_cols=166  Identities=20%  Similarity=0.202  Sum_probs=123.8

Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|.+++...   ...+++..++.++.|++.||+|||+.   +      ||+|||++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6788888753   23489999999999999999999999   5      999999999999999  99998654321   


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                         ..||+.|+|||.+.+..++.++|||||||++|||+||+.||.......   .............       ++. ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~-------~~~-~~  129 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPAD-------DPR-DR  129 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhccC-------Ccc-cc
Confidence               258899999999999999999999999999999999999985332111   0111111110000       000 00


Q ss_pred             CCCHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          354 NYNIQEVE--TMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       354 ~~~~~~~~--~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ........  .+.+++.+||+.+|++||++.|+++.+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            01112222  68999999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.4e-26  Score=218.80  Aligned_cols=199  Identities=25%  Similarity=0.375  Sum_probs=164.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCC
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT  182 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  182 (437)
                      ....+.|...++||+|.|++||++.+.    .++.||+|.+.....   ......|+++|..+. +.||+++.+++...+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            344567888999999999999999854    367899999876443   345789999999884 999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFG  261 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg  261 (437)
                      ...+|+||+++....+++..       ++...+..++..+..||+++|.+   ||+||||||.|+|.+. .+.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            99999999999998888775       67888899999999999999999   9999999999999985 4667999999


Q ss_pred             CceecccCC-------------------------------C-cc-----------cccccccccccccccccC-CCCCCc
Q 013750          262 LAKLVDVRK-------------------------------T-NV-----------TTQVRGTMGHIAPEYLST-GKSSER  297 (437)
Q Consensus       262 la~~~~~~~-------------------------------~-~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~  297 (437)
                      +|.......                               . ..           .....||+||.|||++.. ...+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            987211000                               0 00           001358999999999865 457899


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCC
Q 013750          298 TDVFGYGIMLLELVTGQRAIDF  319 (437)
Q Consensus       298 sDv~s~Gv~l~elltg~~p~~~  319 (437)
                      .||||-||+++-+++++.||-.
T Consensus       259 iDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             cceeeccceeehhhcccccccc
Confidence            9999999999999999999853

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.4e-24  Score=211.20  Aligned_cols=165  Identities=27%  Similarity=0.305  Sum_probs=129.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEeccCC----CCcchHHHHHHHHHHHhccccccee-eeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLR-LIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~  181 (437)
                      ...++|...+.||+|+||+||+|.++  +++.||||++....    .....+.|.+|++++++++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34678999999999999999999875  57788999875321    1223567899999999999999985 4432    


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCCeeecCCCcEEEeec
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Df  260 (437)
                      ...++||||+++++|... .   ..    .   ...++.+++++|.|||++   +|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~---~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R---PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C---cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            457999999999998622 1   11    1   145788999999999999   9999999 999999999999999999


Q ss_pred             CCceecccCCCccc-------ccccccccccccccccC
Q 013750          261 GLAKLVDVRKTNVT-------TQVRGTMGHIAPEYLST  291 (437)
Q Consensus       261 gla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~  291 (437)
                      |+++.+........       +...+++.|+|||++.-
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99997754322111       23567889999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-23  Score=204.80  Aligned_cols=257  Identities=20%  Similarity=0.243  Sum_probs=190.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCC--CEEEEEEeccCCCCcchHHHHHHHHHHHhccc----ccceeeeeee-ecCCeeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVH----RNLLRLIGFC-TTPTERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~  185 (437)
                      +|.+.+.||+|+||.||++...+.  ..+|+|........... .+..|+.++..+.+    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            788999999999999999997653  47888887653322222 67889999888873    5888888888 4777889


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-----CcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-----FEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-----~~~kl~Df  260 (437)
                      +||+.+ +-+|.++.....  ...++..+..+++.|++.+|++||+.   +++||||||.|+++...     ..+.|.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999987 668888776544  44589999999999999999999999   99999999999999765     46999999


Q ss_pred             CCce--ecccCCCc------c-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          261 GLAK--LVDVRKTN------V-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       261 gla~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      |+++  ........      . .....||..|.++..+.+...+.+.|+||++.++.|++.|..||........     .
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~  246 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K  246 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence            9998  32222111      1 1235699999999999999999999999999999999999999864332211     0


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ............    ..     .....+..+.++...+-+.+..++|....+...|+.
T Consensus       247 ~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  247 SKFEKDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHHHHHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            011111100000    00     111123355556666666899999999999988765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3e-22  Score=192.33  Aligned_cols=262  Identities=26%  Similarity=0.330  Sum_probs=197.0

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc--chHHHHHHHHHHHhcccc-cceeeeeeeecCCeeEEEEec
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~  190 (437)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....|.+|+.+++.+.|+ |++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999986  889999997544333  477899999999999988 799999999777778999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  269 (437)
                      +.++++..++...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++... .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666543211 2478888999999999999999999   899999999999999988 7999999999855433


Q ss_pred             CCc-----ccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          270 KTN-----VTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       270 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ...     ......|+..|+|||.+..   ..++...|+||+|++++++++|..|+....... ............... 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~-  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTP-  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCc-
Confidence            322     2345679999999999987   578999999999999999999999965433210 000011111111000 


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          .................+.+++..|+..+|..|.++.+....
T Consensus       234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                000000000001223578889999999999999998887754

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-21  Score=178.03  Aligned_cols=258  Identities=17%  Similarity=0.243  Sum_probs=190.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .-+|.+.++||+|.||..+.|+ +-+++.||||.-..   .....++..|.+..+.+. .++|-..+-+-.++.+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            4578889999999999999999 34799999996542   233456778888888774 688888887777888889999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-----CCcEEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla  263 (437)
                      |.+ +-||++++.-+.   ..++..+...+|.|+..-++|+|++   .+|.|||||+|+||..     ...+.++|||+|
T Consensus       104 dLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 568888876543   3388999999999999999999999   9999999999999953     345899999999


Q ss_pred             eecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          264 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       264 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +.+......      ..+...||.+||+--.+.+...+.+.|.-|+|-++...+-|..||+.-..+.....  ...+...
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k--YeKIGe~  254 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK--YEKIGET  254 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--HHHhccc
Confidence            977543322      23456799999999999999999999999999999999999999986554432210  0111111


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      .+...+.++.+     . .+++.......++   +.+-++-|...-+...+.
T Consensus       255 Kr~T~i~~Lc~-----g-~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  255 KRSTPIEVLCE-----G-FPEEFATYLRYVR---RLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             cccCCHHHHHh-----c-CHHHHHHHHHHHH---hcCcccCCCHHHHHHHHH
Confidence            11111222222     1 2334444444444   567888888777665544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=8.9e-23  Score=211.81  Aligned_cols=261  Identities=20%  Similarity=0.246  Sum_probs=191.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHH--HHhcccccceeeeeeeecCCeeEEEEec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++...+.||++.|=+|.+|++++|. |+||++.+....-..+.|.++++-  ....+|||.+++.-+..+.+..|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998887 899998765544455556554443  5566899999998777777778888888


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec--cc
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DV  268 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~--~~  268 (437)
                      ..+ +|.+.+.    ..+.+...+.+=|+.|+..||.-+|..   +|+|||||.+|||++.=.=+.|+||..-+-.  ..
T Consensus       103 vkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            865 6776665    455577788888999999999999999   9999999999999998778999999876522  11


Q ss_pred             CCCcc----cccccccccccccccccCC-----------CCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          269 RKTNV----TTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       269 ~~~~~----~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      +....    ......-.+|+|||.+-..           ..+++-||||.||++.||++ |+++|..+           +
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----------Q  243 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----------Q  243 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----------H
Confidence            11111    1112234589999977431           15778999999999999998 67877632           2


Q ss_pred             HHHHHHh-ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCCCcchhhh
Q 013750          333 HVKKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQ  401 (437)
Q Consensus       333 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~  401 (437)
                      ....... ....+.++.. +.       -..+..++..|++.||.+|-+++++++.-.+..+++.+..+.
T Consensus       244 L~aYr~~~~~~~e~~Le~-Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL  305 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEK-IE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFL  305 (1431)
T ss_pred             HHhHhccCccCHHHHHHh-Cc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHH
Confidence            2221111 1111111111 00       026788999999999999999999999999999998876654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=6.5e-22  Score=174.43  Aligned_cols=272  Identities=17%  Similarity=0.228  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc-ccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..+|...+.||+|+||.+|.|. ..+|..||||.-..   .....++..|.++...++| ..|-.+..|..+...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~---~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS---KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc---cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            4678889999999999999999 46799999998754   3334567889999998875 56666777788888889999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~~  265 (437)
                      +.+ +-||++++.-+.   ..++..+.+-++-|+..-++|+|.+   +++||||||+|+|..-+   ..+.++|||+++.
T Consensus        91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence            998 568888876543   2377888999999999999999999   99999999999999643   4689999999997


Q ss_pred             cccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          266 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       266 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +......      ......||.+|.+--.+.+-..+...|+-|+|.++...--|..||+.........            
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q------------  231 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ------------  231 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH------------
Confidence            6432221      2234679999999988888888999999999999999999999998644332111            


Q ss_pred             ccchhhhccccccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc-----CCCCCcchhhhhhhhh
Q 013750          340 EKRLDAIVDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG-----EGLAERWEEWQHVEVT  406 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~-----~~~~~~~~~~~~~~~~  406 (437)
                        ..+.+....+....   ....+.++.-.+..|=..--++-|...-+-+.+..     ....+.--+|..++..
T Consensus       232 --KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk  304 (341)
T KOG1163|consen  232 --KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK  304 (341)
T ss_pred             --HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence              11111111111100   11123567777888999999999998777766553     1222333466666543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.6e-22  Score=209.25  Aligned_cols=255  Identities=18%  Similarity=0.192  Sum_probs=184.4

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEec----cCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLT----DFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~----~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ...+++|.|.+|.|+..... .....+.|...    .... ......+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35688999999988877643 23333333221    1111 111112556777777889999988888777777666679


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||++. +|..++...    ..+....+..++.|+..|++|+|+.   ++.|||+|++|++++.++.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 998888753    2367778888999999999999999   999999999999999999999999999988765


Q ss_pred             CCC---cccccccccccccccccccCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          269 RKT---NVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       269 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ...   ......+|+..|+|||.+....|. ...||||.|+++..|.+|+.||.........   .    ...   ....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~---~----~~~---~~~~  542 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS---F----KTN---NYSD  542 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc---h----hhh---cccc
Confidence            444   334557899999999999998886 4689999999999999999998644332111   0    000   0000


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +.-...-........+.....++.++++.||.+|.|+++|++.
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0000000011223455678899999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2.1e-21  Score=173.75  Aligned_cols=140  Identities=16%  Similarity=0.179  Sum_probs=107.4

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC-cc-------hHHH-----------------HHHHHHHHhcccccc
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG-------DAAF-----------------QREVEMISVAVHRNL  171 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~-------~~~~-----------------~~E~~~l~~l~H~ni  171 (437)
                      ...||+|+||.||+|...+|+.||||+++..... ..       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999999753211 11       1122                 349999999988876


Q ss_pred             eeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEecCCCCCCeeec
Q 013750          172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLD  250 (437)
Q Consensus       172 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiH~dlk~~NIll~  250 (437)
                      .....+..  ...++||||++++++......    ...++......++.|++.+|.|+ |+.   +++||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            43332222  234899999998776544322    12478889999999999999999 688   999999999999998


Q ss_pred             CCCcEEEeecCCceec
Q 013750          251 EDFEAVVGDFGLAKLV  266 (437)
Q Consensus       251 ~~~~~kl~Dfgla~~~  266 (437)
                      + +.++|+|||++...
T Consensus       153 ~-~~v~LiDFG~a~~~  167 (190)
T cd05147         153 D-GKLYIIDVSQSVEH  167 (190)
T ss_pred             C-CcEEEEEccccccC
Confidence            4 78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2.7e-21  Score=191.77  Aligned_cols=212  Identities=22%  Similarity=0.386  Sum_probs=161.7

Q ss_pred             HHhcccccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce-EecC
Q 013750          163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI-IHRD  241 (437)
Q Consensus       163 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-iH~d  241 (437)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..   ....++|.....+..+|+.||+|||+.   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            3567899999999999999999999999999999999986   344589999999999999999999987   44 9999


Q ss_pred             CCCCCeeecCCCcEEEeecCCceecccC-CCcccccccccccccccccccCCC-------CCCchhhHHHHHHHHHHHhC
Q 013750          242 VKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGK-------SSERTDVFGYGIMLLELVTG  313 (437)
Q Consensus       242 lk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~s~Gv~l~elltg  313 (437)
                      +++.|+++|....+||+|||+....... .........-..-|.|||.+....       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998765321 111111222456899999997642       46789999999999999999


Q ss_pred             CCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCC-H-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          314 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN-I-QEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       314 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..||+........ ..+...+..   .  ..    +.+++... . +....+..++..||..+|++||++.++-..++.
T Consensus       155 ~~~~~~~~~~~~~-~eii~~~~~---~--~~----~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  155 SGPFDLRNLVEDP-DEIILRVKK---G--GS----NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             cCccccccccCCh-HHHHHHHHh---c--CC----CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            9999754333322 111111211   0  11    11111111 1 233479999999999999999999999999887

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2.1e-20  Score=167.63  Aligned_cols=140  Identities=17%  Similarity=0.170  Sum_probs=109.6

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC-cc------------------------hHHHHHHHHHHHhcccccc
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG------------------------DAAFQREVEMISVAVHRNL  171 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~------------------------~~~~~~E~~~l~~l~H~ni  171 (437)
                      .+.||+|+||.||+|...+|+.||||++...... ..                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998753211 00                        1123578899999999987


Q ss_pred             eeeeeeeecCCeeEEEEecccCchhhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeee
Q 013750          172 LRLIGFCTTPTERLLVYPFMQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       172 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll  249 (437)
                      .....+...  ..++||||++++++... +..     ..++......++.+++.++.++|+ .   +++||||||+||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            544433332  34899999998755433 322     236777889999999999999999 8   99999999999999


Q ss_pred             cCCCcEEEeecCCceecc
Q 013750          250 DEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~  267 (437)
                      + ++.++|+|||++....
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            9 7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=2.8e-21  Score=175.42  Aligned_cols=174  Identities=13%  Similarity=0.089  Sum_probs=133.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc--chHH------HHHHHHHHHhcccccceeeeeeeec
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAA------FQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~------~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ...++|...+++|.|+||.||+... ++..+|+|.+.+.....  ..+.      |.+|+..+.+++|++|..+..+...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3568899999999999999999766 57789999997533211  1122      6789999999999999999887543


Q ss_pred             C--------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          181 P--------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       181 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      .        ...+++|||+++.+|.++..        ++.    ....+++.++..+|+.   +++|+|++|.||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            2        35789999999999977632        221    2456899999999999   99999999999999998


Q ss_pred             CcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh
Q 013750          253 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT  312 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt  312 (437)
                      + ++|+|||.......+..  .           ..+.....+..++|+||||+.+.-+..
T Consensus       172 g-i~liDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence            8 99999998875421111  0           113344556789999999998876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=5.4e-20  Score=172.02  Aligned_cols=233  Identities=22%  Similarity=0.258  Sum_probs=149.6

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhccc----------cc-ceeeeeee--
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVH----------RN-LLRLIGFC--  178 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H----------~n-iv~l~g~~--  178 (437)
                      ...+.||.|+++.||.+++. +|+.+|+|+..-.  ......+++.+|.-....+.+          -. ++++.-.-  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34678999999999999986 4899999987532  223445677777655544322          12 22221111  


Q ss_pred             ------ecCC--------eeEEEEecccCchhhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecC
Q 013750          179 ------TTPT--------ERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD  241 (437)
Q Consensus       179 ------~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~d  241 (437)
                            ....        ..+++|+-+ .++|...+..   .......+....++.+..|+.+.+++||+.   +++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence                  1111        235677776 4577777543   222223355667778889999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccC--------CCCCCchhhHHHHHHHHHHHhC
Q 013750          242 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELVTG  313 (437)
Q Consensus       242 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~Gv~l~elltg  313 (437)
                      |+|+|++++.+|.++|+||+.....+...   . ....+..|.+||....        -.++.+.|.|++|+++|.|.+|
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE---E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee---e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999998877543211   1 1234578999997743        2478999999999999999999


Q ss_pred             CCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 013750          314 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR  378 (437)
Q Consensus       314 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R  378 (437)
                      +.||+..........                     .+ .... +.++.+..|+..+++.||++|
T Consensus       247 ~lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999986543322211                     11 1223 677899999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.6e-19  Score=160.74  Aligned_cols=183  Identities=21%  Similarity=0.120  Sum_probs=137.1

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC---CcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEecc
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ....|++|+||+||.+.- .+.+++.+.+.....   .-....|.+|+++|+++. |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997665 688888887764322   111225789999999995 5789999886    4569999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC-CCCCeeecCCCcEEEeecCCceecccCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      .+.+|...+..           ....++.|++++|.++|++   +++|||| ||.|||++.++.++|+|||++.......
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99888643211           1134678999999999999   9999999 7999999999999999999998655332


Q ss_pred             Cc----cc-------c-cccccccccccccccCC-CCC-CchhhHHHHHHHHHHHhCCCCC
Q 013750          271 TN----VT-------T-QVRGTMGHIAPEYLSTG-KSS-ERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       271 ~~----~~-------~-~~~gt~~y~aPE~~~~~-~~~-~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      ..    ..       + -...++.|++|+-...- ..+ ...+.++-|+-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    00       0 01257788888755332 233 5678899999999999998875

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.6e-19  Score=189.39  Aligned_cols=201  Identities=19%  Similarity=0.193  Sum_probs=162.4

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc---cccceeeeeeeecC
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTP  181 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~  181 (437)
                      .+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-++..    .-+|.--.+++.+|+   -+.|..+.....-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN----PWEFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC----ceeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            45666778899999999999999999998889999999876533    223444444555555   23344444445666


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-------CCCc
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-------EDFE  254 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-------~~~~  254 (437)
                      +..+||+||.+.|+|.+++.    ....++|...+.++.|+++.++.||..   +|||+||||+|.+|.       +...
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence            77899999999999999987    345589999999999999999999999   999999999999993       3456


Q ss_pred             EEEeecCCceecccC-CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCC
Q 013750          255 AVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA  316 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p  316 (437)
                      ++|+|||.+.-+..- +....+..++|-.+-.+|...+..++++.|-|.|+.+++-|+.|+..
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            899999998755332 22345556789999999999999999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-20  Score=185.90  Aligned_cols=234  Identities=24%  Similarity=0.261  Sum_probs=179.7

Q ss_pred             eeeecCcEEEEEEE----ECCCCEEEEEEeccCCCC-cchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEeccc
Q 013750          119 VLGQGGFGKVYRGV----LADGTKVAVKRLTDFESP-GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~----~~~g~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      .+|+|.||.|+++.    .+.|..+|+|.+.+.... ........|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999865    345788999988753321 11224556778888887 9999999999999999999999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      +|.|...+....    .+.......+...++-+++++|+.   +++|+|+|++||+++.+|++++.|||+++..-.....
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999887776432    256666667778899999999999   9999999999999999999999999999865432221


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                           +||..|||||++.  .....+|.||||++.+||+||..||..            +....         ++.  ..
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~---------Il~--~~  203 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKR---------ILK--AE  203 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHH---------Hhh--hc
Confidence                 7899999999997  567789999999999999999999863            00111         111  01


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHHHHh
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAM--SEVVRMLE  389 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~--~evl~~L~  389 (437)
                      ...+.+......++...++..+|.+|--.  ..+.+.++
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            23355666678888888999999999665  34444443

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.7e-18  Score=156.64  Aligned_cols=137  Identities=20%  Similarity=0.259  Sum_probs=105.1

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-----ccccceeeeeeeecCC---eeE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-----VHRNLLRLIGFCTTPT---ERL  185 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~  185 (437)
                      ++..+.||+|+||.||.  +++....+||++.... ....+.+.+|+++++.+     .||||++++|++.++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34568899999999996  4433334799886532 33456799999999999     5799999999998764   333


Q ss_pred             -EEEec--ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceEecCCCCCCeeecC----CCcEEE
Q 013750          186 -LVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL-EYLHEHCNPKIIHRDVKAANVLLDE----DFEAVV  257 (437)
Q Consensus       186 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~iiH~dlk~~NIll~~----~~~~kl  257 (437)
                       +|+||  +++++|.+++.+..     ++..  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  66899999996521     3443  34567777777 999999   9999999999999974    347999


Q ss_pred             eecCCc
Q 013750          258 GDFGLA  263 (437)
Q Consensus       258 ~Dfgla  263 (437)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=9.8e-19  Score=164.45  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=166.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C-----------------------------------CEEEEEEeccCCCCcchH
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-G-----------------------------------TKVAVKRLTDFESPGGDA  154 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----------------------------------~~vAvK~l~~~~~~~~~~  154 (437)
                      .++|++.+.||+|....||.+.+++ |                                   -+.|||.+.+.+......
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            3568889999999999999987542 1                                   036788876544333333


Q ss_pred             HHHH----HH------HHH--------Hh--------cccccceeeeeeeec---------------------------C
Q 013750          155 AFQR----EV------EMI--------SV--------AVHRNLLRLIGFCTT---------------------------P  181 (437)
Q Consensus       155 ~~~~----E~------~~l--------~~--------l~H~niv~l~g~~~~---------------------------~  181 (437)
                      .+++    |.      .++        +.        -+|||||++.+.+.+                           +
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence            3332    21      111        11        249999999887633                           2


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee--cCCC--cEEE
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDF--EAVV  257 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll--~~~~--~~kl  257 (437)
                      ...|+||.-++. +|..++....     .+.-...-++.|+++|+.|||.+   ++.|||+|++|||+  |+|.  ...+
T Consensus       316 ~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVv  386 (598)
T KOG4158|consen  316 KTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVV  386 (598)
T ss_pred             ceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEE
Confidence            345777766644 7777776432     45556677889999999999999   99999999999999  4443  3689


Q ss_pred             eecCCceecccC-----CCcccccccccccccccccccCCC------CCCchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 013750          258 GDFGLAKLVDVR-----KTNVTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEED  326 (437)
Q Consensus       258 ~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~  326 (437)
                      +|||.+---...     ........-|...-||||+....+      .-.|+|.|+-|.+.||+++...||...     .
T Consensus       387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-----G  461 (598)
T KOG4158|consen  387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-----G  461 (598)
T ss_pred             cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-----c
Confidence            999987522110     001111234677899999886432      146899999999999999999999641     1


Q ss_pred             hhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ++.+ +.       ...++---+.    .+..++..+.+++...++.||.+||+..=....|+
T Consensus       462 em~L-~~-------r~Yqe~qLPa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  462 EMLL-DT-------RTYQESQLPA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hhee-ch-------hhhhhhhCCC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            1111 00       0011111111    22334457888999999999999999766665554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=7.1e-18  Score=153.76  Aligned_cols=135  Identities=19%  Similarity=0.267  Sum_probs=113.6

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc-------chHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.||+|++|.||+|.. +|..+++|+........       ....+.+|++++..+.|+|+.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999998 67889999865322111       123577899999999999998777777777888999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +++++|.+++...       .+ .+..++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888642       12 7788999999999999999   999999999999999 78899999999864

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=5.9e-18  Score=156.64  Aligned_cols=142  Identities=14%  Similarity=0.099  Sum_probs=109.4

Q ss_pred             CCCCCCeeeecCcEEEEEEE--ECCCCEEEEEEeccCCCCc-----------------------chHHHHHHHHHHHhcc
Q 013750          113 NFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPG-----------------------GDAAFQREVEMISVAV  167 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vAvK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~  167 (437)
                      .|.+.+.||+|+||.||+|.  ..+|+.||+|++.......                       ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  4689999999986432100                       0123568999999997


Q ss_pred             ccc--ceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eEecCCCC
Q 013750          168 HRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKA  244 (437)
Q Consensus       168 H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-iiH~dlk~  244 (437)
                      +.+  +.+++++    ...++||||+++.+|......    ...+.......++.|++.++.+||+.   + ++|+||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            633  3344443    235899999999887665422    12245556778999999999999999   8 99999999


Q ss_pred             CCeeecCCCcEEEeecCCceec
Q 013750          245 ANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       245 ~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.1e-17  Score=151.01  Aligned_cols=145  Identities=20%  Similarity=0.147  Sum_probs=111.2

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC---------------------cchHHHHHHHHHHH
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP---------------------GGDAAFQREVEMIS  164 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~~~~~~~~E~~~l~  164 (437)
                      ++......|...+.||+|+||.||++..++|+.||||++......                     .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333334447778999999999999999888999999987532100                     01123567888899


Q ss_pred             hccccc--ceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC
Q 013750          165 VAVHRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV  242 (437)
Q Consensus       165 ~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl  242 (437)
                      .+.|++  +...++    ....+++|||+++++|......          .....++.+++.++.++|+.   +++|+||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            998874  444443    2345899999999988764321          23456888999999999998   9999999


Q ss_pred             CCCCeeecCCCcEEEeecCCceecc
Q 013750          243 KAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       243 k~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||.||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.2e-17  Score=150.96  Aligned_cols=131  Identities=19%  Similarity=0.280  Sum_probs=107.1

Q ss_pred             eeeecCcEEEEEEEECCCCEEEEEEeccCCCCc-------chHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .||+|+||.||+|.+ +|..+++|.........       ....+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 57899999865322111       1256778999999999988765555666677789999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ++++|.+++....     .      .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988775421     0      6889999999999999   999999999999999 78999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=9.2e-18  Score=174.04  Aligned_cols=141  Identities=16%  Similarity=0.218  Sum_probs=113.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEec-cCCCC------cchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESP------GGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~-~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      .....|...+.||+|+||+||+|.+.+. .+++|+.. +....      ...+.+.+|++++..++|+|++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3345556789999999999999998544 44444432 21111      1235688999999999999999888888877


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ...++||||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence            88899999999999988775            3467899999999999999   99999999999999 57789999999


Q ss_pred             Cceec
Q 013750          262 LAKLV  266 (437)
Q Consensus       262 la~~~  266 (437)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=5.7e-19  Score=172.30  Aligned_cols=174  Identities=25%  Similarity=0.357  Sum_probs=130.6

Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++.|++|...+|.+|+....... ..++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e-~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE-ERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc-ccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4678999999999999998655433 36888899999999999999   6   899999999999999999999999999


Q ss_pred             ceecccCC-----CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 013750          263 AKLVDVRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       263 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      ........     ....+...||..||+||.+.+..|+.++||||||++++|++. -..+++                  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------  464 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------  464 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence            98665443     234556789999999999999999999999999999999988 222211                  


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV  384 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev  384 (437)
                        +.....++-|..+.+.+..+.+ .=..+..++++..|.+||++.++
T Consensus       465 --r~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  465 --RIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             --HHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence              1111222222222211111111 33467778999999999955443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=3.2e-17  Score=170.83  Aligned_cols=210  Identities=23%  Similarity=0.284  Sum_probs=143.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|+.++.+..|++|.||..+++. .+.+|+| +.+..      ..++-  ++.....|.+|                
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee----------------
Confidence            34678889999999999999998763 6778884 43211      11110  22222333333                


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                           |+-...+.....    +..        +++.+++|||+.   +|+|||+||+|.+|+.=|++|++|||+++....
T Consensus       136 -----gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 444444443222    221        237899999999   999999999999999999999999999875432


Q ss_pred             CCC--------------cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          269 RKT--------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       269 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ...              ...++.+||+.|.|||++....|...+|+|++|+++||.+-|..||.....++-.+..+.+.+
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            111              112446899999999999999999999999999999999999999976544321111111100


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA  380 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  380 (437)
                      .       ..         +-....+.+..+++.+.++.+|..|--
T Consensus       276 ~-------wp---------E~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  276 E-------WP---------EEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             c-------cc---------ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            0       00         001122347788888999999999943

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=1.1e-15  Score=130.76  Aligned_cols=135  Identities=17%  Similarity=0.145  Sum_probs=114.0

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc--ccceeeeeeeecCCeeEEEEecccC
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.+.||+|.++.||++... +..+++|.......   ...+.+|+.++..++|  .++.+++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            3577999999999999985 47899998864322   5678999999999987  4889999988888889999999988


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +.+..+           +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            776543           4556677899999999999986445799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=2.9e-16  Score=140.31  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=97.2

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc-chHHH----------------------HHHHHHHHhccccc--c
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-GDAAF----------------------QREVEMISVAVHRN--L  171 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-~~~~~----------------------~~E~~~l~~l~H~n--i  171 (437)
                      .+.||+|+||+||+|...+|+.||||++....... ....+                      ..|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999986432111 11111                      24555555554433  3


Q ss_pred             eeeeeeeecCCeeEEEEecccCchhhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeee
Q 013750          172 LRLIGFCTTPTERLLVYPFMQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       172 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll  249 (437)
                      .+.+++    ...++||||++++++... +....     .. .....++.+++.++.++|. .   +++|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333332    245899999999654321 21111     11 5567889999999999999 7   99999999999999


Q ss_pred             cCCCcEEEeecCCceecc
Q 013750          250 DEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~  267 (437)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=1.2e-14  Score=134.83  Aligned_cols=136  Identities=18%  Similarity=0.159  Sum_probs=104.8

Q ss_pred             CCeee-ecCcEEEEEEEECCCCEEEEEEeccCC------------CCcchHHHHHHHHHHHhcccccc--eeeeeeeecC
Q 013750          117 KNVLG-QGGFGKVYRGVLADGTKVAVKRLTDFE------------SPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTP  181 (437)
Q Consensus       117 ~~~lG-~G~fg~Vy~~~~~~g~~vAvK~l~~~~------------~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~  181 (437)
                      ...|| .|+.|+||+.... +..+++|+.....            +......+.+|++++..++|+++  ...+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999885 7889999874311            01233567889999999999885  5667665332


Q ss_pred             C----eeEEEEecccC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          182 T----ERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       182 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      .    ..++|+|++++ .+|.+++...     .++..    ...+++.+|.+||+.   +|+|+||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    22599999997 6888877542     13332    356899999999999   999999999999999988999


Q ss_pred             EeecCCcee
Q 013750          257 VGDFGLAKL  265 (437)
Q Consensus       257 l~Dfgla~~  265 (437)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=6.9e-16  Score=160.06  Aligned_cols=256  Identities=21%  Similarity=0.262  Sum_probs=183.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  186 (437)
                      ...|...+.||+|.|+.|-......  ...+|+|.+.... +....+....|..+-..+. |+|++.+++....++..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456667789999999999887643  4456666665322 1222233334777666666 9999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEecCCCCCCeeecCCC-cEEEeecCCce
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK  264 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~  264 (437)
                      ..+|..++++..-+...  .....+-.....+..|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999988777311  1112445556678899999999999 77   999999999999999999 99999999999


Q ss_pred             eccc-CCC-cccccccc-cccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          265 LVDV-RKT-NVTTQVRG-TMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       265 ~~~~-~~~-~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      .+.. ... .......| ++.|+|||...+. ......|+||.|+++.-+++|..|++........-   ..|....   
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---~~~~~~~---  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---SSWKSNK---  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---eeecccc---
Confidence            7765 222 22333567 9999999999874 45788999999999999999999987554332110   0111000   


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                      ..        ..............++..+++..+|..|.+.+++-
T Consensus       248 ~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cc--------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence            00        00111112234667788888889999999988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.1e-14  Score=132.65  Aligned_cols=202  Identities=18%  Similarity=0.265  Sum_probs=141.7

Q ss_pred             HHHhcccccceeeeeeeecCC-----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 013750          162 MISVAVHRNLLRLIGFCTTPT-----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK  236 (437)
Q Consensus       162 ~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  236 (437)
                      -+-.+.|.|||++..|..+.+     +..++.|||..|++..+|++.......+......+++.||..||.|||+. .|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            455667999999998885543     46789999999999999998877777788888889999999999999986 778


Q ss_pred             eEecCCCCCCeeecCCCcEEEeecCCceecccCC----CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh
Q 013750          237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT  312 (437)
Q Consensus       237 iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt  312 (437)
                      ++|+++..+.|++..++-+|++-- .........    ........+.++|.+||+=...+.+.++|||+||...+||--
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999988887532 111111110    111222346789999998877788889999999999999988


Q ss_pred             CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          313 GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       313 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      |..-..-+    +.....-......     ...+-++            .=..++..|++..|..||+|.+++.
T Consensus       278 lEiq~tns----eS~~~~ee~ia~~-----i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNS----ESKVEVEENIANV-----IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCC----cceeehhhhhhhh-----eeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence            76432111    1110000000000     0000011            1123566899999999999999873

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1.1e-13  Score=139.18  Aligned_cols=142  Identities=23%  Similarity=0.245  Sum_probs=99.6

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcch---------------------------------------HHHH
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD---------------------------------------AAFQ  157 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~---------------------------------------~~~~  157 (437)
                      .+.||+|++|.||+|++++|+.||||+..+.....-.                                       -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4689999999999999999999999998653210000                                       0233


Q ss_pred             HHHHHHHhcc----cccceeeeeeee-cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 013750          158 REVEMISVAV----HRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-GLEYLHE  231 (437)
Q Consensus       158 ~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~  231 (437)
                      +|...+.+++    |.+-+.+-.++. -....+|||||+++++|.+.......+   .   .+.+++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence            4554444442    333333333332 234579999999999998876532111   1   23456666666 4678898


Q ss_pred             cCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       232 ~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      .   +++|+|++|.||++++++.++++|||++..++
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   99999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=2e-11  Score=123.17  Aligned_cols=231  Identities=17%  Similarity=0.177  Sum_probs=151.2

Q ss_pred             ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCH
Q 013750          133 LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW  212 (437)
Q Consensus       133 ~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  212 (437)
                      ..++.+|.|...+.... ...+...+-++.++.++||||++++.........|+|+|-+.  .|..++.+.       .-
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GK  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HH
Confidence            34688888888765332 334456678889999999999999999999999999999874  466666653       23


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCC
Q 013750          213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG  292 (437)
Q Consensus       213 ~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  292 (437)
                      ....-.+.||+.||.|||+.|  +++|+||....|++++.|+.||++|-++.....-.. ......--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            344556789999999999877  899999999999999999999999998864432111 01111122356777765432


Q ss_pred             CCCCchhhHHHHHHHHHHHhCCCCCCCCcc-cccch-hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHh
Q 013750          293 KSSERTDVFGYGIMLLELVTGQRAIDFSRL-EEEDD-VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLC  370 (437)
Q Consensus       293 ~~~~~sDv~s~Gv~l~elltg~~p~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C  370 (437)
                      .  -..|.|.||++++|++.|..+...... ..... .......+         .+...      +...+. .++++..|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k---------~~~~~------~~~r~n-~~~~~~~~  242 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCK---------KLGAT------ELKRPN-KLRFILEC  242 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHH---------Hhccc------cccccc-hhhHHHHH
Confidence            2  346999999999999999332211000 00000 00000000         11110      111111 55667777


Q ss_pred             ccCCCCCCCCHHHHHHHHhcCCCC
Q 013750          371 TQASPEDRPAMSEVVRMLEGEGLA  394 (437)
Q Consensus       371 l~~dp~~RPs~~evl~~L~~~~~~  394 (437)
                      ....+--|=.+-+++.+|+...+-
T Consensus       243 ~~~~gff~n~fvd~~~fLeel~lk  266 (690)
T KOG1243|consen  243 RLLGGFFRNDFVDTLLFLEELRLK  266 (690)
T ss_pred             HhccccccchHHHHHHHHHhcccC
Confidence            777777777888888888774444

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=1e-12  Score=134.09  Aligned_cols=147  Identities=20%  Similarity=0.196  Sum_probs=92.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCC---------------------------------cchH--
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESP---------------------------------GGDA--  154 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---------------------------------~~~~--  154 (437)
                      ...|+. +.||+|++|.||+|++++ |+.||||+..+....                                 ...+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345765 789999999999999987 999999999753100                                 0011  


Q ss_pred             ----HHHHHHHHHHhcc----cccceeeeeeeec-CCeeEEEEecccCchhhhhhhhcCCCC--CCCCHHHHHHHHHHHH
Q 013750          155 ----AFQREVEMISVAV----HRNLLRLIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAA  223 (437)
Q Consensus       155 ----~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~l~~~~~~~i~~~ia  223 (437)
                          +|.+|..-+.+++    +.+.+.+-.++.+ ....+|||||++++.+.+...-...+.  ..+.......++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence                1333433333332    3333333333322 345789999999999976422111110  01222222222233  


Q ss_pred             HHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeecCCceeccc
Q 013750          224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDFGLAKLVDV  268 (437)
Q Consensus       224 ~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~  268 (437)
                           +...   +++|+|++|.||+++.++    .+++.|||++..++.
T Consensus       276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3345   999999999999999988    999999999987753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=4.1e-12  Score=111.41  Aligned_cols=129  Identities=22%  Similarity=0.174  Sum_probs=96.4

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee-eeeeeecCCeeEEEEecccCchh
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-LIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      +.|+.|.++.||++... +..|++|......  .....+..|+.++..+.+.++++ ++++.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT--ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCc--ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56889999999999975 7889999875432  12345678999999887766654 44433  3345899999999877


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          197 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       197 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ...  .       .   .......+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            543  0       0   11235678999999999983  22369999999999999 6689999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.4e-12  Score=127.41  Aligned_cols=247  Identities=19%  Similarity=0.175  Sum_probs=173.9

Q ss_pred             CCCCCCeeee--cCcEEEEEEEE---CCCCEEEEEEecc-CCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeE
Q 013750          113 NFSEKNVLGQ--GGFGKVYRGVL---ADGTKVAVKRLTD-FESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       113 ~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  185 (437)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-+. ...+.....=.+|+....++ .|+|.++........+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3455678999  99999999986   3588899997432 22223333334666666666 4999999888888999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Df  260 (437)
                      +-+|++. .+|..+.+....   .++....+....+..+    |+.++|+.   +++|-|+||.||++..+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999986 677777665332   2444555566666667    99999999   99999999999999999 88999999


Q ss_pred             CCceecccCCCcc----cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          261 GLAKLVDVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       261 gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |+...++...-..    .....+...|++||.. .+-++..+|+|++|.++.+..++..+........        |. .
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~-~  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WS-Q  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cc-c
Confidence            9998776443111    1223578899999987 4567889999999999999999877654221110        00 0


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                      ........+.++.         -..++.....++++.+|-.|++.+.+.
T Consensus       338 ~r~~~ip~e~~~~---------~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  338 LRQGYIPLEFCEG---------GSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccccCchhhhcC---------cchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0000111122211         123555588899999999999987765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.5e-10  Score=105.97  Aligned_cols=143  Identities=22%  Similarity=0.280  Sum_probs=107.6

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc--cceeeeeeeecCC---eeEEEEeccc
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIGFCTTPT---ERLLVYPFMQ  192 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lv~e~~~  192 (437)
                      +.|+.|..+.||++...+|..+++|.............+..|++++..+.+.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999998777899999876433222355788999999998764  4566777776542   5689999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC---------------------------------------  233 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------  233 (437)
                      +.++...+..     ..++......++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765431     12566666677777777777777421                                       


Q ss_pred             --------------CCceEecCCCCCCeeecC--CCcEEEeecCCcee
Q 013750          234 --------------NPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKL  265 (437)
Q Consensus       234 --------------~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~  265 (437)
                                    ...++|+|+.+.||+++.  +..+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=5.6e-10  Score=99.46  Aligned_cols=138  Identities=14%  Similarity=0.148  Sum_probs=96.9

Q ss_pred             CCeeeecCcEEEEEEEECC-------CCEEEEEEeccCCC---------------------CcchHHHH----HHHHHHH
Q 013750          117 KNVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFES---------------------PGGDAAFQ----REVEMIS  164 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~~---------------------~~~~~~~~----~E~~~l~  164 (437)
                      ...||.|.-+.||.|...+       +..+|||+.+....                     ....+.+.    +|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998543       47999997752110                     01122333    7888888


Q ss_pred             hcccc--cceeeeeeeecCCeeEEEEecccCchhhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEec
Q 013750          165 VAVHR--NLLRLIGFCTTPTERLLVYPFMQNLSVAY-RLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHR  240 (437)
Q Consensus       165 ~l~H~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiH~  240 (437)
                      ++...  ++-..+++    ...++||||+.+..+.. .+.+     ..++......+..+++.+|..| |..   +++|+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            88643  44455543    56789999997653321 2222     1234445667788999999999 777   99999


Q ss_pred             CCCCCCeeecCCCcEEEeecCCceecc
Q 013750          241 DVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       241 dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||++.||++++ +.+.|+|||.+....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 579999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=2.2e-11  Score=121.58  Aligned_cols=250  Identities=18%  Similarity=0.166  Sum_probs=173.7

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEeccCCCCc-chHHHHHHHHHHHhc-ccccceeeeeeeecCCe
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESPG-GDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  183 (437)
                      ...+.+|.....||.|.|+.|++...+  ++..|++|.+.+..... ....-+.|+-+...+ .|.+.+.....+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            334567888899999999999997743  68899999886533222 222233566666555 48888887766666677


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCC
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGL  262 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgl  262 (437)
                      .++--||++++++.....-    ...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-++.|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence            7888999999988776622    22366677888999999999999999   99999999999999886 7889999999


Q ss_pred             ceecccCCCccccccccccccc--ccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHI--APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ...+...    ........++.  +|+......+..+.|++|||.-+.|.+++..-....     ..             
T Consensus       414 ~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----~~-------------  471 (524)
T KOG0601|consen  414 WTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----VQ-------------  471 (524)
T ss_pred             cccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-----cc-------------
Confidence            8742211    11112233444  555556667889999999999999999987532210     00             


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ...+....+ .. .+.....+..+...+...++..||.+.++....+.
T Consensus       472 --~~~i~~~~~-p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  472 --SLTIRSGDT-PN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             --ceeeecccc-cC-CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence              000000000 00 11222567778888999999999999988766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=3.3e-09  Score=104.31  Aligned_cols=220  Identities=14%  Similarity=0.157  Sum_probs=152.8

Q ss_pred             CcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec----CCeeEEEEecccC-chhh
Q 013750          124 GFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVYPFMQN-LSVA  197 (437)
Q Consensus       124 ~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~  197 (437)
                      .-.+.||+.. -||..|++|+++...... ...-..-+++++++.|+|+|++..++.+    +..+++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            3467889885 479999999995432211 1122356889999999999999998863    3457899999976 5666


Q ss_pred             hhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          198 YRLREIKP-----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       198 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ++.....+           ..........+.++.|++.||.++|+.   |+..+-|.+++||++.+.+++|+.+|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            55433221           223466788899999999999999999   9999999999999999999999999988766


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..++..               -+..   -.+-|.=.||.+++.|.||........      ........           
T Consensus       444 ~~d~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d------~~~~s~~~-----------  488 (655)
T KOG3741|consen  444 QEDPTE---------------PLES---QQQNDLRDLGLLLLALATGTENSNRTD------STQSSHLT-----------  488 (655)
T ss_pred             cCCCCc---------------chhH---HhhhhHHHHHHHHHHHhhccccccccc------chHHHHHH-----------
Confidence            544311               1111   235688899999999999965321100      00000011           


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .+....+.++.+++..-...++++ -+..+++.+.-.
T Consensus       489 -------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  489 -------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             -------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence                   112334456777777777888887 778888876644

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=3.7e-09  Score=91.06  Aligned_cols=144  Identities=19%  Similarity=0.215  Sum_probs=104.5

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEecc-CCC-C-----cchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FES-P-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~-~~~-~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ...++-+|+-+.|+++.++ |+.+.||.-.. .-. +     -....-.+|.+.+.+++--.|..-.=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678999999999999995 88888885432 111 1     12345668999999887656654444566667778999


Q ss_pred             ecccC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---cEEEeecCCce
Q 013750          189 PFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAK  264 (437)
Q Consensus       189 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~  264 (437)
                      ||+++ -++.+++.......  ..-.....++..|-+.+.-||.+   .++|+||.++||+|..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 47777776543222  22223357788899999999999   999999999999996554   35899999986


Q ss_pred             e
Q 013750          265 L  265 (437)
Q Consensus       265 ~  265 (437)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=3.1e-09  Score=91.90  Aligned_cols=132  Identities=21%  Similarity=0.289  Sum_probs=98.9

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEec-cCCCCcc------hHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGG------DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~-~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ..+++|+-+.+|.+.+. |.++++|.-. +.-....      ...-.+|..++.+++--.|..-.=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999875 5556777542 2211111      22345789999888765554444456778888999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      .++-.|.+.+...           ...++..+-.-+.-||..   +|+|+||.++||.+..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888763           134566777778889999   999999999999998875 99999999974

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=1.4e-08  Score=95.42  Aligned_cols=142  Identities=16%  Similarity=0.079  Sum_probs=101.8

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc----------chHHHHHHHHHHHhcccccc--eeeeeeeec-----
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNL--LRLIGFCTT-----  180 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----  180 (437)
                      +.+-+.....|++..+ +|+.|.||+........          ....+.+|...+.++...+|  ..++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555555566778777 57899999775322111          11247789998888854443  344555532     


Q ss_pred             CCeeEEEEecccCc-hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-------C
Q 013750          181 PTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-------D  252 (437)
Q Consensus       181 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-------~  252 (437)
                      ....++|+|++++- +|.+++.+...  ...+...+..++.+++..+.-||+.   +++|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23578999999885 78888754321  2245566778999999999999999   9999999999999975       5


Q ss_pred             CcEEEeecCCcee
Q 013750          253 FEAVVGDFGLAKL  265 (437)
Q Consensus       253 ~~~kl~Dfgla~~  265 (437)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            7899999998863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.96  E-value=4.4e-08  Score=94.29  Aligned_cols=263  Identities=16%  Similarity=0.153  Sum_probs=155.9

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeee-------ecCCeeEEE
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC-------TTPTERLLV  187 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lv  187 (437)
                      ..+-||+|+-+.+|-.-.- +..|| |+.+... +...   .+.+..|... .||-+-.-+.+-       ......-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pp-pa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPP-PAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCC-chHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4577999999999954321 33344 7765422 1111   1233444433 465443211111       112224566


Q ss_pred             EecccCch-hhhhhh--hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          188 YPFMQNLS-VAYRLR--EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |+.+++.- ...++.  .....-+..+|...++.+.++|.+.+-||..   |.+-+|+.++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            77665531 222221  1122335579999999999999999999999   99999999999999999999999865443


Q ss_pred             ecccCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHH
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      ..  .........+|...|.+||.-.     +..-+..+|-|.+|+++++++.| ++||...........-.-..+....
T Consensus       166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            32  2333445567899999999764     34457889999999999999987 9998743222111100000000000


Q ss_pred             --hccchhhhccccccCCCC-HHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHHhc
Q 013750          339 --REKRLDAIVDRNLNKNYN-IQEVETMIQVALLCTQA--SPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       339 --~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~--dp~~RPs~~evl~~L~~  390 (437)
                        .......-..+. ....+ .-.+..+.-+..+|+..  ++.-|||++..+..|..
T Consensus       244 f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         244 FAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence              000000000000 01112 22345677777788865  36789999988877653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.93  E-value=2.7e-10  Score=119.87  Aligned_cols=250  Identities=17%  Similarity=0.180  Sum_probs=164.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ...+.+.+.+-+.+|.++.++.+.-. .|...++|......  .....+....+-.++-..+||-++...--+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567777788889999999987743 35445555443211  1111222333333333345566665544444566788


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      |+++|..+++|...|+....    .+..-.......+..+++|||+.   .+.|+|++|.|.|...++..+++|||....
T Consensus       881 L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            99999999999988876542    33333444556678899999998   799999999999999999999999984332


Q ss_pred             cccC------------------------------CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCC
Q 013750          266 VDVR------------------------------KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR  315 (437)
Q Consensus       266 ~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~  315 (437)
                      ...-                              .........+|+.|.+||...+......+|+|+.|+.++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2100                              0001122468999999999999999999999999999999999999


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhccchhhhcccccc-CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          316 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       316 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      ||.........                 +.+...... ...+........+++..-+..+|.+|-.+.
T Consensus      1034 p~na~tpq~~f-----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIF-----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhh-----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99754432110                 011110000 111223344667777778888999997765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=4.3e-08  Score=87.01  Aligned_cols=126  Identities=19%  Similarity=0.233  Sum_probs=80.5

Q ss_pred             EEEEEEECCCCEEEEEEeccCCC------------Cc-------------chHHHHHHHHHHHhccccc--ceeeeeeee
Q 013750          127 KVYRGVLADGTKVAVKRLTDFES------------PG-------------GDAAFQREVEMISVAVHRN--LLRLIGFCT  179 (437)
Q Consensus       127 ~Vy~~~~~~g~~vAvK~l~~~~~------------~~-------------~~~~~~~E~~~l~~l~H~n--iv~l~g~~~  179 (437)
                      .||.|...+|..+|+|.......            ..             ......+|.+.|.++..-+  +-+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999998899999998753110            00             0123557999999997664  4445443  


Q ss_pred             cCCeeEEEEeccc--CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          180 TPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY-LHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       180 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                        ...++||||++  +..+..+... .     ++......++.+++..+.. +|..   +++|+||.+.||+++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  5555443322 1     1123345567777775555 4677   99999999999999988 999


Q ss_pred             EeecCCceec
Q 013750          257 VGDFGLAKLV  266 (437)
Q Consensus       257 l~Dfgla~~~  266 (437)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=6.3e-09  Score=105.76  Aligned_cols=151  Identities=15%  Similarity=0.265  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc--------ccccccccccccccccccCC
Q 013750          221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--------VTTQVRGTMGHIAPEYLSTG  292 (437)
Q Consensus       221 ~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~  292 (437)
                      +++.|+.|+|...  ++||++|.|++|.++.++.+||+.|+.+.........        ..........|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4569999999874  8999999999999999999999999987644321110        01112245689999999998


Q ss_pred             CCCCchhhHHHHHHHHHHHhCCCC-CCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhc
Q 013750          293 KSSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT  371 (437)
Q Consensus       293 ~~~~~sDv~s~Gv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  371 (437)
                      ..+.++|+||+|+++|-+..|..+ +.........      .         .....+..-...+..+.+.++.+=+.+.+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------~---------~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------S---------FSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh------h---------hhhcccccccccccccCcHHHHHHHHHHh
Confidence            889999999999999999954443 3322111100      0         00000111111122344556777777889


Q ss_pred             cCCCCCCCCHHHHHHHH
Q 013750          372 QASPEDRPAMSEVVRML  388 (437)
Q Consensus       372 ~~dp~~RPs~~evl~~L  388 (437)
                      +.++.-||++.++....
T Consensus       250 ~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cCCcccCcchhhhhccc
Confidence            99999999888876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.66  E-value=2.8e-07  Score=84.60  Aligned_cols=136  Identities=21%  Similarity=0.176  Sum_probs=92.1

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC---------------------CcchHHHHHHHHHHHhcccc--c
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---------------------PGGDAAFQREVEMISVAVHR--N  170 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---------------------~~~~~~~~~E~~~l~~l~H~--n  170 (437)
                      ..+...||-|.-+.||.|..++|.++|||.-....+                     .-......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345688999999999999999999999995432110                     00112345788888887644  4


Q ss_pred             ceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec
Q 013750          171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD  250 (437)
Q Consensus       171 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~  250 (437)
                      +-+.++    .+...+||||.++-.|...-         ++-...-.++..|++-+.-+-..   |++|+|+++-||+++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            444433    35568999999886554321         11222233444444444444455   999999999999999


Q ss_pred             CCCcEEEeecCCcee
Q 013750          251 EDFEAVVGDFGLAKL  265 (437)
Q Consensus       251 ~~~~~kl~Dfgla~~  265 (437)
                      +|+.+.++||--+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.63  E-value=3.7e-07  Score=82.78  Aligned_cols=124  Identities=19%  Similarity=0.207  Sum_probs=90.2

Q ss_pred             CCEEEEEEeccCCC------CcchHHHHHHHHHHHhccccc--ceeeeeeeecCC----eeEEEEecccC-chhhhhhhh
Q 013750          136 GTKVAVKRLTDFES------PGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPT----ERLLVYPFMQN-LSVAYRLRE  202 (437)
Q Consensus       136 g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~----~~~lv~e~~~~-gsL~~~l~~  202 (437)
                      ++.+-+|.......      .-......+|...+..+....  ..+.+++.....    ..++|+|++++ .+|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            55666775432111      123446778888887775433  445566654432    45899999987 478888875


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---cEEEeecCCceec
Q 013750          203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKLV  266 (437)
Q Consensus       203 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~~~  266 (437)
                      ...    .+-.....++.+++..++-||+.   +++|+|+++.|||++.+.   .+.++||+.++..
T Consensus       112 ~~~----~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WEQ----LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hcc----cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            332    45556778999999999999999   999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=2.2e-06  Score=76.78  Aligned_cols=139  Identities=19%  Similarity=0.176  Sum_probs=102.1

Q ss_pred             eeecCcEEEEEEEECCCCEEEEEEeccCC----C-CcchHHHHHHHHHHHhccccc--ceeeeeeee-c--C--CeeEEE
Q 013750          120 LGQGGFGKVYRGVLADGTKVAVKRLTDFE----S-PGGDAAFQREVEMISVAVHRN--LLRLIGFCT-T--P--TERLLV  187 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----~-~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~--~--~~~~lv  187 (437)
                      -|.||-+.|++-.+. |..+-+|+-...-    . +-....|.+|...+..+..-+  +.+.. ++. .  +  -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            567899999998875 5579999875211    1 445678999999999886443  33333 332 1  1  135789


Q ss_pred             EecccC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc--EEEeecCCce
Q 013750          188 YPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~  264 (437)
                      +|-+++ -+|.+++.+...  ...+...+..+..+++..++-||+.   ++.|+|+-+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            996653 578877754321  2356677789999999999999999   9999999999999986666  9999998765


Q ss_pred             e
Q 013750          265 L  265 (437)
Q Consensus       265 ~  265 (437)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=1.2e-06  Score=89.25  Aligned_cols=147  Identities=22%  Similarity=0.265  Sum_probs=92.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcch-----------------------------H--------
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-----------------------------A--------  154 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~-----------------------------~--------  154 (437)
                      ..|+ .+-|+.++-|.||+|++++|+.||||+..+.-...-.                             +        
T Consensus       126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            3444 3689999999999999999999999988752211000                             0        


Q ss_pred             --HHHHHHHHHHhcc----cccceeeeeeee-cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHH-H
Q 013750          155 --AFQREVEMISVAV----HRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG-L  226 (437)
Q Consensus       155 --~~~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-l  226 (437)
                        +|.+|..-+.+++    +..-+.+=.++. -.....|+|||++|-.+.+...-...+   .+   +..++..++++ +
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d---~k~ia~~~~~~f~  278 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---ID---RKELAELLVRAFL  278 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CC---HHHHHHHHHHHHH
Confidence              1222333333332    111122222332 245678999999998888874332222   33   23333333332 2


Q ss_pred             HHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       227 ~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      .-+-..   ++.|.|..|.||+++.++.+.+.|||+....+.
T Consensus       279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222234   899999999999999999999999999886653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=5.8e-06  Score=76.04  Aligned_cols=139  Identities=14%  Similarity=0.152  Sum_probs=85.8

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc--eeeeeeeecCCeeEEEEecccCch
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      ..||+|..+.||+.   .|..+++|......   ......+|.+++..+..-.+  .+.++++...+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984   25567788775422   34456889999988865444  566777777777889999998863


Q ss_pred             -hhhh---------------------hhhcCCCCCCCCHHHHHH-HHH----------HH-HHHHHHHHhc-CCCceEec
Q 013750          196 -VAYR---------------------LREIKPGEPVLDWVTRKR-VAL----------GA-ARGLEYLHEH-CNPKIIHR  240 (437)
Q Consensus       196 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~i-a~~l~yLH~~-~~~~iiH~  240 (437)
                       +...                     ++......  ........ +..          .+ .....+|... ..+.++|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence             1111                     11111111  11111100 000          01 1122333322 13468999


Q ss_pred             CCCCCCeeecCCCcEEEeecCCcee
Q 013750          241 DVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       241 dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      |+.|.||++++++ +.++||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.25  E-value=1.3e-05  Score=72.24  Aligned_cols=138  Identities=14%  Similarity=0.136  Sum_probs=91.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHH---------HHHHHHHHhcccc---cceeeee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF---------QREVEMISVAVHR---NLLRLIG  176 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~---------~~E~~~l~~l~H~---niv~l~g  176 (437)
                      ....+|...+++-......|.+... +|..+++|...+.. ....+.|         .+++..+.+++..   ....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3456788888888888888888877 47899999876532 1122222         2333333344322   2222222


Q ss_pred             ee-----ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC
Q 013750          177 FC-----TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE  251 (437)
Q Consensus       177 ~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~  251 (437)
                      ++     .-....+++|||++|..|.+...        ++.    .++..+++++.-||+.   |+.|+|..|.|+++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence            22     22234568999999988765532        121    2455677889999999   9999999999999996


Q ss_pred             CCcEEEeecCCce
Q 013750          252 DFEAVVGDFGLAK  264 (437)
Q Consensus       252 ~~~~kl~Dfgla~  264 (437)
                      ++ +++.||+..+
T Consensus       171 ~~-i~iID~~~k~  182 (229)
T PF06176_consen  171 NG-IRIIDTQGKR  182 (229)
T ss_pred             Cc-EEEEECcccc
Confidence            64 9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.19  E-value=2.8e-05  Score=71.29  Aligned_cols=144  Identities=19%  Similarity=0.214  Sum_probs=85.6

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeeeeec---CCeeEEEEeccc
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTT---PTERLLVYPFMQ  192 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~---~~~~~lv~e~~~  192 (437)
                      +.++.|..+.||+....+ ..+++|.....   .....+..|..++..+....  +.+++.++..   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568999999999999876 69999987542   34567788999988886443  3456654432   234689999999


Q ss_pred             Cchhhh----------------hh---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 013750          193 NLSVAY----------------RL---REIKPGEPVLDWVTR---------KRV------------ALGAAR-GLEYLHE  231 (437)
Q Consensus       193 ~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-~l~yLH~  231 (437)
                      +..+..                .+   +..........+...         ...            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987777                11   111111111111110         000            112222 3444443


Q ss_pred             c----CCCceEecCCCCCCeeec-CCCcEEEeecCCcee
Q 013750          232 H----CNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKL  265 (437)
Q Consensus       232 ~----~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~  265 (437)
                      .    ....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    234799999999999999 666678999988763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.18  E-value=2e-05  Score=71.87  Aligned_cols=154  Identities=22%  Similarity=0.243  Sum_probs=93.8

Q ss_pred             cCHHHHHHHhcCCCCCCe---eeecCcEEEEEEEECCCCEEEEEEeccCCCCcc--------hHHH--------------
Q 013750          102 YSWRELQLATDNFSEKNV---LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG--------DAAF--------------  156 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~---lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~--------~~~~--------------  156 (437)
                      .+++.+....+...+...   |.+|.-+.||+|.-.++..+|||+.......-.        ...|              
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            444555555555555544   556778899999988899999999864221100        0111              


Q ss_pred             -HHHHHHHHhccccc--ceeeeeeeecCCeeEEEEecccCc-hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 013750          157 -QREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH  232 (437)
Q Consensus       157 -~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  232 (437)
                       .+|+.-|.++....  +-+-+++    ..-.|||||+... .-.-.|.+     ..+.......+..++.+.+.-|-..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence             12444444432221  1111111    2346999998654 11111222     1223335666777888888877773


Q ss_pred             CCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       233 ~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +  +++|+||+.-|||+. ++.+.++|+|-|....
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            3  899999999999999 7899999999887543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=1.8e-05  Score=80.54  Aligned_cols=144  Identities=19%  Similarity=0.170  Sum_probs=88.9

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchH------------------------------------HHHHHH
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA------------------------------------AFQREV  160 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~------------------------------------~~~~E~  160 (437)
                      .+-||..+.|.||+|++++|+.||||+-++.-......                                    +|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999876522111000                                    133333


Q ss_pred             HHHHh----cccccc---eeeeeeee-cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 013750          161 EMISV----AVHRNL---LRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH  232 (437)
Q Consensus       161 ~~l~~----l~H~ni---v~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  232 (437)
                      +-..+    +.|-+.   |.+=.++. -...+.|+||||+|..+.+...-...+   ++-.   .++..+.++.  ++.-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~---~i~~~l~~~~--~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPH---DILNKLVEAY--LEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHH---HHHHHHHHHH--HHHH
Confidence            32222    234441   11212222 234678999999998887764322222   3333   3333333332  2221


Q ss_pred             CCCceEecCCCCCCeeec----CCCcEEEeecCCceeccc
Q 013750          233 CNPKIIHRDVKAANVLLD----EDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       233 ~~~~iiH~dlk~~NIll~----~~~~~kl~Dfgla~~~~~  268 (437)
                      ...|++|.|-.|.||+++    .++++.+-|||+......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            122899999999999998    378899999999886643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=5.9e-05  Score=82.55  Aligned_cols=151  Identities=13%  Similarity=0.215  Sum_probs=94.7

Q ss_pred             CCeeeecCcEEEEEEEECCC---CEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccc--eeeeeeeecC---CeeEEE
Q 013750          117 KNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNL--LRLIGFCTTP---TERLLV  187 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv  187 (437)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|.++++.+. |+++  .+++++|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999887654   4677887643322233457889999999985 6665  6778888764   357899


Q ss_pred             EecccCchhhh--------------------h---hhhcCCCC-------CCCCH--------HHHHHH---------HH
Q 013750          188 YPFMQNLSVAY--------------------R---LREIKPGE-------PVLDW--------VTRKRV---------AL  220 (437)
Q Consensus       188 ~e~~~~gsL~~--------------------~---l~~~~~~~-------~~l~~--------~~~~~i---------~~  220 (437)
                      |||+++..+.+                    .   |+......       .+..+        .....-         .-
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998764321                    1   11111000       01111        111000         11


Q ss_pred             HHHHHHHHHHhcCC--------CceEecCCCCCCeeecCC-Cc-EEEeecCCceecc
Q 013750          221 GAARGLEYLHEHCN--------PKIIHRDVKAANVLLDED-FE-AVVGDFGLAKLVD  267 (437)
Q Consensus       221 ~ia~~l~yLH~~~~--------~~iiH~dlk~~NIll~~~-~~-~kl~Dfgla~~~~  267 (437)
                      .+.+.+.+|..+.+        +.++|+|+++.||+++.+ .. .-|.||.++..-+
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            23445677765432        359999999999999853 33 5799999887543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=3.1e-05  Score=66.84  Aligned_cols=126  Identities=17%  Similarity=0.216  Sum_probs=85.7

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceee-eeeeecCCeeEEEEecccCch
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL-IGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .+.|++|++|.||+|.+. |..+|+|+-..   +.....+..|.+++..+.-.++.+= +.|-    +-++.|||..+-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            467999999999999996 66889997654   4456789999999999987777543 3322    2234599998877


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCC--CCeeecCCCcEEEeecCCcee
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA--ANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~--~NIll~~~~~~kl~Dfgla~~  265 (437)
                      |.+.-...       +-    +-...+++.---|-..   +|-|+.|.-  .||++.+ ..+.|+||..|+.
T Consensus        99 L~~~~~~~-------~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-------DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-------cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            76554321       11    2233344442233334   888888864  4555544 4899999998873

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=8e-05  Score=69.29  Aligned_cols=140  Identities=16%  Similarity=0.099  Sum_probs=84.0

Q ss_pred             eeecCc-EEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEecccCchhh
Q 013750          120 LGQGGF-GKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNLSVA  197 (437)
Q Consensus       120 lG~G~f-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  197 (437)
                      |-.|.. ..||+...+ +..+.+|+.....    .....+|+++++.+. +--+.+++++....+..++|||++++.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            344444 889998764 4788888775421    345678898888774 333446677776666788999999987776


Q ss_pred             hhh-------------------hhcCCCCCCCC-H-HHHHHHHH--------------------HHHHHHHHHHhc----
Q 013750          198 YRL-------------------REIKPGEPVLD-W-VTRKRVAL--------------------GAARGLEYLHEH----  232 (437)
Q Consensus       198 ~~l-------------------~~~~~~~~~l~-~-~~~~~i~~--------------------~ia~~l~yLH~~----  232 (437)
                      ...                   +.......... + ........                    .+...+..|-..    
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   11111010111 0 00000000                    011222233221    


Q ss_pred             CCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       233 ~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23569999999999999998778999998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.02  E-value=5e-07  Score=91.36  Aligned_cols=185  Identities=16%  Similarity=0.111  Sum_probs=127.6

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc-ceeeeeeeecCCeeEEEEeccc
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN-LLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      +...+-+++|++++++|.+-...+....+.+..    .  ....-++++|.+++||| .+..++-+.......++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~----~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ----T--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeecc----c--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            333456788999999987743233333444321    1  34456889999999999 6666666666677788899987


Q ss_pred             Cc-hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          193 NL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       193 ~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      .+ +-.....   ...-.+...+...+...-+++++|+|+.   .=+|+|    ||+..+ ...+.+||+....+.... 
T Consensus       318 ~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  318 TGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             CCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-
Confidence            76 2211111   1111233333444555667899999987   457888    888776 578999999987665432 


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                       ......+++.|+|||......+....|+|+.|+--.++--|..|-
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence             233456899999999999999999999999998777777666654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.01  E-value=2.7e-05  Score=69.36  Aligned_cols=102  Identities=21%  Similarity=0.192  Sum_probs=81.3

Q ss_pred             HHHHHHHhccc-ccceeeeeeeecCCeeEEEEecccCchhhhh---hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 013750          158 REVEMISVAVH-RNLLRLIGFCTTPTERLLVYPFMQNLSVAYR---LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC  233 (437)
Q Consensus       158 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  233 (437)
                      .|.-++..+++ +++.+++|+|-    .+++.||...+++...   +...    ...+|..|.+||.++++.+.+|++..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            57778888876 69999999993    4678999987765321   1111    12589999999999999999999864


Q ss_pred             CCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       234 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ...+.-.|++++|+-+++++++|++|...+....
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            4467789999999999999999999998876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.98  E-value=0.00025  Score=63.60  Aligned_cols=136  Identities=21%  Similarity=0.271  Sum_probs=94.9

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC---------------CCcchHHHHHHHHHHHhcc------ccccee
Q 013750          115 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE---------------SPGGDAAFQREVEMISVAV------HRNLLR  173 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~---------------~~~~~~~~~~E~~~l~~l~------H~niv~  173 (437)
                      +....||+|+.-.||  .++++....||+.....               ......+..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            345779999999999  46667788899887533               1123566777887766665      788999


Q ss_pred             eeeeeecCCeeEEEEecccC--c----hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          174 LIGFCTTPTERLLVYPFMQN--L----SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       174 l~g~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      ++|+..++.-.-+|+|.+.+  |    +|.+++.+.     .++.    .+...+-+-..||-++   .|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH----HHHHHHHHHHHHHHHc---CCeecCCCcccE
Confidence            99999999999999988743  2    455555332     1333    2333444556677777   899999999999


Q ss_pred             eecCC---C-cEEEee-cCCce
Q 013750          248 LLDED---F-EAVVGD-FGLAK  264 (437)
Q Consensus       248 ll~~~---~-~~kl~D-fgla~  264 (437)
                      ++..+   . .+.|+| ||-..
T Consensus       150 v~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EEEecCCCceEEEEEeCCCCcc
Confidence            99533   2 567777 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.00019  Score=63.97  Aligned_cols=126  Identities=25%  Similarity=0.310  Sum_probs=89.8

Q ss_pred             cCCCCCCeeeecCc-EEEEEEEECCCCEEEEEEecc---CCC-------C----------cchHHHHHHHHHHHhcc---
Q 013750          112 DNFSEKNVLGQGGF-GKVYRGVLADGTKVAVKRLTD---FES-------P----------GGDAAFQREVEMISVAV---  167 (437)
Q Consensus       112 ~~~~~~~~lG~G~f-g~Vy~~~~~~g~~vAvK~l~~---~~~-------~----------~~~~~~~~E~~~l~~l~---  167 (437)
                      .+++..+.||.|.- |.||+++. +|..+|+|....   ...       .          .....|..|.+..++++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78888999999999 99999999 488999999321   000       0          11235778988877775   


Q ss_pred             cccc--eeeeeeeecC------------------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 013750          168 HRNL--LRLIGFCTTP------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE  227 (437)
Q Consensus       168 H~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~  227 (437)
                      +.++  |+.+||..-.                  ..+.+|.||.+...             .+.    .+-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            4566  8889987221                  12357777775532             011    223456777788


Q ss_pred             HHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       228 yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .+|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89999   9999999999986     4689999864

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00044  Score=66.38  Aligned_cols=79  Identities=14%  Similarity=0.164  Sum_probs=57.1

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc---ccceeeeeeeec---CCeeEEE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH---RNLLRLIGFCTT---PTERLLV  187 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv  187 (437)
                      ....+.||+|..+.||+....++ .+.+|..+.   ......|..|.+.++.+..   ..+.+++++|..   .+..++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34457799999999999877555 466676432   1133578899999988853   356778887754   3568999


Q ss_pred             EecccCchh
Q 013750          188 YPFMQNLSV  196 (437)
Q Consensus       188 ~e~~~~gsL  196 (437)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.79  E-value=0.00025  Score=65.66  Aligned_cols=141  Identities=20%  Similarity=0.256  Sum_probs=75.5

Q ss_pred             CeeeecCcE-EEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc---cceeeeeeeecCC---eeEEEEec
Q 013750          118 NVLGQGGFG-KVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCTTPT---ERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lv~e~  190 (437)
                      +.++.|+.. .||+.    +..+++|....   ......+.+|.+++..+...   .+-..++.....+   ..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 58875    24567776443   22345788999998877532   2223343333221   34789999


Q ss_pred             ccCchhhhh------------------hhhcCCCCCC------------C-CHHHHH--HHH-------HHHHH-HHHHH
Q 013750          191 MQNLSVAYR------------------LREIKPGEPV------------L-DWVTRK--RVA-------LGAAR-GLEYL  229 (437)
Q Consensus       191 ~~~gsL~~~------------------l~~~~~~~~~------------l-~~~~~~--~i~-------~~ia~-~l~yL  229 (437)
                      +++.++...                  |+........            + .|....  .+.       .+... ..+.+
T Consensus        76 i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  155 (235)
T cd05155          76 LEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAA  155 (235)
T ss_pred             ecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHH
Confidence            988666322                  1111111000            0 121110  000       01111 11111


Q ss_pred             Hhc---CCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          230 HEH---CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       230 H~~---~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ...   ..+.++|+|+.+.||+++++...-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         156 LRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             hcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            111   234599999999999999876678999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.71  E-value=0.00048  Score=63.55  Aligned_cols=141  Identities=18%  Similarity=0.219  Sum_probs=81.1

Q ss_pred             CeeeecCcEEEEEEEECC--CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.|..|-...+|+....+  +..|++|+......  ...+-.+|+.++..+...+++ ++++.+.    ..++|||+++.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            457778888999998764  67899997654221  112334788888888654444 3443322    24799999887


Q ss_pred             hhhhh--------------h---hhcCCCC-------CCCC-HHHHHHHHH----------------------HHHHHHH
Q 013750          195 SVAYR--------------L---REIKPGE-------PVLD-WVTRKRVAL----------------------GAARGLE  227 (437)
Q Consensus       195 sL~~~--------------l---~~~~~~~-------~~l~-~~~~~~i~~----------------------~ia~~l~  227 (437)
                      ++...              +   +......       .... |.....+..                      .+.+.+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65321              1   1111110       1111 222111111                      1111112


Q ss_pred             HH----Hhc-CCCceEecCCCCCCeeecC-CCcEEEeecCCce
Q 013750          228 YL----HEH-CNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK  264 (437)
Q Consensus       228 yL----H~~-~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~  264 (437)
                      .|    ... ....++|+|+.+.||++++ +..+.++||..+.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            22    111 2346999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.68  E-value=0.00022  Score=77.30  Aligned_cols=195  Identities=18%  Similarity=0.207  Sum_probs=133.1

Q ss_pred             HHHHHHHHhcccccceeeeeeeecCCeeE----EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 013750          157 QREVEMISVAVHRNLLRLIGFCTTPTERL----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH  232 (437)
Q Consensus       157 ~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  232 (437)
                      .-|.+.+.++.|+|++.+++|-......-    +..+++...++...+....    ..+..+.+.+..+...|++|+|+.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            35666788899999999998876554433    3346777777777666543    377888888999999999999998


Q ss_pred             CCCceEecCCCCC---CeeecCCCcEEEe--ecCCceecccCCCcccccccccccccccccccCCCCC--CchhhHHHHH
Q 013750          233 CNPKIIHRDVKAA---NVLLDEDFEAVVG--DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS--ERTDVFGYGI  305 (437)
Q Consensus       233 ~~~~iiH~dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~sDv~s~Gv  305 (437)
                         ...|.-+..+   +-..+..+...++  ||+.+.........  .....+..|.+||......+.  ...|+|.+|.
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence               5666555555   5555667777777  88888755432221  122345678888888766554  4479999999


Q ss_pred             HHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013750          306 MLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       306 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                      ....+..|..+......                    ...+++..     ..   ....+....|+..++++|++..+++
T Consensus       381 l~~~~~~~~~i~~~~~~--------------------~~~~l~~~-----~~---~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV--------------------PVSLLDVL-----ST---SELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHhhhhhcCcccccccc--------------------hhhhhccc-----cc---hhhhhhhhhhcchhhhhccchhhhh
Confidence            99999998765321110                    01111100     00   1456677789999999999999998


Q ss_pred             HHH
Q 013750          386 RML  388 (437)
Q Consensus       386 ~~L  388 (437)
                      ...
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            653

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.66  E-value=0.0004  Score=65.13  Aligned_cols=139  Identities=16%  Similarity=0.076  Sum_probs=79.1

Q ss_pred             eeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEecccCchhhh
Q 013750          120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFMQNLSVAY  198 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL~~  198 (437)
                      +..|-.+.+|+... ++..+++|....... ...-+..+|.++++.+....++ ++++.+.    ..+||||+++..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCK-ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccc-cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45677889998874 577888887643221 1112357888888888654443 3333322    368999999866542


Q ss_pred             h-----------------hhhcCCCCCCCCHHHHH-HHHH---------HHHHHHHHHHhc-----CCCceEecCCCCCC
Q 013750          199 R-----------------LREIKPGEPVLDWVTRK-RVAL---------GAARGLEYLHEH-----CNPKIIHRDVKAAN  246 (437)
Q Consensus       199 ~-----------------l~~~~~~~~~l~~~~~~-~i~~---------~ia~~l~yLH~~-----~~~~iiH~dlk~~N  246 (437)
                      .                 ++........++..... ....         .+...+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111111122222111 1111         111122222211     12368999999999


Q ss_pred             eeecCCCcEEEeecCCcee
Q 013750          247 VLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~  265 (437)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999988863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.53  E-value=0.00082  Score=64.40  Aligned_cols=143  Identities=16%  Similarity=0.093  Sum_probs=86.3

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeee------eecCCeeEEEE
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGF------CTTPTERLLVY  188 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~  188 (437)
                      .+.+..|....+|+....+ ..+++|+...    ........|++++..+.+.+  +.+++..      ....+..+.++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4567778778999987654 4788888753    22345667888888775433  3344331      12234568999


Q ss_pred             ecccCchhhh----h----------hhhcC----C---CCCCCCHHHHHH----------HHHHHHHHHHHHHh----cC
Q 013750          189 PFMQNLSVAY----R----------LREIK----P---GEPVLDWVTRKR----------VALGAARGLEYLHE----HC  233 (437)
Q Consensus       189 e~~~~gsL~~----~----------l~~~~----~---~~~~l~~~~~~~----------i~~~ia~~l~yLH~----~~  233 (437)
                      +|+++..+..    .          ++...    .   ......|.....          ....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998866532    0          11111    0   011123332211          11223344555553    12


Q ss_pred             CCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       234 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3479999999999999998778999998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.53  E-value=0.0017  Score=64.43  Aligned_cols=75  Identities=16%  Similarity=0.204  Sum_probs=53.2

Q ss_pred             CeeeecCcEEEEEEEECCC-CEEEEEEeccCC------CCcchHHHHHHHHHHHhcc---cccceeeeeeeecCCeeEEE
Q 013750          118 NVLGQGGFGKVYRGVLADG-TKVAVKRLTDFE------SPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~------~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv  187 (437)
                      +.||.|.+..||++...+| +.++||.-.+..      .+-..+.+..|.+.|..+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998777 489999854211      1234566778888887753   2345566655  44567899


Q ss_pred             EecccCc
Q 013750          188 YPFMQNL  194 (437)
Q Consensus       188 ~e~~~~g  194 (437)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.34  E-value=0.0077  Score=58.09  Aligned_cols=144  Identities=18%  Similarity=0.168  Sum_probs=82.2

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeeee------ecCCeeEEEE
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFC------TTPTERLLVY  188 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lv~  188 (437)
                      .+.++.|....+|+....+| .+++|+.....   ..+....|.+++..+....  +.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777789999876545 67788765421   2334556677776664322  33333321      1234568999


Q ss_pred             ecccCchhhhh--------------hhhcCCC----C----CCCCHHHHH------------HHHHHHHHHHHHHHh---
Q 013750          189 PFMQNLSVAYR--------------LREIKPG----E----PVLDWVTRK------------RVALGAARGLEYLHE---  231 (437)
Q Consensus       189 e~~~~gsL~~~--------------l~~~~~~----~----~~l~~~~~~------------~i~~~ia~~l~yLH~---  231 (437)
                      +|++|..+...              ++....+    .    ..-.|....            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            99987543210              1111110    0    011222111            011223345555543   


Q ss_pred             -cCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          232 -HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       232 -~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                       ....+++|+|+.+.||++++++...|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             234589999999999999998777899998875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.33  E-value=0.0017  Score=62.39  Aligned_cols=141  Identities=23%  Similarity=0.218  Sum_probs=82.6

Q ss_pred             CeeeecCcEEEEEEEECC-------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEe
Q 013750          118 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYP  189 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e  189 (437)
                      +.+..|-...+|+....+       +..+++|+.....  ....+..+|.+++..+....+. ++++++..    .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            445667777999988755       5789999865432  2223456888888877644443 44554432    35899


Q ss_pred             cccCchhhhh-----------------hhhcCCCC------C-CCCHHHHHH--------------------------HH
Q 013750          190 FMQNLSVAYR-----------------LREIKPGE------P-VLDWVTRKR--------------------------VA  219 (437)
Q Consensus       190 ~~~~gsL~~~-----------------l~~~~~~~------~-~l~~~~~~~--------------------------i~  219 (437)
                      |++|.++...                 ++......      . ..-|....+                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9888765431                 11111110      0 001111100                          11


Q ss_pred             HHHHHHHHHHHh------cCCCceEecCCCCCCeeecCC----CcEEEeecCCce
Q 013750          220 LGAARGLEYLHE------HCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAK  264 (437)
Q Consensus       220 ~~ia~~l~yLH~------~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~  264 (437)
                      ..+...+.++-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122233344432      234579999999999999985    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.30  E-value=0.0064  Score=58.92  Aligned_cols=142  Identities=13%  Similarity=0.099  Sum_probs=76.3

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeee------eeecCCeeEEEEe
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIG------FCTTPTERLLVYP  189 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lv~e  189 (437)
                      +.++.|....+|+...++| .+++|+... .   ..+....|+.++..+...+  +.+.+.      +....+..+++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            4566777789999887655 688898751 1   1233334555555543222  222221      1122445689999


Q ss_pred             cccCchhhh-----------h---hhhcCC-------CCCCCCH-HHHHH------------HH-HHHHHHHHHHHhc--
Q 013750          190 FMQNLSVAY-----------R---LREIKP-------GEPVLDW-VTRKR------------VA-LGAARGLEYLHEH--  232 (437)
Q Consensus       190 ~~~~gsL~~-----------~---l~~~~~-------~~~~l~~-~~~~~------------i~-~~ia~~l~yLH~~--  232 (437)
                      |+++..+..           .   ++....       ....+.| .....            .. ..+...++.+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            998864321           1   111110       0011112 11111            11 1111222333311  


Q ss_pred             --CCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          233 --CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       233 --~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                        .+.+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              34589999999999999977666899999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.12  E-value=0.0033  Score=59.88  Aligned_cols=143  Identities=24%  Similarity=0.284  Sum_probs=73.8

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc---cccceeeeeeeecCCeeEEEEecc
Q 013750          115 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      +..+.++.|....+|+.. .++..+.||.-.    ......|..|.+-|+.+.   --.+.+.+++....+..+|++||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678889999999987 568899999765    233457888999888874   334667888887777789999999


Q ss_pred             cCch--------hhh---hhhh-cC-----------------CCCCCCCHHHHH-----HHHHHHH-----------HHH
Q 013750          192 QNLS--------VAY---RLRE-IK-----------------PGEPVLDWVTRK-----RVALGAA-----------RGL  226 (437)
Q Consensus       192 ~~gs--------L~~---~l~~-~~-----------------~~~~~l~~~~~~-----~i~~~ia-----------~~l  226 (437)
                      +.+.        |..   .|+. ..                 .+...-+|....     .-..+.+           +.+
T Consensus        95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~  174 (288)
T PF03881_consen   95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV  174 (288)
T ss_dssp             ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence            8761        111   1222 11                 001113343221     1111111           112


Q ss_pred             HHHHh-----cCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          227 EYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       227 ~yLH~-----~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      +-+.+     ...|.++|+||-+.|++.+.++.+.|.|-..
T Consensus       175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~  215 (288)
T PF03881_consen  175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC  215 (288)
T ss_dssp             HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred             HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence            22222     1256799999999999999998899988763

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.92  E-value=0.011  Score=56.14  Aligned_cols=31  Identities=29%  Similarity=0.493  Sum_probs=26.0

Q ss_pred             CceEecCCCCCCeeecCCCc-EEEeecCCcee
Q 013750          235 PKIIHRDVKAANVLLDEDFE-AVVGDFGLAKL  265 (437)
Q Consensus       235 ~~iiH~dlk~~NIll~~~~~-~kl~Dfgla~~  265 (437)
                      +.++|+|+.+.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.81  E-value=0.00027  Score=78.45  Aligned_cols=161  Identities=12%  Similarity=0.001  Sum_probs=112.6

Q ss_pred             HHHHHHHHHhcccccceeeeeee--ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 013750          156 FQREVEMISVAVHRNLLRLIGFC--TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC  233 (437)
Q Consensus       156 ~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  233 (437)
                      .+.|.+.+++..|+++.....=.  .+..+.+.+++|+..|.+...+-......+.++..-....-.+......-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34455556667898887654322  3344567889999999998887654444444444333333333345555555442


Q ss_pred             C--CceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 013750          234 N--PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV  311 (437)
Q Consensus       234 ~--~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ell  311 (437)
                      +  .--+|+++|+-|.+|..+..+|++++|+.+...+... ......+++-|++|+....-.++.++|+|..|+.+|+..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2  2368999999999999999999999999984332222 223345778899999998888999999999999999998


Q ss_pred             hCCCCC
Q 013750          312 TGQRAI  317 (437)
Q Consensus       312 tg~~p~  317 (437)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887664

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.68  E-value=0.027  Score=54.15  Aligned_cols=147  Identities=22%  Similarity=0.283  Sum_probs=84.4

Q ss_pred             eeeecCcEEEEEEEECCCCEEEEEEecc-CCCCcchHHHHHHHHHHHhccc--ccceeeeeeeecCC--eeEEEEecccC
Q 013750          119 VLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPT--ERLLVYPFMQN  193 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lv~e~~~~  193 (437)
                      ....|..-.+|..... ++++++. ... ...........+|..+++.+.-  .-+-..+++|.++.  ..+.||+|.++
T Consensus        32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            3333434444544443 7788888 321 2223334455678888877643  22335577787666  66899999987


Q ss_pred             chhh------------------hhhhhcC----------------CCCCCCCHHHHHHHHH--------HHHHHHHHHHh
Q 013750          194 LSVA------------------YRLREIK----------------PGEPVLDWVTRKRVAL--------GAARGLEYLHE  231 (437)
Q Consensus       194 gsL~------------------~~l~~~~----------------~~~~~l~~~~~~~i~~--------~ia~~l~yLH~  231 (437)
                      ..+.                  +.|....                .+.+.-.|....+.+.        ....-..||+.
T Consensus       110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            3222                  1111110                0011122222221111        22334566665


Q ss_pred             cC-----CCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          232 HC-----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       232 ~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      +.     .+.++|+|+.+.|++++.+.-+-+.||+++...+
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            53     3579999999999999999889999999998654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.63  E-value=0.0021  Score=61.00  Aligned_cols=137  Identities=18%  Similarity=0.111  Sum_probs=88.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC----CCcc-----------------hHHHHHHHHHHHhccc-cc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE----SPGG-----------------DAAFQREVEMISVAVH-RN  170 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----~~~~-----------------~~~~~~E~~~l~~l~H-~n  170 (437)
                      -++..+.||-|.-+.+|.+-..+|++.++|.-.-..    ....                 .-...+|...|+.+.. -.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            357789999999999999999999999988432100    0000                 1123467777777743 22


Q ss_pred             ce-eeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          171 LL-RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       171 iv-~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      =| +.+    +.+..++|||++.+-.|...-+-       .+..+.   ...+..-+--|..+   |+||+|..--||++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV-------EDPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec-------CChHHH---HHHHHHHHHHHHHc---CceecccchheeEE
Confidence            22 222    33456889999887665432211       122222   22333334445566   99999999999999


Q ss_pred             cCCCcEEEeecCCceec
Q 013750          250 DEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~  266 (437)
                      +++..++++||--....
T Consensus       236 ~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMVST  252 (465)
T ss_pred             ecCCCEEEeechHhhcc
Confidence            99999999999765443

>PLN02236 choline kinase

Probab=96.52  E-value=0.031  Score=54.83  Aligned_cols=141  Identities=18%  Similarity=0.201  Sum_probs=80.6

Q ss_pred             CeeeecCcEEEEEEEECC-----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEecc
Q 013750          118 NVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~  191 (437)
                      ..+-.|-.-.+|+....+     +..|++|+..... . ..-+-.+|..++..+...++. ++++.+..+    .|++|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            345457778899987542     3678999876432 2 222336788888888665554 455554332    578998


Q ss_pred             cCchhhhh-----------------hhhcC-CCCC-CCCHHHHHHHHHH-----------------HHHHHHHHHh----
Q 013750          192 QNLSVAYR-----------------LREIK-PGEP-VLDWVTRKRVALG-----------------AARGLEYLHE----  231 (437)
Q Consensus       192 ~~gsL~~~-----------------l~~~~-~~~~-~l~~~~~~~i~~~-----------------ia~~l~yLH~----  231 (437)
                      ++.++...                 ++... +... ..-|....++..+                 +...+..|..    
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665421                 11111 1111 1122222222211                 1122222221    


Q ss_pred             -cCCCceEecCCCCCCeeecC-CCcEEEeecCCce
Q 013750          232 -HCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK  264 (437)
Q Consensus       232 -~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~  264 (437)
                       .....++|+|+++.||++++ +..+.++||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             12336899999999999986 4689999998875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.45  E-value=0.084  Score=50.77  Aligned_cols=29  Identities=31%  Similarity=0.398  Sum_probs=25.4

Q ss_pred             CceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       235 ~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999988 578999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.43  E-value=0.029  Score=54.41  Aligned_cols=142  Identities=15%  Similarity=0.189  Sum_probs=91.5

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEeccC----CC----------------CcchHH-----HHHHHHHHHhcccc
Q 013750          115 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDF----ES----------------PGGDAA-----FQREVEMISVAVHR  169 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~----~~----------------~~~~~~-----~~~E~~~l~~l~H~  169 (437)
                      .+...|..|.-+.||.+.-.+|..+|||+.+..    .+                ....+.     ..+|++-|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345678889999999999999999999987531    00                000000     12466666666544


Q ss_pred             cceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       170 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      .|-.-.-+..  ....|||+|+......    ...-....++...+..+-.+++.-|.-|...|  ++||.||+--|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            4321110000  1246899998532211    11112233666677778888888899998888  89999999999998


Q ss_pred             cCCCcEEEeecCCcee
Q 013750          250 DEDFEAVVGDFGLAKL  265 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~  265 (437)
                      -+ |.+.|+|-+-+..
T Consensus       299 hd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVE  313 (520)
T ss_pred             EC-CEEEEEEcccccc
Confidence            65 5799999987754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.17  E-value=0.095  Score=51.27  Aligned_cols=74  Identities=16%  Similarity=0.139  Sum_probs=47.2

Q ss_pred             eeeecCcEEEEEEEECCC-CEEEEEEeccC------CCCcchHHHHHHHHHHHhcc--cccceeeeeeeecCCeeEEEEe
Q 013750          119 VLGQGGFGKVYRGVLADG-TKVAVKRLTDF------ESPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~~g-~~vAvK~l~~~------~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .||.|....||++..++| +.|+||.-.+.      ..+-..++-.-|.+.|....  -|..|+-+ |..++....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence            379999999999998654 58999975421      12333445556777776543  34444422 2345556678999


Q ss_pred             cccC
Q 013750          190 FMQN  193 (437)
Q Consensus       190 ~~~~  193 (437)
                      +++.
T Consensus        81 dL~~   84 (370)
T TIGR01767        81 DLSH   84 (370)
T ss_pred             hCcc
Confidence            9854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=95.98  E-value=0.0061  Score=37.92  Aligned_cols=32  Identities=28%  Similarity=0.567  Sum_probs=20.8

Q ss_pred             CCceEEEehHHHHHHHHHHHHHHHHHhhhccc
Q 013750           45 KPKIGIIVGIVGGLIVLISGGLLFFLCKGRHK   76 (437)
Q Consensus        45 ~~~~~ii~~i~~~~~~l~~~~~~~~~~~~r~~   76 (437)
                      ++.++|+++++++++++++..+.+.+|+||.+
T Consensus         3 ~s~IaIIv~V~vg~~iiii~~~~YaCcykk~~   34 (38)
T PF02439_consen    3 SSTIAIIVAVVVGMAIIIICMFYYACCYKKHR   34 (38)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence            34567778888877776666555555665554

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.92  E-value=0.081  Score=51.59  Aligned_cols=141  Identities=16%  Similarity=0.209  Sum_probs=79.0

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEeccc
Q 013750          118 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~  192 (437)
                      +.|..|=...+|+....+    +..|++|+..+...  ..-+-.+|..+++.+..-++. ++++++..+    +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence            445557777889887643    23788998764321  222345788888888766664 455554322    4889987


Q ss_pred             Cchhhhh--------------h---hhcC-CCCC-CCCHHHHHHHHHH----------------------HHHHHHHHHh
Q 013750          193 NLSVAYR--------------L---REIK-PGEP-VLDWVTRKRVALG----------------------AARGLEYLHE  231 (437)
Q Consensus       193 ~gsL~~~--------------l---~~~~-~~~~-~l~~~~~~~i~~~----------------------ia~~l~yLH~  231 (437)
                      +.++...              +   +... +... .--|....++..+                      +.+-+..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7654221              1   1111 1111 1123322222211                      1111222211


Q ss_pred             -----cCCCceEecCCCCCCeeecC-CCcEEEeecCCce
Q 013750          232 -----HCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK  264 (437)
Q Consensus       232 -----~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~  264 (437)
                           ..+..++|+|+.+.||++++ ++.++++||..|.
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence                 11235899999999999975 5789999998875

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.78  E-value=0.21  Score=49.82  Aligned_cols=74  Identities=15%  Similarity=0.163  Sum_probs=49.1

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCC------CcchHHHHHHHHHHHhcc---cccceeeeeeeecCCeeEEE
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES------PGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv  187 (437)
                      .+.||.|....||+.... +..++||.-.....      +.....-..|.+.|..+.   ..++.+++.+|.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998874 56789997652111      123333345566665543   246777888776  446788


Q ss_pred             EecccC
Q 013750          188 YPFMQN  193 (437)
Q Consensus       188 ~e~~~~  193 (437)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.76  E-value=0.14  Score=49.31  Aligned_cols=31  Identities=19%  Similarity=0.274  Sum_probs=27.9

Q ss_pred             CCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       234 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ..+++|+|+.+.|+++++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3479999999999999999999999998776

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.64  E-value=0.048  Score=49.37  Aligned_cols=30  Identities=30%  Similarity=0.453  Sum_probs=21.7

Q ss_pred             ceEecCCCCCCeee-cCCCcEEEeecCCcee
Q 013750          236 KIIHRDVKAANVLL-DEDFEAVVGDFGLAKL  265 (437)
Q Consensus       236 ~iiH~dlk~~NIll-~~~~~~kl~Dfgla~~  265 (437)
                      .++|+|+.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            68999999999999 8889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.61  E-value=0.24  Score=48.16  Aligned_cols=140  Identities=19%  Similarity=0.240  Sum_probs=82.3

Q ss_pred             eeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc---ee---e----eeeeecCCeeEEEEe
Q 013750          120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL---LR---L----IGFCTTPTERLLVYP  189 (437)
Q Consensus       120 lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni---v~---l----~g~~~~~~~~~lv~e  189 (437)
                      |.+ .-..+|+....+|.. ++|.....   ....+...|...+..+.-..+   ++   +    +.....+...+-+++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 456789888876666 88887653   234555667777766642222   22   1    111222236778899


Q ss_pred             cccCchhhh-h--------------hh----hcC---C-CCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 013750          190 FMQNLSVAY-R--------------LR----EIK---P-GEPVLDWVT-------------RKRVALGAARGLEYLHEHC  233 (437)
Q Consensus       190 ~~~~gsL~~-~--------------l~----~~~---~-~~~~l~~~~-------------~~~i~~~ia~~l~yLH~~~  233 (437)
                      |++|..+.. .              ++    ...   + ......|..             ......++...+..+.+..
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999887772 1              11    111   1 111234431             0123344555555555432


Q ss_pred             ----CCc---eEecCCCCCCeeecCCCc-EEEeecCCce
Q 013750          234 ----NPK---IIHRDVKAANVLLDEDFE-AVVGDFGLAK  264 (437)
Q Consensus       234 ----~~~---iiH~dlk~~NIll~~~~~-~kl~Dfgla~  264 (437)
                          +..   +||+|+-|.||+++.+.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                223   899999999999999875 8999999876

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.57  E-value=0.17  Score=46.04  Aligned_cols=137  Identities=15%  Similarity=0.179  Sum_probs=81.4

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc---ccceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH---RNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.+..|.--..|.... +..++-||+=.    ......|..|+.-|..+.-   -++-+.+.+-.+..+.|+|+||++.+
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            4444444444454443 46788888532    3345678888887776654   44667777778888999999999987


Q ss_pred             hhhhh-----------hhhcC--------------CCCCCCCHHHHH---------HHHHH--------------HHHHH
Q 013750          195 SVAYR-----------LREIK--------------PGEPVLDWVTRK---------RVALG--------------AARGL  226 (437)
Q Consensus       195 sL~~~-----------l~~~~--------------~~~~~l~~~~~~---------~i~~~--------------ia~~l  226 (437)
                      .+...           |+...              ....+-.|...+         ..-.+              +...+
T Consensus        97 ~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v  176 (286)
T COG3001          97 PLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKI  176 (286)
T ss_pred             CCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHH
Confidence            66511           11110              111122232221         11122              22334


Q ss_pred             HHHHhcC--CCceEecCCCCCCeeecCCCcEEEeec
Q 013750          227 EYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       227 ~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      ..+=..+  .|.++|+||-..|.....++ +.+-|-
T Consensus       177 ~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP  211 (286)
T COG3001         177 QELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP  211 (286)
T ss_pred             HHHHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence            4333333  37899999999999999998 666553

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.38  E-value=0.89  Score=44.19  Aligned_cols=71  Identities=17%  Similarity=0.127  Sum_probs=43.8

Q ss_pred             cCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc--cceeee---e--eeecCCeeEEEEecccCch
Q 013750          123 GGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLI---G--FCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       123 G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lv~e~~~~gs  195 (437)
                      +.-..||+...++|..+++|......  ....+...|++.+..+...  .++...   |  +...++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            44578999988788899999875322  2355667788877666421  122211   1  1222345678899988754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.34  E-value=0.064  Score=54.19  Aligned_cols=49  Identities=16%  Similarity=0.224  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHHhcccccceeeeeeeecCCe-eEEEEecccCchhhhhhhhc
Q 013750          154 AAFQREVEMISVAVHRNLLRLIGFCTTPTE-RLLVYPFMQNLSVAYRLREI  203 (437)
Q Consensus       154 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~  203 (437)
                      .+.+-...+++.+.|+|+...+++...... ..+|+|++ +.||++.+...
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            456667788999999999999988765544 56778888 45888877653

>PRK06148 hypothetical protein; Provisional

Probab=95.04  E-value=0.37  Score=54.19  Aligned_cols=144  Identities=19%  Similarity=0.187  Sum_probs=77.5

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-------cccceeee-e----eeec-CC--
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-------HRNLLRLI-G----FCTT-PT--  182 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-------H~niv~l~-g----~~~~-~~--  182 (437)
                      +.|+ |..-.+|+....+|..+++|+.....   .......|.+.+..+.       -|.+++-. |    .... +.  
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~---~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE---PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc---chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            3454 45678899888788899999987532   2223334445554332       23333321 1    1111 12  


Q ss_pred             eeEEEEecccCchhhhh-----------------h----hhcCC--CCCCCCHHH-----------------HHHHHHHH
Q 013750          183 ERLLVYPFMQNLSVAYR-----------------L----REIKP--GEPVLDWVT-----------------RKRVALGA  222 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~-----------------l----~~~~~--~~~~l~~~~-----------------~~~i~~~i  222 (437)
                      ..+-+++|.++..+...                 +    .....  ....+.|..                 ...++..+
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            35668999998776541                 0    01110  111233321                 11222233


Q ss_pred             HHHHHH----HHhcCCCceEecCCCCCCeeecCCC--cE-EEeecCCcee
Q 013750          223 ARGLEY----LHEHCNPKIIHRDVKAANVLLDEDF--EA-VVGDFGLAKL  265 (437)
Q Consensus       223 a~~l~y----LH~~~~~~iiH~dlk~~NIll~~~~--~~-kl~Dfgla~~  265 (437)
                      .+...-    .-......+||+|+.+.|||++.+.  .+ -|+|||.+..
T Consensus       187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            322211    1122244799999999999999875  44 4999998863

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.84  E-value=0.12  Score=50.99  Aligned_cols=61  Identities=23%  Similarity=0.155  Sum_probs=40.2

Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE  251 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~  251 (437)
                      ..++-+|+++.++..++....     .......+++.-.++|+--+--.-  +++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            346667888888888876533     233455566665556554332221  6999999999999953

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.80  E-value=0.02  Score=36.35  Aligned_cols=23  Identities=35%  Similarity=0.447  Sum_probs=11.9

Q ss_pred             CCCCCCCceEEEehHHHHHHHHH
Q 013750           40 TGSSKKPKIGIIVGIVGGLIVLI   62 (437)
Q Consensus        40 ~~~~~~~~~~ii~~i~~~~~~l~   62 (437)
                      ++++.++...|.+|+++.+.+++
T Consensus         3 s~~~~~~~vaIa~~VvVPV~vI~   25 (40)
T PF08693_consen    3 SKSSNSNTVAIAVGVVVPVGVII   25 (40)
T ss_pred             cccCCCceEEEEEEEEechHHHH
Confidence            33344555666666655544433

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.60  E-value=0.21  Score=45.24  Aligned_cols=139  Identities=15%  Similarity=0.139  Sum_probs=84.3

Q ss_pred             EEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHH
Q 013750          139 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV  218 (437)
Q Consensus       139 vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  218 (437)
                      ..+|++......-....|..+.++++++.  .|++|..  ...-..-++.|+|-.-.              ..  . ..+
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~--------------i~--~-~N~  146 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK--------------IN--F-SNF  146 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc--------------cc--h-hHH
Confidence            44566654333334567888899998875  4677652  12334457788873311              00  0 111


Q ss_pred             HHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCch
Q 013750          219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT  298 (437)
Q Consensus       219 ~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  298 (437)
                      +.-=.++|.-.|+. .++.+|+|-.|+||+-|..|.+||.|-+..-.             .+..|.--|   ....|.++
T Consensus       147 i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN~~---Y~~lT~~a  209 (308)
T PF07387_consen  147 ITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVNIE---YESLTQEA  209 (308)
T ss_pred             HHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEeee---ccccChHH
Confidence            11113567777865 44899999999999999999999999875421             011122211   23347778


Q ss_pred             hhHHHHHHHHHHHhCCC
Q 013750          299 DVFGYGIMLLELVTGQR  315 (437)
Q Consensus       299 Dv~s~Gv~l~elltg~~  315 (437)
                      .+-+|=.-++++....+
T Consensus       210 E~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  210 EVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             HHHHHHHHHHHHHHHHh
Confidence            88787777777766443

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=94.48  E-value=0.49  Score=47.07  Aligned_cols=74  Identities=15%  Similarity=0.235  Sum_probs=45.1

Q ss_pred             CeeeecCcEEEEEEEECCC--CE-----EEEEEeccCCCCcchHHHHHHHHHHHhccccccee-eeeeeecCCeeEEEEe
Q 013750          118 NVLGQGGFGKVYRGVLADG--TK-----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-LIGFCTTPTERLLVYP  189 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g--~~-----vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e  189 (437)
                      +.|..|-...+|++...++  ..     |.++.... . ....-+-.+|+++++.+...++.+ +++.+.    -.+++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-C-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            4555688889999986543  22     44443221 1 111223357889999987777654 444443    258999


Q ss_pred             cccCchhh
Q 013750          190 FMQNLSVA  197 (437)
Q Consensus       190 ~~~~gsL~  197 (437)
                      |+++.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	437
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-124
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-122
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 217/326 (66%), Positives = 256/326 (78%)
Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F DV  E D  +  GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVK
Sbjct: 9   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 68
Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +    GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 69  RLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 128
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
               +P LDW  R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 129 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
           AKL+D +  +V   VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +R 
Sbjct: 189 AKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 248
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                           +EK+L+A+VD +L  NY  +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 249 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 308
Query: 383 EVVRMLEGEGLAERWEEWQHVEVTRR 408
           EVVRMLEG+GLAERWEEWQ  E+ R+
Sbjct: 309 EVVRMLEGDGLAERWEEWQKEEMFRQ 334

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  436 bits (1122), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 214/326 (65%), Positives = 254/326 (77%)
Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F DV  E D  +  GQLKR+S RELQ+A+DNF  KN+LG+GGFGKVY+G LADG  VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
               +P LDW  R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
           AKL+D +  +V   VRG +GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +R 
Sbjct: 181 AKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                           +EK+L+A+VD +L  NY  +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 383 EVVRMLEGEGLAERWEEWQHVEVTRR 408
           EVVRMLEG+GLAERWEEWQ  E+ R+
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 162/285 (56%), Gaps = 7/285 (2%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           +L+ AT+NF  K ++G G FGKVY+GVL DG KVA+KR T  ES  G   F+ E+E +S 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFETEIETLSF 91
Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
             H +L+ LIGFC    E +L+Y +M+N ++   L         + W  R  + +GAARG
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQVRGTMGHI 284
           L YLH      IIHRDVK+ N+LLDE+F   + DFG++K   ++ +T++   V+GT+G+I
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
            PEY   G+ +E++DV+ +G++L E++  + AI   +                    +L+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWAVESHNNGQLE 266
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            IVD NL      + +      A+ C   S EDRP+M +V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 162/285 (56%), Gaps = 7/285 (2%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           +L+ AT+NF  K ++G G FGKVY+GVL DG KVA+KR T  ES  G   F+ E+E +S 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFETEIETLSF 91
Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
             H +L+ LIGFC    E +L+Y +M+N ++   L         + W  R  + +GAARG
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQVRGTMGHI 284
           L YLH      IIHRDVK+ N+LLDE+F   + DFG++K   ++ +T++   V+GT+G+I
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
            PEY   G+ +E++DV+ +G++L E++  + AI   +                    +L+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWAVESHNNGQLE 266
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            IVD NL      + +      A+ C   S EDRP+M +V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 167/298 (56%), Gaps = 20/298 (6%)
Query: 102 YSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLT---DFESPGG 152
           +S+ EL+  T+NF E+      N +G+GGFG VY+G + + T VAVK+L    D  +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 153 DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
              F +E+++++   H NL+ L+GF +   +  LVY +M N S+  RL  +  G P L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKT 271
             R ++A GAA G+ +LHE+ +   IHRD+K+AN+LLDE F A + DFGLA+  +   +T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXX 331
            + +++ GT  ++APE L  G+ + ++D++ +G++LLE++TG  A+D  R          
Sbjct: 190 VMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 332 XXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    +     +D+ +N + +   VE M  VA  C       RP + +V ++L+
Sbjct: 249 EIEDEEKTIEDY---IDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 166/298 (55%), Gaps = 20/298 (6%)
Query: 102 YSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLT---DFESPGG 152
           +S+ EL+  T+NF E+      N +G+GGFG VY+G + + T VAVK+L    D  +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 153 DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
              F +E+++++   H NL+ L+GF +   +  LVY +M N S+  RL  +  G P L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKT 271
             R ++A GAA G+ +LHE+ +   IHRD+K+AN+LLDE F A + DFGLA+  +   +T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXX 331
            +  ++ GT  ++APE L  G+ + ++D++ +G++LLE++TG  A+D  R          
Sbjct: 190 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 332 XXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    +     +D+ +N + +   VE M  VA  C       RP + +V ++L+
Sbjct: 249 EIEDEEKTIEDY---IDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 164/298 (55%), Gaps = 20/298 (6%)
Query: 102 YSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLT---DFESPGG 152
           +S+ EL+  T+NF E+      N +G+GGFG VY+G + + T VAVK+L    D  +   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 153 DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
              F +E+++++   H NL+ L+GF +   +  LVY +M N S+  RL  +  G P L W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 126
Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
             R ++A GAA G+ +LHE+ +   IHRD+K+AN+LLDE F A + DFGLA+  +     
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 273 V-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXX 331
           V   ++ GT  ++APE L  G+ + ++D++ +G++LLE++TG  A+D  R          
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 242
Query: 332 XXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    +     +D+ +N + +   VE M  VA  C       RP + +V ++L+
Sbjct: 243 EIEDEEKTIEDY---IDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 159/298 (53%), Gaps = 20/298 (6%)
Query: 102 YSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLT---DFESPGG 152
           +S+ EL+  T+NF E+      N  G+GGFG VY+G + + T VAVK+L    D  +   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 153 DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
              F +E+++ +   H NL+ L+GF +   +  LVY +  N S+  RL  +  G P L W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSW 123
Query: 213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
             R ++A GAA G+ +LHE+ +   IHRD+K+AN+LLDE F A + DFGLA+  +     
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 273 V-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXX 331
           V  +++ GT  + APE L  G+ + ++D++ +G++LLE++TG  A+D  R          
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 239
Query: 332 XXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    +     +D+  N + +   VE    VA  C       RP + +V ++L+
Sbjct: 240 EIEDEEKTIEDY---IDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 108/206 (52%), Gaps = 9/206 (4%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT--DFESPGGDAAFQREVEMISVAVHRN 170
           N  EK  +G G FG V+R     G+ VAVK L   DF +   +  F REV ++    H N
Sbjct: 40  NIKEK--IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPN 95
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++  +G  T P    +V  ++   S+ YRL         LD   R  +A   A+G+ YLH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
              NP I+HRD+K+ N+L+D+ +   V DFGL++L        +    GT   +APE L 
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLR 212
Query: 291 TGKSSERTDVFGYGIMLLELVTGQRA 316
              S+E++DV+ +G++L EL T Q+ 
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 108/206 (52%), Gaps = 9/206 (4%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT--DFESPGGDAAFQREVEMISVAVHRN 170
           N  EK  +G G FG V+R     G+ VAVK L   DF +   +  F REV ++    H N
Sbjct: 40  NIKEK--IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPN 95
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++  +G  T P    +V  ++   S+ YRL         LD   R  +A   A+G+ YLH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
              NP I+HR++K+ N+L+D+ +   V DFGL++L        +    GT   +APE L 
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 291 TGKSSERTDVFGYGIMLLELVTGQRA 316
              S+E++DV+ +G++L EL T Q+ 
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V +  +T   +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
            P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      IIH
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ +GI+L EL+TGQ
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V +  +T   +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
            P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      IIH
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ +GI+L EL+TGQ
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V +  +T   +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
            P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      IIH
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ +GI+L EL+TGQ
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      II
Sbjct: 79  TKP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL---STGKS 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      II
Sbjct: 101 TKP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL---STGKS 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 214 SFQSDVYAFGIVLYELMTGQ 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V +  +T   +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
            P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      IIH
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ +GI+L EL+TGQ
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      II
Sbjct: 102 TKP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL---STGKS 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L      E   +      +A   ARG++YLH      II
Sbjct: 78  TKP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGKS--- 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +    S   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 191 SFQSDVYAFGIVLYELMTGQ 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 39/294 (13%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAA------FQREVE 161
           LA +    +  +G+GGFG V++G ++ D + VA+K L   +S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           ++S   H N+++L G    P    +V  F+    + +RL  +    P+  W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL--LDKAHPI-KWSVKLRLMLD 130
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFE--AVVGDFGLAKLVDVRKTNVTTQ 276
            A G+EY+    NP I+HRD+++ N+    LDE+    A V DFGL++    +  +  + 
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 277 VRGTMGHIAPEYLSTGKSS--ERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXX 334
           + G    +APE +   + S  E+ D + + ++L  ++TG+   D                
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---------------E 230
Query: 335 XXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               + K ++ I +  L           +  V  LC    P+ RP  S +V+ L
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V +  +T   +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
            P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      IIH
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 240 RDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ +GI+L EL+TGQ
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      II
Sbjct: 94  TKP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYL---STGKS 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 207 SFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L  I   E   + +    +A   A+G++YLH      II
Sbjct: 102 TKP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYL---STGKS 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +        
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 215 SFQSDVYAFGIVLYELMTGQ 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L      E   +      +A   ARG++YLH      II
Sbjct: 90  TAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS--- 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +    S   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N+L  +G+ 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
           T P +  +V  + +  S+ + L      E   +      +A   ARG++YLH      II
Sbjct: 90  TKP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS--- 294
           HRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +    S   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           S ++DV+ +GI+L EL+TGQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 80  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 133
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 194 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 232
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 193 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 231
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 88  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 141
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 202 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 240
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 193 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 231
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 81  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 134
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 195 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 233
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 199 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 237
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 199 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 237
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 140
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 201 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 239
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 193 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 231
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 84  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 137
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 198 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 236
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 146
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 142
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 203 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 241
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 39/294 (13%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAA------FQREVE 161
           LA +    +  +G+GGFG V++G ++ D + VA+K L   +S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           ++S   H N+++L G    P    +V  F+    + +RL  +    P+  W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL--LDKAHPI-KWSVKLRLMLD 130
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFE--AVVGDFGLAKLVDVRKTNVTTQ 276
            A G+EY+    NP I+HRD+++ N+    LDE+    A V DFG ++    +  +  + 
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSG 185
Query: 277 VRGTMGHIAPEYLSTGKSS--ERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXX 334
           + G    +APE +   + S  E+ D + + ++L  ++TG+   D                
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---------------E 230
Query: 335 XXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               + K ++ I +  L           +  V  LC    P+ RP  S +V+ L
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 39/294 (13%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAA------FQREVE 161
           LA +    +  +G+GGFG V++G ++ D + VA+K L   +S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           ++S   H N+++L G    P    +V  F+    + +RL  +    P+  W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL--LDKAHPI-KWSVKLRLMLD 130
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFE--AVVGDFGLAKLVDVRKTNVTTQ 276
            A G+EY+    NP I+HRD+++ N+    LDE+    A V DF L++    +  +  + 
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSG 185
Query: 277 VRGTMGHIAPEYLSTGKSS--ERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXX 334
           + G    +APE +   + S  E+ D + + ++L  ++TG+   D                
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---------------E 230
Query: 335 XXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               + K ++ I +  L           +  V  LC    P+ RP  S +V+ L
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 146
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 142
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 145
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 147
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 147
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 74  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 188 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 226
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 139
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 72
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 130
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 131 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 222
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 223 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 134
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 226
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 227 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 67
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAM 125
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 126 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 182
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 221
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 222 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 165
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 129
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 221
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 222 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 166
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           YL    + K +HRD+ A N +LDE F   V DFGLA+ + D    +V   T  +  +  +
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 129
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 221
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 222 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 39/276 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 180 TPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                 LV+ FM++  ++  LR    +   E +L       + L    G+ YL E C   
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC--- 126
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           +IHRD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYN 356
           ++DV+ +G+++ E V  +  I +                    E R ++ V  +++  + 
Sbjct: 187 KSDVWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFR 225
Query: 357 IQE----VETMIQVALLCTQASPEDRPAMSEVVRML 388
           + +       + Q+   C +  PEDRPA S ++R L
Sbjct: 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 134
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 226
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 227 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 68
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAM 126
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 222
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 223 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 79
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +
Sbjct: 80  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAM 137
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 138 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 194
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 233
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 234 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 133
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 225
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 39/276 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 180 TPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                 LV+ FM++  ++  LR    +   E +L       + L    G+ YL E C   
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC--- 121
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           +IHRD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYN 356
           ++DV+ +G+++ E V  +  I +                    E R ++ V  +++  + 
Sbjct: 182 KSDVWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFR 220
Query: 357 IQE----VETMIQVALLCTQASPEDRPAMSEVVRML 388
           + +       + Q+   C +  PEDRPA S ++R L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 134
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 226
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 227 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 33/273 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 LV+ FM++  ++  LR  +    +    T   + L    G+ YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S ++D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +G+++ E V  +  I +                    E R ++ V  +++  + + +
Sbjct: 187 VWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFRLYK 225
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRML 388
                  + Q+   C +  PEDRPA S ++R L
Sbjct: 226 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 68
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAM 126
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 222
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 223 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 33/273 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK--EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 LV+ FM++  ++  LR  +    +    T   + L    G+ YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S ++D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +G+++ E V  +  I +                    E R ++ V  +++  + + +
Sbjct: 207 VWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFRLYK 245
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRML 388
                  + Q+   C +  PEDRPA S ++R L
Sbjct: 246 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 131
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 132 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 223
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 224 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK 134
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 226
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 227 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G FG+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 64
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 122
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ--------------------- 218
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 219 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 66
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 124
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 220
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 221 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 66
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 124
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 220
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 221 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 148
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNV--TTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ ++D    +V   T  +  +  +
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 66
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 124
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 220
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 221 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 66
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 124
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------------- 220
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 221 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +EYL +
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK 134
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 226
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 227 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G   + TKVAVK L     PG  +  AF  E  ++    H  L+RL   
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            T      ++  +M   S+   L+  + G+ +L     K +   A  A G+ Y+      
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK--- 129
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHRD++AANVL+ E     + DFGLA++++  +       +  +   APE ++ G  +
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 296 ERTDVFGYGIMLLELVT 312
            ++DV+ +GI+L E+VT
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 75  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           R+++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 189 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 227
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 116/231 (50%), Gaps = 33/231 (14%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-----FQREVE 161
           L++     + + ++G GGFGKVYR     G +VAVK       P  D +      ++E +
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAAR--HDPDEDISQTIENVRQEAK 58
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKRVAL 220
           + ++  H N++ L G C       LV  F +   +   L   + P + +++W      A+
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AV 112
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA--------VVGDFGLAKLVDVRKTN 272
             ARG+ YLH+     IIHRD+K++N+L+ +  E          + DFGLA     R+ +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----REWH 167
Query: 273 VTTQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ---RAID 318
            TT++   G    +APE +     S+ +DV+ YG++L EL+TG+   R ID
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 148
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 145
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 33/302 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 147
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           A E L T K + ++DV+ +G++L EL+T        R                  + R  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGR-- 254
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVE 404
               R L   Y     + + +V L C     E RP+ SE+V  +         E + HV 
Sbjct: 255 ----RLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 307
Query: 405 VT 406
            T
Sbjct: 308 AT 309

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 152
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           A E L T K + ++DV+ +G++L EL+T
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +EYL +
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEK 127
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 128 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
            K S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ-------------------------V 219
Query: 348 DRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 220 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 119 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G+G FG VY G   D  +     A+K L+         AF RE  ++    H N+L L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 175 IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           IG    P E L  ++ P+M +  +   +R  +    V D ++     L  ARG+EYL E 
Sbjct: 88  IGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGMEYLAEQ 143
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ---VRGTMGHIAPEYL 289
              K +HRD+ A N +LDE F   V DFGLA+ +  R+     Q    R  +   A E L
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 290 STGKSSERTDVFGYGIMLLELVT 312
            T + + ++DV+ +G++L EL+T
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G   + TKVAVK L     PG  +  AF  E  ++    H  L+RL   
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            T      ++  FM   S+   L+  + G+ +L     K +   A  A G+ Y+      
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK--- 128
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHRD++AANVL+ E     + DFGLA++++  +       +  +   APE ++ G  +
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 296 ERTDVFGYGIMLLELVT 312
            +++V+ +GI+L E+VT
Sbjct: 189 IKSNVWSFGILLYEIVT 205

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 33/302 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 147
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           A E L T K + ++DV+ +G++L EL+T        R                  + R  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGR-- 254
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVE 404
               R L   Y     + + +V L C     E RP+ SE+V  +         E + HV 
Sbjct: 255 ----RLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 307
Query: 405 VT 406
            T
Sbjct: 308 AT 309

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 180 TPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                 LV  FM++  ++  LR    +   E +L       + L    G+ YL E C   
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC--- 124
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           +IHRD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYN 356
           ++DV+ +G+++ E V  +  I +                    E R ++ V  +++  + 
Sbjct: 185 KSDVWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFR 223
Query: 357 IQE----VETMIQVALLCTQASPEDRPAMSEVVRML 388
           + +       + Q+   C +  PEDRPA S ++R L
Sbjct: 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 33/302 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL--ADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L   DG K+  AVK L      G  + F  E  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +   +R       V D +      L  A+G++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMK 206
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           +L    + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           A E L T K + ++DV+ +G++L EL+T        R                  + R  
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGR-- 313
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVE 404
               R L   Y     + + +V L C     E RP+ SE+V  +         E + HV 
Sbjct: 314 ----RLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 366
Query: 405 VT 406
            T
Sbjct: 367 AT 368

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 119 VLGQGGFGKVYRGV-LADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           VLG G FG VY+G+ + +G      VA+K L +   P  +  F  E  +++   H +L+R
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 174 LIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           L+G C +PT +L+  + P    L   +  ++    + +L+W  +       A+G+ YL E
Sbjct: 82  LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 289
               +++HRD+ A NVL+       + DFGLA+L+  D ++ N     +  +  +A E +
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECI 191
Query: 290 STGKSSERTDVFGYGIMLLELVT 312
              K + ++DV+ YG+ + EL+T
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++   
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEI 64
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +A   +  +
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAM 122
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           EYL +      IHRD+ A N L+ E+    V DFGL++L+           +  +   AP
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP 179
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
           E L+  K S ++DV+ +G++L E+ T        ID S+                     
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ--------------------- 218
Query: 343 LDAIVDRNLNKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               V   L K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 219 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G  G+V+ G     TKVAVK L   +      AF  E  ++    H+ L+RL    T
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 ++  +M+N S+   L+   P    L       +A   A G+ ++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ G  + ++D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 300 VFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQE 359
           V+ +GI+L E+VT  R I +                        +  V +NL + Y +  
Sbjct: 193 VWSFGILLTEIVTHGR-IPYPGMT--------------------NPEVIQNLERGYRMVR 231
Query: 360 ----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                E + Q+  LC +  PEDRP    +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 118 NVLGQGGFGKVYRGV-LADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
            VLG G FG VY+G+ + +G      VA+K L +   P  +  F  E  +++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 173 RLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           RL+G C +PT +L+  + P    L   +  ++    + +L+W  +       A+G+ YL 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 157
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEY 288
           E    +++HRD+ A NVL+       + DFGLA+L+  D ++ N     +  +  +A E 
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALEC 213
Query: 289 LSTGKSSERTDVFGYGIMLLELVT 312
           +   K + ++DV+ YG+ + EL+T
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G FG+V+ G L AD T VAVK   +   P   A F +E  ++    H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
              T++  +Y  M+ +     L  ++     L   T  ++   AA G+EYL   C    I
Sbjct: 182 ---TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGK 293
           HRD+ A N L+ E     + DFG+++     + +      G +  +     APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 294 SSERTDVFGYGIMLLE 309
            S  +DV+ +GI+L E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 16/210 (7%)
Query: 115 SEKNVLGQGGFGKVYRGVL--ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           + + V+G G FG+VY+G+L  + G K   VA+K L    +      F  E  ++    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEY 228
           N++RL G  +     +++  +M+N ++   LRE K GE  VL  V   R   G A G++Y
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLR---GIAAGMKY 162
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAP 286
           L    N   +HRD+ A N+L++ +    V DFGL++++  D   T  T+  +  +   AP
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
           E +S  K +  +DV+ +GI++ E++T G+R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L++L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 180 TPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
                 LV+ FM++  ++  LR    +   E +L       + L    G+ YL E     
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEE---AS 123
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           +IHRD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S  + S 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYN 356
           ++DV+ +G+++ E V  +  I +                    E R ++ V  +++  + 
Sbjct: 184 KSDVWSFGVLMWE-VFSEGKIPY--------------------ENRSNSEVVEDISTGFR 222
Query: 357 IQE----VETMIQVALLCTQASPEDRPAMSEVVRML 388
           + +       + Q+   C +  PEDRPA S ++R L
Sbjct: 223 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G FG+V+ G L AD T VAVK   +   P   A F +E  ++    H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
              T++  +Y  M+ +     L  ++     L   T  ++   AA G+EYL   C    I
Sbjct: 182 ---TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGK 293
           HRD+ A N L+ E     + DFG+++     + +      G +  +     APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 294 SSERTDVFGYGIMLLE 309
            S  +DV+ +GI+L E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 22/285 (7%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D++  + V+G G    V     A    KVA+KR+   +         +E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEP---VLDWVTRKRVALGAARGL 226
           ++          E  LV   +   SV   ++ I   GE    VLD  T   +      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTTQVRGTMG 282
           EYLH++     IHRDVKA N+LL ED    + DFG++  +    D+ +  V     GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 283 HIAPEYLSTGKSSE-RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREK 341
            +APE +   +  + + D++ +GI  +EL TG  A  + +                  E 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
               + D+ + K Y  +    MI    LC Q  PE RP  +E++R
Sbjct: 250 ---GVQDKEMLKKYG-KSFRKMIS---LCLQKDPEKRPTAAELLR 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 22/285 (7%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D++  + V+G G    V     A    KVA+KR+   +         +E++ +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEP---VLDWVTRKRVALGAARGL 226
           ++          E  LV   +   SV   ++ I   GE    VLD  T   +      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTTQVRGTMG 282
           EYLH++     IHRDVKA N+LL ED    + DFG++  +    D+ +  V     GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 283 HIAPEYLSTGKSSE-RTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREK 341
            +APE +   +  + + D++ +GI  +EL TG  A  + +                  E 
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQNDPPSLE- 243
Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
               + D+ + K Y  +    MI    LC Q  PE RP  +E++R
Sbjct: 244 --TGVQDKEMLKKYG-KSFRKMIS---LCLQKDPEKRPTAAELLR 282

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 117 KNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL++L+
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
           G CT      ++  FM   ++   LRE    E  ++ V    +A   +  +EYL +    
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK--- 376
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHR++ A N L+ E+    V DFGL++L+           +  +   APE L+  K S
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 296 ERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNL 351
            ++DV+ +G++L E+ T        ID S+                         V   L
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------VYELL 471
Query: 352 NKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 472 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 41/282 (14%)
Query: 117 KNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL++L+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
           G CT      ++  FM   ++   LRE    E  +  V    +A   +  +EYL +    
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK--- 337
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             IHR++ A N L+ E+    V DFGL++L+           +  +   APE L+  K S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 296 ERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNL 351
            ++DV+ +G++L E+ T        ID S+                         V   L
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------VYELL 432
Query: 352 NKNYNIQE----VETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            K+Y ++      E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           +G G FG VY+G       V + ++ D  +P    AF+ EV ++    H N+L  +G+ T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
              + L +       S  Y+   ++  E          +A   A+G++YLH      IIH
Sbjct: 103 K--DNLAIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIH 155
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL---STGKSS 295
           RD+K+ N+ L E     +GDFGLA +      +    Q  G++  +APE +        S
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 296 ERTDVFGYGIMLLELVTGQ 314
            ++DV+ YGI+L EL+TG+
Sbjct: 216 FQSDVYSYGIVLYELMTGE 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 41/296 (13%)
Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF 156
           G L    ++E+++       + V+G+G FG V +        VA+K++   ES     AF
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAF 49
Query: 157 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 216
             E+  +S   H N+++L G C  P    LV  + +  S+   L   +P    L + T  
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEP----LPYYTAA 103
Query: 217 RV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTN 272
                 L  ++G+ YLH      +IHRD+K  N+LL      + + DFG A  +    TN
Sbjct: 104 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN 163
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXX 332
                +G+   +APE       SE+ DVF +GI+L E++T ++  D              
Sbjct: 164 N----KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFR 213
Query: 333 XXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                    R   I  +NL K      +E+++     C    P  RP+M E+V+++
Sbjct: 214 IMWAVHNGTRPPLI--KNLPK-----PIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 26/236 (11%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDF 147
           +F     Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + + 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEA 60
Query: 148 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-- 205
            S      F  E  ++      +++RL+G  +     L++   M    +   LR ++P  
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 206 -GEPVLDWVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
              PVL   +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 262 LAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  D+ +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 178 MTR--DIXETDXXR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 51/299 (17%)
Query: 120 LGQGGFGKVYR----GVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           +G+G FG+V++    G+L     T VAVK L +  S    A FQRE  +++   + N+++
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 174 LIGFCTTPTERLLVYPFM--------------------QNLSVAYRLREIKPGEPVLDWV 213
           L+G C       L++ +M                     +  ++ R R   PG P L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRK 270
            +  +A   A G+ YL E    K +HRD+   N L+ E+    + DFGL++ +   D  K
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXX 330
            +    +   +  + PE +   + +  +DV+ YG++L E+        FS          
Sbjct: 232 ADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI--------FSYGLQPYYGMA 281
Query: 331 XXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                   R+  + A  +    + YN+           LC    P DRP+   + R+L+
Sbjct: 282 HEEVIYYVRDGNILACPENCPLELYNLMR---------LCWSKLPADRPSFCSIHRILQ 331

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------ 126
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 41/286 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + + K+ LG G +G+VY GV    +  VAVK L   E       F +E  ++    H NL
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L+G CT      +V  +M   ++   LRE    E  +  V    +A   +  +EYL +
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREE--VTAVVLLYMATQISSAMEYLEK 148
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+ 
Sbjct: 149 K---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 205
Query: 292 GKSSERTDVFGYGIMLLELVT----GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIV 347
              S ++DV+ +G++L E+ T        ID S+                         V
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------------V 240
Query: 348 DRNLNKNYNIQEVE----TMIQVALLCTQASPEDRPAMSEVVRMLE 389
              L K Y +++ E     + ++   C + SP DRP+ +E  +  E
Sbjct: 241 YDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 143/316 (45%), Gaps = 45/316 (14%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDF 147
           +F     Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + + 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEA 60
Query: 148 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-- 205
            S      F  E  ++      +++RL+G  +     L++   M    +   LR ++P  
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 206 -GEPVLDWVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
              PVL   +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 262 LAKLVDVRKTNVTTQVRGTMG-----HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 316
           + +  D+ +T+     +G  G      ++PE L  G  +  +DV+ +G++L E+ T    
Sbjct: 178 MTR--DIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---- 229
Query: 317 IDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASP 375
                                  E+ L  +++   L+K  N  ++  + ++  +C Q +P
Sbjct: 230 ------------LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNP 275
Query: 376 EDRPAMSEVVRMLEGE 391
           + RP+  E++  ++ E
Sbjct: 276 KMRPSFLEIISSIKEE 291

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           + V+G+G FG V +        VA+K++   ES     AF  E+  +S   H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            C  P    LV  + +  S+   L   +P  P           L  ++G+ YLH      
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 237 IIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
           +IHRD+K  N+LL      + + DFG A  +    TN     +G+   +APE       S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYS 181
Query: 296 ERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNY 355
           E+ DVF +GI+L E++T ++  D                       R   I  +NL K  
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLI--KNLPK-- 231
Query: 356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               +E+++     C    P  RP+M E+V+++
Sbjct: 232 ---PIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 135
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 136 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 141/305 (46%), Gaps = 45/305 (14%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQR 158
           E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S      F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTR 215
           E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL   + 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 216 KRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
            ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+ +T+
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETD 177
Query: 273 VTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXX 327
                +G  G +     +PE L  G  +  +DV+ +G++L E+ T               
Sbjct: 178 XXR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------------- 220
Query: 328 XXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                       E+ L  +++   L+K  N  ++  ++++  +C Q +P+ RP+  E++ 
Sbjct: 221 -LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFLEIIS 277
Query: 387 MLEGE 391
            ++ E
Sbjct: 278 SIKEE 282

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 119
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 128
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 127
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 126
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 128
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 128
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 129
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 127
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 128
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 132
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 131
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 132 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFE 148
           F     Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAA 67
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG-- 206
           S      F  E  ++      +++RL+G  +     L++   M    +   LR ++P   
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 207 -EPVLDWVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
             PVL   +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 263 AKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
            +  D+ +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 185 TR--DIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 142/315 (45%), Gaps = 45/315 (14%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFE 148
           F     Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  
Sbjct: 31  FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAA 89
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP--- 205
           S      F  E  ++      +++RL+G  +     L++   M    +   LR ++P   
Sbjct: 90  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 149
Query: 206 GEPVLDWVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
             PVL   +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 263 AKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
            +  D+ +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T     
Sbjct: 207 TR--DIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 257
Query: 318 DFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPE 376
                                 E+ L  +++   L+K  N  ++  + ++  +C Q +P+
Sbjct: 258 -----------LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPK 304
Query: 377 DRPAMSEVVRMLEGE 391
            RP+  E++  ++ E
Sbjct: 305 MRPSFLEIISSIKEE 319

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 150
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 151 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 141/309 (45%), Gaps = 45/309 (14%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDA 154
           Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S     
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLD 211
            F  E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL 
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 212 WVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
             +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI 178
Query: 269 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXX 323
            +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T           
Sbjct: 179 YETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 225
Query: 324 XXXXXXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                           E+ L  +++   L+K  N  ++  + ++  +C Q +P+ RP+  
Sbjct: 226 -----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFL 278
Query: 383 EVVRMLEGE 391
           E++  ++ E
Sbjct: 279 EIISSIKEE 287

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFE 148
           F     Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAA 67
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP--- 205
           S      F  E  ++      +++RL+G  +     L++   M    +   LR ++P   
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 206 GEPVLDWVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
             PVL   +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 263 AKLVDVRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
            +  D+ +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 185 TR--DIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 26/229 (11%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDA 154
           Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S     
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLD 211
            F  E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 212 WVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
             +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI 181
Query: 269 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
            +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 182 YETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 26/229 (11%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDA 154
           Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S     
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLD 211
            F  E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 212 WVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
             +  ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI 181
Query: 269 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
            +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 182 YETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQR 158
           E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S      F  
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTR 215
           E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL   + 
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 216 KRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
            ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+ +T+
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD 183
Query: 273 VTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
                +G  G +     +PE L  G  +  +DV+ +G++L E+ T
Sbjct: 184 YYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 122
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 123 IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 140/305 (45%), Gaps = 45/305 (14%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQR 158
           E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S      F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTR 215
           E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL   + 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 216 KRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
            ++   A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+ +T+
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD 179
Query: 273 VTTQVRGTMG-----HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXX 327
                +G  G      ++PE L  G  +  +DV+ +G++L E+ T               
Sbjct: 180 YYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------------- 222
Query: 328 XXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                       E+ L  +++   L+K  N  ++  + ++  +C Q +P+ RP+  E++ 
Sbjct: 223 -LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIIS 279
Query: 387 MLEGE 391
            ++ E
Sbjct: 280 SIKEE 284

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLRE-------IKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + RE         P 
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPS 140
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 141/309 (45%), Gaps = 45/309 (14%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDA 154
           Y   E ++A +  +    LGQG FG VY GV A G       T+VA+K + +  S     
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLD 211
            F  E  ++      +++RL+G  +     L++   M    +   LR ++P     PVL 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 212 WVTRKRVALGA---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
             +  ++   A   A G+ YL+ +   K +HRD+ A N  + EDF   +GDFG+ +  D+
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR--DI 175
Query: 269 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXX 323
            +T+     +G  G +     +PE L  G  +  +DV+ +G++L E+ T           
Sbjct: 176 YETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 222
Query: 324 XXXXXXXXXXXXXXXREKRLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                           E+ L  +++   L+K  N  ++  ++++  +C Q +P+ RP+  
Sbjct: 223 -----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFL 275
Query: 383 EVVRMLEGE 391
           E++  ++ E
Sbjct: 276 EIISSIKEE 284

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y  M+ +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVMEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 168
           ++  F +   LG G +  VY+G+    G  VA+K +      G  +   RE+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV-LDWVTRKRVALGAARGLE 227
            N++RL     T  +  LV+ FM N    Y         P  L+    K       +GL 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + HE+   KI+HRD+K  N+L+++  +  +GDFGLA+   +     +++V  T+ + AP+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178
Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTGQ 314
            L   ++ S   D++  G +L E++TG+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VL  G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPS 140
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 198 RDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+  L +  SP  +     E  ++
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 159
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 160 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VL  G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 132
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VL  G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 132
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFGLAKL+   +     +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLPVR 194
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 238
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P+ RP   E+V +L+ +
Sbjct: 239 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 129
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 127
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 127
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLPVR 197
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P+ RP   E+V +L+ +
Sbjct: 242 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 125
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 127
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y  ++ +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 72
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 73  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 132
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 133 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 190 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMI 163
           L    F +  VLG G FG VY+G+ + +G KV    A+K L +  SP  +     E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 164 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +   + ++ RL+G C T T +L+  + PF   L      ++    + +L+W  +      
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 132
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGT 280
            A+G+ YL +    +++HRD+ A NVL+       + DFG AKL+   +     +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
           +  +A E +     + ++DV+ YG+ + EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 69
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 70  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 129
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 130 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 187 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 73
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 74  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 133
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 134 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 191 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLPVR 197
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P  RP   E+V +L+ +
Sbjct: 242 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 140
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLRE-------IKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 125
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y  ++ +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPVR 197
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P+ RP   E+V +L+ +
Sbjct: 242 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLRE-------IKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 140
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE        + V + A  A G+ Y+ E  N 
Sbjct: 75  VSEEP----IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 127
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 128 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 187 IKSDVWSFGILLTELTTKGR 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 73  VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 125
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 126 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 185 IKSDVWSFGILLTELTTKGR 204

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE        + V + A  A G+ Y+ E  N 
Sbjct: 248 VSEEP----IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 300
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G +G VY+   + G  VA+KR+  D E  G  +   RE+ ++    H N++ LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
            +     LV+ FM+   +   L E K G   L     K       RG+ + H+H   +I+
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSER 297
           HRD+K  N+L++ D    + DFGLA+   +   + T +V  T+ + AP+ L  + K S  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 298 TDVFGYGIMLLELVTGQ 314
            D++  G +  E++TG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G +G VY+   + G  VA+KR+  D E  G  +   RE+ ++    H N++ LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
            +     LV+ FM+   +   L E K G   L     K       RG+ + H+H   +I+
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSER 297
           HRD+K  N+L++ D    + DFGLA+   +   + T +V  T+ + AP+ L  + K S  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 298 TDVFGYGIMLLELVTGQ 314
            D++  G +  E++TG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 118 NVLGQGGFGKVYRGV-LADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
            VLG G FG VY+G+ + DG      VA+K L +  SP  +     E  +++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 222
           RL+G C T T +L+               ++ P   +LD V   R  LG+          
Sbjct: 83  RLLGICLTSTVQLVT--------------QLMPYGCLLDHVRENRGRLGSQDLLNWCMQI 128
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTM 281
           A+G+ YL +    +++HRD+ A NVL+       + DFGLA+L+D+ +T       +  +
Sbjct: 129 AKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 185
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 318
             +A E +   + + ++DV+ YG+ + EL+T G +  D
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+ G     TKVA+K L     PG     +F  E +++    H  L++L   
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL----KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEP-VLDWVTRKRVALGAARGLEYLHEHCNPK 236
            +       +Y   + ++    L  +K GE   L       +A   A G+ Y+ E  N  
Sbjct: 73  VSEEP----IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN-- 125
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHRD+++AN+L+       + DFGLA+L++  +       +  +   APE    G+ + 
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 297 RTDVFGYGIMLLELVTGQR 315
           ++DV+ +GI+L ELVT  R
Sbjct: 186 KSDVWSFGILLTELVTKGR 204

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE        + V + A  A G+ Y+ E  N 
Sbjct: 248 VSEEP----IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 300
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 71  VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 124 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 183 IKSDVWSFGILLTELTTKGR 202

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPVR 196
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 240
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P+ RP   E+V +L+ +
Sbjct: 241 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVCEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 156
           +L  D       LG+G FG+V   VLA+            TKVAVK L    +    +  
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 157 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR-------EIKPG 206
             E+EM+  +  H+N++ L+G CT   P   ++ Y    NL    + R          P 
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
               + ++ K +   A   ARG+EYL    + K IHRD+ A NVL+ ED    + DFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + +  +     TT  R  +  +APE L     + ++DV+ +G++L E+ T
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +      +V  +M   S+   L+    GE        + V + A  A G+ Y+ E  N 
Sbjct: 72  VSE-EPIXIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 125 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 184 IKSDVWSFGILLTELTTKGR 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVTEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 57/230 (24%)
Query: 117 KNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 172
           ++V+G+G FG+V +  +  DG ++  A+KR+ ++ S      F  E+E++  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 218
            L+G C             ++    Y   E  P   +LD++ + RV              
Sbjct: 80  NLLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 126
Query: 219 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                      A   ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +
Sbjct: 127 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 183
Query: 268 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           V        V+ TMG +     A E L+    +  +DV+ YG++L E+V+
Sbjct: 184 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 33/258 (12%)
Query: 84  VDVAGEVDRRIAFGQLKRYSWR-ELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT- 137
           V V G  D    +   + Y +  + +   +N     VLG G FGKV      G+   G  
Sbjct: 16  VQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVS 75
Query: 138 -KVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQN 193
            +VAVK L +        A   E++M++ +  H N++ L+G CT   P   +  Y    +
Sbjct: 76  IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 194 LSVAYRLREIKPGEPVLDWVTRKRV-----------------ALGAARGLEYLH-EHCNP 235
           L    R +  K  E  +++  +KR+                 A   A+G+E+L  + C  
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-- 193
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 294
             +HRD+ A NVL+       + DFGLA+ ++      V    R  +  +APE L  G  
Sbjct: 194 --VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251
Query: 295 SERTDVFGYGIMLLELVT 312
           + ++DV+ YGI+L E+ +
Sbjct: 252 TIKSDVWSYGILLWEIFS 269

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEXSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 57/230 (24%)
Query: 117 KNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 172
           ++V+G+G FG+V +  +  DG ++  A+KR+ ++ S      F  E+E++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 218
            L+G C             ++    Y   E  P   +LD++ + RV              
Sbjct: 90  NLLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 219 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                      A   ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
Query: 268 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           V        V+ TMG +     A E L+    +  +DV+ YG++L E+V+
Sbjct: 194 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +      +V  +M   S+   L+    GE        + V + A  A G+ Y+ E  N 
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLK----GETGKYLRLPQLVDMSAQIASGMAYV-ERMN- 131
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 132 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HRD+ A N ++  DF   +GDFG+ +  D+ +T      +G  G +   
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYR--KGGKGLLPVR 197
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P+ RP   E+V +L+ +
Sbjct: 242 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +      +V  +M   S+   L+    GE        + V + A  A G+ Y+ E  N 
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLK----GETGKYLRLPQLVDMSAQIASGMAYV-ERMN- 131
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 132 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGLA+++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE        + V + A  A G+ Y+ E  N 
Sbjct: 248 VSEEP----IYIVGEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 300
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVE-MISVAV--HRNLL 172
            VLG G FG V++GV + +G  + +       E   G  +FQ   + M+++    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 222
           RL+G C   + +L+               +  P   +LD V + R ALG           
Sbjct: 79  RLLGLCPGSSLQLVT--------------QYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTM 281
           A+G+ YL EH    ++HR++ A NVLL    +  V DFG+A L+    K  + ++ +  +
Sbjct: 125 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             +A E +  GK + ++DV+ YG+ + EL+T
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 82  VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD+ AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 135 -YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 128
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 129 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 45/280 (16%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+       TKVAVK +     PG  +  AF  E  ++    H  L++L   
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 178 CTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
            T      ++  FM   S+   L+      +P   ++D+  +       A G+ ++ +  
Sbjct: 79  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQR- 130
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
               IHRD++AAN+L+       + DFGLA++++  +       +  +   APE ++ G 
Sbjct: 131 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 294 SSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNK 353
            + ++DV+ +GI+L+E+VT  R I +                        +  V R L +
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGR-IPYPGMS--------------------NPEVIRALER 227
Query: 354 NYNIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
            Y +   E     +  + + C +  PE+RP    +  +L+
Sbjct: 228 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVE-MISVAV--HRNLL 172
            VLG G FG V++GV + +G  + +       E   G  +FQ   + M+++    H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 222
           RL+G C   + +L+               +  P   +LD V + R ALG           
Sbjct: 97  RLLGLCPGSSLQLVT--------------QYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 142
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTM 281
           A+G+ YL EH    ++HR++ A NVLL    +  V DFG+A L+    K  + ++ +  +
Sbjct: 143 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             +A E +  GK + ++DV+ YG+ + EL+T
Sbjct: 200 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 145
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 146 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 237

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 18/233 (7%)
Query: 89  EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-- 146
           E D+   F Q K      + L  ++FS   ++G+GGFG+VY    AD  K+   +  D  
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 147 -FESPGGDAAFQREVEMISVAVHRNLLRLIGFC---TTPTERLLVYPFMQNLSVAYRLRE 202
             +   G+     E  M+S+    +   ++       TP +   +   M    + Y L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                 V      +  A     GLE++H   N  +++RD+K AN+LLDE     + D GL
Sbjct: 286 ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           A     +K + +    GT G++APE L  G + + + D F  G ML +L+ G 
Sbjct: 339 ACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 18/233 (7%)
Query: 89  EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-- 146
           E D+   F Q K      + L  ++FS   ++G+GGFG+VY    AD  K+   +  D  
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 147 -FESPGGDAAFQREVEMISVAVHRNLLRLIGFC---TTPTERLLVYPFMQNLSVAYRLRE 202
             +   G+     E  M+S+    +   ++       TP +   +   M    + Y L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                 V      +  A     GLE++H   N  +++RD+K AN+LLDE     + D GL
Sbjct: 286 ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           A     +K + +    GT G++APE L  G + + + D F  G ML +L+ G 
Sbjct: 339 ACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 18/233 (7%)
Query: 89  EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-- 146
           E D+   F Q K      + L  ++FS   ++G+GGFG+VY    AD  K+   +  D  
Sbjct: 166 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 147 -FESPGGDAAFQREVEMISVAVHRNLLRLIGFC---TTPTERLLVYPFMQNLSVAYRLRE 202
             +   G+     E  M+S+    +   ++       TP +   +   M    + Y L +
Sbjct: 225 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 284
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                 V      +  A     GLE++H   N  +++RD+K AN+LLDE     + D GL
Sbjct: 285 ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 337
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           A     +K + +    GT G++APE L  G + + + D F  G ML +L+ G 
Sbjct: 338 ACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 18/233 (7%)
Query: 89  EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-- 146
           E D+   F Q K      + L  ++FS   ++G+GGFG+VY    AD  K+   +  D  
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 147 -FESPGGDAAFQREVEMISVAVHRNLLRLIGFC---TTPTERLLVYPFMQNLSVAYRLRE 202
             +   G+     E  M+S+    +   ++       TP +   +   M    + Y L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
                 V      +  A     GLE++H   N  +++RD+K AN+LLDE     + D GL
Sbjct: 286 ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           A     +K + +    GT G++APE L  G + + + D F  G ML +L+ G 
Sbjct: 339 ACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HR++ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPVR 197
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P  RP   E+V +L+ +
Sbjct: 242 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 120 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LGQG FG VY G   D       T+VAVK + +  S      F  E  ++      +++R
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 227
           L+G  +     L+V   M +  +   LR ++P      G P        ++A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           YL+     K +HR++ A N ++  DF   +GDFG+ +  D+ +T+     +G  G +   
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPVR 198
Query: 285 --APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE L  G  +  +D++ +G++L E+ +                           E+ 
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 242
Query: 343 LDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 391
           L  ++D   L++  N  E  T   +  +C Q +P  RP   E+V +L+ +
Sbjct: 243 LKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE        + V + A  A G+ Y+ E  N 
Sbjct: 331 VSEEP----IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYV-ERMN- 383
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 443 IKSDVWSFGILLTELTTKGR 462

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 119 VLGQGGFGKVYRGVL-ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V RG L A G K   VA+K L    +      F  E  ++    H N++RL
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     +++  FM+N ++   LR       V+  V   R   G A G+ YL E   
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM-- 137
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYL 289
              +HRD+ A N+L++ +    V DFGL++ ++   ++  T+     G I     APE +
Sbjct: 138 -SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTETSSLGGKIPIRWTAPEAI 195
Query: 290 STGKSSERTDVFGYGIMLLELVT-GQR 315
           +  K +  +D + YGI++ E+++ G+R
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 120 LGQGGFGKVYRG-VLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +GQG FG+V++      G KVA+K+ L + E  G      RE++++ +  H N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 178 CTT---PTERL-----LVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           C T   P  R      LV+ F        + N+ V + L EIK            RV   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG-- 279
              GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+   + K +   +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 280 -TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT 312
            T+ +  PE L   +      D++G G ++ E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +GQG FG+V++      G KVA+K+ L + E  G      RE++++ +  H N++ LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 178 CTT---PTERL-----LVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           C T   P  R      LV+ F        + N+ V + L EIK            RV   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 132
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG-- 279
              GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+   + K +   +     
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 280 -TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT 312
            T+ +  PE L   +      D++G G ++ E+ T
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARR-PPGMEYSYDINRV 149
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAV-KRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           VLG+G FG+  +    +  +V V K L  F+       F +EV+++    H N+L+ IG 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                    +  +++  ++   ++ +    P   W  R   A   A G+ YLH      I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSM---NI 129
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-------------TQVRGTMGHI 284
           IHRD+ + N L+ E+   VV DFGLA+L+   KT                  V G    +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELV 311
           APE ++     E+ DVF +GI+L E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 155
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 156 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 120 LGQGGFGKVYRG-VLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +GQG FG+V++      G KVA+K+ L + E  G      RE++++ +  H N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 178 CTT---PTERL-----LVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           C T   P  R      LV+ F        + N+ V + L EIK            RV   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG-- 279
              GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+   + K +   +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 280 -TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT 312
            T+ +  PE L   +      D++G G ++ E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 120 LGQGGFGKVYRGVL-ADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +GQG FG+V++      G KVA+K+ L + E  G      RE++++ +  H N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 178 CTT---PTERL-----LVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           C T   P  R      LV+ F        + N+ V + L EIK            RV   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG-- 279
              GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+   + K +   +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 280 -TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT 312
            T+ +  PE L   +      D++G G ++ E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 136
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 194 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 83  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 141
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 199 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 119 VLGQGGFGKVYRGVL-ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V RG L A G K   VA+K L    +      F  E  ++    H N++RL
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     +++  FM+N ++   LR       V+  V   R   G A G+ YL E   
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM-- 135
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHI---APEYLS 290
              +HRD+ A N+L++ +    V DFGL++ ++   ++ T T   G    I   APE ++
Sbjct: 136 -SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 291 TGKSSERTDVFGYGIMLLELVT-GQR 315
             K +  +D + YGI++ E+++ G+R
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 45/280 (16%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+       TKVAVK +     PG  +  AF  E  ++    H  L++L   
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 178 CTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
            T      ++  FM   S+   L+      +P   ++D+  +       A G+ ++ +  
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQR- 303
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
               IHRD++AAN+L+       + DFGLA++++  +       +  +   APE ++ G 
Sbjct: 304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 294 SSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNK 353
            + ++DV+ +GI+L+E+VT  R I +                        +  V R L +
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGR-IPYPGMS--------------------NPEVIRALER 400
Query: 354 NYNIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
            Y +   E     +  + + C +  PE+RP    +  +L+
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 177
           LGQG FG+V+ G     T+VA+K L     PG     AF +E +++    H  L++L   
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCNP 235
            +       +Y   + +S    L  +K GE    L       +A   A G+ Y+ E  N 
Sbjct: 249 VSEEP----IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 301
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD++AAN+L+ E+    V DFGL +L++  +       +  +   APE    G+ +
Sbjct: 302 -YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 296 ERTDVFGYGIMLLELVTGQR 315
            ++DV+ +GI+L EL T  R
Sbjct: 361 IKSDVWSFGILLTELTTKGR 380

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 57/230 (24%)
Query: 117 KNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 172
           ++V+G+G FG+V +  +  DG ++  A+KR+ ++ S      F  E+E++  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 218
            L+G C             ++    Y   E  P   +LD++ + RV              
Sbjct: 87  NLLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 133
Query: 219 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                      A   ARG++YL +    + IHR++ A N+L+ E++ A + DFGL++  +
Sbjct: 134 STLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQE 190
Query: 268 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 312
           V        V+ TMG +     A E L+    +  +DV+ YG++L E+V+
Sbjct: 191 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 138
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 196 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V  +M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL +++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 117 KNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L G  T  T  +++  FM+N S+   LR+      V+  V   R   G A G++YL + 
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLADM 154
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMG--HIAPEY 288
                +HRD+ A N+L++ +    V DFGL++ +  D      T+ + G +     APE 
Sbjct: 155 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRA 316
           +   K +  +DV+ YGI++ E+++ G+R 
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 120 LGQGGFGKV---YRGVLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV         DGT   VAVK L +   P   + +QRE+E++    H ++++ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARGL 226
            G C    E+          SV   +  +  G  + D++ R  V L            G+
Sbjct: 77  KGCCEDQGEK----------SVQLVMEYVPLGS-LRDYLPRHCVGLAQLLLFAQQICEGM 125
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
            YLH       IHR + A NVLLD D    +GDFGLAK V         +  G   +   
Sbjct: 126 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 182
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           APE L   K    +DV+ +G+ L EL+T
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 212
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 212
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 227
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 227
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           +   D  +    LG+G FG+V      G+  D  K    VAVK L D  +    +    E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 160 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG---------- 206
           +EM+  +  H+N++ L+G CT   P   ++ Y    NL    R R   PG          
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDINRV 195
Query: 207 -EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
            E  + +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+ 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 266 V-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + ++     TT  R  +  +APE L     + ++DV+ +G+++ E+ T
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 229
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 120 LGQGGFGKV---YRGVLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV         DGT   VAVK L +   P   + +QRE+E++    H ++++ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARGL 226
            G C    E+          SV   +  +  G  + D++ R  V L            G+
Sbjct: 76  KGCCEDQGEK----------SVQLVMEYVPLGS-LRDYLPRHCVGLAQLLLFAQQICEGM 124
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
            YLH       IHR + A NVLLD D    +GDFGLAK V         +  G   +   
Sbjct: 125 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 181
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           APE L   K    +DV+ +G+ L EL+T
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 119 VLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA--VHRNLLRLI 175
           +  +G FG V++  ++ D   V +  L D +S      +Q E E+ S     H NLL+ I
Sbjct: 22  IKARGRFGCVWKAQLMNDFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQFI 75
Query: 176 GF----CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
                      E  L+  F    S+   L+       ++ W     VA   +RGL YLHE
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKG-----NIITWNELCHVAETMSRGLSYLHE 130
Query: 232 HC--------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-GTMG 282
                      P I HRD K+ NVLL  D  AV+ DFGLA   +  K    T  + GT  
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 283 HIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQRAID 318
           ++APE L    + +     R D++  G++L ELV+  +A D
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 239
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 213
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 227
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 213
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWM 219
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ + +   +    M  +   
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ--DIYRASYYRKGGCAMLPVKWM 213
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V   M+N S+   LR+      V+  V   R   G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 128
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 129 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           N   K  LG+G FGKV+           D   VAVK L D  S      F RE E+++  
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNL 72
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRK--R 217
            H ++++  G C      ++V+ +M++  +   LR   P       G P  +    +   
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
           +A   A G+ YL    +   +HRD+   N L+ E+    +GDFG+++  DV  T+     
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVG 187
Query: 278 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
             TM  I    PE +   K +  +DV+  G++L E+ T
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 119 VLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVE-MISVAV------ 167
           +LG+G FG V  G L   DGT  KVAVK +        D + QRE+E  +S A       
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK------LDNSSQREIEEFLSEAACMKDFS 94
Query: 168 HRNLLRLIGFCTTPTER-----LLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           H N++RL+G C   + +     +++ PFM+  +L        ++ G   +   T  +  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQV 277
             A G+EYL    N   +HRD+ A N +L +D    V DFGL+K +   D  +     ++
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
              +  IA E L+    + ++DV+ +G+ + E+ T
Sbjct: 212 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ +     +    M  +   
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWM 230
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     KV   ++ D E    +    Q+E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++   M+ L     L  ++PG   LD      +     +GL+YLH  
Sbjct: 69  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 123
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
              K IHRD+KAANVLL E  E  + DFG+A  +   +    T V GT   +APE +   
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
               + D++  GI  +EL  G+
Sbjct: 180 AYDSKADIWSLGITAIELARGE 201

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 120 LGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG+G FGKV+      +L +  K  VAVK L +  S      FQRE E++++  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVR 84
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL---DWVTRKRVALG--------A 222
             G CT     L+V+ +M++  +   LR   P   +L   + V    + LG         
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A G+ YL        +HRD+   N L+ +     +GDFG+++  D+  T+       TM 
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 199
Query: 283 HI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
            I    PE +   K +  +DV+ +G++L E+ T
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 120 LGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N++R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP-VLDWVTRKRVALGAARGLEYLH 230
            IG       R ++   M    +   LRE   +P +P  L  +    VA   A G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 231 EHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 284
           E+     IHRD+ A N LL        A +GDFG+A+  D+ +     +    M  +   
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWM 253
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
            PE    G  + +TD + +G++L E+ +
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 120 LGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG+G FGKV+      +L +  K  VAVK L +  S      FQRE E++++  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVR 78
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL---DWVTRKRVALG--------A 222
             G CT     L+V+ +M++  +   LR   P   +L   + V    + LG         
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A G+ YL        +HRD+   N L+ +     +GDFG+++  D+  T+       TM 
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 193
Query: 283 HI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
            I    PE +   K +  +DV+ +G++L E+ T
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     KV   ++ D E    +    Q+E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++   M+ L     L  ++PG   LD      +     +GL+YLH  
Sbjct: 69  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 123
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 286
              K IHRD+KAANVLL E  E  + DFG+A +L D       TQ++     GT   +AP
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNXFVGTPFWMAP 173
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E +       + D++  GI  +EL  G+
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 119 VLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA--VHRNLLRLI 175
           V  +G FG V++  +L +   V +  + D +S      +Q E E+ S+    H N+L+ I
Sbjct: 31  VKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS------WQNEYEVYSLPGMKHENILQFI 84
Query: 176 GF----CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           G      +   +  L+  F +  S++  L+       V+ W     +A   ARGL YLHE
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE 139
Query: 232 HC-------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-GTMGH 283
                     P I HRD+K+ NVLL  +  A + DFGLA   +  K+   T  + GT  +
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 284 IAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQRAID 318
           +APE L    + +     R D++  G++L EL +   A D
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 94  IAFGQLKRYSWRELQ-LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG 152
           + F +  ++ W E Q +  D F +  VLG+GGFG+V+   +    K+   +  + +    
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK 225
Query: 153 DAAFQREV--EMISVAVHRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREI---KPG 206
              +Q  +  + I   VH   +  + +   T T+  LV   M    + Y +  +    PG
Sbjct: 226 RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 207 --EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 264
             EP   + T + V+     GLE+LH+     II+RD+K  NVLLD+D    + D GLA 
Sbjct: 286 FQEPRAIFYTAQIVS-----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +   +T  T    GT G +APE L   +     D F  G+ L E++  +
Sbjct: 338 ELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     KV   ++ D E    +    Q+E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++   M+ L     L  ++PG   LD      +     +GL+YLH  
Sbjct: 84  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 138
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 286
              K IHRD+KAANVLL E  E  + DFG+A +L D       TQ++     GT   +AP
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNXFVGTPFWMAP 188
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E +       + D++  GI  +EL  G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q   ++F     LG+G FG VY       + +LA   KV  K  T  E  G +   +REV
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFK--TQLEKAGVEHQLRREV 63
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSRFDEQRTAT 116
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL  + E  + DFG +  V    +  TT +
Sbjct: 117 YITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT-L 170
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT+ ++ PE +      E+ D++  G++  E + G
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V   M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 94  IAFGQLKRYSWRELQ-LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG 152
           + F +  ++ W E Q +  D F +  VLG+GGFG+V+   +    K+   +  + +    
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK 225
Query: 153 DAAFQREV--EMISVAVHRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREI---KPG 206
              +Q  +  + I   VH   +  + +   T T+  LV   M    + Y +  +    PG
Sbjct: 226 RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 207 --EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 264
             EP   + T + V+     GLE+LH+     II+RD+K  NVLLD+D    + D GLA 
Sbjct: 286 FQEPRAIFYTAQIVS-----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +   +T  T    GT G +APE L   +     D F  G+ L E++  +
Sbjct: 338 ELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIG 176
           ++G+G FG+VY G      +VA+ RL D E    D   AF+REV       H N++  +G
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAI-RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            C +P    ++    +  ++   +R+ K    VLD    +++A    +G+ YLH      
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIAPEYLSTG 292
           I+H+D+K+ NV  D   + V+ DFGL  +  V    R+ +      G + H+APE +   
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 293 KS---------SERTDVFGYGIMLLEL 310
                      S+ +DVF  G +  EL
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 94  IAFGQLKRYSWRELQ-LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG 152
           + F +  ++ W E Q +  D F +  VLG+GGFG+V+   +    K+   +  + +    
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK 225
Query: 153 DAAFQREV--EMISVAVHRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREI---KPG 206
              +Q  +  + I   VH   +  + +   T T+  LV   M    + Y +  +    PG
Sbjct: 226 RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 207 --EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 264
             EP   + T + V+     GLE+LH+     II+RD+K  NVLLD+D    + D GLA 
Sbjct: 286 FQEPRAIFYTAQIVS-----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +   +T  T    GT G +APE L   +     D F  G+ L E++  +
Sbjct: 338 ELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 31/285 (10%)
Query: 120 LGQGGFGKV---YRGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D  G  VAVK+L     P     FQRE++++  A+H + +  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILK-ALHSDFIV- 74
Query: 175 IGFCTTPTERLLVY-PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
                    R + Y P  Q+L +   + E  P   + D++ R R  L A+R L Y  + C
Sbjct: 75  -------KYRGVSYGPGRQSLRL---VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 234 -------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
                  + + +HRD+ A N+L++ +    + DFGLAKL+ + K     +  G   +   
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           APE LS    S ++DV+ +G++L EL T                          R   L 
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELL 244
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               R         EV  +++   LC   SP+DRP+ S +   L+
Sbjct: 245 EEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 286

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 96  FGQLKRYSWRELQ-LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA 154
           F +  ++ W E Q +  D F +  VLG+GGFG+V+   +    K+   +  + +      
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 155 AFQREV--EMISVAVHRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREI---KPG-- 206
            +Q  +  + I   VH   +  + +   T T+  LV   M    + Y +  +    PG  
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 207 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 266
           EP   + T + V+     GLE+LH+     II+RD+K  NVLLD+D    + D GLA  +
Sbjct: 288 EPRAIFYTAQIVS-----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
              +T  T    GT G +APE L   +     D F  G+ L E++  +
Sbjct: 340 KAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMI 163
           +L   N S   V+G G FG+V  G L   +K    VA+K L    +      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
               H N++RL G  T     ++V   M+N S+   LR+      V+  V   R   G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIA 157
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTM 281
            G++YL +      +HRD+ A N+L++ +    V DFGL++++  D      T   +  +
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
              +PE ++  K +  +DV+ YGI+L E+++ G+R
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     KV   ++ D E    +    Q+E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     T+  ++   M+ L     L  ++PG   LD      +     +GL+YLH  
Sbjct: 89  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 143
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLST 291
              K IHRD+KAANVLL E  E  + DFG+A +L D +    T    GT   +APE +  
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
                + D++  GI  +EL  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 120 LGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
           LG+G FGKV+      +L +  K  VAVK L +  S      FQRE E++++  H++++R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVR 107
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL---DWVTRKRVALG--------A 222
             G CT     L+V+ +M++  +   LR   P   +L   + V    + LG         
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A G+ YL        +HRD+   N L+ +     +GDFG+++  D+  T+       TM 
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 222
Query: 283 HI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
            I    PE +   K +  +DV+ +G++L E+ T
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 46/310 (14%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-----EIKPG 206
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       KP 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 207 EPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
           +   D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFGLA
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 264 KLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
           + +      V     R  +  +APE +     + ++DV+ +G++L E+        FS  
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSLG 247
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPEDR 378
                              ++D    R L +   ++  +     M Q  L C    P  R
Sbjct: 248 ASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
Query: 379 PAMSEVVRML 388
           P  SE+V  L
Sbjct: 296 PTFSELVEHL 305

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 120 LGQGGFGKV---YRGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 172
           LG+G FG V       L D  G  VAVK+L     P     FQRE++++  A+H + +  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIVK 72
Query: 173 -RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            R + +     E  LV  ++             P   + D++ R R  L A+R L Y  +
Sbjct: 73  YRGVSYGPGRPELRLVMEYL-------------PSGCLRDFLQRHRARLDASRLLLYSSQ 119
Query: 232 HC-------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMG 282
            C       + + +HRD+ A N+L++ +    + DFGLAKL+ + K     +  G   + 
Sbjct: 120 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKR 342
             APE LS    S ++DV+ +G++L EL T                          R   
Sbjct: 180 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLE 239
Query: 343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L     R         EV  +++   LC   SP+DRP+ S +   L+
Sbjct: 240 LLEEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 283

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           E  L  DN     ++G+G +G VY+G L D   VAVK      S      F  E  +  V
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRV 61
Query: 166 AV--HRNLLRLIGFCTTPT-----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
            +  H N+ R I      T     E LLV  +  N S+   L          DWV+  R+
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRL 116
Query: 219 ALGAARGLEYLH------EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVR-- 269
           A    RGL YLH      +H  P I HRD+ + NVL+  D   V+ DFGL+ +L   R  
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 270 ----KTNVTTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLEL 310
               + N      GT+ ++APE L           + ++ D++  G++  E+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 64
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 117
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 171
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
            +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G  
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 179 TTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                 L +V  +M   S+   LR    G  VL      + +L     +EYL  +     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K S +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 194
Query: 298 TDVFGYGIMLLELVTGQR 315
           +DV+ +GI+L E+ +  R
Sbjct: 195 SDVWSFGILLWEIYSFGR 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++ + +G+G FG+VY+G+     +V   ++ D E    +    Q+E+ ++S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           R  G     T+  ++   M+ L     L  +KPG   L+      +     +GL+YLH  
Sbjct: 81  RYFGSYLKSTKLWII---MEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 135
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 286
              + IHRD+KAANVLL E  +  + DFG+A +L D       TQ++     GT   +AP
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNXFVGTPFWMAP 185
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E +       + D++  GI  +EL  G+
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 64
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T   L+  +     V   L+++       D         
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYIT 120
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGT 174
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           + ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 31/285 (10%)
Query: 120 LGQGGFGKV---YRGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D  G  VAVK+L     P     FQRE++++  A+H + +  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILK-ALHSDFIV- 87
Query: 175 IGFCTTPTERLLVY-PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
                    R + Y P  Q+L +   + E  P   + D++ R R  L A+R L Y  + C
Sbjct: 88  -------KYRGVSYGPGRQSLRL---VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 234 -------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
                  + + +HRD+ A N+L++ +    + DFGLAKL+ + K     +  G   +   
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           APE LS    S ++DV+ +G++L EL T                          R   L 
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               R         EV  +++   LC   SP+DRP+ S +   L+
Sbjct: 258 EEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 299

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILA--LKVLFK--AQLEKAGVEHQLRREV 56
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 57  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 109
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 110 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 163
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 58
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 59  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 111
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 112 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 165
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+T++   
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 167
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 168 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQ----KLSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++  T++
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTEL 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
            +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G  
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 179 TTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                 L +V  +M   S+   LR    G  VL      + +L     +EYL  +     
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K S +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 298 TDVFGYGIMLLELVTGQR 315
           +DV+ +GI+L E+ +  R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 131/312 (41%), Gaps = 48/312 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 262 LAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           LA+ +      V     R  +  +APE +     + ++DV+ +G++L E+        FS
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FS 236
Query: 321 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPE 376
                                ++D    R L +   ++  +     M Q  L C    P 
Sbjct: 237 LGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 377 DRPAMSEVVRML 388
            RP  SE+V  L
Sbjct: 285 QRPTFSELVEHL 296

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 64
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 117
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 171
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+T++   
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 167
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 168 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 131/312 (41%), Gaps = 48/312 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 262 LAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           LA+ +      V     R  +  +APE +     + ++DV+ +G++L E+        FS
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FS 236
Query: 321 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPE 376
                                ++D    R L +   ++  +     M Q  L C    P 
Sbjct: 237 LGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 377 DRPAMSEVVRML 388
            RP  SE+V  L
Sbjct: 285 QRPTFSELVEHL 296

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 60
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 113
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+T ++  
Sbjct: 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS-- 168
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 169 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPGGDAAFQREVEMIS 164
           Q A ++F     LG+G FG VY         + A+K L     E  G +   +REVE+ S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---G 221
              H N+LRL G+    T    VY  ++   +    RE++     L     +R A     
Sbjct: 81  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 133
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT + GT+
Sbjct: 134 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 187
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 130/312 (41%), Gaps = 48/312 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 262 LAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           LA+ +      V     R  +  +APE +     + ++DV+ +G++L E+        FS
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FS 245
Query: 321 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPE 376
                                ++D    R L +   ++  +     M Q  L C    P 
Sbjct: 246 LGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 377 DRPAMSEVVRML 388
            RP  SE+V  L
Sbjct: 294 QRPTFSELVEHL 305

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 63
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 116
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 117 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 170
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQ----KLSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT +
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-L 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 50/279 (17%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 81  GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 130
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V+       T + GT  +IAP
Sbjct: 131 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAP 186
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAI 346
           E LS    S   DV+  G ++  L+ G+   + S                  R K+ +  
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----------CLKETYLRIKKNEYS 235
Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
           + +++N         ++IQ  L   Q  P  RP ++E++
Sbjct: 236 IPKHIN-----PVAASLIQKML---QTDPTARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 50/279 (17%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 81  GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 130
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V+       T + GT  +IAP
Sbjct: 131 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAP 186
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAI 346
           E LS    S   DV+  G ++  L+ G+   + S                  R K+ +  
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----------CLKETYLRIKKNEYS 235
Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
           + +++N         ++IQ  L   Q  P  RP ++E++
Sbjct: 236 IPKHIN-----PVAASLIQKML---QTDPTARPTINELL 266

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 64
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 117
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+T++   
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 172
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 173 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 60
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 113
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+T++   
Sbjct: 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 169 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 84
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 85  GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 134
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V+       T + GT  +IAP
Sbjct: 135 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAP 190
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           E LS    S   DV+  G ++  L+ G+   + S
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPGGDAAFQREVEMIS 164
           Q A ++F     LG+G FG VY         + A+K L     E  G +   +REVE+ S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---G 221
              H N+LRL G+    T    VY  ++   +    RE++     L     +R A     
Sbjct: 90  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 142
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            A  L Y H   + ++IHRD+K  N+LL    E  + DFG +  V    +  TT + GT+
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTL 196
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 31/285 (10%)
Query: 120 LGQGGFGKV---YRGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D  G  VAVK+L     P     FQRE++++  A+H + +  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILK-ALHSDFIV- 75
Query: 175 IGFCTTPTERLLVY-PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
                    R + Y P  Q+L +   + E  P   + D++ R R  L A+R L Y  + C
Sbjct: 76  -------KYRGVSYGPGRQSLRL---VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 234 -------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
                  + + +HRD+ A N+L++ +    + DFGLAKL+ + K     +  G   +   
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           APE LS    S ++DV+ +G++L EL T                          R   L 
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELL 245
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               R         EV  +++   LC   SP+DRP+ S +   L+
Sbjct: 246 EEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 76  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 131
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 192 KFSVASDVWSFGVVLYELFT 211

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
            +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G  
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 179 TTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                 L +V  +M   S+   LR    G  VL      + +L     +EYL  +     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K S +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366
Query: 298 TDVFGYGIMLLELVTGQR 315
           +DV+ +GI+L E+ +  R
Sbjct: 367 SDVWSFGILLWEIYSFGR 384

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 75  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 130
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 80  KGVCYSAGRRNLKL-IMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 83  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 138
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 199 KFSVASDVWSFGVVLYELFT 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 27/271 (9%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VAVK + +  S   D  FQ    M+ ++ H  L++  G C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCS 73
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 239
                 +V  ++ N  +   LR    G   L+      +      G+ +L  H   + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 299
           RD+ A N L+D D    V DFG+ + V   +   +   +  +   APE     K S ++D
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 300 VFGYGIMLLELVT-GQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQ 358
           V+ +GI++ E+ + G+   D                     E  L       L + +   
Sbjct: 188 VWAFGILMWEVFSLGKMPYDL----------------YTNSEVVLKVSQGHRLYRPHLAS 231
Query: 359 EVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +T+ Q+   C    PE RP   +++  +E
Sbjct: 232 --DTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 81  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 136
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 197 KFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 80  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 84  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 139
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 200 KFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 82  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 137
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 198 KFSVASDVWSFGVVLYELFT 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 133/316 (42%), Gaps = 56/316 (17%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 262 LAKLV-----DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 316
           LA+ +      VRK +     R  +  +APE +     + ++DV+ +G++L E+      
Sbjct: 194 LARDIYKDPDXVRKGD----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------ 243
Query: 317 IDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQ 372
             FS                     ++D    R L +   ++  +     M Q  L C  
Sbjct: 244 --FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289
Query: 373 ASPEDRPAMSEVVRML 388
             P  RP  SE+V  L
Sbjct: 290 GEPSQRPTFSELVEHL 305

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++  T +
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXL 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 95  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 117 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF--QREVEMISVAVHRNLLR 173
           +  LG+G FGKV          KVA+K ++       D     +RE+  + +  H ++++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-RKRVALGAAR-------- 224
           L    TTPT+ ++V  +               G  + D++  +KR+     R        
Sbjct: 74  LYDVITTPTDIVMVIEYA--------------GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            +EY H H   KI+HRD+K  N+LLD++    + DFGL+ +  +   N      G+  + 
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSPNYA 174
Query: 285 APEYLSTGK--SSERTDVFGYGIMLLELVTGQRAID 318
           APE ++ GK  +    DV+  GI+L  ++ G+   D
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 117 KNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L G  T  T  +++  FM+N S+   LR+      V+  V   R   G A G++YL + 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLADM 128
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMG--HIAPEY 288
                +HR + A N+L++ +    V DFGL++ +  D      T+ + G +     APE 
Sbjct: 129 ---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRA 316
           +   K +  +DV+ YGI++ E+++ G+R 
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q   ++F     LG+G FG VY       + +LA   KV  K  T  E  G +   +REV
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFK--TQLEKAGVEHQLRREV 63
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSRFDEQRTAT 116
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL  + E  + DFG +      + +     
Sbjct: 117 YITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC-- 171
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT+ ++ PE +      E+ D++  G++  E + G
Sbjct: 172 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 120 LGQGGFGKVYRGVLADGT----KVAVKRLTDFESPGGDAA----FQREVEMISVAVHRNL 171
           LG GG   VY   LA+ T    KVA+K +  F  P         F+REV   S   H+N+
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAI--FIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           + +I          LV  +++  +++  +    P    L   T          G+++ H+
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHD 129
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
               +I+HRD+K  N+L+D +    + DFG+AK +       T  V GT+ + +PE    
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
             + E TD++  GI+L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 133/314 (42%), Gaps = 52/314 (16%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 262 LAKLVDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           LA+  D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        
Sbjct: 185 LAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-------- 234
Query: 319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQAS 374
           FS                     ++D    R L +   ++  +     M Q  L C    
Sbjct: 235 FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 282
Query: 375 PEDRPAMSEVVRML 388
           P  RP  SE+V  L
Sbjct: 283 PSQRPTFSELVEHL 296

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 132/314 (42%), Gaps = 52/314 (16%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 184
Query: 262 LAKLVDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           LA+  D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        
Sbjct: 185 LAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-------- 234
Query: 319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQAS 374
           FS                     ++D    R L +   ++  +     M Q  L C    
Sbjct: 235 FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 282
Query: 375 PEDRPAMSEVVRML 388
           P  RP  SE+V  L
Sbjct: 283 PSQRPTFSELVEHL 296

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKVYR---GVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 108 KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 120 LGQGGFGKVY---RGVLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV         DGT   VAVK L     P   + +++E++++    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARGL 226
            G C    E+ L             + E  P   + D++ R  + L            G+
Sbjct: 82  KGCCEDQGEKSLQL-----------VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
            YLH       IHR++ A NVLLD D    +GDFGLAK V         +  G   +   
Sbjct: 131 AYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           APE L   K    +DV+ +G+ L EL+T
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 120 LGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV            G +VAVK L         A  ++E+E++    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 175 IGFCTTPTER--LLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHE 231
            G CT        L+  F+ + S    L+E  P  +  ++   + + A+   +G++YL  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYL 289
               + +HRD+ A NVL++ + +  +GDFGL K ++  K   T +      +   APE L
Sbjct: 133 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 290 STGKSSERTDVFGYGIMLLELVT 312
              K    +DV+ +G+ L EL+T
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 95  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 132/314 (42%), Gaps = 52/314 (16%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 262 LAKLVDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           LA+  D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        
Sbjct: 194 LAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-------- 243
Query: 319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQAS 374
           FS                     ++D    R L +   ++  +     M Q  L C    
Sbjct: 244 FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 291
Query: 375 PEDRPAMSEVVRML 388
           P  RP  SE+V  L
Sbjct: 292 PSQRPTFSELVEHL 305

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 54/281 (19%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 79  GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHI 284
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V  D  +  V     GT  +I
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 182
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLD 344
           APE LS    S   DV+  G ++  L+ G+   + S                  R K+ +
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----------CLKETYLRIKKNE 231
Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
             + +++N         ++IQ  L   Q  P  RP ++E++
Sbjct: 232 YSIPKHIN-----PVAASLIQKML---QTDPTARPTINELL 264

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPGGDAAFQREVEMIS 164
           Q A ++F     LG+G FG VY     +   + A+K L     E  G +   +REVE+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---G 221
              H N+LRL G+    T    VY  ++   +    RE++     L     +R A     
Sbjct: 64  HLRHPNILRLYGYFHDSTR---VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 116
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            A  L Y H   + K+IHRD+K  N+LL    E  + DFG +       ++    + GT+
Sbjct: 117 LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRAALCGTL 170
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 120 LGQGGFGKV--YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           LG+GGF  V    G L DG   A+KR+   E    + A QRE +M  +  H N+LRL+ +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA-QREADMHRLFNHPNILRLVAY 94
Query: 178 CT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           C        E  L+ PF +  ++   +  +K     L       + LG  RGLE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----VDVRKTNVTTQ----VRGTMGHIA 285
                HRD+K  N+LL ++ + V+ D G        V+  +  +T Q     R T+ + A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 286 PEYLSTGKSS---ERTDVFGYGIMLLELVTGQRAIDF 319
           PE  S        ERTDV+  G +L  ++ G+   D 
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 120 LGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV            G +VAVK L         A  ++E+E++    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 175 IGFCTTPTER--LLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHE 231
            G CT        L+  F+ + S    L+E  P  +  ++   + + A+   +G++YL  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYL 289
               + +HRD+ A NVL++ + +  +GDFGL K ++  K   T +      +   APE L
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 290 STGKSSERTDVFGYGIMLLELVT 312
              K    +DV+ +G+ L EL+T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 132/314 (42%), Gaps = 52/314 (16%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR-------EIK 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +       ++ 
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 230
Query: 262 LAKLVDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           LA+  D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        
Sbjct: 231 LAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-------- 280
Query: 319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQAS 374
           FS                     ++D    R L +   ++  +     M Q  L C    
Sbjct: 281 FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 328
Query: 375 PEDRPAMSEVVRML 388
           P  RP  SE+V  L
Sbjct: 329 PSQRPTFSELVEHL 342

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 120 LGQGGFGKVY---RGVLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV         DGT   VAVK L     P   + +++E++++    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARGL 226
            G C    E+ L             + E  P   + D++ R  + L            G+
Sbjct: 82  KGCCEDQGEKSLQL-----------VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
            YLH       IHR++ A NVLLD D    +GDFGLAK V         +  G   +   
Sbjct: 131 AYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           APE L   K    +DV+ +G+ L EL+T
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLVYPF------MQNLSVAYRLREIKPGEPVLDWVT 214
           ++S +  H N++ L+G CT     L++  +      +  L    R+ E  P   + +   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 215 RKRVALG----AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVR 269
             R  L      A+G+ +L    +   IHRDV A NVLL     A +GDFGLA+ +++  
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
              V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 33/245 (13%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFE 148
           AF  L+   W   +    N      LG+G FGKV +         A  T VAVK L +  
Sbjct: 9   AFKILEDPKW---EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE---IKP 205
           SP        E  ++    H ++++L G C+     LL+  + +  S+   LRE   + P
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 206 G---------EPVLDWVTRKRVALG--------AARGLEYLHEHCNPKIIHRDVKAANVL 248
           G            LD    + + +G         ++G++YL E    K++HRD+ A N+L
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182
Query: 249 LDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
           + E  +  + DFGL++ V    + V  +Q R  +  +A E L     + ++DV+ +G++L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 308 LELVT 312
            E+VT
Sbjct: 243 WEIVT 247

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++     +D +   +      +G+EYL     
Sbjct: 80  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++  D     V       +   APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 117 KNVLGQGGFGKVYRG------VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           K  LG+G FGKV+           D   VAVK L D  +      FQRE E+++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRK-----------RV 218
           +++  G C      ++V+ +M++  +   LR   P   +L D   R+            +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A   A G+ YL    +   +HRD+   N L+  +    +GDFG+++  DV  T+      
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 193
Query: 279 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 312
            TM  I    PE +   K +  +DV+ +G++L E+ T
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNL--LRLI 175
           LG+GGF K Y     D  +V   ++     P        Q+E     +A+H++L    ++
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVV----PKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 89
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    Y + EI     +L+   R++ V    AR        G+
Sbjct: 90  GF----------HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV 139
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGH 283
           +YLH   N ++IHRD+K  N+ L++D +  +GDFGLA  ++    RK ++     GT  +
Sbjct: 140 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC----GTPNY 192
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           IAPE L     S   D++  G +L  L+ G+   + S
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG V RG           VAVK L       P     F REV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G   TP  ++ V       S+  RLR+ + G  +L   T  R A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLE--- 132
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLST 291
           + + IHRD+ A N+LL       +GDFGL + +     +   Q   +      APE L T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 292 GKSSERTDVFGYGIMLLELVT 312
              S  +D + +G+ L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
            +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G  
Sbjct: 19  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 179 TTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                 L +V  +M   S+   LR    G  VL      + +L     +EYL  +     
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L     S +
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFSTK 185
Query: 298 TDVFGYGIMLLELVTGQR 315
           +DV+ +GI+L E+ +  R
Sbjct: 186 SDVWSFGILLWEIYSFGR 203

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG V RG           VAVK L       P     F REV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G   TP  ++ V       S+  RLR+ + G  +L   T  R A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLE--- 128
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLST 291
           + + IHRD+ A N+LL       +GDFGL + +     +   Q   +      APE L T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 292 GKSSERTDVFGYGIMLLELVT 312
              S  +D + +G+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 40/221 (18%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLT--DFESPGGDAAFQREVEMIS 164
           +D +  + VLG+G FG+V   +L      G + AVK ++    +      +  REV+++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA-LGA 222
              H N+++L             Y F ++    Y + E+  G  + D  ++RKR + + A
Sbjct: 88  QLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 134
Query: 223 AR-------GLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTN 272
           AR       G+ Y+H++   KI+HRD+K  N+LL+   +D    + DFGL+   +  K  
Sbjct: 135 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-K 190
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           +  ++ GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 191 MKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG V RG           VAVK L       P     F REV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G   TP  ++ V       S+  RLR+ + G  +L   T  R A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLE--- 132
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLST 291
           + + IHRD+ A N+LL       +GDFGL + +     +   Q   +      APE L T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 292 GKSSERTDVFGYGIMLLELVT 312
              S  +D + +G+ L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG V RG           VAVK L       P     F REV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G   TP  ++ V       S+  RLR+ + G  +L   T  R A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLE--- 128
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLST 291
           + + IHRD+ A N+LL       +GDFGL + +     +   Q   +      APE L T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 292 GKSSERTDVFGYGIMLLELVT 312
              S  +D + +G+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 120 LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLR 173
           LG G FG V RG           VAVK L       P     F REV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           L G   TP  ++ V       S+  RLR+ + G  +L   T  R A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLE--- 128
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV--RGTMGHIAPEYLST 291
           + + IHRD+ A N+LL       +GDFGL + +     +   Q   +      APE L T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 292 GKSSERTDVFGYGIMLLELVT 312
              S  +D + +G+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 61
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 114
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + +FG +  V    +  TT +
Sbjct: 115 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-L 168
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 102
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 103 GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 152
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHI 284
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V  D  +  V     GT  +I
Sbjct: 153 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 206
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           APE LS    S   DV+  G ++  L+ G+   + S
Sbjct: 207 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 134/310 (43%), Gaps = 48/310 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D  +    LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR--EIKPGEPV 209
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +  E  P + +
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 210 L-DWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
             D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFGLA+ 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR- 192
Query: 266 VDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
            D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        FS  
Sbjct: 193 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSLG 243
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPEDR 378
                              ++D    R L +   ++  +     M Q  L C    P  R
Sbjct: 244 ASPYPGV------------KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 291
Query: 379 PAMSEVVRML 388
           P  SE+V  L
Sbjct: 292 PTFSELVEHL 301

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHIAPEYLSTG 292
            + IHRD+   N+L++ +    +GDFGL K++   K     +  G   +   APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 33/245 (13%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFE 148
           AF  L+   W   +    N      LG+G FGKV +         A  T VAVK L +  
Sbjct: 9   AFKILEDPKW---EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE---IKP 205
           SP        E  ++    H ++++L G C+     LL+  + +  S+   LRE   + P
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 206 G---------EPVLDWVTRKRVALG--------AARGLEYLHEHCNPKIIHRDVKAANVL 248
           G            LD    + + +G         ++G++YL E    K++HRD+ A N+L
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182
Query: 249 LDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
           + E  +  + DFGL++ V    + V  +Q R  +  +A E L     + ++DV+ +G++L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 308 LELVT 312
            E+VT
Sbjct: 243 WEIVT 247

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + +FG +  V    +  TT +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-L 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 47/311 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D  +    LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLREIK------P 205
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +  +      P
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 206 GEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
            +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFGL
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 263 AKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 321
           A+ +      V     R  +  +APE +     + ++DV+ +G++L E+        FS 
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL 246
Query: 322 XXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPED 377
                               ++D    R L +   ++  +     M Q  L C    P  
Sbjct: 247 GASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 294
Query: 378 RPAMSEVVRML 388
           RP  SE+V  L
Sbjct: 295 RPTFSELVEHL 305

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 60
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 113
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      + +     
Sbjct: 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC-- 168
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 169 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLR--LI 175
           LG+GGF K +    AD  +V   ++     P        QRE   + +++HR+L    ++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    + + E+     +L+   R++ +    AR        G 
Sbjct: 105 GF----------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHI 284
           +YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V  D  +  V     GT  +I
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 208
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           APE LS    S   DV+  G ++  L+ G+   + S
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 107 LQLATDNFSEKNV-----LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAA 155
           LQ  T    EK++     LG G FG V RG           VAVK L       P     
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 156 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
           F REV  +    HRNL+RL G   TP  ++ V       S+  RLR+ + G  +L   T 
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TL 123
Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
            R A+  A G+ YL    + + IHRD+ A N+LL       +GDFGL + +     +   
Sbjct: 124 SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 276 QV--RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           Q   +      APE L T   S  +D + +G+ L E+ T
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLVYPF------MQNLSVAYRLREIKPGEPVLDWVT 214
           ++S +  H N++ L+G CT     L++  +      +  L    R+ E  P   + +   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 215 RKRVALG----AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVR 269
             R  L      A+G+ +L    +   IHRDV A NVLL     A +GDFGLA+ +++  
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
              V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 107 LQLATDNFSEKNV-----LGQGGFGKVYRG----VLADGTKVAVKRLTD--FESPGGDAA 155
           LQ  T    EK++     LG G FG V RG           VAVK L       P     
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 156 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
           F REV  +    HRNL+RL G   TP  ++ V       S+  RLR+ + G  +L   T 
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLG--TL 123
Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
            R A+  A G+ YL    + + IHRD+ A N+LL       +GDFGL + +     +   
Sbjct: 124 SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 276 QV--RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           Q   +      APE L T   S  +D + +G+ L E+ T
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 64
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T   L+  +     V   L+++       D         
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYIT 120
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLXGT 174
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           + ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNL--LRLI 175
           LG+GGF K Y     D  +V   ++     P        Q+E     +A+H++L    ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV----PKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    Y + EI     +L+   R++ V    AR        G+
Sbjct: 106 GF----------HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGH 283
           +YLH   N ++IHRD+K  N+ L++D +  +GDFGLA  ++    RK ++     GT  +
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC----GTPNY 208
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           IAPE L     S   D++  G +L  L+ G+   + S
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G +G VY+     G   A+K++  + E  G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 179 TTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
            T    +LV+  + Q+L    +L ++  G   L+ VT K   L    G+ Y H+    ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 296
           +HRD+K  N+L++ + E  + DFGLA+   +     T +V  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 297 RTDVFGYGIMLLELVTG 313
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G +G VY+     G   A+K++  + E  G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 179 TTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
            T    +LV+  + Q+L    +L ++  G   L+ VT K   L    G+ Y H+    ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 296
           +HRD+K  N+L++ + E  + DFGLA+   +     T +V  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 297 RTDVFGYGIMLLELVTG 313
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 46/224 (20%)
Query: 111 TDNFSEKNVLGQGGFGKVY---------RGVLADGTKVAVKRLTDFESPGGDAAFQREVE 161
           +D +  + VLG+G FG+V             +   +K  VK+ TD ES        REV+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES------LLREVQ 78
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA- 219
           ++    H N+++L             Y F ++    Y + E+  G  + D  ++RKR + 
Sbjct: 79  LLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 220 LGAAR-------GLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVR 269
           + AAR       G+ Y+H++   KI+HRD+K  N+LL+   +D    + DFGL+   +  
Sbjct: 126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           K  +  ++ GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 183 K-KMKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNL--LRLI 175
           LG+GGF K Y     D  +V   ++     P        Q+E     +A+H++L    ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV----PKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    Y + EI     +L+   R++ V    AR        G+
Sbjct: 106 GF----------HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           +YLH   N ++IHRD+K  N+ L++D +  +GDFGLA  ++       T + GT  +IAP
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           E L     S   D++  G +L  L+ G+   + S
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      + +    +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---DL 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 48/310 (15%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D  +    LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLR--EIKPGEPV 209
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +  E  P + +
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 210 L-DWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
             D++T + +   +   A+G+E+L    + K IHRD+ A N+LL E     + DFGLA+ 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR- 192
Query: 266 VDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 322
            D+ K     +    R  +  +APE +     + ++DV+ +G++L E+ +          
Sbjct: 193 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------- 241
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQASPEDR 378
                              ++D    R L +   ++  +     M Q  L C    P  R
Sbjct: 242 ----------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 291
Query: 379 PAMSEVVRML 388
           P  SE+V  L
Sbjct: 292 PTFSELVEHL 301

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 120 LGQGGFGKVY---RGVLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FGKV         DGT   VAVK L     P   + +++E++++    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARGL 226
            G C       L             + E  P   + D++ R  + L            G+
Sbjct: 99  KGCCEDAGAASLQL-----------VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
            YLH       IHRD+ A NVLLD D    +GDFGLAK V         +  G   +   
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY 204
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT 312
           APE L   K    +DV+ +G+ L EL+T
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 37/234 (15%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPG 151
            G ++   W++ +   D +  ++VLG G F +V   +LA+  +    VA+K +      G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEG 58
Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
            + + + E+ ++    H N++ L     +      +Y  MQ +S          G  + D
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGH---LYLIMQLVS----------GGELFD 105
Query: 212 WVTRK---------RVALGAARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGD 259
            +  K         R+       ++YLH   +  I+HRD+K  N+L   LDED + ++ D
Sbjct: 106 RIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           FGL+K+ D    +V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 163 FGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    +
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAAL 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXL 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 61
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 114
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    +
Sbjct: 115 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXL 168
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 37/234 (15%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPG 151
            G ++   W++ +   D +  ++VLG G F +V   +LA+  +    VA+K +      G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEG 58
Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
            + + + E+ ++    H N++ L     +      +Y  MQ +S          G  + D
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGH---LYLIMQLVS----------GGELFD 105
Query: 212 WVTRK---------RVALGAARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGD 259
            +  K         R+       ++YLH   +  I+HRD+K  N+L   LDED + ++ D
Sbjct: 106 RIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           FGL+K+ D    +V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 163 FGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 37/234 (15%)
Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPG 151
            G ++   W++ +   D +  ++VLG G F +V   +LA+  +    VA+K +      G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEG 58
Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
            + + + E+ ++    H N++ L     +      +Y  MQ +S          G  + D
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGH---LYLIMQLVS----------GGELFD 105
Query: 212 WVTRK---------RVALGAARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGD 259
            +  K         R+       ++YLH   +  I+HRD+K  N+L   LDED + ++ D
Sbjct: 106 RIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           FGL+K+ D    +V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 163 FGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 85
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQ----KLSKFDEQRTAT 138
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQ 276
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +      R+ ++   
Sbjct: 139 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-- 193
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 194 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 105 RELQLATDNFSEKNV-LGQGGFGKVYRGVLADGTK---VAVKRLTDFESPGGDAAFQREV 160
           ++L L  DN    ++ LG G FG V +GV     K   VA+K L             RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           +++    +  ++RLIG C      L++              E+  G P+  ++  KR  +
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALMLVM--------------EMAGGGPLHKFLVGKREEI 107
Query: 221 GAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +           G++YL E      +HRD+ A NVLL     A + DFGL+K +    
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 271 TNVTTQVRG--TMGHIAPEYLSTGKSSERTDVFGYGIMLLE-LVTGQR 315
           +  T +  G   +   APE ++  K S R+DV+ YG+ + E L  GQ+
Sbjct: 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G+G +G VY+     G   A+K++  + E  G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 179 TTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
            T    +LV+  + Q+L    +L ++  G   L+ VT K   L    G+ Y H+    ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 296
           +HRD+K  N+L++ + E  + DFGLA+   +     T ++  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 297 RTDVFGYGIMLLELVTG 313
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 52/293 (17%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +F E  ++G GGFG+V++     DG    +KR+        +   +REV+ ++   H N+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNI 66
Query: 172 LRL----IGFCTTP-----------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 216
           +       GF   P           T+ L +     +     +  E + GE  LD V   
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLAL 125
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
            +     +G++Y+H   + K+I+RD+K +N+ L +  +  +GDFGL  +  ++      +
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXR 180
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV-TGQRAIDFSRXXXXXXXXXXXXXX 335
            +GT+ +++PE +S+    +  D++  G++L EL+     A + S+              
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-------- 232
Query: 336 XXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                   D I+    +K     + +T++Q  L      PEDRP  SE++R L
Sbjct: 233 --------DGIISDIFDK-----KEKTLLQKLL---SKKPEDRPNTSEILRTL 269

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 59
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 112
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    +
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXL 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 46/224 (20%)
Query: 111 TDNFSEKNVLGQGGFGKVY---------RGVLADGTKVAVKRLTDFESPGGDAAFQREVE 161
           +D +  + VLG+G FG+V             +   +K  VK+ TD ES        REV+
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES------LLREVQ 101
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA- 219
           ++    H N+++L             Y F ++    Y + E+  G  + D  ++RKR + 
Sbjct: 102 LLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 148
Query: 220 LGAAR-------GLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVR 269
           + AAR       G+ Y+H++   KI+HRD+K  N+LL+   +D    + DFGL+   +  
Sbjct: 149 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           K  +  ++ GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 206 K-KMKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVE--M 162
           +++L  ++F    +LG+G FGKV+        +  A+K L        D      VE  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 163 ISVAVHRNLLRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           +S+A     L  + FCT  T+     V  ++    + Y ++         D       A 
Sbjct: 72  LSLAWEHPFLTHM-FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAA 126
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVTTQV 277
               GL++LH   +  I++RD+K  N+LLD+D    + DFG+ K   L D +    T + 
Sbjct: 127 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNEF 179
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
            GT  +IAPE L   K +   D + +G++L E++ GQ   
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 84  VDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEK-NVLGQGGFGKVYRGVLADGTKVAVK 142
           VD+  E    + F  +K+Y      L  ++F E    LG G FGKVY+    + + +A  
Sbjct: 11  VDLGTE---NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           ++ D +S      +  E+++++   H N+++L+          ++  F    +V   + E
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
           +   E  L     + V       L YLH++   KIIHRD+KA N+L   D +  + DFG+
Sbjct: 128 L---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 263 AKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLEL 310
           +      K   T Q R    GT   +APE +    S +R      DV+  GI L+E+
Sbjct: 182 SA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-------RGVLADGTKVAVKRLTDFESPGGDAAFQREV 160
           Q A ++F     LG+G FG VY       + +LA   KV  K     E  G +   +REV
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA--LKVLFK--AQLEKAGVEHQLRREV 62
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           E+ S   H N+LRL G+    T    VY  ++   +    RE++     L     +R A 
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQK----LSKFDEQRTAT 115
Query: 221 ---GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                A  L Y H   + ++IHRD+K  N+LL    E  + DFG +       ++    +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAAL 169
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
            GT+ ++ PE +      E+ D++  G++  E + G+   +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 120 LGQGGFGKV---YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           LG+G FG V       L D T   VAVK+L    +      F+RE+E++    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G C +   R L    M+ L        ++  +  +D +   +      +G+EYL     
Sbjct: 78  KGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 133
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHIAPEYLSTG 292
            + IHR++   N+L++ +    +GDFGL K++   K     +  G   +   APE L+  
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 293 KSSERTDVFGYGIMLLELVT 312
           K S  +DV+ +G++L EL T
Sbjct: 194 KFSVASDVWSFGVVLYELFT 213

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 46/224 (20%)
Query: 111 TDNFSEKNVLGQGGFGKVY---------RGVLADGTKVAVKRLTDFESPGGDAAFQREVE 161
           +D +  + VLG+G FG+V             +   +K  VK+ TD ES        REV+
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES------LLREVQ 102
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA- 219
           ++    H N+++L             Y F ++    Y + E+  G  + D  ++RKR + 
Sbjct: 103 LLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 149
Query: 220 LGAAR-------GLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVR 269
           + AAR       G+ Y+H++   KI+HRD+K  N+LL+   +D    + DFGL+   +  
Sbjct: 150 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           K  +  ++ GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 207 K-KMKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNL--LRLI 175
           LG+GGF K Y     D  +V   ++     P        Q+E     +A+H++L    ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV----PKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-VALGAAR--------GL 226
           GF          + F ++    Y + EI     +L+   R++ V    AR        G+
Sbjct: 106 GF----------HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGH 283
           +YLH   N ++IHRD+K  N+ L++D +  +GDFGLA  ++    RK  +     GT  +
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC----GTPNY 208
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           IAPE L     S   D++  G +L  L+ G+   + S
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 33/245 (13%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFE 148
           AF  L+   W   +    N      LG+G FGKV +         A  T VAVK L +  
Sbjct: 9   AFKILEDPKW---EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE---IKP 205
           SP        E  ++    H ++++L G C+     LL+  + +  S+   LRE   + P
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 206 G---------EPVLDWVTRKRVALG--------AARGLEYLHEHCNPKIIHRDVKAANVL 248
           G            LD    + + +G         ++G++YL E     ++HRD+ A N+L
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNIL 182
Query: 249 LDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
           + E  +  + DFGL++ V    + V  +Q R  +  +A E L     + ++DV+ +G++L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 308 LELVT 312
            E+VT
Sbjct: 243 WEIVT 247

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 169
           N+  +  +G+G F KV   R VL  G +VAVK +   + +P       REV ++ +  H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAAR 224
           N+++L  F    TE+ L           Y + E   G  V D++      +++ A    R
Sbjct: 75  NIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 121
Query: 225 GLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            +    ++C+ K I+HRD+KA N+LLD D    + DFG +    V   N      G+  +
Sbjct: 122 QIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTV--GNKLDTFCGSPPY 179
Query: 284 IAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
            APE     K      DV+  G++L  LV+G    D
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLSFC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQRE 159
           W++ +   D +  ++VLG G F +V   +LA+  +    VA+K +      G + + + E
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--- 216
           + ++    H N++ L     +     L+   MQ +S          G  + D +  K   
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLI---MQLVS----------GGELFDRIVEKGFY 113
Query: 217 ------RVALGAARGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGDFGLAKLVD 267
                 R+       ++YLH   +  I+HRD+K  N+L   LDED + ++ DFGL+K+ D
Sbjct: 114 TERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 170
Query: 268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               +V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 171 --PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 13/153 (8%)
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVAL 220
           M+S+  H  ++R+ G      +  ++  +++   +   LR+ +    PV      K  A 
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAA 113
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
                LEYLH      II+RD+K  N+LLD++    + DFG AK V     +VT  + GT
Sbjct: 114 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGT 166
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             +IAPE +ST   ++  D + +GI++ E++ G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 16/233 (6%)
Query: 84  VDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEK-NVLGQGGFGKVYRGVLADGTKVAVK 142
           VD+  E    + F  +K+Y      L  ++F E    LG G FGKVY+    + + +A  
Sbjct: 11  VDLGTE---NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           ++ D +S      +  E+++++   H N+++L+          ++  F    +V   + E
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
           +   E  L     + V       L YLH++   KIIHRD+KA N+L   D +  + DFG+
Sbjct: 128 L---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLEL 310
           +   + R         GT   +APE +    S +R      DV+  GI L+E+
Sbjct: 182 SA-KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + +   D       LG+G FG+V      G+    T   VAVK L +  +     A
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLV---YPFMQNLSVAYRLREIK------- 204
              E++ +I +  H N++ L+G CT P   L+V   +    NLS   R +  +       
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 205 PGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           P +   D++T + +   +   A+G+E+L      K IHRD+ A N+LL E     + DFG
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 195
Query: 262 LAKLVDVRKTNVTTQ---VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           LA+  D+ K     +    R  +  +APE +     + ++DV+ +G++L E+        
Sbjct: 196 LAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-------- 245
Query: 319 FSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE----TMIQVALLCTQAS 374
           FS                     ++D    R L +   ++  +     M Q  L C    
Sbjct: 246 FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 293
Query: 375 PEDRPAMSEVVRML 388
           P  RP  SE+V  L
Sbjct: 294 PSQRPTFSELVEHL 307

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 136/306 (44%), Gaps = 65/306 (21%)
Query: 113 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +F E  ++G GGFG+V++     DG    ++R+        +   +REV+ ++   H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-----KYNNEKAEREVKALAKLDHVNI 67
Query: 172 LRLIGFC--------TTPTERLLVYPF-MQNLSVAYRLR--------EIKPGEPVLDWVT 214
           +   G C         T  + L    +  +N   + R +        E      +  W+ 
Sbjct: 68  VHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 215 RKR-------VAL----GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
           ++R       +AL       +G++Y+H   + K+IHRD+K +N+ L +  +  +GDFGL 
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGL- 182
Query: 264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV-TGQRAIDFSRX 322
            +  ++     T+ +GT+ +++PE +S+    +  D++  G++L EL+     A + S+ 
Sbjct: 183 -VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 241
Query: 323 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
                                D I+    +K     + +T++Q  L      PEDRP  S
Sbjct: 242 FTDLR----------------DGIISDIFDK-----KEKTLLQKLL---SKKPEDRPNTS 277
Query: 383 EVVRML 388
           E++R L
Sbjct: 278 EILRTL 283

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 117 KNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L G  T     +++  +M+N S+   LR+      V+  V   R   G   G++YL + 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 135
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLS 290
                +HRD+ A N+L++ +    V DFG+++++  D      T   +  +   APE ++
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 291 TGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRXXXXXXXXXXXXXXXXXREKRLDAIVD 348
             K +  +DV+ YGI++ E+++ G+R   D S                     RL   +D
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---------RLPPPMD 243
Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +           + Q+ L C Q    DRP   ++V ML+
Sbjct: 244 CPI----------ALHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 117 KNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L G  T     +++  +M+N S+   LR+      V+  V   R   G   G++YL + 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 129
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLS 290
                +HRD+ A N+L++ +    V DFG+++++  D      T   +  +   APE ++
Sbjct: 130 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 291 TGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRXXXXXXXXXXXXXXXXXREKRLDAIVD 348
             K +  +DV+ YGI++ E+++ G+R   D S                     RL   +D
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---------RLPPPMD 237
Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +           + Q+ L C Q    DRP   ++V ML+
Sbjct: 238 CPI----------ALHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 16/233 (6%)
Query: 84  VDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEK-NVLGQGGFGKVYRGVLADGTKVAVK 142
           VD+  E    + F  +K+Y      L  ++F E    LG G FGKVY+    + + +A  
Sbjct: 11  VDLGTE---NLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           ++ D +S      +  E+++++   H N+++L+          ++  F    +V   + E
Sbjct: 68  KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 127
Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
           +   E  L     + V       L YLH++   KIIHRD+KA N+L   D +  + DFG+
Sbjct: 128 L---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLEL 310
           +   + R         GT   +APE +    S +R      DV+  GI L+E+
Sbjct: 182 SA-KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 120 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 173
           +G+G +GKV+  R +   G  VA+KR+       G   +  REV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 174 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L   CT       T+  LV+  +      Y  +  +PG P     T K +     RGL++
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H   +++HRD+K  N+L+    +  + DFGLA++   +     T V  T+ + APE 
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 289 LSTGKSSERTDVFGYGIMLLEL 310
           L     +   D++  G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 120 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 173
           +G+G +GKV+  R +   G  VA+KR+       G   +  REV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 174 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L   CT       T+  LV+  +      Y  +  +PG P     T K +     RGL++
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H   +++HRD+K  N+L+    +  + DFGLA++   +     T V  T+ + APE 
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 190
Query: 289 LSTGKSSERTDVFGYGIMLLEL 310
           L     +   D++  G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 126
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 120 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 173
           +G+G +GKV+  R +   G  VA+KR+       G   +  REV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 174 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           L   CT       T+  LV+  +      Y  +  +PG P     T K +     RGL++
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H   +++HRD+K  N+L+    +  + DFGLA++   +     T V  T+ + APE 
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 289 LSTGKSSERTDVFGYGIMLLEL 310
           L     +   D++  G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 123
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 179
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 117 KNVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L G  T     +++  +M+N S+   LR+      V+  V   R   G   G++YL + 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 150
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLS 290
                +HRD+ A N+L++ +    V DFG+++++  D      T   +  +   APE ++
Sbjct: 151 ---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 291 TGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRXXXXXXXXXXXXXXXXXREKRLDAIVD 348
             K +  +DV+ YGI++ E+++ G+R   D S                     RL   +D
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---------RLPPPMD 258
Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +           + Q+ L C Q    DRP   ++V ML+
Sbjct: 259 CPI----------ALHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHRNLLRL 174
           + LG G FGKV  G     G KVAVK L   +    D     +RE++ + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
               +TP++  +V   M+ +S       I K G   LD    +R+      G++Y H H 
Sbjct: 82  YQVISTPSDIFMV---MEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM 136
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
              ++HRD+K  NVLLD    A + DFGL+ ++            G+  + APE +S G+
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYAAPEVIS-GR 190
Query: 294 --SSERTDVFGYGIMLLELVTGQRAID 318
             +    D++  G++L  L+ G    D
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVE--M 162
           +++L  ++F    +LG+G FGKV+        +  A+K L        D      VE  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 163 ISVAVHRNLLRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           +S+A     L  + FCT  T+     V  ++    + Y ++         D       A 
Sbjct: 71  LSLAWEHPFLTHM-FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAA 125
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVR 278
               GL++LH   +  I++RD+K  N+LLD+D    + DFG+ K  ++   KTN      
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC--- 179
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           GT  +IAPE L   K +   D + +G++L E++ GQ   
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 126
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 109 LATDNFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMIS 164
           L   N+     +G+G F KV   R +L  G +VAVK +  T   S      F REV ++ 
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMK 61
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVA 219
           V  H N+++L  F    TE+ L           Y + E   G  V D++      +++ A
Sbjct: 62  VLNHPNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGWMKEKEA 108
Query: 220 LGAARGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
               R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      
Sbjct: 109 RAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFC 166
Query: 279 GTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           G+  + APE     K      DV+  G++L  LV+G    D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 119 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++ L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     ++V  FM+N ++   LR+      V+  V   R   G A G+ YL +   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYLADM-- 164
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG--HIAPEYLSTG 292
              +HRD+ A N+L++ +    V DFGL+++++     V T   G +     APE +   
Sbjct: 165 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 293 KSSERTDVFGYGIMLLELVT-GQR 315
           K +  +DV+ YGI++ E+++ G+R
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGER 247

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 55/280 (19%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 177
           LG G FG+V+       TKVAVK +     PG  +  AF  E  ++    H  L++L   
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 178 CTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
            T      ++  FM   S+   L+      +P   ++D+  +       A G+ ++ +  
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQR- 297
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
               IHRD++AAN+L+       + DFGLA++            +  +   APE ++ G 
Sbjct: 298 --NYIHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGS 345
Query: 294 SSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNK 353
            + ++DV+ +GI+L+E+VT  R I +                        +  V R L +
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGR-IPYPGMS--------------------NPEVIRALER 384
Query: 354 NYNIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 389
            Y +   E     +  + + C +  PE+RP    +  +L+
Sbjct: 385 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 120 LGQGGFGKVYRGVLA-DGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V   +    G KVA+K+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD- 90
Query: 178 CTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
             TP   L       LV PFMQ  +   ++  +K  E  + ++  + +     +GL+Y+H
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGLKFSEEKIQYLVYQML-----KGLKYIH 143
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 289
              +  ++HRD+K  N+ ++ED E  + DFGLA+  D   T        T  + APE  L
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVIL 196
Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
           S    ++  D++  G ++ E++TG+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 33/209 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLLRLIG 176
           +LG+G FG+V +        + AVK +    +   D +   REVE++    H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA-LGAAR-------GLE 227
                      +  +++ S  Y + E+  G  + D  + RKR +   AAR       G+ 
Sbjct: 87  -----------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 228 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           Y+H+H    I+HRD+K  N+LL   ++D +  + DFGL+     + T +  ++ GT  +I
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYI 190
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTG 313
           APE L  G   E+ DV+  G++L  L++G
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG----------EPVL 210
           ++S +  H N++ L+G CT     L++  +     +   LR  +P            P  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 211 DWVTRKRVALGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVD 267
              +R  +   +  A+G+ +L    +   IHRDV A NVLL     A +GDFGLA+ +++
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
                V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/275 (20%), Positives = 117/275 (42%), Gaps = 22/275 (8%)
Query: 113 NFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHR 169
           NF  +  +G+G F +VYR   L DG  VA+K++  F+       A   +E++++    H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++         E  +V        ++  ++  K  + ++   T  +  +     LE++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H     +++HRD+K ANV +       +GD GL +     KT     + GT  +++PE +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDR 349
                + ++D++  G +L E+   Q      +                   K+++     
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC------------KKIEQCDYP 256
Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
            L  ++  +E+  ++    +C    PE RP ++ V
Sbjct: 257 PLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 33/209 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLLRLIG 176
           +LG+G FG+V +        + AVK +    +   D +   REVE++    H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA-LGAAR-------GLE 227
                      +  +++ S  Y + E+  G  + D  + RKR +   AAR       G+ 
Sbjct: 87  -----------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 228 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           Y+H+H    I+HRD+K  N+LL   ++D +  + DFGL+     + T +  ++ GT  +I
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYI 190
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTG 313
           APE L  G   E+ DV+  G++L  L++G
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 33/209 (15%)
Query: 119 VLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLLRLIG 176
           +LG+G FG+V +        + AVK +    +   D +   REVE++    H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA-LGAAR-------GLE 227
                      +  +++ S  Y + E+  G  + D  + RKR +   AAR       G+ 
Sbjct: 87  -----------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 228 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           Y+H+H    I+HRD+K  N+LL   ++D +  + DFGL+     + T +  ++ GT  +I
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYI 190
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTG 313
           APE L  G   E+ DV+  G++L  L++G
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAVK +  T   S      F REV ++ V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      G+  
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 19/229 (8%)
Query: 94  IAFGQLKRYSWRELQLATDN-FSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPG 151
           I F +  ++ W E Q  T N F +  VLG+GGFG+V    V A G   A K+L       
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 152 --GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEP 208
             G+A    E +++     R ++ L     T     LV   M    + + +  + + G P
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 209 VLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
                   R    AA    GLE LH     +I++RD+K  N+LLD+     + D GLA  
Sbjct: 285 ------EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-- 333
Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           V V +        GT+G++APE +   + +   D +  G +L E++ GQ
Sbjct: 334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAVK +  T   S      F REV ++ V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      G+  
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 46/224 (20%)
Query: 111 TDNFSEKNVLGQGGFGKVY---------RGVLADGTKVAVKRLTDFESPGGDAAFQREVE 161
           +D +  + VLG+G FG+V             +   +K  VK+ TD ES        REV+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES------LLREVQ 78
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVA- 219
           ++    H N+ +L             Y F ++    Y + E+  G  + D  ++RKR + 
Sbjct: 79  LLKQLDHPNIXKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 220 LGAAR-------GLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVR 269
           + AAR       G+ Y H++   KI+HRD+K  N+LL+   +D    + DFGL+   +  
Sbjct: 126 VDAARIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           K        GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 183 KK--XKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 119 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           V+G G FG+V  G L    K    VA+K L    +      F  E  ++    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
            G  T     ++V  +M+N S+   L++      V+  V   R   G + G++YL +   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYLSDM-- 143
Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 292
              +HRD+ A N+L++ +    V DFGL++++  D      T   +  +   APE ++  
Sbjct: 144 -GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 293 KSSERTDVFGYGIMLLELVT-GQRA 316
           K +  +DV+ YGI++ E+V+ G+R 
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G +G+V+RG    G  VAVK      S   + ++ RE E+ +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 178 CTTP---TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH---- 230
             T    + +L +      +   Y   ++      LD V+  R+ L  A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 231 -EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTNVTTQVR-GTMGHIAP 286
                P I HRD+K+ N+L+ ++ +  + D GLA +      + +V    R GT  ++AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 287 EYLSTG------KSSERTDVFGYGIMLLEL 310
           E L          S +R D++ +G++L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIG- 176
           ++G G +G+VY+G      ++A  ++ D  +   +   ++E+ M+   + HRN+    G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 177 -FCTTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
                P     +  LV  F    SV   ++  K      +W+    +     RGL +LH+
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 147
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
           H   K+IHRD+K  NVLL E+ E  + DFG++  +D R         GT   +APE ++ 
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIAC 203
Query: 292 GKSSE-----RTDVFGYGIMLLELVTG 313
            ++ +     ++D++  GI  +E+  G
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 19/229 (8%)
Query: 94  IAFGQLKRYSWRELQLATDN-FSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPG 151
           I F +  ++ W E Q  T N F +  VLG+GGFG+V    V A G   A K+L       
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 152 --GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEP 208
             G+A    E +++     R ++ L     T     LV   M    + + +  + + G P
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 209 VLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
                   R    AA    GLE LH     +I++RD+K  N+LLD+     + D GLA  
Sbjct: 285 ------EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-- 333
Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           V V +        GT+G++APE +   + +   D +  G +L E++ GQ
Sbjct: 334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAV+ +  T   S      F REV ++ V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N   +  G+  
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGSPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G +G+V+RG    G  VAVK      S   + ++ RE E+ +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 178 CTTP---TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH---- 230
             T    + +L +      +   Y   ++      LD V+  R+ L  A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 231 -EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVR-GTMGHIA 285
                P I HRD+K+ N+L+ ++ +  + D GLA ++  + TN   V    R GT  ++A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 286 PEYLSTG------KSSERTDVFGYGIMLLEL 310
           PE L          S +R D++ +G++L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 95/226 (42%), Gaps = 25/226 (11%)
Query: 97  GQLKRYSWRELQLATDN---FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD 153
           G LK     EL    D    FS+   +G G FG VY       ++V   +   +     +
Sbjct: 36  GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 154 AAFQ---REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEP 208
             +Q   +EV  +    H N ++  G         LV  +   L  A  L E+  KP   
Sbjct: 96  EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC--LGSASDLLEVHKKP--- 150
Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
            L  V    V  GA +GL YLH H    +IHRDVKA N+LL E     +GDFG A ++  
Sbjct: 151 -LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206
Query: 269 RKTNVTTQVRGTMGHIAPEY---LSTGKSSERTDVFGYGIMLLELV 311
               V     GT   +APE    +  G+   + DV+  GI  +EL 
Sbjct: 207 ANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMIS 164
           E     D   ++ VLG+G +G VY G  L++  ++A+K + + +S         E+ +  
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHK 74
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLRE----IKPGEPVLDWVTRKR 217
              H+N+++ +G   + +E   +  FM+ +   S++  LR     +K  E  + + T++ 
Sbjct: 75  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV--VGDFGLAK-LVDVRKTNVT 274
           +      GL+YLH++   +I+HRD+K  NVL++  +  V  + DFG +K L  +     T
Sbjct: 132 L-----EGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP--CT 180
Query: 275 TQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQ 314
               GT+ ++APE +  G     +  D++  G  ++E+ TG+
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHR 169
           N+     LG+G FGKV        G KVA+K +        D     +RE+  + +  H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++++L     +  E ++V  +  N    Y ++  K  E        +R        +EY 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 129
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   KI+HRD+K  N+LLDE     + DFGL+ +  +   N      G+  + APE +
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVI 184
Query: 290 STGK--SSERTDVFGYGIMLLELVTGQRAID 318
           S GK  +    DV+  G++L  ++  +   D
Sbjct: 185 S-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 121
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 177
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR-------EIKPGEPVLDWV 213
           ++S +  H N++ L+G CT     L++  +     +   LR       + + G P L+  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELR 160
Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTN 272
                +   A+G+ +L    +   IHRDV A NVLL     A +GDFGLA+ +++     
Sbjct: 161 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHR 169
           N+     LG+G FGKV        G KVA+K +        D     +RE+  + +  H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++++L     +  E ++V  +  N    Y ++  K  E        +R        +EY 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   KI+HRD+K  N+LLDE     + DFGL+ +  +   N      G+  + APE +
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVI 174
Query: 290 STGK--SSERTDVFGYGIMLLELVTGQRAID 318
           S GK  +    DV+  G++L  ++  +   D
Sbjct: 175 S-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHR 169
           N+     LG+G FGKV        G KVA+K +        D     +RE+  + +  H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++++L     +  E ++V  +  N    Y ++  K  E        +R        +EY 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 128
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   KI+HRD+K  N+LLDE     + DFGL+ +  +   N      G+  + APE +
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVI 183
Query: 290 STGK--SSERTDVFGYGIMLLELVTGQRAID 318
           S GK  +    DV+  G++L  ++  +   D
Sbjct: 184 S-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR-------EIKPGEPVLDWV 213
           ++S +  H N++ L+G CT     L++  +     +   LR       + + G P L+  
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELR 152
Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTN 272
                +   A+G+ +L    +   IHRDV A NVLL     A +GDFGLA+ +++     
Sbjct: 153 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMIS 164
           E     D   ++ VLG+G +G VY G  L++  ++A+K + + +S         E+ +  
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHK 60
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLRE----IKPGEPVLDWVTRKR 217
              H+N+++ +G   + +E   +  FM+ +   S++  LR     +K  E  + + T++ 
Sbjct: 61  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV--VGDFGLAK-LVDVRKTNVT 274
           +      GL+YLH++   +I+HRD+K  NVL++  +  V  + DFG +K L  +     T
Sbjct: 118 L-----EGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP--CT 166
Query: 275 TQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQ 314
               GT+ ++APE +  G     +  D++  G  ++E+ TG+
Sbjct: 167 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAVK +  T   S      F REV ++ V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      G   
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRN 170
           FS+   +G G FG VY       ++V   +   +     +  +Q   +EV  +    H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEY 228
            ++  G         LV  +   L  A  L E+  KP    L  V    V  GA +GL Y
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAY 130
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH H    +IHRDVKA N+LL E     +GDFG A ++      V     GT   +APE 
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 289 ---LSTGKSSERTDVFGYGIMLLELV 311
              +  G+   + DV+  GI  +EL 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 120
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE L
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G +G+V+RG    G  VAVK  +  +    + ++ RE E+ +  +  H N+L  I  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIAS 99
Query: 178 CTTP---TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH---- 230
             T    + +L +      +   Y   ++      LD V+  R+ L  A GL +LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 231 -EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTNVTTQVR-GTMGHIAP 286
                P I HRD+K+ N+L+ ++ +  + D GLA +      + +V    R GT  ++AP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 287 EYLSTG------KSSERTDVFGYGIMLLEL 310
           E L          S +R D++ +G++L E+
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHR 169
           N+     LG+G FGKV        G KVA+K +        D     +RE+  + +  H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++++L     +  E ++V  +  N    Y ++  K  E        +R        +EY 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 123
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   KI+HRD+K  N+LLDE     + DFGL+ +  +   N      G+  + APE +
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVI 178
Query: 290 STGK--SSERTDVFGYGIMLLELVTGQRAID 318
           S GK  +    DV+  G++L  ++  +   D
Sbjct: 179 S-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+ ++  D E+ G  +   RE+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 119
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+ ++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHRNLLRL 174
           + LG G FGKV  G     G KVAVK L   +    D     +RE++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAARGL------- 226
               +TPT+  +V  ++              G  + D++ +  RV    AR L       
Sbjct: 77  YQVISTPTDFFMVMEYVS-------------GGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 227 -EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
            +Y H H    ++HRD+K  NVLLD    A + DFGL+ ++   +   T+   G+  + A
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAA 178
Query: 286 PEYLSTGK--SSERTDVFGYGIMLLELVTGQRAID 318
           PE +S G+  +    D++  G++L  L+ G    D
Sbjct: 179 PEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 105 RELQLATDNFSEKNV-LGQGGFGKVYRGVLADGTK---VAVKRLTDFESPGGDAAFQREV 160
           ++L L  DN    ++ LG G FG V +GV     K   VA+K L             RE 
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           +++    +  ++RLIG C    E L++            + E+  G P+  ++  KR  +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQA--EALML------------VMEMAGGGPLHKFLVGKREEI 433
Query: 221 GAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +           G++YL E      +HR++ A NVLL     A + DFGL+K +    
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 271 TNVTTQVRG--TMGHIAPEYLSTGKSSERTDVFGYGIMLLE-LVTGQRA 316
           +  T +  G   +   APE ++  K S R+DV+ YG+ + E L  GQ+ 
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAV+ +  T   S      F REV ++ V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVMEYASGGEVFDYLVAHGRMKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      G+  
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 118 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAA--FQREVEMISVAVHRNLLRL 174
           + LG G FGKV  G     G KVAVK L   +    D     +RE++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAARGL------- 226
               +TPT+  +V  ++              G  + D++ +  RV    AR L       
Sbjct: 77  YQVISTPTDFFMVMEYVS-------------GGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 227 -EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
            +Y H H    ++HRD+K  NVLLD    A + DFGL+ ++            G+  + A
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPNYAA 178
Query: 286 PEYLSTGK--SSERTDVFGYGIMLLELVTGQRAID 318
           PE +S G+  +    D++  G++L  L+ G    D
Sbjct: 179 PEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 114 FSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           F  K  LG G F +V   VLA+    G   AVK +      G +++ + E+ ++    H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++ L     +P    LV   +    +  R+ E K      D  T  R  L A   + YL
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVE-KGFYTEKDASTLIRQVLDA---VYYL 136
Query: 230 HEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           H      I+HRD+K  N+L    DE+ + ++ DFGL+K+    K +V +   GT G++AP
Sbjct: 137 HRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG--KGDVMSTACGTPGYVAP 191
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTG 313
           E L+    S+  D +  G++   L+ G
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 120 LGQGGFGKVYRGVLA-DGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V   V    G KVA+K+L   F+S        RE+ ++    H N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD- 91
Query: 178 CTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
             TP E L       LV PFM    +   ++  K GE  + ++  + +     +GL Y+H
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQML-----KGLRYIH 145
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 289
                 IIHRD+K  N+ ++ED E  + DFGLA+  D            T  + APE  L
Sbjct: 146 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWYRAPEVIL 198
Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
           +  + ++  D++  G ++ E++TG+
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 113 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 169
           N+     +G+G F KV   R +L  G +VA+K +   + +P       REV ++ +  H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAAR 224
           N+++L  F    TE+ L           Y + E   G  V D++      +++ A    R
Sbjct: 72  NIVKL--FEVIETEKTL-----------YLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 118
Query: 225 GLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            +    ++C+ K I+HRD+KA N+LLD D    + DFG +    V     T    G+  +
Sbjct: 119 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPY 176
Query: 284 IAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
            APE     K      DV+  G++L  LV+G    D
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 120 LGQGGFGKVYRGVLA-DGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V   +    G KVA+K+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD- 108
Query: 178 CTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
             TP   L       LV PFMQ  +   ++  ++  E  + ++  + +     +GL+Y+H
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGMEFSEEKIQYLVYQML-----KGLKYIH 161
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 289
              +  ++HRD+K  N+ ++ED E  + DFGLA+  D   T        T  + APE  L
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVIL 214
Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
           S    ++  D++  G ++ E++TG+
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 186 SDIWAFGVLMWEIYS 200

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+  +      +       G P+      K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL---PLIKSYLFQLLQGLAFC 118
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H   +++HRD+K  N+L++ +    + DFGLA+   V     T +V  T+ + APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 290 STGK-SSERTDVFGYGIMLLELVT 312
              K  S   D++  G +  E+VT
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 187 SDIWAFGVLMWEIYS 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+ F+      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 12/211 (5%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVH 168
           ++F   N+LG+G F  VYR   +  G +VA+K +        G     Q EV++     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLE 227
            ++L L  +        LV     N  +   L+  +KP          +        G+ 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP----FSENEARHFMHQIITGML 126
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH H    I+HRD+  +N+LL  +    + DFGLA  + +      T + GT  +I+PE
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
             +       +DV+  G M   L+ G+   D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 182 SDIWAFGVLMWEIYS 196

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGKS 294
           +HRD+ A N L+++     V DFGL++ V     +  T  RG+   +    PE L   K 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 295 SERTDVFGYGIMLLELVT 312
           S ++D++ +G+++ E+ +
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 117 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL---- 171
           K  LG GGFG V R +  D G +VA+K+     SP     +  E++++    H N+    
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 172 -----LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
                L+ +     P   LL   + +   +   L + +    + +   R  ++   +  L
Sbjct: 79  EVPDGLQKLAPNDLP---LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG---DFGLAKLVDVRKTNVTTQVRGTMGH 283
            YLHE+   +IIHRD+K  N++L    + ++    D G AK +D  +  + T+  GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQY 189
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 316
           +APE L   K +   D + +G +  E +TG R 
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 117 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL---- 171
           K  LG GGFG V R +  D G +VA+K+     SP     +  E++++    H N+    
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 172 -----LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
                L+ +     P   LL   + +   +   L + +    + +   R  ++   +  L
Sbjct: 80  EVPDGLQKLAPNDLP---LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG---DFGLAKLVDVRKTNVTTQVRGTMGH 283
            YLHE+   +IIHRD+K  N++L    + ++    D G AK +D  +  + T+  GT+ +
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQY 190
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 316
           +APE L   K +   D + +G +  E +TG R 
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 193 SDIWAFGVLMWEIYS 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 169
           N+     +G+G F KV   R +L  G +VA+K +   + +P       REV ++ +  H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAAR 224
           N+++L  F    TE+ L           Y + E   G  V D++      +++ A    R
Sbjct: 75  NIVKL--FEVIETEKTL-----------YLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 225 GLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            +    ++C+ K I+HRD+KA N+LLD D    + DFG +    V          G   +
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPY 179
Query: 284 IAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
            APE     K      DV+  G++L  LV+G    D
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           L+ A+D F E  VLGQG FG+V +   A D    A+K++   E     +    EV +++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLAS 58
Query: 166 AVHRNLLRLIGFCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRK------- 216
             H+ ++R   +      R  V P   ++  S  +   E      + D +  +       
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVR 269
              R+       L Y+H      IIHRD+K  N+ +DE     +GDFGLAK V    D+ 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 270 K----------TNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV 311
           K           N+T+ + GT  ++A E L  TG  +E+ D++  GI+  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G +G+V+RG L  G  VAVK  +  +    + ++ RE E+ +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRD----EQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 178 CTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--- 230
             T     T+  L+  + ++ S+ Y   + +  EP L      R+A+ AA GL +LH   
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSL-YDFLQRQTLEPHL----ALRLAVSAACGLAHLHVEI 125
Query: 231 --EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----VDVRKTNVTTQVRGTMGHI 284
                 P I HRD K+ NVL+  + +  + D GLA +     D        +V GT  ++
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYM 184
Query: 285 APEYLSTG------KSSERTDVFGYGIMLLEL 310
           APE L         +S + TD++ +G++L E+
Sbjct: 185 APEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/315 (21%), Positives = 128/315 (40%), Gaps = 25/315 (7%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMISVAV 167
           + + +    ++G+G +G V +    D G  VA+K+  + +          RE++++    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H NL+ L+  C       LV+ F+ + ++   L     G   LD+   ++       G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG---LDYQVVQKYLFQIINGIG 138
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H    IIHRD+K  N+L+ +     + DFG A+ +         +V  T  + APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPE 194
Query: 288 YL-STGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREK----- 341
            L    K  +  DV+  G ++ E+  G+                        R +     
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 342 -------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEGEG 392
                  RL  I +R   +    +  E +I +A  C    P+ RP  +E++     + +G
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 393 LAERWEEWQHVEVTR 407
            AER+ +   ++V +
Sbjct: 315 FAERFSQELQLKVQK 329

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
            F+   +LG+G FG V    L   DG+  KVAVK L  D  +      F RE   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 168 HRNLLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGE-PV-LDWVTRKRVA 219
           H ++ +L+G       +      +++ PFM++  +   L   + GE P  L   T  R  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQ 276
           +  A G+EYL        IHRD+ A N +L ED    V DFGL++ +   D  +    ++
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           +   +  +A E L+    +  +DV+ +G+ + E++T
Sbjct: 201 L--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 113 NFSEKNVLGQGGFGKV--YRGVLADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           N+     +G+G F KV   R +L  G +VAVK +  T   S      F REV +  V  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIXKVLNH 72
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT-----RKRVALGAA 223
            N+++L  F    TE+ L           Y + E   G  V D++      +++ A    
Sbjct: 73  PNIVKL--FEVIETEKTL-----------YLVXEYASGGEVFDYLVAHGRXKEKEARAKF 119
Query: 224 RGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R +    ++C+ K I+HRD+KA N+LLD D    + DFG +   +    N      G   
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPP 177
Query: 283 HIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAID 318
           + APE     K      DV+  G++L  LV+G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 202 SDIWAFGVLMWEIYS 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V  G       VA+K +   E    +  F  E +++    H  L++L G CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL--GAARGLEYLHEHCNPKI 237
                 ++  +M N  +   LRE++       + T++ + +       +EYL    + + 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L   K S +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 298 TDVFGYGIMLLELVT 312
           +D++ +G+++ E+ +
Sbjct: 202 SDIWAFGVLMWEIYS 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++L  D+F + + LG G  G V++        V  ++L   E              I  A
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPA 46
Query: 167 VHRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------- 216
           +   ++R   ++  C +P        F  +  ++  +  +  G   LD V +K       
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 104
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTN 272
              +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    +
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +     GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++L  D+F + + LG G  G V++        V  ++L   E              I  A
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPA 46
Query: 167 VHRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------- 216
           +   ++R   ++  C +P        F  +  ++  +  +  G   LD V +K       
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 104
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTN 272
              +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    +
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +     GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++L  D+F + + LG G  G V++        V  ++L   E              I  A
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPA 46
Query: 167 VHRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------- 216
           +   ++R   ++  C +P        F  +  ++  +  +  G   LD V +K       
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 104
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTN 272
              +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    +
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +     GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           L+ A+D F E  VLGQG FG+V +   A D    A+K++   E     +    EV +++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLAS 58
Query: 166 AVHRNLLRLIGFCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRK------- 216
             H+ ++R   +      R  V P   ++  S  +   E      + D +  +       
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVR 269
              R+       L Y+H      IIHRD+K  N+ +DE     +GDFGLAK V    D+ 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 270 K----------TNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV 311
           K           N+T+ + GT  ++A E L  TG  +E+ D++  GI+  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++L  D+F + + LG G  G V++        V  ++L   E              I  A
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPA 46
Query: 167 VHRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------- 216
           +   ++R   ++  C +P        F  +  ++  +  +  G   LD V +K       
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 104
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTN 272
              +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    +
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +     GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           ++L  D+F + + LG G  G V++        V  ++L   E              I  A
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPA 46
Query: 167 VHRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------- 216
           +   ++R   ++  C +P        F  +  ++  +  +  G   LD V +K       
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 104
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTN 272
              +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    +
Sbjct: 105 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +     GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLL 172
           F++   +G+G FG+V++G+     +V   ++ D E    +    Q+E+ ++S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           +  G     ++  ++  ++   S    LR     E  +  + ++ +     +GL+YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSE 139
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
              K IHRD+KAANVLL E  +  + DFG+A  +   +    T V GT   +APE +   
Sbjct: 140 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
               + D++  GI  +EL  G+
Sbjct: 196 AYDSKADIWSLGITAIELAKGE 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL-----ADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +N      LG G FGKV           D   KVAVK L          A   E++
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 162 MIS-VAVHRNLLRLIGFCTTPTERLLV---------YPFMQNLSVAYRLREIKPGEPV-- 209
           ++S +  H N++ L+G CT     L++           F++  + A     + PG+    
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 210 LDWVTRKRVAL--------GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
           LD    + + L          A+G+ +L    +   IHRDV A NVLL     A +GDFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 262 LAK-LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           LA+ +++     V    R  +  +APE +     + ++DV+ YGI+L E+ +
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +L  D+F + + LG G  G V++        V  ++L   E              I  A+
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPAI 66
Query: 168 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
              ++R   ++  C +P        F  +  ++  +  +  G   LD V +K        
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 124
Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 273
             +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    ++
Sbjct: 125 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 178
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-----RGVLADGTKVAVKRLTDFESPGGDAAFQREVEM 162
           +   D+F     LG+G FG VY     +       KV  K  +  E  G +   +RE+E+
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEI 68
Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALG 221
            S   H N+LR+  +     +R  +Y  ++        +E+ K G    D          
Sbjct: 69  QSHLRHPNILRMYNYFH---DRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 123
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGT 280
            A  L Y HE    K+IHRD+K  N+L+    E  + DFG +     +R+  +     GT
Sbjct: 124 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GT 176
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           + ++ PE +      E+ D++  G++  E + G    D
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +L  D+F + + LG G  G V++        V  ++L   E              I  A+
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPAI 74
Query: 168 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
              ++R   ++  C +P        F  +  ++  +  +  G   LD V +K        
Sbjct: 75  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 132
Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 273
             +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    ++
Sbjct: 133 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 186
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVY-----RGVLADGTKVAVKRLTDFESPGGDAAFQREVEM 162
           +   D+F     LG+G FG VY     +       KV  K  +  E  G +   +RE+E+
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEI 67
Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALG 221
            S   H N+LR+  +     +R  +Y  ++        +E+ K G    D          
Sbjct: 68  QSHLRHPNILRMYNYFH---DRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 122
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGT 280
            A  L Y HE    K+IHRD+K  N+L+    E  + DFG +     +R+  +     GT
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GT 175
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           + ++ PE +      E+ D++  G++  E + G    D
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 120 LGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           LG+G +  VY+G   L D   VA+K +      G      REV ++    H N++ L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
             T     LV+ ++      Y    +     +++    K       RGL Y H     K+
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQY----LDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 296
           +HRD+K  N+L++E  E  + DFGLA+   +       +V  T+ +  P+  L +   S 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 297 RTDVFGYGIMLLELVTGQ 314
           + D++G G +  E+ TG+
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVH 168
           ++F    +LG+G F  V     LA   + A+K L               RE +++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 169 RNLLRLIGFCTTPTERLLV-YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
              ++L  FC    E+L     + +N  +   +R+I       D    +         LE
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALE 151
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAP 286
           YLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +++P
Sbjct: 152 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTG 313
           E L+   + + +D++  G ++ +LV G
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           +E+ ++    H N+++L+     P E  L           Y + E+    PV++  T K 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELVNQGPVMEVPTLKP 133
Query: 218 VALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
           ++   AR        G+EYLH     KIIHRD+K +N+L+ ED    + DFG++      
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQ 314
              ++  V GT   +APE LS  +   S +  DV+  G+ L   V GQ
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 87
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 139
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HR++K+ N+LL  D    + DFG    +   ++  +T V GT   +APE ++      + 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLT----DFESPGGDAAFQREVEMISVAVH 168
           + + + LG+G F  VY+    +  + VA+K++          G +    RE++++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N++ L+      +   LV+ FM+ +L V      IK    VL     K   L   +GLE
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH+H    I+HRD+K  N+LLDE+    + DFGLAK           QV  T  + APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPE 182
Query: 288 YLSTGKS-SERTDVFGYGIMLLELV 311
            L   +      D++  G +L EL+
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 142
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   +S+ +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +  V GT   +APE ++      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +L  D+F + + LG G  G V++        V  ++L   E              I  A+
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPAI 109
Query: 168 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
              ++R   ++  C +P        F  +  ++  +  +  G   LD V +K        
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 167
Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 273
             +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D    ++
Sbjct: 168 LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 221
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                GT  +++PE L     S ++D++  G+ L+E+  G+  I
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++++  V+G G FG VY+  L D G  VA+K++       G A   RE++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 172 LRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR 224
           +RL  F  +  E+       LV  ++   +  YR+ R     +  L  +  K       R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 284 IAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
            APE +      +   DV+  G +L EL+ GQ
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 87
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 139
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +  V GT   +APE ++      + 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N+++L+    T  +  LV+  +      +       G P+      K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           + H H   +++HRD+K  N+L++ +    + DFGLA+   V       +V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 288 YLSTGK-SSERTDVFGYGIMLLELVT 312
            L   K  S   D++  G +  E+VT
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +GQG  G VY  + +A G +VA++++   + P  +     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 238
               E  +V  ++   S+   + E    E  +  V R+       + LE+LH +   ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRD+K+ N+LL  D    + DFG    +   ++  +  V GT   +APE ++      + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 299 DVFGYGIMLLELVTGQ 314
           D++  GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFE-SPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+    L D   VAVK L  D    P     F+RE +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 126
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+L+       V DFG+A+ +     +V  T  V GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTT 275
           ++ L   + L +L E  N KIIHRD+K +N+LLD      + DFG++ +LVD   +   T
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKT 183
Query: 276 QVRGTMGHIAPEYLSTGKSSE----RTDVFGYGIMLLELVTGQ 314
           +  G   ++APE +    S +    R+DV+  GI L EL TG+
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 142
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +L  D+F + + LG G  G V++        V  ++L   E              I  A+
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------------IKPAI 50
Query: 168 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
              ++R   ++  C +P        F  +  ++  +  +  G   LD V +K        
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 108
Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 273
             +V++   +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D     +
Sbjct: 109 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EM 162
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             +  GT  +++PE L     S ++D++  G+ L+E+  G+
Sbjct: 163 ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 12/215 (5%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLT-DFESPGGDA-AFQREVEMIS 164
           +L  DNF    VLG+G FGKV    V   G   AVK L  D      D      E  ++S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 165 VAVHRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           +A +   L  +  C  TP     V  F+    + + +++ +      D    +  A    
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEII 134
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             L +LH+     II+RD+K  NVLLD +    + DFG+ K   +     T    GT  +
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDY 190
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           IAPE L         D +  G++L E++ G    +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 44/222 (19%)
Query: 113 NFSEKNVLGQGGFGK-VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRN 170
           +F  K+VLG G  G  VYRG+  D   VAVKR+     P   +   REV+++  +  H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRIL----PECFSFADREVQLLRESDEHPN 79
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-LG-------- 221
           ++R   FC   TE+   + ++     A  L+E         +V +K  A LG        
Sbjct: 80  VIRY--FC---TEKDRQFQYIAIELCAATLQE---------YVEQKDFAHLGLEPITLLQ 125
Query: 222 -AARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLAKLVDVRKTNVT- 274
               GL +LH   +  I+HRD+K  N+L+         +A++ DFGL K + V + + + 
Sbjct: 126 QTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 275 -TQVRGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVT 312
            + V GT G IAPE LS       T   D+F  G +   +++
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 140
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 140
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++++  V+G G FG VY+  L D G  VA+K++       G A   RE++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 172 LRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR 224
           +RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 188
Query: 284 IAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
            APE +      +   DV+  G +L EL+ GQ
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 142
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++++  V+G G FG VY+  L D G  VA+K++       G A   RE++++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 172 LRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR 224
           +RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 188
Query: 284 IAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
            APE +      +   DV+  G +L EL+ GQ
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 117 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + ++G G  G+V  G L         VA+K L    +      F  E  ++    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL G  T     ++V  +M+N S+   LR       ++  V   R   G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYL--- 167
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLS 290
            +   +HRD+ A NVL+D +    V DFGL++++  D      TT  +  +   APE ++
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 291 TGKSSERTDVFGYGIMLLE-LVTGQR 315
               S  +DV+ +G+++ E L  G+R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFE-SPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+    L D   VAVK L  D    P     F+RE +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 126
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 148
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 149 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 140
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L  ++P + + D++T +R AL       +  
Sbjct: 75  VIRLLDWFERPDSFVLI------------LERMEPVQDLFDFIT-ERGALQEELARSFFW 121
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 178
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 140
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 160
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 161 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFE-SPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+    L D   VAVK L  D    P     F+RE +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 126
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G +G+V+ G    G KVAVK     E    +A++ RE E+    +  H N+L  I  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAA 99
Query: 178 ----CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
                 + T+  L+  + +N S+   L+        LD  +  ++A  +  GL +LH   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 234 -----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVR-GTMGHIA 285
                 P I HRD+K+ N+L+ ++    + D GLA   + D  + ++    R GT  ++ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 286 PEYLSTG------KSSERTDVFGYGIMLLEL 310
           PE L         +S    D++ +G++L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 117/245 (47%), Gaps = 44/245 (17%)
Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA- 154
           G++ R+  R+ +L          LG+G +G V++ +    G  VAVK++ D      DA 
Sbjct: 1   GRVDRHVLRKYELVKK-------LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ 53
Query: 155 -AFQREVEMISVAVHRNLLRLIGFCTTPTER--LLVYPFMQ-NLSVAYRLREIKPGEPVL 210
             F+  + +  ++ H N++ L+       +R   LV+ +M+ +L    R   ++P     
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP----- 108
Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVR 269
             V ++ V     + ++YLH   +  ++HRD+K +N+LL+ +    V DFGL++  V++R
Sbjct: 109 --VHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 270 K-TN------------------VTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLE 309
           + TN                  + T    T  + APE  L + K ++  D++  G +L E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 310 LVTGQ 314
           ++ G+
Sbjct: 224 ILCGK 228

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 38/242 (15%)
Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL---ADGTK---VAVKRLTDFESP 150
            Q K+   +E+ L+   F E+  LG+  FGKVY+G L   A G +   VA+K L D    
Sbjct: 13  NQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 70
Query: 151 GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL---------- 200
                F+ E  + +   H N++ L+G  T      +++ +  +  +   L          
Sbjct: 71  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 201 -----REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 255
                R +K      D+V    +    A G+EYL  H    ++H+D+   NVL+ +    
Sbjct: 131 STDDDRTVKSALEPPDFV---HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184
Query: 256 VVGDFGLAKLV---DVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            + D GL + V   D  K   N    +R     +APE +  GK S  +D++ YG++L E+
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEV 240
Query: 311 VT 312
            +
Sbjct: 241 FS 242

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     +Q+L      + +K      D +          RGL+Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYI 140
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ----REVEMI 163
           +AT  +     +G G +G VY+      G  VA+K +     P G+        REV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 164 ---SVAVHRNLLRLIGFCTTP-TER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
                  H N++RL+  C T  T+R     LV+  +      Y  +   PG P     T 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA---ETI 114
Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           K +     RGL++LH +C   I+HRD+K  N+L+       + DFGLA++   +      
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171
Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            V  T+ + APE L     +   D++  G +  E+
Sbjct: 172 VV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 117 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + ++G G  G+V  G L         VA+K L    +      F  E  ++    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL G  T     ++V  +M+N S+   LR       ++  V   R   G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYL--- 167
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLS 290
            +   +HRD+ A NVL+D +    V DFGL++++  D      TT  +  +   APE ++
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 291 TGKSSERTDVFGYGIMLLE-LVTGQR 315
               S  +DV+ +G+++ E L  G+R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           L+ A+D F E  VLGQG FG+V +   A D    A+K++   E     +    EV +++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVXLLAS 58
Query: 166 AVHRNLLRLIGFCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRK------- 216
             H+ ++R   +      R  V P   ++  S  +   E      + D +  +       
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 217 ---RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVR 269
              R+       L Y+H      IIHR++K  N+ +DE     +GDFGLAK V    D+ 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 270 K----------TNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV 311
           K           N+T+ + GT  ++A E L  TG  +E+ D +  GI+  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 121 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 120 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +F     LG+GGFG V+      D    A+KR+             REV+ ++   H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 172 LRLIG--FCTTPTERLL-----VYPFMQ-NLSVAYRLREIKPGEPVLDWVTRK---RVAL 220
           +R          TE+L      VY ++Q  L     L++   G   ++   R     + L
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT------ 274
             A  +E+LH      ++HRD+K +N+    D    VGDFGL   +D  +   T      
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 275 -----TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
                T   GT  +++PE +     S + D+F  G++L EL+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 125
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 181
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 120
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 176
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA 166
           +L  D+F   + LG G  G V +        +  ++L   E  P       RE++++   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAAR 224
               ++   G   +  E  +    M   S+   L+E K  P E         +V++   R
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE------ILGKVSIAVLR 125
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGH 283
           GL YL E    +I+HRDVK +N+L++   E  + DFG++ +L+D    ++     GT  +
Sbjct: 126 GLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 179
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
           +APE L     S ++D++  G+ L+EL  G+  I
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 119
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 175
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 141 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 122
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 178
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 119 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 122 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 145 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ----REVEMI 163
           +AT  +     +G G +G VY+      G  VA+K +     P G+        REV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 164 ---SVAVHRNLLRLIGFCTTP-TER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
                  H N++RL+  C T  T+R     LV+  +      Y  +   PG P     T 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA---ETI 114
Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           K +     RGL++LH +C   I+HRD+K  N+L+       + DFGLA++   +      
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV 171
Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            V  T+ + APE L     +   D++  G +  E+
Sbjct: 172 VV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           + +F  K++LG+G +G V        G  VA+K++  F+ P       RE++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV---------AL 220
           N++ +       +         +N +  Y ++E+   +  L  V   ++           
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---VRKTNVTTQV 277
              R ++ LH      +IHRD+K +N+L++ + +  V DFGLA+++D      +  T Q 
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 278 RGTMGHI------APE-YLSTGKSSERTDVFGYGIMLLEL 310
            G   ++      APE  L++ K S   DV+  G +L EL
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 126 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 141 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 71  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 117
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 71  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 117
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 139
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 140 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 145 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 74  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 120
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 177
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 139
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 140 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 145
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 201
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 146
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 147 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 147 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 147
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 148 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 138
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 139 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 71  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 117
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGH 283
            LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +
Sbjct: 144 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++PE L+   + + +D++  G ++ +LV G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ----REVEMI 163
           +AT  +     +G G +G VY+      G  VA+K +     P G+        REV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALL 57
Query: 164 ---SVAVHRNLLRLIGFCTTP-TER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
                  H N++RL+  C T  T+R     LV+  +      Y  +   PG P     T 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA---ETI 114
Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           K +     RGL++LH +C   I+HRD+K  N+L+       + DFGLA++   +      
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LD 169
Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
            V  T+ + APE L     +   D++  G +  E+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 76  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 122
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 114 FSEKNVLGQGGFGKV---YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++  + +G+G +G V   Y  V  +  +VA+K+++ FE         RE++++    H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 171 LLRLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ +      PT E++     + +L  A   + +K      D +          RGL+Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY--FLYQILRGLKYI 160
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPE 287
           H   +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE
Sbjct: 161 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 288 YLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            +   K   ++ D++  G +L E+++ +
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--HRNLLRLIGF 177
           +G+G FG+V+RG    G +VAVK  +  E    + ++ RE E+    +  H N+L  I  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 178 CT----TPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-- 230
                 T T+  LV  + ++ S+  Y  R     E ++      ++AL  A GL +LH  
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 158
Query: 231 ---EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR-------GT 280
                  P I HRD+K+ N+L+ ++    + D GLA    VR  + T  +        GT
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----VRHDSATDTIDIAPNHRVGT 214
Query: 281 MGHIAPEYLSTG------KSSERTDVFGYGIMLLELV 311
             ++APE L         +S +R D++  G++  E+ 
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 75  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 121
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 178
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           + +F  K++LG+G +G V        G  VA+K++  F+ P       RE++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV---------AL 220
           N++ +       +         +N +  Y ++E+   +  L  V   ++           
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT------ 274
              R ++ LH      +IHRD+K +N+L++ + +  V DFGLA+++D    + +      
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 275 ---TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLEL 310
              T+   T  + APE  L++ K S   DV+  G +L EL
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 76  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 122
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
           + +F  K++LG+G +G V        G  VA+K++  F+ P       RE++++    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV---------AL 220
           N++ +       +         +N +  Y ++E+   +  L  V   ++           
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---VRKTNVTTQV 277
              R ++ LH      +IHRD+K +N+L++ + +  V DFGLA+++D      +  T Q 
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 278 RGTMGHI------APE-YLSTGKSSERTDVFGYGIMLLEL 310
            G +  +      APE  L++ K S   DV+  G +L EL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 76  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 122
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 179
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 74
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 187
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 75
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 134 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 188
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 74
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 187
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 98  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 144
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 145 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 201
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FGKVY+    +   +A  ++ + +S      +  E+E+++   H  +++L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
              +  ++  F    +V   + E+  G  EP +  V R+ +       L +LH   + +I
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLH---SKRI 138
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYL--ST 291
           IHRD+KA NVL+  + +  + DFG++      K   T Q R    GT   +APE +   T
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 292 GKSSE---RTDVFGYGIMLLEL 310
            K +    + D++  GI L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEM 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLIL 115
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG 172
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FGKVY+    +   +A  ++ + +S      +  E+E+++   H  +++L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
              +  ++  F    +V   + E+  G  EP +  V R+ +       L +LH   + +I
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLH---SKRI 130
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYL--ST 291
           IHRD+KA NVL+  + +  + DFG++      K   T Q R    GT   +APE +   T
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 292 GKSSE---RTDVFGYGIMLLEL 310
            K +    + D++  GI L+E+
Sbjct: 186 MKDTPYDYKADIWSLGITLIEM 207

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 118 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 164
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 221
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 74
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 187
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 90  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 136
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 193
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 90  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 136
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 193
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 103 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 149
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 38/234 (16%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVL---ADGTK---VAVKRLTDFESPGGDAAFQR 158
           +E+ L+   F E+  LG+  FGKVY+G L   A G +   VA+K L D         F+ 
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL---------------REI 203
           E  + +   H N++ L+G  T      +++ +  +  +   L               R +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 204 KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
           K      D+V    +    A G+EYL  H    ++H+D+   NVL+ +     + D GL 
Sbjct: 122 KSALEPPDFV---HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 264 KLV---DVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
           + V   D  K   N    +R     +APE +  GK S  +D++ YG++L E+ +
Sbjct: 176 REVYAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVE--MISVA 166
           +F+   VLG+G FGKV   +LAD  GT+   A+K L        D      VE  ++++ 
Sbjct: 20  DFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 167 VHRNLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAAR 224
                L  +  C    +RL  V  ++    + Y ++++ K  EP   +      A   + 
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISI 131
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGH 283
           GL +LH+     II+RD+K  NV+LD +    + DFG+ K  +     VTT +  GT  +
Sbjct: 132 GLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDY 186
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           IAPE ++     +  D + YG++L E++ GQ   D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 78
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 137 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 191
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 103 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 149
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 104 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 150
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 86
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 199
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 74
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 187
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 91  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 137
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 104 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 150
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 118 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 164
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 221
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 104 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 150
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 86
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 199
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 93
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 152 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 206
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 91  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 137
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 104 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 150
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 207
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 103 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 149
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 103 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 149
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 206
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+++++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T   T+   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 82
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 141 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 195
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 91  VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 137
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 194
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 110 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 156
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 213
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V     +  G K+AVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA--------LGAARGLEYL 229
            T  T        ++  +  Y +  +  G  + + V  +++             RGL+Y+
Sbjct: 119 FTPATS-------LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 170
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H   +  IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +
Sbjct: 171 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIM 223
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
                   T D++  G ++ EL+TG+
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 87
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 146 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 200
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 113 NFSEKNVLGQGGFGKVY--RGVL--ADGTKVAVKRLTDFESPGGDAAFQR-EVEMISVAV 167
           +F    VLGQG FGKV+  R V     G   A+K L        D    + E ++++   
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H  +++L     T  +  L+  F++   +  RL +    E +      K      A GL+
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALGLD 144
Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAP 286
           +LH   +  II+RD+K  N+LLDE+    + DFGL+K  +D  K   +    GT+ ++AP
Sbjct: 145 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAP 199
Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E ++    S   D + YG+++ E++TG 
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGS 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 61/110 (55%), Gaps = 10/110 (9%)
Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
           +LDW  +  +AL      +++H+    KI+HRD+K+ N+ L +D    +GDFG+A++++ 
Sbjct: 127 ILDWFVQICLAL------KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN- 176
Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
               +     GT  +++PE       + ++D++  G +L EL T + A +
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTK----VAVKRL--TDFESPGGDAAFQREVE 161
               D+F     LG+G FG VY   LA   K    VA+K L  +  E  G +   +RE+E
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIE 75
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           + +   H N+LRL  +     +R  +Y  ++        +E++      D      +   
Sbjct: 76  IQAHLHHPNILRLYNYFY---DRRRIYLILEYAPRGELYKELQ-KSCTFDEQRTATIMEE 131
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGT 280
            A  L Y H     K+IHRD+K  N+LL    E  + DFG +     +R+  +     GT
Sbjct: 132 LADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GT 184
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           + ++ PE +     +E+ D++  G++  EL+ G    +
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRN 170
           +LG GGFG VY G+ ++D   VA+K     R++D+ E P G       V +  V+     
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+            L   +P + + D++T +R AL       +  
Sbjct: 123 VIRLLDWFERPDSFVLI------------LERPEPVQDLFDFIT-ERGALQEELARSFFW 169
Query: 231 E------HC-NPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           +      HC N  ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  
Sbjct: 170 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 226
Query: 283 HIAPEYLSTGKSSERT-DVFGYGIMLLELVTG 313
           +  PE++   +   R+  V+  GI+L ++V G
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 221
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ + ++  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 79
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 138 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 192
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 102
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 161 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 215
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 115
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 119 VLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGG-DAAFQREVEMISVAVHRNLLRLI 175
           VLG G F +V+  +  L  G   A+K +   +SP   D++ + E+ ++    H N++ L 
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
               + T   LV   +    +  R+ E      V        V       ++YLHE+   
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN--- 125
Query: 236 KIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
            I+HRD+K  N+L    +E+ + ++ DFGL+K+    +  + +   GT G++APE L+  
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 293 KSSERTDVFGYGIMLLELVTG 313
             S+  D +  G++   L+ G
Sbjct: 183 PYSKAVDCWSIGVITYILLCG 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNAMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 145
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T    +   T  + APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+      L     V V R      P     F+RE +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 143
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 173 RLIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
            +      PT E++     +Q+L      + +K      D +          RGL+Y+H 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--FLYQILRGLKYIH- 146
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV--RKTNVTTQVRGTMGHIAPEYL 289
             +  ++HRD+K +N+LL+   +  + DFGLA++ D     T    +   T  + APE +
Sbjct: 147 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 290 STGKSSERT-DVFGYGIMLLELVTGQ 314
              K   ++ D++  G +L E+++ +
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 72  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 122
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 112
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 225
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 153
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 266
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRN 170
           ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H N
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 110
Query: 171 LLRLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAA 223
           ++RL  F  +  E+       LV  ++      YR+ R     +  L  +  K       
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMG 282
           R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   + NV+     +  
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 223
Query: 283 HIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           + APE +      +   DV+  G +L EL+ GQ
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+      L     V V R      P     F+RE +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 126
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 115
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 117
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 118 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 174
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+      L     V V R      P     F+RE +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 168 HRNLLRL--IGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +   G   TP   L  +V  ++  ++    LR+I   E  +       V   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 126
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +++PE         R+DV+  G +L E++TG+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 71  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 120 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 75  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 124 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKW 180
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 91  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 140 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 91  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 140 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 118
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 119 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 75  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 124 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 180
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 69  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 117
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 118 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 175 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 149
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 205
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 81  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 130 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQ--REVEM 162
            +AT  +     +G G +G VY+      G  VA+K  R+ +    GG       REV +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 163 I---SVAVHRNLLRLIGFCTTP-TER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVT 214
           +       H N++RL+  C T  T+R     LV+  +      Y  +   PG P     T
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA---ET 121
Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
            K +     RGL++LH +C   I+HRD+K  N+L+       + DFGLA++   +     
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--L 176
Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 310
           T V  T+ + APE L     +   D++  G +  E+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 120
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 11/104 (10%)
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTT 275
           ++ +   + L YL E     +IHRDVK +N+LLDE  +  + DFG++ +LVD +  + + 
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 276 QVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 314
              G   ++APE +     ++     R DV+  GI L+EL TGQ
Sbjct: 186 ---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLIL 495
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL    + + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 496 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMIS 164
           +A ++     +LG+G FG+VY GV  +  G K  VAVK      +      F  E  ++ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 165 VAVHRNLLRLIGFCTT-PTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
              H ++++LIG     PT  ++ +YP+ +   + + L   K    VL  V     +L  
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVLTLVL---YSLQI 118
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
            + + YL E  N   +HRD+   N+L+       +GDFGL++ ++       +  R  + 
Sbjct: 119 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 175
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 75/283 (26%)
Query: 102 YSWRELQLATDNFSEKNVLGQGGFGKVYR----GVLADGT--KVAVKRLTDFESPGGDAA 155
           Y   + + A +       LG+G FGKV +    G+    T   VAVK L +  +     A
Sbjct: 17  YDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKA 76
Query: 156 FQREVEMIS-VAVHRNLLRLIGFCTTPTERLLV------YPFMQN--------------- 193
              E+++++ +  H N++ L+G CT     L+V      Y  + N               
Sbjct: 77  LMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDA 136
Query: 194 -LSVAYRLREIKPG-----EPVLDWVTRKR------------------------------ 217
            L +  +  +++PG     +P LD VT                                 
Sbjct: 137 ALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPI 196
Query: 218 -------VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
                   +   ARG+E+L      K IHRD+ A N+LL E+    + DFGLA+ +    
Sbjct: 197 TMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNP 253
Query: 271 TNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
             V     R  +  +APE +     S ++DV+ YG++L E+ +
Sbjct: 254 DYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARG 225
           +R+IG C   +  L++            + E+ P    L     V  K +       + G
Sbjct: 89  VRMIGICEAESWMLVM-----------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 137
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGH 283
           ++YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +  
Sbjct: 138 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 194
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE ++  K S ++DV+ +G+++ E  + GQ+
Sbjct: 195 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 150
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 206
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 114 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           +++   +G+G +G V         T+VA+K+++ FE         RE++++    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 173 RLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
            +       T   +  VY  +Q+L      + +K  +   D +          RGL+Y+H
Sbjct: 105 GIRDILRASTLEAMRDVY-IVQDLMETDLYKLLKSQQLSNDHICY--FLYQILRGLKYIH 161
Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR--KTNVTTQVRGTMGHIAPEY 288
              +  ++HRD+K +N+L++   +  + DFGLA++ D     T   T+   T  + APE 
Sbjct: 162 ---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 289 LSTGKSSERT-DVFGYGIMLLELVTGQ 314
           +   K   ++ D++  G +L E+++ +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L+YL    N +IIHRD+K  N+LLDE     + DF +A ++  R+T +TT + GT  ++
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT-MAGTKPYM 181
Query: 285 APEYLSTGKS---SERTDVFGYGIMLLELVTGQRA 316
           APE  S+ K    S   D +  G+   EL+ G+R 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 178 CTTPTERLL----VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
             TP   L     VY  + +L  A     +K  +   D V  + +     RGL+Y+H   
Sbjct: 85  VFTPARSLEEFNDVY-LVTHLMGADLNNIVKCAKLTDDHV--QFLIYQILRGLKYIH--- 138
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTG 292
           +  IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWM 194
Query: 293 KSSERTDVFGYGIMLLELVTGQ 314
             ++  D++  G ++ EL+TG+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 143
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ 
Sbjct: 144 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 119 VLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
            +G+G FG V++G+          VA+K   +  S      F +E   +    H ++++L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 175 IGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           IG  T  P   ++    +  L    ++R+       LD  +    A   +  L YL    
Sbjct: 74  IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLESK- 127
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 293
             + +HRD+ A NVL+  +    +GDFGL++ ++       ++ +  +  +APE ++  +
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 294 SSERTDVFGYGIMLLELV 311
            +  +DV+ +G+ + E++
Sbjct: 186 FTSASDVWMFGVCMWEIL 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLIL 115
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL      + +HRD+ A NVL+       +GDFGL++ ++       ++ 
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 99
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 155
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 211
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 150
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 206
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 151
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 207
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 156
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 212
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 156
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 212
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 149
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 205
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 124
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 150
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 206
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 149
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 205
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 98
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 154
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 210
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 211 NQTVDIWSVGCIMAELLTGR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 156
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 212
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 213 NQTVDIWSVGCIMAELLTGR 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 99
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 155
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 211
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 212 NQTVDIWSVGCIMAELLTGR 231

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMIS 164
           +A ++     +LG+G FG+VY GV  +  G K  VAVK      +      F  E  ++ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 165 VAVHRNLLRLIGFCTT-PTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
              H ++++LIG     PT  ++ +YP+ +   + + L   K    VL  V     +L  
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVLTLVL---YSLQI 122
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
            + + YL E  N   +HRD+   N+L+       +GDFGL++ ++       +  R  + 
Sbjct: 123 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 120 LGQGGFGKVYRGVLADGT-KVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G F  VY+G+  + T +VA   L D + +      F+ E E +    H N++R    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 178 ---------CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
                    C      L     ++     +++ +IK    VL    R+ +     +GL++
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK----VLRSWCRQIL-----KGLQF 144
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           LH    P IIHRD+K  N+ +     +V +GD GLA L   ++ +    V GT    APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPE 200
Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
                K  E  DV+ +G   LE  T +
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSE 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 85
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 141
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 197
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMIS 164
           +A ++     +LG+G FG+VY GV  +  G K  VAVK      +      F  E  ++ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 165 VAVHRNLLRLIGFCTT-PTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
              H ++++LIG     PT  ++ +YP+ +   + + L   K    VL  V     +L  
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVLTLVL---YSLQI 134
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
            + + YL E  N   +HRD+   N+L+       +GDFGL++ ++       +  R  + 
Sbjct: 135 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 191
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 192 WMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 146
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 202
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 146
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 202
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 85
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 141
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 197
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 198 NQTVDIWSVGCIMAELLTGR 217

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           R LQ+  +++    V+G+G FG+V         KV A+K L+ FE       A F  E +
Sbjct: 68  RGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +++ A    +++L  FC    ++ L           Y + E  PG  +++ ++   V   
Sbjct: 128 IMAFANSPWVVQL--FCAFQDDKYL-----------YMVMEYMPGGDLVNLMSNYDVPEK 174
Query: 222 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
            A+         L+ +H      +IHRDVK  N+LLD+     + DFG    +D      
Sbjct: 175 WAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH 231
Query: 274 TTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQ 314
                GT  +I+PE L +    G      D +  G+ L E++ G 
Sbjct: 232 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 276

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 149
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 205
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 206 NQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 87
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 143
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 199
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 200 NQTVDIWSVGCIMAELLTGR 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 150
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 206
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 207 NQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 140
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 196
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 146
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 202
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 146
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 202
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 203 NQTVDIWSVGCIMAELLTGR 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 107
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 163
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 219
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 162
           R+L++  +++    V+G+G FG+V         KV A+K L+ FE     D+AF  E   
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           I           + F  +P    L Y F Q+    Y + E  PG  +++ ++   V    
Sbjct: 122 I-----------MAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 169
Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L+ +H       IHRDVK  N+LLD+     + DFG    ++       
Sbjct: 170 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 275 TQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQ 314
               GT  +I+PE L +    G      D +  G+ L E++ G 
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 162
           R+L++  +++    V+G+G FG+V         KV A+K L+ FE     D+AF  E   
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           I           + F  +P    L Y F Q+    Y + E  PG  +++ ++   V    
Sbjct: 127 I-----------MAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 174
Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L+ +H       IHRDVK  N+LLD+     + DFG    ++       
Sbjct: 175 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 231
Query: 275 TQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQ 314
               GT  +I+PE L +    G      D +  G+ L E++ G 
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 164
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 220
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 162
           R+L++  +++    V+G+G FG+V         KV A+K L+ FE     D+AF  E   
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           I           + F  +P    L Y F Q+    Y + E  PG  +++ ++   V    
Sbjct: 127 I-----------MAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 174
Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L+ +H       IHRDVK  N+LLD+     + DFG    ++       
Sbjct: 175 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 231
Query: 275 TQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQ 314
               GT  +I+PE L +    G      D +  G+ L E++ G 
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 140
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 196
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 107
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 163
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 219
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 220 NQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 111
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 167
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 223
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 86
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 142
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE +      
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 198
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 199 NQTVDIWSVGCIMAELLTGR 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 164
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D   T        T  + APE  L+    
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 220
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 119 VLGQGGFGKVYRG-------VLADGTKVAVKRLTDFESPGGDAA--------FQREVEMI 163
            L QG F K+           L    K  +++  DF     D          F+ E+++I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV----AYRLREIKPGEPVLDWVTRKRVA 219
           +   +   L   G  T   E  ++Y +M+N S+     Y     K     +     K + 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
                   Y+H   N  I HRDVK +N+L+D++    + DFG ++ +  +K   +   RG
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RG 212
Query: 280 TMGHIAPEYLSTGKSSE--RTDVFGYGIML 307
           T   + PE+ S   S    + D++  GI L
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVK--RLTDFESPGGDAA--FQREVEMI 163
           L  D +    V+G+G F  V R +  + G + AVK   +  F S  G +    +RE  + 
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
            +  H +++ L+   ++     +V+ FM    + + + +      V              
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVR-G 279
             L Y H++    IIHRDVK  NVLL   +      +GDFG+A  + + ++ +    R G
Sbjct: 141 EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVG 195
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T   +APE +      +  DV+G G++L  L++G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 20/121 (16%)
Query: 206 GEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 257
           G  + D VT  R        V L   R L YLH   N  +IHRD+K+ ++LL  D    +
Sbjct: 126 GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKL 182
Query: 258 GDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            DFG    ++K V  RK  V     GT   +APE +S        D++  GIM++E++ G
Sbjct: 183 SDFGFCAQVSKEVPKRKXLV-----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237
Query: 314 Q 314
           +
Sbjct: 238 E 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKEIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFGLAK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRL---TDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           LG+G +G VY+ +  + G  VA+K++   +D +         +E+ ++      ++++  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQCDSPHVVKYY 90
Query: 176 GFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 233
           G     T+  +V  +    SV+   RLR     E  +  + +  +     +GLEYLH   
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-----KGLEYLHFM- 144
Query: 234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVRGTMGHIAPEYLST 291
             + IHRD+KA N+LL+ +  A + DFG+A +L D + K N    V GT   +APE +  
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX---VIGTPFWMAPEVIQE 199
Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
              +   D++  GI  +E+  G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKEIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFGLAK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQR 158
           S R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 159 EVEMISVAVHRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           E   +    H ++++LIG  T  P   ++    +  L    ++R+       LD  +   
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLIL 495
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
            A   +  L YL    + + +HRD+ A NVL+       +GDFGL++ ++       ++ 
Sbjct: 496 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +  +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 4/136 (2%)
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           ++HRD+K ANV LD      +GDFGLA++++   T+      GT  +++PE ++    +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 297 RTDVFGYGIMLLELVTGQRAID-FSRXXXXXXXXXXXXXXXXXR-EKRLDAIVDRNLN-K 353
           ++D++  G +L EL         FS+                 R    L+ I+ R LN K
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 354 NYNIQEVETMIQVALL 369
           +Y+   VE +++  L+
Sbjct: 256 DYHRPSVEEILENPLI 271

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V     A    KVAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------VALGAARGLEY 228
            T  T        +++ S  Y +  +   +  L+ + + +         +     RGL+Y
Sbjct: 96  FTPATS-------IEDFSEVYLVTTLMGAD--LNNIVKSQALSDEHVQFLVYQLLRGLKY 146
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE- 287
           +H   +  IIHRD+K +NV ++ED E  + DFGLA+  D   T        T  + APE 
Sbjct: 147 IH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----ATRWYRAPEI 199
Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            L+    ++  D++  G ++ EL+ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 4/136 (2%)
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           ++HRD+K ANV LD      +GDFGLA++++   T+      GT  +++PE ++    +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNRMSYNE 195
Query: 297 RTDVFGYGIMLLELVTGQRAID-FSRXXXXXXXXXXXXXXXXXR-EKRLDAIVDRNLN-K 353
           ++D++  G +L EL         FS+                 R    L+ I+ R LN K
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 354 NYNIQEVETMIQVALL 369
           +Y+   VE +++  L+
Sbjct: 256 DYHRPSVEEILENPLI 271

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            LG+G  G+V   V       VAVK +    +       ++E+ +  +  H N+++  G 
Sbjct: 13  TLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                E  + Y F++  S       I+P  G P  D    +R       G+ YLH     
Sbjct: 73  ---RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---AQRFFHQLMAGVVYLH---GI 123
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGK- 293
            I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 294 SSERTDVFGYGIMLLELVTGQRAID 318
            +E  DV+  GI+L  ++ G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V     A    KVAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALGAARGLEY 228
            T  T        +++ S  Y +  +   +  L+ + +         + +     RGL+Y
Sbjct: 88  FTPATS-------IEDFSEVYLVTTLMGAD--LNNIVKCQALSDEHVQFLVYQLLRGLKY 138
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE- 287
           +H   +  IIHRD+K +NV ++ED E  + DFGLA+  D   T        T  + APE 
Sbjct: 139 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV----ATRWYRAPEI 191
Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            L+    ++  D++  G ++ EL+ G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + D+GLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGL +  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 17/216 (7%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           ++  +NF    VLG G +GKV+      G      +L   +        Q+         
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTG--KLYAMKVLKKATIVQKAKTTEHTRT 107
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR--- 224
            R +L  I    +P    L Y F     +   L  I  GE       R+R      +   
Sbjct: 108 ERQVLEHI--RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 165
Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
                 LE+LH+     II+RD+K  N+LLD +   V+ DFGL+K     +T       G
Sbjct: 166 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 280 TMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 313
           T+ ++AP+ +  G S   +  D +  G+++ EL+TG
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 114 FSEKNVLGQGGFGKVYRGVL-ADGTKVAVK-------RLTDFESPGGDAAFQREVEMI-S 164
           +  K+V+G+G    V R V  A G + AVK       RL+  +      A +RE  ++  
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
           VA H +++ LI    + +   LV+  M+             GE + D++T K VAL    
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRK------------GE-LFDYLTEK-VALSEKE 201
Query: 225 ----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
                      + +LH +    I+HRD+K  N+LLD++ +  + DFG +    +      
Sbjct: 202 TRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKL 256
Query: 275 TQVRGTMGHIAPEYLSTGKSS------ERTDVFGYGIMLLELVTG 313
            ++ GT G++APE L            +  D++  G++L  L+ G
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L Y F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L Y F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L Y F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     +G G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  + DFGLA+  D            T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 120 LGQGGFGKVYRGVLADGTK-VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL---- 174
           LG GG G V+  V  D  K VA+K++     P       RE+++I    H N++++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 175 ----------IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
                     +G  T      +V  +M+       L  +    P+L+   R        R
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMET-----DLANVLEQGPLLEEHAR-LFMYQLLR 131
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TM 281
           GL+Y+H   +  ++HRD+K AN+ ++ ED    +GDFGLA+++D   ++      G  T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 282 GHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            + +P   LS    ++  D++  G +  E++TG+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     +G G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D            T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 151
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+       +  T    T  + APE  L+    
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V     A    KVAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALGAARGLEY 228
            T  T        +++ S  Y +  +   +  L+ + +         + +     RGL+Y
Sbjct: 96  FTPATS-------IEDFSEVYLVTTLMGAD--LNNIVKCQALSDEHVQFLVYQLLRGLKY 146
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE- 287
           +H   +  IIHRD+K +NV ++ED E  + DFGLA+  D   T        T  + APE 
Sbjct: 147 IH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----ATRWYRAPEI 199
Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            L+    ++  D++  G ++ EL+ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 151
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+       +  T    T  + APE  L+    
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 151
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+       +  T    T  + APE  L+    
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 140
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D            T  + APE  L+    
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHY 196
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA----- 223
            N++RL       +   LV+  +              GE   D V R+  +   A     
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTG------------GELFEDIVAREFYSEADASHCIQ 111
Query: 224 ---RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQV 277
                + Y H +    I+HR++K  N+LL    +     + DFGLA  ++V  +      
Sbjct: 112 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGF 166
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT G+++PE L     S+  D++  G++L  L+ G
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 76
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 135
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 136 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTP 188
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 120 LGQGGFGKVY---RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG G +G+V      V      + + R T   S   ++    EV ++ +  H N+++L  
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKL-- 101
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR--KRVALGAA-------RGLE 227
                      Y F ++    Y + E   G  + D +    K   + AA        G+ 
Sbjct: 102 -----------YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 228 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           YLH+H    I+HRD+K  N+LL   ++D    + DFGL+ + + +K     +  GT  +I
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYI 205
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTG 313
           APE L   K  E+ DV+  G++L  L+ G
Sbjct: 206 APEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA----- 223
            N++RL       +   LV+  +              GE   D V R+  +   A     
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTG------------GELFEDIVAREFYSEADASHCIQ 112
Query: 224 ---RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQV 277
                + Y H +    I+HR++K  N+LL    +     + DFGLA  ++V  +      
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGF 167
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT G+++PE L     S+  D++  G++L  L+ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 172 LRLIGFCTTPTERLLVY-----PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
           +R+IG C   +  L++      P  + L     +++    + +++ V +       + G+
Sbjct: 433 VRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQ------VSMGM 482
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
           +YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +   
Sbjct: 483 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 539
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRA 316
           APE ++  K S ++DV+ +G+++ E  + GQ+ 
Sbjct: 540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREV----EMISVAVHRNL 171
           E   LG G FG V +G       V    +   ++   D A + E+     ++    +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 172 LRLIGFCTTPTERLLVY-----PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
           +R+IG C   +  L++      P  + L     +++    + +++ V +       + G+
Sbjct: 434 VRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQ------VSMGM 483
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHI 284
           +YL E      +HRD+ A NVLL     A + DFGL+K +   +     Q  G   +   
Sbjct: 484 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 540
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRA 316
           APE ++  K S ++DV+ +G+++ E  + GQ+ 
Sbjct: 541 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 111
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 167
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D            T  + APE  L+    
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV----ATRWYRAPEIMLNWMHY 223
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 224 NQTVDIWSVGCIMAELLTGR 243

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R     AR     
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     +G G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA----- 223
            N++RL       +   LV+  +              GE   D V R+  +   A     
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTG------------GELFEDIVAREFYSEADASHCIQ 112
Query: 224 ---RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQV 277
                + Y H +    I+HR++K  N+LL    +     + DFGLA  ++V  +      
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGF 167
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT G+++PE L     S+  D++  G++L  L+ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 4/136 (2%)
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           ++HRD+K ANV LD      +GDFGLA++++    +   +  GT  +++PE ++    +E
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAKEFVGTPYYMSPEQMNRMSYNE 195
Query: 297 RTDVFGYGIMLLELVTGQRAID-FSRXXXXXXXXXXXXXXXXXR-EKRLDAIVDRNLN-K 353
           ++D++  G +L EL         FS+                 R    L+ I+ R LN K
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 354 NYNIQEVETMIQVALL 369
           +Y+   VE +++  L+
Sbjct: 256 DYHRPSVEEILENPLI 271

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 99/268 (36%), Gaps = 73/268 (27%)
Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +F     +G+GGFG V+      D    A+KR+             REV+ ++   H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 172 LRLI-GFCTTPTER-----------------LLVYPF-----------MQNLSVAYRLRE 202
           +R    +  TP E+                  L  P            M   S    + +
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 203 IKPGEPVL---------------DWVTRK------------RVALGAARGLEYLHEHCNP 235
           ++P  P +               DW+ R+             + +  A  +E+LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK--- 183
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT------------QVRGTMGH 283
            ++HRD+K +N+    D    VGDFGL   +D  +   T             QV GT  +
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV-GTKLY 242
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELV 311
           ++PE +     S + D+F  G++L EL+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 164
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DFGLA+  D            T  + APE  L+    
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV----ATRWYRAPEIMLNWMHY 220
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 221 NQTVDIWSVGCIMAELLTGR 240

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +I
Sbjct: 133 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 188
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           APE L         D +  G+++ E++ G+   D
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +I
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           APE L         D +  G+++ E++ G+   D
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +I
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 177
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           APE L         D +  G+++ E++ G+   D
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 53/221 (23%)
Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            VLGQG FGKV+           VK+++     G DA   R++  + V + +  L++   
Sbjct: 30  KVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATLKVRDR 70
Query: 178 CTTPTERLLV----YPFMQNLSVAYR--------LREIKPGEPVLDWVTR--KRVALGA- 222
             T  ER ++    +PF+  L  A++        L  ++ G    D  TR  K V     
Sbjct: 71  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSKEVMFTEE 126
Query: 223 ---------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTN 272
                    A  L++LH   +  II+RD+K  N+LLDE+    + DFGL+K  +D  K  
Sbjct: 127 DVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +    GT+ ++APE ++    ++  D + +G+++ E++TG
Sbjct: 184 YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALG 221
             R++     P    L + F  N S  Y + E  PG  +   + R         +  A  
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T+   GT  +I
Sbjct: 118 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 173
Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           APE L         D +  G+++ E++ G+   D
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALG 221
             R++     P    L + F  N S  Y + E  PG  +   + R         +  A  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 53/221 (23%)
Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            VLGQG FGKV+           VK+++     G DA   R++  + V + +  L++   
Sbjct: 30  KVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATLKVRDR 70
Query: 178 CTTPTER-LLV---YPFMQNLSVAYR--------LREIKPGEPVLDWVTR--KRVALGA- 222
             T  ER +LV   +PF+  L  A++        L  ++ G    D  TR  K V     
Sbjct: 71  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSKEVMFTEE 126
Query: 223 ---------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTN 272
                    A  L++LH   +  II+RD+K  N+LLDE+    + DFGL+K  +D  K  
Sbjct: 127 DVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +    GT+ ++APE ++    ++  D + +G+++ E++TG
Sbjct: 184 YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R     AR     
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALG 221
             R++     P    L + F  N S  Y + E  PG  +   + R         +  A  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 202
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 53/221 (23%)
Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
            VLGQG FGKV+           VK+++     G DA   R++  + V + +  L++   
Sbjct: 31  KVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATLKVRDR 71
Query: 178 CTTPTER-LLV---YPFMQNLSVAYR--------LREIKPGEPVLDWVTR--KRVALGA- 222
             T  ER +LV   +PF+  L  A++        L  ++ G    D  TR  K V     
Sbjct: 72  VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSKEVMFTEE 127
Query: 223 ---------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTN 272
                    A  L++LH   +  II+RD+K  N+LLDE+    + DFGL+K  +D  K  
Sbjct: 128 DVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 184
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +    GT+ ++APE ++    ++  D + +G+++ E++TG
Sbjct: 185 YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGVLAD---GTKVAVK--RLTDFESPGGDAAFQREVE 161
            Q  +D +     LG G +G+V   +  D   G + A+K  + +   +     A   EV 
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVA 73
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT--RKRVA 219
           ++    H N+++L             Y F ++    Y + E+  G  + D +   +K   
Sbjct: 74  VLKQLDHPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE 120
Query: 220 LGAA-------RGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKLVDVR 269
           + AA        G  YLH+H    I+HRD+K  N+LL+    D    + DFGL+   +V 
Sbjct: 121 VDAAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV- 176
Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
                 +  GT  +IAPE L   K  E+ DV+  G++L  L+ G
Sbjct: 177 -GGKMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 111 TDNFSEKNVLGQGGFGKVY--RGVLADGTKVAVK--RLTDFESPGGDAAFQREVEMISVA 166
           +D +     LG G +G+V   +  L  G + A+K  + +   +     A   EV ++   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT--RKRVALGAA- 223
            H N+++L             Y F ++    Y + E+  G  + D +   +K   + AA 
Sbjct: 62  DHPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV 108
Query: 224 ------RGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKLVDVRKTNVT 274
                  G  YLH+H    I+HRD+K  N+LL+    D    + DFGL+   +V      
Sbjct: 109 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV--GGKM 163
Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +  GT  +IAPE L   K  E+ DV+  G++L  L+ G
Sbjct: 164 KERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 83
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 142
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 195
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            IIHRD+K +N+ ++ED E  +  FGLA+  D   T        T  + APE +      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 296 ERT-DVFGYGIMLLELVTGQ 314
            +T D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + DF LA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 120 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
           LG G FG V+R V     +V V +  +   P      + E+ +++   H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 180 TPTERLLVYPFMQN-------LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
              E +L+  F+          +  Y++ E +    V++++ +      A  GL+++HEH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VINYMRQ------ACEGLKHMHEH 168
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVG--DFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYL 289
               I+H D+K  N++ +    + V   DFGLA KL       VTT    T    APE +
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 290 STGKSSERTDVFGYGIMLLELVTG 313
                   TD++  G++   L++G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA----- 223
            N++RL       +   LV+  +              GE   D V R+  +   A     
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTG------------GELFEDIVAREFYSEADASHCIQ 135
Query: 224 ---RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQV 277
                + Y H +    I+HR++K  N+LL    +     + DFGLA  ++V  +      
Sbjct: 136 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGF 190
Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            GT G+++PE L     S+  D++  G++L  L+ G
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + D GLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVEM 162
           +N+  K +LG+G    V R +     K    ++ D    G  +A +         +EV++
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 163 I-SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +  V+ H N+++L     T T   LV+  M            K GE + D++T K V L 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLM------------KKGE-LFDYLTEK-VTLS 109
Query: 222 AARG-------LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
                      LE +       I+HRD+K  N+LLD+D    + DFG +  +D  +    
Sbjct: 110 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--L 167
Query: 275 TQVRGTMGHIAPEYLSTGKSS------ERTDVFGYGIMLLELVTGQ 314
            +V GT  ++APE +    +       +  D++  G+++  L+ G 
Sbjct: 168 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  + F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKIL------------KKEVIVA 191
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   L   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 192 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE-LFFHLSRERVFSE 250
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++   
Sbjct: 251 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGA 307
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 308 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 111
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R++     P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 223
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 120 LGQGGFGKVYRGVLADGTK-VAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G V++    +  + VA+KR+  D +  G  ++  RE+ ++    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 178 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
             +  +  LV+ F  Q+L   +   +   G+  LD    K       +GL + H      
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYF---DSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS 295
           ++HRD+K  N+L++ + E  + DFGLA+   +     + +V  T+ +  P+ L   K  S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 296 ERTDVFGYGIMLLELVTGQRAI 317
              D++  G +  EL    R +
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  + F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKIL------------KKEVIVA 188
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   L   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE-LFFHLSRERVFSE 247
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++   
Sbjct: 248 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGA 304
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + D GLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 125
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 126 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 177
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 134
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 135 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 186
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 187 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 119 VLGQGGFGKV-----YRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNL 171
            LG G FGKV     Y  + +D    VAVK L          A   E++++S +  H N+
Sbjct: 48  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 107
Query: 172 LRLIGFCTT--PTERLLVY-------PFMQNLSVAYRLREIKPG-----EPVLDWVTRKR 217
           + L+G CT   PT  +  Y        F++    ++   +  P      E  LD      
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 218 VALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---V 273
            +   A+G+ +L  ++C    IHRD+ A N+LL       + DFGLA+  D++  +   V
Sbjct: 168 FSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVV 221
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
               R  +  +APE +     +  +DV+ YGI L EL +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 119 VLGQGGFGKV-----YRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNL 171
            LG G FGKV     Y  + +D    VAVK L          A   E++++S +  H N+
Sbjct: 46  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 105
Query: 172 LRLIGFCTT--PTERLLVY-------PFMQNLSVAYRLREIKPG-----EPVLDWVTRKR 217
           + L+G CT   PT  +  Y        F++    ++   +  P      E  LD      
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 218 VALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---V 273
            +   A+G+ +L  ++C    IHRD+ A N+LL       + DFGLA+  D++  +   V
Sbjct: 166 FSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVV 219
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
               R  +  +APE +     +  +DV+ YGI L EL +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 83
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR---------KRVALG 221
             R++     P    L + F  N S  Y + E  PG  +   + R         +  A  
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 142
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTP 195
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  + F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKIL------------KKEVIVA 49
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   L   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 50  KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE-LFFHLSRERVFSE 108
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++   
Sbjct: 109 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGA 165
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 166 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  + F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKIL------------KKEVIVA 50
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   L   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 51  KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE-LFFHLSRERVFSE 109
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++   
Sbjct: 110 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGA 166
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 167 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 108 QLATDNFSEKNVLGQGGFGKV-----YRGVLADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +  S    LG G FGKV     Y  + +D    VAVK L          A   E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTT--PTERLLVY-------PFMQNLSVAYRLREIKPG----- 206
           ++S +  H N++ L+G CT   PT  +  Y        F++    ++   +  P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 207 EPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
           E  LD       +   A+G+ +L  ++C    IHRD+ A N+LL       + DFGLA+ 
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR- 216
Query: 266 VDVRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            D++  +   V    R  +  +APE +     +  +DV+ YGI L EL +
Sbjct: 217 -DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  + F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKIL------------KKEVIVA 48
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   L   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 49  KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE-LFFHLSRERVFSE 107
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++   
Sbjct: 108 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGA 164
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 165 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVEM 162
           +N+  K +LG+G    V R +     K    ++ D    G  +A +         +EV++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 163 I-SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +  V+ H N+++L     T T   LV+  M            K GE + D++T K V L 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLM------------KKGE-LFDYLTEK-VTLS 122
Query: 222 AARG-------LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
                      LE +       I+HRD+K  N+LLD+D    + DFG +  +D  +    
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--L 180
Query: 275 TQVRGTMGHIAPEYLSTGKSS------ERTDVFGYGIMLLELVTGQ 314
            +V GT  ++APE +    +       +  D++  G+++  L+ G 
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 129
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 130 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 181
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 182 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 136
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 137 LQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 188
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 189 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G G +G V        G +VAVK+L+  F+S        RE+ ++    H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 178 CTTPTERLLVYP--FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             TP   L  +   ++    +   L  I   + + D   +  +     RGL+Y+H   + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SA 144
Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKS 294
            IIHRD+K +N+ ++ED E  + D GLA+  D   T        T  + APE  L+    
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 200
Query: 295 SERTDVFGYGIMLLELVTGQ 314
           ++  D++  G ++ EL+TG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 119 VLGQGGFGKV-----YRGVLADGT-KVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNL 171
            LG G FGKV     Y  + +D    VAVK L          A   E++++S +  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 172 LRLIGFCTT--PTERLLVY-------PFMQNLSVAYRLREIKPG-----EPVLDWVTRKR 217
           + L+G CT   PT  +  Y        F++    ++   +  P      E  LD      
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 218 VALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---V 273
            +   A+G+ +L  ++C    IHRD+ A N+LL       + DFGLA+  D++  +   V
Sbjct: 150 FSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVV 203
Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
               R  +  +APE +     +  +DV+ YGI L EL +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR----- 224
             R+      P    L + F  N S  Y + E  PG  +   + R  R +   AR     
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDN-SNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
                EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTP 203
Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 108 QLATDNFSEKNVLGQGGFGKV-----YRGVLADGT-KVAVKRLTDFESPGGDAAFQREVE 161
           +   +  S    LG G FGKV     Y  + +D    VAVK L          A   E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 162 MIS-VAVHRNLLRLIGFCTT--PTERLLVY-------PFMQNLSVAYRLREIKPG----- 206
           ++S +  H N++ L+G CT   PT  +  Y        F++    ++   +  P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 207 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 266
           E  LD       +   A+G+ +L    +   IHRD+ A N+LL       + DFGLA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 267 DVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
                 V     R  +  +APE +     +  +DV+ YGI L EL +
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 120 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G V++    D G  VA+K+  + E  P       RE+ M+    H NL+ L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
                   LV+ +  + +V + L   + G P       K +     + + + H+H     
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH---LVKSITWQTLQAVNFCHKH---NC 123
Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 296
           IHRDVK  N+L+ +     + DFG A+L+         +V  T  + +PE L    +   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGP 182
Query: 297 RTDVFGYGIMLLELVTG 313
             DV+  G +  EL++G
Sbjct: 183 PVDVWAIGCVFAELLSG 199

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)
Query: 117 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           + VL +GGF  VY    +  G + A+KRL   E     A  Q    M  ++ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 176 GFCTTPT-----------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
            FC+  +           E LL+    +   V + L++++   P L   T  ++     R
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEF-LKKMESRGP-LSCDTVLKIFYQTCR 147
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---------VRKTNVTT 275
            ++++H    P IIHRD+K  N+LL       + DFG A  +           R+  V  
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 276 QV--RGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXX 330
           ++    T  +  PE +   S     E+ D++  G +L  L   Q   +            
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE------------ 254
Query: 331 XXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQV------ALLCTQASPEDRPAMSEV 384
                        D    R +N  Y+I   +T   V      A+L  Q +PE+R +++EV
Sbjct: 255 -------------DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAML--QVNPEERLSIAEV 299
Query: 385 VRMLE 389
           V  L+
Sbjct: 300 VHQLQ 304

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVEM 162
           +N+  K +LG+G    V R +     K    ++ D    G  +A +         +EV++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 163 I-SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +  V+ H N+++L     T T   LV+  M            K GE + D++T K V L 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLM------------KKGE-LFDYLTEK-VTLS 122
Query: 222 AARG-------LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
                      LE +       I+HRD+K  N+LLD+D    + DFG +  +D  +    
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--L 180
Query: 275 TQVRGTMGHIAPEYLSTGKSS------ERTDVFGYGIMLLELVTGQ 314
             V GT  ++APE +    +       +  D++  G+++  L+ G 
Sbjct: 181 RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVD---VRKTNVTTQ- 276
           A  GLEYLH     +I+H DVKA NVLL  D   A + DFG A  +    + K+ +T   
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + GT  H+APE +       + DV+    M+L ++ G
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 179
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 180 LQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 231
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 112 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF +   +G+G  G V    V + G  VAVK++ D            EV ++    H N
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 222
           ++ +        E  +V  F++             G  + D VT  R        V L  
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 256
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 278
            + L  LH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     
Sbjct: 257 LQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----- 308
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           GT   +APE +S        D++  GIM++E+V G+
Sbjct: 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 50
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 51  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 109
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 110 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 165
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 166 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 1/82 (1%)
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           II+RD+K  NV+LD +    + DFG+ K  ++     T    GT  +IAPE ++     +
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK 521
Query: 297 RTDVFGYGIMLLELVTGQRAID 318
             D + +G++L E++ GQ   +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFE 543

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVD---VRKTNVTTQ- 276
           A  GLEYLH     +I+H DVKA NVLL  D   A + DFG A  +    + K+ +T   
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + GT  H+APE +       + D++    M+L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVD---VRKTNVTTQ- 276
           A  GLEYLH     +I+H DVKA NVLL  D   A + DFG A  +    + K+ +T   
Sbjct: 173 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + GT  H+APE +       + D++    M+L ++ G
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVD---VRKTNVTTQ- 276
           A  GLEYLH     +I+H DVKA NVLL  D   A + DFG A  +    + K+ +T   
Sbjct: 175 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + GT  H+APE +       + D++    M+L ++ G
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRNLL 172
           ++   V+G G FG V++  L +  +VA+K++        D  F+ RE++++ +  H N++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVV 95
Query: 173 RLIGFCTTPTERL------LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAARG 225
            L  F  +  ++       LV  ++      YR  R     +  +  +  K       R 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           L Y+H      I HRD+K  N+LLD     + + DFG AK++   + NV+     +  + 
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYR 208
Query: 285 APEYL-STGKSSERTDVFGYGIMLLELVTGQ 314
           APE +      +   D++  G ++ EL+ GQ
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 45
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 104
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 161 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 1/82 (1%)
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
           II+RD+K  NV+LD +    + DFG+ K  ++     T    GT  +IAPE ++     +
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK 200
Query: 297 RTDVFGYGIMLLELVTGQRAID 318
             D + +G++L E++ GQ   +
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 111 TDNFSEKNVLGQGGFGKVYR----GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
           +D F  ++ LG+G    VYR    G         +K+  D          + E+ ++   
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRL 105
Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            H N+++L     TPTE  LV   +    +  R+ E         + + +  A    + L
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-------KGYYSERDAADAVKQIL 158
Query: 227 E---YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
           E   YLHE+    I+HRD+K  N+L      D    + DFGL+K+V+ +    T  V GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGT 213
Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            G+ APE L         D++  GI+   L+ G
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 77
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 137
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+DE     V DFG AK V  R    T  + GT  
Sbjct: 138 VLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPE 190
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V     +  G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R A   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 121 GQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
            QG     +  VL  G  VAVK+L+  F++        RE+ ++    H+N++ L+    
Sbjct: 34  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN-VF 90
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPK 236
           TP + L  +   Q++ +   L +    + +   +  +R++    +   G+++LH   +  
Sbjct: 91  TPQKTLEEF---QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 144
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSS 295
           IIHRD+K +N+++  D    + DFGLA+      TN + T    T  + APE +      
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 296 ERTDVFGYGIMLLELVTG 313
           E  D++  G ++ ELV G
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 118 NVLGQGGFGKVYRGVLADGTKV-----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           ++LG+G +GKV + VL   T        +K+      P G+A  ++E++++    H+N++
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-------- 224
           +L+       E+  +Y  M+       ++E+      LD V  KR  +  A         
Sbjct: 70  QLVDVLYN-EEKQKMYMVMEYCVCG--MQEM------LDSVPEKRFPVCQAHGYFCQLID 120
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           GLEYLH      I+H+D+K  N+LL       +   G+A+ +     + T +        
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 285 APEYLSTGK---SSERTDVFGYGIMLLELVTG 313
            P  ++ G    S  + D++  G+ L  + TG
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 45
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 104
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 161 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 7/162 (4%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTD-FESPGGDAAFQREVEMISVAVHR 169
           DN+  K+++G+G +G VY     +  K VA+K++   FE         RE+ +++     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVA-YRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
            ++RL      P + L        L +A   L+++      L     K +      G ++
Sbjct: 88  YIIRLHDL-IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           +HE     IIHRD+K AN LL++D    + DFGLA+ ++  K
Sbjct: 147 IHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 45
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 104
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLV--DVRKTNVTT--Q 276
           A  GLEYLH     +I+H DVKA NVLL  D   A + DFG A  +  D    ++ T   
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + GT  H+APE +       + DV+    M+L ++ G
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 45
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 104
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 161 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 45
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 46  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 104
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 120 LGQGGFGKVYRGVLADGTK-VAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G +G V++    +  + VA+KR+  D +  G  ++  RE+ ++    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 178 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
             +  +  LV+ F  Q+L   +   +   G+  LD    K       +GL + H      
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYF---DSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS 295
           ++HRD+K  N+L++ + E  + +FGLA+   +     + +V  T+ +  P+ L   K  S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 296 ERTDVFGYGIMLLELVTGQRAI 317
              D++  G +  EL    R +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRG 279
           + L YLH      +IHRD+K+ ++LL  D    + DFG    ++K V  RK  V     G
Sbjct: 152 QALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-----G 203
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           T   +APE +S    +   D++  GIM++E+V G+
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           ++  ++F    +LG+G FGKV   +L    A G   A+K L            ++EV + 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKIL------------RKEVIIA 48
Query: 164 SVAVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-- 219
              V   +   R++     P    L Y F  +  + + +     GE +   ++R+RV   
Sbjct: 49  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-LFFHLSRERVFTE 107
Query: 220 -----LGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 GA     LEYLH      +++RD+K  N++LD+D    + DFGL K   +    
Sbjct: 108 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 163
Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 GT  ++APE L         D +G G+++ E++ G+
Sbjct: 164 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A  L YLH      I++RD+K  N+LLD     V+ DFGL K  ++   + T+   GT  
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE L         D +  G +L E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVH 168
           TD++     LG+G F  V R V    T+    ++ + +  S       +RE  +  +  H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA----- 223
            N++RL    +      LV+  +              GE   D V R+  +   A     
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTG------------GELFEDIVAREYYSEADASHCIH 137
Query: 224 ---RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVR-KTNVTTQ 276
                + ++H+H    I+HRD+K  N+LL    +     + DFGLA  ++V+ +      
Sbjct: 138 QILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFG 192
Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             GT G+++PE L      +  D++  G++L  L+ G
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 8/172 (4%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTD-FESPGGDAAFQREVEMISVAV 167
             DN+  K+++G+G +G VY     +  K VA+K++   FE         RE+ +++   
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVA-YRLREIKPGEPVLDWVTRKRVALGAARGL 226
              ++RL      P + L        L +A   L+++      L     K +      G 
Sbjct: 84  SDYIIRLYDLII-PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-TNVTTQV 277
            ++HE     IIHRD+K AN LL++D    V DFGLA+ ++  K TN+   +
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 91
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 152 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 204
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 110 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           + D +     LG+G +G+VY+ +       VA+KR+  + E  G      REV ++    
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           HRN++ L           L++ + +N      L++     P +     K        G+ 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-----DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 228 YLHEHCNPKIIHRDVKAANVLL-----DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           + H     + +HRD+K  N+LL      E     +GDFGLA+   +     T ++  T+ 
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLW 202
Query: 283 HIAPEYLSTGKS-SERTDVFGYGIMLLELV 311
           +  PE L   +  S   D++    +  E++
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++ V  H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G+++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 120 LGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           LGQG F K+++GV  +         T+V +K L D        +F     M+S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +   G C    E +LV  F++  S+   L++ K    +L W  +  VA   A  + +L E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEE 131
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH----IAPE 287
           +    +IH +V A N+LL  + +   G+    KL D    ++T   +  +      + PE
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD-PGISITVLPKDILQERIPWVPPE 187
Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTG 313
            +   K+ +  TD + +G  L E+ +G
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTT 275
           ++A+   + LE+LH   +  +IHRDVK +NVL++   +  + DFG++  LVD     +  
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 276 QVRGTMG--HIAPEYLSTGKSSERTDVFGYGIMLLEL 310
             +  M    I PE    G S  ++D++  GI ++EL
Sbjct: 215 GCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIEL 250

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 120 LGQGGFGKVYRGV-----LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLR 173
           LG+G F    + V      A   K+  KR+        +A  Q+E+  + +   H N+++
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRM--------EANTQKEITALKLCEGHPNIVK 70
Query: 174 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEH 232
           L           LV   +    +  R+++ K   E    ++ RK V+      + ++H+ 
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD- 124
Query: 233 CNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
               ++HRD+K  N+L    +++ E  + DFG A+L       + T    T+ + APE L
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELL 181
Query: 290 STGKSSERTDVFGYGIMLLELVTGQ 314
           +     E  D++  G++L  +++GQ
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 16/116 (13%)
Query: 210 LDWVTRKRVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLA 263
           LD+V R+++     R     L YLH   N  I HRD+K  N L   ++ FE  + DFGL+
Sbjct: 161 LDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLS 217
Query: 264 ----KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS--ERTDVFGYGIMLLELVTG 313
               KL +     +TT+  GT   +APE L+T   S   + D +  G++L  L+ G
Sbjct: 218 KEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R     AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVK--RLTDFESPGGDAA--FQREVEMI 163
           L  D +    V+G+G F  V R +  + G + AVK   +  F S  G +    +RE  + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
            +  H +++ L+   ++     +V+ FM    + + + +      V              
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVR-G 279
             L Y H++    IIHRDVK   VLL   +      +G FG+A  + + ++ +    R G
Sbjct: 141 EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 195
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T   +APE +      +  DV+G G++L  L++G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 120 LGQGGFGKV---YRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           +G G  G V   Y  +L     VA+K+L+  F++        RE+ ++ V  H+N++ L+
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEH 232
               TP + L  +   Q++ +   L +    + +   +  +R++    +   G+++LH  
Sbjct: 90  N-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH-- 143
Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
            +  IIHRD+K +N+++  D    + DFGLA+      + + T    T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 200
Query: 293 KSSERTDVFGYGIMLLELVTG 313
              E  D++  G+++ E++ G
Sbjct: 201 GYKENVDIWSVGVIMGEMIKG 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 48/231 (20%)
Query: 115 SEKNVLGQGGFGKVYRGVLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAV-HRNLL 172
           SEK +LG G  G V       G  VAVKR L DF     D A   E+++++ +  H N++
Sbjct: 19  SEK-ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALM-EIKLLTESDDHPNVI 72
Query: 173 RLIGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------AR 224
           R   +C+  T+R L     + NL+    L+++   + V D   + +            A 
Sbjct: 73  RY--YCSETTDRFLYIALELCNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 271
           G+ +LH   + KIIHRD+K  N+L+              E+   ++ DFGL K +D  ++
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 272 NVTTQVR---GTMGHIAPEYLSTGKS-------SERTDVFGYGIMLLELVT 312
           +  T +    GT G  APE L    +       +   D+F  G +   +++
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTT 275
           ++A+   + LE+LH   +  +IHRDVK +NVL++   +  + DFG++  LVD    ++  
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 276 QVRGTMG--HIAPEYLSTGKSSERTDVFGYGIMLLEL 310
             +  M    I PE    G S  ++D++  GI ++EL
Sbjct: 171 GCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIEL 206

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R     AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 85
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R     AR      
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 146 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 198
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVTTQVRGT 280
           RGL+Y+H   + ++IHRD+K +N+L++E+ E  +GDFG+A+             T+   T
Sbjct: 170 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 281 MGHIAPE-YLSTGKSSERTDVFGYGIMLLELVT 312
             + APE  LS  + ++  D++  G +  E++ 
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 121 GQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 179
            QG     +  VL  G  VAVK+L+  F++        RE+ ++    H+N++ L+    
Sbjct: 36  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-F 92
Query: 180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPK 236
           TP + L  +   Q++ +   L +    + +   +  +R++    +   G+++LH   +  
Sbjct: 93  TPQKTLEEF---QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSS 295
           IIHRD+K +N+++  D    + DFGLA+      TN + T    T  + APE +     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 296 ERTDVFGYGIMLLELVTG 313
              D++  G ++ ELV G
Sbjct: 204 ANVDIWSVGCIMGELVKG 221

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R     AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 38/76 (50%)
Query: 239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 298
           HRDVK  N+L+  D  A + DFG+A      K        GT+ + APE  S   ++ R 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 299 DVFGYGIMLLELVTGQ 314
           D++    +L E +TG 
Sbjct: 217 DIYALTCVLYECLTGS 232

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 109 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVK--RLTDFESPGGDAA--FQREVEMI 163
           L  D +    V+G+G F  V R +  + G + AVK   +  F S  G +    +RE  + 
Sbjct: 23  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 82
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
            +  H +++ L+   ++     +V+ FM    + + + +      V              
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVR-G 279
             L Y H++    IIHRDVK   VLL   +      +G FG+A  + + ++ +    R G
Sbjct: 143 EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 197
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T   +APE +      +  DV+G G++L  L++G
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+++D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 48/288 (16%)
Query: 120 LGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           LGQG F K+++GV  +         T+V +K L        ++ F+    M+S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMMSKLSHKHL 74
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +   G C    E +LV  F++  S+   L++ K    +L W  +  VA   A  + +L E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEE 131
Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH----IAPE 287
           +    +IH +V A N+LL  + +   G+    KL D    ++T   +  +      + PE
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD-PGISITVLPKDILQERIPWVPPE 187
Query: 288 YLSTGKS-SERTDVFGYGIMLLELVTGQ----RAIDFSRXXXXXXXXXXXXXXXXXREKR 342
            +   K+ +  TD + +G  L E+ +G      A+D  R                    +
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--------------------K 227
Query: 343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 390
           L    DR+        E+  +I     C    P+ RP+   ++R L  
Sbjct: 228 LQFYEDRHQLPAPKAAELANLINN---CMDYEPDHRPSFRAIIRDLNS 272

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 111
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK    R    T  + GT  
Sbjct: 172 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPE 224
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVTTQVRGT 280
           RGL+Y+H   + ++IHRD+K +N+L++E+ E  +GDFG+A+             T+   T
Sbjct: 169 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 281 MGHIAPE-YLSTGKSSERTDVFGYGIMLLELVT 312
             + APE  LS  + ++  D++  G +  E++ 
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 111
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R     AR      
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 171
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 172 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 224
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++APE + +   ++  D +  G+++ ++  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           TD +     +G+G F  V R V L  G + A K +   +    D    +RE  +  +  H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-LGAARGLE 227
            N++RL    +      LV+  +              GE   D V R+  +   A+  ++
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTG------------GELFEDIVAREYYSEADASHCIQ 110
Query: 228 YLHE---HCNPK-IIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVR-KTNVTTQVRG 279
            + E   HC+   ++HRD+K  N+LL    +     + DFGLA  ++V+          G
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T G+++PE L      +  D++  G++L  L+ G
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++ V  H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++ V  H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
            +APE + +   ++  D +  G+++ E+  G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-RLTDFESPGGDAAFQREVEMISVAVHR 169
           D++     LG G FG V+R    A G   A K  +T  ES       ++E++ +SV  H 
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 108
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
            L+ L        E +++Y FM              G  + + V  +   +     +EY+
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMS-------------GGELFEKVADEHNKMSEDEAVEYM 155
Query: 230 --------HEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKT-NVTTQVR 278
                   H H N   +H D+K  N++       E  + DFGL   +D +++  VTT   
Sbjct: 156 RQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 211
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           GT    APE          TD++  G++   L++G
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 37/266 (13%)
Query: 119 VLGQGGFGKVYRGVLADGTKVA-------VKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           VLG+GG+GKV++     G           +K+     +    A  + E  ++    H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRL-RE-IKPGEPVLDWVTRKRVALGAARGLEYL 229
           + LI    T  +  L+  ++    +  +L RE I   +    ++    +ALG      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H+     II+RD+K  N++L+      + DFGL K   +    VT    GT+ ++APE L
Sbjct: 138 HQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDR 349
                +   D +  G ++ +++TG  A  F+                  R+K +D I+  
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG--APPFT---------------GENRKKTIDKILKC 236
Query: 350 NLN-KNYNIQEVETMIQVALLCTQAS 374
            LN   Y  QE   +++  L    AS
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAAS 262

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 37/266 (13%)
Query: 119 VLGQGGFGKVYRGVLADGTKVA-------VKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           VLG+GG+GKV++     G           +K+     +    A  + E  ++    H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRL-RE-IKPGEPVLDWVTRKRVALGAARGLEYL 229
           + LI    T  +  L+  ++    +  +L RE I   +    ++    +ALG      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H+     II+RD+K  N++L+      + DFGL K   +    VT    GT+ ++APE L
Sbjct: 138 HQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPEIL 193
Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDR 349
                +   D +  G ++ +++TG  A  F+                  R+K +D I+  
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG--APPFT---------------GENRKKTIDKILKC 236
Query: 350 NLN-KNYNIQEVETMIQVALLCTQAS 374
            LN   Y  QE   +++  L    AS
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAAS 262

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 34/193 (17%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG------GDAAF--- 156
           EL      ++ +  +  G +G V  GV ++G  VA+KR+ +  S G       D+     
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 157 -QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
             RE+ +++   H N+L L        E     P M  L +   L      + + D    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHD---- 126
Query: 216 KRVALGAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK- 264
           +R+ +              GL  LHE     ++HRD+   N+LL ++ +  + DF LA+ 
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 265 -LVDVRKTNVTTQ 276
              D  KT+  T 
Sbjct: 184 DTADANKTHYVTH 196

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIG 176
           +LG+G + KV   V L +G + AVK +           F REVE +     ++N+L LI 
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVF-REVETLYQCQGNKNILELIE 78
Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
           F    T   LV+  +Q  S+   +++ K      +     RV    A  L++LH      
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLH---TKG 131
Query: 237 IIHRDVKAANVLLD--EDFEAV-VGDFGLAKLVDVRK--TNVTTQ----VRGTMGHIAPE 287
           I HRD+K  N+L +  E    V + DF L   + +    T +TT       G+  ++APE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 288 YLS--TGKSS---ERTDVFGYGIMLLELVTG 313
            +   T +++   +R D++  G++L  +++G
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 34/193 (17%)
Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG------GDAAF--- 156
           EL      ++ +  +  G +G V  GV ++G  VA+KR+ +  S G       D+     
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 157 -QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
             RE+ +++   H N+L L        E     P M  L +   L      + + D    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHD---- 126
Query: 216 KRVALGAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK- 264
           +R+ +              GL  LHE     ++HRD+   N+LL ++ +  + DF LA+ 
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 265 -LVDVRKTNVTTQ 276
              D  KT+  T 
Sbjct: 184 DTADANKTHYVTH 196

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-RLTDFESPGGDAAFQREVEMISVAVHR 169
           D++     LG G FG V+R    A G   A K  +T  ES       ++E++ +SV  H 
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 214
Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
            L+ L        E +++Y FM              G  + + V  +   +     +EY+
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMS-------------GGELFEKVADEHNKMSEDEAVEYM 261
Query: 230 --------HEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKT-NVTTQVR 278
                   H H N   +H D+K  N++       E  + DFGL   +D +++  VTT   
Sbjct: 262 RQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 317
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           GT    APE          TD++  G++   L++G
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 13/159 (8%)
Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
            E+ ++    H N+++L           LV  F +       L E        D      
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE----GGELFEQIINRHKFDECDAAN 150
Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAKLVDVRKTNVT 274
           +      G+ YLH+H    I+HRD+K  N+LL+         + DFGL+      K    
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKL 205
Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               GT  +IAPE L   K +E+ DV+  G+++  L+ G
Sbjct: 206 RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 31/207 (14%)
Query: 190 FMQNLSVAYRLREIKPGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAAN 246
           F++  S++    E  P +   D++T + +   +   A+G+E+L    + K IHRD+ A N
Sbjct: 165 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 221
Query: 247 VLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGI 305
           +LL E     + DFGLA+ +      V     R  +  +APE +     + ++DV+ +G+
Sbjct: 222 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 281
Query: 306 MLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE---- 361
           +L E+        FS                     ++D    R L +   ++  +    
Sbjct: 282 LLWEI--------FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTP 321
Query: 362 TMIQVALLCTQASPEDRPAMSEVVRML 388
            M Q  L C    P  RP  SE+V  L
Sbjct: 322 EMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 190 FMQNLSVAYRLREIKPGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAAN 246
           F++  S++    E  P +   D++T + +   +   A+G+E+L      K IHRD+ A N
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 223
Query: 247 VLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGI 305
           +LL E     + DFGLA+ +      V     R  +  +APE +     + ++DV+ +G+
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 306 MLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE---- 361
           +L E+        FS                     ++D    R L +   ++  +    
Sbjct: 284 LLWEI--------FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTP 323
Query: 362 TMIQVALLCTQASPEDRPAMSEVVRML 388
            M Q  L C    P  RP  SE+V  L
Sbjct: 324 EMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D F     LG G FG+V      + G   A+K L            Q+ V++  +    N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----------QKVVKLKQIEHTLN 90
Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR------ 224
             R++     P    L + F  N ++   +  +  GE         R +   AR      
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
               EYLH   +  +I+RD+K  N+L+D+     V DFG AK V  R    T  + GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPE 203
Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           ++AP  + +   ++  D +  G+++ E+  G
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 190 FMQNLSVAYRLREIKPGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAAN 246
           F++  S++    E  P +   D++T + +   +   A+G+E+L      K IHRD+ A N
Sbjct: 172 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 228
Query: 247 VLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGI 305
           +LL E     + DFGLA+ +      V     R  +  +APE +     + ++DV+ +G+
Sbjct: 229 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 288
Query: 306 MLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE---- 361
           +L E+        FS                     ++D    R L +   ++  +    
Sbjct: 289 LLWEI--------FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTP 328
Query: 362 TMIQVALLCTQASPEDRPAMSEVVRML 388
            M Q  L C    P  RP  SE+V  L
Sbjct: 329 EMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 115 SEKNVLGQGGFGKVYRGVLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAV-HRNLL 172
           SEK +LG G  G V       G  VAVKR L DF     D A   E+++++ +  H N++
Sbjct: 37  SEK-ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALM-EIKLLTESDDHPNVI 90
Query: 173 RLIGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------AR 224
           R   +C+  T+R L     + NL+    L+++   + V D   + +            A 
Sbjct: 91  RY--YCSETTDRFLYIALELCNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 271
           G+ +LH     KIIHRD+K  N+L+              E+   ++ DFGL K +D  + 
Sbjct: 145 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 272 NVTTQVR---GTMGHIAPEYL--STGKSSERT-DVFGYGIMLLELVT 312
                +    GT G  APE L  ST +   R+ D+F  G +   +++
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 190 FMQNLSVAYRLREIKPGEPVLDWVTRKRV---ALGAARGLEYLHEHCNPKIIHRDVKAAN 246
           F++  S++    E  P +   D++T + +   +   A+G+E+L      K IHRD+ A N
Sbjct: 174 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 230
Query: 247 VLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGI 305
           +LL E     + DFGLA+ +      V     R  +  +APE +     + ++DV+ +G+
Sbjct: 231 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 290
Query: 306 MLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVE---- 361
           +L E+        FS                     ++D    R L +   ++  +    
Sbjct: 291 LLWEI--------FSLGASPYPGV------------KIDEEFCRRLKEGTRMRAPDYTTP 330
Query: 362 TMIQVALLCTQASPEDRPAMSEVVRML 388
            M Q  L C    P  RP  SE+V  L
Sbjct: 331 EMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 44/227 (19%)
Query: 115 SEKNVLGQGGFGKVYRGVLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAV-HRNLL 172
           SEK +LG G  G V       G  VAVKR L DF     D A   E+++++ +  H N++
Sbjct: 37  SEK-ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALM-EIKLLTESDDHPNVI 90
Query: 173 RLIGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------AR 224
           R   +C+  T+R L     + NL+    L+++   + V D   + +            A 
Sbjct: 91  RY--YCSETTDRFLYIALELCNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 271
           G+ +LH   + KIIHRD+K  N+L+              E+   ++ DFGL K +D  + 
Sbjct: 145 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 272 NVTTQVR---GTMGHIAPEYL--STGKSSERT-DVFGYGIMLLELVT 312
                +    GT G  APE L  ST +   R+ D+F  G +   +++
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 319
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           +E+QL  ++F    V+G+G FG+V    + +  ++ A+K L  +E       A F+ E +
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRV 218
           ++     + +  L           LV  +      L++  +  +  P +    ++    +
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A+ +   L Y         +HRD+K  NVLLD +    + DFG    ++   T  ++   
Sbjct: 187 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 237
Query: 279 GTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 314
           GT  +I+PE L       GK     D +  G+ + E++ G+
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 305
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 125 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 179
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLSQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           +E+QL  ++F    V+G+G FG+V    + +  ++ A+K L  +E       A F+ E +
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRV 218
           ++     + +  L           LV  +      L++  +  +  P +    ++    +
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A+ +   L Y         +HRD+K  NVLLD +    + DFG    ++   T  ++   
Sbjct: 203 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 253
Query: 279 GTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 314
           GT  +I+PE L       GK     D +  G+ + E++ G+
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
            ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +T++   + GT 
Sbjct: 132 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 186
Query: 282 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTG 313
            ++APE L    T   +   D +  G++L   ++G
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 20  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 68
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 124
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 21  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 69
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 70  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 125
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 126 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 182
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
             V   V  T  + APE +      E  D++  G ++ E++ G
Sbjct: 183 MMVPFVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRN 170
           NF  K  L +   G++++G    G  + VK  ++ D+ +      F  E   + +  H N
Sbjct: 13  NFLTK--LNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPN 68
Query: 171 LLRLIGFCTTP--TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           +L ++G C +P      L+  +M   S+   L E      V+D     + AL  ARG+ +
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAF 126
Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM---GHIA 285
           LH    P I    + + +V++DED  A +       + DV+    + Q  G M     +A
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARIS------MADVK---FSFQSPGRMYAPAWVA 176
Query: 286 PEYLSTGKSSERT-----DVFGYGIMLLELVTGQRAIDFS 320
           PE L   K  E T     D++ + ++L ELVT  R + F+
Sbjct: 177 PEALQ--KKPEDTNRRSADMWSFAVLLWELVT--REVPFA 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGF 177
           LG+G F  V R V +  G + A K +   +    D    +RE  +  +  H N++RL   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-LGAARGLEYLHE---HC 233
            +      L++  +              GE   D V R+  +   A+  ++ + E   HC
Sbjct: 90  ISEEGHHYLIFDLVTG------------GELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 234 NPK-IIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           +   ++HRD+K  N+LL    +     + DFGLA  V+  +        GT G+++PE L
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVL 196
Query: 290 STGKSSERTDVFGYGIMLLELVTG 313
                 +  D++  G++L  L+ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 12  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVL 210
               RE+ ++    H+N++ L+   T   T  E   VY  M+ +     L ++   E  L
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--NLXQVIQME--L 116
Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           D      +      G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 117 DHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-- 171
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVL 210
               RE+ ++    H+N++ L+   T   T  E   VY  M+ +     L ++   E  L
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--NLXQVIQME--L 123
Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           D      +      G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMI----SVAVH 168
           +LG+GGFG V+ G  L D  +VA+K     R+  +           EV ++    +   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
             ++RL+ +  T    +LV            L    P + + D++T K   LG      +
Sbjct: 98  PGVIRLLDWFETQEGFMLV------------LERPLPAQDLFDYITEKG-PLGEGPSRCF 144
Query: 229 LHE------HCNPK-IIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             +      HC+ + ++HRD+K  N+L+D     A + DFG   L+        T   GT
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGT 201
Query: 281 MGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSR 321
             +  PE++S  +  +    V+  GI+L ++V G   I F R
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IPFER 241

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR--------EVEM 162
           +  +S  + LG G FG V+  V  +  K  V +    E    D   +         E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 163 ISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVAL 220
           +S   H N+++++  F      +L++      L + A+  R  +  EP+  ++ R+ V+ 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS- 141
Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             A G   L +     IIHRD+K  N+++ EDF   + DFG A  ++  K   T    GT
Sbjct: 142 --AVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGT 192
Query: 281 MGHIAPEYL-STGKSSERTDVFGYGIMLLELV 311
           + + APE L          +++  G+ L  LV
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           + + T    T  + APE +      E  D++  G ++ E++ G
Sbjct: 179 SFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           TD +     LG+G F  V R + +  G + A K +   +    D    +RE  +  +  H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-LGAARGLE 227
            N++RL    +      LV+  +              GE   D V R+  +   A+  ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTG------------GELFEDIVAREYYSEADASHCIQ 110
Query: 228 YLHE---HCNPK-IIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVR-KTNVTTQVRG 279
            + E   HC+   I+HRD+K  N+LL    +     + DFGLA  ++V+          G
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T G+++PE L      +  D++  G++L  L+ G
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 13  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 61
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 117
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 118 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 172
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 20  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 68
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 124
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 20  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 68
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 124
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 13  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 61
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 117
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 118 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 172
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVL 210
               RE+ ++    H+N++ L+   T   T  E   VY  M+ +     L ++   E  L
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--NLXQVIQME--L 123
Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           D      +      G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 12  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 116
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 117 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 18  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 66
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 67  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 122
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 123 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 177
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 178 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLN-VFTPQKTLEEF---QDVYLVMELMDANLXQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLN-VFTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-- 178
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 20/221 (9%)
Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           ++++L  ++F    V+G+G FG+V    L +  KV A+K L  +E       A F+ E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRV 218
           ++     + +  L           LV  +      L++  +  +  P E    ++    +
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A+ +   L Y         +HRD+K  N+L+D +    + DFG    +    T  ++   
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 279 GTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 314
           GT  +I+PE L       G+     D +  G+ + E++ G+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 48/231 (20%)
Query: 115 SEKNVLGQGGFGKVYRGVLADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAV-HRNLL 172
           SEK +LG G  G V       G  VAVKR L DF     D A   E+++++ +  H N++
Sbjct: 19  SEK-ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALM-EIKLLTESDDHPNVI 72
Query: 173 RLIGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------AR 224
           R   +C+  T+R L     + NL+    L+++   + V D   + +            A 
Sbjct: 73  RY--YCSETTDRFLYIALELCNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 271
           G+ +LH   + KIIHRD+K  N+L+              E+   ++ DFGL K +D  + 
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 183
Query: 272 NVTTQVR---GTMGHIAPEYLSTGKS-------SERTDVFGYGIMLLELVT 312
                +    GT G  APE L    +       +   D+F  G +   +++
Sbjct: 184 XFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 57  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 105
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 161
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 162 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 113 NFSEKNVLGQGGFGKVYR-GVLADGTKVAVKR-LTDFESPGGDAAFQREV-EMISVAVHR 169
           +F   + LG G +G+V++     DG   AVKR ++ F  P   A    EV     V  H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 170 NLLRL------IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
             +RL       G     TE  L  P +Q    A+      P   V  ++    +AL   
Sbjct: 118 CCVRLEQAWEEGGILYLQTE--LCGPSLQQHCEAWGAS--LPEAQVWGYLRDTLLALA-- 171
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
               +LH      ++H DVK AN+ L       +GDFGL  LV++          G   +
Sbjct: 172 ----HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRY 222
Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELV 311
           +APE L  G      DVF  G+ +LE+ 
Sbjct: 223 MAPELLQ-GSYGTAADVFSLGLTILEVA 249

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           TD +     LG+G F  V R + +  G + A K +   +    D    +RE  +  +  H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-LGAARGLE 227
            N++RL    +      LV+  +              GE   D V R+  +   A+  ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTG------------GELFEDIVAREYYSEADASHCIQ 110
Query: 228 YLHE---HCNPK-IIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVR-KTNVTTQVRG 279
            + E   HC+   I+HRD+K  N+LL    +     + DFGLA  ++V+          G
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T G+++PE L      +  D++  G++L  L+ G
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTT 275
           ++A+   + LE+LH   +  +IHRDVK +NVL++   +    DFG++  LVD    ++  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 276 QVRGTMGHIAPE----YLSTGKSSERTDVFGYGIMLLEL 310
              G   + APE     L+    S ++D++  GI  +EL
Sbjct: 198 ---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  VL     VA+K+L+  F++    
Sbjct: 57  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 105
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEF---QDVYLVMELMDANLCQVIQMEL 161
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 162 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 13  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 61
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 62  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 117
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 118 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 172
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           + + T    T  + APE +      E  D++  G ++ E+V  +
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 24  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 72
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 73  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 128
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 129 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 183
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 311
           + + T    T  + APE +      E  D++  G ++ E+V
Sbjct: 184 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 17/129 (13%)
Query: 198 YRLREIKPGEPVLDWVTRKR---------VALGAARGLEYLHEHCNPKIIHRDVKAANVL 248
           Y + E+  G  +LD + R++         V     + +EYLH      ++HRD+K +N+L
Sbjct: 92  YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNIL 148
Query: 249 -LDE--DFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
            +DE  + E++ + DFG AK +      + T    T   +APE L         D++  G
Sbjct: 149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLG 207
Query: 305 IMLLELVTG 313
           ++L  ++TG
Sbjct: 208 VLLYTMLTG 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++ +N +G+G +G+V +  +  GT++  A K++  +     D  F++E+E++    H N+
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 85
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV--ALGAAR----- 224
           +RL             Y   ++ +  Y + E+  G  + + V  KRV     AAR     
Sbjct: 86  IRL-------------YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 132
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
              + Y H+     + HRD+K  N L      D    + DFGLA      K  + T+V G
Sbjct: 133 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-G 187
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T  +++P+ L  G      D +  G+M+  L+ G
Sbjct: 188 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 114 FSEKNVLGQGGFGKVYRGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++ +N +G+G +G+V +  +  GT++  A K++  +     D  F++E+E++    H N+
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNI 68
Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV--ALGAAR----- 224
           +RL             Y   ++ +  Y + E+  G  + + V  KRV     AAR     
Sbjct: 69  IRL-------------YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
              + Y H+     + HRD+K  N L      D    + DFGLA      K  + T+V G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-G 170
Query: 280 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           T  +++P+ L  G      D +  G+M+  L+ G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 17/129 (13%)
Query: 198 YRLREIKPGEPVLDWVTRKR---------VALGAARGLEYLHEHCNPKIIHRDVKAANVL 248
           Y + E+  G  +LD + R++         V     + +EYLH      ++HRD+K +N+L
Sbjct: 92  YVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNIL 148
Query: 249 -LDE--DFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
            +DE  + E++ + DFG AK +      + T    T   +APE L         D++  G
Sbjct: 149 YVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLG 207
Query: 305 IMLLELVTG 313
           ++L   +TG
Sbjct: 208 VLLYTXLTG 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 V  T  + APE +      E  D++  G ++ E+V  +
Sbjct: 181 MMEPEVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 17/129 (13%)
Query: 198 YRLREIKPGEPVLDWVTRKR---------VALGAARGLEYLHEHCNPKIIHRDVKAANVL 248
           Y + E+  G  +LD + R++         V     + +EYLH      ++HRD+K +N+L
Sbjct: 97  YLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNIL 153
Query: 249 -LDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
            +DE        + DFG AK +      + T    T   +APE L      E  D++  G
Sbjct: 154 YVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 305 IMLLELVTG 313
           I+L  ++ G
Sbjct: 213 ILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 17/129 (13%)
Query: 198 YRLREIKPGEPVLDWVTRKR---------VALGAARGLEYLHEHCNPKIIHRDVKAANVL 248
           Y + E+  G  +LD + R++         V     + +EYLH      ++HRD+K +N+L
Sbjct: 97  YLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNIL 153
Query: 249 -LDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
            +DE        + DFG AK +      + T    T   +APE L      E  D++  G
Sbjct: 154 YVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLG 212
Query: 305 IMLLELVTG 313
           I+L  ++ G
Sbjct: 213 ILLYTMLAG 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG-- 282
           G+ YLH++    I+H D+K  N+LL   +   +GD  +      RK     ++R  MG  
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYP--LGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 283 -HIAPEYLSTGKSSERTDVFGYGIMLLELVT 312
            ++APE L+    +  TD++  GI+   L+T
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGD 153
            F  LKRY          N        QG     Y  +L     VA+K+L+  F++    
Sbjct: 19  TFTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               RE+ ++    H+N++ L+    TP + L  +   Q++ +   L +    + +   +
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEF---QDVYIVMELMDANLCQVIQMEL 123
Query: 214 TRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
             +R++    +   G+++LH   +  IIHRD+K +N+++  D    + DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                 V  T  + APE +      E  D++  G ++ E+V  +
Sbjct: 181 MMEPEVV--TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
           G++Y+H   +  I+HRD+K AN L+++D    V DFGLA+ VD
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 32/197 (16%)
Query: 133 LADGTKVAVK-----RLTDF-ESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL 185
           ++D   VA+K     R++D+ E P G       V +  V+     ++RL+ +   P   +
Sbjct: 73  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE------HC-NPKII 238
           L+            L   +P + + D++T +R AL       +  +      HC N  ++
Sbjct: 133 LI------------LERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVL 179
Query: 239 HRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 297
           HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  +  PE++   +   R
Sbjct: 180 HRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGR 236
Query: 298 T-DVFGYGIMLLELVTG 313
           +  V+  GI+L ++V G
Sbjct: 237 SAAVWSLGILLYDMVCG 253

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 108 QLATDNF---SEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           Q A ++F   S+  +LG G FG+V++    A G K+A K +            + E+ ++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVM 140
Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           +   H NL++L     +  + +LV  ++    +  R+ +       LD +   +      
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QIC 197
Query: 224 RGLEYLHEHCNPKIIHRDVKAANVL-LDEDFEAV-VGDFGLAKLVDVR---KTNVTTQVR 278
            G+ ++H+     I+H D+K  N+L ++ D + + + DFGLA+    R   K N      
Sbjct: 198 EGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF----- 249
Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           GT   +APE ++    S  TD++  G++   L++G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	437
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-144
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-130
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-77
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-48
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-17
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-17
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-04
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  561 bits (1449), Expect = 0.0
 Identities = 230/326 (70%), Positives = 272/326 (83%)

Query: 83  FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 142
           F DV  E D  +  GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 143 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 202
           RL +  + GG+  FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA  LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 203 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 262
               +P LDW  R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           AKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
             +DDV+LLD VK L +EK+L+A+VD +L  NY  +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 383 EVVRMLEGEGLAERWEEWQHVEVTRR 408
           EVVRMLEG+GLAERWEEWQ  E+ R+
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  412 bits (1061), Expect = e-144
 Identities = 107/311 (34%), Positives = 182/311 (58%), Gaps = 22/311 (7%)

Query: 91  DRRIAFGQLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRL 144
              ++  +   +S+ EL+  T+NF E+      N +G+GGFG VY+G + + T VAVK+L
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62

Query: 145 T---DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR 201
               D  +      F +E+++++   H NL+ L+GF +   +  LVY +M N S+  RL 
Sbjct: 63  AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 202 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 261
               G P L W  R ++A GAA G+ +LHE+     IHRD+K+AN+LLDE F A + DFG
Sbjct: 123 C-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178

Query: 262 LAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 320
           LA+  +   +T +T+++ GT  ++APE L  G+ + ++D++ +G++LLE++TG  A+D  
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237

Query: 321 RLEEEDDVLLLDHVKKLEREKR-LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 379
           R    +  LLLD  +++E E++ ++  +D+ +N + +   VE M  VA  C       RP
Sbjct: 238 R----EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 380 AMSEVVRMLEG 390
            + +V ++L+ 
Sbjct: 293 DIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  378 bits (974), Expect = e-130
 Identities = 113/294 (38%), Positives = 171/294 (58%), Gaps = 7/294 (2%)

Query: 98  QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 157
           +  R    +L+ AT+NF  K ++G G FGKVY+GVL DG KVA+KR T  ES  G   F+
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFE 83

Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
            E+E +S   H +L+ LIGFC    E +L+Y +M+N ++   L         + W  R  
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ 276
           + +GAARGL YLH      IIHRDVK+ N+LLDE+F   + DFG++K   ++ +T+++T 
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 336
           V+GT+G+I PEY   G+ +E++DV+ +G++L E++  + AI  S   E   V L +   +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVE 258

Query: 337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 390
                +L+ IVD NL      + +      A+ C   S EDRP+M +V+  LE 
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  242 bits (619), Expect = 2e-77
 Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 37/310 (11%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS 164
             L   +       V  +G FG V++  L     VAVK            ++Q E E+ S
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYEVYS 71

Query: 165 VAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
           +    H N+L+ IG          +  L+  F +  S++  L+       V+ W     +
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126

Query: 219 ALGAARGLEYLHEH-------CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
           A   ARGL YLHE          P I HRD+K+ NVLL  +  A + DFGLA   +  K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 272 NV-TTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
              T    GT  ++APE L         +  R D++  G++L EL +   A D     +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV--DE 244

Query: 326 DDVLLLDHV-KKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQASPEDRP 379
             +   + + +    E   + +V +       +       +  + +    C     E R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 380 AMSEVVRMLE 389
           +   V   + 
Sbjct: 305 SAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  209 bits (533), Expect = 3e-64
 Identities = 74/321 (23%), Positives = 117/321 (36%), Gaps = 44/321 (13%)

Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM 162
           +  E  L  DN     ++G+G +G VY+G L D   VAVK      S      F  E  +
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNI 58

Query: 163 ISVAV--HRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 215
             V +  H N+ R I            E LLV  +  N S+   L          DWV+ 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSS 113

Query: 216 KRVALGAARGLEYLHE------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-- 267
            R+A    RGL YLH       H  P I HRD+ + NVL+  D   V+ DFGL+  +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 268 -----VRKTNVTTQVRGTMGHIAPEYL-------STGKSSERTDVFGYGIMLLELVTGQR 315
                  + N      GT+ ++APE L           + ++ D++  G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 316 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN-----LNKNYNIQEV--ETMIQVAL 368
            +       E  +     V      + +  +V R        + +    +   ++ +   
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 369 LCTQASPEDRPAMSEVVRMLE 389
            C     E R         + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  190 bits (486), Expect = 1e-57
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 29/287 (10%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 162
           W +L +       K  +G G FG V+R     G+ VAVK L            F REV +
Sbjct: 36  WCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAI 87

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           +    H N++  +G  T P    +V  ++   S+   L +    E  LD   R  +A   
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDV 146

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           A+G+ YLH + NP I+HR++K+ N+L+D+ +   V DFGL++L        +    GT  
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPE 204

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 342
            +APE L    S+E++DV+ +G++L EL T Q    +  L     V  +       + KR
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV-----GFKCKR 257

Query: 343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L+  + RNLN      +V  +I+    C    P  RP+ + ++ +L 
Sbjct: 258 LE--IPRNLNP-----QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  190 bits (485), Expect = 1e-57
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 36/283 (12%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
                + V+G+G FG V +        VA+K++   ES     AF  E+  +S   H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNI 63

Query: 172 LRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           ++L G C  P     E      + +  S+   L   +P  P           L  ++G+ 
Sbjct: 64  VKLYGACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVA 116

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           YLH      +IHRD+K  N+LL      + + DFG A           T  +G+   +AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAP 172

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
           E       SE+ DVF +GI+L E++T ++   F  +           +  +    R    
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEI----GGPAFRIMWAVHNGTRPP-- 224

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + +NL K      +E+++     C    P  RP+M E+V+++ 
Sbjct: 225 LIKNLPK-----PIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (465), Expect = 8e-55
 Identities = 71/299 (23%), Positives = 131/299 (43%), Gaps = 53/299 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD------AAFQREVEMIS 164
           +    +  +G+GGFG V++G  + D + VA+K L   +S G          FQREV ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 165 VAVHRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
              H N+++L G    P     E      F+    + +RL       P + W  + R+ L
Sbjct: 79  NLNHPNIVKLYGLMHNPPRMVME------FVPCGDLYHRLL--DKAHP-IKWSVKLRLML 129

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-----VGDFGLAKLVDVRKTNVTT 275
             A G+EY+  + NP I+HRD+++ N+ L    E       V DFGL++       +  +
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVS 184

Query: 276 QVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQ---RAIDFSRLEEEDDVLL 330
            + G    +APE +       +E+ D + + ++L  ++TG+       + +++  + +  
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-- 242

Query: 331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                  E   R        + ++     +  +I+   LC    P+ RP  S +V+ L 
Sbjct: 243 ------REEGLRPT------IPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  176 bits (449), Expect = 1e-52
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 44/297 (14%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL---TDFESPGGDAAFQREV 160
           + EL L       + ++G GGFGKVYR     G +VAVK      D +        ++E 
Sbjct: 6   FAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           ++ ++  H N++ L G C       LV  F +   +   L   +     +        A+
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAV 112

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTN 272
             ARG+ YLH+     IIHRD+K++N+L+ +  E          + DFGLA+     +T 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTT 170

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 332
             +   G    +APE +     S+ +DV+ YG++L EL+TG+  + F  ++         
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVA---- 223

Query: 333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                  +  L   +     + +     + M      C    P  RP+ + ++  L 
Sbjct: 224 -YGVAMNKLALP--IPSTCPEPF----AKLMED----CWNPDPHSRPSFTNILDQLT 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 6e-52
 Identities = 68/316 (21%), Positives = 126/316 (39%), Gaps = 44/316 (13%)

Query: 99  LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 158
           ++R   +++Q+          +G+G +G+V+ G    G KVAVK     E    +A++ R
Sbjct: 31  VQRTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFR 78

Query: 159 EVEMISVAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
           E E+    +  H N+L  I          T+  L+  + +N S+   L+        LD 
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDA 133

Query: 213 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
            +  ++A  +  GL +LH         P I HRD+K+ N+L+ ++    + D GLA    
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

Query: 268 VRKTNV---TTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
                V        GT  ++ PE        +  +S    D++ +G++L E+    R + 
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVS 251

Query: 319 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 373
              +EE               E   + +  + L     N+  + + +  M ++   C   
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311

Query: 374 SPEDRPAMSEVVRMLE 389
           +P  R     V + L 
Sbjct: 312 NPASRLTALRVKKTLA 327

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  175 bits (447), Expect = 6e-52
 Identities = 73/330 (22%), Positives = 122/330 (36%), Gaps = 46/330 (13%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEM 162
             +L           VLG+G FG+  +      G  + +K L  F+       F +EV++
Sbjct: 9   PSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKV 60

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           +    H N+L+ IG          +  +++  ++   ++     +    W  R   A   
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDI 117

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-------------VR 269
           A G+ YLH      IIHRD+ + N L+ E+   VV DFGLA+L+                
Sbjct: 118 ASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
                  V G    +APE ++     E+ DVF +GI+L E++    A             
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDF 232

Query: 330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            L+    L+R    +                 +   + + C    PE RP+  ++   LE
Sbjct: 233 GLNVRGFLDRYCPPNCP--------------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

Query: 390 G--EGLAERWEEWQHVEVTRRQEYERLQRR 417
                LA        +E   R  +E  +R 
Sbjct: 279 TLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (439), Expect = 8e-51
 Identities = 71/321 (22%), Positives = 134/321 (41%), Gaps = 54/321 (16%)

Query: 99  LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 158
           ++R   R++ L          +G+G +G+V+RG    G  VAVK  +  +    + ++ R
Sbjct: 2   MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFR 49

Query: 159 EVEMISVAV--HRNLLRLIGFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 212
           E E+ +  +  H N+L  I    T     T+  L+  + +  S+   L+        LD 
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDT 104

Query: 213 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
           V+  R+ L  A GL +LH         P I HRD+K+ N+L+ ++ +  + D GLA +  
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164

Query: 268 ----VRKTNVTTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
                       +V GT  ++APE       +    S +R D++ +G++L E+    R +
Sbjct: 165 QSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMV 221

Query: 318 DFSRLEEE----DDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVAL 368
               +E+      DV+  D       E     +          N+ ++   + ++ ++  
Sbjct: 222 SNGIVEDYKPPFYDVVPNDPSF----EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277

Query: 369 LCTQASPEDRPAMSEVVRMLE 389
            C   +P  R     + + L 
Sbjct: 278 ECWYQNPSARLTALRIKKTLT 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  171 bits (436), Expect = 2e-50
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 44/296 (14%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 162
             ++ +          +G G FG VY+G       VAVK L     +P    AF+ EV +
Sbjct: 23  DGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 163 ISVAVHRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
           +    H N+L  +G+ T P     T+      + +  S+ Y    +   E   +      
Sbjct: 74  LRKTRHVNILLFMGYSTAPQLAIVTQ------WCEGSSL-YHH--LHASETKFEMKKLID 124

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQ 276
           +A   ARG++YLH      IIHRD+K+ N+ L ED    +GDFGLA        ++   Q
Sbjct: 125 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181

Query: 277 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 333
           + G++  +APE      +   S ++DV+ +GI+L EL+TGQ  + +S +   D ++ +  
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEM-- 237

Query: 334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           V +      L  +      +   +     M +    C +   ++RP+   ++  +E
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRL-----MAE----CLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  171 bits (435), Expect = 2e-50
 Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 40/292 (13%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEM 162
           +++L            L +   G++++G    G  + VK L   + S      F  E   
Sbjct: 9   FKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 163 ISVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           + +  H N+L ++G C +P       +  +M   S+   L   +    V+D     + AL
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFAL 118

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             ARG+ +LH    P I    + + +V++DED  A +    +           +      
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYA 171

Query: 281 MGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 337
              +APE L            D++ + ++L ELVT +  + F+ L   +       +K  
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE--VPFADLSNMEIG-----MKVA 224

Query: 338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               R    +   ++       V  +++   +C    P  RP    +V +LE
Sbjct: 225 LEGLRPT--IPPGISP-----HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  169 bits (430), Expect = 3e-49
 Identities = 67/300 (22%), Positives = 130/300 (43%), Gaps = 47/300 (15%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 162
           + +L++         ++G+G FG+VY G      +VA++ +  + ++     AF+REV  
Sbjct: 32  FEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
                H N++  +G C +P    ++    +  ++   +R+ K    VLD    +++A   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEI 139

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVR 278
            +G+ YLH      I+H+D+K+ NV  D   + V+ DFGL  +  V    R+ +      
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 279 GTMGHIAPEYLSTGKS---------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
           G + H+APE +              S+ +DVF  G +  EL   +    F     E  + 
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIW 253

Query: 330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                 ++    + + +    + K     E+  ++     C     E+RP  ++++ MLE
Sbjct: 254 ------QMGTGMKPN-LSQIGMGK-----EISDILL---FCWAFEQEERPTFTKLMDMLE 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (426), Expect = 2e-48
 Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 46/316 (14%)

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 159
           +R   R + L       +  +G+G FG+V+RG    G +VAVK  +  E    + ++ RE
Sbjct: 37  QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFRE 84

Query: 160 VEMISVAV--HRNLLRLIGFCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
            E+    +  H N+L  I        T T+  LV  + ++ S+   L         +   
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVE 139

Query: 214 TRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
              ++AL  A GL +LH         P I HRD+K+ N+L+ ++    + D GLA   D 
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199

Query: 269 RKTNVT---TQVRGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQRAIDF 319
               +        GT  ++APE L         +S +R D++  G++  E+         
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--- 256

Query: 320 SRLEEEDDVLLLDHVK-KLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 373
             + E+  +   D V      E+    + ++ L     N+  + + +  M ++   C  A
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316

Query: 374 SPEDRPAMSEVVRMLE 389
           +   R     + + L 
Sbjct: 317 NGAARLTALRIKKTLS 332

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 5e-38
 Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)

Query: 118 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
            V+G+G FG VY G L D        AVK L      G  + F  E  ++    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 174 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           L+G C       L+V P+M++  +   +R       V D +      L  A+G++YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKYLASK 147

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 287
              K +HRD+ A N +LDE F   V DFGLA+  D+      +    T   +     A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 288 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 343
            L T K + ++DV+ +G++L EL+T G      ++        D+        L + +RL
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DIT-----VYLLQGRRL 251

Query: 344 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    L   Y +     M++    C     E RP+ SE+V  + 
Sbjct: 252 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (350), Expect = 7e-38
 Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 116 EKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              V+G+G FG VY G   D      + A+K L+         AF RE  ++    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 172 LRLIGFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           L LIG    P      + P+M +  +   +R  +    V D ++     L  ARG+EYL 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGMEYLA 141

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 285
           E    K +HRD+ A N +LDE F   V DFGLA+  D+      +  +     +     A
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTA 196

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREK 341
            E L T + + ++DV+ +G++L EL+T G      ID        D+        L + +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID------PFDLT-----HFLAQGR 245

Query: 342 RLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           RL        +L   Y +     M Q    C +A P  RP    +V  +E
Sbjct: 246 RLPQPEYCPDSL---YQV-----MQQ----CWEADPAVRPTFRVLVGEVE 283

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (352), Expect = 1e-37
 Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)

Query: 118 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 173
            V+G+G FG VY G L D        AVK L      G  + F  E  ++    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 174 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           L+G C       L+V P+M++  +   +R       V D +      L  A+G+++L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKFLASK 211

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 287
              K +HRD+ A N +LDE F   V DFGLA+  D+      +    T   +     A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 288 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 343
            L T K + ++DV+ +G++L EL+T G      ++        D+        L + +RL
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDIT-----VYLLQGRRL 315

Query: 344 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    L   Y +     M++    C     E RP+ SE+V  + 
Sbjct: 316 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 351

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (343), Expect = 3e-36
 Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 49/292 (16%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++      +G+G FG+V+ G L AD T VAVK   +   P   A F +E  ++    H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RLIG CT      +V   +Q       LR        L   T  ++   AA G+EYL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 285
                  IHRD+ A N L+ E     + DFG+++        V     G +  +     A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAA-SGGLRQVPVKWTA 283

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL- 343
           PE L+ G+ S  +DV+ +GI+L E  + G     +  L  +         + +E+  RL 
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSNQ-QTR-----EFVEKGGRLP 335

Query: 344 ------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                 DA+        + +     M Q    C    P  RP+ S + + L+
Sbjct: 336 CPELCPDAV--------FRL-----MEQ----CWAYEPGQRPSFSTIYQELQ 370

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (338), Expect = 5e-36
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 47/293 (16%)

Query: 117 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 171
             +LG+G FG V  G L        KVAVK +  D  S      F  E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 172 LRLIGFCT-----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAAR 224
           +RL+G C         + +++ PFM+   +   L   +          +   +  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           G+EYL        +HRD+ A N +L +D    V DFGL+K   +   +   Q R     +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPV 213

Query: 285 ---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 340
              A E L+    + ++DV+ +G+ + E+ T G     +  ++  +   + D++    R 
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHE---MYDYLLHGHRL 268

Query: 341 KR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           K+    LD +        Y I     M      C +  P DRP  S +   LE
Sbjct: 269 KQPEDCLDEL--------YEI-----MYS----CWRTDPLDRPTFSVLRLQLE 304

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (336), Expect = 7e-36
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 42/299 (14%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
                   LG+G FGKV            G +VAVK L         A  ++E+E++   
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 167 VHRNLLRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
            H N+++  G CT        L+  F+ + S+   L +    +  ++   + + A+   +
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICK 137

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---- 280
           G++YL      + +HRD+ A NVL++ + +  +GDFGL K ++  K   T +        
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 281 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED------DVLLLD 332
                APE L   K    +DV+ +G+ L EL+T          L  +        + +  
Sbjct: 195 WY---APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 333 HVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            V  L+  KRL    +    +   Y +     M +    C +  P +R +   ++   E
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEV---YQL-----MRK----CWEFQPSNRTSFQNLIEGFE 298

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  133 bits (337), Expect = 8e-36
 Identities = 74/299 (24%), Positives = 112/299 (37%), Gaps = 54/299 (18%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              LG+G FGKV            G  VAVK L     P   + +++E++++    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 172 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++  G C         LV  ++   S+   L     G   L        A     G+ YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 284
           H       IHRD+ A NVLLD D    +GDFGLAK V         +  G          
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE------DDVLLLDHVKKL 337
           APE L   K    +DV+ +G+ L EL+T    +        E        + +L   + L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 338 EREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           ER +RL         +        Y++     M      C +     RP    ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEV--------YHL-----MKN----CWETEASFRPTFENLIPILK 306

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  132 bits (335), Expect = 2e-35
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 43/294 (14%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
            + LG+G FG V            G  VAVK+L     P     FQRE++++       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFI 86

Query: 172 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++  G    P  +   LV  ++ +  +   L+        LD       +    +G+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYL 143

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI----- 284
                 + +HRD+ A N+L++ +    + DFGLAKL+ + K      V    G       
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSPIFWY 197

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVT-------GQRAIDFSRLEEEDDVLLLDHVKKL 337
           APE LS    S ++DV+ +G++L EL T                  E D   L   ++ L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 338 EREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           E  +RL A       +   + +     M      C   SP+DRP+ S +   L+
Sbjct: 258 EEGQRLPAPPACPAEV---HEL-----MKL----CWAPSPQDRPSFSALGPQLD 299

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  131 bits (332), Expect = 4e-35
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 48/294 (16%)

Query: 117 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 171
             +LG+G FG V    L        KVAVK L  D  +      F RE   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 172 LRLIGFCT------TPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAA 223
            +L+G              +++ PFM++  +   L   + GE    L   T  R  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            G+EYL        IHRD+ A N +L ED    V DFGL++   +   +   Q   +   
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASKLP 202

Query: 284 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 339
           +   A E L+    +  +DV+ +G+ + E++T GQ    ++ +E  +   + +++    R
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAE---IYNYLIGGNR 257

Query: 340 EKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            K+    ++ +        Y++     M Q    C  A P+ RP+ + +   LE
Sbjct: 258 LKQPPECMEEV--------YDL-----MYQ----CWSADPKQRPSFTCLRMELE 294

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  129 bits (327), Expect = 2e-34
 Identities = 71/292 (24%), Positives = 131/292 (44%), Gaps = 45/292 (15%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
              LGQG FG VY GV          T+VA+K + +  S      F  E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKR---VALGAAR 224
           ++RL+G  +     L++   M    +   LR ++P     PVL   +  +   +A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ +  D+ +T+     +G  G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLL 202

Query: 285 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 338
                +PE L  G  +  +DV+ +G++L E+ T  ++   +  L  E  +  +     L+
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLD 260

Query: 339 R-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + +   D +        + +     M      C Q +P+ RP+  E++  ++
Sbjct: 261 KPDNCPDML--------FEL-----MRM----CWQYNPKMRPSFLEIISSIK 295

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (324), Expect = 5e-34
 Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              LG+G FG V            G  VAVK+L    +      F+RE+E++    H N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 104

Query: 172 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++  G C +   R   L+  ++   S+   L++    +  +D +   +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 161

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 284
                 + IHRD+   N+L++ +    +GDFGL K++   K     +  G          
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 336
           APE L+  K S  +DV+ +G++L EL T          E            +++   ++ 
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 337 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L+   RL         +   Y I     M +    C   +   RP+  ++   ++
Sbjct: 276 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 318

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (324), Expect = 5e-34
 Identities = 70/300 (23%), Positives = 134/300 (44%), Gaps = 60/300 (20%)

Query: 117 KNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLL 172
           ++V+G+G FG+V +  +         A+KR+ ++ S      F  E+E +  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RVAL 220
            L+G C       L   +  + ++   LR+ +  E    +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
             ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +V        V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199

Query: 281 MGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLL 331
           MG +     A E L+    +  +DV+ YG++L E+V+ G      +  + L         
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------- 250

Query: 332 DHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              +KL +  RL+  ++    +   Y++     M Q    C +  P +RP+ ++++  L 
Sbjct: 251 --YEKLPQGYRLEKPLNCDDEV---YDL-----MRQ----CWREKPYERPSFAQILVSLN 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  127 bits (321), Expect = 7e-34
 Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              LG+G FG V            G  VAVK+L    +      F+RE+E++    H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 73

Query: 172 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++  G C +   R   L+  ++   S+   L++    +  +D +   +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 130

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 284
                 + IHRD+   N+L++ +    +GDFGL K++   K     +  G          
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 336
           APE L+  K S  +DV+ +G++L EL T          E            +++   ++ 
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 337 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L+   RL         +   Y I     M +    C   +   RP+  ++   ++
Sbjct: 245 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 287

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  128 bits (323), Expect = 9e-34
 Identities = 68/307 (22%), Positives = 119/307 (38%), Gaps = 56/307 (18%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 162
           D  +    LG+G FG+V                  VAVK L D  +    +    E+E M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 210
             +  H+N++ L+G CT      ++  +                 + Y     +  E  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
            +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+  D+  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209

Query: 271 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 326
            +   +       +   APE L     + ++DV+ +G+++ E+ T G     +  +  E+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 267

Query: 327 DVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
              L   +K+   +++     + +        Y +     M      C  A P  RP   
Sbjct: 268 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 307

Query: 383 EVVRMLE 389
           ++V  L+
Sbjct: 308 QLVEDLD 314

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (319), Expect = 2e-33
 Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 54/301 (17%)

Query: 117 KNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 169
              LG+G FG+V                VAVK L +  +     A   E++ +I +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 170 NLLRLIGFCTTPTE-RLLVYPFMQN------------LSVAYRLREIKPGEPVLDWVTRK 216
           N++ L+G CT P    +++  F +               V Y++      +  L      
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 217 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
             +   A+G+E+L      K IHRD+ A N+LL E     + DFGLA+  D+ K      
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--Y 204

Query: 277 VRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 330
           VR     +     APE +     + ++DV+ +G++L E+ + G     +  ++ +++   
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC- 261

Query: 331 LDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
               ++L+   R+         +   Y       M+     C    P  RP  SE+V  L
Sbjct: 262 ----RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHL 305

Query: 389 E 389
            
Sbjct: 306 G 306

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (319), Expect = 3e-33
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 47/293 (16%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
              LG G FG+VY G ++         +VAVK L +  S   +  F  E  +IS   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 227
           ++R IG       R ++   M    +   LRE +P       +       VA   A G +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 228 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           YL E+     IHRD+ A N LL        A +GDFG+A+  D+ + +     +G    +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR--KGGCAML 207

Query: 285 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 338
                 PE    G  + +TD + +G++L E+ + G     +     + +VL     + + 
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQ-EVL-----EFVT 259

Query: 339 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              R+D   +    +   Y I     M Q    C Q  PEDRP  + ++  +E
Sbjct: 260 SGGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 300

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (320), Expect = 4e-33
 Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 47/293 (16%)

Query: 117 KNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
              LG G FG+VY G +          +VAVK L +  S   +  F  E  +IS   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 227
           ++R IG       R ++   M    +   LRE +P       +       VA   A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 228 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           YL E+     IHRD+ A N LL        A +GDFG+A+  D+ +       +G    +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYR--KGGCAML 248

Query: 285 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 338
                 PE    G  + +TD + +G++L E+ + G     +     ++   +L+ V    
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTS-- 301

Query: 339 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              R+D   +    +   Y I     M Q    C Q  PEDRP  + ++  +E
Sbjct: 302 -GGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 341

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  127 bits (320), Expect = 5e-33
 Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 56/317 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 162
           D  +    LG+G FG+V                  VAVK L D  +    +    E+E M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 210
             +  H+N++ L+G CT      ++  +                 + Y     +  E  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
            +          ARG+EYL      K IHRD+ A NVL+ E+    + DFGLA+  D+  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 255

Query: 271 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 326
            +   +       +   APE L     + ++DV+ +G+++ E+ T G     +  +  E+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 313

Query: 327 DVLLLDHVKKLEREKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
              L   +K+  R  +     + +        Y +     M      C  A P  RP   
Sbjct: 314 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 353

Query: 383 EVVRMLEGEGLAERWEE 399
           ++V  L+        EE
Sbjct: 354 QLVEDLDRILTLTTNEE 370

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  125 bits (317), Expect = 6e-33
 Identities = 70/291 (24%), Positives = 115/291 (39%), Gaps = 56/291 (19%)

Query: 118 NVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
            VLG G FG VY+G+           VA+K L +  SP  +     E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL+G C T T   L+   M    +   +RE K        +      +  A+G+ YL + 
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLL---NWCVQIAKGMNYLEDR 136

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYL 289
              +++HRD+ A NVL+       + DFGLAKL+            G    I   A E +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESI 191

Query: 290 STGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL-- 343
                + ++DV+ YG+ + EL+T G +    I  S      ++        LE+ +RL  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EIS-----SILEKGERLPQ 240

Query: 344 -----DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                  +        Y I     M +    C     + RP   E++    
Sbjct: 241 PPICTIDV--------YMI-----MRK----CWMIDADSRPKFRELIIEFS 274

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (323), Expect = 1e-32
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
             LGQG FG+V+ G     T+VA+K L           F +E +++    H  L++L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 330

Query: 178 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            +  P    +V  +M   S+   L+        L       +A   A G+ Y+       
Sbjct: 331 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 383

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ + 
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 354
           ++DV+ +GI+L EL T  R + +  +    +V     + ++ER  R+    +   +L   
Sbjct: 444 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 493

Query: 355 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +++     M Q    C +  PE+RP    +   LE
Sbjct: 494 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 519

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (317), Expect = 2e-32
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 56/302 (18%)

Query: 117 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAV 167
              LG+G FG+V                TKVAVK L    +    +    E+E M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------- 217
           H+N++ L+G CT      ++  +    ++   L+  +P      +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 218 --VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
              A   ARG+EYL      K IHRD+ A NVL+ ED    + DFGLA+  D+   +   
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 248

Query: 276 QVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 331
           +       +   APE L     + ++DV+ +G++L E+ T G     +  +  E+   L 
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LF 303

Query: 332 DHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
             +K+   +++     + +        Y +     M      C  A P  RP   ++V  
Sbjct: 304 KLLKEGHRMDKPSNCTNEL--------YMM-----MRD----CWHAVPSQRPTFKQLVED 346

Query: 388 LE 389
           L+
Sbjct: 347 LD 348

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  124 bits (314), Expect = 2e-32
 Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 60/307 (19%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 169
             VLG G FGKV               +VAVK L +        A   E++ M  +  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 170 NLLRLIGFCTTPTERLLVYPFMQN----------------LSVAYRLREIKPGEPVLDWV 213
           N++ L+G CT      L++ +                     + Y  ++    E  L+ +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 214 TRKR---VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           T +     A   A+G+E+L        +HRD+ A NVL+       + DFGLA+  D+  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMS 224

Query: 271 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 324
            +    V      +     APE L  G  + ++DV+ YGI+L E+ + G     +  +  
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPV 280

Query: 325 EDDVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
           + +       K ++   ++D        +   Y I     M      C       RP+  
Sbjct: 281 DANFY-----KLIQNGFKMDQPFYATEEI---YII-----MQS----CWAFDSRKRPSFP 323

Query: 383 EVVRMLE 389
            +   L 
Sbjct: 324 NLTSFLG 330

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  125 bits (316), Expect = 5e-32
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
             LGQG FG+V+ G     T+VA+K L           F +E +++    H  L++L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 247

Query: 178 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            +  P    +V  +M   S+   L+        L       +A   A G+ Y+       
Sbjct: 248 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 300

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    G+ + 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 297 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 354
           ++DV+ +GI+L EL T  R + +  +    +V     + ++ER  R+    +   +L   
Sbjct: 361 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 410

Query: 355 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +++     M Q    C +  PE+RP    +   LE
Sbjct: 411 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 436

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (310), Expect = 6e-32
 Identities = 69/302 (22%), Positives = 108/302 (35%), Gaps = 49/302 (16%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 164
           +N      LG G FGKV               KVAVK L          A   E++ M  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 216
           +  H N++ L+G CT     L++  +     +   LR                       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 217 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
               +   A+G+ +L        IHRDV A NVLL     A +GDFGLA+  D+   +  
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSN- 219

Query: 275 TQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDV 328
             +      +     APE +     + ++DV+ YGI+L E+ + G     +  +      
Sbjct: 220 -YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKF 276

Query: 329 LLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
                 K ++   ++         KN Y+I     M      C    P  RP   ++   
Sbjct: 277 Y-----KLVKDGYQMAQ--PAFAPKNIYSI-----MQA----CWALEPTHRPTFQQICSF 320

Query: 388 LE 389
           L+
Sbjct: 321 LQ 322

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  122 bits (309), Expect = 7e-32
 Identities = 66/289 (22%), Positives = 111/289 (38%), Gaps = 50/289 (17%)

Query: 117 KNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
             VLG G FG V++GV           V +K + D        A    +  I    H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +RL+G C   +   LV  ++   S+   +R+ +        +      +  A+G+ YL E
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN---WGVQIAKGMYYLEE 133

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEY 288
           H    ++HR++ A NVLL    +  V DFG+A L+     +           I   A E 
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP--PDDKQLLYSEAKTPIKWMALES 188

Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---- 343
           +  GK + ++DV+ YG+ + EL+T G              + L +    LE+ +RL    
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPY--------AGLRLAEVPDLLEKGERLAQPQ 240

Query: 344 ---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                +        Y +     M++    C       RP   E+     
Sbjct: 241 ICTIDV--------YMV-----MVK----CWMIDENIRPTFKELANEFT 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  121 bits (306), Expect = 8e-32
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIG 176
            +G+G F  VY+G+      +VA   L D +    +   F+ E EM+    H N++R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 177 FCTTPTE---RLLVYP-FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
              +  +    +++    M + ++   L+  K     +     +       +GL++LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148

Query: 233 CNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
             P IIHRD+K  N+ +     +V +GD GLA L    + +    V GT   +APE    
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 204

Query: 292 GKSSERTDVFGYGIMLLELVTGQ 314
               E  DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  121 bits (306), Expect = 9e-32
 Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 37/298 (12%)

Query: 98  QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 157
                 +   ++   + +    LG G FG V  G       VA+K + +      +  F 
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFI 67

Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 217
            E +++    H  L++L G CT      ++  +M N  +   LRE               
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLE 124

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
           +       +EYL      + +HRD+ A N L+++     V DFGL++ V     +  T  
Sbjct: 125 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS 178

Query: 278 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 333
            G+   +    PE L   K S ++D++ +G+++ E+ + G+    + R     +      
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNS-ETA---- 231

Query: 334 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            + + +  RL         +   Y I     M      C     ++RP    ++  + 
Sbjct: 232 -EHIAQGLRLYRPHLASEKV---YTI-----MYS----CWHEKADERPTFKILLSNIL 276

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 1e-31
 Identities = 74/341 (21%), Positives = 128/341 (37%), Gaps = 45/341 (13%)

Query: 61  LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL 120
           L S G      +       R + +D +          +LK       +   +       L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR--DNLLIADIEL 344

Query: 121 GQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           G G FG V +GV         VA+K L             RE +++    +  ++RLIG 
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 237
           C      +LV        +   L   +     +       +    + G++YL E      
Sbjct: 405 CQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NF 457

Query: 238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAPEYLST 291
           +HR++ A NVLL     A + DFGL+K +    +  T +  G           APE ++ 
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINF 513

Query: 292 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 348
            K S R+DV+ YG+ + E ++ GQ+   + +++   +V+       +E+ KR++   +  
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMECPPECP 565

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             L   Y +     M      C     EDRP    V + + 
Sbjct: 566 PEL---YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 594

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  126 bits (319), Expect = 1e-31
 Identities = 59/298 (19%), Positives = 119/298 (39%), Gaps = 46/298 (15%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREV 160
           R+ ++  +       +G+G FG V++G+          VA+K   +  S      F +E 
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
             +    H ++++LIG  T      ++        +   L+  K    +   +     A 
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLI---LYAY 498

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ---- 276
             +  L YL      + +HRD+ A NVL+  +    +GDFGL++   +  +         
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGK 553

Query: 277 --VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 333
             ++      APE ++  + +  +DV+ +G+ + E++  G +   F  ++   DV+    
Sbjct: 554 LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI---- 602

Query: 334 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             ++E  +RL    +    L   Y++     M +    C    P  RP  +E+   L 
Sbjct: 603 -GRIENGERLPMPPNCPPTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 647

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (305), Expect = 1e-31
 Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 52/289 (17%)

Query: 117 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
             +LG+G FG+VY GV      +   VAVK      +      F  E  ++    H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 173 RLIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +LIG     PT   ++        + + L   K    VL  V     +L   + + YL  
Sbjct: 77  KLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLV---LYSLQICKAMAYLES 131

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEY 288
                 +HRD+   N+L+       +GDFGL++ ++        +   T   I   +PE 
Sbjct: 132 I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPES 185

Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---- 343
           ++  + +  +DV+ + + + E+++ G++   F  LE + DV+       LE+  RL    
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENK-DVI-----GVLEKGDRLPKPD 237

Query: 344 ---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                +        Y +     M +    C    P DRP  +E+V  L 
Sbjct: 238 LCPPVL--------YTL-----MTR----CWDYDPSDRPRFTELVCSLS 269

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  120 bits (304), Expect = 1e-31
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              +G G FG V+ G   +  KVA+K + +      +  F  E E++    H  L++L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            C       LV  FM++  ++  LR       +    T   + L    G+ YL E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---C 124

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 293
           +IHRD+ A N L+ E+    V DFG+ + V     +  T   GT   +   +PE  S  +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSR 181

Query: 294 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 350
            S ++DV+ +G+++ E+ + G+    +       +V+     + +    RL        +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP--YENRSNS-EVV-----EDISTGFRLYKPRLASTH 233

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   Y I     M      C +  PEDRPA S ++R L 
Sbjct: 234 V---YQI-----MNH----CWRERPEDRPAFSRLLRQLA 260

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  121 bits (306), Expect = 2e-31
 Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVA 166
             F +  VLG G FG VY+G+           VA+K L +  SP  +     E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            + ++ RL+G C T T   L+   M    +   +RE K        +      +  A+G+
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLL---NWCVQIAKGM 130

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-- 284
            YL +    +++HRD+ A NVL+       + DFGLAKL+            G    I  
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKW 185

Query: 285 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 342
            A E +     + ++DV+ YG+ + EL+T G +          D +   +    LE+ +R
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--------DGIPASEISSILEKGER 237

Query: 343 LDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L        ++   Y I     M++    C     + RP   E++    
Sbjct: 238 LPQPPICTIDV---YMI-----MVK----CWMIDADSRPKFRELIIEFS 274

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 2e-31
 Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 61/312 (19%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISV 165
            N      LG+G FGKV +            T VAVK L +  SP        E  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--- 222
             H ++++L G C+     LL+  + +  S+   LRE +   P        R +      
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 223 -----------------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
                            ++G++YL E    K++HRD+ A N+L+ E  +  + DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 266 VDVRKTNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR 321
            DV + +   +       +   A E L     + ++DV+ +G++L E+VT G     +  
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPG 255

Query: 322 LEEEDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED 377
           +  E    L + +K    +ER +   + +        Y +     M+Q    C +  P+ 
Sbjct: 256 IPPER---LFNLLKTGHRMERPDNCSEEM--------YRL-----MLQ----CWKQEPDK 295

Query: 378 RPAMSEVVRMLE 389
           RP  +++ + LE
Sbjct: 296 RPVFADISKDLE 307

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (304), Expect = 3e-31
 Identities = 65/305 (21%), Positives = 108/305 (35%), Gaps = 51/305 (16%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 164
           +  S    LG G FGKV                VAVK L          A   E++ +  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV------ 218
           +  H N++ L+G CT     L++  +     +   LR  +                    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 219 --------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
                   +   A+G+ +L        IHRD+ A N+LL       + DFGLA+  D++ 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR--DIKN 197

Query: 271 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 326
            +           +   APE +     +  +DV+ YGI L EL + G     +  +  + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDS 255

Query: 327 DVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
                   K ++   R+         +   Y+I     M      C  A P  RP   ++
Sbjct: 256 KFY-----KMIKEGFRMLSPEHAPAEM---YDI-----MKT----CWDADPLKRPTFKQI 298

Query: 385 VRMLE 389
           V+++E
Sbjct: 299 VQLIE 303

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  123 bits (311), Expect = 4e-31
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 31/276 (11%)

Query: 118 NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           + LG G +G+VY GV       VAVK L   E       F +E  ++    H NL++L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            CT      ++  FM   ++   LR  +     +  V    +A   +  +EYL +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 296
            IHR++ A N L+ E+    V DFGL++L+           +  +   APE L+  K S 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 297 RTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNK 353
           ++DV+ +G++L E+ T G        L +          + LE++ R++        +  
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRMERPEGCPEKV-- 448

Query: 354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            Y +     M      C Q +P DRP+ +E+ +  E
Sbjct: 449 -YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 474

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (304), Expect = 4e-31
 Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 53/298 (17%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           K  LG+G FGKV+     +         VAVK L +  S      FQRE E++++  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQH 104

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-----------VA 219
           ++R  G CT     L+V+ +M++  +   LR   P   +L                  VA
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
              A G+ YL        +HRD+   N L+ +     +GDFG+++  D+  T+      G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYR--VG 217

Query: 280 TMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 333
               +      PE +   K +  +DV+ +G++L E+ T G++   + +L    + +    
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNT-EAI---- 270

Query: 334 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              + + + L+        +   Y I     M      C Q  P+ R ++ +V   L+
Sbjct: 271 -DCITQGRELERPRACPPEV---YAI-----MRG----CWQREPQQRHSIKDVHARLQ 315

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  123 bits (310), Expect = 4e-31
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 37/277 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 253

Query: 177 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                   L +V  +M   S+   LR    G  VL      + +L     +EYL  +   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364

Query: 296 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 352
            ++DV+ +GI+L E+ + G+    + R+  + DV     V ++E+  ++DA       + 
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DV-----VPRVEKGYKMDAPDGCPPAV- 415

Query: 353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             Y++     M      C       RP   ++   LE
Sbjct: 416 --YDV-----MKN----CWHLDAATRPTFLQLREQLE 441

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  119 bits (300), Expect = 6e-31
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)

Query: 116 EKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
               LG G FG V +GV         VA+K L             RE +++    +  ++
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RLIG C      +LV        +   L   +     +       +    + G++YL E 
Sbjct: 74  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 129

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 286
                +HRD+ A NVLL     A + DFGL+K +    +  T +  G           AP
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----AP 182

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           E ++  K S R+DV+ YG+ + E ++ GQ+   + +++   +V+       +E+ KR++ 
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMEC 234

Query: 346 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +    L   Y +     M      C     EDRP    V + + 
Sbjct: 235 PPECPPEL---YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 268

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  119 bits (300), Expect = 6e-31
 Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 49/297 (16%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
              LG+  FGKVY+G L           VA+K L D         F+ E  + +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RV 218
           ++ L+G  T      +++ +  +  +   L    P   V      +             +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
               A G+EYL  H    ++H+D+   NVL+ +     + D GL +  +V   +    + 
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYKLLG 188

Query: 279 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 334
            ++  I   APE +  GK S  +D++ YG++L E+ + G +   +     + DV+     
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQ-DVV----- 240

Query: 335 KKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + +   + L    D    +   Y +     MI+    C    P  RP   ++   L 
Sbjct: 241 EMIRNRQVLPCPDDCPAWV---YAL-----MIE----CWNEFPSRRPRFKDIHSRLR 285

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  118 bits (298), Expect = 9e-31
 Identities = 65/279 (23%), Positives = 108/279 (38%), Gaps = 37/279 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              LG G FG V  G       VAVK + +      +  F +E + +    H  L++  G
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            C+      +V  ++ N  +   LR    G      +    +      G+ +L  H   +
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL---EMCYDVCEGMAFLESH---Q 124

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 293
            IHRD+ A N L+D D    V DFG+ + V     +      GT   +   APE     K
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 294 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 350
            S ++DV+ +GI++ E+ + G+    +       +V+      K+ +  RL         
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP--YDLYTNS-EVV-----LKVSQGHRLYRPHLASDT 233

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   Y I     M      C    PE RP   +++  +E
Sbjct: 234 I---YQI-----MYS----CWHELPEKRPTFQQLLSSIE 260

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  118 bits (298), Expect = 1e-30
 Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 40/281 (14%)

Query: 119 VLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
            +G+G FG V++G+          VA+K   +  S      F +E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
           IG  T      ++        +   L+  K    +   +     A   +  L YL     
Sbjct: 82  IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI---LYAYQLSTALAYLESK-- 135

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLST 291
            + +HRD+ A NVL+  +    +GDFGL++ ++    +   +       I   APE ++ 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESINF 191

Query: 292 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 348
            + +  +DV+ +G+ + E++  G +   F  ++   DV+      ++E  +RL    +  
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI-----GRIENGERLPMPPNCP 243

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             L   Y++     M +    C    P  RP  +E+   L 
Sbjct: 244 PTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 272

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (297), Expect = 1e-30
 Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 37/277 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              +G+G FG V  G    G KVAVK + +  +     AF  E  +++   H NL++L+G
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 81

Query: 177 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
                   L +V  +M   S+   LR    G  VL      + +L     +EYL  +   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
             +HRD+ A NVL+ ED  A V DFGL K     +      V+ T    APE L   K S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192

Query: 296 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 352
            ++DV+ +GI+L E+ + G+    + R+  + DV+      ++E+  ++DA       + 
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DVV-----PRVEKGYKMDAPDGCPPAV- 243

Query: 353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             Y +     M      C       RP+  ++   LE
Sbjct: 244 --YEV-----MKN----CWHLDAAMRPSFLQLREQLE 269

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  118 bits (299), Expect = 2e-30
 Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 65/309 (21%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
              +G+G FG+V++            T VAVK L +  S    A FQRE  +++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 171 LLRLIGFCTTPTERLLVYPFMQN--------------------LSVAYRLREIKPGEPVL 210
           +++L+G C       L++ +M                        ++ R R   PG P L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
               +  +A   A G+ YL E    K +HRD+   N L+ E+    + DFGL++  ++  
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR--NIYS 226

Query: 271 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 324
            +           I      PE +   + +  +DV+ YG++L E+ + G +   +  +  
Sbjct: 227 ADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAH 282

Query: 325 EDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 380
           E+   ++ +V+    L   E     +        YN+     M      C    P DRP+
Sbjct: 283 EE---VIYYVRDGNILACPENCPLEL--------YNL-----MRL----CWSKLPADRPS 322

Query: 381 MSEVVRMLE 389
              + R+L+
Sbjct: 323 FCSIHRILQ 331

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  118 bits (298), Expect = 2e-30
 Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 43/286 (15%)

Query: 117 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           + ++G G  G+V  G L         VA+K L    +      F  E  ++    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL G  T     ++V  +M+N S+   LR     +     +    +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 286
                +HRD+ A NVL+D +    V DFGL+++++       T   G      T    AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           E ++    S  +DV+ +G+++ E++  G+R   +  +    DV+       +E   RL A
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNR-DVI-----SSVEEGYRLPA 275

Query: 346 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            +     L   + +     M+     C       RP  S++V +L+
Sbjct: 276 PMGCPHAL---HQL-----MLD----CWHKDRAQRPRFSQIVSVLD 309

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  117 bits (295), Expect = 3e-30
 Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 55/289 (19%)

Query: 119 VLGQGGFGKVYRGVL---ADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRL 174
            LG G FG V +G          VAVK L  +   P        E  ++    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 234
           IG C   +  +LV    +   +   L++ +     +       +    + G++YL E   
Sbjct: 84  IGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES-- 136

Query: 235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAPEY 288
              +HRD+ A NVLL     A + DFGL+K +   +     Q  G           APE 
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191

Query: 289 LSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---- 343
           ++  K S ++DV+ +G+++ E  + GQ+   +  ++   +V        LE+ +R+    
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGS-EVT-----AMLEKGERMGCPA 243

Query: 344 ---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                +        Y++     M      C     E+RP  + V   L 
Sbjct: 244 GCPREM--------YDL-----MNL----CWTYDVENRPGFAAVELRLR 275

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (293), Expect = 7e-30
 Identities = 69/297 (23%), Positives = 130/297 (43%), Gaps = 50/297 (16%)

Query: 117 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           K  LG+G FGKV+     +         VAVK L D  +      FQRE E+++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR------------V 218
           +++  G C      ++V+ +M++  +   LR   P   +L     ++            +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A   A G+ YL        +HRD+   N L+  +    +GDFG+++  DV  T+      
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 193

Query: 279 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 334
            TM  I    PE +   K +  +DV+ +G++L E+ T G++   + +L    +V+     
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNT-EVI----- 245

Query: 335 KKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           + + + + L+      + +   Y++     M+     C Q  P+ R  + E+ ++L 
Sbjct: 246 ECITQGRVLERPRVCPKEV---YDV-----MLG----CWQREPQQRLNIKEIYKILH 290

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  116 bits (292), Expect = 8e-30
 Identities = 80/280 (28%), Positives = 126/280 (45%), Gaps = 39/280 (13%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
              LG G FG+V+ G     TKVAVK L           F  E  ++    H+ L+RL  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75

Query: 177 FCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
             T  P    ++  +M+N S+   L+   P    L       +A   A G+ ++ E    
Sbjct: 76  VVTQEPI--YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER--- 128

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 292
             IHRD++AAN+L+ +     + DFGLA+L+   + N  T   G    I   APE ++ G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 293 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--R 349
             + ++DV+ +GI+L E+VT G+    +  +    +V+     + LER  R+    +   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNP-EVI-----QNLERGYRMVRPDNCPE 237

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            L   Y +     M     LC +  PEDRP    +  +LE
Sbjct: 238 EL---YQL-----M----RLCWKERPEDRPTFDYLRSVLE 265

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (292), Expect = 9e-30
 Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 37/280 (13%)

Query: 117 KNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
           K+ LG G +G+VY GV       VAVK L   E       F +E  ++    H NL++L+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
           G CT      ++  FM   ++   LRE    E  +  V    +A   +  +EYL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK--- 130

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 292
             IHRD+ A N L+ E+    V DFGL++L+     +  T   G    I   APE L+  
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 293 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--R 349
           K S ++DV+ +G++L E+ T G     +  ++    V      + LE++ R++       
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS-QVY-----ELLEKDYRMERPEGCPE 239

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
            +   Y +     M      C Q +P DRP+ +E+ +  E
Sbjct: 240 KV---YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 267

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  117 bits (295), Expect = 2e-29
 Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 37/283 (13%)

Query: 117 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
             V+G G FG+V  G L         VA+K L    +      F  E  ++    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
           RL G  T     ++V  +M+N S+   LR+    +     +    +  G A G++YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYL 289
                +HRD+ A N+L++ +    V DFGL ++++       T  RG    I   +PE +
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-RGGKIPIRWTSPEAI 222

Query: 290 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
           +  K +  +DV+ YGI+L E+++ G+R   +  +  + DV+     K ++   RL   +D
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-DVI-----KAVDEGYRLPPPMD 274

Query: 349 --RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               L   Y +     M+     C Q    +RP   ++V +L+
Sbjct: 275 CPAAL---YQL-----MLD----CWQKDRNNRPKFEQIVSILD 305

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  118 bits (298), Expect = 2e-29
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 39/279 (13%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
             LG G FG+V+       TKVAVK +           F  E  ++    H  L++L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 178 CT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
            T  P    ++  FM   S+   L+                 +   A G+ ++ +     
Sbjct: 252 VTKEPI--YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 293
            IHRD++AAN+L+       + DFGLA++++    N  T   G    I   APE ++ G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 294 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 350
            + ++DV+ +GI+L+E+VT G+    +  +    +V+     + LER  R+    +    
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNP-EVI-----RALERGYRMPRPENCPEE 413

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L   YNI     M++    C +  PE+RP    +  +L+
Sbjct: 414 L---YNI-----MMR----CWKNRPEERPTFEYIQSVLD 440

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  115 bits (290), Expect = 3e-29
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 44/287 (15%)

Query: 117 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           + V+G G FG+VY+G+L          VA+K L    +      F  E  ++    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +RL G  +     +++  +M+N ++   LRE    +     +    +  G A G++YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ-----VRGTMGHIA 285
                 +HRD+ A N+L++ +    V DFGL++++ D  +   TT      +R T    A
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
           PE +S  K +  +DV+ +GI++ E++T G+R   +  L    +V+     K +    RL 
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNH-EVM-----KAINDGFRLP 270

Query: 345 AIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +D    +   Y +     M+Q    C Q     RP  +++V +L+
Sbjct: 271 TPMDCPSAI---YQL-----MMQ----CWQQERARRPKFADIVSILD 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (287), Expect = 9e-29
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 25/219 (11%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEM 162
           E +      + +  +G+G FG+V+R      G + AVK  RL  F           E+  
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVA 103

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALG 221
            +      ++ L G         +    ++  S+   ++++    E    +   +  AL 
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL- 160

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQ---- 276
              GLEYLH     +I+H DVKA NVLL  D     + DFG A  +       +      
Sbjct: 161 --EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           + GT  H+APE +       + D++    M+L ++ G  
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (286), Expect = 1e-28
 Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 52/309 (16%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
             + +   ++     LG+GGF  V     L DG   A+KR+            QRE +M 
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREADMH 80

Query: 164 SVAVHRNLLRLIGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
            +  H N+LRL+ +C           L+ PF +  ++   +  +K     L       + 
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT---- 275
           LG  RGLE +H        HRD+K  N+LL ++ + V+ D G      +           
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 276 ----QVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 327
                 R T+ + APE L + +S     ERTDV+  G +L  ++ G+    +  + ++ D
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGD 254

Query: 328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALLCTQASPEDRPA 380
            + L                   +    +I         +  ++   +      P  RP 
Sbjct: 255 SVAL------------------AVQNQLSIPQSPRHSSALWQLLNSMM---TVDPHQRPH 293

Query: 381 MSEVVRMLE 389
           +  ++  LE
Sbjct: 294 IPLLLSQLE 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  112 bits (282), Expect = 2e-28
 Identities = 64/213 (30%), Positives = 86/213 (40%), Gaps = 30/213 (14%)

Query: 119 VLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLL 172
            LG G FG V RG           VAVK L       P     F REV  +    HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYL 229
           RL G   TP    +V       S+  RLR+ +    +     +      A+  A G+ YL
Sbjct: 85  RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYL 137

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGH 283
                 + IHRD+ A N+LL       +GDFGL + +     +   Q             
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC--- 191

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQR 315
            APE L T   S  +D + +G+ L E+ T GQ 
Sbjct: 192 -APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 7e-28
 Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 42/290 (14%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQR 158
            E QL +      ++LG+G F +VY           +  K  +K      +P       +
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQ 116

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKR 217
            +E +  ++    ++           +LV       ++   +   K   E V+       
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 218 VALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----------DEDFEAVVGDFGLAKLV 266
            A+     +E +H+    +IIH D+K  N +L           D      + D G +  +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 267 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG------------ 313
            +       T    T G    E LS    + + D FG    +  ++ G            
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 314 QRAIDFSRLEEED------DVLL-LDHVKKLEREKRLDAIVDRNLNKNYN 356
           +    F RL   D       V+L +     L     L   + +   ++Y 
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (277), Expect = 1e-27
 Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 52/292 (17%)

Query: 117 KNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 168
              LGQG F K+++GV            T+V +K L          +F     M+S   H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSH 71

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           ++L+   G C    E +LV  F++  S+   L++    +  ++ + +  VA   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTNVTTQ-VRG 279
           L E+    +IH +V A N+LL  + +          + D G++    V   ++  + +  
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQERIPW 183

Query: 280 TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 337
                 PE +   K+ +  TD + +G  L E+ + G +    S L+ +   L     +  
Sbjct: 184 V----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQ-RKL-----QFY 231

Query: 338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           E   +L A     L    N+     +      C    P+ RP+   ++R L 
Sbjct: 232 EDRHQLPAPKAAEL---ANL-----INN----CMDYEPDHRPSFRAIIRDLN 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (270), Expect = 1e-26
 Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            +F     LG+GGFG V+      D    A+KR+             REV+ ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 171 LLRLIGF---------CTTPTERLLVYPFMQ---NLSVAYRLREIKPGEPVLDWVTRKRV 218
           ++R                 + ++ +Y  MQ     ++   +      E   +      +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD----------- 267
            L  A  +E+LH      ++HRD+K +N+    D    VGDFGL   +D           
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 268 -VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 326
                  T QV GT  +++PE +     S + D+F  G++L EL+       FS      
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FS------ 228

Query: 327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNI--QEVETMIQVALLCTQASPEDRPAMSEV 384
                    ++ER + L  + +      +         M+Q        SP +RP    +
Sbjct: 229 --------TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI 277

Query: 385 VR 386
           + 
Sbjct: 278 IE 279

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (274), Expect = 1e-26
 Identities = 35/233 (15%), Positives = 60/233 (25%), Gaps = 40/233 (17%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMI----------SV 165
           VLGQ              G    V      E P  +A    + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 166 AVHRNLLRLIGFCTTP-----------------TERLLVYPFMQ--NLSVAYRLREIKPG 206
            VH   +        P                   R  +YP MQ    +    L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 207 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 266
              L    R ++ L   R L  LH +    ++H  ++  +++LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 267 DVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQ 314
                +   +        A   L          +   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  107 bits (269), Expect = 1e-26
 Identities = 62/298 (20%), Positives = 122/298 (40%), Gaps = 60/298 (20%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            +F E  ++G GGFG+V++     DG    +KR+  + +       +REV+ ++   H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNN----EKAEREVKALAKLDHVN 65

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRL-------------REIK-------PGEPVL 210
           ++   G                + S    L             + I+            L
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
           +   +        +G++Y+H     K+I+RD+K +N+ L +  +  +GDFGL   +    
Sbjct: 126 ELFEQ------ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--N 174

Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 330
               T+ +GT+ +++PE +S+    +  D++  G++L EL+                   
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------- 219

Query: 331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 388
                  E  K    + D  ++  ++ ++ +T++Q         PEDRP  SE++R L
Sbjct: 220 ----TAFETSKFFTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  107 bits (269), Expect = 2e-26
 Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 19/214 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVH 168
            NF  +  +G+G F +VYR   L DG  VA+K  ++ D       A   +E++++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGA 222
            N+++         E  +V        ++  ++  K      P   V  +  +       
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
              LE++H     +++HRD+K ANV +       +GD GL +    + T   + V GT  
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 316
           +++PE +     + ++D++  G +L E+   Q  
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  107 bits (268), Expect = 2e-26
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 164
           E     D   ++ VLG+G +G VY G  L++  ++A+K +              E+ +  
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHK 74

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVAL 220
              H+N+++ +G  +      +    +   S++  LR     +K  E  + + T++ +  
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 132

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRG 279
               GL+YLH++   +I+HRD+K  NVL++     + + DFG +K +        T   G
Sbjct: 133 ---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTG 185

Query: 280 T---MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 315
           T   M   APE +  G     +  D++  G  ++E+ TG+ 
Sbjct: 186 TLQYM---APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (269), Expect = 3e-26
 Identities = 59/313 (18%), Positives = 136/313 (43%), Gaps = 37/313 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           + +     +G+G FGK        DG +  +K +     S       +REV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARG 225
           N+++            +V  + +   +  R+   K      + +LDW  +          
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L+++H+    KI+HRD+K+ N+ L +D    +GDFG+A++++         + GT  +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           PE       + ++D++  G +L EL T + A +   ++      L+  +           
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIISGSFPP---- 244

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 405
                ++ +Y+  ++ +++       + +P DRP+++ +   LE   +A+R E++   ++
Sbjct: 245 -----VSLHYS-YDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQL 292

Query: 406 TRRQEYERLQRRF 418
              +   +   +F
Sbjct: 293 IAEEFCLKTFSKF 305

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 4e-26
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH 168
            + F++   +G+G FG+V++G+       VA+K + D E    +    Q+E+ ++S    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
             + +  G     T+  ++  ++   S    L      E  +  + R        +GL+Y
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDY 134

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MGHIA 285
           LH     K IHRD+KAANVLL E  E  + DFG+A  +   +    T V GT   M   A
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM---A 187

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           PE +       + D++  GI  +EL  G+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGE 216

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  107 bits (268), Expect = 5e-26
 Identities = 29/301 (9%), Positives = 65/301 (21%), Gaps = 50/301 (16%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
            L  G    V+    +      A+K   +    S              +  +  +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 176 GFC--------------------------TTPTERLLVYPFMQ--NLSVAYRLREIKPGE 207
                                              LL+ P        +   L  +    
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                +    +     R    L       ++H      N+ +  D   ++GD        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241

Query: 268 VRKTNVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
            +           + +   E+L+   +  +   + +  G+ +  +        F  +   
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299

Query: 326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 385
                     ++     L       L        V+T+I    L        R    E +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLP-----DFVKTLIG-RFL--NFDRRRRLLPLEAM 351

Query: 386 R 386
            
Sbjct: 352 E 352

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 8e-26
 Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 71/320 (22%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-M 162
           + ++L       + VL +GGF  VY    +  G + A+KRL        + A  +EV  M
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR----- 217
             ++ H N+++     +   E           +    L E+  G+ +++++ +       
Sbjct: 80  KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133

Query: 218 -------VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
                  +     R ++++H    P IIHRD+K  N+LL       + DFG A  +    
Sbjct: 134 SCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 271 TNVTT-----------QVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRA 316
               +               T  +  PE +    +    E+ D++  G +L  L   Q  
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

Query: 317 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALL 369
             F     ED   L               I    +N  Y+I           ++I+  L 
Sbjct: 253 --F-----EDGAKL--------------RI----VNGKYSIPPHDTQYTVFHSLIRAML- 286

Query: 370 CTQASPEDRPAMSEVVRMLE 389
             Q +PE+R +++EVV  L+
Sbjct: 287 --QVNPEERLSIAEVVHQLQ 304

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 1e-25
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+GGF K +           A K +  +    P        E+ +     H++++   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 227
           F         V+  +          E+     +L+    RK +    AR        G +
Sbjct: 83  FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V+           GT  +IAPE
Sbjct: 130 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTG 313
            LS    S   DV+  G ++  L+ G
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG 211

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 1e-25
 Identities = 62/310 (20%), Positives = 120/310 (38%), Gaps = 41/310 (13%)

Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVE 161
             +  +L  D+F + + LG G  G V++      G  +A K +     P       RE++
Sbjct: 24  KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83

Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVAL 220
           ++       ++   G   +  E  +    M   S+   L++     E +L      +V++
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSI 138

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVR 278
              +GL YL E    KI+HRDVK +N+L++   E  + DFG++ +L+D +  + V     
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-------RAIDFSRLEEEDDVLLL 331
           GT  +++PE L     S ++D++  G+ L+E+  G+                 + +    
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMI---QVALL---------------CTQA 373
           +   +     R       +      I E+   I       L               C   
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311

Query: 374 SPEDRPAMSE 383
           +P +R  + +
Sbjct: 312 NPAERADLKQ 321

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (265), Expect = 1e-25
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+GGF K +           A K +  +    P        E+ +     H++++   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 227
           F         V+  +          E+     +L+    RK +    AR        G +
Sbjct: 109 FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH +   ++IHRD+K  N+ L+ED E  +GDFGLA  V+           GT  +IAPE
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 211

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTG 313
            LS    S   DV+  G ++  L+ G
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVG 237

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (263), Expect = 1e-25
 Identities = 51/208 (24%), Positives = 71/208 (34%), Gaps = 17/208 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMI-SVAVH 168
            +F   + LG G +G+V++     DG   AVKR    F  P   A    EV     V  H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGL 226
              +RL           L        S+            E  +               L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQV-----WGYLRDTLLAL 170

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
            +LH      ++H DVK AN+ L       +GDFGL   +            G   ++AP
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAP 225

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E L  G      DVF  G+ +LE+    
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEVACNM 252

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 2e-25
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHR 169
           D++  + V+G G    V          KVA+KR+ + E          +E++ +S   H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVA------YRLREIKPG---EPVLDWVTRKRVAL 220
           N++          E  LV   +   SV           E K G   E  +  + R+    
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 280
               GLEYLH++     IHRDVKA N+LL ED    + DFG++  +         +VR T
Sbjct: 130 -VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 281 M-GH---IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
             G    +APE +   +    + D++ +GI  +EL TG 
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (264), Expect = 3e-25
 Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 25/220 (11%)

Query: 111 TDNFSEKNVLGQG--GFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISV 165
              +    V+G+G      V        G  V V+R+ + E+   +     Q E+ +  +
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKL 82

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGA 222
             H N++          E  +V  FM   S    +         E  + ++ +     G 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GV 137

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVD--VRKTNVTTQVRG 279
            + L+Y+H       +HR VKA+++L+  D +  +        ++    R+  V    + 
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 280 TMGHI---APEYLSTGKS--SERTDVFGYGIMLLELVTGQ 314
           ++  +   +PE L         ++D++  GI   EL  G 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  107 bits (269), Expect = 3e-25
 Identities = 48/281 (17%), Positives = 93/281 (33%), Gaps = 51/281 (18%)

Query: 119 VLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
            +  GG G +Y  +    +G  V +K L         A    E + ++  VH +++++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 177 FCTTPTERLLVYPF--MQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           F            +  M+     Y     L+  K  +  +         L     L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
                 +++ D+K  N++L E+ +  + D G        + N    + GT G  APE + 
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRINSFGYLYGTPGFQAPE-IV 249

Query: 291 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 350
               +  TD++  G  L  L       +   ++   +   +     L+       ++ R 
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV-----LKTYDSYGRLLRRA 304

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLEG 390
           ++ +                    P  R     E+   L G
Sbjct: 305 IDPD--------------------PRQRFTTAEEMSAQLTG 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  103 bits (259), Expect = 4e-25
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 32/229 (13%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
             +F E  VLGQG FG+V +     D    A+K++    +    +    EV +++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---GAAR-- 224
            ++R           +     ++  S  +   E      + D +  + +        R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------ 267
                 L Y+H      IIHRD+K  N+ +DE     +GDFGLAK V             
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 268 --VRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTG 313
                 N+T+ + GT  ++A E L  TG  +E+ D++  GI+  E++  
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 8e-25
 Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 42/222 (18%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 171
           +F  K+VLG G  G +    + D   VAVKR+     P   +   REV+ +     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---------- 221
           +R              Y  +          E+     + ++V +K  A            
Sbjct: 81  IRYFCTEKDRQF---QYIAI----------ELCAAT-LQEYVEQKDFAHLGLEPITLLQQ 126

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLAKLV--DVRKTNVT 274
              GL +LH      I+HRD+K  N+L+          A++ DFGL K +       +  
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 275 TQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTG 313
           + V GT G IAPE LS       +   D+F  G +   +++ 
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  100 bits (252), Expect = 3e-24
 Identities = 57/258 (22%), Positives = 98/258 (37%), Gaps = 44/258 (17%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLLR 173
           LG GG   VY         KVA+K +                F+REV   S   H+N++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPP---REKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 174 LIGFCTTPTERLLVYPFMQNLSVAY---------RLREIKPGEPVLDWVTRKRVALGAAR 224
                        +    +     Y          L E       L   T          
Sbjct: 76  -------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           G+++ H+    +I+HRD+K  N+L+D +    + DFG+AK +       T  V GT+ + 
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQR--------AIDFSRLEEEDDVLLLDHVKK 336
           +PE      + E TD++  GI+L E++ G+         +I    +++    +  D  K 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 337 LEREKRLDAIVDRNLNKN 354
           + +   L  ++ R   K+
Sbjct: 240 IPQS--LSNVILRATEKD 255

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (254), Expect = 5e-24
 Identities = 34/238 (14%), Positives = 64/238 (26%), Gaps = 51/238 (21%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA---------------------- 155
           VLGQ              G    V      E P  +A                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 156 -----FQREVEMISVAVHRNLLRLIGFCTTPT--ERLLVYPFMQ--NLSVAYRLREIKPG 206
                F    +++     + ++R+           R  +YP MQ    +    L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 207 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 266
              L    R ++ L   R L  LH +    ++H  ++  +++LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 267 DVRKTNVTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTG 313
             R          + G   PE  +               +   D +  G+++  +   
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  100 bits (251), Expect = 5e-24
 Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 30/220 (13%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 171
            +S    +G GG  KV++ +       A+K +  +        +++ E+  ++     + 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 172 --LRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
             +RL  +  T      +Y  M   N+ +   L++ K     +D   RK         + 
Sbjct: 89  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 141

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 285
            +H+H    I+H D+K AN L+ +     + DFG+A  +    T+V   +QV GT+ ++ 
Sbjct: 142 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 196

Query: 286 PEYL-----------STGKSSERTDVFGYGIMLLELVTGQ 314
           PE +           S  K S ++DV+  G +L  +  G+
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 99.6 bits (249), Expect = 7e-24
 Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 39/289 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +++     +G G +G+  +    +DG  +  K L     +         EV ++    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 170 NLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           N++R        T   L Y  M           ++   + R+    E VL  +T+     
Sbjct: 66  NIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ----- 119

Query: 221 GAARGLEYLHEHCNP--KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
                L+  H   +    ++HRD+K ANV LD      +GDFGLA++++   +   T V 
Sbjct: 120 -LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
           GT  +++PE ++    +E++D++  G +L EL            +E     L   +++ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIREGK 232

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
             +         +   Y+  E+  +I             RP++ E++  
Sbjct: 233 FRR---------IPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILEN 268

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (252), Expect = 8e-24
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAV 167
              FS+   +G G FG VY    + +   VA+K+   +  +S        +EV  +    
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARG 225
           H N ++  G         LV  +    S +    + +    E  +  VT      GA +G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTH-----GALQG 166

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MG 282
           L YLH H    +IHRDVKA N+LL E     +GDFG A ++    + V     GT   M 
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM- 217

Query: 283 HIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQ 314
             APE +      +   + DV+  GI  +EL   +
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (250), Expect = 9e-24
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
                    +G+G  G V        G +VAVK + D            EV ++    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++ +        E  ++  F+Q  ++   + +++  E  +  V          + L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-----VLQALAYL 157

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT---MG 282
           H      +IHRD+K+ ++LL  D    + DFG  A++      RK+ V     GT   M 
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWM- 208

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             APE +S    +   D++  GIM++E+V G+
Sbjct: 209 --APEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  100 bits (250), Expect = 2e-23
 Identities = 47/220 (21%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 171
            +S    +G GG  KV++ +       A+K +  +        +++ E+  ++     + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 172 --LRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
             +RL  +  T      +Y  M+  N+ +   L++ K     +D   RK         + 
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 169

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 285
            +H+H    I+H D+K AN L+ +     + DFG+A  +    T+V   +QV G + ++ 
Sbjct: 170 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMP 224

Query: 286 PEYLS-----------TGKSSERTDVFGYGIMLLELVTGQ 314
           PE +              K S ++DV+  G +L  +  G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL--LRL 174
             +G GG  KV++ +       A+K +  +        +++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 175 IGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
             +  T      +Y  M+  N+ +   L++ K     +D   RK         +  +H+H
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPEYL- 289
               I+H D+K AN L+ +     + DFG+A  +    T+V   +QV GT+ ++ PE + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182

Query: 290 ----------STGKSSERTDVFGYGIMLLELVTGQ 314
                     S  K S ++DV+  G +L  +  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
              ++    +GQG  G VY  + +A G +VA++++ + +          E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++  +       E  +V  ++   S+   + E    E  +  V R+       + LE+L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFL 132

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MGHIAP 286
           H +   ++IHRD+K+ N+LL  D    + DFG    +   ++  +T V GT   M   AP
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM---AP 185

Query: 287 EYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           E ++      + D++  GIM +E++ G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 40/230 (17%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVK----------------RLTDFESPGGD 153
           +++     L QG F K+    L   D    A+K                           
Sbjct: 31  NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGE 207
             F+ E+++I+   +   L   G  T   E  ++Y +M+N          + L +     
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC- 146

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 266
            +   V +  +         Y+H   N  I HRDVK +N+L+D++    + DFG ++ + 
Sbjct: 147 FIPIQVIKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 267 -DVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 313
               K       RGT   + PE+ S     +  + D++  GI L  +   
Sbjct: 204 DKKIKG-----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 25/215 (11%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMIS 164
           Q A ++F     LG+G FG VY          +A+K L     E  G +   +REVE+ S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGEPVLDWVTRKRV 218
              H N+LRL G+    T   L+  +         L    +  E           T   +
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---------QRTATYI 115

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
               A  L Y H     ++IHRD+K  N+LL    E  + DFG +      +        
Sbjct: 116 TE-LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--- 168

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           GT+ ++ PE +      E+ D++  G++  E + G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.9 bits (249), Expect = 5e-23
 Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 58/305 (19%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVE-MISVAVHR 169
           +    + +LG G  G V       G  VAVKR+  DF           E++ +     H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69

Query: 170 NLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTR---KRVALGAAR 224
           N++R     TT     +    ++  NL++   +      +  L          +    A 
Sbjct: 70  NVIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 271
           G+ +LH     KIIHRD+K  N+L+              E+   ++ DFGL K +D  ++
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 272 NVTTQVR---GTMGHIAPEYLSTGKSSERT-------DVFGYGIMLLELVTGQRAIDFSR 321
           +  T +    GT G  APE L    + +         D+F  G +   +++  +     +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 322 LEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRP 379
              E +++         +     +++    +L        +  MI          P  RP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDL--------ISQMIDH-------DPLKRP 288

Query: 380 AMSEV 384
              +V
Sbjct: 289 TAMKV 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 96.8 bits (242), Expect = 6e-23
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 18/201 (8%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+G F  VYR   +  G +VA+K +        G     Q EV++     H ++L L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 236
           +        LV     N  +   L+     +P  +   R  +      G+ YLH H    
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMH-QIITGMLYLHSH---G 132

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIAPEYLSTG 292
           I+HRD+  +N+LL  +    + DFGLA  + +      T     + GT  +I+PE  +  
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPEIATRS 187

Query: 293 KSSERTDVFGYGIMLLELVTG 313
                +DV+  G M   L+ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 32/219 (14%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
            + +     LG G FGKVY+      G   A K + + +S      +  E+E+++   H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            +++L+G      +  ++  F    +V       +    EP +  V R          L 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALN 131

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT--- 280
           +LH     +IIHRD+KA NVL+  + +  + DFG+ AK +     R + +     GT   
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYW 183

Query: 281 MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 314
           M   APE +      +     + D++  GI L+E+   +
Sbjct: 184 M---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 30/228 (13%)

Query: 95  AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPG 151
           A  ++ +  +       D+F     LG+G FG VY      +   +A+K L  +  E  G
Sbjct: 2   ALAEMPKRKFT-----IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 205
            +   +RE+E+ S   H N+LR+  +        L+  F         L    R  E   
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--- 113

Query: 206 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
                   +   +    A  L Y HE    K+IHRD+K  N+L+    E  + DFG +  
Sbjct: 114 ------QRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               +        GT+ ++ PE +      E+ D++  G++  E + G
Sbjct: 164 APSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 24/231 (10%)

Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 155
           G+LK    +      ++  +   +G+G +G V + V    G  +AVKR+           
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66

Query: 156 FQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFM-----QNLSVAYRLREIKPGEPV 209
              +++++   +    +++  G      +  +    M     +     Y + +    E +
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD- 267
           L  +T   V     + L +L E  N KIIHRD+K +N+LLD      + DFG+  +LVD 
Sbjct: 127 LGKITLATV-----KALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179

Query: 268 VRKTNVTTQVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 314
           + KT       G   ++APE +    S      R+DV+  GI L EL TG+
Sbjct: 180 IAKTRDA----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 44/230 (19%), Positives = 74/230 (32%), Gaps = 37/230 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAV- 167
           T  F E   +G G FG V++ V   DG   A+KR          +    REV   +V   
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 168 HRNLLRLIGFCTTPTERLLVYPFM---QNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
           H +++R         E   +          S+A  + E             K + L   R
Sbjct: 70  HSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-------------------GDFGLAKL 265
           GL Y+H      ++H D+K +N+ +                           GD G    
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           +   +        G    +A E L    +   + D+F   + ++     +
Sbjct: 184 ISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGGDAAFQREVEMISVA 166
            + F     LG+G +G VY+ +    G  VA+K++   +D +         +E+ ++   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQC 81

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAAR 224
              ++++  G     T+  +V  +    SV+   RLR     E  +  + +        +
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLK 136

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---M 281
           GLEYLH     + IHRD+KA N+LL+ +  A + DFG+A  +        T + GT   M
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWM 192

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
              APE +     +   D++  GI  +E+  G+
Sbjct: 193 ---APEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVH 168
              F    ++G G +G+VY+G  +  G   A+K + D      +   ++E+ M+   + H
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG-DEEEEIKQEINMLKKYSHH 80

Query: 169 RNLLRLIG-----FCTTPTERL-LVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVA 219
           RN+    G           ++L LV  F    SV   ++  K     E  + ++ R    
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---- 136

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 279
               RGL +LH+H   K+IHRD+K  NVLL E+ E  + DFG++  +D       T + G
Sbjct: 137 -EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191

Query: 280 T---MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 314
           T   M   APE ++  ++ +     ++D++  GI  +E+  G 
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 34/212 (16%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLL 172
           ++G+GG G VY          VA+K +         D       QRE          +++
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETL---SSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---------RVALGAA 223
                         ++ F +     Y    +  G  +   + R+          +     
Sbjct: 98  P-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             L+  H        HRDVK  N+L+  D  A + DFG+A      K        GT+ +
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           +APE  S   ++ R D++    +L E +TG  
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSP 233

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 40/213 (18%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--------RLTDFESPGGDAAFQREVE 161
            +N+  K +LG+G    V R +      + AVK          +  E      A  +EV+
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 162 -MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 216
            +  V+ H N+++L     T T   LV+  M+             GE + D++T K    
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GE-LFDYLTEKVTLS 122

Query: 217 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
            +      R     +  LH+     I+HRD+K  N+LLD+D    + DFG +  +D    
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PG 177

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
               +V GT  ++APE +    +       GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 16/215 (7%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
              +  K  LG GGFG V R +    G +VA+K+     SP     +  E++++    H 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 170 NLLRLIGFCTTPTE------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           N++          +       LL   + +   +   L + +    + +   R  +    +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDIS 131

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGT 280
             L YLHE+   +IIHRD+K  N++L    + +   + D G AK +D  +  + T+  GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGT 186

Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           + ++APE L   K +   D + +G +  E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLLR 173
           LG GG  +V+    L D   VAVK L  D      D +    F+RE +  +   H  ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADL---ARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 174 L--IGFCTTPTERLLVYPFMQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLE 227
           +   G         L Y  M+     Y     LR+I   E  +       V   A + L 
Sbjct: 77  VYDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIA 285
           + H++    IIHRDVK AN+++       V DFG+A+ +     +VT    V GT  +++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
           PE         R+DV+  G +L E++TG+ 
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 55/293 (18%), Positives = 98/293 (33%), Gaps = 28/293 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
             +   ++LGQG    V+RG     G   A+K   +           RE E++    H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 171 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           +++L       T R   L+  F    S+   L E      + +      V      G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127

Query: 229 LHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           L E+    I+HR++K  N++     D      + DFG A+ ++         + GT  ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYL 182

Query: 285 APEYLSTGKS--------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 336
            P+                   D++  G+      TG            +  ++     K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238

Query: 337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   K   AI      +N  I     M     L         P ++    +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-------RLTDFESPGGDAAFQREVE- 161
              +  K+V+G+G    V R V  A G + AVK       RL+  +      A +RE   
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----- 216
           +  VA H +++ LI    + +   LV+  M+             GE + D++T K     
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GE-LFDYLTEKVALSE 199

Query: 217 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
           +      R     + +LH +    I+HRD+K  N+LLD++ +  + DFG +    +    
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGE 254

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
              ++ GT G++APE L   K S      GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 25/221 (11%)

Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-S 164
           +++  D+      LG+G +G V +   +  G  +AVKR+    +         ++++   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPG---EPVLDWVTRKRVAL 220
                  +   G      +  +    M  +L   Y+    K     E +L  +    V  
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV-- 119

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD--VRKTNVTTQV 277
              + LE+LH      +IHRDVK +NVL++   +  + DFG+   LVD   +  +     
Sbjct: 120 ---KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---- 170

Query: 278 RGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 314
            G   ++APE ++   +    S ++D++  GI ++EL   +
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 22/228 (9%)

Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 155
           G L     R  Q   ++      +G G  G+V++      G  +AVK++    +   +  
Sbjct: 11  GYLTIGGQR-YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKR 69

Query: 156 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWV 213
              +++ ++       +++  G   T T+  +    M   +   + R   P  E +L  +
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129

Query: 214 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD-VRKT 271
           T   V     + L YL E     +IHRDVK +N+LLDE  +  + DFG+  +LVD   K 
Sbjct: 130 TVAIV-----KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 314
                  G   ++APE +     ++     R DV+  GI L+EL TGQ
Sbjct: 183 RSA----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 28/293 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
             +   ++LGQG    V+RG     G   A+K   +           RE E++    H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 171 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           +++L       T R   L+  F    S+   L E      + +      V      G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127

Query: 229 LHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           L E+    I+HR++K  N++    ED ++V    DFG A+ ++       +   GT  ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYL 182

Query: 285 APEYLSTGKSSERT--------DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 336
            P+        +          D++  G+      TG            +  ++     K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238

Query: 337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   K   AI      +N  I     M     L         P ++    +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 39/216 (18%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVE-MISV---AVH 168
           +LG+GGFG V+ G  L D  +VA+K     R+  +           EV  +  V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 224
             ++RL+ +  T    +LV                 P + + D++T K  +  G +R   
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVR 278
                 +++ H      ++HRD+K  N+L+D       + DFG   L  +     T    
Sbjct: 146 GQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDFD- 199

Query: 279 GTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 313
           GT  +  PE++S  +  +    V+  GI+L ++V G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.0 bits (226), Expect = 7e-20
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 14/226 (6%)

Query: 96  FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPG 151
           F +  ++ W E Q    D F +  VLG+GGFG+V+   +    K+ A K+L     +   
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
           G      E ++++    R ++ L     T T+  LV   M    + Y +  +    P   
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287

Query: 212 WVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
                R     A+   GLE+LH+     II+RD+K  NVLLD+D    + D GLA  +  
Sbjct: 288 ---EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +T       GT G +APE L   +     D F  G+ L E++  +
Sbjct: 342 GQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 56/243 (23%)

Query: 93  RIAFGQLKRYSWR-------ELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVA 140
            IA    +   +        +  +      ++      LG G  G+V          KVA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164

Query: 141 VK-------RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 193
           ++        +            + E+E++    H  ++++  F          Y  +  
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVL-- 218

Query: 194 LSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKA 244
                   E+  G  + D  V  KR+     +         ++YLHE+    IIHRD+K 
Sbjct: 219 --------ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKP 267

Query: 245 ANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVF 301
            NVLL   +ED    + DFG +K++   +T++   + GT  ++APE L +  ++      
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA------ 319

Query: 302 GYG 304
           GY 
Sbjct: 320 GYN 322

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 17/226 (7%)

Query: 96  FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPG 151
           F +  ++ W E Q  T + F +  VLG+GGFG+V    +    K+ A K+L     +   
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
           G+A    E +++     R ++ L     T     LV   M    + + +     G+    
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP 284

Query: 212 WVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
                R    AA    GLE LH     +I++RD+K  N+LLD+     + D GLA    V
Sbjct: 285 ---EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV--HV 336

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +        GT+G++APE +   + +   D +  G +L E++ GQ
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 174
           +LG+G +GKV   +      + AVK   +      P G+A  ++E++++    H+N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-VLDWVTRKRVALGAAR--------G 225
           +       ++ + Y  M+     Y       G   +LD V  KR  +  A         G
Sbjct: 72  VDVLYNEEKQKM-YMVME-----Y----CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMG 282
           LEYLH      I+H+D+K  N+LL       +   G+A+ +     +    T+Q  G+  
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176

Query: 283 HIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 313
              PE  +     S  + D++  G+ L  + TG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 37/214 (17%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVAVHR--N 170
           +LG GGFG VY G+ ++D   VA+K     R++D+           EV ++         
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR----- 224
           ++RL+ +   P   +L+                +P + + D++T +  +    AR     
Sbjct: 110 VIRLLDWFERPDSFVLILER------------PEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 225 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGT 280
               + + H      ++HRD+K  N+L+D +   + + DFG   L  ++ T  T    GT
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFD-GT 211

Query: 281 MGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 313
             +  PE++   +       V+  GI+L ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 9e-19
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 39/238 (16%)

Query: 96  FGQLKRYSWRELQ--LATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGG 152
           F +  ++   EL   L  ++FS   ++G+GGFG+VY    AD  K+ A+K L        
Sbjct: 171 FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------ 224

Query: 153 DAAFQR-EVEM----------ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL- 200
                +    +          +S      ++ +     TP +   +   M    + Y L 
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 201 REIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 257
           +     E          +   AA    GLE++H      +++RD+K AN+LLDE     +
Sbjct: 285 QHGVFSEA--------DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333

Query: 258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
            D GLA     +K +    V GT G++APE L  G + + + D F  G ML +L+ G 
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 33/219 (15%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 168
           ++ +     LG G +G+V          + A+K +     S   ++    EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 223
            N+++L  F        LV              E   G  + D +  +       A    
Sbjct: 96  PNIMKLYDFFEDKRNYYLVM-------------ECYKGGELFDEIIHRMKFNEVDAAVII 142

Query: 224 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
           +    G+ YLH+H    I+HRD+K  N+LL   ++D    + DFGL+ + +        +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKE 197

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
             GT  +IAPE L   K  E+ DV+  G++L  L+ G  
Sbjct: 198 RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 83.0 bits (205), Expect = 8e-18
 Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 36/175 (20%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------VRKTN 272
            +E+LH      ++HRD+K +N+    D    VGDFGL   +D                 
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 332
            T QV GT  +++PE +     S + D+F  G++L EL+       FS   E   ++   
Sbjct: 233 HTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII--- 283

Query: 333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 387
               + R  +   +  +         +   M+Q        SP +RP  ++++  
Sbjct: 284 --TDV-RNLKFPLLFTQ------KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            +F     +G+GGFG V+      D    A+KR+             REV+ ++   H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSV 196
           ++R                  +    
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLK 91

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)

Query: 107 LQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQRE 159
           +Q +T  FS++     VLG+G FG+V        G + AVK +     +      +  RE
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--- 216
           V+++    H N+++L  F        LV              E+  G  + D +  +   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVG-------------EVYTGGELFDEIISRKRF 123

Query: 217 --RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVD 267
               A    R    G+ Y+H++   KI+HRD+K  N+LL    +D    + DFGL+   +
Sbjct: 124 SEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
              +       GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 181 --ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
              F    VLG G F +V+       G   A+K +        D++ + E+ ++    H 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR 224
           N++ L     + T     Y  M          ++  G  + D +  +     + A    +
Sbjct: 67  NIVTLEDIYESTTH---YYLVM----------QLVSGGELFDRILERGVYTEKDASLVIQ 113

Query: 225 ----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQV 277
                ++YLHE+    I+HRD+K  N+L    +E+ + ++ DFGL+K+    +  + +  
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTA 167

Query: 278 RGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
            GT G++APE L+    S+  D +  G++ 
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 48/251 (19%), Positives = 77/251 (30%), Gaps = 51/251 (20%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 165
              +  K  +GQG +G V   +        A+K          +P      + EV ++  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 166 AVHRNLLRLIGFCTTPTERLLV------------------YPFMQNLSVAYRLREIKPGE 207
             H N+ RL           LV                      +      + +     E
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 208 PVLDWVTRKRVALG-----------AAR-------GLEYLHEHCNPKIIHRDVKAANVLL 249
              + +                    +         L YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201

Query: 250 --DEDFEAVVGDFGLAKLVDVRKTNVTTQVR---GTMGHIAPEYLSTG--KSSERTDVFG 302
             ++ FE  + DFGL+K            +    GT   +APE L+T       + D + 
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 303 YGIMLLELVTG 313
            G++L  L+ G
Sbjct: 262 AGVLLHLLLMG 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 37/228 (16%)

Query: 98  QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG 152
                S RE       F+E+     +LG+G FG+V +        + AVK +    +   
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 153 D-AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
           D +   REVE++    H N+++L       +   +V              E+  G  + D
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV---G----------ELYTGGELFD 110

Query: 212 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 259
            + ++       A    +    G+ Y+H+H    I+HRD+K  N+LL   ++D +  + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167

Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
           FGL+      +        GT  +IAPE L  G   E+ DV+  G++L
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 51/259 (19%)

Query: 100 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFES 149
           K+Y  + +++  D+  +       LG G FG V+R    A G   A K       +D E+
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200

Query: 150 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV 209
                  ++E++ +SV  H  L+ L        E +++Y FM              GE +
Sbjct: 201 ------VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GE-L 241

Query: 210 LDWVTRKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-- 257
            + V  +   +    A         GL ++HE+     +H D+K  N++        +  
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298

Query: 258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 317
            DFGL   +D           GT    APE          TD++  G++   L++G    
Sbjct: 299 IDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG---- 352

Query: 318 DFSRLEEEDDVLLLDHVKK 336
             S    E+D   L +VK 
Sbjct: 353 -LSPFGGENDDETLRNVKS 370

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 45/214 (21%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGD--AAFQREVEM 162
            D +     LG G  G+V          KVA+K     +     +   D     + E+E+
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALG 221
           +    H  ++++  F          Y  +          E+  G  + D  V  KR+   
Sbjct: 69  LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114

Query: 222 AAR--------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRK 270
             +         ++YLHE+    IIHRD+K  NVLL   +ED    + DFG +K++   +
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169

Query: 271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
           T++   + GT  ++APE L +  ++      GY 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 164
            D +     LG G F  V +    + G + A K     +             +REV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 219
             +H N++ L       T+ +L+   +              GE + D++ +K       A
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117

Query: 220 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 271
               +    G+ YLH     KI H D+K  N++L   +     + + DFGLA  ++    
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
                + GT   +APE ++        D++  G++   L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 33/217 (15%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           + + +   +G+G +G V++      G  VA+K+     + P       RE+ M+    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 170 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           NL+ L+          LV+ +    +     L E+   +  +     K +     + + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 283
            H+H     IHRDVK  N+L+ +     + DFG A+L+         +V     R     
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169

Query: 284 IAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 314
            +PE L               DV+  G +  EL++G 
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           + +    ++G+G +G V +      G  VA+K+     +         RE++++    H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 170 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           NL+ L+  C       LV+ F+   +     L +++     LD+   ++       G+ +
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 283
            H H    IIHRD+K  N+L+ +     + DFG A+ +         +V     R     
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191

Query: 284 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
            APE L       +  DV+  G ++ E+  G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 164
            D +     LG G F  V +    + G + A K     +             +REV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 219
             +H N++ L       T+ +L+   +              GE + D++ +K       A
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117

Query: 220 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 271
               +    G+ YLH     KI H D+K  N++L   +     + + DFGLA  ++    
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
                + GT   +APE ++        D++  G++   L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 164
            D++     LG G F  V +      G + A K     RL+           +REV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 219
              H N++ L       T+ +L+   +              GE + D++  K       A
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSG------------GE-LFDFLAEKESLTEDEA 110

Query: 220 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 271
               +    G+ YLH     +I H D+K  N++L      +    + DFG+A  ++    
Sbjct: 111 TQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AG 165

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           N    + GT   +APE ++        D++  G++   L++G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 31/211 (14%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           T+ +     LG+G F  V R V +  G + A   +   +    D    +RE  +  +  H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 223
            N++RL    +      L++  +              GE + + +  +       A    
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTG------------GE-LFEDIVAREYYSEADASHCI 116

Query: 224 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
           +     + + H+     ++HR++K  N+LL    +     + DFGLA  V+  +      
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
             GT G+++PE L      +  D++  G++L
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 52/232 (22%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVK-------------------------RLTDFESPGGD 153
           +G+G +G V       D T  A+K                              +  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 154 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 213
               +E+ ++    H N+++L+     P E  L           Y + E+    PV++  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELVNQGPVMEVP 129

Query: 214 TRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
           T K ++   AR        G+EYLH     KIIHRD+K +N+L+ ED    + DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQ 314
                  ++  V GT   +APE LS  +   S +  DV+  G+ L   V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 36/231 (15%)

Query: 100 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA 154
           K+Y  + +++   +  +       LG G FG V+R V  A G     K + +   P    
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93

Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 214
             + E+ +++   H  L+ L        E +L+  F+              GE + D + 
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE-LFDRIA 140

Query: 215 RKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGL 262
            +   +              GL+++HEH    I+H D+K  N++    +     + DFGL
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           A  ++     +      T    APE +        TD++  G++   L++G
Sbjct: 198 ATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 35/225 (15%)

Query: 110 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDA----AFQREV--- 160
           AT  +     +G G +G VY+      G  VA+K +       GG         REV   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVALL 65

Query: 161 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 214
             +    H N++RL+  C T          LV+  + Q+L       +  P  P L   T
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR---TYLDKAPP-PGLPAET 121

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
            K +     RGL++LH +    I+HRD+K  N+L+       + DFGLA++   +   +T
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177

Query: 275 TQV-----RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             V     R      APE L     +   D++  G +  E+   +
Sbjct: 178 PVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 82.6 bits (203), Expect = 7e-17
 Identities = 56/369 (15%), Positives = 118/369 (31%), Gaps = 89/369 (24%)

Query: 81  EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL--GQGGFGKVYRGVLADGTK 138
           +VF      V R   + +L++ +  EL+        KNVL  G  G GK     +A    
Sbjct: 124 QVFAK--YNVSRLQPYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---TWVA---- 167

Query: 139 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 198
           + V      +          ++  +++            C +P   L +   +Q L   Y
Sbjct: 168 LDVCLSYKVQC-----KMDFKIFWLNL----------KNCNSPETVLEM---LQKLL--Y 207

Query: 199 RLREIKPGEPVLDWVTRKRVALGAA----RGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 254
           ++          D  +  ++ + +     R L     + N  ++  +V+ A       F 
Sbjct: 208 QID--PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF- 262

Query: 255 AVVGDFGLAKLVDVRKTNVTTQVRG-TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               +     L+  R   VT  +   T  HI+ ++ S   + +          LL     
Sbjct: 263 ----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SLLLKYLD 312

Query: 314 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQ 372
            R  D  R     +   L  + +  R+      +    N K+ N  ++ T+I+ +L   +
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDG-----LATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 373 AS------------PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRR--- 417
            +            P      + ++ ++        W +    +V       +L +    
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLI--------WFDVIKSDV--MVVVNKLHKYSLV 417

Query: 418 FDWGEDSVY 426
               ++S  
Sbjct: 418 EKQPKESTI 426

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 8e-04
 Identities = 58/370 (15%), Positives = 112/370 (30%), Gaps = 110/370 (29%)

Query: 3   QVAWLDVGSAFILWKMFSRVEPLNLLGCLVAECFLILTGSSKKPKIGIIVGIVGGLIVLI 62
           ++ WL++ +        + +E L  L   +   +   +  S   K+          I  I
Sbjct: 183 KIFWLNLKNCN---SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR---------IHSI 230

Query: 63  SGGLLFFLCKGRHKGYKREVFV--DVAGEVDRRI--AFGQLKRYSWRELQLATDNFSEKN 118
              L   L   + K Y+  + V  +V    + +   AF      S + L L T      +
Sbjct: 231 QAELRRLL---KSKPYENCLLVLLNVQ---NAKAWNAFN----LSCKIL-LTTRFKQVTD 279

Query: 119 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
            L       +     +         LT  E             ++   +      L    
Sbjct: 280 FLSAATTTHISLDHHSMT-------LTPDEV----------KSLLLKYLDCRPQDL---- 318

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP--K 236
             P E L   P   ++ +A  +R+                  G A    + H +C+    
Sbjct: 319 --PREVLTTNPRRLSI-IAESIRD------------------GLATWDNWKHVNCDKLTT 357

Query: 237 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKS 294
           II   +   NVL   ++  +     +         ++ T +           LS      
Sbjct: 358 IIESSL---NVLEPAEYRKMFDRLSVFP-PSA---HIPTIL-----------LSLIWFDV 399

Query: 295 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV-------LLLDHVKKLEREKRL-DAI 346
            +        +++ +L        +S +E++          + L+   KLE E  L  +I
Sbjct: 400 IKSDV----MVVVNKLH------KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 347 VDR-NLNKNY 355
           VD  N+ K +
Sbjct: 450 VDHYNIPKTF 459

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 43/251 (17%)

Query: 105 RELQLATDNFSE----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQRE 159
           ++L   +  F++    K  +G G +    R +  A   + AVK +   +          E
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65

Query: 160 VE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 216
           +E ++    H N++ L           +V   M+             GE +LD + R+  
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG------------GE-LLDKILRQKF 112

Query: 217 ---RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKL 265
              R A          +EYLH      ++HRD+K +N+L      + E++ + DFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
           +      + T    T   +APE L         D++  G++L  ++TG     F+   ++
Sbjct: 170 LRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDD 226

Query: 326 DDVLLLDHVKK 336
               +L  +  
Sbjct: 227 TPEEILARIGS 237

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 36/220 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
            D F  K  LG G FG V+     + G +  +K +    S       + E+E++    H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG------AA 223
           N++++           +V   M          E   G  +L+ +   +           A
Sbjct: 81  NIIKIFEVFEDYHNMYIV---M----------ETCEGGELLERIVSAQARGKALSEGYVA 127

Query: 224 R-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 273
                    L Y H      ++H+D+K  N+L           + DFGLA+L        
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEH 182

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           +T   GT  ++APE       + + D++  G+++  L+TG
Sbjct: 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 44/225 (19%)

Query: 105 RELQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQR 158
           +  +      ++     K VLG G  GKV        G K A+K L D          ++
Sbjct: 17  QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70

Query: 159 EVE-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 216
           EV+     +   +++ ++  +      +  +   M          E   G  +   +  +
Sbjct: 71  EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120

Query: 217 RVAL----GAAR-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGL 262
                    AA         +++LH H    I HRDVK  N+L    ++D    + DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
           AK       N       T  ++APE L   K  +  D++  G+++
Sbjct: 178 AKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 37/234 (15%)

Query: 98  QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPG 151
                S RE       F+E+     +LG+G FG+V +        + AVK +        
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 152 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 211
             +   REVE++    H N+++L       +     Y   +  +          G  + D
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSS---FYIVGELYT----------GGELFD 110

Query: 212 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 259
            + ++       A    +    G+ Y+H+H    I+HRD+K  N+LL   ++D +  + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167

Query: 260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           FGL+      +        GT  +IAPE L  G   E+ DV+  G++L  L++G
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 48/213 (22%), Positives = 77/213 (36%), Gaps = 37/213 (17%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-------DFESPGGDAAFQREVEMISVAVHRNL 171
           LG G FG V+  V      +V VK +         +           E+ ++S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR------ 224
           ++++          LV                  G  +  +     R+    A       
Sbjct: 92  IKVLDIFENQGFFQLVMEKH------------GSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 225 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
              + YL       IIHRD+K  N+++ EDF   + DFG A  ++  K   T    GT+ 
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIE 194

Query: 283 HIAPEYLSTGKSSE--RTDVFGYGIMLLELVTG 313
           + APE L  G        +++  G+ L  LV  
Sbjct: 195 YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFE 226

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 22/211 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 170
           + + +   +G+G +G VY+   + G  VA+KR+  D E  G  +   RE+ ++    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 171 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           ++ LI    +     LV+ FM ++L      + +   +  L     K       RG+ + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLK-----KVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 284
           H+H   +I+HRD+K  N+L++ D    + DFGLA+   +   + T +V     R      
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186

Query: 285 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           AP+ L   K  S   D++  G +  E++TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 223
            N++RL       +   LV+  +              GE + + +  +       A    
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 134

Query: 224 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
           +     + Y H +    I+HR++K  N+LL    +     + DFGLA  V+   +     
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 189

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
             GT G+++PE L     S+  D++  G++L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 47/219 (21%)

Query: 111 TDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREV 160
             + ++     N +G+G +G+V   V      + A K      + D +       F++E+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR------FKQEI 57

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 216
           E++    H N++RL       T+  LV   M          E+  G  + + V  K    
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFR 104

Query: 217 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 268
              A    +     + Y H+     + HRD+K  N L      D    + DFGLA     
Sbjct: 105 ESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
               +     GT  +++P+ L  G      D +  G+M+
Sbjct: 161 -PGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 47/228 (20%), Positives = 86/228 (37%), Gaps = 44/228 (19%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL------------TDFESPGGDAAFQ 157
            +++ +   LG G +G+V         ++ A+K +             +           
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 158 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK- 216
            E+ ++    H N+++L           LV    +             G  + + +  + 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLV---TEFYE----------GGELFEQIINRH 141

Query: 217 ----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 265
                 A    +    G+ YLH+H    I+HRD+K  N+LL   +      + DFGL+  
Sbjct: 142 KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               K        GT  +IAPE L   K +E+ DV+  G+++  L+ G
Sbjct: 199 FS--KDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 35/205 (17%)

Query: 117 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 174
              LG+G F    + V        AVK ++       +A  Q+E+  +     H N+++L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 225
                      LV   M          E+  G  + + + +K       A    R     
Sbjct: 72  HEVFHDQLHTFLV---M----------ELLNGGELFERIKKKKHFSETEASYIMRKLVSA 118

Query: 226 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
           + ++H+     ++HRD+K  N+L    +++ E  + DFG A+L       + T    T+ 
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLH 174

Query: 283 HIAPEYLSTGKSSERTDVFGYGIML 307
           + APE L+     E  D++  G++L
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 37/222 (16%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 164
            D +     LG G F  V +    + G + A K     R             +REV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 219
              H N++ L       T+ +L+   +              GE + D++  K       A
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAG------------GE-LFDFLAEKESLTEEEA 116

Query: 220 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 271
               +    G+ YLH     +I H D+K  N++L           + DFGLA  +D    
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FG 171

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
           N    + GT   +APE ++        D++  G++   L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.8 bits (190), Expect = 5e-16
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVH 168
           +DN+  K  LG+G F  V R V    G + A K +   +    D    +RE  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 223
            N++RL       +   LV+  +              GE + + +  +       A    
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 111

Query: 224 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
           +     + Y H +    I+HR++K  N+LL    +     + DFGLA  V+   +     
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 166

Query: 277 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
             GT G+++PE L     S+  D++  G++L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREV---EMISV 165
             +     +G+G +GKV++   +   G  VA+KR+       G   +  REV     +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 166 AVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVA 219
             H N++RL   CT           LV+  + Q+L+      +  P EP +   T K + 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT---TYLDKVP-EPGVPTETIKDMM 126

Query: 220 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTN--VTT 275
               RGL++LH H   +++HRD+K  N+L+    +  + DFGLA++    +  T+  VT 
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             R      APE L     +   D++  G +  E+   +
Sbjct: 184 WYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 58/232 (25%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVH 168
             ++++  V+G G FG VY+  L D G  VA+K++        D  F+ RE++++    H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDH 106

Query: 169 RNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
            N++RL  F  +  E+       LV  ++ + +   YR         V    +R +  L 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YR---------VARHYSRAKQTLP 154

Query: 222 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRK 270
                       R L Y+H      I HRD+K  N+LLD D   + + DFG AK +   +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

Query: 271 TNVTTQV-----RGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 314
            N  + +     R      APE +    +++ T   DV+  G +L EL+ GQ
Sbjct: 212 PN-VSYICSRYYR------APELIFG--ATDYTSSIDVWSAGCVLAELLLGQ 254

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 229
                    Y F++     Y       GE + D       +    A+        G+ YL
Sbjct: 75  REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPE 287
           H      I HRD+K  N+LLDE     + DFGLA +         +     GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177

Query: 288 YLSTGK--SSERTDVFGYGIMLLELVTG 313
            L   +   +E  DV+  GI+L  ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 51/236 (21%)

Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ-REVE 161
             +  +     ++   V+G G FG V++  L +  +VA+K++        D  F+ RE++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQ 84

Query: 162 MISVAVHRNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 214
           ++ +  H N++ L  F  +  ++       LV  ++ + +   YR               
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YR---------ASRHYA 132

Query: 215 RKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLA 263
           + +  +             R L Y+H      I HRD+K  N+LLD     + + DFG A
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

Query: 264 KLVDVRKTNVTTQV----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           K++   + NV+       R      APE +    + +   D++  G ++ EL+ GQ
Sbjct: 190 KILIAGEPNVSYICSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 42/219 (19%)

Query: 113 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVA 166
             S+  +LG G FG+V++    A G K+A K      + D E        + E+ +++  
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------VKNEISVMNQL 143

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---AA 223
            H NL++L     +  + +LV  ++              GE + D +  +   L      
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG------------GE-LFDRIIDESYNLTELDTI 190

Query: 224 R-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNVT 274
                   G+ ++H+     I+H D+K  N+L    +  +  + DFGLA+          
Sbjct: 191 LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKL 245

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
               GT   +APE ++    S  TD++  G++   L++G
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 23/215 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
             + +   +G+G +G V++         VA+KR+  D +  G  ++  RE+ ++    H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 170 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           N++RL     +  +  LV+ F  Q+L      +        LD    K       +GL +
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLK-----KYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 283
            H      ++HRD+K  N+L++ + E  + +FGLA+   +     + +V     R     
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR----- 168

Query: 284 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 317
             P+ L   K  S   D++  G +  EL    R +
Sbjct: 169 -PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 38/218 (17%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 165
            D +    V+G+G F  V R +    G + AVK                  +RE  +  +
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--------- 216
             H +++ L+   ++     +V+ FM               + +   + ++         
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDG------------AD-LCFEIVKRADAGFVYSE 129

Query: 217 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVR 269
            VA    R     L Y H++    IIHRDVK   VLL   +      +G FG+A  +   
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186

Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
                 +V GT   +APE +      +  DV+G G++L
Sbjct: 187 GLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L+YL      +IIHRD+K  N+LLDE     + DF +A    + +    T + GT  ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYM 181

Query: 285 APEYLSTGKS---SERTDVFGYGIMLLELVTGQR 315
           APE  S+ K    S   D +  G+   EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 75.6 bits (187), Expect = 2e-15
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 170
           + +     +G+G +G VY+     G   A+K++  + E  G  +   RE+ ++    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 171 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           +++L     T    +LV+  + Q+L      + +   E  L+ VT K   L    G+ Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLK-----KLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 284
           H+    +++HRD+K  N+L++ + E  + DFGLA+   +     T ++     R      
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------ 167

Query: 285 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           AP+ L   K  S   D++  G +  E+V G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 43/209 (20%)

Query: 117 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 174
           ++VLG+G   +V   + L    + AVK +   +     +   REVE +     HRN+L L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 225
           I F        LV+  M+             G  +L  + ++       A    +     
Sbjct: 77  IEFFEEEDRFYLVFEKMRG------------GS-ILSHIHKRRHFNELEASVVVQDVASA 123

Query: 226 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV-------DVRKTNVTT 275
           L++LH      I HRD+K  N+L    ++     + DF L   +        +    + T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYG 304
              G+  ++APE +             Y 
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEAS----IYD 204

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 40/213 (18%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT---DFESPGGDAAFQREVEMISVA 166
           +D F  ++ LG+G    VYR          A+K L    D +        + E+ ++   
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK------IVRTEIGVLLRL 105

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALG 221
            H N+++L     TPTE   +   +          E+  G  + D +  K     R A  
Sbjct: 106 SHPNIIKLKEIFETPTE---ISLVL----------ELVTGGELFDRIVEKGYYSERDAAD 152

Query: 222 AAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVT 274
           A +     + YLHE+    I+HRD+K  N+L      D    + DFGL+K+V+     + 
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLM 207

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
             V GT G+ APE L         D++  GI+ 
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 43/223 (19%)

Query: 107 LQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 160
           LQ+  +   +       VLG G  GKV +        K A+K L D          +REV
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 105

Query: 161 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 216
           E     +   +++R++  +      R  +   M+ L           G  +   +  +  
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----------GGELFSRIQDRGD 155

Query: 217 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 264
                R A    +     ++YLH      I HRDVK  N+L      +    + DFG AK
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

Query: 265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 307
                  N  T    T  ++APE L   K  +  D++  G+++
Sbjct: 213 E--TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           + + + + LG+G +  VY+G        VA+K +  + E  G      REV ++    H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHA 60

Query: 170 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           N++ L     T     LV+ ++ ++L      + +     +++    K       RGL Y
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLK-----QYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 283
            H     K++HRD+K  N+L++E  E  + DFGLA+   +       +V     R     
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR----- 167

Query: 284 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
             P+ L      S + D++G G +  E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 31/274 (11%), Positives = 71/274 (25%), Gaps = 53/274 (19%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 175
             G     + ++ +  A   +VA+                       +S      + R++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 176 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 235
               T    L+V    +       L+E+    P      R       A   +  H     
Sbjct: 98  DVVHTRAGGLVV---AE-WIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA--- 148

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 295
            +       + V +  D + V+                               +    ++
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD--AN 180

Query: 296 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 355
            + D+ G G  L  L+  +  +  + +         D   +      +D  +   ++   
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS--- 237

Query: 356 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                     VA    Q     R A S ++ +++
Sbjct: 238 ---------AVAARSVQGDGGIRSA-STLLNLMQ 261

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 29/219 (13%)

Query: 110 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 167
           ++  F +   LG G +  VY+G+    G  VA+K +  D E  G  +   RE+ ++    
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELK 61

Query: 168 HRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
           H N++RL     T  +  LV+ FM  +L      R +      L+    K       +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTM 281
            + HE+   KI+HRD+K  N+L+++  +  +GDFGLA+   +     +++V     R   
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--- 175

Query: 282 GHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 314
              AP+ L      ST       D++  G +L E++TG+
Sbjct: 176 ---APDVLMGSRTYSTS-----IDIWSCGCILAEMITGK 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 34/179 (18%)

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNV 273
           +   A+G+E+L      K IHRD+ A N+LL E     + DFGLA+ +      VRK + 
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 332
              ++      APE +     + ++DV+ +G++L E+ + G  A  +  ++ +++     
Sbjct: 256 RLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLG--ASPYPGVKIDEEFC--- 306

Query: 333 HVKKLEREKRLDA--IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             ++L+   R+ A       +   Y       M+     C    P  RP  SE+V  L 
Sbjct: 307 --RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHLG 351

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 32/208 (15%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 229
                    Y F++     Y       GE + D       +    A+        G+ YL
Sbjct: 75  REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPE 287
           H      I HRD+K  N+LLDE     + DFGLA +               GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177

Query: 288 YLSTGK--SSERTDVFGYGIMLLELVTG 313
            L   +   +E  DV+  GI+L  ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 41/220 (18%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 165
            + +     LG+G FG V+R V  +       K    + TD          ++E+ ++++
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNI 57

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---A 222
           A HRN+L L     +  E ++++ F+               + + + +      L     
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISG------------LD-IFERINTSAFELNEREI 104

Query: 223 AR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNV 273
                     L++LH H    I H D++  N++          + +FG A+ +       
Sbjct: 105 VSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-F 160

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
                    + APE       S  TD++  G ++  L++G
Sbjct: 161 RLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 33/208 (15%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG G FGKV  G     G KVAVK L      S       +RE++ + +  H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 227
             +TPT+  +V  ++              GE + D+     RV    AR         ++
Sbjct: 79  VISTPTDFFMVMEYVSG------------GE-LFDYICKHGRVEEMEARRLFQQILSAVD 125

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           Y H H    ++HRD+K  NVLLD    A + DFGL+ ++   +   T+   G+  + APE
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 180

Query: 288 YLSTGK--SSERTDVFGYGIMLLELVTG 313
            +S G+  +    D++  G++L  L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 40/222 (18%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGG---DAAFQREVEMIS 164
             + + + LG+G F  VY+         VA+K++      E+  G    A   RE++++ 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--REIKLLQ 67

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
              H N++ L+      +   LV+ FM  +L        IK    VL     K   L   
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTL 122

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----R 278
           +GLEYLH+H    I+HRD+K  N+LLDE+    + DFGLAK         T QV     R
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 179

Query: 279 GTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 314
                 APE L        G      D++  G +L EL+   
Sbjct: 180 ------APELLFGARMYGVG-----VDMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
             + +   +GQG FG+V++      G KVA+K++  + E  G      RE++++ +  H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 170 NLLRLIGFCTTPTERL--------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           N++ LI  C T             LV+ F   +L+    L      +        KRV  
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA---GLLSNVLVK--FTLSEIKRVMQ 131

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----VDVRKTNVTTQ 276
               GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+      + +    T +
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 277 V-----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 314
           V     R       PE L   +      D++G G ++ E+ T  
Sbjct: 189 VVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 29/217 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           D +     LG+G +G+VY+ +       VA+KR+  + E  G      REV ++    HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++ L           L++ + +       L++     P +     K        G+ + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNVTTQV-----RG 279
           H     + +HRD+K  N+LL     +        DFGLA+   +     T ++     R 
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR- 204

Query: 280 TMGHIAPEYL--STGKSSERTDVFGYGIMLLELVTGQ 314
                 PE L  S   S+   D++    +  E++   
Sbjct: 205 -----PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 32/207 (15%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 177
           +G+G F KV     +  G +VA+K +     +P       REV ++ +  H N+++L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 178 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEY 228
             T     L+   M          E   G  V D+ V   R+    AR         ++Y
Sbjct: 83  IETEKTLYLI---M----------EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
            H+     I+HRD+KA N+LLD D    + DFG +    V    +     G   + APE 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYAAPEL 184

Query: 289 LSTGKSSE--RTDVFGYGIMLLELVTG 313
              GK  +    DV+  G++L  LV+G
Sbjct: 185 FQ-GKKYDGPEVDVWSLGVILYTLVSG 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 39/211 (18%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG G FGKV  G     G KVAVK L      S       +RE++ + +  H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 227
             +TP++  +V  ++              GE + D+     R+    +R        G++
Sbjct: 84  VISTPSDIFMVMEYVSG------------GE-LFDYICKNGRLDEKESRRLFQQILSGVD 130

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           Y H H    ++HRD+K  NVLLD    A + DFGL+ ++   +  +T+      G+  + 
Sbjct: 131 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYA 182

Query: 285 APEYLSTGKSSE--RTDVFGYGIMLLELVTG 313
           APE +S G+       D++  G++L  L+ G
Sbjct: 183 APEVIS-GRLYAGPEVDIWSSGVILYALLCG 212

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 34/208 (16%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           LG+G FGKV          KVA+K +     +        +RE+  + +  H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 227
             TTPT+ ++V   +          E   GE + D+ V +KR+     R         +E
Sbjct: 77  VITTPTDIVMV---I----------EYAGGE-LFDYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           Y H H   KI+HRD+K  N+LLD++    + DFGL+ ++       T+   G+  + APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE 177

Query: 288 YLSTGKSSE--RTDVFGYGIMLLELVTG 313
            ++ GK       DV+  GI+L  ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 57/230 (24%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
              +     +G G +G V   +    G KVA+K+L+  F+S    A  A+ RE+ ++   
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAY-RELLLLKHM 80

Query: 167 VHRNLLRLIGFCTTPTERL-------LVYPFM---------QNLS---VAYRLREIKPGE 207
            H N++ L+    TP   L       LV PFM            S   + Y + ++    
Sbjct: 81  QHENVIGLLD-VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM---- 135

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                           +GL+Y+H   +  ++HRD+K  N+ ++ED E  + DFGLA+  D
Sbjct: 136 ---------------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177

Query: 268 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 314
              T  V T+  R      APE  LS    ++  D++  G ++ E++TG+
Sbjct: 178 AEMTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 40/225 (17%)

Query: 111 TDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-M 162
            +NF+         LG+G F  V + +  + G + A K L          A    E+  +
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------ 216
                   ++ L       +E +L+  +               GE +      +      
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GE-IFSLCLPELAEMVS 129

Query: 217 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 268
               +   +    G+ YLH++    I+H D+K  N+LL       +  + DFG+++ +  
Sbjct: 130 ENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG- 185

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 313
                  ++ GT  ++APE L+    +  TD++  GI+   L+T 
Sbjct: 186 -HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 56/213 (26%), Positives = 79/213 (37%), Gaps = 45/213 (21%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 178
           +G G FG             VAVK +        D   QRE+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--------GLEYL 229
            TPT   ++   M          E   G  + + +    R +   AR        G+ Y 
Sbjct: 86  LTPTHLAII---M----------EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAV--VGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
           H     +I HRD+K  N LLD        + DFG +K        K+ V     GT  +I
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYI 184

Query: 285 APEYLS----TGKSSERTDVFGYGIMLLELVTG 313
           APE L      GK +   DV+  G+ L  ++ G
Sbjct: 185 APEVLLRQEYDGKIA---DVWSCGVTLYVMLVG 214

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 44/226 (19%)

Query: 116 EKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 172
           E   +G+G +G VY+       D    A+K+    E  G   +  RE+ ++    H N++
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ---IEGTGISMSACREIALLRELKHPNVI 81

Query: 173 RLIGFCTTPTERL--LVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            L     +  +R   L++ + ++    +   +R  +       L     K +      G+
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAV----VGDFGLAKL--VDVRK-TNVTTQV-- 277
            YLH +    ++HRD+K AN+L+  +        + D G A+L    ++   ++   V  
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 278 ---RGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 314
              R      APE L      +        D++  G +  EL+T +
Sbjct: 199 FWYR------APELLLGARHYTKA-----IDIWAIGCIFAELLTSE 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 58/235 (24%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMI---SV 165
            D F  + + GQG FG V  G     G  VA+K++        D  F  RE++++   +V
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAV 75

Query: 166 AVHRNLLRLIGFCTTPTER-------LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKR 217
             H N+++L  +  T  ER        +V  ++   L   +R               R++
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HR---------CCRNYYRRQ 123

Query: 218 VALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLV 266
           VA              R +  LH      + HRD+K  NVL++  D    + DFG AK +
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 267 DVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 314
              + NV    +   R      APE +    +   T   D++  G +  E++ G+
Sbjct: 183 SPSEPNVAYICSRYYR------APELIFG--NQHYTTAVDIWSVGCIFAEMMLGE 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 44/221 (19%), Positives = 84/221 (38%), Gaps = 27/221 (12%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQ---------REV 160
              ++ +  +  G +G V  GV ++G  VA+KR+ +                     RE+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 161 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFMQ-NLSVAYRLREIKPGEPVLDWVT 214
            +++   H N+L L        E       LV   M+ +L+     + I     V+    
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVISPQH 135

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
            +        GL  LH      ++HRD+   N+LL ++ +  + DF LA+          
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANK 190

Query: 275 TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 314
           T       + APE  +     ++  D++  G ++ E+   +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 20/223 (8%)

Query: 103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGD--AAFQRE 159
             ++++L  ++F    V+G+G FG+V    L +  KV A+K L  +E       A F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 219
            +++     + +  L           LV  +     +   L + +      D +  +   
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMAR 178

Query: 220 LGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 276
              A     ++ +H+      +HRD+K  N+L+D +    + DFG    +    T  ++ 
Sbjct: 179 FYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 277 VRGTMGHIAPEYLSTGKSSERT-----DVFGYGIMLLELVTGQ 314
             GT  +I+PE L   +  +       D +  G+ + E++ G+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
              +     +G G  G V           VA+K+L+  F++    A  A+ RE+ ++   
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 81

Query: 167 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 208
            H+N++ L+   T            +V   M           L    ++Y L ++     
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM----- 136

Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
                           G+++LH   +  IIHRD+K +N+++  D    + DFGLA+    
Sbjct: 137 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 178

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             + + T    T  + APE +      E  D++  G ++ E++ G 
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 161
           R+L++  +++    V+G+G FG+V         KV A+K L+ FE       A F  E +
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 162 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +++ A    +++L           +V  +M             PG  +++ ++   V   
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEK 168

Query: 222 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
            AR         L+ +H       IHRDVK  N+LLD+     + DFG    ++      
Sbjct: 169 WARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 274 TTQVRGTMGHIAPEYL-STGKSSERT---DVFGYGIMLLELVTGQ 314
                GT  +I+PE L S G         D +  G+ L E++ G 
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
              +     +G G  G V           VA+K+L+  F++    A  A+ RE+ ++   
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 118

Query: 167 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 208
            H+N++ L+   T            LV   M           L    ++Y L ++     
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM----- 173

Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
                           G+++LH   +  IIHRD+K +N+++  D    + DFGLA+    
Sbjct: 174 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 215

Query: 269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
             + + T    T  + APE +      E  D++  G ++ E+V  +
Sbjct: 216 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 167
              ++  + +G+G +G V       +  +VA+K+++ FE           RE++++    
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-YCQRTL-REIKILLRFR 83

Query: 168 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 209
           H N++ +      PT        +V   M          Q+LS   + Y L +I      
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
                         RGL+Y+H   +  ++HRD+K +N+LL+   +  + DFGLA++ D  
Sbjct: 138 -------------LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 270 KTNVT--TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 314
             +    T+   T  + APE  L++   ++  D++  G +L E+++ +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 47/249 (18%), Positives = 89/249 (35%), Gaps = 60/249 (24%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMISVAVH 168
           +  +S    LG G FG V      + G + A+K++        D  +  RE++++ V  H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-------------------- 208
            N+++L+ +  T  +     P   +       +                           
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 209 -------VLDWVTRKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD- 250
                  VL    R   ++             R + ++H      I HRD+K  N+L++ 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176

Query: 251 EDFEAVVGDFGLAKLVDVRKTNV----TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGI 305
           +D    + DFG AK +   + +V    +   R      APE +      +   D++  G 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230

Query: 306 MLLELVTGQ 314
           +  EL+ G+
Sbjct: 231 VFGELILGK 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 166
           ++   +F+   VLG+G FGKV         ++ AVK L        D   Q + ++    
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389

Query: 167 VHRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTR 215
           V + +L L G          C    +RL  V  ++    + Y + +  +  EP       
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------- 442

Query: 216 KRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 272
                 AA    GL +L       II+RD+K  NV+LD +    + DFG+ K  ++    
Sbjct: 443 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGV 497

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
            T    GT  +IAPE ++     +  D + +G++L E++ GQ
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 38/206 (18%), Positives = 74/206 (35%), Gaps = 39/206 (18%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
            D +  ++++G G +G V       +   VA+K++   FE    D      RE+ +++  
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI-DCKRIL-REIAILNRL 109

Query: 167 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
            H ++++++               +V                   +     + R  V L 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFRTPVYLT 154

Query: 222 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
                        G++Y+H      I+HRD+K AN L+++D    V DFGLA+ VD  + 
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSER 297
             +                    + +
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLK 237

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 50/254 (19%)

Query: 74  RHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV- 132
              G+ R+     A EV                       + +   +G G +G V   V 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAV--------------------YRDLQPVGSGAYGAVCSAVD 46

Query: 133 LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVAVHRNLLRLIGFCTTPTERL---- 185
              G KVA+K+L   F+S    A  A+ RE+ ++    H N++ L+   T          
Sbjct: 47  GRTGAKVAIKKLYRPFQSEL-FAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104

Query: 186 --LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVK 243
             LV PFM        L ++   E  L     + +     +GL Y+H      IIHRD+K
Sbjct: 105 FYLVMPFMG-----TDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLK 155

Query: 244 AANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQ-VRGTMGHIAPEY-LSTGKSSERTDV 300
             N+ ++ED E  + DFGLA+  D   T  V T+  R      APE  L+  + ++  D+
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR------APEVILNWMRYTQTVDI 209

Query: 301 FGYGIMLLELVTGQ 314
           +  G ++ E++TG+
Sbjct: 210 WSVGCIMAEMITGK 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 35/219 (15%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           ++F    +LG+G F  V        ++  A+K L             +E ++  V   R+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-------RHIIKENKVPYVTRERD 82

Query: 171 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR--- 224
           ++  +   F        L + F Q+    Y          +L ++ +         R   
Sbjct: 83  VMSRLDHPFFVK-----LYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136

Query: 225 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVR 278
                 LEYLH      IIHRD+K  N+LL+ED    + DFG AK++    K        
Sbjct: 137 AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 279 GTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 314
           GT  +++PE L+     KSS   D++  G ++ +LV G 
Sbjct: 194 GTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 28/219 (12%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 166
           ++  + F    +LG+G FGKV         +  A+K L        +    ++ E+    
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK------EVIVAKD-EVAHTL 196

Query: 167 VHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAA 223
               +L+     F T      L Y F Q       + E   G  +   ++R+RV +   A
Sbjct: 197 TENRVLQNSRHPFLTA-----LKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250

Query: 224 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           R         L+YLH   N  +++RD+K  N++LD+D    + DFGL K   ++      
Sbjct: 251 RFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMK 307

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
              GT  ++APE L         D +G G+++ E++ G+
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 60/224 (26%), Positives = 87/224 (38%), Gaps = 46/224 (20%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           DNF    VLG+G FGKV    + +   + AVK L        D   Q + ++      + 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75

Query: 171 LLRLIG---------FCTTPTERL-LVYPF------MQNLSVAYRLREIKPGEPVLDWVT 214
           +L L            C    +RL  V  F      M ++  + R  E            
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE------------ 123

Query: 215 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
             R    AA     L +LH+     II+RD+K  NVLLD +    + DFG+ K   +   
Sbjct: 124 -ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178

Query: 272 NVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
             T    GT  +IAPE L          D +  G++L E++ G 
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 5e-12
 Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 35/220 (15%)

Query: 112 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAV 167
           + F    VLG+GG+GKV+  R V    T    A+K L            +   +      
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70

Query: 168 HRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKR 217
            RN+L  +         +      +L L+  ++    +  +L RE    E          
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122

Query: 218 VALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
                A     L +LH+     II+RD+K  N++L+      + DFGL K   +    VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
               GT+ ++APE L     +   D +  G ++ +++TG 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 43/186 (23%), Positives = 67/186 (36%), Gaps = 41/186 (22%)

Query: 107 LQLATDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 160
           LQ+  +   +       VLG G  GKV +        K A+K L D          +REV
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 61

Query: 161 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 216
           E     +   +++R++  +      R  +   M+ L           GE +   +  +  
Sbjct: 62  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD---------GGE-LFSRIQDRGD 111

Query: 217 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 264
                R A    +     ++YLH      I HRDVK  N+L      +    + DFG AK
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

Query: 265 LVDVRK 270
                K
Sbjct: 169 ETTGEK 174

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 56/230 (24%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
            + +   + +G G +G V        G +VAVK+L+  F+S    A   + RE+ ++   
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTY-RELRLLKHM 85

Query: 167 VHRNLLRLIGFCTTPTERL------LVYPFM----------QNLS---VAYRLREIKPGE 207
            H N++ L+   T            LV   M          Q L+   V + + +I    
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI---- 141

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
                           RGL+Y+H   +  IIHRD+K +N+ ++ED E  + DFGLA+   
Sbjct: 142 ---------------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183

Query: 268 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 314
              T  V T+  R      APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 184 DEMTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 112 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQR-EVEMISVA 166
             F    VLGQG FGKV+  + +     +   A+K L             R  V      
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75

Query: 167 VHRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRK 216
             R++L  +         +      +L L+  F++   +  RL +E+   E         
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126

Query: 217 RVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 273
            V    A     L++LH      II+RD+K  N+LLDE+    + DFGL+K   +     
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182

Query: 274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
                GT+ ++APE ++    ++  D + +G+++ E++TG 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 10/97 (10%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            ++ +H       +HRD+K  N+LLD      + DFG    +    T  +    GT  ++
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 285 APEYLSTGKSSERTDVFG-------YGIMLLELVTGQ 314
           +PE L        T  +G        G+   E+  GQ
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 166
            L   +F    V+G+G + KV    L    ++ A+K +        +     E ++  V 
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57

Query: 167 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 222
             +++        F        L   F Q  S  + + E   G  ++  + R+R      
Sbjct: 58  TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111

Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T
Sbjct: 112 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 167

Query: 275 TQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           +   GT  +IAPE L  G+    + D +  G+++ E++ G+
Sbjct: 168 STFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           GL++LH      I++RD+K  N+LLD+D    + DFG+ K  ++     T    GT  +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           APE L   K +   D + +G++L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            L YLH      I++RD+K  N+LLD     V+ DFGL K  ++   + T+   GT  ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           APE L         D +  G +L E++ G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 30/220 (13%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 166
            L   +F    V+G+G + KV    L    ++ A++ +        +     E ++  V 
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100

Query: 167 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 222
             +++        F        L   F Q  S  + + E   G  ++  + R+R      
Sbjct: 101 TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154

Query: 223 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
           AR         L YLHE     II+RD+K  NVLLD +    + D+G+ K   +R  + T
Sbjct: 155 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 210

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           +   GT  +IAPE L         D +  G+++ E++ G+
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 50/222 (22%), Positives = 82/222 (36%), Gaps = 46/222 (20%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVE-------MI 163
           D F     LG G FG+V      +     A+K L             +++E       ++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95

Query: 164 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
                  L++L       +   +V  ++    +   LR               R +   A
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR------------IGRFSEPHA 143

Query: 224 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
           R          EYLH      +I+RD+K  N+L+D+     V DFG AK V  R    T 
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196

Query: 276 QVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 314
            + GT   +APE + +    K+    D +  G+++ E+  G 
Sbjct: 197 TLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            LEYLH      +++RD+K  N++LD+D    + DFGL K   +          GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYL 172

Query: 285 APEYLSTGKSSERT-DVFGYGIMLLELVTGQ 314
           APE L       R  D +G G+++ E++ G+
Sbjct: 173 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 39/196 (19%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 166
            DN+  K+++G+G +G VY          VA+K++   FE    D      RE+ +++  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKRIL-REITILNRL 82

Query: 167 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
               ++RL                +V                   +  L  + +  + L 
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIA---------------DSDLKKLFKTPIFLT 127

Query: 222 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
                        G  ++HE     IIHRD+K AN LL++D    V DFGLA+ ++  K 
Sbjct: 128 EEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 272 NVTTQVRGTMGHIAPE 287
                         P 
Sbjct: 185 TNIVNDLEENEEPGPH 200

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
           GL +L       II+RD+K  NV+LD +    + DFG+ K  ++     T    GT  +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 314
           APE ++     +  D + +G++L E++ GQ
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 46/225 (20%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVH 168
            D++     LG+G + +V+  + + +  KV VK L   +        +RE++ + ++   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGG 90

Query: 169 RNLLRLIGFCTTPTERLLVYPF-----------MQNLS---VAYRLREIKPGEPVLDWVT 214
            N++ L      P  R     F            Q L+   + + + EI           
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI----------- 139

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNV 273
                    + L+Y H      I+HRDVK  NV++D E  +  + D+GLA+     +   
Sbjct: 140 --------LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-Y 187

Query: 274 TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 317
             +V  +     PE L   +      D++  G ML  ++  +   
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            LE+LH+     II+RD+K  N+LLD +   V+ DFGL+K     +T       GT+ ++
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 285 APEYLSTGKSSERTDV--FGYGIMLLELVTGQ 314
           AP+ +  G S     V  +  G+++ EL+TG 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 4e-11
 Identities = 36/223 (16%), Positives = 66/223 (29%), Gaps = 45/223 (20%)

Query: 97  GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDA 154
            Q     +    L T+       +G+G FG+V++ + AD T VA+K   +   +   G  
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63

Query: 155 -----------AFQREVEMISVAV---HRNLLRLIGFC----TTPTERLLVY-------- 188
                         +E+ ++S  V       + L        + P   L  +        
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 189 -----PFMQNLSVAYRLREIKPGEPVL--------DWVTRKRVALGAARGLEYLHEHCNP 235
                P        + + E + G   L           T K +       L       + 
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SL 181

Query: 236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           +  HRD+   NVLL +     +      K   +    +   + 
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 57/236 (24%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 167
           + +F  K++LG+G +G V        G  VA+K++  F+ P   A     RE++++    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67

Query: 168 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 209
           H N++ +       +        ++   M          Q LS   + Y + +       
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT------ 121

Query: 210 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 269
                         R ++ LH      +IHRD+K +N+L++ + +  V DFGLA+++D  
Sbjct: 122 -------------LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 270 KTNVTTQVRGTMGHI----------APEY-LSTGKSSERTDVFGYGIMLLELVTGQ 314
             +  ++  G    +          APE  L++ K S   DV+  G +L EL   +
Sbjct: 166 AAD-NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.8 bits (151), Expect = 9e-11
 Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 13/93 (13%)

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 284
            LEYLH      II+RD+K  N+LLD++    + DFG AK V       T  + GT  +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170

Query: 285 APEYLST---GKSSERTDVFGYGIMLLELVTGQ 314
           APE +ST    KS    D + +GI++ E++ G 
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 71/244 (29%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 167
              + +   LG GG G V+  V      +VA+K++     P      A  RE+++I    
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQ-SVKHAL-REIKIIRRLD 66

Query: 168 HRNLLRLIGFCTTPTERL--------------LVYPFM----------QNLS---VAYRL 200
           H N++++         +L              +V  +M            L        +
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 201 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGD 259
            ++                    RGL+Y+H   +  ++HRD+K AN+ ++ ED    +GD
Sbjct: 127 YQL-------------------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD 164

Query: 260 FGLAKLVDVRKTN-------VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLEL 310
           FGLA+++D   ++       + T+  R      +P   LS    ++  D++  G +  E+
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEM 218

Query: 311 VTGQ 314
           +TG+
Sbjct: 219 LTGK 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 41/202 (20%), Positives = 80/202 (39%), Gaps = 44/202 (21%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMIS-V 165
              +     LG+G +G V++ +    G  VAVK++ D F++   DA   F RE+ +++ +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTF-REIMILTEL 65

Query: 166 AVHRNLLRLIGFCTTPTER--LLVYPFM----------QNLS---VAYRLREIKPGEPVL 210
           + H N++ L+       +R   LV+ +M            L      Y + ++       
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL------- 118

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
                        + ++YLH      ++HRD+K +N+LL+ +    V DFGL++     +
Sbjct: 119 ------------IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 271 TNVTTQVRGTMGHIAPEYLSTG 292
                       +         
Sbjct: 164 RVTNNIPLSINENTENFDDDQP 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 57/181 (31%)

Query: 120 LGQGGFGKVYRGVLADGTKVAVKR-----LTDFESPGGDAAFQREVEM-----------I 163
           +GQGGFG +Y   +     V         +   ++           E+           I
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------PLFTELKFYQRAAKPEQI 96

Query: 164 SVAVHRNLLRLIGFCT-----TPTERLLVYPFM------QNLSVAYRLREIKPGEPVLDW 212
              +    L+ +G           +    Y FM       +L            + + + 
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL------------QKIYEA 144

Query: 213 VTRK-------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLA 263
             ++       +++L     LEY+HEH     +H D+KA+N+LL+      V   D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 264 K 264
            
Sbjct: 202 Y 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 34/179 (18%), Positives = 61/179 (34%), Gaps = 53/179 (29%)

Query: 120 LGQGGFGKVYRGV---------LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISV 165
             +   G +Y                 K ++K     ++  G        FQR  + + V
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK----LDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 166 AVHRNLL--------RLIGFCTTPTE-RLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTR 215
              + L           +GF     + R LV P + ++L            +  LD   +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL------------QSALDVSPK 153

Query: 216 K--------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAK 264
                    +VA      LE+LHE+     +H +V A N+ +D + ++ V    +G A 
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 43/247 (17%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-----------SVA 166
            LG G F  V+    + + T VA+K +   +    +AA + E++++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAA-EDEIKLLQRVNDADNTKEDSM 83

Query: 167 VHRNLLRLIG---FCTTPTERL-LVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVAL 220
              ++L+L+            + +V+  + +NL     L +      + L +V  K+++ 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENL---LALIKKYEHRGIPLIYV--KQISK 138

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDE------DFEAVVGDFGLAKLVDVRKTN-- 272
               GL+Y+H  C   IIH D+K  NVL++         +  + D G A   D   TN  
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 332
            T + R      +PE L         D++    ++ EL+TG     F   E        D
Sbjct: 197 QTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDD 248

Query: 333 HVKKLER 339
           H+ ++  
Sbjct: 249 HIAQIIE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 11/97 (11%)

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGH 283
           LEY+HE+     +H D+KAAN+LL       V   D+GL+        +   Q     GH
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220

Query: 284 I-APEYLST----GKS-SERTDVFGYGIMLLELVTGQ 314
               E+ S     G + S R+DV   G  +L  + G+
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 35/162 (21%), Positives = 54/162 (33%), Gaps = 37/162 (22%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH-RNLLRLIG 176
           +G G FG++  G  L     VA+K     E     A     E            + ++  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 177 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 227
           F        +V   ++ L  S+          E + D   R         +A+     +E
Sbjct: 73  FGPCGKYNAMV---LELLGPSL----------EDLFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAK 264
           Y+H      +I+RDVK  N L+              DF LAK
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 35/161 (21%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVH-RNLLRLIG 176
           +G+G FG ++ G  L +  +VA+K      ++P      + E     +      +  +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYY 73

Query: 177 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 228
           F       +LV   +  +L            E +LD   RK         A      ++ 
Sbjct: 74  FGQEGLHNVLVIDLLGPSL------------EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 229 LHEHCNPKIIHRDVKAANVLL----DEDFEAV-VGDFGLAK 264
           +HE     +++RD+K  N L+     ++   + V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 48/223 (21%), Positives = 79/223 (35%), Gaps = 55/223 (24%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISV-AVHRNLLRLIG 176
           +G G FG++Y G  +    +VA+K     E+          E ++  +      +  +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 177 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 227
           F       +LV   M  L  S+          E + ++ +RK        +A      +E
Sbjct: 71  FGVEGDYNVLV---MDLLGPSL----------EDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEA---VVGDFGLAKLVDVRKTNV------TTQVR 278
           ++H       +HRD+K  N L+     A    + DFGLAK      T+          + 
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 279 GTMGHIAPEYLS----TGKSSERTD---VFGYGIMLLELVTGQ 314
           GT       Y S     G    R D     GY  +L+  + G 
Sbjct: 175 GT-----ARYASVNTHLGIEQSRRDDLESLGY--VLMYFLRGS 210

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 37/168 (22%), Positives = 64/168 (38%), Gaps = 33/168 (19%)

Query: 120 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISV-AVHRNLLRLIG 176
           +G G FG +Y G  +A G +VA+K      + P        E ++  +      +  +  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRW 72

Query: 177 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 228
                   ++V   +  +L            E + ++ +RK        +A      +EY
Sbjct: 73  CGAEGDYNVMVMELLGPSL------------EDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 229 LHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 273
           +H       IHRDVK  N L+    +     + DFGLAK     +T+ 
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	437
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.93
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.34
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.33
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.32
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.2
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.05
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.87
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.76
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.22
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.92
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.76
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.74
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	92.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.84
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	91.45
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.1
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.33
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.45
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	84.36
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	82.71

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-58  Score=442.18  Aligned_cols=257  Identities=22%  Similarity=0.315  Sum_probs=212.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++...+.||+|+||+||+|.+.      +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3445688999999999999963      4678999999865555667899999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          187 VYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      |||||++|+|.++|....+.            ...++|..+++++.|||+||+|||++   +|+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            99999999999999654321            24589999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          255 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      +||+|||+++....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....     ..+..
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~~~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVVE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            99999999986643322 22344679999999999999999999999999999999999 8999864321     11111


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .....          .....+.+++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       259 ---~i~~~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          259 ---MIRNR----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ---HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HHHcC----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               11111          1122344566789999999999999999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.4e-58  Score=438.20  Aligned_cols=257  Identities=24%  Similarity=0.367  Sum_probs=211.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.. +....++|.+|++++++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            56777899999999999999864      4778999999753 3455678999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          186 LVYPFMQNLSVAYRLREIK---------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      +|||||++|+|.++++...         .....++|..+++++.|||+||+|||++   +|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999997642         2234699999999999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 013750          257 VGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      |+|||+|+......... .....||+.|||||.+.+..|+.++|||||||++|||+| |+.||...+.     ..+..  
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~--  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIE--  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHH--
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH--
Confidence            99999998664433222 233568999999999999999999999999999999999 8999964321     11111  


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       ......          ....+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       242 -~i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          242 -CITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             -HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             111111          112234456689999999999999999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-57  Score=438.88  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.. +....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45667789999999999999874      4788999999753 3455678999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          186 LVYPFMQNLSVAYRLREIKP-----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      +|||||++|+|.++++....           ....++|..+++++.|||+||+|||++   +|+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999976432           224699999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 013750          255 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~  332 (437)
                      +||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....     .....
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAID  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            99999999986643332 22344679999999999999999999999999999999999 8999964321     11111


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         ......          ....+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       272 ---~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          272 ---CITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             ---HHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             ---HHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence               111111          112233455689999999999999999999999999976

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-56  Score=428.01  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +...+++...+.||+|+||+||+|+++  ..||||+++... +....+.|.+|++++++++|||||+++|+|.+ +..++
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            344577888899999999999999975  369999987433 34456789999999999999999999999865 56899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |||||++|+|.+++...   ...++|..+.+++.|||+||+|||++   +|+||||||+||||++++.+||+|||+|+..
T Consensus       109 VmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999753   23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCC-CcccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          267 DVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       267 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .... ........||+.|||||++.+   +.|+.++|||||||++|||+||+.||...+...    ..    ....... 
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~----~~~~~~~-  253 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QI----IFMVGRG-  253 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HH----HHHHHTT-
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HH----HHHHhcC-
Confidence            5322 223445679999999999964   468999999999999999999999996432110    01    1111111 


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         ...+.+ ...+.+++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       254 ---~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          254 ---YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             ---CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             ---CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               011111 12234456789999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.7e-56  Score=432.40  Aligned_cols=269  Identities=25%  Similarity=0.369  Sum_probs=219.9

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhccc-ccceee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRL  174 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l  174 (437)
                      +...+++...++|++.+.||+|+||+||+|.+.+      ++.||||++.........++|.+|++++.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4456777888999999999999999999999642      358999999875555567789999999999965 899999


Q ss_pred             eeeeecC-CeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecC
Q 013750          175 IGFCTTP-TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD  241 (437)
Q Consensus       175 ~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~d  241 (437)
                      +|+|.+. +..++|||||++|+|.++|+....            ....++|..++.++.|||+||+|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999975421            134589999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013750          242 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF  319 (437)
Q Consensus       242 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~  319 (437)
                      |||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999976544332 2344678999999999999999999999999999999998 8999975


Q ss_pred             CcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          320 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....    .+...+   ...          .+...+..++.++.+++..||+.||++||||.||++.|+.
T Consensus       291 ~~~~~----~~~~~i---~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          291 VKIDE----EFCRRL---KEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCCSH----HHHHHH---HHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHH----HHHHHH---HcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            33211    111111   111          1122233445689999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-54  Score=418.62  Aligned_cols=317  Identities=71%  Similarity=1.135  Sum_probs=267.5

Q ss_pred             ccchhhccCCccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc
Q 013750           89 EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH  168 (437)
Q Consensus        89 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H  168 (437)
                      ..+.....++...+++.++....++|...+.||+|+||.||+|..++|+.||||++...........+.+|+++++.++|
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h   86 (326)
T 3uim_A            7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH   86 (326)
T ss_dssp             --------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred             ccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence            34455566778889999999999999999999999999999999888999999999765444445579999999999999


Q ss_pred             ccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       169 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                      |||+++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++++||||||+|||
T Consensus        87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  166 (326)
T 3uim_A           87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL  166 (326)
T ss_dssp             TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred             CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence            99999999999999999999999999999999877666667999999999999999999999998889999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      ++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+..........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            99999999999999997765555555556799999999999988999999999999999999999999975444444444


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCCCcchhhhhhhh
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV  405 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~~  405 (437)
                      ....+............+.+..+....+.+++..+.+++.+||+.||++|||+.|+++.|++..+.+.|+.|+..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  323 (326)
T 3uim_A          247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM  323 (326)
T ss_dssp             BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred             hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence            56666666666777778888888888899999999999999999999999999999999999999999998876544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-53  Score=413.02  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            56888899999999999999985 69999999996533 34456789999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+......
T Consensus       153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            9999999998752     289999999999999999999999   99999999999999999999999999999765432


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       ...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     ......+..   .      ..+.
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~---~------~~~~  289 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD---N------LPPR  289 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH---S------SCCC
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHc---C------CCCC
Confidence             234456899999999999999999999999999999999999999964321     111111111   1      0001


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +  ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       290 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             C--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1  111233457899999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-54  Score=418.66  Aligned_cols=251  Identities=20%  Similarity=0.330  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.... .....+.|.+|++++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67889999999999999999975 69999999997533 33446789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ||++|+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999997542  33478889999999999999999999   9999999999999999999999999999865422


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                       ....+..+||+.|||||.+.+..|+.++|||||||++|||+||+.||...+..     .+   ........ .      
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~---~~~i~~~~-~------  242 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-----NL---VLKIISGS-F------  242 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HH---HHHHHHTC-C------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HH---HHHHHcCC-C------
Confidence             12234467999999999999999999999999999999999999999743211     11   11111111 0      


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       243 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0112234467899999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-54  Score=414.25  Aligned_cols=251  Identities=22%  Similarity=0.219  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .+.|...+.||+|+||+||+|++. +|+.||||++....      .+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            355777889999999999999975 68999999997422      12479999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCceeccc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDV  268 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~  268 (437)
                      ||++|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+|+....
T Consensus       131 y~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999998653    389999999999999999999999   999999999999999987 699999999997654


Q ss_pred             CCCcc----cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          269 RKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       269 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .....    ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.......     +...+..   ..   
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~---~~---  272 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LCLKIAS---EP---  272 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CHHHHHH---SC---
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHc---CC---
Confidence            32211    223579999999999999999999999999999999999999997543221     1111111   10   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           ......++..+..+.+++.+||+.||++|||+.|+++.|..
T Consensus       273 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          273 -----PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -----CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                 00012233445688999999999999999999999988764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6e-54  Score=412.11  Aligned_cols=265  Identities=23%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHH--HHHHHHHhcccccceeeeeeeecCC----eeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHRNLLRLIGFCTTPT----ERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~g~~~~~~----~~~  185 (437)
                      ++|...+.||+|+||+||+|++ +|+.||||++...    ..+.+.  .|+..+.+++|||||+++|+|..++    ..+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            3466678999999999999998 5899999999642    233344  4555667889999999999997654    579


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecCCCCCCeeecCCCcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      ||||||++|+|.++++..     .++|..+.+++.|+++||+|||+++     .++|+||||||+||||++++++||+||
T Consensus        78 lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            999999999999999763     2899999999999999999999863     458999999999999999999999999


Q ss_pred             CCceecccCCCcc---cccccccccccccccccCC------CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc--hh-
Q 013750          261 GLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DV-  328 (437)
Q Consensus       261 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~--~~-  328 (437)
                      |+++.........   .....||+.|||||++.+.      .++.++|||||||++|||+||+.|+.........  .. 
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            9998765433222   2235799999999999754      4678999999999999999998877532211100  00 


Q ss_pred             ---hHHHHHHHHHhccchhhhccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          329 ---LLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       329 ---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         ............    ...++.+... .+.+.+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence               000111111101    1111111111 123567789999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-53  Score=405.04  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=195.3

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec----CCeeEEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY  188 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~  188 (437)
                      ...+.||+|+||+||+|.+. ++..||+|++.... .....+.|.+|++++++++|||||++++++.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34567999999999999975 58899999996432 33446689999999999999999999999864    34579999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceecc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVD  267 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~  267 (437)
                      |||++|+|.+++....    .+++..+..++.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999998643    389999999999999999999998 113999999999999984 7899999999998543


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                         .......+||+.|||||.+.+ .|+.++|||||||++|||+||+.||......    .   .......... .....
T Consensus       184 ---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~---~~~~~i~~~~-~~~~~  251 (290)
T 3fpq_A          184 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----A---QIYRRVTSGV-KPASF  251 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----H---HHHHHHTTTC-CCGGG
T ss_pred             ---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----H---HHHHHHHcCC-CCCCC
Confidence               223345689999999998864 6999999999999999999999999632211    1   1111111111 11011


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                              +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       252 --------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    1112246889999999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-53  Score=407.97  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..  .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 68999999996421  2345678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .++...+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999998653    389999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+.     ..+...+..   .       
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~---~-------  249 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIK---L-------  249 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH---T-------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc---C-------
Confidence            332 234456899999999999999999999999999999999999999974321     111111111   1       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                        .  ..++...+.++.+|+.+||+.||++|||+.|++
T Consensus       250 --~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 --E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --C--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --C--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              0  011222345789999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=413.77  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.|+..+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56889999999999999999975 69999999997533 44566789999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      |++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999998753     289999999999999999999999   99999999999999999999999999999765432


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     ......+..   .      ..+.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~---~------~~~~  366 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD---N------LPPR  366 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH---S------CCCC
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHc---C------CCCC
Confidence             233456799999999999999999999999999999999999999964321     111111111   1      0011


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +  ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1  111223457899999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-52  Score=392.58  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=190.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|... +|+.||||++.+..  .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999974 69999999996432  2334567999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+ +|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 679999887643    389999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .  ......+||+.|||||.+.+..+ +.++||||+||++|||+||+.||...+..     .+..   ......      
T Consensus       165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~---~i~~~~------  228 (275)
T 3hyh_A          165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFK---NISNGV------  228 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH---HHHHTC------
T ss_pred             C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH---HHHcCC------
Confidence            2  22344679999999999998876 58999999999999999999999743211     1111   111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           ..++...+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 0112223457889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-52  Score=399.79  Aligned_cols=243  Identities=22%  Similarity=0.257  Sum_probs=194.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.... .......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67899999999999999999862    47899999996432 22334578899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999998643    389999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      .... ......+||+.|||||.+.+..|+.++|||||||++|||+||+.||...+..     .+...+   ...      
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i---~~~------  241 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-----ETMTMI---LKA------  241 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH---HHC------
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-----HHHHHH---HcC------
Confidence            4322 2234467999999999999999999999999999999999999999743221     111111   111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                         .  ..++...+.++.+|+.+||+.||++|||+
T Consensus       242 ---~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          242 ---K--LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---C--CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence               0  11222344578999999999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.3e-52  Score=396.19  Aligned_cols=251  Identities=21%  Similarity=0.307  Sum_probs=189.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC--------
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--------  182 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------  182 (437)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.........+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888899999999999999975 689999999975444455678999999999999999999999986544        


Q ss_pred             ----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          183 ----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       183 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                          ..|+||||+++|+|.+++..... ....++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999976432 22356777889999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCc-----------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 013750          259 DFGLAKLVDVRKTN-----------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD  327 (437)
Q Consensus       259 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~  327 (437)
                      |||+|+........           ..+..+||+.|||||.+.+..|+.++|||||||++|||++   ||....      
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------  231 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------  231 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence            99999876543221           1233579999999999999999999999999999999996   664210      


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       .......... ....+.         ...+....+.+|+.+||+.||++|||+.|+++
T Consensus       232 -~~~~~~~~~~-~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 -ERVRTLTDVR-NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHHHHH-TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHh-cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0111111111 111100         01223345678999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8e-49  Score=379.70  Aligned_cols=284  Identities=38%  Similarity=0.630  Sum_probs=240.3

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          101 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       101 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ++++.++...+++|...+.||+|+||.||+|.+++|+.||||++.... ....+.+.+|+++++.++||||+++++++..
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            445556667889999999999999999999998889999999987543 4556789999999999999999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      .+..++||||+++|+|.+++.........+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999976544445689999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          261 GLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       261 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      |+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ....+......
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~  261 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV--NLAEWAVESHN  261 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC--CHHHHTHHHHT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH--HHHHHhhhccc
Confidence            99986543222 2233456899999999999899999999999999999999999999754433222  23344444444


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .......+++.+.....++.+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            555666777777777888999999999999999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=386.04  Aligned_cols=263  Identities=18%  Similarity=0.254  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec------CCe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PTE  183 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~  183 (437)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57889999999999999999975 69999999997533 23345678899999999999999999998754      357


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+|||||+ |+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 6788888653    3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCC---CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          264 KLVDVRK---TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       264 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      +.+....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+..     .....+.....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~g  280 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVLG  280 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhcC
Confidence            8664321   2233456899999999998775 4699999999999999999999999754321     12222211111


Q ss_pred             ccchh-----------hhcccc-ccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 EKRLD-----------AIVDRN-LNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ~~~~~-----------~~~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....           ...... .....+     +..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000           000000 000001     1223578899999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-48  Score=379.85  Aligned_cols=197  Identities=24%  Similarity=0.377  Sum_probs=170.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ..+.|.+.+.||+|+||+||+|+.+    +++.||+|++...   .....+.+|++++..+ +|||||++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999863    4678999998653   3356788999999988 699999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCCc
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA  263 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla  263 (437)
                      |+||||+++|+|.+++..       +++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|
T Consensus        96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999998842       78899999999999999999999   99999999999999877 79999999999


Q ss_pred             eecccCCC---------------------------cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCC
Q 013750          264 KLVDVRKT---------------------------NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQR  315 (437)
Q Consensus       264 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~  315 (437)
                      +.......                           ...+..+||+.|+|||++.+. .|+.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211                           112235799999999999775 58999999999999999999999


Q ss_pred             CCCC
Q 013750          316 AIDF  319 (437)
Q Consensus       316 p~~~  319 (437)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9954

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.7e-47  Score=393.21  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=207.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+.+..++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999975 69999999997532 3445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC--CcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfgla~~~~  267 (437)
                      ||++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+.
T Consensus       235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            99999999988642   23489999999999999999999999   99999999999999854  899999999999765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......     .....+   ....      
T Consensus       309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i---~~~~------  372 (573)
T 3uto_A          309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNV---KSCD------  372 (573)
T ss_dssp             TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHH---HTTC------
T ss_pred             CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHH---HhCC------
Confidence            33  2334467999999999999999999999999999999999999999743221     111111   1110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ..+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       373 -~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 -WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000111112234578899999999999999999999873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-46  Score=390.21  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHH---HHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.+..  .......+.+|   +.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999975 69999999996421  12223333444   5667778999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |+||||+++|+|..++....    .++...+..++.||+.||+|||++   +|+||||||+||||+.++++||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999998643    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ......   ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||........  .   .......     
T Consensus       341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~---~i~~~i~-----  407 (689)
T 3v5w_A          341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H---EIDRMTL-----  407 (689)
T ss_dssp             ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--H---HHHHHHH-----
T ss_pred             ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H---HHHHhhc-----
Confidence            764322   334679999999999975 5799999999999999999999999974332211  0   1111110     


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                          ...  ..++...+.++.+|+.+||+.||++|++     +.|+.+
T Consensus       408 ----~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          408 ----TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----HCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----CCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                000  1122233457899999999999999998     677764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.2e-45  Score=348.94  Aligned_cols=282  Identities=37%  Similarity=0.668  Sum_probs=231.1

Q ss_pred             CccccCHHHHHHHhcCCCCC------CeeeecCcEEEEEEEECCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhccc
Q 013750           98 QLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH  168 (437)
Q Consensus        98 ~~~~~~~~e~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H  168 (437)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....   .....+.|.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8999999999999997 58999999986432   23446789999999999999


Q ss_pred             ccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       169 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                      |||+++++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||++   +++|+||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999987543 234589999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD  327 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~  327 (437)
                      ++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|..||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            999999999999999866533222 2234568999999998864 589999999999999999999999975443221  


Q ss_pred             hhHHHHHHHHH-hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          328 VLLLDHVKKLE-REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       328 ~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ......... ........+++.+ ...+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          243 --LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             --TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence              111112211 1223444455443 34567788899999999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=354.17  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||+||++.+. ++..||+|++... .....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            456778899999999999999975 5899999998653 34566789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999863   23489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcc-------------cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          270 KTNV-------------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       270 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      ....             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.............      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------  235 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------  235 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC------
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh------
Confidence            2211             113568999999999999999999999999999999999999986433222111000      


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .....+..    .+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       236 ------~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          236 ------VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             ------HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  00111111    112233478899999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.2e-46  Score=366.80  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=212.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      .++|...+.||+|+||.||+|.+.        ++..||||++.........+.+.+|+.+++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888899999999999999862        35679999997654445567899999999999 899999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      +..++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999986532            123478999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 013750          250 DEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDD  327 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~  327 (437)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986653322 22333457889999999999999999999999999999999 999986432211   


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ...   ...          .......+..++..+.+++..||+.||++|||+.|+++.|+.
T Consensus       314 --~~~---~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 --LFK---LLK----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             --HHH---HHH----------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHH---HHh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              111   111          111112233445689999999999999999999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=358.95  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=207.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||++.........+.|.+|++++++++||||+++++++...+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356777899999999999999974    3456999999865455566789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999653   23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .......  .....+|..|+|||.+.+..++.++||||||+++|||++ |..||......        .........   
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~---  270 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEG---  270 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTT---
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcC---
Confidence            5432222  222346778999999998999999999999999999999 99998643211        111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   1112233445689999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-46  Score=370.17  Aligned_cols=259  Identities=27%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ....++|...+.||+|+||.||+|.+. +++.||||++.........+.|.+|++++++++||||++++++|...+..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            345677888999999999999999986 6899999999754444445678999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       190 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999997532   2378999999999999999999999   9999999999999999999999999999864


Q ss_pred             ccCCCccc-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ........ ....++..|+|||.+.++.++.++||||||+++|||+| |..||......        .........    
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~----  331 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKG----  331 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTT----
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC----
Confidence            32211111 11235678999999998899999999999999999998 99998643211        111111111    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .....+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       332 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          332 ------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                  1112233345688999999999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-44  Score=345.49  Aligned_cols=251  Identities=20%  Similarity=0.299  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46799999999999999999996 468999999986533 3446778999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++...     .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999763     278999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        ...........       
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~-------  233 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGT-------  233 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCS-------
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-------
Confidence            32 233457999999999999999999999999999999999999999643211        01111111100       


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       .....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             0011122334578999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.8e-46  Score=366.05  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|...+.||+|+||.||+|++.    ++..||||++.........+.|.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            467899999999999999999864    5778999999765445556789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++...   ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999753   23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCccc--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .......     
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~-----  264 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVD-----  264 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHH-----
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH-----
Confidence            54322211  12335778999999999999999999999999999998 99998643211        1111111     


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           .......+..++..+.+++..||+.||++||++.++++.|+.
T Consensus       265 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          265 -----EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             -----TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence                 111112233445689999999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-46  Score=358.26  Aligned_cols=263  Identities=26%  Similarity=0.403  Sum_probs=204.0

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      .++....++|.+.+.||+|+||+||+|.. +|+.||||++.... .....+.|.+|++++++++||||+++++++...+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            34445567888899999999999999988 58899999987533 23345678999999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEecCCCCCCeeecCCCcEEEeecC
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      .++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++   +  ++||||||+|||++.++.+||+|||
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            999999999999999997532 112388999999999999999999999   7  9999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      +++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......        ......... 
T Consensus       185 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~-  254 (309)
T 3p86_A          185 LSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFK-  254 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHS-
T ss_pred             CCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc-
Confidence            99854322 12233456899999999999999999999999999999999999999643211        111111000 


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       255 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~  295 (309)
T 3p86_A          255 --------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP  295 (309)
T ss_dssp             --------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                    01112223344578999999999999999999999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-45  Score=347.37  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|...+.||+|+||+||+|.+.++..||+|++...  ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            4678888999999999999999988999999999753  33457899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999753   23489999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......        .........         
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~---------  223 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTG---------  223 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTT---------
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcC---------
Confidence            222333456788999999999999999999999999999999 99998643211        111111111         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence             0111122234578999999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.8e-45  Score=344.41  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=211.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..++|...+.||+|+||.||+|.++++..||+|++...  ....+++.+|++++.+++||||+++++++......++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            35678888999999999999999988889999999753  3345779999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999997642   2489999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......        ..........       
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~-------  222 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGH-------  222 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTC-------
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCC-------
Confidence            3333334456778999999998899999999999999999999 99998643221        1111111110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         ....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       223 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          223 ---RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP  261 (268)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred             ---CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               001111223578999999999999999999999999987

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.4e-44  Score=346.73  Aligned_cols=262  Identities=21%  Similarity=0.268  Sum_probs=213.2

Q ss_pred             cccCHHHHHHHhcC----------CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc
Q 013750          100 KRYSWRELQLATDN----------FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH  168 (437)
Q Consensus       100 ~~~~~~e~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H  168 (437)
                      ..++++++..+++.          |...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence            45778888887765          556678999999999999986 69999999997533 4456789999999999999


Q ss_pred             ccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       169 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                      |||+++++++...+..++||||+++++|.+++...     .+++..+..++.|++.||.|||++   +++||||||+|||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            99999999999999999999999999999988642     389999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      ++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~  247 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----V  247 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H
T ss_pred             ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence            99999999999999987654322 23345799999999999999999999999999999999999999964321     1


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..   ........      .+.+.  .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~---~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          248 QA---MKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH---HHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH---HHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11   11111110      00000  011233578899999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=358.81  Aligned_cols=264  Identities=25%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      ++...++|...+.||+|+||.||+|.+      .++..||+|++.........+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445678899999999999999999996      245689999997654455667899999999999 8999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPG-------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR  240 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~  240 (437)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||++   +++||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            999999999999999999999764321                   13479999999999999999999999   99999


Q ss_pred             CCCCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 013750          241 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID  318 (437)
Q Consensus       241 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~  318 (437)
                      ||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999866543322 2223457889999999999999999999999999999998 999986


Q ss_pred             CCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          319 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......    ......             ........+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       277 ~~~~~~----~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          277 GIPVDA----NFYKLI-------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             TCCCSH----HHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCcHH----HHHHHH-------------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            543211    011111             1111112223345689999999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-46  Score=376.96  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=213.4

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .+++...++|...+.||+|+||+||+|.++++..||||++...  ....+.|.+|++++++++||||+++++++. .+..
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            4455667888899999999999999999988999999999753  345778999999999999999999999986 5678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            99999999999999997532  12378889999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............++..|+|||.+....++.++||||||+++|||+| |+.||......        .........   
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~---  401 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERG---  401 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHT---
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC---
Confidence            654322222223446789999999999999999999999999999999 99998643211        111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                             .....+..++..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       402 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          402 -------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                   11112334456899999999999999999999999999873

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-45  Score=362.67  Aligned_cols=269  Identities=26%  Similarity=0.382  Sum_probs=215.7

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRL  174 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l  174 (437)
                      +...+++...++|...+.||+|+||.||+|.+      .+++.||||++.........+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            45567777889999999999999999999984      245789999997654445567899999999999 79999999


Q ss_pred             eeeeecCCe-eEEEEecccCchhhhhhhhcCCC-----------------------------------------------
Q 013750          175 IGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPG-----------------------------------------------  206 (437)
Q Consensus       175 ~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  206 (437)
                      ++++...+. .++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 89999999999999999764321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          207 ---------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       207 ---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                                     ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12288999999999999999999999   999999999999999999999999999986543322


Q ss_pred             -cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          272 -NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       272 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                       .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......    .......   ..         
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~---~~---------  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLK---EG---------  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHH---HT---------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHHHHH---cC---------
Confidence             22334568899999999999999999999999999999998 999996543221    0111111   10         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       313 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          313 -TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             0111122234578999999999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-45  Score=374.98  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=216.4

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      +++...++|...+.||+|+||.||+|.+++ +..||||++...  ....+.|.+|+.++++++||||++++++|......
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            344456778888999999999999999864 889999999753  33467899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            99999999999999998643  23489999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............++..|+|||.+....++.++||||||+++|||+| |+.||.......     ....          
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----~~~~----------  431 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYEL----------  431 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHH----------
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHH----------
Confidence            765333222333456789999999999999999999999999999999 999986533211     1111          


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCC
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG  392 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  392 (437)
                         +........+..++..+.+|+.+||+.||++|||+.++++.|+...
T Consensus       432 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          432 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               1111222233445568999999999999999999999999999743

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-45  Score=353.85  Aligned_cols=262  Identities=28%  Similarity=0.401  Sum_probs=213.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      ....++|...+.||+|+||.||+|..      .++..||+|++.........+.+.+|++++++++||||+++++++...
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            33467788899999999999999986      245889999997654455567899999999999999999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD  241 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~d  241 (437)
                      +..++||||+++++|.+++.....                    ....+++..++.++.|++.||+|||++   +++|+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            999999999999999999986532                    123488999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013750          242 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF  319 (437)
Q Consensus       242 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~  319 (437)
                      |||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876443222 2233457789999999998899999999999999999999 9999864


Q ss_pred             CcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          320 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....     ......             .......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       256 ~~~~~-----~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          256 IPPER-----LFNLLK-------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             CCGGG-----HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHH-----HHHHhh-------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            33211     111111             011112223345689999999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.1e-45  Score=354.15  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||+||+|.+. +++    +||+|.+.........+.|.+|+.++++++||||++++++|.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356888899999999999999964 344    468888865555566788999999999999999999999998765 78


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +|+||+++|+|.+++....   ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            9999999999999997632   3489999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........ .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......     ...           
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~-----------  230 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISS-----------  230 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH-----------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHH-----------
Confidence            65433222 223456889999999999999999999999999999999 999997533211     111           


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        .+........+..++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       231 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          231 --ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             --HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             --HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence              111111112233345689999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-44  Score=348.94  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|...+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356788899999999999999997 579999999996432 334456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999997643    288999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..  .......||+.|+|||.+.+..++ .++|||||||++|||++|+.||+.....        .........      
T Consensus       166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~------  229 (328)
T 3fe3_A          166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRG------  229 (328)
T ss_dssp             SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC------
T ss_pred             CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC------
Confidence            32  233456799999999999888765 7999999999999999999999753321        111111111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         ..  ..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ---~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 ---KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               00  1122234578899999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=358.20  Aligned_cols=264  Identities=25%  Similarity=0.410  Sum_probs=214.2

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT  179 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  179 (437)
                      .+....++|...+.||+|+||.||+|...      +++.||+|++.........+.|.+|++++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34456688999999999999999999974      347899999986544555678999999999999999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPG--------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH  239 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH  239 (437)
                      ..+..++||||+++|+|.+++......                    ...+++..++.++.||++||.|||++   +++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            999999999999999999999864321                    24689999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCC
Q 013750          240 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI  317 (437)
Q Consensus       240 ~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~  317 (437)
                      |||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999986543221 12233467889999999998899999999999999999999 99998


Q ss_pred             CCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          318 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......        ......... ..         ...+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       278 ~~~~~~--------~~~~~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~  332 (343)
T 1luf_A          278 YGMAHE--------EVIYYVRDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  332 (343)
T ss_dssp             TTSCHH--------HHHHHHHTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCChH--------HHHHHHhCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence            643211        111111111 10         11223344689999999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=345.37  Aligned_cols=277  Identities=18%  Similarity=0.204  Sum_probs=217.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC--eeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv  187 (437)
                      .++|...+.||+|+||+||+|... +++.||||++.........+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            356788899999999999999986 489999999976444455678899999999999999999999997665  67999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee----cCCCcEEEeecCCc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA  263 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla  263 (437)
                      |||+++++|.+++..... ...+++..++.++.|++.||+|||++   +++||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999986542 23389999999999999999999999   99999999999999    78888999999999


Q ss_pred             eecccCCCccccccccccccccccccc--------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLS--------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +......  ......||..|+|||.+.        +..++.++|||||||++|||++|+.||..................
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            8765332  223456899999999986        567899999999999999999999999644332222211111111


Q ss_pred             HHHhccchhhhc-----------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCC
Q 013750          336 KLEREKRLDAIV-----------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA  394 (437)
Q Consensus       336 ~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  394 (437)
                      . ........+.           +-.............+.+++..||+.||++|||+.|+++...++..+
T Consensus       242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             H-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             C-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1 1111000000           00112245677888999999999999999999999999988774443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-44  Score=349.11  Aligned_cols=258  Identities=17%  Similarity=0.172  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||+||+|.. .+|+.||||++....   ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            46788899999999999999996 468999999986432   234688999999999 9999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc-----EEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfgla  263 (437)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.     +||+|||++
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999 99999999864   23489999999999999999999999   9999999999999998887     999999999


Q ss_pred             eecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          264 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       264 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  ......+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~  235 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDT  235 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhh
Confidence            876433221      12346799999999999999999999999999999999999999975432211  1111111111


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ........+.         ...+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus       236 ~~~~~~~~~~---------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          236 KRATPIEVLC---------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHSCHHHHT---------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hccCCHHHHh---------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            1111111000         0122 89999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-44  Score=345.29  Aligned_cols=260  Identities=23%  Similarity=0.307  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||++... ++..||+|++....  .....+.|.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467888999999999999999975 68999999985432  223456789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999997653    389999999999999999999999   99999999999999999999999999998665


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ...........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        ......... ..   
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~-~~---  230 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--------IAIKHIQDS-VP---  230 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--------HHHHHHSSC-CC---
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhhcc-CC---
Confidence            433333444568999999999999999999999999999999999999997432210        001110000 00   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcC
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGE  391 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~  391 (437)
                        ........+.+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       231 --~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          231 --NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             --CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             --CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence              000111223346789999999999999998 899999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-44  Score=345.95  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHh--cccccceeeeeeeec----CCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFCTT----PTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~  184 (437)
                      .++|...+.||+|+||+||+|.+ +|+.||||++..    .....+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            56788899999999999999998 689999999863    345567778887776  799999999998754    3457


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecCCCCCCeeecCCCcEE
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      ++||||+++|+|.+++...     .+++..+++++.|++.||+|||        +.   +++||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            8999999999999999542     3899999999999999999999        77   999999999999999999999


Q ss_pred             EeecCCceecccCCCcc---cccccccccccccccccCC------CCCCchhhHHHHHHHHHHHhC----------CCCC
Q 013750          257 VGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTG----------QRAI  317 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gv~l~elltg----------~~p~  317 (437)
                      |+|||+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765433322   2234689999999999876      456799999999999999999          7777


Q ss_pred             CCCcccccchhhHHHHHHHHHhccchhhhcccccc-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          318 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..........    ...........    ..+.+. ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       234 ~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          234 YDVVPNDPSF----EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTSCSSCCH----HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCCCCcch----hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            5332221111    11111110000    011111 11233567889999999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=359.62  Aligned_cols=262  Identities=29%  Similarity=0.395  Sum_probs=213.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeee
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC  178 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~  178 (437)
                      +...++|.+.+.||+|+||+||+|...        ++..||||++.........+.+.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            345578888999999999999999862        24579999998655455567899999999999 999999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      ...+..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||++   +++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            9999999999999999999999865421            24589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      ||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999986643222 22333457889999999999999999999999999999999 99998643211 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .........          .....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       301 -------~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          301 -------ELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             -------HHHHHHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------HHHHHHHcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   111111111          1111222344589999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=361.51  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|...+.||+|+||+||+|.+.      ++..||||++...........+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888899999999999999953      46789999997655555667899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---cEEEe
Q 013750          185 LLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVG  258 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~  258 (437)
                      ++||||+++|+|.+++.....   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987542   224589999999999999999999999   999999999999999554   59999


Q ss_pred             ecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 013750          259 DFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       259 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......        .....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~~  298 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLEF  298 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence            9999985532221 22233457899999999999999999999999999999998 99998643211        11111


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....          ....+...+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus       299 i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          299 VTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11111          111223344578999999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-44  Score=350.62  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||+||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            467888999999999999999976 6899999998654434445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999988643    3489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CC-cccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          270 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       270 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........   ....+    ......    
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~----~~~~~~----  227 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW----KEKKTY----  227 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHH----HTTCTT----
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHH----hccccc----
Confidence            22 22334579999999999987775 7899999999999999999999975432211   01110    000000    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                           .......+..+.+|+.+||+.||++|||+.|+++.-
T Consensus       228 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence                 000112335788999999999999999999998653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-44  Score=345.95  Aligned_cols=264  Identities=24%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec--CCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~  183 (437)
                      .++|.+.+.||+|+||+||++++     .+++.||||++... .....+.|.+|++++++++||||+++++++..  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            46778889999999999999985     25889999999753 24455789999999999999999999999854  356


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            899999999999999997642   2489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          264 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       264 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      .........  ......++..|+|||.+.+..++.++||||||+++|||+||..|+......         .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~  232 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---------FMRMIGNDK  232 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---------HHHHHCTTC
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---------HHhhhcCcc
Confidence            876543221  122345677899999999999999999999999999999999987632110         000000000


Q ss_pred             -------chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          342 -------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       342 -------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .....+........+..++..+.+++..||+.||++|||+.|+++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                   0111111111222334455789999999999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1e-44  Score=344.05  Aligned_cols=256  Identities=20%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ..++|...+.||+|+||.||+|.+..    +..||+|++.........+.|.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45678889999999999999999743    45799999876544555678999999999999999999999984 56789


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            999999999999999753   23489999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......     ...   ......   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~---~i~~~~---  234 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIG---RIENGE---  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH---HHHTTC---
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHH---HHHcCC---
Confidence            65433333334456789999999998899999999999999999997 999987433211     111   111110   


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ....+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   111223345688999999999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.2e-45  Score=345.24  Aligned_cols=257  Identities=20%  Similarity=0.351  Sum_probs=208.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ....++|...+.||+|+||.||++.+.++..||+|++...  ....+++.+|++++.+++||||+++++++.+.+..++|
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            3446788889999999999999999988889999999753  33457899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           98 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             ECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            99999999999997632   2389999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......        .........      
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~------  237 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQG------  237 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTT------
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcc------
Confidence            332222333456788999999998899999999999999999998 99998643211        111111111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       238 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          238 ----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                1111122234578999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.7e-45  Score=352.54  Aligned_cols=268  Identities=28%  Similarity=0.310  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC----eeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----ERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  185 (437)
                      ..++|...+.||+|+||+||+|++. ++.||||++...  ......+..|+.++++++||||+++++++....    ..+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            3567888999999999999999985 899999999642  233455667899999999999999999997754    369


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCceEecCCCCCCeeecCCCcEEEe
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-------NPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      +||||+++|+|.+++...     .+++..++.++.|++.||+|||+.+       .++++||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999999763     2899999999999999999999862       3489999999999999999999999


Q ss_pred             ecCCceecccCCCc-ccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh---
Q 013750          259 DFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL---  329 (437)
Q Consensus       259 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~---  329 (437)
                      |||+++........ ......||+.|+|||.+.+     ..++.++|||||||++|||+||+.||............   
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876543322 2333568999999999976     35667899999999999999999999754332211110   


Q ss_pred             -----HHHHHHHHHhccchhhhccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          330 -----LLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       330 -----~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           ......... ...    ..+.+... .....+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       254 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVV-HKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHT-TSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhh-ccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 000000000 000    01111111 123456779999999999999999999999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-44  Score=342.17  Aligned_cols=259  Identities=15%  Similarity=0.183  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....   ..+.+.+|+.++..+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            46788899999999999999996 468999999986432   334688999999999 7999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc-----EEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfgla  263 (437)
                      ||+ +++|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.     +||+|||++
T Consensus        86 e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999 999999997642   3489999999999999999999999   9999999999999987776     999999999


Q ss_pred             eecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          264 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       264 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~  236 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEK  236 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHhh
Confidence            876543221      123456899999999999999999999999999999999999999754322211  111111111


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .........         ....+..+.+++..||+.||++||++.+|++.|+.
T Consensus       237 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          237 KQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             HHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence            111111111         11234588999999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.3e-45  Score=371.01  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=207.4

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      ..++...++|...+.||+|+||.||+|.++++..||||++....  ...++|.+|++++++++||||+++++++.. +..
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            33445567788899999999999999999888899999997532  345789999999999999999999999876 678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence            99999999999999997532  12378999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .........   
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~---  397 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG---  397 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT---
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC---
Confidence            765333222333456789999999999999999999999999999999 99998643211        111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .....+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       398 -------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          398 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  437 (452)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   1112233455689999999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.9e-44  Score=347.11  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=213.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  180 (437)
                      +...++|...+.||+|+||.||+|++      .++..||+|++.........+.+.+|+++++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457788899999999999999985      246799999998654445567899999999999 99999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPG--------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      .+..++||||+++|+|.+++......              ...+++..++.++.|++.||+|||++   +++|+||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            99999999999999999999764321              23589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      |+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999999999999999998765433221 223456789999999999999999999999999999999 999986433211


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .......             .......+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       256 ----~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          256 ----KFYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             ----HHHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHHhc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                0111111             111111122334688999999999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.6e-45  Score=354.90  Aligned_cols=265  Identities=25%  Similarity=0.360  Sum_probs=212.9

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC  178 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~  178 (437)
                      +++...++|...+.||+|+||.||+|....      ...||+|.+.........+.+.+|+++++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345567889999999999999999999743      2479999997655455667899999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                      ...+..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||++   +++||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999875321          123478999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED  326 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~  326 (437)
                      ++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence            999999999999999866433322 1223456789999999999999999999999999999999 899986432211  


Q ss_pred             hhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ........             ......+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       275 --~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          275 --KFYKLVKD-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             --HHHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHhc-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence              01111110             11111122234578999999999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.5e-44  Score=362.54  Aligned_cols=251  Identities=28%  Similarity=0.394  Sum_probs=206.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-eeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv  187 (437)
                      ...++|...+.||+|+||.||+|.+. |+.||||+++..   ...+.|.+|++++++++||||+++++++...+ ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            34567888899999999999999985 789999999753   24678999999999999999999999987665 78999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999998643  33478999999999999999999999   99999999999999999999999999998543


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......     .   .......      
T Consensus       341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~---~~~i~~~------  402 (450)
T 1k9a_A          341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEKG------  402 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----H---HHHHHTT------
T ss_pred             cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHHcC------
Confidence            21    122357889999999999999999999999999999998 999987433211     1   1111111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .....+..++..+.+++..||+.||++|||+.++++.|+.
T Consensus       403 ----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          403 ----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                1122233455689999999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.1e-44  Score=348.01  Aligned_cols=253  Identities=20%  Similarity=0.294  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC-------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------  182 (437)
                      .++|+..+.||+|+||.||+|++. +|+.||||++.........+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            456888899999999999999986 799999999975554556788999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeEEEEecccCchhhhhhhhcCCCCCCCCH
Q 013750          183 --------------------------------------------------ERLLVYPFMQNLSVAYRLREIKPGEPVLDW  212 (437)
Q Consensus       183 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  212 (437)
                                                                        ..++||||+++++|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              27899999999999999986542 233577


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC-----------cccccccccc
Q 013750          213 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-----------NVTTQVRGTM  281 (437)
Q Consensus       213 ~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~  281 (437)
                      ..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78899999999999999999   999999999999999999999999999987654321           1123346899


Q ss_pred             cccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHH
Q 013750          282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE  361 (437)
Q Consensus       282 ~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  361 (437)
                      .|+|||.+.+..++.++||||||+++|||++|..|+..          ......... .....         ........
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~-~~~~~---------~~~~~~~~  300 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVR-NLKFP---------LLFTQKYP  300 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHH-TTCCC---------HHHHHHCH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhh-ccCCC---------cccccCCh
Confidence            99999999999999999999999999999998766320          001111110 00000         01123345


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          362 TMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       362 ~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .+.+++.+||+.||++|||+.|+++.
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            77899999999999999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8e-45  Score=345.66  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=215.8

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      +++...++|...+.||+|+||.||+|.+.+ +..||+|++...  ....+.+.+|++++++++||||+++++++...+..
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            344557788889999999999999999864 889999999742  44567899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence            99999999999999997643  34489999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......     ....          
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~~----------  224 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYEL----------  224 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHH----------
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH----------
Confidence            765444333444557889999999999999999999999999999999 999986433211     1111          


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         +........+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       225 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          225 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence               11111122233345689999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.8e-44  Score=354.14  Aligned_cols=266  Identities=17%  Similarity=0.184  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEeccCCCCc----------chHHHHHHHHHHHhccccccee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLR  173 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~  173 (437)
                      ..++|.+.+.||+|+||.||+|.+.+      ++.||||++.......          ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35688899999999999999999864      4789999986432100          0112334555666778999999


Q ss_pred             eeeeeecC----CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          174 LIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       174 l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      +++++...    ...++||||+ +++|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998764    4579999999 99999999763   23489999999999999999999999   99999999999999


Q ss_pred             c--CCCcEEEeecCCceecccCCCcc------cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCc
Q 013750          250 D--EDFEAVVGDFGLAKLVDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR  321 (437)
Q Consensus       250 ~--~~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~  321 (437)
                      +  .++.+||+|||+++.........      .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765332211      123459999999999999999999999999999999999999997422


Q ss_pred             ccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          322 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...    ........ ........+.++.+..   ...+..+.+++..||+.||++||++.++++.|+.
T Consensus       266 ~~~----~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          266 KDP----KYVRDSKI-RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             TCH----HHHHHHHH-HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cCH----HHHHHHHH-HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            211    11111111 1112233444433321   1224578999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.6e-45  Score=365.73  Aligned_cols=265  Identities=18%  Similarity=0.236  Sum_probs=211.6

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeee
Q 013750          103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCT  179 (437)
Q Consensus       103 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  179 (437)
                      .+.++....++|+..+.||+|+||+||+|++++ ++.||+|++.+..  .....+.+.+|..++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345666778899999999999999999999864 7899999996421  1223345889999999999999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEee
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD  259 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D  259 (437)
                      +.+..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999763   23489999999999999999999999   999999999999999999999999


Q ss_pred             cCCceecccCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ||+++..............||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...     ....+
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-----~~~~i  293 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKI  293 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-----HHHhh
Confidence            9999876554444444567999999999997     5678999999999999999999999997432211     11111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  387 (437)
                      .....     ...-+.    .....+..+.+|+.+|+..+|++  ||+++|+++.
T Consensus       294 ~~~~~-----~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 MNHKE-----RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HTHHH-----HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhccc-----cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            10000     000000    01123457889999999888888  9999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-43  Score=341.97  Aligned_cols=264  Identities=22%  Similarity=0.296  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|...+.||+|+||+||+|.+.+|+.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357788899999999999999999889999999996432 2333567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99985 777777643   23488999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch---h
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---D  344 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  344 (437)
                      .. .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ..............   .
T Consensus       172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHHHHHCCCCTTTSG
T ss_pred             Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHHCCCChHHhh
Confidence            22 22334568999999999876 568999999999999999999999997543321     11111111110000   0


Q ss_pred             hhc------cccc-------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          345 AIV------DRNL-------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       345 ~~~------d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...      +...       .....+..+.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000      0000       00011122357889999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-44  Score=337.88  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|...+.||+|+||.||++.+.++..||+|++...  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4677888999999999999999988899999999753  23457899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999763   23478999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .........         
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~---------  221 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTG---------  221 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTT---------
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcC---------
Confidence            222233456788999999998899999999999999999999 89998643211        111111111         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             0011122234578999999999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-44  Score=340.64  Aligned_cols=259  Identities=28%  Similarity=0.425  Sum_probs=210.5

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      +++...++|...+.||+|+||.||+|..+++..||+|++...  ....+.+.+|++++++++||||+++++++. .+..+
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   83 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY   83 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence            344456788889999999999999999988889999999753  234678999999999999999999999886 45689


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||++..
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            9999999999999986432  12388999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .........    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~----  226 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERG----  226 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT----
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcc----
Confidence            65433333334456789999999998899999999999999999999 89998643211        111111111    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       227 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          227 ------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                  0111122334688999999999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.5e-43  Score=344.87  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|.+.+.||+|+||.||++... +|+.||+|++......     ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467888999999999999999976 5899999999753321     1356899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeec
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF  260 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Df  260 (437)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999998653    3489999999999999999999999   999999999999998877    7999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++......  .......||+.|+|||.+.+..++.++|||||||++|+|++|..||......     ..   .......
T Consensus       164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~---~~~i~~~  233 (361)
T 2yab_A          164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ET---LANITAV  233 (361)
T ss_dssp             SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HH---HHHHHTT
T ss_pred             CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHhc
Confidence            999876432  2233456999999999999999999999999999999999999999643211     11   1111110


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..   -.++..    ....+..+.+++..||+.||++|||+.|+++.
T Consensus       234 ~~---~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          234 SY---DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CC---CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CC---CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00   000000    01123578899999999999999999999863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=347.68  Aligned_cols=246  Identities=22%  Similarity=0.239  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|+..+.||+|+||+||+|.+. +|+.||||++.... .......+..|+..+.++ +||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467899999999999999999986 69999999986432 223344566666666555 899999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+ +++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 668888887642   3489999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .......||+.|+|||.+.+ .++.++||||||+++|||++|..|+....           ........ ...   
T Consensus       209 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~-~~~---  270 (311)
T 3p1a_A          209 TA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQG-YLP---  270 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTT-CCC---
T ss_pred             cC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhcc-CCC---
Confidence            32  22334568999999998875 79999999999999999999977654210           01111111 000   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus       271 -----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 -----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                 0111123458899999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-43  Score=346.22  Aligned_cols=250  Identities=22%  Similarity=0.255  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|+..+.||+|+||+||+++.+ +|+.||+|++.+..  .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467888999999999999999975 68999999996421  234466788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999987643    378999999999999999999999   99999999999999999999999999998543


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   .......       
T Consensus       157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~---~~~i~~~-------  220 (337)
T 1o6l_A          157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RL---FELILME-------  220 (337)
T ss_dssp             CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHHC-------
T ss_pred             cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HH---HHHHHcC-------
Confidence            22 22234467999999999999999999999999999999999999999643211     11   1111110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                        .  ..++...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       221 --~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 --E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --C--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              0  011223345789999999999999999     89998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-44  Score=345.85  Aligned_cols=263  Identities=24%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC--Cee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  184 (437)
                      +.|...+.||+|+||.||+|.+     .+++.||+|++.........+.+.+|++++++++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577789999999999999984     358899999998655555668899999999999999999999999876  668


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            99999999999999996532   3389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCccc-------ccchhhHHHHHH
Q 013750          265 LVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE-------EEDDVLLLDHVK  335 (437)
Q Consensus       265 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~  335 (437)
                      ........  ......+|..|+|||.+.+..++.++||||||+++|||++|..|+......       .........   
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  251 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR---  251 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH---
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH---
Confidence            76543322  223345788899999999999999999999999999999999986421100       000000000   


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .............+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       252 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          252 -------LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             -------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence                   011111111222334455689999999999999999999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=339.98  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|...+.||+|+||.||++... +|+.||+|++......     ...+.+.+|+.++++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888899999999999999975 5899999998643221     2357899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeec
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF  260 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Df  260 (437)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999998653    3489999999999999999999999   999999999999999887    8999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|..||......     .........  .
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~--~  233 (326)
T 2y0a_A          163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAV--N  233 (326)
T ss_dssp             TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHHT--C
T ss_pred             CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHHhc--C
Confidence            9998764322  233456999999999999999999999999999999999999999643211     111111110  0


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ....        .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 YEFE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCCC--------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCcC--------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000        00001123578899999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.9e-44  Score=347.08  Aligned_cols=261  Identities=27%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      ...++|...+.||+|+||.||+|.+.        ++..||+|++.........+.+.+|+++++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34578889999999999999999863        46789999997654445567899999999999 8999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      ..+..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            999999999999999999999865421            23488999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE  325 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~  325 (437)
                      +++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence            9999999999999999876543221 2233457789999999998889999999999999999999 99998643211  


Q ss_pred             chhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            ..........          ....+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       267 ------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          267 ------ELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             ------HHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHHHHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  1111111110          111223344678999999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.1e-43  Score=334.81  Aligned_cols=260  Identities=18%  Similarity=0.244  Sum_probs=202.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeee-ecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv  187 (437)
                      ..++|...+.||+|+||.||+|.. .+++.||||++....   ..+.+.+|++++..++|+|++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            357899999999999999999997 568999999875422   234588999999999998888777766 667778999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCce
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~  264 (437)
                      |||+ +++|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+|||+   +.++.+||+|||+++
T Consensus        84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 999999987532   2389999999999999999999999   99999999999999   789999999999998


Q ss_pred             ecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          265 LVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       265 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........  ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~  234 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISEKK  234 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--HHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh--hhhhhccc
Confidence            76543321      12345689999999999999999999999999999999999999975433322221  11111111


Q ss_pred             hccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       339 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ........         ....+..+.+++..||+.||++|||+.++++.|+.
T Consensus       235 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          235 MSTPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HHSCHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ccchhhhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence            01111000         01123579999999999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-44  Score=347.37  Aligned_cols=266  Identities=25%  Similarity=0.345  Sum_probs=208.4

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec--CCeeEE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLL  186 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  186 (437)
                      |...+.||+|+||+||++.+.     +++.||||++.........+.+.+|++++++++||||+++++++..  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            477899999999999998753     5889999999865444556789999999999999999999999987  457899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++....     +++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999999999997532     79999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.........   ...............
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE---LIGIAQGQMTVLRLT  261 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh---hhcccccchhHHHHH
Confidence            543321  123345788899999999989999999999999999999999998632111000   000000000001112


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..+........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            2222222233344556789999999999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.3e-44  Score=336.97  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=196.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC---CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+|.+. ++.||||++.....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467888899999999999999985 89999999864321   23356789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC--------CCcEEEee
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--------DFEAVVGD  259 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~--------~~~~kl~D  259 (437)
                      |||+++++|.+++..     ..+++..+..++.|++.||+|||++...+++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999998853     23899999999999999999999992222999999999999986        77899999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .....   
T Consensus       160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~---  225 (271)
T 3dtc_A          160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYG---  225 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHH---
T ss_pred             CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHh---
Confidence            99998654322   22346899999999999999999999999999999999999999643211        01111   


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            ..........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          226 ------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                  111111122233445689999999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-44  Score=349.76  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||+||+|.+. +++    +||+|.+.........+.+.+|+.++++++||||++++++|. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            356778899999999999999974 344    388888865444455567889999999999999999999986 45688


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +|+||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999998753   23478899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ....... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......     .....   ....  
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~---~~~~--  234 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VPDLL---EKGE--  234 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HHHHH---HTTC--
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HHHHH---HcCC--
Confidence            6543322 2334567889999999999999999999999999999999 999997533211     11111   1110  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       235 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~  273 (325)
T 3kex_A          235 --------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR  273 (325)
T ss_dssp             --------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred             --------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    111112233468889999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-43  Score=336.96  Aligned_cols=253  Identities=28%  Similarity=0.477  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcc------hHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGG------DAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      .++|...+.||+|+||+||+|.+. +++.||+|++........      .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467888899999999999999974 689999999864332221      167899999999999999999999987655 


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEecCCCCCCeeecCCCc-----EE
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFE-----AV  256 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~-----~k  256 (437)
                       ++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +  ++|+||||+||+++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             6999999999998888653   33589999999999999999999999   7  999999999999988776     99


Q ss_pred             EeecCCceecccCCCccccccccccccccccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          257 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS--TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       257 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      |+|||+++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.......   .   ...
T Consensus       170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~---~~~  239 (287)
T 4f0f_A          170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I---KFI  239 (287)
T ss_dssp             ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---H---HHH
T ss_pred             eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---H---HHH
Confidence            999999974332    233456899999999984  4567899999999999999999999997433221   1   111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...         .........+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       240 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          240 NMI---------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHH---------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHH---------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111         11111222233445689999999999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-43  Score=351.05  Aligned_cols=254  Identities=21%  Similarity=0.264  Sum_probs=200.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  185 (437)
                      ..++|+..+.||+|+||+||+++.+ +++.||+|++.+..  .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3567889999999999999999976 57899999997532  233345688999999877 8999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999987643    389999999999999999999999   999999999999999999999999999985


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....................        
T Consensus       203 ~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------  273 (396)
T 4dc2_A          203 GLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------  273 (396)
T ss_dssp             CCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------
T ss_pred             ccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------
Confidence            322 22234456799999999999999999999999999999999999999964322111110000111111        


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      +....  ..++...+..+.+|+.+||+.||++||++
T Consensus       274 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          274 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             Hhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11111  11223344578999999999999999995

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-44  Score=347.33  Aligned_cols=269  Identities=24%  Similarity=0.389  Sum_probs=217.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI  175 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~  175 (437)
                      +..++++...++|...+.||+|+||.||+|.+.      ++..||+|++...........|.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444566677889999999999999999999864      36789999997654445566799999999999999999999


Q ss_pred             eeeecCCeeEEEEecccCchhhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee
Q 013750          176 GFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL  249 (437)
Q Consensus       176 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll  249 (437)
                      +++...+..++||||+++|+|.+++....      .....+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            99999999999999999999999987532      1123478999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccch
Q 013750          250 DEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDD  327 (437)
Q Consensus       250 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~  327 (437)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......    
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  247 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----  247 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence            99999999999999865432221 1223456889999999999999999999999999999999 88888643211    


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                          .......... .         ...+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus       248 ----~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          248 ----QVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             ----HHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ----HHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                1111111111 0         111223446789999999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.5e-43  Score=333.61  Aligned_cols=259  Identities=19%  Similarity=0.246  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeee-ecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....   ..+.+.+|+.+++.++|+|++..++++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46788899999999999999997 578999999986432   335688999999999999877777666 5667789999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~  265 (437)
                      ||+ +++|.+++....   ..+++..++.++.|++.||+|||++   +++||||||+|||+   +.++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 899999997532   3489999999999999999999999   99999999999999   5889999999999987


Q ss_pred             cccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          266 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       266 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........  .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~  235 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--HHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh--hhhhccccc
Confidence            6543321      12345689999999999999999999999999999999999999975433222211  111111110


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......     +    ....+..+.+++..||+.||++|||+.++++.|+.
T Consensus       236 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          236 STPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HSCHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             CCchHH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence            100000     0    11123578999999999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.2e-43  Score=344.07  Aligned_cols=256  Identities=21%  Similarity=0.292  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC----CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||+||+|... +|+.||||++...    ......+.+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457888999999999999999975 6899999998531    11234678999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEeecCC
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGL  262 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgl  262 (437)
                      +||||+++++|.+++.........+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999988865543445589999999999999999999999   9999999999999987655   99999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      +....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ...   ........
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~---~~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLF---EGIIKGKY  249 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHH---HHHHHTCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHH---HHHHcCCC
Confidence            98765422 223345699999999999999999999999999999999999999964211      011   11111100


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .   ..+..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       250 ~---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K---MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C---CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0   00000    0112357899999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-44  Score=344.91  Aligned_cols=269  Identities=26%  Similarity=0.391  Sum_probs=215.3

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRL  174 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l  174 (437)
                      +...++....++|...+.||+|+||+||+|.+      .+++.||||++.........+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556666788999999999999999999985      246899999997655445567899999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEecccCchhhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecC
Q 013750          175 IGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD  241 (437)
Q Consensus       175 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~d  241 (437)
                      ++++...+ ..++||||+++++|.+++......            ...+++..++.++.|++.||.|||++   +++|+|
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99987655 489999999999999999765431            22378999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013750          242 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF  319 (437)
Q Consensus       242 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~  319 (437)
                      |||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999866433322 2233457889999999999999999999999999999998 9999865


Q ss_pred             CcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          320 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....    ...   .......          ....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       254 ~~~~~----~~~---~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          254 VKIDE----EFC---RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCCSH----HHH---HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cchhH----HHH---HHhccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            33211    111   1111110          011122234578999999999999999999999999975

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.6e-44  Score=338.00  Aligned_cols=256  Identities=21%  Similarity=0.351  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ..++|...+.||+|+||+||+|.+.+    +..||+|.+.........+.|.+|+.++++++||||+++++++.. +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35678889999999999999998643    236999999765445567789999999999999999999999865 4568


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+++++|.+++....   ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            9999999999999997642   3478999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......     ......   ....  
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~---~~~~--  232 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLE---KGDR--  232 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHH---HTCC--
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHh---cCCC--
Confidence            65433333334557889999999998899999999999999999998 999986432211     111111   1110  


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 --------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                    11122234578999999999999999999999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-44  Score=347.60  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=196.7

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECCC----CEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ++....++|...+.||+|+||.||+|.+...    ..||||++.... .....+.+.+|++++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3344567899999999999999999996543    279999987532 34456789999999999999999999999987


Q ss_pred             CCee------EEEEecccCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          181 PTER------LLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       181 ~~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ....      ++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||++   +++||||||+|||++++
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            7665      999999999999999865432  223589999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhH
Q 013750          253 FEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL  330 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~  330 (437)
                      +.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     .
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~  248 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----I  248 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----H
Confidence            99999999999865433221 2223456789999999999999999999999999999999 899987433211     1


Q ss_pred             HHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       331 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..   ......          ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       249 ~~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          249 YN---YLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             HH---HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH---HHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11   111110          111223344689999999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.9e-43  Score=339.41  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||+|... +|+.||+|++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467888999999999999999975 5899999999754444556788999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |++ ++|.+++.....  ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 589888865432  223589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc---c-
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---R-  342 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-  342 (437)
                      .... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......     ....+.......   . 
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-----QLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCCTTTC
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCChhHh
Confidence            3222 2234568999999999976 468999999999999999999999997543211     111111110000   0 


Q ss_pred             --------------------hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 --------------------LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 --------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                          ....+.+..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                000001111    1123357899999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-43  Score=336.07  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||+||+|...+|+.||+|++.... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4678889999999999999999889999999986432 223346788999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++ +|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            985 8888886532   3488999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc---hhh-
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR---LDA-  345 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-  345 (437)
                       .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......     ..............   ... 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTG
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHHCCCChhhchhh
Confidence             122334689999999999764 5899999999999999999999999743211     11111111100000   000 


Q ss_pred             ----hcccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 ----IVDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ----~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ..++...       .......+..+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                0000000       0111223467889999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-43  Score=339.79  Aligned_cols=252  Identities=18%  Similarity=0.233  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||++... ++..||+|.+...  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            467888999999999999999975 5889999998642  3445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC--CCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~  267 (437)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999998652   23489999999999999999999999   9999999999999987  7899999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|..||......     ...   .........   .
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~---~~i~~~~~~---~  222 (321)
T 1tki_A          156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QII---ENIMNAEYT---F  222 (321)
T ss_dssp             TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHH---HHHHHTCCC---C
T ss_pred             CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHH---HHHHcCCCC---C
Confidence            32  2233456899999999999888999999999999999999999999643211     111   111111000   0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +...    ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000    01224578999999999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=337.07  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=206.2

Q ss_pred             cCCCCCC-eeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++.........+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4454555 8999999999999863   57889999998654455677899999999999999999999999 45668999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999998642   33489999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          268 VRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       268 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ......  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......     ...   ......    
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~---~~i~~~----  229 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVM---AFIEQG----  229 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHH---HHHHTT----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HHH---HHHhcC----
Confidence            433222  222346889999999988889999999999999999999 99998643221     111   111111    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .....+...+..+.+++..||+.||++||++.++++.|+.
T Consensus       230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                  1112233445689999999999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=373.52  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=211.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      ..++...++|...+.||+|+||.||+|.++++..||||++....  ...++|.+|++++++++||||+++++++.. +..
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            34445567788899999999999999999888899999997532  345789999999999999999999999876 678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            99999999999999997532  12378999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ..............++..|+|||.+....++.++||||||+++|||++ |+.||......        .........   
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~---  480 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG---  480 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTT---
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC---
Confidence            654322112223446789999999999999999999999999999999 89998643211        111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             .+...+..++..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       481 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          481 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                   1112233445689999999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=343.85  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .++|...+.||+|+||+||+|.+. +++    +||+|.+.........+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467888999999999999999964 344    468888876555667788999999999999999999999998765 78


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +|++|+++|+|.+++....   ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            9999999999999997642   3488999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ....... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ....          
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~----------  231 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI----------  231 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH----------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHH----------
Confidence            6433222 2223456789999999999999999999999999999999 999997533211     1111          


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         +........+...+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       232 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  275 (327)
T 3lzb_A          232 ---LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             ---HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               11111111223344578999999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=338.81  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-------------------------CcchHHHHHHHHHHH
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------------------------PGGDAAFQREVEMIS  164 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------------------~~~~~~~~~E~~~l~  164 (437)
                      .++|...+.||+|+||.||+|... +++.||||++.....                         ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467888999999999999999975 588999999864321                         112357899999999


Q ss_pred             hcccccceeeeeeeec--CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC
Q 013750          165 VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV  242 (437)
Q Consensus       165 ~l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl  242 (437)
                      +++||||+++++++..  ....++||||+++++|.+++..     ..+++..+..++.|++.||+|||++   +++||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  5678999999999999876432     3489999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCC---CCCchhhHHHHHHHHHHHhCCCCCCC
Q 013750          243 KAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDF  319 (437)
Q Consensus       243 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gv~l~elltg~~p~~~  319 (437)
                      ||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999987653322 233457999999999997765   47889999999999999999999964


Q ss_pred             CcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          320 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...     ...   .......         .+........+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~-----~~~---~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI-----MCL---HSKIKSQ---------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH-----HHH---HHHHHHC---------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH-----HHH---HHHHhcc---------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321     111   1111110         0000111223457899999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=344.38  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|...+.||+|+||.||+|.+..     +..||+|++...........+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999998643     236999999765444556689999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus       124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999763   23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          267 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       267 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .......  .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......        ..........  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~--  267 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF--  267 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC--
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCC--
Confidence            5332211  222346788999999999999999999999999999999 99998643211        1111111110  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    111122345688999999999999999999999999976

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.6e-44  Score=358.08  Aligned_cols=263  Identities=20%  Similarity=0.235  Sum_probs=210.5

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      .++....++|...+.||+|+||+||+++.+ +++.||+|++.+..  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            455667789999999999999999999986 58899999986421  122344688999999999999999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      +..++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999998753     278899999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||......     .....+...
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~  288 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMNH  288 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTH
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-----hHHHHHHhc
Confidence            99876544333344567999999999997655    789999999999999999999999743221     111111100


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHhc
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRMLEG  390 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~~  390 (437)
                      ...          +........+..+.+|+.+|++.+|.+  ||++.|+++.--.
T Consensus       289 ~~~----------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          289 KNS----------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             HHH----------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             ccc----------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence            000          000001123357899999999999988  9999999975443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=372.02  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=199.8

Q ss_pred             eeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          119 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       119 ~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .||+|+||.||+|.+.   ++..||||+++........++|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874   4667999999865545567889999999999999999999999976 56899999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCccc-
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-  274 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  274 (437)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... 
T Consensus       422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            99998653   34489999999999999999999999   999999999999999999999999999986643322221 


Q ss_pred             -ccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccccc
Q 013750          275 -TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN  352 (437)
Q Consensus       275 -~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  352 (437)
                       ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......     ..   .......          ..
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~---~~~i~~~----------~~  557 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EV---MAFIEQG----------KR  557 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----HH---HHHHHTT----------CC
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HH---HHHHHcC----------CC
Confidence             22345689999999999999999999999999999998 99999753321     11   1111111          11


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          353 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+..++..+.+|+..||+.||++||++.++++.|+.
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            22234455789999999999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.4e-43  Score=332.80  Aligned_cols=263  Identities=20%  Similarity=0.254  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|+..+.||+|+||+||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            56888899999999999999985 58999999997433 23345788899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |++++ +..++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~-l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQD-LKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEE-HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCCC-HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99864 44444432   23489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh----
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD----  344 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  344 (437)
                      . .......||+.|+|||.+.+.. ++.++||||||+++|||++|..|+.....    ..................    
T Consensus       155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTT
T ss_pred             c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhhhhh
Confidence            2 2233456899999999997766 89999999999999999999888642221    111111111111100000    


Q ss_pred             --hhcc---------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          345 --AIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       345 --~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        ...+         ........+..+..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              0000         00001112334567889999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4e-43  Score=334.04  Aligned_cols=254  Identities=21%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||+||++... ++..||+|++.........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            356888999999999999999975 5899999999765555567889999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCceec
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~  266 (437)
                      |+++++|.+++.........+++..+..++.|++.||+|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999876533345589999999999999999999999   99999999999999   45688999999999865


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...  .......||+.|+|||.+. +.++.++||||||+++|||++|+.||......        ..........     
T Consensus       178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~-----  241 (285)
T 3is5_A          178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYKE-----  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-----
T ss_pred             CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccCC-----
Confidence            432  2233456899999999885 57899999999999999999999999743211        1111111000     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        +..... ....+..+.+++.+||+.||++|||+.|+++
T Consensus       242 --~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 --PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000000 0012357889999999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-43  Score=343.84  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||+||+|.+ .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36788899999999999999997 568999999986321  123345789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+ +|+|.+++....    .+++..+..++.|++.||.|||++   +++||||||+|||+++++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 688888887543    389999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..  .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+........                 ..+
T Consensus       160 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i  220 (336)
T 3h4j_B          160 DG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKV  220 (336)
T ss_dssp             TS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCC
T ss_pred             CC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHH
Confidence            32  22334569999999999988776 78999999999999999999999643322110                 000


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...  ....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       221 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          221 NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            000  011122334578899999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.1e-44  Score=335.14  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC--CeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  187 (437)
                      .++|...+.||+|+||.||+|+++ ++.||+|++.... .....+.|.+|+.++++++||||+++++++...  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467888899999999999999985 8999999997533 234456799999999999999999999999877  778999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      |||+++|+|.+++....  ...+++..++.++.|++.||+|||++   +  ++|+||||+||+++.++.++|+|||++..
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            99999999999997632  23589999999999999999999998   7  99999999999999999999999998764


Q ss_pred             cccCCCcccccccccccccccccccCCCCCC---chhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ..      .....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......        ......     
T Consensus       163 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~-----  223 (271)
T 3kmu_A          163 FQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--------EIGMKV-----  223 (271)
T ss_dssp             TS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--------HHHHHH-----
T ss_pred             ec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--------HHHHHH-----
Confidence            32      12245799999999998765544   799999999999999999999643211        111111     


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .........+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          224 ----ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             ----HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                11111122233345689999999999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.1e-43  Score=343.26  Aligned_cols=253  Identities=22%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|...+.||+|+||.||+++.+ +++.||+|++....  .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            356888899999999999999985 58899999997532  223345688999999987 89999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999997643    389999999999999999999999   9999999999999999999999999999853


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....................        +
T Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i  231 (345)
T 3a8x_A          161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------I  231 (345)
T ss_dssp             CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------H
T ss_pred             cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------H
Confidence            322 2233446799999999999999999999999999999999999999964322111100000111110        1


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM  381 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  381 (437)
                      ....  ..++...+..+.+++.+||+.||++||++
T Consensus       232 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          232 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1111  11223344578999999999999999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-43  Score=338.94  Aligned_cols=271  Identities=23%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc--ccccceeeeeeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA--VHRNLLRLIGFCT  179 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~  179 (437)
                      ..........++|.+.+.||+|+||.||+|+.. ++.||||++..    .....+..|.+++...  +||||+++++++.
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            344445556788999999999999999999985 89999999863    2344556666666554  8999999999998


Q ss_pred             cC----CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecCCCCCCeeec
Q 013750          180 TP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLD  250 (437)
Q Consensus       180 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~dlk~~NIll~  250 (437)
                      ..    ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||+++     .++++||||||+|||++
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            77    6789999999999999999753     3899999999999999999999762     34899999999999999


Q ss_pred             CCCcEEEeecCCceecccCCCcc---cccccccccccccccccCCCCCCc------hhhHHHHHHHHHHHhC--------
Q 013750          251 EDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG--------  313 (437)
Q Consensus       251 ~~~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDv~s~Gv~l~elltg--------  313 (437)
                      .++.+||+|||++..........   .....||+.|+|||.+.+...+..      +|||||||++|||+||        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999999998664333221   123468999999999987766655      9999999999999999        


Q ss_pred             --CCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          314 --QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       314 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        +.||..........    ...........    ..+.+... ...+++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       257 ~~~~p~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSY----EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCCTTTTTSCSSCCH----HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccHhhhcCCCCch----hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence              55554322211110    11111111100    01111111 123677889999999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=340.40  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee----cCCee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT----TPTER  184 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~  184 (437)
                      ..++|...+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.    .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            356788999999999999999997 57899999998643 2455678899999999999999999999986    34578


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+++++|.+++.........+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            899999999999999987654556689999999999999999999999   99999999999999999999999999987


Q ss_pred             ecccCCCcc--------cccccccccccccccccCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          265 LVDVRKTNV--------TTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       265 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      .........        .....||+.|+|||.+....   ++.++||||||+++|||++|+.||.........   .   
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---  256 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---V---  256 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---H---
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---h---
Confidence            653211110        12235799999999987554   689999999999999999999998521111000   0   


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCC
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA  394 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  394 (437)
                                ................+..+.+++.+||+.||++|||+.++++.|+....+
T Consensus       257 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          257 ----------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             ----------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             ----------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                      000000111111223346899999999999999999999999999875443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=348.05  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888999999999999999975 58899999986421  234456889999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|..++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999999753    2389999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ..  .......||+.|+|||.+..   ..++.++|||||||++|||++|+.||.........     .........    
T Consensus       167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~~----  235 (384)
T 4fr4_A          167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFETT----  235 (384)
T ss_dssp             TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHHHC----
T ss_pred             CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHhhc----
Confidence            32  23345679999999999974   45899999999999999999999999743322111     111111100    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~  386 (437)
                             ...++...+..+.+|+.+||+.||++||+ +.++.+
T Consensus       236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   01122233468899999999999999999 777664

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=345.68  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhccc--ccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||++...+++.||||++.... .....+.+.+|+.++.+++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45688899999999999999999889999999986432 23345678999999999987  9999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      || +.+++|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++ ++.+||+|||+++...
T Consensus        88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 56889999998643    388999999999999999999999   999999999999997 5789999999998765


Q ss_pred             cCCCc-ccccccccccccccccccC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          268 VRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       268 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      ..... ......||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......       ...  
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~--  229 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISK--  229 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHH--
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHH--
Confidence            33222 2234579999999999864           67899999999999999999999999632111       011  


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                             .....++......+...+..+.+++..||+.||++|||+.|+++..
T Consensus       230 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          230 -------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                   1112222222222223345788999999999999999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=345.16  Aligned_cols=253  Identities=20%  Similarity=0.257  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            467889999999999999999975 68999999987532 3345678999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC--CCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~  267 (437)
                      |+++|+|.+++...   ...+++..+..++.||+.||+|||++   +++||||||+|||++.  ++.+||+|||+++...
T Consensus       129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999988642   23489999999999999999999999   9999999999999974  5779999999998765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ...  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ....   .......      
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~---~~i~~~~------  266 (387)
T 1kob_A          203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETL---QNVKRCD------  266 (387)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHH---HHHHHCC------
T ss_pred             CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHH---HHHHhCC------
Confidence            332  22334689999999999999999999999999999999999999974321     1111   1111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus       267 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          267 -WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             001111112334578999999999999999999999974

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-42  Score=342.50  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999975 58999999997433 233456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEEeecCCce
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~  264 (437)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999888653    3489999999999999999999999   99999999999999865   459999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      .....  .......||+.|+|||.+.+..++.++|||||||++|||++|..||.....     ..+...+.   ... ..
T Consensus       180 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~---~~~-~~  248 (362)
T 2bdw_A          180 EVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIK---AGA-YD  248 (362)
T ss_dssp             CCTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH---HTC-CC
T ss_pred             EecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH---hCC-CC
Confidence            66432  223345799999999999999999999999999999999999999964321     11111111   110 00


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                            .........+..+.+++.+||+.||++|||+.|+++.
T Consensus       249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0000011234578999999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.2e-42  Score=338.78  Aligned_cols=269  Identities=23%  Similarity=0.322  Sum_probs=210.4

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHh--cccccceeeeeee
Q 013750          101 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFC  178 (437)
Q Consensus       101 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~  178 (437)
                      ..++.......++|...+.||+|+||.||+|+. +|+.||||++..    .....+.+|.+++..  ++||||+++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            344455566778999999999999999999998 589999999863    345678889999887  7899999999999


Q ss_pred             ecCC----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecCCCCCC
Q 013750          179 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAAN  246 (437)
Q Consensus       179 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiH~dlk~~N  246 (437)
                      ....    ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.   +++||||||+|
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N  177 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN  177 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence            8776    789999999999999999753     3899999999999999999999        67   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCCc---ccccccccccccccccccCC------CCCCchhhHHHHHHHHHHHhC----
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTG----  313 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gv~l~elltg----  313 (437)
                      ||++.++.+||+|||++.........   ......||+.|+|||.+.+.      .++.++||||||+++|||+||    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            99999999999999999876543322   12335689999999999765      234789999999999999999    


Q ss_pred             ------CCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          314 ------QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       314 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            ..||.........   ......... ..    ...+.+... ...+.+..+.+|+.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~p~~~~~~~~~~---~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS---VEEMRKVVC-EQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC---HHHHHHHHT-TS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcccccccCccccCcCccc---HHHHHHHHH-HH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  6676533221111   111111110 10    011111111 12466778999999999999999999999999


Q ss_pred             HHhc
Q 013750          387 MLEG  390 (437)
Q Consensus       387 ~L~~  390 (437)
                      .|+.
T Consensus       330 ~L~~  333 (342)
T 1b6c_B          330 TLSQ  333 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=347.74  Aligned_cols=251  Identities=26%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ...++|+..+.||+|+||+||+++.+ +|+.||+|++....  .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34578999999999999999999975 58999999996421  233456788999999988 799999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999999999997643    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ..... .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   ......     
T Consensus       173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~---~~~i~~-----  238 (353)
T 3txo_A          173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DL---FEAILN-----  238 (353)
T ss_dssp             CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHH-----
T ss_pred             ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HH---HHHHHc-----
Confidence            53322 22334467999999999999889999999999999999999999999743221     11   111111     


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM------SEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~------~evl~  386 (437)
                          ..  ..++...+..+.+++.+||+.||++||++      .|+++
T Consensus       239 ----~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          239 ----DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                11  01122234578899999999999999998      67764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.6e-43  Score=346.87  Aligned_cols=272  Identities=18%  Similarity=0.197  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeec--CcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|++.+.||+|  +||+||+++.. +|+.||||++.... .....+.+.+|+++++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4678889999999  99999999986 69999999997433 23345678889999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999976422  3389999999999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCC------cccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          267 DVRKT------NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       267 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      .....      .......||..|+|||.+.+  ..++.++|||||||++|||++|+.||.....................
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            32111      11122468899999999987  57999999999999999999999999753322111000000000000


Q ss_pred             hcc------------------chhhhcc---------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          339 REK------------------RLDAIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       339 ~~~------------------~~~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...                  .......         .......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000                  0000000         000001223345679999999999999999999999854

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=352.16  Aligned_cols=255  Identities=18%  Similarity=0.239  Sum_probs=204.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|...+.||+|+||+||++... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567888999999999999999974 68999999987533 223456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec---CCCcEEEeecCCce
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~  264 (437)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999987643    389999999999999999999999   999999999999998   46789999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.....     ......+.   ... . 
T Consensus       162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~---~~~-~-  230 (444)
T 3soa_A          162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIK---AGA-Y-  230 (444)
T ss_dssp             CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH---HTC-C-
T ss_pred             EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH---hCC-C-
Confidence            664332 223345799999999999999999999999999999999999999964321     11111111   110 0 


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           ..........+..+.+++..||+.||++|||+.|+++.
T Consensus       231 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 -----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 00000111234578999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=344.89  Aligned_cols=268  Identities=18%  Similarity=0.200  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCCCCc----------chHHHHHHHHHHHhcccccceeeee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLRLIG  176 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~g  176 (437)
                      .++|...+.||+|+||.||+|...    ++..+|+|+........          ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467888999999999999999985    57889999987532111          1234667888899999999999999


Q ss_pred             eeec----CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          177 FCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       177 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ++..    ....++||||+ +++|.+++....    .+++..++.++.||+.||+|||++   +++||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9987    67889999999 999999987643    489999999999999999999999   99999999999999988


Q ss_pred             C--cEEEeecCCceecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 013750          253 F--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE  324 (437)
Q Consensus       253 ~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~  324 (437)
                      +  .+||+|||+++........      ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... 
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence            7  9999999999876432211      123456899999999999999999999999999999999999999532111 


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCC
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA  394 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  394 (437)
                        .... .......... ..........   ....+..+.+++..||+.||++|||+.+|++.|+...++
T Consensus       267 --~~~~-~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          267 --PVAV-QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             --HHHH-HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             --cHHH-HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence              1111 1111111111 1111100000   012345899999999999999999999999999985554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=334.89  Aligned_cols=254  Identities=29%  Similarity=0.378  Sum_probs=201.6

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-C---CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCee-EEEE
Q 013750          114 FSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER-LLVY  188 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~  188 (437)
                      |...+.||+|+||+||+|.+.+ +   ..||+|.+.........+.|.+|+.++++++||||+++++++.+.+.. ++|+
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            4456889999999999998632 2   379999997655455667899999999999999999999999876665 9999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+.+++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus       103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999752   33478999999999999999999999   999999999999999999999999999985533


Q ss_pred             CC---CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          269 RK---TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       269 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ..   ........+|..|+|||.+.+..++.++||||||+++|||++|..|+......    .........   .     
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~---~-----  244 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQ---G-----  244 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHT---T-----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhc---C-----
Confidence            21   11223345788999999999999999999999999999999966664322111    111111111   1     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           .....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       245 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          245 -----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 0111122334578999999999999999999999999976

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-43  Score=337.26  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             HHhcCCCCCC-eeeecCcEEEEEEEEC---CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          109 LATDNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       109 ~~~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ...++|...+ .||+|+||+||+|.+.   ++..||||++.... .....+.+.+|+++++.++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3345666666 9999999999999652   46889999997533 233367899999999999999999999999 5667


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....    .+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            899999999999999998643    388999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          264 KLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       264 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ..........  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......     ..   .......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~---~~~~~~~  236 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EV---TAMLEKG  236 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HH---HHHHHTT
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HH---HHHHHcC
Confidence            8765433322  122346788999999998889999999999999999999 99998643211     11   1111111


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                                .....+...+..+.+++..||+.||++||++.++++.|+.
T Consensus       237 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          237 ----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                      1112233345689999999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=349.99  Aligned_cols=254  Identities=28%  Similarity=0.416  Sum_probs=194.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC--CC--CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCeeEEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA--DG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLV  187 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv  187 (437)
                      .|...+.||+|+||+||+|.+.  ++  ..||+|.+.........+.|.+|+.++++++||||++++++|.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556688999999999999964  22  36899999765555667889999999999999999999999754 4578999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++...   ...+++..+..++.||++||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999753   23478999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCc---ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .....   ......+|..|+|||.+.+..++.++||||||+++|||+| |..||.......     .....   ....  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~---~~~~--  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYL---LQGR--  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHH---HTTC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHH---HcCC--
Confidence            32211   1223457789999999999999999999999999999999 666765432211     11111   1111  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                              ....+..++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    011122334579999999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=338.95  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      ++|...+.||+|+||+||++.+. ++.||+|++..   ....+.|.+|++++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            56777899999999999999985 78999999864   3456789999999999999999999998874  479999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc-EEEeecCCceecccCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVDVRK  270 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~  270 (437)
                      ++++|.+++..... ...+++..++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            99999999975432 234788899999999999999999932238999999999999998876 799999999754322 


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   .   ..........         
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~~~~~---------  221 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---F---RIMWAVHNGT---------  221 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---H---HHHHHHHTTC---------
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---H---HHHHHHhcCC---------
Confidence               223458999999999999999999999999999999999999996432211   0   1111111110         


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       ........+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  260 (307)
T 2eva_A          222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH  260 (307)
T ss_dssp             -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence             011112234578999999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-44  Score=345.44  Aligned_cols=271  Identities=25%  Similarity=0.326  Sum_probs=210.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee--cCCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~  183 (437)
                      .++|...+.||+|+||.||++.+     .++..||||++... .....+.+.+|++++++++||||+++++++.  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            36778889999999999999984     35889999999753 2445567999999999999999999999886  4566


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            889999999999999997632   2389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          264 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       264 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      .........  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...........   ..........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~  251 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM---GCERDVPALS  251 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC---C----CCHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc---ccccccccHH
Confidence            876543322  22234578889999999998999999999999999999999999853221100000   0000000000


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                      ..............+...+..+.+++..||+.||++|||+.|+++.|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11112222222333445567899999999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=348.97  Aligned_cols=273  Identities=18%  Similarity=0.214  Sum_probs=213.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC--eeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv  187 (437)
                      .++|...+.||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356788899999999999999986 489999999975444455678889999999999999999999997665  67999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee----cCCCcEEEeecCCc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA  263 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla  263 (437)
                      |||+++|+|.+++..... ...+++..++.++.|++.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999976432 22389999999999999999999999   99999999999999    78888999999999


Q ss_pred             eecccCCCcccccccccccccccccccC--------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +......  ......||..|+|||.+..        ..++.++|||||||++|||++|+.||............... ..
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~~  240 (396)
T 4eut_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-II  240 (396)
T ss_dssp             EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH-HH
T ss_pred             eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH-Hh
Confidence            8764322  2334568999999999865        56788999999999999999999999643332222111111 11


Q ss_pred             HHHhccchhhh---c--------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          336 KLEREKRLDAI---V--------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       336 ~~~~~~~~~~~---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..........+   .        +-.............+.+++..||+.||++||++.++++.++.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            11110000000   0        0011223457788899999999999999999999999998876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4e-43  Score=334.63  Aligned_cols=260  Identities=28%  Similarity=0.462  Sum_probs=195.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ...++|...+.||+|+||+||+|.+.  ..||+|++.... .....+.|.+|++++++++||||+++++++ .....++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            34678889999999999999999874  469999997433 234457899999999999999999999965 45568999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999998653   34489999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCC-Cccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRK-TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ... ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||.......    .......   .. ..
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~---~~-~~  243 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVG---RG-SL  243 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHH---HT-SC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhc---cc-cc
Confidence            322 22233456899999999986   5678899999999999999999999996432211    1111111   11 11


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .    +. .......++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       244 ~----~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  285 (289)
T 3og7_A          244 S----PD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE  285 (289)
T ss_dssp             C----CC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C----cc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            0    00 011122345689999999999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-42  Score=336.49  Aligned_cols=250  Identities=22%  Similarity=0.254  Sum_probs=195.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      .++|...+.||+|+||.||+++.    .+|+.||+|++....   .......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46788899999999999999997    478999999997532   12334567899999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999997643    378899999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      +...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .........   
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~---  236 (327)
T 3a62_A          169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKC---  236 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHT---
T ss_pred             cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC---
Confidence            7543222 2233456899999999999999999999999999999999999999743211        111111111   


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                            .  ...+...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       237 ------~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 ------K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ------C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ------C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                  0  111223345789999999999999999     77788764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5e-43  Score=344.87  Aligned_cols=253  Identities=21%  Similarity=0.245  Sum_probs=194.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||+||++... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            567888999999999999999986 68999999997532  334678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc--EEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~~~  267 (437)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.  +||+|||+++...
T Consensus        97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999987643    389999999999999999999999   9999999999999987765  9999999997433


Q ss_pred             cCCCcccccccccccccccccccCCCCCCc-hhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSER-TDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..  .......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........    .........        
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~--------  235 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRIL--------  235 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHH--------
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHh--------
Confidence            22  22234569999999999988887655 8999999999999999999975332211    111111111        


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          236 -SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             1111101111223578899999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-42  Score=332.85  Aligned_cols=259  Identities=20%  Similarity=0.234  Sum_probs=199.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..++|...+.||+|+||.||++... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999975 688999999875321  2234678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999998643    389999999999999999999999   9999999999999999999999999999866


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ............|+..|+|||.+.+..++.++||||||+++|||++|+.||......        .............  
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~--  254 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIPRP--  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCCCG--
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCCCc--
Confidence            543333333456899999999999999999999999999999999999999743211        0011111100000  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcC
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGE  391 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~  391 (437)
                            ...+...+..+.+++.+||+.||++|| +++++++.|+..
T Consensus       255 ------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          255 ------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             ------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             ------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence                  111223345789999999999999999 999999999873

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.6e-43  Score=337.38  Aligned_cols=261  Identities=22%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++....  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45788899999999999999997 468999999997422  233456789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++.........+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999976544455689999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ........... ...   
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~---  256 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQC-DYP---  256 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTT-CSC---
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcc-cCC---
Confidence            3222 223346899999999999999999999999999999999999998643211      11111111111 100   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           .......+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       257 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          257 -----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                 00112234578999999999999999999999999976

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=355.33  Aligned_cols=265  Identities=18%  Similarity=0.218  Sum_probs=210.2

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      +.+++.....++|+..+.||+|+||+||+++.+ +|+.||+|++.+..  .....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566677889999999999999999999985 68999999996421  122344688999999999999999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                      .+.+..++||||+++|+|.+++....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++++||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            99999999999999999999997642   2488999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCccccccccccccccccccc-------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      |||+++..............||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..     ...
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~  279 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ETY  279 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHH
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            99999876544333334467999999999997       457899999999999999999999999743221     111


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---PAMSEVVRM  387 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ps~~evl~~  387 (437)
                      ..+......     ..-+.    .....+..+.+++.+||+ +|++|   |+++|+++.
T Consensus       280 ~~i~~~~~~-----~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          280 GKIVHYKEH-----LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHTHHHH-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHhcccC-----cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            111110000     00000    112234588999999999 99998   689998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.4e-43  Score=329.47  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888999999999999999985 6899999999754444556789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999988642    3489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CC-cccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          270 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       270 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .. .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........   ....    .......    
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~~----  227 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSD----WKEKKTY----  227 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHH----HHTTCTT----
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHH----hhhcccc----
Confidence            21 12334568999999999987765 7899999999999999999999975332111   1111    1100000    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           .......+..+.+++.+||+.||++|||+.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0001123357889999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-42  Score=339.53  Aligned_cols=264  Identities=20%  Similarity=0.200  Sum_probs=203.4

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC----CCCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ++....++|...+.||+|+||.||+|... ++..||+|++...    ......+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34556788999999999999999999974 6889999998642    124556789999999999999999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPG------------------------------------EPVLDWVTRKRVALGAAR  224 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~  224 (437)
                      .+..++||||+++|+|.+++......                                    ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998532110                                    122456778889999999


Q ss_pred             HHHHHHhcCCCceEecCCCCCCeeecCCC--cEEEeecCCceecccCCCc---ccccccccccccccccccC--CCCCCc
Q 013750          225 GLEYLHEHCNPKIIHRDVKAANVLLDEDF--EAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST--GKSSER  297 (437)
Q Consensus       225 ~l~yLH~~~~~~iiH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~  297 (437)
                      ||+|||++   +++||||||+||+++.++  .+||+|||++.........   ......||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999   999999999999998776  8999999999876432221   2334568999999999975  678999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC
Q 013750          298 TDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED  377 (437)
Q Consensus       298 sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~  377 (437)
                      +||||||+++|||++|+.||......        .............       ........+..+.+++.+||+.||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999999643221        1111111111000       00001123457899999999999999


Q ss_pred             CCCHHHHHHH
Q 013750          378 RPAMSEVVRM  387 (437)
Q Consensus       378 RPs~~evl~~  387 (437)
                      |||+.++++.
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=334.81  Aligned_cols=247  Identities=25%  Similarity=0.293  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+++.. +|+.||+|++....  .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467888999999999999999975 68999999996421  123456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999997643    388999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ........        
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~--------  217 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILN--------  217 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHH--------
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh--------
Confidence            21    23457999999999999999999999999999999999999999643211        11111111        


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                       ..+  .++...+..+.+++.+|++.||++||     ++.++++.
T Consensus       218 -~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          218 -AEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -CCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence             111  11222345789999999999999999     88888743

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=344.45  Aligned_cols=260  Identities=18%  Similarity=0.217  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC---------CCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee--------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR--------  173 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------  173 (437)
                      .++|...+.||+|+||.||+|....         ++.||+|++...      +.+.+|++++.+++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3678889999999999999999763         789999998642      35889999999999999998        


Q ss_pred             -------eeeeeec-CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 013750          174 -------LIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA  245 (437)
Q Consensus       174 -------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~  245 (437)
                             +++++.. ....++||||+ +++|.+++....  ...+++..++.++.|++.||+|||++   +++||||||+
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                   5677765 77889999999 999999998642  23489999999999999999999999   9999999999


Q ss_pred             CeeecCCC--cEEEeecCCceecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          246 NVLLDEDF--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       246 NIll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      |||++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  8999999999866432221      113346899999999999999999999999999999999999999


Q ss_pred             CCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          318 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .......   ............  ....+.+....   ....+..+.+++..||+.||++|||+.++++.|+.
T Consensus       269 ~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          269 TNCLPNT---EDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             GGGTTCH---HHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccCCcCH---HHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            7432111   111111111111  11111111000   01123579999999999999999999999999976

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.2e-43  Score=348.92  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc--cccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|.+.+.||+|+||.||++...+++.||||++.... .....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588899999999999999998889999999986432 2344578999999999996  599999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      | +.+++|.+++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 57889999998643    478889999999999999999999   999999999999996 57899999999987643


Q ss_pred             CCCc-ccccccccccccccccccC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          269 RKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       269 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......       ....  
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~--  277 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL--  277 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHH--
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHH--
Confidence            3222 2334579999999999865           46899999999999999999999999642211       0111  


Q ss_pred             HHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          337 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                             ..++++......+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       278 -------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 -------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                   11222222222222224578999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=343.11  Aligned_cols=252  Identities=23%  Similarity=0.287  Sum_probs=190.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|...+.||+|+||.||+|... +++.||||++....   ..+.+.+|++++++++||||+++++++...+..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            4567888999999999999999986 57899999997532   3467889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~  265 (437)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.   ++.+||+|||+++.
T Consensus       128 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            999999999998753    3389999999999999999999999   9999999999999975   88999999999986


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    ..   .........   
T Consensus       201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~---~~~i~~~~~---  268 (349)
T 2w4o_A          201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FM---FRRILNCEY---  268 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HH---HHHHHTTCC---
T ss_pred             cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HH---HHHHHhCCC---
Confidence            5432  22334568999999999999999999999999999999999999986432110    01   111111000   


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          ........+.+..+.+++.+||+.||++|||+.|+++.
T Consensus       269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00011112334578999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.4e-43  Score=341.09  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCE--EEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~--vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|...+.||+|+||.||+|... ++..  +|+|.+.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67888999999999999999964 4554  4999987655555667899999999999 899999999999999999999


Q ss_pred             EecccCchhhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          188 YPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                      |||+++++|.+++....            .....+++..++.++.|++.||+|||++   +++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997643            2234589999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        ...
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY  251 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHH
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------HHH
Confidence            99999999743221  11223456889999999998889999999999999999998 99998643211        111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....          ......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       252 ~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          252 EKLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HHGGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhc----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11111          11111223344689999999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=334.87  Aligned_cols=263  Identities=19%  Similarity=0.261  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|...+.||+|+||+||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999985 589999999865332 2235678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|..++....    .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999998876532    389999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh---------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------  339 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  339 (437)
                      .. ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ..........         
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-----QLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCCHHHHHH
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhcccccccccc
Confidence            22 2234568999999999976 568999999999999999999999997543221     1111111100         


Q ss_pred             ---ccchhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          340 ---EKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       340 ---~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         .........+......     .+..+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence               0000000000000000     02234578999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.2e-43  Score=334.42  Aligned_cols=255  Identities=28%  Similarity=0.397  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee-cCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~l  186 (437)
                      .+|...+.||+|+||+||+|.+.+    ...||+|.+.........+.+.+|+.++++++||||++++++|. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778999999999999999643    23689999986555556678999999999999999999999864 4567899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999752   33478999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCC---cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          267 DVRKT---NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       267 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .....   .......+|+.|+|||.+.+..++.++||||||+++|||++| ..|+.......     ....   ..... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~---~~~~~-  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVY---LLQGR-  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHH---HHTTC-
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHH---HhcCC-
Confidence            43221   112234577899999999999999999999999999999995 45554322111     1111   11000 


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                               ....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                     011112234578999999999999999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-43  Score=335.53  Aligned_cols=258  Identities=20%  Similarity=0.281  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeee--cCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l  186 (437)
                      .++|...+.||+|+||.||++... +|+.||+|++.... .....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467888899999999999999985 68999999997433 2344567899999999999999999999884  4678899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-----eEecCCCCCCeeecCCCcEEEeecC
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-----IIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++|+||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999986544455689999999999999999999999   7     9999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......     ...   ...... 
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~---~~i~~~-  231 (279)
T 2w5a_A          162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELA---GKIREG-  231 (279)
T ss_dssp             HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHHT-
T ss_pred             hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----HHH---HHHhhc-
Confidence            997654322 1222346899999999999989999999999999999999999998743211     111   111111 


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..         ...+...+..+.+++.+||+.||++|||+.|+++.+..
T Consensus       232 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            10         11122344688999999999999999999999987765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-42  Score=335.91  Aligned_cols=251  Identities=19%  Similarity=0.272  Sum_probs=180.6

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEecccCc
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      .+.||+|+||+||+|... +++.||||++..    .....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999985 589999999863    34567889999999997 999999999999999999999999999


Q ss_pred             hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---cEEEeecCCceecccCCC
Q 013750          195 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       195 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~  271 (437)
                      +|.+++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++   .+||+|||+++...... 
T Consensus        92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  163 (325)
T 3kn6_A           92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-  163 (325)
T ss_dssp             BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence            9999998643    389999999999999999999999   999999999999997765   89999999998654332 


Q ss_pred             cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccc
Q 013750          272 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL  351 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  351 (437)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ............. .      ..
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~i~~~~-~------~~  235 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-SAVEIMKKIKKGD-F------SF  235 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC-CHHHHHHHHTTTC-C------CC
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc-cHHHHHHHHHcCC-C------CC
Confidence            22334568999999999999999999999999999999999999997533211100 0111111111100 0      00


Q ss_pred             cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ........+..+.+|+..||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            000012234688999999999999999999999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.8e-43  Score=342.57  Aligned_cols=210  Identities=20%  Similarity=0.267  Sum_probs=183.0

Q ss_pred             ccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-----cccce
Q 013750           99 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----HRNLL  172 (437)
Q Consensus        99 ~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H~niv  172 (437)
                      ...+++++.....++|.+.+.||+|+||+||+|... +++.||||++...  ....+.+..|+.++..++     ||||+
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            445666777777899999999999999999999974 6899999999642  344567788999999986     99999


Q ss_pred             eeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-
Q 013750          173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-  251 (437)
Q Consensus       173 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-  251 (437)
                      ++++++...+..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999999999999 8999999976432  3488999999999999999999999   9999999999999975 


Q ss_pred             ------------------------CCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHH
Q 013750          252 ------------------------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML  307 (437)
Q Consensus       252 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l  307 (437)
                                              ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    789999999999864432    2345689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 013750          308 LELVTGQRAIDFS  320 (437)
Q Consensus       308 ~elltg~~p~~~~  320 (437)
                      |||++|+.||...
T Consensus       250 ~ell~g~~pf~~~  262 (360)
T 3llt_A          250 AELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHSSCSCCCS
T ss_pred             HHHHHCCCCCCCC
Confidence            9999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-42  Score=339.57  Aligned_cols=246  Identities=21%  Similarity=0.244  Sum_probs=204.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+++.. +|+.||+|++....  .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367888899999999999999975 68999999986421  233456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999998643    288999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .........       
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-------  253 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSG-------  253 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-------
T ss_pred             CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--------HHHHHHHcC-------
Confidence            32    23456899999999999999999999999999999999999999643211        111111111       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                        .  ..++...+..+.+++.+||+.||++||+     +.++++
T Consensus       254 --~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          254 --K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --C--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              1  0112233457899999999999999998     788765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-43  Score=331.44  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C-------CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD-G-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      .++|...+.||+|+||+||+|.... +       ..||+|++.... ....+.+.+|++++++++||||+++++++..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4577888999999999999998653 3       479999986533 455678999999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc--------
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--------  254 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--------  254 (437)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            999999999999999999763   23378999999999999999999999   9999999999999998887        


Q ss_pred             EEEeecCCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          255 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      +||+|||++.....     .....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+......       ...
T Consensus       160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~  227 (289)
T 4fvq_A          160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRK  227 (289)
T ss_dssp             EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred             eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHH
Confidence            99999999874422     122457889999999987 67999999999999999999965554321110       011


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCCCC
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA  394 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  394 (437)
                      ..........            +...+..+.+++..||+.||++|||+.++++.|+....+
T Consensus       228 ~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          228 LQFYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHhhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111111110            111123688999999999999999999999999984443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.6e-43  Score=336.74  Aligned_cols=254  Identities=23%  Similarity=0.298  Sum_probs=193.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCe----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  183 (437)
                      .++|.+.+.||+|+||.||++.+ .+++.||||++.....  ......|.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788899999999999999997 4689999999975322  2334578899999999999999999999876544    


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....    .+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            399999999999999997643    389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          264 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       264 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      +........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED  235 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCC
Confidence            866433221  223356899999999999999999999999999999999999999643221        1111111111


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....       ......+..+.+++.+||+.||++||++.+++.
T Consensus       236 ~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          236 PIPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CCCHH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCCcc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            10000       001113457899999999999999997666553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.5e-43  Score=342.17  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCC
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT  182 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  182 (437)
                      .....++|...+.||+|+||.||+|+.+ +|+.||+|++....  .....+.+..|..++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3455788999999999999999999985 58899999996421  123456788899999877 8999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence            9999999999999999997643    388999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ....   .....  
T Consensus       165 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~---~i~~~--  233 (345)
T 1xjd_A          165 CKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFH---SIRMD--  233 (345)
T ss_dssp             CBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH---HHHHC--
T ss_pred             hhhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-----HHHH---HHHhC--
Confidence            9854322 22234567999999999999999999999999999999999999999743211     1111   11111  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVV  385 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl  385 (437)
                           .    ..++...+..+.+++.+||+.||++||++. ++.
T Consensus       234 -----~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 -----N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 0    111222345789999999999999999997 654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-42  Score=327.91  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            477888999999999999999975 58999999986433 2334567889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgla~~  265 (437)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999998887643    389999999999999999999999   9999999999999986655   99999999986


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ....  .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ...   .........  
T Consensus       158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~---~~~~~~~~~--  225 (284)
T 3kk8_A          158 VNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLY---AQIKAGAYD--  225 (284)
T ss_dssp             CCSS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHHTCCC--
T ss_pred             cccC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHH---HHHHhcccc--
Confidence            5432  2233456899999999999999999999999999999999999998643211     111   111111000  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           .........+..+.+++.+||+.||++|||+.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 000001123457889999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.8e-43  Score=341.37  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +.|...+.||+|+||+||+|.. .+|+.||||++.....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4578889999999999999997 4789999999964322  223457889999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+. |+|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 67777775432   3489999999999999999999999   999999999999999999999999999986542


Q ss_pred             CCCccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .     ....||+.|+|||.+.   ...++.++||||||+++|||++|+.||......        ...........   
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~---  270 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES---  270 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC---
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC---
Confidence            2     2346899999999984   567899999999999999999999998643211        11111111110   


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                         +.+   .....+..+.+++..||+.||++|||+.++++..
T Consensus       271 ---~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          271 ---PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ---CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ---CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence               011   1112345788999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.1e-42  Score=331.00  Aligned_cols=253  Identities=20%  Similarity=0.245  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+......     ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            466888999999999999999975 5899999998753321     1367899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeec
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF  260 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Df  260 (437)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999753    3489999999999999999999999   999999999999999887    7999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        .........
T Consensus       164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~  233 (321)
T 2a2a_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSV  233 (321)
T ss_dssp             TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTT
T ss_pred             ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhc
Confidence            9998664322  223456899999999999999999999999999999999999999643211        111111110


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..   -.++..    ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          234 SY---DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CC---CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             cc---ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00   000000    01123578999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=341.19  Aligned_cols=267  Identities=26%  Similarity=0.376  Sum_probs=197.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHH--HHhcccccceeeeeeee-----cCC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCT-----TPT  182 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~-----~~~  182 (437)
                      ..++|...+.||+|+||.||+|+. +++.||||++...    ....+..|.++  +..++||||+++++.+.     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            357788899999999999999988 6899999998632    23445555555  44689999999998553     233


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCceEecCCCCCCeeecCCCcEE
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------NPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                      ..++||||+++|+|.+++....     .++..+..++.|++.||+|||+.+      .++|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            5689999999999999997543     488999999999999999999873      33899999999999999999999


Q ss_pred             EeecCCceecccCCC-------cccccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          257 VGDFGLAKLVDVRKT-------NVTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       257 l~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      |+|||+++.......       .......||+.|+|||.+.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643221       11223468999999999976       4567899999999999999999877643322


Q ss_pred             cccchhhHHH---------HHHHHHhccchhhhccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          323 EEEDDVLLLD---------HVKKLEREKRLDAIVDRNLNK--NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       323 ~~~~~~~~~~---------~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ..........         ..........    ..+.+..  ......+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            2211111100         0000000000    0011111  1123466789999999999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-43  Score=344.13  Aligned_cols=258  Identities=22%  Similarity=0.267  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEeccCC---CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  182 (437)
                      .++|...+.||+|+||.||+++.    .+++.||||++....   .....+.+.+|++++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46788899999999999999997    368999999986422   123345677899999999 5999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+++++|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999997643    388999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ++..............||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.........    ..........
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~  281 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS  281 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHC
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhcc
Confidence            987654433334456799999999999863  4789999999999999999999999743322111    1111111100


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~~  390 (437)
                                 ....+...+..+.+|+.+||+.||++||     ++.|+++..-.
T Consensus       282 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          282 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             -----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence                       0112233445788999999999999999     99999876543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.2e-43  Score=366.83  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             CeeeecCcEEEEEEEEC---CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||.||+|.+.   +++.||||+++... .....++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   46789999997532 23446789999999999999999999999964 458899999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc-
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-  272 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  272 (437)
                      |+|.+++....    .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999997532    389999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             -ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          273 -VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       273 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......        ........          .
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~----------~  588 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEK----------G  588 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHT----------T
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc----------C
Confidence             2223456789999999999999999999999999999998 99999643221        11111111          1


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....+..++..+.+|+..||+.||++||++.+|++.|+.
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1122233455689999999999999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=332.57  Aligned_cols=265  Identities=24%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC----CCcchHHHHHHHHHHHhcc---cccceeeeeeeec
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAV---HRNLLRLIGFCTT  180 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  180 (437)
                      ...++|...+.||+|+||+||+|.. .+++.||+|++....    .......+.+|++++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999996 468999999986322    1222456778888877765   9999999999977


Q ss_pred             CC-----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          181 PT-----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       181 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                      ..     ..++||||+. ++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            65     4789999997 59999887643  23389999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      ||+|||+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     .......
T Consensus       160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~  232 (308)
T 3g33_A          160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIF  232 (308)
T ss_dssp             EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHH
T ss_pred             EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH
Confidence            99999999865432  2234457899999999999999999999999999999999999999643321     1111111


Q ss_pred             HHHhccchhhh------cccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          336 KLEREKRLDAI------VDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       336 ~~~~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...........      ......       ....++.+..+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11100000000      000000       0011223467899999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.9e-43  Score=339.92  Aligned_cols=260  Identities=27%  Similarity=0.384  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ..++|...+.||+|+||.||+|.+      .++..||||++...........+.+|+.++++++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357888899999999999999984      24778999999755445566789999999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEE
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV  257 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl  257 (437)
                      .++||||+++++|.+++......   ...+++..++.++.|++.||.|||++   +++||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999875422   24589999999999999999999999   9999999999999984   456999


Q ss_pred             eecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 013750          258 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       258 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......        ....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~  256 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLE  256 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HHHH
Confidence            99999975533221 12223457889999999998999999999999999999998 99998643211        1111


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......          ....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       257 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          257 FVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            111111          111122344588999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.9e-43  Score=330.42  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||+||+|... +++.||+|++.... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467888999999999999999986 69999999987532 344566888999999999 999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC----------------
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----------------  251 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~----------------  251 (437)
                      |||+++++|.+++.........+++..+..++.|++.||+|||++   +++||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999976533334589999999999999999999999   9999999999999984                


Q ss_pred             ---CCcEEEeecCCceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch
Q 013750          252 ---DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD  327 (437)
Q Consensus       252 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~  327 (437)
                         ...+||+|||++.......     ...||..|+|||.+.+. .++.++||||||+++|||++|..++....      
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence               4479999999998764322     23489999999999766 56789999999999999999987753211      


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        .   ...... ...         ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 --~---~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 --Q---WHEIRQ-GRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             --H---HHHHHT-TCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --H---HHHHHc-CCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence              0   011111 111         11122234578999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-43  Score=338.33  Aligned_cols=265  Identities=25%  Similarity=0.388  Sum_probs=199.8

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT  179 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  179 (437)
                      .++....++|...+.||+|+||.||+|.+.    ++..||+|++.... .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            334445677888899999999999999864    34589999987432 2334567999999999999999999999997


Q ss_pred             cCCe-----eEEEEecccCchhhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          180 TPTE-----RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       180 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ....     .++||||+++++|.+++....  .....+++..++.++.|++.||.|||++   +++||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            7653     499999999999999985432  2345689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhH
Q 013750          253 FEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL  330 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~  330 (437)
                      +.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     .
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~  258 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----M  258 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----H
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----H
Confidence            99999999999865432221 1223456789999999999999999999999999999999 888886433211     1


Q ss_pred             HHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       331 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...   .....          ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       259 ~~~---~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          259 YDY---LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHH---HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH---HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111   11110          111122344589999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=341.99  Aligned_cols=246  Identities=20%  Similarity=0.223  Sum_probs=194.7

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccCch
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            567999999999999974 68999999997532 3456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee--cCCCcEEEeecCCceecccCCCcc
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |.+++...   ...+++..+..++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++......  .
T Consensus       173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~  244 (373)
T 2x4f_A          173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K  244 (373)
T ss_dssp             EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence            99988653   23488999999999999999999999   99999999999999  567899999999998764322  2


Q ss_pred             cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccC
Q 013750          274 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK  353 (437)
Q Consensus       274 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  353 (437)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   .........       .+..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~---~~~i~~~~~-------~~~~  309 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ET---LNNILACRW-------DLED  309 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH---HHHHHHTCC-------CSCS
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHhccC-------CCCh
Confidence            23346899999999999999999999999999999999999999643211     11   111111100       0000


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          354 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       354 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ......+..+.+++.+||+.||++|||+.|+++
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            001123457899999999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-43  Score=354.61  Aligned_cols=251  Identities=22%  Similarity=0.247  Sum_probs=195.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..++|+..+.||+|+||.||++... +|+.||||++...  ........+.+|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3467889999999999999999975 6899999999642  223445678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ||||+++|+|..++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++.
T Consensus       226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999987643    38999999999999999999998 7   899999999999999999999999999985


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      .... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...   ......     
T Consensus       299 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~---~~i~~~-----  364 (446)
T 4ejn_A          299 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF---ELILME-----  364 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHHC-----
T ss_pred             ccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHH---HHHHhC-----
Confidence            4322 22234467999999999999999999999999999999999999999643211     111   111110     


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  387 (437)
                          .  ..++...+..+.+++..||+.||++||     ++.|+++.
T Consensus       365 ----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 ----E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                0  011222345789999999999999999     99999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.9e-42  Score=330.67  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .+.|...+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888899999999999999974 6899999999765545567889999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999864     2389999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .. ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....     .....   .....      ..+
T Consensus       173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~---~~~~~------~~~  237 (303)
T 3a7i_A          173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLF---LIPKN------NPP  237 (303)
T ss_dssp             BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHH---HHHHS------CCC
T ss_pred             cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHH---HhhcC------CCC
Confidence            21 22345689999999999999999999999999999999999999864321     11111   11110      011


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                      .    .+...+..+.+++..||+.||++|||+.++++..
T Consensus       238 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          238 T----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             C----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             C----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            1    1222345789999999999999999999998643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=336.52  Aligned_cols=264  Identities=23%  Similarity=0.357  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC--e
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--E  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~  183 (437)
                      .++|...+.||+|+||.||++.+     .+++.||+|++... .....+.+.+|++++++++||||+++++++...+  .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            45678889999999999999984     35889999999753 3455678999999999999999999999986654  6


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            899999999999999997642   3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc-
Q 013750          264 KLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-  340 (437)
Q Consensus       264 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  340 (437)
                      ..........  .....++..|+|||.+.+..++.++||||||+++|||+||..|+......         ........ 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---------~~~~~~~~~  263 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---------FMRMIGNDK  263 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---------HHHHHCTTC
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---------HHHhhcccc
Confidence            8765433221  22245677899999999888999999999999999999999987532100         00000000 


Q ss_pred             ------cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 ------KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            ..+.+.+........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                  00111111111122233455689999999999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-41  Score=322.19  Aligned_cols=246  Identities=20%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            466888999999999999999976 47799999987543 3456789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCceec
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~  266 (437)
                      |+++++|.+++....    .+++..+..++.|++.||+|||++   +++|+||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999887643    389999999999999999999999   99999999999999   78899999999999876


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......        ...........    
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~----  224 (277)
T 3f3z_A          160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTF----  224 (277)
T ss_dssp             CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC----
T ss_pred             cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCC----
Confidence            5322  2334568999999999865 4899999999999999999999999643211        11111111100    


Q ss_pred             ccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             ..+.    ..+..+.+++.+||+.||++|||+.++++
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0011    12457899999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-42  Score=329.30  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=201.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      +.++|...+.||+|+||.||+|... ++..||+|++....  .......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3567888999999999999999975 57799999985421  12235678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++++|.+++.....    +++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9999999999999976533    88999999999999999999999   9999999999999999999999999998644


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......        .........      
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~------  222 (279)
T 3fdn_A          160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRV------  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHT------
T ss_pred             Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhC------
Confidence            322   223456899999999999999999999999999999999999999743211        111111110      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       223 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 -----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 011122234578899999999999999999999963

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-42  Score=337.88  Aligned_cols=251  Identities=22%  Similarity=0.270  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ...++|...+.||+|+||+||+++.++ |+.||+|++....  .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            345789999999999999999999864 7899999996421  233456788999999887 899999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+++|+|.+++....    .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999999999997643    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......     .+.   .....     
T Consensus       170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~---~~i~~-----  235 (353)
T 2i0e_A          170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELF---QSIME-----  235 (353)
T ss_dssp             CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHH-----
T ss_pred             ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HHH---HHHHh-----
Confidence            54322 22234467999999999999999999999999999999999999999743211     111   11111     


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                          ..  ..++...+..+.+++.+||+.||++||+     +.++++
T Consensus       236 ----~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          236 ----HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                11  1122234468899999999999999995     567664

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=327.65  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=184.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....  .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688889999999999999997 468999999986421  123356789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999998753   23489999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........                 ....
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------------~~~~  225 (278)
T 3cok_A          164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------------NKVV  225 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CC
T ss_pred             CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------------HHHh
Confidence            3222 222356899999999999889999999999999999999999999754322110                 0000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...  ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000  0112223457889999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-42  Score=341.99  Aligned_cols=265  Identities=22%  Similarity=0.329  Sum_probs=192.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc-cccceeeeeeeecCC--e
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--E  183 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~  183 (437)
                      ...++|...+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999974 68999999986432 2344567889999999997 999999999997544  6


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||++ ++|..++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999998 5888888752     378999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccC--------------------CCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          264 KLVDVR--------------------KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       264 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      +.....                    .....+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            865321                    1112234579999999999976 6789999999999999999999999975432


Q ss_pred             cccchhhHHHHHHHHHhccchhhh-----------c----------cccccC------------CCCHHHHHHHHHHHHH
Q 013750          323 EEEDDVLLLDHVKKLEREKRLDAI-----------V----------DRNLNK------------NYNIQEVETMIQVALL  369 (437)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~----------d~~l~~------------~~~~~~~~~l~~l~~~  369 (437)
                      ..     ....+...........+           .          ......            ......+..+.+|+.+
T Consensus       237 ~~-----~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          237 MN-----QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             HH-----HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             HH-----HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            11     11111111000000000           0          000000            0001224578999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 013750          370 CTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       370 Cl~~dp~~RPs~~evl~~  387 (437)
                      ||+.||++|||+.|+++.
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999865

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=338.12  Aligned_cols=263  Identities=22%  Similarity=0.321  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||+||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            56888899999999999999986 68999999997543333333566899999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      ++ |+|..++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 5888888763   23488999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc---chhhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---RLDAI  346 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  346 (437)
                       .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ....+.......   .....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence             22233468999999999876 568999999999999999999999997543211     111111111100   00000


Q ss_pred             cc---------ccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VD---------RNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d---------~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..         +....    ...+.....+.+|+.+||+.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00         00000    0011234578899999999999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-43  Score=339.35  Aligned_cols=245  Identities=21%  Similarity=0.257  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-------CcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      ..++|...+.||+|+||.||+|... +++.||||++.....       ....+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3567899999999999999999964 688999999975321       11334677899999999999999999999999


Q ss_pred             CeeEEEEecccCc-hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          182 TERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       182 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      +..++||||+.+| +|..++....    .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999887532    389999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      |++.......  ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......                
T Consensus       175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            9998765332  2334568999999999988876 88999999999999999999998632110                


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                             .....  ..+...+..+.+++..||+.||++|||+.++++.-
T Consensus       237 -------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          237 -------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             -------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             -------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                   00000  00111235789999999999999999999999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-42  Score=327.73  Aligned_cols=252  Identities=19%  Similarity=0.272  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-----CcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|...+.||+|+||.||++... +|+.||+|.+.....     ....+.+.+|++++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356888899999999999999986 689999999864321     12367899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeec
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF  260 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Df  260 (437)
                      ++||||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999997643    389999999999999999999999   999999999999998877    8999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++.......  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......        .........
T Consensus       157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~  226 (283)
T 3bhy_A          157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAV  226 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT
T ss_pred             ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhc
Confidence            9998654322  223446899999999999999999999999999999999999998643211        111111100


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..       ..........+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 NY-------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC-------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc-------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00       0000000112357899999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.2e-43  Score=342.88  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||++.+. ++..||+|++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467888999999999999999986 6899999999765445556789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.+  +++|+||||+||+++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999997643    3889999999999999999999842  7999999999999999999999999999755322


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH-----------------
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD-----------------  332 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~-----------------  332 (437)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...............                 
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               123356899999999999999999999999999999999999999753321100000000                 


Q ss_pred             ----HHHHHHhccchhhhcc----ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          333 ----HVKKLEREKRLDAIVD----RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       333 ----~~~~~~~~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ............+..+    ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                0000000000001111    00001111123457899999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-42  Score=329.41  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec--------
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--------  180 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------  180 (437)
                      ..++|...+.||+|+||.||+|.+. +++.||+|++....     +.+.+|++++++++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3467888999999999999999986 79999999986422     357799999999999999999998854        


Q ss_pred             --------CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          181 --------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       181 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                              ....++||||+++++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                    445789999999999999997643  23489999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 013750          253 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  332 (437)
                      +.+||+|||++.......  ......+|+.|+|||.+.+..++.++||||||+++|||++|..|+...          ..
T Consensus       159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~  226 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK  226 (284)
T ss_dssp             TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred             CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence            999999999998765332  223456899999999999999999999999999999999999876310          01


Q ss_pred             HHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          333 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       333 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....         +.+..+..    ..+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       227 ~~~~---------~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          227 FFTD---------LRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHHH---------HHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHH---------hhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111         11111111    123468899999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.7e-43  Score=329.86  Aligned_cols=250  Identities=28%  Similarity=0.393  Sum_probs=197.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-CeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-TERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~  188 (437)
                      ..++|...+.||+|+||+||++..+ |+.||+|++..   ....+.|.+|++++++++||||+++++++... +..++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecc---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            3567888999999999999999984 89999999874   23567899999999999999999999997554 4789999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999997532  12368889999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .    .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......     .   ......        
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~---~~~~~~--------  229 (278)
T 1byg_A          170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEK--------  229 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----H---HHHHTT--------
T ss_pred             c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHhc--------
Confidence            2    122357889999999998899999999999999999998 999986432211     1   111111        


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ......+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus       230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          230 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence              11112223345689999999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=337.17  Aligned_cols=255  Identities=17%  Similarity=0.172  Sum_probs=206.0

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEE------ECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc---cccceeeee
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIG  176 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g  176 (437)
                      +++...++|.+.+.||+|+||+||+|.      ..+++.||+|++..    ....++..|++++..++   |+|++.+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            344456788899999999999999994      34688999999964    23567888888888886   999999999


Q ss_pred             eeecCCeeEEEEecccCchhhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC----
Q 013750          177 FCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----  251 (437)
Q Consensus       177 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~----  251 (437)
                      ++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++   +|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence            99999999999999999999999976432 345589999999999999999999999   9999999999999998    


Q ss_pred             -------CCcEEEeecCCceecccC-CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCccc
Q 013750          252 -------DFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE  323 (437)
Q Consensus       252 -------~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~  323 (437)
                             ++.+||+|||+++..... .........||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   899999999999865422 223344567999999999999999999999999999999999999998532111


Q ss_pred             ccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHhc
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR-PAMSEVVRMLEG  390 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Ps~~evl~~L~~  390 (437)
                      ..                ..    ...+....   ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       292 ~~----------------~~----~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          292 EC----------------KP----EGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             EE----------------EE----CSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ce----------------ee----chhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            00                00    01111111   13467788889999999999 778888888875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-42  Score=333.12  Aligned_cols=257  Identities=20%  Similarity=0.260  Sum_probs=196.6

Q ss_pred             cCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +.|.+. +.||+|+||+||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            556663 78999999999999964 68999999997543 44567899999999884 7999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgla~~  265 (437)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||++   +++||||||+|||++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999997643    388999999999999999999999   9999999999999998776   99999999976


Q ss_pred             cccCCC------cccccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch-------
Q 013750          266 VDVRKT------NVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-------  327 (437)
Q Consensus       266 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~-------  327 (437)
                      ......      .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||.........-       
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            542211      11223458999999999875     568999999999999999999999997543221000       


Q ss_pred             hhHHHHHHHHHhccchhhhccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          328 VLLLDHVKKLEREKRLDAIVDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...........         ....  ..+.    ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~i~---------~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQ---------EGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHH---------HCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHh---------ccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000011111         1000  1111    124578999999999999999999999873

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-42  Score=354.32  Aligned_cols=256  Identities=25%  Similarity=0.340  Sum_probs=207.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+++.. +|+.||+|++....  .....+.+.+|++++++++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999985 69999999996422  123456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|..++.........+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999987654455689999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    .......         
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~----~~~~~i~---------  406 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK----ELKQRVL---------  406 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH----HHHHHHH---------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH----HHHHHHh---------
Confidence            3322 2334579999999999999999999999999999999999999997543211111    1111111         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM-----SEVV  385 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl  385 (437)
                      ...  ..++...+..+.+++.+||+.||++||++     .+++
T Consensus       407 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          407 EQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             hcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence            100  11223344688999999999999999975     5555

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-42  Score=347.42  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+|.+. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367888899999999999999986 69999999996421  123456789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            9999999999998743    3489999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..  .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+.....        ........       
T Consensus       168 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~-------  230 (476)
T 2y94_A          168 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICD-------  230 (476)
T ss_dssp             TT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHT-------
T ss_pred             cc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhc-------
Confidence            32  22334579999999999988765 78999999999999999999999743221        11111111       


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        ...  ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       231 --~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          231 --GIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --TCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              100  111223357889999999999999999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-42  Score=330.20  Aligned_cols=256  Identities=19%  Similarity=0.240  Sum_probs=188.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHH-HHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~-~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|+..+.||+|+||+||++... +|+.||+|++...........+ .++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3567888999999999999999974 6899999999754333333333 3444557888999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||++ |+|.+++.........+++..+..++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99997 5888877654434456899999999999999999999853  79999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ...  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......       ..........  
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--  230 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEP--  230 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSC--
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccC--
Confidence            322  22234689999999996    56678999999999999999999999996422110       1111111111  


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             .........+..+.+++.+||+.||++|||+.|+++
T Consensus       231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 -------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   001111223457899999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-42  Score=337.22  Aligned_cols=271  Identities=20%  Similarity=0.270  Sum_probs=200.8

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCc----------chHHHHHHHHHHHhcccccce
Q 013750          103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLL  172 (437)
Q Consensus       103 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv  172 (437)
                      ...++....++|...+.||+|+||.||+|...+|..||||++.......          ..+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3567888999999999999999999999998889999999986432211          126789999999999999999


Q ss_pred             eeeeeeec-----CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          173 RLIGFCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       173 ~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                      ++++++..     ....++||||++ |+|.+++..   ....+++..+..++.|++.||.|||++   +++|+||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            99999843     346799999998 577777764   233589999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED  326 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~  326 (437)
                      +++.++.+||+|||+++.....  .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--  241 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--  241 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred             EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence            9999999999999999754322  22334568999999999877 678999999999999999999999997533211  


Q ss_pred             hhhHHHHHHHHHhccchh-----------hhccccccC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          327 DVLLLDHVKKLEREKRLD-----------AIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         ...............           ......+..       ...+..+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          242 ---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             ---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence               111111111111000           000000000       0112234578999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-42  Score=341.12  Aligned_cols=252  Identities=21%  Similarity=0.257  Sum_probs=191.3

Q ss_pred             cCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHH-hcccccceeeeeeeec----CCee
Q 013750          112 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTT----PTER  184 (437)
Q Consensus       112 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~  184 (437)
                      ++|... +.||+|+||+||++... +|+.||||++..      ...+.+|++++. ..+||||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            455554 68999999999999975 689999999863      245778888874 5589999999998865    5678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeecC
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFG  261 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg  261 (437)
                      ++||||+++|+|.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999997632  34589999999999999999999999   9999999999999998   7899999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+..   . 
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~~---~-  282 (400)
T 1nxk_A          210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRM---G-  282 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHHH---T-
T ss_pred             cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHHc---C-
Confidence            99865422  223345689999999999999999999999999999999999999975432221110 1111110   0 


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..      .+........+..+.+|+..||+.||++|||+.|+++.
T Consensus       283 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00      00000012234578999999999999999999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=324.96  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            34555679999999999999974 68899999987543 44567899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeecCCceecccC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~  269 (437)
                      +++++|.+++.... +...+++..+..++.|++.||.|||++   +++|+||||+||+++. ++.+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999997643 233467888999999999999999999   9999999999999987 899999999999865432


Q ss_pred             CCcccccccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      . .......|+..|+|||.+.+..  ++.++||||||+++|||++|+.||.......   .   .......         
T Consensus       177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~~---------  240 (295)
T 2clq_A          177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---A---AMFKVGM---------  240 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---H---HHHHHHH---------
T ss_pred             C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---H---HHHhhcc---------
Confidence            2 1223456899999999997654  8899999999999999999999985321110   0   0000000         


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       .......+...+..+.+++.+||+.||++|||+.++++
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          241 -FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00111222334468899999999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.5e-41  Score=331.38  Aligned_cols=259  Identities=22%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-------cchHHHHHHHHHHHhc-ccccceee
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------GGDAAFQREVEMISVA-VHRNLLRL  174 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~~~~~E~~~l~~l-~H~niv~l  174 (437)
                      +.......++|...+.||+|+||.||+|.+. +|+.||||++......       ...+.+.+|+.++.++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556678999999999999999999985 6999999998653311       1135678999999999 79999999


Q ss_pred             eeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc
Q 013750          175 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE  254 (437)
Q Consensus       175 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~  254 (437)
                      ++++......++||||+++++|.+++....    .+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            999999999999999999999999997643    389999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCceecccCCCcccccccccccccccccccC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          255 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      +||+|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.....     .
T Consensus       239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~  311 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----I  311 (365)
T ss_dssp             EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred             EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----H
Confidence            9999999998765322  2334578999999999863      3588999999999999999999999964321     1


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+..   .....  ..+..     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       312 ~~~~~i~~---~~~~~--~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LMLRMIME---GQYQF--SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHH---TCCCC--CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHh---CCCCC--CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111111   10000  00000     012347899999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.6e-42  Score=333.13  Aligned_cols=264  Identities=21%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC-CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            456788899999999999999985 489999999865332 223456789999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|..++....    .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999988765432    389999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-----------H
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK-----------K  336 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~  336 (437)
                      ... ......||..|+|||.+.+. .++.++||||||+++|||++|+.||........    ......           .
T Consensus       177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ----LYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHH
T ss_pred             Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhhhH
Confidence            222 22345689999999999775 689999999999999999999999975432110    111100           0


Q ss_pred             HHhccchhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          337 LEREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       337 ~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ............+.+....     .+..+..+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0011111111111111111     1233568999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-42  Score=339.28  Aligned_cols=263  Identities=18%  Similarity=0.230  Sum_probs=197.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-----
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----  181 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  181 (437)
                      +...++|...+.||+|+||+||+|.. .+|+.||||++.....     ...+|+++++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            45677899999999999999999997 4689999999864321     223799999999999999999998443     


Q ss_pred             ---------------------------------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013750          182 ---------------------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY  228 (437)
Q Consensus       182 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~y  228 (437)
                                                       ...++||||++ ++|.+.+.........+++..+..++.|++.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             34789999998 58887776544344568999999999999999999


Q ss_pred             HHhcCCCceEecCCCCCCeeec-CCCcEEEeecCCceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHH
Q 013750          229 LHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIM  306 (437)
Q Consensus       229 LH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~  306 (437)
                      ||++   +|+||||||+|||++ .++.+||+|||+++......  ......+|..|+|||.+.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999998 68899999999998664332  23345689999999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh---------------ccccccCCCCHHHHHHHHHHHHHhc
Q 013750          307 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI---------------VDRNLNKNYNIQEVETMIQVALLCT  371 (437)
Q Consensus       307 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~l~~l~~~Cl  371 (437)
                      +|||++|+.||.......    .+....... .......+               ........++...+..+.+|+.+||
T Consensus       232 l~ell~g~~pf~~~~~~~----~~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID----QLVRIIQIM-GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH----HHHHHHHHH-CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             HHHHHhCCCCCCCCChHH----HHHHHHHHh-CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            999999999997533211    111111111 00000000               0011111122334567899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 013750          372 QASPEDRPAMSEVVR  386 (437)
Q Consensus       372 ~~dp~~RPs~~evl~  386 (437)
                      +.||++|||+.|+++
T Consensus       307 ~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          307 RYEPDLRINPYEAMA  321 (383)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhhCCCHHHHhc
Confidence            999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=335.93  Aligned_cols=256  Identities=23%  Similarity=0.295  Sum_probs=187.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeee------
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT------  179 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~------  179 (437)
                      +....+|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++.++. ||||+++++++.      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            334567888999999999999999975 6899999998643 2445667899999999996 999999999983      


Q ss_pred             --cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEecCCCCCCeeecCCCcE
Q 013750          180 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       180 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~  255 (437)
                        .....++++||+. |+|.+++..... ...+++..++.++.|++.||+|||++   +  ++|+||||+|||++.++.+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence              3345789999996 789888875432 23489999999999999999999999   7  9999999999999999999


Q ss_pred             EEeecCCceecccCCCcc-----------cccccccccccccccc---cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCc
Q 013750          256 VVGDFGLAKLVDVRKTNV-----------TTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSR  321 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~  321 (437)
                      ||+|||+++.........           .....||+.|+|||.+   .+..++.++||||||+++|||++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765332211           1134589999999998   56678999999999999999999999986322


Q ss_pred             ccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          322 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...                     +.............+..+.+++..||+.||++|||+.|+++.|+.
T Consensus       258 ~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          258 KLR---------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH---------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            110                     000001011111122357889999999999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-42  Score=354.14  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ..++|...+.||+|+||.||++... +|+.||+|++....  .......+.+|+++++.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3466888899999999999999985 69999999986421  23345678899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|..++....  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999987643  23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .+...+..   .      
T Consensus       337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~~---~------  404 (576)
T 2acx_A          337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE---V------  404 (576)
T ss_dssp             CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHHH---C------
T ss_pred             ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhhc---c------
Confidence            4322  2334579999999999999899999999999999999999999997543221110 11111110   0      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                           ...++...+..+.+|+.+||+.||++||     ++.|+++
T Consensus       405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                 0112223345889999999999999999     7888874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3e-41  Score=327.43  Aligned_cols=257  Identities=19%  Similarity=0.253  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeec--CCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT--PTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~l  186 (437)
                      .++|+..+.||+|+||+||+|.. .+++.||+|++..    ...+.+.+|++++.+++ ||||+++++++..  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            46788899999999999999996 4689999999863    33577999999999997 9999999999987  567899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCcee
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL  265 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~  265 (437)
                      ||||+++++|..++..       ++...+..++.|++.||+|||++   +++||||||+|||++.++ .+||+|||+++.
T Consensus       111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999988854       78889999999999999999999   999999999999999776 899999999987


Q ss_pred             cccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ......  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........    ...............
T Consensus       181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~----~l~~~~~~~~~~~~~  254 (330)
T 3nsz_A          181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD----QLVRIAKVLGTEDLY  254 (330)
T ss_dssp             CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH----HHHHHHHHHCHHHHH
T ss_pred             cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH----HHHHHHHhcCCchhh
Confidence            653322  234468999999999877 6789999999999999999999999853322111    111111100000000


Q ss_pred             h---------------hccc--------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 A---------------IVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~---------------~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +               ....        ..........+..+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0               0000        00011111235688999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-42  Score=342.07  Aligned_cols=253  Identities=22%  Similarity=0.250  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHH-HHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|...+.||+|+||.||+++.+ ++..||+|++.+..  .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467889999999999999999986 58899999996532  22334556677776 577899999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999999997643    378889999999999999999999   9999999999999999999999999999854


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..   ....         
T Consensus       190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~---~~~i---------  251 (373)
T 2r5t_A          190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EM---YDNI---------  251 (373)
T ss_dssp             BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----HH---HHHH---------
T ss_pred             ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HH---HHHH---------
Confidence            322 22334467999999999999999999999999999999999999999643211     11   1111         


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....+  .++...+..+.+++.+||+.||++||++.+.++.+..
T Consensus       252 ~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~  293 (373)
T 2r5t_A          252 LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS  293 (373)
T ss_dssp             HHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred             Hhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence            11111  1122234578999999999999999998654444443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.2e-43  Score=346.74  Aligned_cols=244  Identities=14%  Similarity=0.115  Sum_probs=191.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccC--CCCcchHHHHHHH---HHHHhcccccceeee-------ee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREV---EMISVAVHRNLLRLI-------GF  177 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~  177 (437)
                      .++|...+.||+|+||+||+|.+ .+|+.||||++...  ......+.|.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999996 46999999998642  2344567899999   455666899999998       66


Q ss_pred             eecCCe-----------------eEEEEecccCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 013750          178 CTTPTE-----------------RLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKI  237 (437)
Q Consensus       178 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i  237 (437)
                      +...+.                 .++||||+ +|+|.+++.....   ....+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            655432                 78999999 6899999975321   123455788899999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCC-----------CCCCchhhHHHHHH
Q 013750          238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIM  306 (437)
Q Consensus       238 iH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~s~Gv~  306 (437)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985332    2334557 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          307 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       307 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +|||++|+.||........                 ...+...      ....+..+.+++.+||+.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG-----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CC-----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccc-----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999864322111                 1111110      0122357889999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-41  Score=323.45  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||++... +++.||+|++....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356788899999999999999986 57899999986432  233456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999887643    389999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......        ..........      
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~------  231 (294)
T 2rku_A          167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE------  231 (294)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC------
T ss_pred             cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhcc------
Confidence            3222 233456899999999999989999999999999999999999999743211        1111111100      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                           ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 01112233578899999999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.7e-42  Score=324.98  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=196.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec----CCeeEE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLL  186 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l  186 (437)
                      .|...+.||+|+||+||+|... ++..||+|++.... .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566778999999999999975 57899999986432 33456678999999999999999999998864    355799


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEecCCCCCCeeec-CCCcEEEeecCCc
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLD-EDFEAVVGDFGLA  263 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--iiH~dlk~~NIll~-~~~~~kl~Dfgla  263 (437)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +  ++|+||||+||+++ +++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999997643    388999999999999999999999   7  99999999999998 7899999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ......   ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||......       ............ 
T Consensus       180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-  247 (290)
T 1t4h_A          180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK-  247 (290)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC-
T ss_pred             cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCC-
Confidence            754322   223456899999999886 46999999999999999999999999643211       111111111111 


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...        .+...+..+.+++..||+.||++|||+.|+++
T Consensus       248 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            100        11112247899999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-41  Score=344.65  Aligned_cols=195  Identities=24%  Similarity=0.344  Sum_probs=154.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec-----CCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-----PTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~  183 (437)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999975 68999999986432 23345678999999999999999999999943     356


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+||||+. ++|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999984 6888888643    3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCC--------------------------cccccccccccccccccc-cCCCCCCchhhHHHHHHHHHHHhC
Q 013750          264 KLVDVRKT--------------------------NVTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTG  313 (437)
Q Consensus       264 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gv~l~elltg  313 (437)
                      +.......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            87642211                          122345689999999986 456799999999999999999993

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-42  Score=345.32  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=191.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-------CCcchHHHHHHHHHHHhcccccceeeeeeeec
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT  180 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  180 (437)
                      ...++|...+.||+|+||+||+|... +++.||||++....       .......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45688999999999999999999975 58999999986421       11223358899999999999999999999754


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEE
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVV  257 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl  257 (437)
                       +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.+   ..+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence             5579999999999998888643    3489999999999999999999999   99999999999999754   45999


Q ss_pred             eecCCceecccCCCcccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      +|||+++....  ........||+.|+|||++.+   ..++.++||||||+++|||++|+.||........    +....
T Consensus       284 ~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~i  357 (419)
T 3i6u_A          284 TDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQI  357 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHHHH
T ss_pred             eecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHHHH
Confidence            99999986543  222344679999999999853   5688999999999999999999999974332211    11111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .... .......         ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       358 ~~~~-~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 TSGK-YNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HTTC-CCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCC-CCCCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1000 0000000         01124578999999999999999999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-42  Score=336.76  Aligned_cols=252  Identities=20%  Similarity=0.292  Sum_probs=199.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ..++|...+.||+|+||.||++..+ +|+.||+|++.....     .+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3567888999999999999999985 588999999975321     245788888887 799999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC----CcEEEeecCCc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLA  263 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla  263 (437)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||+.++    +.+||+|||++
T Consensus        95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            9999999999998753    2389999999999999999999999   99999999999998543    35999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      +....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||.......  .   ........... .
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~---~~~~~~i~~~~-~  240 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--P---EEILARIGSGK-F  240 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--H---HHHHHHHHHCC-C
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--H---HHHHHHHccCC-c
Confidence            87653322 2334568999999999988889999999999999999999999997432111  1   11111111110 0


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            .+........+..+.+++.+||+.||++|||+.++++
T Consensus       241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  0111112234468899999999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-41  Score=342.99  Aligned_cols=260  Identities=20%  Similarity=0.228  Sum_probs=194.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC------C
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  182 (437)
                      .++|...+.||+|+||+||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            577888999999999999999975 58999999996432 234466788999999999999999999999654      3


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||++++ |...+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            569999999875 4444432      278999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc-
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  341 (437)
                      ++....  ....+...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ....+....... 
T Consensus       211 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-----~~~~i~~~lg~p~  283 (464)
T 3ttj_A          211 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-----QWNKVIEQLGTPC  283 (464)
T ss_dssp             C-------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCSCC
T ss_pred             eeecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCC
Confidence            986543  223345679999999999999999999999999999999999999997543211     111111100000 


Q ss_pred             ------------------------chhhhccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 ------------------------RLDAIVDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ------------------------~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                              .........+...   ........+.+|+.+||+.||++|||+.|+++.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                    0000110000000   011225679999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-41  Score=324.60  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|...+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            467888899999999999999975 68999999997532 3345678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCceec
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~  266 (437)
                      |+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999987643    378999999999999999999999   99999999999999   78899999999999754


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     ..   .........    
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~---~~~i~~~~~----  224 (304)
T 2jam_A          160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KL---FEKIKEGYY----  224 (304)
T ss_dssp             CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HH---HHHHHHCCC----
T ss_pred             CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HH---HHHHHcCCC----
Confidence            321   223346899999999999999999999999999999999999998643211     11   111111100    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 ---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0011112233468899999999999999999999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-42  Score=330.13  Aligned_cols=256  Identities=30%  Similarity=0.387  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC--CCC--EEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|...+.||+|+||+||+|.+.  +++  .||+|++....  .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467888899999999999999863  233  68999986432  2345678999999999999999999999998765 8


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+++++|.+++....   ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            89999999999999987642   3378999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          265 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       265 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      .........  .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......        ..........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~  241 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEG  241 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHccC
Confidence            765433221  223457788999999998889999999999999999999 99998643211        1111111111


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                               .....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       242 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  281 (291)
T 1u46_A          242 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  281 (291)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence                     1111123345689999999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=331.36  Aligned_cols=268  Identities=23%  Similarity=0.258  Sum_probs=198.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC----CcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ...++|...+.||+|+||.||+|... +|+.||||++.....    ....+.+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 589999999864221    1123478899999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++ +|..++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999986 787777642   33478889999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      +...... .......+|+.|+|||.+.+. .++.++||||||+++|||++|..||......     .....+........
T Consensus       160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-----~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPT  233 (346)
T ss_dssp             STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCC
T ss_pred             eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHcCCCC
Confidence            8654322 223345689999999999764 5899999999999999999999998643211     11111111100000


Q ss_pred             hhhh------cc---ccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          343 LDAI------VD---RNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       343 ~~~~------~d---~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ....      .+   .......+     ...+..+.+++.+||+.||++|||+.|+++.--
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            0000      00   00000111     223468999999999999999999999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-41  Score=323.47  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||+|... ++..||+|++....  .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367888899999999999999976 57889999986421  123356789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999997643    388999999999999999999999   99999999999999999999999999997654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..   ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......        .........       
T Consensus       166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~-------  227 (284)
T 2vgo_A          166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNV-------  227 (284)
T ss_dssp             SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT-------
T ss_pred             cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhcc-------
Confidence            22   123356899999999999999999999999999999999999999643211        111111100       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +    ..++...+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            0    1122233457899999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.1e-42  Score=331.89  Aligned_cols=265  Identities=18%  Similarity=0.264  Sum_probs=192.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ...++|...+.||+|+||+||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44678999999999999999999965 68999999996433 22334567899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee-----cCCCcEEEeecC
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----DEDFEAVVGDFG  261 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll-----~~~~~~kl~Dfg  261 (437)
                      ||||++ |+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+     +.++.+||+|||
T Consensus       111 v~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            999998 58999887643    389999999999999999999999   99999999999999     455669999999


Q ss_pred             CceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      +++...... .......+|..|+|||.+.+. .++.++|||||||++|||++|+.||.......    .+..........
T Consensus       183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~  257 (329)
T 3gbz_A          183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLGLP  257 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC
T ss_pred             CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhCCC
Confidence            998664322 223344689999999999875 48999999999999999999999996432211    111111111000


Q ss_pred             c--chhhhcc--------ccccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 K--RLDAIVD--------RNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~--~~~~~~d--------~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .  .......        +.....     ........+.+|+.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0  0000000        000000     00112357889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-41  Score=329.75  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||++... +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            466888899999999999999985 47899999986432  233456788999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999887643    389999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......        ..........      
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~------  257 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE------  257 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC------
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHhcCC------
Confidence            3222 233456899999999999999999999999999999999999999743211        1111111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       .    ..+......+.+++.+||+.||++|||+.|+++
T Consensus       258 -~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0    111223357889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.4e-43  Score=333.79  Aligned_cols=265  Identities=27%  Similarity=0.393  Sum_probs=187.2

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ....++|...+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            445688999999999999999999964 6899999998754434456778899999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          187 VYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ||||+++++|.+++....    .....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999987531    1234589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCC----cccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          263 AKLVDVRKT----NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       263 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +........    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......     ...  ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~--~~~  240 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----VLM--LTL  240 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHH--HHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----HHH--HHh
Confidence            876543211    11223468999999999876 568999999999999999999999997533211     100  010


Q ss_pred             Hhc-cch-hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          338 ERE-KRL-DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       338 ~~~-~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ... ... ....+...    ....+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QNDPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSSCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000 000 01111111    1223357889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-41  Score=330.39  Aligned_cols=261  Identities=18%  Similarity=0.228  Sum_probs=204.4

Q ss_pred             HHHHHHhcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc-cccceeeeeeeec
Q 013750          105 RELQLATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT  180 (437)
Q Consensus       105 ~e~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  180 (437)
                      ...+...+.|... +.||+|+||.||+|... +++.||+|++.... .......+.+|+.++..+. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344556667766 88999999999999976 58999999987533 2334678999999999985 6999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEE
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV  257 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl  257 (437)
                      .+..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +++||||||+|||++.   ++.+||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence            99999999999999999988643  224489999999999999999999999   9999999999999988   789999


Q ss_pred             eecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......     ........
T Consensus       176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~  248 (327)
T 3lm5_A          176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNISQV  248 (327)
T ss_dssp             CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHT
T ss_pred             eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHhc
Confidence            9999998764322  2234568999999999999999999999999999999999999996432210     11111110


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                ............+..+.+++.+||+.||++|||+.++++.
T Consensus       249 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 ----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                      0011111122334578999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-42  Score=341.90  Aligned_cols=255  Identities=11%  Similarity=0.023  Sum_probs=181.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhc--ccccceeee-------eee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVA--VHRNLLRLI-------GFC  178 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~  178 (437)
                      ..+|...+.||+|+||.||+|.+. +|+.||||++.....  ....+.+.+|++++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345788899999999999999975 689999999976432  23455677886555544  699987754       444


Q ss_pred             ecC-----------------CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 013750          179 TTP-----------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR------KRVALGAARGLEYLHEHCNP  235 (437)
Q Consensus       179 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~  235 (437)
                      ...                 ...++||||++ |+|.+++.....   .+.+..+      ..++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            332                 33799999999 899999986421   1344455      77889999999999999   


Q ss_pred             ceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhC
Q 013750          236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTG  313 (437)
Q Consensus       236 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg  313 (437)
                      +|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++|||||||++|||++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999865421    113456799999999987  6799999999999999999999


Q ss_pred             CCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          314 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       314 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      +.||...........          .....................+..+.+|+.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999975432211100          000000001111111111234568999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.6e-41  Score=333.96  Aligned_cols=265  Identities=20%  Similarity=0.236  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc--------cccceeeeeeee--
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--------HRNLLRLIGFCT--  179 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--  179 (437)
                      .++|.+.+.||+|+||+||+|... +++.||||++...  ....+.+.+|+++++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            478999999999999999999964 5889999999642  344567889999999886        788999999987  


Q ss_pred             --cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----
Q 013750          180 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----  253 (437)
Q Consensus       180 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----  253 (437)
                        .....++||||+.+ +|.+++...  ....+++..++.++.||+.||+|||+++  +|+||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVLGH-HLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEeccCc-cHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence              56678999999955 555555432  2234899999999999999999999964  799999999999999775    


Q ss_pred             ---------------------------------------------cEEEeecCCceecccCCCccccccccccccccccc
Q 013750          254 ---------------------------------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY  288 (437)
Q Consensus       254 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~  288 (437)
                                                                   .+||+|||++......    .....||..|+|||.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         7999999999876432    233468999999999


Q ss_pred             ccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc-hhhHHHHHHHHHhcc---------chhhhcccc--------
Q 013750          289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-DVLLLDHVKKLEREK---------RLDAIVDRN--------  350 (437)
Q Consensus       289 ~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~d~~--------  350 (437)
                      +.+..++.++|||||||++|||++|+.||......... ...............         .........        
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999754432211 111111111111000         000000000        


Q ss_pred             -----------ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 -----------LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 -----------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                 -....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       001235677889999999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-41  Score=332.86  Aligned_cols=263  Identities=19%  Similarity=0.289  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-----Cee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  184 (437)
                      .++|...+.||+|+||.||+|... ++..||||++.........+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467888999999999999999975 68899999997644445557899999999999999999999999655     368


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++|+||+. ++|.+++...     .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 5888888653     289999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcc--cccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          265 LVDVRKTNV--TTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       265 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      .........  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ....+.......
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~~~  251 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILGILGSP  251 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-----HHHHHHHHHCSC
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHHHHhCCC
Confidence            765332221  234578999999998754 458999999999999999999999997543221     111111110000


Q ss_pred             chhh-----------hccc-cccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 RLDA-----------IVDR-NLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~~~~-----------~~d~-~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ....           .... .....     ..+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000           0000 00000     011234578999999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.8e-42  Score=362.27  Aligned_cols=260  Identities=20%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          106 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       106 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      +.+...++|...+.||+|+||.||+|.+..    +..||+|++.........+.|.+|+.++++++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            334445678888999999999999999742    45799999876544555678999999999999999999999985 4


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      +..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            5689999999999999999753   23489999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      +++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......     ..   .......
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~---~~~i~~~  608 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DV---IGRIENG  608 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH---HHHHHHT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HH---HHHHHcC
Confidence            998765433333334457789999999998999999999999999999997 99998643211     11   1111111


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .          ....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       609 ~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          609 E----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1          111233345688999999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.2e-41  Score=339.96  Aligned_cols=259  Identities=18%  Similarity=0.234  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc-cceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++....   ....+..|++++..++|+ ++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46788999999999999999997 468999999886432   234588999999999874 5556666677888899999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~  265 (437)
                      ||+ +++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus        83 e~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 999999997532   3489999999999999999999999   99999999999999   6889999999999987


Q ss_pred             cccCCCcc------cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          266 VDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       266 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ........      .....||..|+|||.+.+..++.++|||||||++|||++|+.||.........  .....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~  233 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEKKV  233 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhccc
Confidence            65433211      22457999999999999999999999999999999999999999754332111  11111111111


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......+..         ..+..+.+++..||+.||++||++.+|++.|+.
T Consensus       234 ~~~~~~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          234 ATSIEALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HSCHHHHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cccHHHHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            111111111         123588999999999999999999999999876

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=332.61  Aligned_cols=258  Identities=23%  Similarity=0.313  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999974 68999999986432 2334567889999999999999999999997653      


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+ +++|..++...     .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 88999998752     378999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .+...+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.......     ....+.......
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~g~~  245 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-----QLKEIMKVTGTP  245 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCC
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCC
Confidence            9865422    334568999999999877 679999999999999999999999997543211     111111100000


Q ss_pred             c-----------hhhhc-------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 R-----------LDAIV-------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~-----------~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .           ....+       ...+ .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0           00000       0000 11122334678999999999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=323.61  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=199.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ...++|+..+.||+|+||.||+|... +|+.||+|.+...   ...+.+.+|+.++..++||||+++++++...+..++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34577889999999999999999986 5899999999752   3456789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            9999999999998742   23489999999999999999999999   99999999999999999999999999998664


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......        ..........      
T Consensus       177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~------  241 (314)
T 3com_A          177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNP------  241 (314)
T ss_dssp             TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC------
T ss_pred             hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCC------
Confidence            3222 223356899999999999999999999999999999999999998643211        1111111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .+.  ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 PPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             Ccc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000  0111223457899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-41  Score=319.70  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467888999999999999999986 68999999986421  233456789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999997643    378999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ..  .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||......        ..........     
T Consensus       163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~-----  227 (276)
T 2h6d_A          163 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGV-----  227 (276)
T ss_dssp             C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-----
T ss_pred             CC--cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCc-----
Confidence            32  22233468999999999987765 68999999999999999999998643211        1111111110     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                            ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  00112233578899999999999999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=333.00  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=199.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeee
Q 013750          102 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT  179 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  179 (437)
                      +++.++....++|...+.||+|+||.||+|.+. +|+.||+|++...  ....+.+.+|+.++.++ +||||+++++++.
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            444455556788999999999999999999974 6899999998643  33457889999999999 7999999999997


Q ss_pred             c------CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC
Q 013750          180 T------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF  253 (437)
Q Consensus       180 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~  253 (437)
                      .      ....++||||+++++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence            6      467899999999999999997642  23478899999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCceecccCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh
Q 013750          254 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV  328 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~  328 (437)
                      .+||+|||++........ ......||..|+|||.+.     ...++.++||||||+++|||++|+.||......     
T Consensus       167 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----  240 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----  240 (326)
T ss_dssp             CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred             CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence            999999999986543211 223346899999999987     567899999999999999999999998643211     


Q ss_pred             hHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          329 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         .......... .     +.+   .....+..+.+++.+||+.||++||++.++++
T Consensus       241 ---~~~~~~~~~~-~-----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          241 ---RALFLIPRNP-A-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---HHHHHHHHSC-C-----CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHhhcCc-c-----ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               1111111110 0     000   11122357899999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.9e-41  Score=343.16  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=201.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC------------cchHHHHHHHHHHHhcccccceeeee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP------------GGDAAFQREVEMISVAVHRNLLRLIG  176 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~g  176 (437)
                      ..++|...+.||+|+||+||+|... +++.||+|++......            ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999975 5789999998743211            33567899999999999999999999


Q ss_pred             eeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC---
Q 013750          177 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---  253 (437)
Q Consensus       177 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---  253 (437)
                      ++.+....++||||+++|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999987643    389999999999999999999999   999999999999998775   


Q ss_pred             cEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          254 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      .+||+|||++.......  ......||+.|+|||.+. +.++.++|||||||++|+|++|..||......        ..
T Consensus       187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~  255 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DI  255 (504)
T ss_dssp             SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred             cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence            69999999998765332  233456999999999986 56999999999999999999999999743221        11


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...........   +...    ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus       256 ~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          256 IKKVEKGKYYF---DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHCCCCC---CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcCCCCC---Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111111000   0000    01123578999999999999999999999854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-41  Score=341.30  Aligned_cols=199  Identities=25%  Similarity=0.341  Sum_probs=166.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC-----Ce
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  183 (437)
                      .++|...+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468889999999999999999975 58899999997532 233456889999999999999999999999766     57


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+. ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999986 5999888753    3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCc---------------------ccccccccccccccccc-cCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          264 KLVDVRKTN---------------------VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       264 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      +........                     ..+...||..|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876433211                     23456789999999986 5567999999999999999999865554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-41  Score=331.76  Aligned_cols=265  Identities=25%  Similarity=0.333  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec--------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--------  180 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------  180 (437)
                      .++|...+.||+|+||+||+|.. .+|+.||+|++.... .......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36788899999999999999998 468999999986433 23345678899999999999999999999976        


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      .+..++||||+++ +|...+...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999985 666666543   23389999999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCC---cccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          261 GLAKLVDVRKT---NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       261 gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |+++.......   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......     ........
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~  243 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQ  243 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH
Confidence            99987643221   22234568999999999876 45899999999999999999999999753321     11111111


Q ss_pred             HHhcc---chhhhccccc--------cCCCC-HH------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          337 LEREK---RLDAIVDRNL--------NKNYN-IQ------EVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       337 ~~~~~---~~~~~~d~~l--------~~~~~-~~------~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .....   ..........        ..... .+      ....+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11100   0000000000        00000 01      12468899999999999999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.5e-41  Score=344.51  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|...+.||+|+||.||++... +|+.||||++....  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888999999999999999986 68999999986432  234567899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee---cCCCcEEEeecCCce
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK  264 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~  264 (437)
                      |||+.+|+|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999887533    389999999999999999999999   99999999999999   567899999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ......  ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||.....     ...   ...........
T Consensus       178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~---~~~i~~~~~~~  246 (484)
T 3nyv_A          178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDI---LKKVEKGKYTF  246 (484)
T ss_dssp             HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH---HHHHHHCCCCC
T ss_pred             Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHH---HHHHHcCCCCC
Confidence            654332  2334569999999999865 699999999999999999999999974321     111   11111111000


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .       .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          247 E-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             C-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            0       00011234578999999999999999999999853

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.5e-41  Score=322.70  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3567888999999999999999986 58999999987533 455678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++++|..++....   ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999887632   2389999999999999999999999   999999999999999999999999998764321


Q ss_pred             CCCcccccccccccccccccc-----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          269 RKTNVTTQVRGTMGHIAPEYL-----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      . ........||..|+|||.+     ....++.++||||||+++|||++|+.||......        ............
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  240 (302)
T 2j7t_A          170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSDPP  240 (302)
T ss_dssp             H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCC
T ss_pred             c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHHHhccCCc
Confidence            1 1112234689999999998     4667899999999999999999999998643211        111111111100


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       .       ...+...+..+.+++..||+.||++|||+.++++.
T Consensus       241 -~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 -T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             0       01112234578999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-41  Score=342.64  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||+||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++......++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888999999999999999985 68899999987532 2344678899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~  265 (437)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999887643    388999999999999999999999   9999999999999976   45599999999987


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ....  .......||+.|+|||.+. +.++.++|||||||++|+|++|..||......     ..   ..........  
T Consensus       189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~---~~~i~~~~~~--  255 (494)
T 3lij_A          189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EI---LRKVEKGKYT--  255 (494)
T ss_dssp             CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHHTCCC--
T ss_pred             CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHhCCCC--
Confidence            6532  2233456999999999886 56999999999999999999999999743221     11   1111111100  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       .+..    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       256 -~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             0000    01123457889999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.1e-41  Score=342.37  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|.+.+.||+|+||+||++... +++.||||++.... .......+.+|++++++++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888999999999999999975 68999999986322 2344678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec---CCCcEEEeecCCcee
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKL  265 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~  265 (437)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999887643    389999999999999999999999   999999999999995   456799999999986


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ....  .......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.....     ....   ...........
T Consensus       174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~---~~i~~~~~~~~  242 (486)
T 3mwu_A          174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDIL---KRVETGKYAFD  242 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH---HHHHHTCCCSC
T ss_pred             CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH---HHHHhCCCCCC
Confidence            5432  22334569999999999875 599999999999999999999999964321     1111   11111110000


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                             .......+..+.+++.+||+.||++|||+.++++.
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   00011234578999999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.8e-42  Score=329.32  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=199.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcc--cccceeeeeeeecC
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTP  181 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~  181 (437)
                      ..+....++|.+.+.||+|+||.||++...+++.||+|++.... .....+.+.+|++++.+++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            34445567889999999999999999999889999999986432 2344578899999999997  49999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      +..++||| +.+++|.+++....    .+++..+..++.|+++||.|||++   +++|+||||+||++++ +.+||+|||
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999 66889999998643    378999999999999999999999   9999999999999975 799999999


Q ss_pred             CceecccCCCc-ccccccccccccccccccC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh
Q 013750          262 LAKLVDVRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       262 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  329 (437)
                      ++......... ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......      
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------  245 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------  245 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------
Confidence            99866433221 1223468999999999875           46889999999999999999999998642211      


Q ss_pred             HHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                       ....         ....++......+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       246 -~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 -ISKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             0111         11112221122222224578999999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.7e-41  Score=327.61  Aligned_cols=263  Identities=21%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC-----Cee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  184 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999975 68999999997544445566788999999999999999999988654     678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||+. ++|..++...     .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 6898888752     389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCc---------ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 013750          265 LVDVRKTN---------VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       265 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~  334 (437)
                      ........         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......     .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~  235 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-----QLLLI  235 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHH
Confidence            76432211         1123468999999998764 678999999999999999999999997543211     11111


Q ss_pred             HHHHhccc------------hhhhccccc-c-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          335 KKLEREKR------------LDAIVDRNL-N-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       335 ~~~~~~~~------------~~~~~d~~l-~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ........            ..+...... .     ....+..+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11000000            000000000 0     00011234678899999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.8e-41  Score=329.32  Aligned_cols=271  Identities=21%  Similarity=0.237  Sum_probs=192.8

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      .+.....++|...+.||+|+||.||+|... +|+.||||++...  ......+.++++.++.++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            456677899999999999999999999985 6899999998643  2334567788899999999999999999965433


Q ss_pred             -------eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceEecCCCCCCeeecC-CC
Q 013750          184 -------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDE-DF  253 (437)
Q Consensus       184 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~iiH~dlk~~NIll~~-~~  253 (437)
                             .++||||++++ |...+.........+++..+..++.|++.||.|||  ++   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   78999999875 44444433334455889999999999999999999  77   9999999999999997 89


Q ss_pred             cEEEeecCCceecccCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 013750          254 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD  332 (437)
Q Consensus       254 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~  332 (437)
                      .+||+|||+++......  ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.......    ....
T Consensus       170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~  243 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLHE  243 (360)
T ss_dssp             EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred             cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHHH
Confidence            99999999998665322  233456899999999986554 8999999999999999999999997533211    1111


Q ss_pred             HHHHHHhc-----------cchhhhcc------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          333 HVKKLERE-----------KRLDAIVD------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       333 ~~~~~~~~-----------~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ........           .......+      ...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11110000           00000000      000111122346789999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-41  Score=332.09  Aligned_cols=260  Identities=19%  Similarity=0.266  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC--cc--------------hHHHHHHHHHHHhcccccceee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP--GG--------------DAAFQREVEMISVAVHRNLLRL  174 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~~--------------~~~~~~E~~~l~~l~H~niv~l  174 (437)
                      .++|...+.||+|+||.||+|.. +|+.||+|++......  ..              .+.|.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999999999 8999999998642211  11              1789999999999999999999


Q ss_pred             eeeeecCCeeEEEEecccCchhhhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCe
Q 013750          175 IGFCTTPTERLLVYPFMQNLSVAYR------LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANV  247 (437)
Q Consensus       175 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NI  247 (437)
                      ++++...+..++||||+++++|.++      +...  ....+++..+..++.|++.||.|||+ .   +++|+||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      4331  24558999999999999999999999 8   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCcccccccccccccccccccCC-CCCC-chhhHHHHHHHHHHHhCCCCCCCCccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEE  325 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~s~Gv~l~elltg~~p~~~~~~~~~  325 (437)
                      +++.++.+||+|||++......   ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||....... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            9999999999999999865432   23345689999999999877 6666 9999999999999999999997543210 


Q ss_pred             chhhHHHHHHHHHhccc-hhh----hccc---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          326 DDVLLLDHVKKLEREKR-LDA----IVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       326 ~~~~~~~~~~~~~~~~~-~~~----~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            ........... ...    ...+   ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       260 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ------HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  11111111100 000    0000   0000001334568899999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.7e-41  Score=326.96  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-------CCcchHHHHHHHHHHHhcccccceeeeeeeecC
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP  181 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  181 (437)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....       .......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467889999999999999999975 57899999986422       112234588999999999999999999998765


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEe
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVG  258 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~  258 (437)
                      . .++||||+++++|.+++...    ..+++.....++.|++.||.|||++   +++||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 89999999999999988643    3489999999999999999999999   9999999999999987654   9999


Q ss_pred             ecCCceecccCCCccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      |||++......  .......||+.|+|||.+.   ...++.++||||||+++|||++|..||........    +.....
T Consensus       160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~  233 (322)
T 2ycf_A          160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQIT  233 (322)
T ss_dssp             CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HHHHHH
T ss_pred             cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HHHHHH
Confidence            99999865422  2223456899999999974   56789999999999999999999999974332211    111111


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ... .......         ....+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~-~~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGK-YNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTC-CCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCc-cccCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            100 0000000         0112357899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-41  Score=337.40  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe------e
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE------R  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~  184 (437)
                      ..+|...+.||+|+||+||+|++.++..||+|++.....     ...+|+++++.++||||+++++++.....      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            356888899999999999999998777899998864321     12379999999999999999999954433      7


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CCCcEEEeecCCc
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLA  263 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla  263 (437)
                      ++||||++++.+...... ......+++..+..++.|++.||+|||++   +|+||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHY-AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEEHHHHHHHH-HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCccHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            899999987655443322 22234589999999999999999999999   999999999999999 7999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      +......  ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.......    .+....... ....
T Consensus       190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~l~~i~~~~-g~p~  262 (394)
T 4e7w_A          190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID----QLVEIIKVL-GTPS  262 (394)
T ss_dssp             EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHH-CCCC
T ss_pred             ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHh-CCCC
Confidence            8764322  23345689999999998765 58999999999999999999999997543211    111111110 0000


Q ss_pred             hh-------hhcc--------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 LD-------AIVD--------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 ~~-------~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ..       ....        ..+...+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00       0000        000111122244689999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.7e-41  Score=323.13  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE--CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhc---ccccceeeeeeee----
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCT----  179 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~----  179 (437)
                      +.++|...+.||+|+||.||+|..  .+|+.||+|++.... .......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457889999999999999999998  368899999986432 222334677888877766   8999999999987    


Q ss_pred             -cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          180 -TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       180 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                       .....++||||++ |+|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999998 69999987643  23488999999999999999999999   99999999999999999999999


Q ss_pred             ecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE  338 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  338 (437)
                      |||+++.....  .......||..|+|||.+.+..++.++||||||+++|||++|+.||......     .....+....
T Consensus       163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~  235 (326)
T 1blx_A          163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVI  235 (326)
T ss_dssp             SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred             cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHc
Confidence            99999865422  2233456899999999999999999999999999999999999999753321     1111111110


Q ss_pred             hccchhh----------hcc---ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          339 REKRLDA----------IVD---RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       339 ~~~~~~~----------~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .......          ...   ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000          000   00001112234567899999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.8e-42  Score=332.05  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=203.0

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          104 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       104 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ..++....++|...+.||+|+||.||+|.+.+  .+|+|++.... .....+.|.+|+.++++++||||+++++++...+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            35555667889999999999999999999853  49999986432 2334456889999999999999999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++ ++.+||+|||+
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999998753   33488999999999999999999999   999999999999998 67999999999


Q ss_pred             ceecccCC----CcccccccccccccccccccC---------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhh
Q 013750          263 AKLVDVRK----TNVTTQVRGTMGHIAPEYLST---------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL  329 (437)
Q Consensus       263 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~  329 (437)
                      +.......    ........|+..|+|||.+..         ..++.++||||||+++|||++|+.||......      
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------  249 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------  249 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence            87553211    112223458999999999864         45789999999999999999999999643211      


Q ss_pred             HHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ......... ..     +.+.   ....+..+.+++..||+.||++|||+.++++.|+.
T Consensus       250 --~~~~~~~~~-~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          250 --AIIWQMGTG-MK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK  299 (319)
T ss_dssp             --HHHHHHHTT-CC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred             --HHHHHhccC-CC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence              111111111 00     1110   11123478899999999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.6e-41  Score=329.76  Aligned_cols=260  Identities=19%  Similarity=0.233  Sum_probs=192.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      .++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467888999999999999999975 68899999997432 2334567889999999999999999999997665      


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            67999999975 67777642      278899999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH------
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK------  336 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------  336 (437)
                      ++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ....+..      
T Consensus       174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~  246 (371)
T 2xrw_A          174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-----QWNKVIEQLGTPC  246 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHC-CCCCC
T ss_pred             ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCC
Confidence            9865422  22334568999999999999999999999999999999999999997543211     0000000      


Q ss_pred             -------------HHhc------cchhhhccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          337 -------------LERE------KRLDAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       337 -------------~~~~------~~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                   ....      .............   ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                         0000      0000000000000   0112346789999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=316.76  Aligned_cols=252  Identities=18%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC---CCcchHHHHHHHHHHHhcccccceeeeeee--ecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFC--TTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~  184 (437)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   .....+.+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999974 68899999996421   134467899999999999999999999998  445678


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      ++||||++++ |.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999887 666665533  23489999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCC-CcccccccccccccccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          265 LVDVRK-TNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       265 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ...... ........||..|+|||.+.+..  ++.++||||||+++|||++|+.||......        ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~~  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKGS  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcCC
Confidence            764322 22223456899999999997654  478999999999999999999999743211        1111111110


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                 ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       01122234578899999999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7e-41  Score=336.11  Aligned_cols=261  Identities=24%  Similarity=0.295  Sum_probs=193.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC----C--ee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----T--ER  184 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~  184 (437)
                      .+|...+.||+|+||.||+|++. +|+.||||++....     ..+.+|++++++++||||+++++++...    +  ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            45778899999999999999985 58999999986432     1234799999999999999999988432    2  35


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-CcEEEeecCCc
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA  263 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla  263 (437)
                      ++||||+++ ++...+.........+++..+..++.||++||+|||++   +|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 55555544333345589999999999999999999999   99999999999999965 67899999999


Q ss_pred             eecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc--
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--  340 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  340 (437)
                      +......  ......||..|+|||++.+. .++.++|||||||++|||++|+.||.......    .+......+...  
T Consensus       205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTR  278 (420)
T ss_dssp             EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCH
T ss_pred             hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCH
Confidence            8754322  22345689999999998765 79999999999999999999999997533211    111111111000  


Q ss_pred             -------cchhhhcccccc-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 -------KRLDAIVDRNLN-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 -------~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                             ....+..-+.+.     ..+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                   000000000000     01122334689999999999999999999999853

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.5e-41  Score=336.02  Aligned_cols=198  Identities=20%  Similarity=0.252  Sum_probs=171.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc------ccccceeeeeeeecCCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA------VHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~  183 (437)
                      ..+|.+.+.||+|+||+||+|... +++.||||++...  ....+.+.+|++++..+      +|+||+++++++...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            457888999999999999999875 5889999999742  33456788899988877      56799999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc--EEEeecC
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFG  261 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfg  261 (437)
                      .++||||+. ++|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 588888876432  3389999999999999999999999   9999999999999999887  9999999


Q ss_pred             CceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      +++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99764322    22356899999999999999999999999999999999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.6e-41  Score=319.07  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=202.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--------CcchHHHHHHHHHHHhcc-cccceeeeeeee
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--------PGGDAAFQREVEMISVAV-HRNLLRLIGFCT  179 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~  179 (437)
                      ..++|...+.||+|+||.||+|... +|+.||||++.....        ....+.+.+|++++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578888999999999999999985 588999999864321        112456789999999996 999999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEee
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD  259 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D  259 (437)
                      ..+..++||||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999997643    389999999999999999999999   999999999999999999999999


Q ss_pred             cCCceecccCCCccccccccccccccccccc------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      ||++.......  ......+++.|+|||.+.      ...++.++||||||+++|||++|+.||.....     ...   
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~---  237 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLM---  237 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH---
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHH---
Confidence            99998764322  233456899999999885      45689999999999999999999999864321     111   


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .........       ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 LRMIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111111100       0000111233467999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-41  Score=356.37  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=205.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCee
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  184 (437)
                      ...++|...+.||+|+||.||+|... +++.||||++....  .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34567888999999999999999975 58899999987421  234456788999999887 799999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |+||||+++|+|..++....    .+++..+..++.||+.||+|||++   +|+||||||+||||+.++++||+|||+++
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999998653    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+..     .+   ....       
T Consensus       491 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~---~~~i-------  554 (674)
T 3pfq_A          491 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----EL---FQSI-------  554 (674)
T ss_dssp             ECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHH-------
T ss_pred             ccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HH---HHHH-------
Confidence            64322 22344567999999999999999999999999999999999999999753211     11   1111       


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM-----SEVVR  386 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~  386 (437)
                        ....  ..++...+..+.+|+..||+.||++||++     .||++
T Consensus       555 --~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          555 --MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --HSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --HhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              1111  11233345688999999999999999997     66653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-40  Score=319.94  Aligned_cols=258  Identities=20%  Similarity=0.258  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-C-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc------ceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-A-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~  182 (437)
                      .++|.+.+.||+|+||+||+|.. . +++.||+|++...  ....+.+.+|++++..++|+|      ++++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            46788899999999999999997 3 6889999999642  344567889999999998775      999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-----------
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----------  251 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-----------  251 (437)
                      ..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 889999987643  23488999999999999999999999   9999999999999987           


Q ss_pred             --------CCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCccc
Q 013750          252 --------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE  323 (437)
Q Consensus       252 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~  323 (437)
                              ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    668999999999864322    23356899999999999999999999999999999999999999754321


Q ss_pred             ccchhhHHHHHHHHHhccchhhh------------------------------cccc-ccCCCCHHHHHHHHHHHHHhcc
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAI------------------------------VDRN-LNKNYNIQEVETMIQVALLCTQ  372 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~------------------------------~d~~-l~~~~~~~~~~~l~~l~~~Cl~  372 (437)
                      .     ........... .....                              ..+. -........+..+.+++.+||+
T Consensus       241 ~-----~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          241 E-----HLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             H-----HHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             H-----HHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            1     11111111000 00000                              0000 0011234567789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 013750          373 ASPEDRPAMSEVVR  386 (437)
Q Consensus       373 ~dp~~RPs~~evl~  386 (437)
                      .||++|||+.|+++
T Consensus       315 ~dP~~Rpt~~ell~  328 (339)
T 1z57_A          315 YDPAKRITLREALK  328 (339)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             cCcccccCHHHHhc
Confidence            99999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=336.27  Aligned_cols=269  Identities=20%  Similarity=0.268  Sum_probs=182.7

Q ss_pred             CCCC-CCeeeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee--cCCeeEE
Q 013750          113 NFSE-KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL  186 (437)
Q Consensus       113 ~~~~-~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l  186 (437)
                      .|.+ .++||+|+||+||+|.+.   ++..||+|++...   .....+.+|+.++++++||||+++++++.  .....++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3444 458999999999999975   4789999999743   33457889999999999999999999994  4678899


Q ss_pred             EEecccCchhhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee----cCCCcEEE
Q 013750          187 VYPFMQNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVV  257 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl  257 (437)
                      ||||+.+ +|..++....     .....+++..++.++.||+.||+|||++   +|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 6776665321     1223489999999999999999999999   99999999999999    77899999


Q ss_pred             eecCCceecccCCC--cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc----hhhH
Q 013750          258 GDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED----DVLL  330 (437)
Q Consensus       258 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~----~~~~  330 (437)
                      +|||+++.......  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........    ....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643221  223345789999999999874 5899999999999999999999999654322100    0001


Q ss_pred             HHHHHHHHhcc---chhhh------------ccccccCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          331 LDHVKKLEREK---RLDAI------------VDRNLNKNYN---------IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       331 ~~~~~~~~~~~---~~~~~------------~d~~l~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...+.......   ....+            ..........         ......+.+|+.+||+.||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111100000   00000            0000000000         001347889999999999999999999997


Q ss_pred             HH
Q 013750          387 ML  388 (437)
Q Consensus       387 ~L  388 (437)
                      .-
T Consensus       334 hp  335 (405)
T 3rgf_A          334 DP  335 (405)
T ss_dssp             SG
T ss_pred             Ch
Confidence            54

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-41  Score=319.59  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec---------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT---------  180 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  180 (437)
                      .++|+..+.||+|+||.||+|... +|+.||+|++...  ....+.+.+|+.++++++||||+++++++..         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467888999999999999999975 6899999998642  3445778999999999999999999998854         


Q ss_pred             ----CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEE
Q 013750          181 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV  256 (437)
Q Consensus       181 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k  256 (437)
                          ....++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                35678999999999999999753   23478889999999999999999999   999999999999999999999


Q ss_pred             EeecCCceecccCC-------------CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcc
Q 013750          257 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL  322 (437)
Q Consensus       257 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~  322 (437)
                      |+|||++.......             ........||..|+|||.+.+. .++.++||||||+++|||++   |+.... 
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-  232 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-  232 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence            99999998654221             1112334689999999999764 68999999999999999998   442110 


Q ss_pred             cccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         .   ..........       ....+....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       233 ---~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 ---E---RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ---H---HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---h---HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence               0   1111111110       01111222334445678999999999999999999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5e-41  Score=325.67  Aligned_cols=258  Identities=22%  Similarity=0.311  Sum_probs=180.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHH-HHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            477888999999999999999985 689999999976444444556667776 677889999999999999999999999


Q ss_pred             ecccCchhhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          189 PFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       189 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||+++ +|.+++... ......+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99985 777766532 112345899999999999999999999853  79999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ...  ......||..|+|||.+    .+..++.++||||||+++|||++|+.||........          ...   ..
T Consensus       178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~---~~  242 (327)
T 3aln_A          178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----------QLT---QV  242 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------C---CC
T ss_pred             ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----------HHH---HH
Confidence            322  22334689999999998    456789999999999999999999999864221100          000   00


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..-..+.+........+..+.+++..||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000011111111233468999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.8e-41  Score=329.47  Aligned_cols=259  Identities=22%  Similarity=0.272  Sum_probs=183.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC------C
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  182 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            477888999999999999999964 68999999986432 233456788999999999999999999998654      5


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++|+||+ +++|.+++..     ..+++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 6899888764     2389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .+...||..|+|||.+.+ ..++.++|||||||++|||++|+.||......     .....+.......
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p  249 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTP  249 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSC
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCC
Confidence            9864321    334568999999999877 67899999999999999999999999754321     1111111111000


Q ss_pred             c-----------hhhhccccc-cCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 R-----------LDAIVDRNL-NKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~-----------~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .           ....+.... ....+     ......+.+|+.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0           000000000 00000     1223578999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=320.33  Aligned_cols=261  Identities=21%  Similarity=0.303  Sum_probs=191.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeee----------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT----------  179 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------  179 (437)
                      .++|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            467888899999999999999986 4899999998743 2455678899999999999999999999873          


Q ss_pred             ----cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CCCc
Q 013750          180 ----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE  254 (437)
Q Consensus       180 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~  254 (437)
                          .....++||||++ |+|.+++..     ..+++..+..++.|++.||+|||++   +++|+||||+||+++ +++.
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence                4467899999998 699988864     2378999999999999999999999   999999999999997 5679


Q ss_pred             EEEeecCCceecccCCC--cccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          255 AVVGDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      +||+|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||.......     ..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~  234 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-----QM  234 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence            99999999986543211  11223457899999998865 678999999999999999999999997543211     11


Q ss_pred             HHHHHHHhc----------cchhhhcccccc-C-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          332 DHVKKLERE----------KRLDAIVDRNLN-K-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       332 ~~~~~~~~~----------~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .........          ............ .     ...+..+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            111100000          000000000000 0     001123468899999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.8e-40  Score=325.50  Aligned_cols=258  Identities=21%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCee----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER----  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----  184 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467888999999999999999975 68999999997532 233356788999999999999999999999877655    


Q ss_pred             --EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          185 --LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       185 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                        ++||||+. ++|..++..      .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999998 577776632      288999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ............
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~  261 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVP  261 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCC
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCC
Confidence            9855322    234568999999999987 678999999999999999999999997533211     111111100000


Q ss_pred             c-----------hhhhcc---ccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 R-----------LDAIVD---RNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~-----------~~~~~d---~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .           ......   .....   ...+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0           000000   00000   0011234688999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.1e-40  Score=311.70  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=202.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999986 68999999986432 24456789999999999999999999999999999999


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC---CcEEEeecCCc
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLA  263 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla  263 (437)
                      |+||+++++|.+++....    .+++..+..++.|++.||.|||++   +++|+||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999998887543    388999999999999999999999   99999999999999754   46999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ........  .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||......        ............
T Consensus       172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYA  240 (287)
T ss_dssp             GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC
T ss_pred             eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            86543221  223357899999998865 5899999999999999999999998643211        111111111100


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..       .......+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC-------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00       0000122457899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.5e-40  Score=324.44  Aligned_cols=266  Identities=19%  Similarity=0.263  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-----------cccceeeeeee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFC  178 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~  178 (437)
                      .++|...+.||+|+||+||+|.. .+++.||||++...  ....+.+.+|++++.+++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            46788899999999999999997 46899999999642  334567889999998886           89999999998


Q ss_pred             ecCC----eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec----
Q 013750          179 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD----  250 (437)
Q Consensus       179 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~----  250 (437)
                      ....    ..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+++  +|+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            7544    689999999 8999999876432  23889999999999999999999954  799999999999994    


Q ss_pred             --CCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccc-h
Q 013750          251 --EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-D  327 (437)
Q Consensus       251 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~-~  327 (437)
                        .++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              4458999999999865432    23346899999999999999999999999999999999999999754322111 1


Q ss_pred             hhHHHHHHHHHhc---------cchhhhccc-------------------cccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 013750          328 VLLLDHVKKLERE---------KRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRP  379 (437)
Q Consensus       328 ~~~~~~~~~~~~~---------~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  379 (437)
                      .............         .......+.                   .-...++...+..+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            0111111110000         000000000                   001134567788999999999999999999


Q ss_pred             CHHHHHHH
Q 013750          380 AMSEVVRM  387 (437)
Q Consensus       380 s~~evl~~  387 (437)
                      |+.|+++.
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-40  Score=334.58  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=187.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEEecc
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .|...+.||+|+||+||.+...+|+.||||++..    ...+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3444688999999999877667899999999864    2345678999999876 8999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC-------------CcE
Q 013750          192 QNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-------------FEA  255 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~-------------~~~  255 (437)
                      . |+|.+++.........   .++..++.++.||+.||+|||++   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999764322211   13345678999999999999999   99999999999999754             589


Q ss_pred             EEeecCCceecccCCCc---ccccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 013750          256 VVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE  324 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~  324 (437)
                      ||+|||+++........   ......||+.|+|||.+.+       ..++.++|||||||++|||+| |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999976543222   1223569999999999975       568999999999999999999 999986432110


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            ....   ......     +.+........+..+.+++.+||+.||++|||+.++++
T Consensus       248 ------~~i~---~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ------SNII---RGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ------HHHH---HTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHh---cCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                  0000   000000     11111224566788999999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-39  Score=320.86  Aligned_cols=204  Identities=21%  Similarity=0.233  Sum_probs=171.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cc-----cceeeeeeee
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HR-----NLLRLIGFCT  179 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~  179 (437)
                      .....++|...+.||+|+||+||+|... +++.||||++...  ......+..|+.++..++ |+     +++++++++.
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3445678999999999999999999975 5889999999742  334567788999988885 44     4999999999


Q ss_pred             cCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec--CCCcEEE
Q 013750          180 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVV  257 (437)
Q Consensus       180 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl  257 (437)
                      ..+..++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999996 599998876432  3389999999999999999999953 22899999999999994  4788999


Q ss_pred             eecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013750          258 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS  320 (437)
Q Consensus       258 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~  320 (437)
                      +|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876432    23456899999999999999999999999999999999999999754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=319.64  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=191.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhc----ccccceee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVA----VHRNLLRL  174 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l----~H~niv~l  174 (437)
                      .+.+...++|...+.||+|+||.||+|... +++.||+|++......     .....+.+|+.++.++    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            345556788999999999999999999864 6889999999643211     1233466799999988    89999999


Q ss_pred             eeeeecCCeeEEEEec-ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CC
Q 013750          175 IGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-ED  252 (437)
Q Consensus       175 ~g~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~  252 (437)
                      ++++...+..++|+|| +.+++|.+++....    .+++..++.++.|++.||+|||++   +++|+||||+||+++ .+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence            9999999999999999 78999999998643    389999999999999999999999   999999999999999 88


Q ss_pred             CcEEEeecCCceecccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 013750          253 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL  331 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~  331 (437)
                      +.+||+|||++.......   .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.....         
T Consensus       177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------  244 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------  244 (312)
T ss_dssp             TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence            999999999998765322   234568999999999987766 4589999999999999999999863110         


Q ss_pred             HHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 013750          332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML  388 (437)
Q Consensus       332 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  388 (437)
                        .  ..          ..  ...+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus       245 --~--~~----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          245 --I--LE----------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             --H--HH----------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             --H--hh----------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence              0  00          00  011222345788999999999999999999998743

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=319.99  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCe-----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  183 (437)
                      .++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888899999999999999975 68999999996532 22335678899999999999999999999977654     


Q ss_pred             -eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          184 -RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       184 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                       .++||||++ ++|..++..      .+++..+..++.||+.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 588777642      288999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......     .............
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~  243 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVP  243 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-----HHHHHHHHHHCBC
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCC
Confidence            9864322    233568999999999877 67899999999999999999999999753321     1111111110000


Q ss_pred             c-----------hhhhc---ccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 R-----------LDAIV---DRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~-----------~~~~~---d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .           .....   .....   .......+..+.+++.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0           00000   00000   11123445689999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.9e-41  Score=325.11  Aligned_cols=248  Identities=22%  Similarity=0.352  Sum_probs=199.7

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhcc--cccceeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIG  176 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~g  176 (437)
                      .+.....++|...+.||+|+||.||+|... +++.||||++......     ...+.+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            444556778999999999999999999964 6889999999653221     12345778999999996  599999999


Q ss_pred             eeecCCeeEEEEecccC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CCCc
Q 013750          177 FCTTPTERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE  254 (437)
Q Consensus       177 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~  254 (437)
                      ++...+..++|+|++.+ ++|.+++....    .+++..+..++.|++.||+|||+.   +++||||||+|||++ +++.
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence            99999999999999976 89999987643    388999999999999999999999   999999999999999 7899


Q ss_pred             EEEeecCCceecccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 013750          255 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH  333 (437)
Q Consensus       255 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~  333 (437)
                      +||+|||+++.....   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....           
T Consensus       189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------  254 (320)
T 3a99_A          189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------  254 (320)
T ss_dssp             EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred             EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence            999999999876432   2234568999999999987765 7889999999999999999999863210           


Q ss_pred             HHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          334 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       334 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         .....       ..    .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       255 ---~~~~~-------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 ---IIRGQ-------VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---HHHCC-------CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---hhccc-------cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000       00    111223578899999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-40  Score=320.69  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=173.4

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHH-HHHhcccccceeeeeeeec----CCe
Q 013750          111 TDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIGFCTT----PTE  183 (437)
Q Consensus       111 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~----~~~  183 (437)
                      .++|.+. +.||+|+||+||+|... +|+.||||++...      ....+|+. .+..++||||+++++++..    ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            5678774 46999999999999986 6899999998642      12233333 4667799999999999865    445


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeec
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF  260 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Df  260 (437)
                      .++||||+++|+|.+++....  ...+++..++.++.|++.||.|||++   +++||||||+|||++.   ++.+||+||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence            799999999999999998643  24589999999999999999999999   9999999999999976   455999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |+++.....   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..........    ....... .
T Consensus       176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~-~  247 (336)
T 3fhr_A          176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIR-L  247 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhh-c
Confidence            999865422   2233468999999999988889999999999999999999999996432211100    0000000 0


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                         .   ............+..+.+++..||+.||++|||+.|+++.
T Consensus       248 ---~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 ---G---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---c---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               0   0000011112334578999999999999999999999973

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.7e-39  Score=314.53  Aligned_cols=258  Identities=18%  Similarity=0.232  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CC-CEEEEEEeccCCCCcchHHHHHHHHHHHhccccc------ceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DG-TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~  182 (437)
                      .++|.+.+.||+|+||+||+|... ++ ..||+|++...  ....+.+.+|++++++++|+|      ++.+.+++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            468888999999999999999975 34 68999999642  344567889999999998877      899999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeee-------------
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-------------  249 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll-------------  249 (437)
                      ..++||||+ ++++.+++....  ...+++..+..++.||+.||+|||++   +|+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 455666665432  23489999999999999999999999   99999999999999             


Q ss_pred             ------cCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCccc
Q 013750          250 ------DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE  323 (437)
Q Consensus       250 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~  323 (437)
                            +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  67889999999999864322    23356899999999999999999999999999999999999999753321


Q ss_pred             ccchhhHHHHHHHHHhccchhhh------------------------------ccc-cccCCCCHHHHHHHHHHHHHhcc
Q 013750          324 EEDDVLLLDHVKKLEREKRLDAI------------------------------VDR-NLNKNYNIQEVETMIQVALLCTQ  372 (437)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~------------------------------~d~-~l~~~~~~~~~~~l~~l~~~Cl~  372 (437)
                      .     .......... ......                              ..+ .........+...+.+|+.+||+
T Consensus       246 ~-----~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          246 E-----HLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             H-----HHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             H-----HHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            1     1111111100 000000                              000 00011123456689999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 013750          373 ASPEDRPAMSEVVR  386 (437)
Q Consensus       373 ~dp~~RPs~~evl~  386 (437)
                      .||++|||+.|+++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=312.24  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=178.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHH-HHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~-~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|...+.||+|+||.||+|.+. +|+.||||++..........++. ++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888899999999999999985 68999999997544333333344 4445678889999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      ||+ ++.+..+....   ...+++..+..++.|++.||.|||+ +   +++|+||||+||+++.++.+||+|||++....
T Consensus       104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 44555544432   2347899999999999999999998 6   89999999999999999999999999997654


Q ss_pred             cCCCccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ...  ......+|+.|+|||.+.     ...++.++||||||+++|||++|+.||......    .   ...........
T Consensus       177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~~~  247 (318)
T 2dyl_A          177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----F---EVLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----H---HHHHHHHHSCC
T ss_pred             CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----H---HHHHHHhccCC
Confidence            322  223346899999999994     556899999999999999999999998642211    1   11111111100


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            +.+.  .....+..+.+++.+||+.||++||++.++++
T Consensus       248 ------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 ------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  0000  01123357889999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=328.01  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=186.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ...+|...+.||+|+||+||.....+|+.||||++....    ...+.+|+++++++ +||||+++++++.+....++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            345678889999999999765555679999999996422    22356899999999 7999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-----CCcEEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla  263 (437)
                      ||+. |+|.+++.....   .........++.||+.||+|||++   +|+||||||+|||++.     ...+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 699999876432   234445678999999999999999   9999999999999943     346889999999


Q ss_pred             eecccCCC--ccccccccccccccccccc---CCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHH
Q 013750          264 KLVDVRKT--NVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       264 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +.......  .......||+.|+|||.+.   ...++.++|||||||++|||++ |..||......         .....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANIL  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHH
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHH
Confidence            87653322  2233457999999999997   4567889999999999999999 88888532111         00011


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ....... .      ..........+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~-~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 LGACSLD-C------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTCCCCT-T------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccCCcc-c------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000000 0      0112234556889999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-39  Score=344.12  Aligned_cols=238  Identities=19%  Similarity=0.297  Sum_probs=192.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe-----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-----  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  183 (437)
                      .++|.+.+.||+|+||.||+|.+.  +|+.||||++.........+.|.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478899999999999999999985  5899999998754444556688999999999999999999999987665     


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++++|.+++..      .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence            6999999999999887643      389999999999999999999999   99999999999999986 8999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      +.....     ....||+.|+|||.+.++. +.++|||||||++|||++|..|+.........                 
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----------------  285 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----------------  285 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred             hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence            876432     3356899999999987654 89999999999999999999887532111000                 


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHh
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLE  389 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~~L~  389 (437)
                              ........+..+.+++.+||+.||++||+ ++++.+.|.
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                    00001122357889999999999999995 566665554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.4e-40  Score=341.35  Aligned_cols=261  Identities=21%  Similarity=0.254  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec------CCe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PTE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~  183 (437)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999974 6899999998765445566789999999999999999999999765      667


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCc---EEEeec
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDF  260 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Df  260 (437)
                      .++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999986442 23488889999999999999999999   9999999999999997654   999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++.......  ......||..|+|||.+.+..++.++||||||+++|||++|..||.......       .+.......
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-------~~~~~i~~~  239 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-------QWHGKVREK  239 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-------HSSTTCC--
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-------hhhhhhhcc
Confidence            9998664322  2344578999999999999999999999999999999999999996432110       000000000


Q ss_pred             c----chhhhccc--------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 013750          341 K----RLDAIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV  384 (437)
Q Consensus       341 ~----~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev  384 (437)
                      .    ........        ..........+..+.+++..||+.||++|||+.++
T Consensus       240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0    00000000        01122345567899999999999999999999763

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.2e-38  Score=299.10  Aligned_cols=230  Identities=11%  Similarity=0.027  Sum_probs=181.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.....  ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367888999999999999999985 489999999975432  22347899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++...      .......+++.|++.||+|||++   +|+||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999998541      24456788999999999999999   99999999999999999999997443      


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                                     |++|       ++.++||||||+++|||+||+.||.............          .....  
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~~~--  220 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDTAG--  220 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCTTS--
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHhcc--
Confidence                           3333       6889999999999999999999997543321100000          00000  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ............+..+.+++.+||+.||++| |+.|+++.|+.
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence            0000000112234578999999999999999 99999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-38  Score=319.35  Aligned_cols=244  Identities=15%  Similarity=0.094  Sum_probs=181.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhccc-ccceee---------e--
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVH-RNLLRL---------I--  175 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H-~niv~l---------~--  175 (437)
                      +.+|...+.||+|+||+||+|.+. +|+.||||++.....  ....+.|.+|+.+++.++| +|...+         .  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345667789999999999999964 699999999873322  2336789999999999977 221111         1  


Q ss_pred             ----------eeeec-----CCeeEEEEecccCchhhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 013750          176 ----------GFCTT-----PTERLLVYPFMQNLSVAYRLREI---KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI  237 (437)
Q Consensus       176 ----------g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i  237 (437)
                                .+...     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                      11111     12346667765 67898888532   22344578899999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccc----------cCCCCCCchhhHHHHHHH
Q 013750          238 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----------STGKSSERTDVFGYGIML  307 (437)
Q Consensus       238 iH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~s~Gv~l  307 (437)
                      +||||||+|||++.++.+||+|||+++.....    .....| +.|+|||.+          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999999865432    334467 999999999          556689999999999999


Q ss_pred             HHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          308 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       308 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      |||++|+.||........                 ...++...  .    ..+..+.+|+..||+.||++||++.++++
T Consensus       308 ~elltg~~Pf~~~~~~~~-----------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-----------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-----------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhhh-----------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999975332111                 11111100  1    12357999999999999999999998864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-37  Score=297.14  Aligned_cols=227  Identities=21%  Similarity=0.272  Sum_probs=178.2

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHH-Hhcccccceeeeeeeec----CCe
Q 013750          111 TDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIGFCTT----PTE  183 (437)
Q Consensus       111 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~  183 (437)
                      .++|... +.||+|+||.||++... +++.||+|++..      ...+.+|+.++ +..+||||+++++++..    ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3556665 77999999999999974 689999999863      24577899887 66699999999999876    667


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeec
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF  260 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Df  260 (437)
                      .++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||+++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            899999999999999998743  23589999999999999999999999   9999999999999998   789999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |++....                       +..++.++||||||+++|||++|+.||.........             .
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~  208 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------P  208 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------C
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------H
Confidence            9997432                       234678999999999999999999999643211100             0


Q ss_pred             cchhhhccccccCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYN----IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+....  ...+    ...+..+.+++.+||+.||++|||+.|+++
T Consensus       209 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 GMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000000  0111    123468999999999999999999999996

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.9e-38  Score=306.71  Aligned_cols=242  Identities=15%  Similarity=0.123  Sum_probs=183.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-------CCcchHHHHHHHHHHHhcc---------cccceee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAV---------HRNLLRL  174 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------~~~~~~~~~~E~~~l~~l~---------H~niv~l  174 (437)
                      .++|...+.||+|+||+||+|+. +|+.||||++....       .....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46688889999999999999998 68999999997532       2233478999999999886         6666666


Q ss_pred             eeee-----------------ec-------------CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 013750          175 IGFC-----------------TT-------------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR  224 (437)
Q Consensus       175 ~g~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  224 (437)
                      .+++                 .+             .+..++||||+++|++.+.+..     ..+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            5543                 32             6789999999999977666643     23789999999999999


Q ss_pred             HHHHHH-hcCCCceEecCCCCCCeeecCCC--------------------cEEEeecCCceecccCCCcccccccccccc
Q 013750          225 GLEYLH-EHCNPKIIHRDVKAANVLLDEDF--------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGH  283 (437)
Q Consensus       225 ~l~yLH-~~~~~~iiH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  283 (437)
                      ||+||| ++   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 89   999999999999999887                    8999999999866421      23689999


Q ss_pred             cccccccCCCCCCchhhHHHHHH-HHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh-hccccccCCCCHHHHH
Q 013750          284 IAPEYLSTGKSSERTDVFGYGIM-LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA-IVDRNLNKNYNIQEVE  361 (437)
Q Consensus       284 ~aPE~~~~~~~~~~sDv~s~Gv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~  361 (437)
                      +|||.+.+.. +.++||||++++ .+++++|..||..           ..|....... .... ..............+.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHh-hhhhhccCcccchhhhhhcCH
Confidence            9999998766 899999998776 7888889888731           0111111000 0000 0011111112345678


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHH
Q 013750          362 TMIQVALLCTQASPEDRPAMSEVV  385 (437)
Q Consensus       362 ~l~~l~~~Cl~~dp~~RPs~~evl  385 (437)
                      .+.+|+.+||+.|     |+.|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999976     999887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.1e-30  Score=267.49  Aligned_cols=185  Identities=14%  Similarity=0.050  Sum_probs=128.0

Q ss_pred             eeecCcEEEEEEE-ECCCCEEEEEEeccCCC---------CcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEEE
Q 013750          120 LGQGGFGKVYRGV-LADGTKVAVKRLTDFES---------PGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       120 lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~---------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      .+.|++|.+..+. .-.|+.+|+|.+.....         ....++|.+|+++|+++ .|+||+++++++.+.+..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3445555444433 12378899999964311         12345799999999999 7999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||++|++|.+++....+    ++.   .+|+.||+.||+|+|++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~~~----l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE----IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC----CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhCCC----CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999986432    444   35899999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCC
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA  316 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p  316 (437)
                      ... .....+||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            322 2344679999999999865 567889999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.8e-28  Score=251.48  Aligned_cols=185  Identities=15%  Similarity=0.193  Sum_probs=146.3

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC-c------chHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-G------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ...+.||+|+||.||+|.. .+..+|+|+....... .      ..+.|.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 5789999987542211 1      134588999999999999999777777778888999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999875            457899999999999999   9999999999999999  99999999999765


Q ss_pred             cCCCcc------cccccccccccccccccC--CCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          268 VRKTNV------TTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       268 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      ......      .....||+.|||||++..  ..|+..+|+||..+-..+-+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211      234679999999999986  56888899999999998888877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1e-24  Score=206.60  Aligned_cols=153  Identities=13%  Similarity=0.035  Sum_probs=122.0

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC-----------------cchHHHHHHHHHHHhcc
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-----------------GGDAAFQREVEMISVAV  167 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~  167 (437)
                      ..+......|...+.||+|+||.||+|.+.+|+.||+|.+......                 .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444455566777999999999999999977999999999642211                 13456889999999999


Q ss_pred             cccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCe
Q 013750          168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV  247 (437)
Q Consensus       168 H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NI  247 (437)
                        | +++.+++.. +..++||||+++++|.. +..          .....++.|++.||.|||+.   +++||||||+||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence              5 666665543 55699999999999987 421          12346999999999999999   999999999999


Q ss_pred             eecCCCcEEEeecCCceecccCCCccccccccccccccccccc
Q 013750          248 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS  290 (437)
Q Consensus       248 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~  290 (437)
                      |++ ++.+||+|||+++.              +..|+|||++.
T Consensus       225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            999 99999999999973              34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=5.2e-20  Score=171.99  Aligned_cols=137  Identities=18%  Similarity=0.163  Sum_probs=105.5

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCCCE--EEEEEeccCCCC-----------------------cchHHHHHHHHHHHhcc
Q 013750          114 FSEKNVLGQGGFGKVYRGVL-ADGTK--VAVKRLTDFESP-----------------------GGDAAFQREVEMISVAV  167 (437)
Q Consensus       114 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vAvK~l~~~~~~-----------------------~~~~~~~~E~~~l~~l~  167 (437)
                      |...+.||+|+||.||+|.. .+|+.  ||||++......                       .....+.+|+..+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999998 67888  999987532111                       01136789999999999


Q ss_pred             cccc--eeeeeeeecCCeeEEEEecccC-c----hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEe
Q 013750          168 HRNL--LRLIGFCTTPTERLLVYPFMQN-L----SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKIIH  239 (437)
Q Consensus       168 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiH  239 (437)
                      |+|+  ..++++    ...++||||+.+ |    +|.+....       .++.....++.|++.||.||| +.   +++|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8864  333332    357899999942 4    55544322       224456789999999999999 88   9999


Q ss_pred             cCCCCCCeeecCCCcEEEeecCCceec
Q 013750          240 RDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       240 ~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      |||||.|||+++  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.6e-17  Score=162.13  Aligned_cols=142  Identities=13%  Similarity=0.092  Sum_probs=101.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCC-------------CcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-------------PGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-------------~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      .-|.+.+.||+|+||.||+|...+|+.||||+++....             .........++++.+...|+|+++++...
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999998999999998753110             11122333444444444455555443221


Q ss_pred             ec------CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          179 TT------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       179 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ..      ....+|||||+++++|..+...          .....++.|++.+|.|||+.   ++|||||||.|||++++
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            11      1123699999999888654321          12356789999999999999   99999999999999887


Q ss_pred             C----------cEEEeecCCceec
Q 013750          253 F----------EAVVGDFGLAKLV  266 (437)
Q Consensus       253 ~----------~~kl~Dfgla~~~  266 (437)
                      +          .+.|+||+-+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=9e-12  Score=115.89  Aligned_cols=148  Identities=13%  Similarity=0.078  Sum_probs=114.1

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeE
Q 013750          107 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       107 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  185 (437)
                      +......|.....++.|+.+.||+.... +..+++|+..... ......+.+|+++++.+. |.++.++++++...+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3344567877788888899999999864 7899999986421 122346889999999884 667778999998888999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--------------------------------  233 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------  233 (437)
                      +||||+++.+|...+..         ......++.+++++|+.||+..                                
T Consensus        87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999999998765311         1123467889999999999810                                


Q ss_pred             ------------------------CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          234 ------------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       234 ------------------------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                                              .+.++|+|+++.||+++++..+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    13699999999999998766678999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.5e-11  Score=113.83  Aligned_cols=129  Identities=14%  Similarity=0.045  Sum_probs=97.4

Q ss_pred             eecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc--eeeeeeeecCCeeEEEEecccCchhhh
Q 013750          121 GQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTPTERLLVYPFMQNLSVAY  198 (437)
Q Consensus       121 G~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lv~e~~~~gsL~~  198 (437)
                      +.|..+.||+....+|..+++|.....    ....+.+|+.+++.+.+.++  .+++++...++..++||||+++.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            456669999998777888999987542    23457899999998876554  45888888777889999999998884 


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 013750          199 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC---------------------------------------------  233 (437)
Q Consensus       199 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------------  233 (437)
                       ...       .+   ...++.++++.|..||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             111       11   2256677778888888642                                             


Q ss_pred             ----------CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          234 ----------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       234 ----------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                                .+.++|+|++|.||+++++..+.|+||+.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                      12399999999999998876677999998864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2.5e-10  Score=111.21  Aligned_cols=144  Identities=14%  Similarity=0.183  Sum_probs=106.4

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEec--cCCCCcchHHHHHHHHHHHhcc--cccceeeeeeeecC---CeeEEEE
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLT--DFESPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTP---TERLLVY  188 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~  188 (437)
                      ..+.++.|.++.||+.... +..+++|+..  ..........+.+|..+++.+.  +.++.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998875 4688888775  3221223456788999999887  45578888888766   3479999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----------------------------------  233 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----------------------------------  233 (437)
                      ||+++..+.+..      ...++...+..++.++++.|+.||+..                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999998774321      112577788889999999999999731                                   


Q ss_pred             --------------------CCceEecCCCCCCeeecCCCc--EEEeecCCceec
Q 013750          234 --------------------NPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKLV  266 (437)
Q Consensus       234 --------------------~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~~  266 (437)
                                          .+.++|+|+++.||+++.++.  +.|.||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                247999999999999997753  689999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=7.4e-10  Score=105.34  Aligned_cols=186  Identities=17%  Similarity=0.172  Sum_probs=119.6

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccc--eeeeeeeecCC---eeEEEEec
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNL--LRLIGFCTTPT---ERLLVYPF  190 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~~---~~~lv~e~  190 (437)
                      .+.++.|....||+..    ..+++|+...   ......+.+|.++++.+. +..+  .++++......   ..++||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4668999999999853    5688887642   234567889999998874 3332  34444443333   34789999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH--------------------------------------  232 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------------------------------------  232 (437)
                      +++.++......      .++...+..++.++++.++.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888653321      145666677777888887777751                                      


Q ss_pred             -----------------CCCceEecCCCCCCeeecC--CCcEEEeecCCceecccCCCcccccc-------------ccc
Q 013750          233 -----------------CNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVDVRKTNVTTQV-------------RGT  280 (437)
Q Consensus       233 -----------------~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~-------------~gt  280 (437)
                                       ..+.++|+|+++.||++++  +..+.|+||+.+..............             ...
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                             1246899999999999998  55679999999876432111000000             000


Q ss_pred             ccccc-cccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013750          281 MGHIA-PEYLSTGKSSERTDVFGYGIMLLELVTGQRAI  317 (437)
Q Consensus       281 ~~y~a-PE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~  317 (437)
                      .++.. |+....  .....+.|+++.++|++.+|..++
T Consensus       252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            01111 221111  122368999999999999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=2.1e-06  Score=79.59  Aligned_cols=135  Identities=18%  Similarity=0.132  Sum_probs=93.6

Q ss_pred             eeeecCcE-EEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCeeEEEEecccCch
Q 013750          119 VLGQGGFG-KVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNLS  195 (437)
Q Consensus       119 ~lG~G~fg-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gs  195 (437)
                      .+..|..| .||+.... ++..+++|+-..    .....+.+|...|+.+. +--+-++++++...+..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            45556555 69988764 467789997642    34557888999988774 3235577888988899999999999988


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 013750          196 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------------------  233 (437)
Q Consensus       196 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------------  233 (437)
                      +.+.....        ......+..+++..|+-||+..                                          
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            76654321        1112234445555555555321                                          


Q ss_pred             -------------CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          234 -------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       234 -------------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                                   .+.++|+|+.+.||+++++..+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         12489999999999999887778999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.45  E-value=2.7e-06  Score=80.71  Aligned_cols=137  Identities=18%  Similarity=0.204  Sum_probs=90.1

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc---cceeeeeeee-cCCeeEEEEeccc
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCT-TPTERLLVYPFMQ  192 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~  192 (437)
                      .+.++.|....||+.    |..+++|+-..   ......+.+|.+++..+.+.   .+-+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888999999987    56788887431   33456788999999998753   2445566664 4455789999999


Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH----------------------------------------  232 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------  232 (437)
                      +.++......      .++...+..++.++++.|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9887652110      012223333333333333333321                                        


Q ss_pred             -----------------CCCceEecCCCCCCeeecC---CCc-EEEeecCCceec
Q 013750          233 -----------------CNPKIIHRDVKAANVLLDE---DFE-AVVGDFGLAKLV  266 (437)
Q Consensus       233 -----------------~~~~iiH~dlk~~NIll~~---~~~-~kl~Dfgla~~~  266 (437)
                                       ..+.++|+|+++.||+++.   ++. ..|+||+.+...
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             2346899999999999987   455 589999988754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=4e-06  Score=81.15  Aligned_cols=80  Identities=10%  Similarity=0.022  Sum_probs=54.6

Q ss_pred             Cee-eecCcEEEEEEEEC-------CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhccc---ccceeeeeeeecC---
Q 013750          118 NVL-GQGGFGKVYRGVLA-------DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVH---RNLLRLIGFCTTP---  181 (437)
Q Consensus       118 ~~l-G~G~fg~Vy~~~~~-------~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---  181 (437)
                      +.| +.|....+|+....       ++..+++|+......  ......+.+|+.+++.+..   ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 78888999998764       267888887643210  0012457789998888753   2456778877655   


Q ss_pred             CeeEEEEecccCchhh
Q 013750          182 TERLLVYPFMQNLSVA  197 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~  197 (437)
                      ...++||||+++.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=1.8e-05  Score=75.64  Aligned_cols=141  Identities=16%  Similarity=0.228  Sum_probs=80.0

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc--cceeeee------eeecCCeeEEEEe
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIG------FCTTPTERLLVYP  189 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lv~e  189 (437)
                      +.|+.|..+.||+....+| .+++|+....     ...+..|..++..+...  .+.+++.      +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3456677899999988655 5899988641     23344555655555321  2233332      1124566789999


Q ss_pred             cccCchhh--------------hhhhhcC-----CCC-----CCCCHHHHH-----------------------------
Q 013750          190 FMQNLSVA--------------YRLREIK-----PGE-----PVLDWVTRK-----------------------------  216 (437)
Q Consensus       190 ~~~~gsL~--------------~~l~~~~-----~~~-----~~l~~~~~~-----------------------------  216 (437)
                      |+++.++.              ..++...     +..     ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1112111     100     112342211                             


Q ss_pred             --HHHHHHHHHHHHHHh----------cCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          217 --RVALGAARGLEYLHE----------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       217 --~i~~~ia~~l~yLH~----------~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                        .+...+..++.+|++          ...+.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              011123446667763          124589999999999999888889999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=2.4e-05  Score=76.90  Aligned_cols=76  Identities=13%  Similarity=0.126  Sum_probs=50.3

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC------CcchHHHHHHHHHHHhccc--ccce-eeeeeeecCCeeEE
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVH--RNLL-RLIGFCTTPTERLL  186 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l  186 (437)
                      .+.||.|.++.||++... ++..+++|.......      ....+.+..|.+++..+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 468899998653211      1234567789998887743  4444 45543  3445689


Q ss_pred             EEecccCc
Q 013750          187 VYPFMQNL  194 (437)
Q Consensus       187 v~e~~~~g  194 (437)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=4.8e-05  Score=75.38  Aligned_cols=80  Identities=13%  Similarity=0.033  Sum_probs=49.9

Q ss_pred             CCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCC---CCCCchhhHHHHHHHHHH
Q 013750          234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLEL  310 (437)
Q Consensus       234 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~Gv~l~el  310 (437)
                      .+.++|+|+++.||+++.+. ++++||+.+............-..-...|.+|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            44899999999999999876 99999999886432111110000012346676655321   112235566788888887


Q ss_pred             HhCC
Q 013750          311 VTGQ  314 (437)
Q Consensus       311 ltg~  314 (437)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.93  E-value=5e-05  Score=71.12  Aligned_cols=78  Identities=24%  Similarity=0.288  Sum_probs=55.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccc---cceeeeeeeecCCeeEEEEe
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e  189 (437)
                      .....+.+|.|..+.||+.+..||+.|.+|+-.... ......|..|...|+.+...   -+.+++++.    ..++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            344457799999999999999999999999865432 33345688999999887432   233444432    3478999


Q ss_pred             cccCch
Q 013750          190 FMQNLS  195 (437)
Q Consensus       190 ~~~~gs  195 (437)
                      |++.+.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=0.00011  Score=69.57  Aligned_cols=140  Identities=16%  Similarity=0.192  Sum_probs=92.7

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc---ccceeeeeeeecCCeeEEEEeccc
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH---RNLLRLIGFCTTPTERLLVYPFMQ  192 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lv~e~~~  192 (437)
                      ..+.|+.|....+|+... ++..+++|+...    .....|..|...|+.+..   ..+.++++++...+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            346789999999999886 477888998653    235678899999888752   457788888887888999999999


Q ss_pred             Cchhhh-----------hhhhcCC-C-----------------CCCCCHHHHH---HHHHH----------------HHH
Q 013750          193 NLSVAY-----------RLREIKP-G-----------------EPVLDWVTRK---RVALG----------------AAR  224 (437)
Q Consensus       193 ~gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~~----------------ia~  224 (437)
                      +..+..           .++.... .                 ...-+|....   ++..+                +..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            875421           1222211 0                 0112455322   11111                111


Q ss_pred             -HHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          225 -GLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       225 -~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                       ....|.. ...|.++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             1223322 2256899999999999999887 8899984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.53  E-value=0.00049  Score=65.16  Aligned_cols=160  Identities=13%  Similarity=0.087  Sum_probs=89.4

Q ss_pred             cCHHHHHHHhcCCCCC-----CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc--eee
Q 013750          102 YSWRELQLATDNFSEK-----NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRL  174 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~-----~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l  174 (437)
                      .+.+++.....+|...     +.|+.|....+|+....+| .+++|.....   ...+.+..|+.++..+...++  .++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC---CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3445555555566542     3466688899999987655 6788987642   123345677777776653332  223


Q ss_pred             eee------eecCCeeEEEEecccCchhhh--------------hhhhcCCC---C-----CCCCHHHHHH---------
Q 013750          175 IGF------CTTPTERLLVYPFMQNLSVAY--------------RLREIKPG---E-----PVLDWVTRKR---------  217 (437)
Q Consensus       175 ~g~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~-----~~l~~~~~~~---------  217 (437)
                      +..      ....+..+++++|+++..+..              .++.....   .     ....|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            221      112345689999998765321              01211100   0     0112332111         


Q ss_pred             ---HHHHHHHHHHHHHhcC----CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          218 ---VALGAARGLEYLHEHC----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       218 ---i~~~ia~~l~yLH~~~----~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                         +...+.+.+++++...    ...++|+|+.+.||+++++..+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               0112445566666431    34799999999999999876668999988763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.34  E-value=0.00086  Score=66.50  Aligned_cols=73  Identities=12%  Similarity=0.167  Sum_probs=50.7

Q ss_pred             CCeeeecCcEEEEEEEECC--------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc-eeeeeeeecCCeeEEE
Q 013750          117 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV  187 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv  187 (437)
                      .+.|+.|....+|+....+        +..+++|+....   ...+.+..|..++..+...++ .++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            3567888889999998753        578999987431   122556689999888865555 456665542    289


Q ss_pred             EecccCchh
Q 013750          188 YPFMQNLSV  196 (437)
Q Consensus       188 ~e~~~~gsL  196 (437)
                      +||+++.++
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.33  E-value=0.0011  Score=63.05  Aligned_cols=143  Identities=17%  Similarity=0.064  Sum_probs=73.0

Q ss_pred             CeeeecCcEE-EEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeeeeecCCeeEEEEecccCc
Q 013750          118 NVLGQGGFGK-VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       118 ~~lG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      +.|+.|.... +|+....+|..+++|......    ...+..|+.++..+....  +.+++.+....  .+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4465554444 667765446778777654321    123445677766664323  34566654333  37899998776


Q ss_pred             hhhhhhhh---------------------cCCC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 013750          195 SVAYRLRE---------------------IKPG-EPVLDWVTRK-------R-------------VALGAARGLEYLHE-  231 (437)
Q Consensus       195 sL~~~l~~---------------------~~~~-~~~l~~~~~~-------~-------------i~~~ia~~l~yLH~-  231 (437)
                      .+..++..                     .... -..++.....       .             ....+...+..+.. 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            55433321                     0000 0111111000       0             00111222333321 


Q ss_pred             --cCCCceEecCCCCCCeeecCC----CcEEEeecCCceec
Q 013750          232 --HCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKLV  266 (437)
Q Consensus       232 --~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~~  266 (437)
                        ...+.++|+|+.+.||+++.+    ..+.|+||+.+...
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              124479999999999999874    67999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.32  E-value=0.0014  Score=61.44  Aligned_cols=140  Identities=11%  Similarity=0.032  Sum_probs=77.1

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEecc-cCc
Q 013750          117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFM-QNL  194 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~-~~g  194 (437)
                      .+.|+.|....+|+.     ..+++|+......  ...+..+|..++..+...++. +++++  ..+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            577999999999998     5688887754211  112235688877777544443 45544  334457899999 665


Q ss_pred             hhhhh------------------hhhcCCC-CCCCCHH-HHHHHHH--------------HHHHHHH----HHHh-cCCC
Q 013750          195 SVAYR------------------LREIKPG-EPVLDWV-TRKRVAL--------------GAARGLE----YLHE-HCNP  235 (437)
Q Consensus       195 sL~~~------------------l~~~~~~-~~~l~~~-~~~~i~~--------------~ia~~l~----yLH~-~~~~  235 (437)
                      ++...                  ++..... ....+.. ....+..              .+.+.+.    .+.. ...+
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            54321                  1111110 0001111 1111100              1111111    2211 2234


Q ss_pred             ceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       236 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      .++|+|+.+.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            6999999999999 56667899999988643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.20  E-value=0.0045  Score=58.60  Aligned_cols=143  Identities=15%  Similarity=0.141  Sum_probs=83.2

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeee-----eecCCeeEEEEec
Q 013750          118 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGF-----CTTPTERLLVYPF  190 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lv~e~  190 (437)
                      ..++ |....||+....+|+.+++|......  .....+..|..++..+....  +.+++..     ....+..+++|+|
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 77889999887778789999986321  23456777888887775333  3334432     1123455789999


Q ss_pred             ccCchhhh----h----------hhhcCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 013750          191 MQNLSVAY----R----------LREIKP-----GEPVLDWVTR----KRV---------------ALGAARGLEYLHEH  232 (437)
Q Consensus       191 ~~~gsL~~----~----------l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~~l~yLH~~  232 (437)
                      +++..+..    .          ++....     .....++...    ..+               ...+...++.+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98765421    0          111110     1112232211    001               11112223333322


Q ss_pred             ----CCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          233 ----CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       233 ----~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                          ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                234689999999999999 4 899999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.05  E-value=0.004  Score=62.13  Aligned_cols=75  Identities=12%  Similarity=0.117  Sum_probs=48.5

Q ss_pred             CCeeeecCcEEEEEEEECC-CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEEecccCc
Q 013750          117 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFMQNL  194 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g  194 (437)
                      .+.|+.|-...+|+....+ +..+++|+..... .. .-+-..|..++..+...++. ++++++.  +  .+|+||+++.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3568888889999998865 4788888774321 11 11225788888888755554 5666663  2  2599999876


Q ss_pred             hhh
Q 013750          195 SVA  197 (437)
Q Consensus       195 sL~  197 (437)
                      +|.
T Consensus       187 ~l~  189 (458)
T 2qg7_A          187 ALS  189 (458)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            553

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.87  E-value=0.0024  Score=61.74  Aligned_cols=73  Identities=10%  Similarity=0.038  Sum_probs=44.0

Q ss_pred             CeeeecCcEEEEEEEECC---------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEE
Q 013750          118 NVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLV  187 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv  187 (437)
                      +.++.|....+|+....+         +..+++|+.....  ....+...|.+++..+...+++ ++++..  .  -.+|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            457778888999998754         2688888765321  1112245788888877644544 555443  2  3689


Q ss_pred             EecccCchh
Q 013750          188 YPFMQNLSV  196 (437)
Q Consensus       188 ~e~~~~gsL  196 (437)
                      |+|+++.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.76  E-value=0.008  Score=58.37  Aligned_cols=142  Identities=15%  Similarity=0.194  Sum_probs=83.0

Q ss_pred             CeeeecCcEEEEEEEEC--------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccc-eeeeeeeecCCeeEEEE
Q 013750          118 NVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLVY  188 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~  188 (437)
                      +.|..|-...+|+....        ++..+.+|+.-..  ......+.+|..+++.+...++ .++++++.+    -+|+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            56777888889998864        2478999986331  2235567789999988764444 356665543    2899


Q ss_pred             ecccCchhhhh-----------------hhhcC-CCCCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 013750          189 PFMQNLSVAYR-----------------LREIK-PGEPVLD--WVTRKRVALGAA-------------------RGLEYL  229 (437)
Q Consensus       189 e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia-------------------~~l~yL  229 (437)
                      ||+++.+|..-                 ++... +......  |.+..++..++.                   ..+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665421                 11111 1111122  334444443321                   123333


Q ss_pred             H----hc-CCCceEecCCCCCCeeecCC----CcEEEeecCCcee
Q 013750          230 H----EH-CNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKL  265 (437)
Q Consensus       230 H----~~-~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~  265 (437)
                      .    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    22 23469999999999999876    7899999988863

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.35  E-value=0.0028  Score=40.48  Aligned_cols=32  Identities=25%  Similarity=0.320  Sum_probs=18.2

Q ss_pred             CCceEEEehHHHHHHHHHHH-HHHHHHhhhccc
Q 013750           45 KPKIGIIVGIVGGLIVLISG-GLLFFLCKGRHK   76 (437)
Q Consensus        45 ~~~~~ii~~i~~~~~~l~~~-~~~~~~~~~r~~   76 (437)
                      ++...|++++++++++++++ +++++++|||+.
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            44456778888877664433 334445555443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.22  E-value=0.036  Score=52.79  Aligned_cols=32  Identities=25%  Similarity=0.338  Sum_probs=28.4

Q ss_pred             CceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          235 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       235 ~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ..++|+|+.+.||++++++.+.+.||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999888753

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.03  E-value=0.0046  Score=39.38  Aligned_cols=33  Identities=18%  Similarity=0.267  Sum_probs=18.4

Q ss_pred             CCceEEEehHHHHHHHHHHH-HHHHHHhhhcccC
Q 013750           45 KPKIGIIVGIVGGLIVLISG-GLLFFLCKGRHKG   77 (437)
Q Consensus        45 ~~~~~ii~~i~~~~~~l~~~-~~~~~~~~~r~~~   77 (437)
                      ++...|+.++++++++++++ ++.++++|||+.+
T Consensus         7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            34455777888777664433 3444555555443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.76  E-value=0.053  Score=47.92  Aligned_cols=103  Identities=16%  Similarity=0.072  Sum_probs=65.5

Q ss_pred             CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCc
Q 013750          193 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN  272 (437)
Q Consensus       193 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  272 (437)
                      .-||.+.|..+   +.+++..+++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ +.+.        
T Consensus        32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence            45788888764   3459999999999999999877622101 1 1233456889999999887764 1110        


Q ss_pred             ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCC
Q 013750          273 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR  315 (437)
Q Consensus       273 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~  315 (437)
                           .....+.|||... ...+.+.=|||+|+++|.-+-=..
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                 0122456888763 345788899999999999886443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.91  E-value=0.016  Score=36.80  Aligned_cols=26  Identities=27%  Similarity=0.501  Sum_probs=11.0

Q ss_pred             EehHHHHHHH-HHHHHHHHHHhhhccc
Q 013750           51 IVGIVGGLIV-LISGGLLFFLCKGRHK   76 (437)
Q Consensus        51 i~~i~~~~~~-l~~~~~~~~~~~~r~~   76 (437)
                      +++.++|+++ ++++++++++.|||+.
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            3334444444 3334444444444443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.74  E-value=0.17  Score=49.64  Aligned_cols=142  Identities=11%  Similarity=0.125  Sum_probs=83.8

Q ss_pred             CCeeeecCcEEEEEEEECC--------CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEE
Q 013750          117 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLV  187 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv  187 (437)
                      .+.+..|-...+|+....+        +..+++|+.....  ...-+..+|..+++.+...+++ ++++.+.    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            3567778889999998753        5789998864321  1122335788888877644443 4454332    3689


Q ss_pred             EecccCchhhhh-----------------hhhcC------C---CCCCCCHHHHHHHHHH-------------------H
Q 013750          188 YPFMQNLSVAYR-----------------LREIK------P---GEPVLDWVTRKRVALG-------------------A  222 (437)
Q Consensus       188 ~e~~~~gsL~~~-----------------l~~~~------~---~~~~l~~~~~~~i~~~-------------------i  222 (437)
                      ++|+++.+|..-                 ++...      +   ...+.-|.+..++..+                   +
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            999998764311                 11100      1   1111123333333222                   1


Q ss_pred             HHHHHHHHhc---------------------CCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          223 ARGLEYLHEH---------------------CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       223 a~~l~yLH~~---------------------~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ...+.+|.+.                     ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233333211                     1236899999999999 8888999999998864

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=92.16  E-value=0.042  Score=34.63  Aligned_cols=18  Identities=22%  Similarity=0.612  Sum_probs=10.7

Q ss_pred             CCceEEEehHHHHHHHHH
Q 013750           45 KPKIGIIVGIVGGLIVLI   62 (437)
Q Consensus        45 ~~~~~ii~~i~~~~~~l~   62 (437)
                      ++...|++++++++++++
T Consensus        10 ~~~~~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           10 SGNLAVIGGVAVGVVLLL   27 (41)
T ss_dssp             CSSTHHHHHHHHHHHHHH
T ss_pred             CceEEEEeehhHHHHHHH
Confidence            344556666666666655

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.84  E-value=1.1  Score=43.51  Aligned_cols=30  Identities=27%  Similarity=0.436  Sum_probs=25.4

Q ss_pred             ceEecCCCCCCeee------cCCCcEEEeecCCcee
Q 013750          236 KIIHRDVKAANVLL------DEDFEAVVGDFGLAKL  265 (437)
Q Consensus       236 ~iiH~dlk~~NIll------~~~~~~kl~Dfgla~~  265 (437)
                      .++|+|+.+.||++      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999998864

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=91.45  E-value=0.086  Score=32.49  Aligned_cols=12  Identities=42%  Similarity=0.778  Sum_probs=6.1

Q ss_pred             EEEehHHHHHHH
Q 013750           49 GIIVGIVGGLIV   60 (437)
Q Consensus        49 ~ii~~i~~~~~~   60 (437)
                      ..++|+++++++
T Consensus        11 GaIAGiVvG~v~   22 (38)
T 2k1k_A           11 GEIVAVIFGLLL   22 (38)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             CceeeeehHHHH
Confidence            344555555543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.10  E-value=0.39  Score=42.21  Aligned_cols=115  Identities=12%  Similarity=0.110  Sum_probs=79.9

Q ss_pred             ccccceeeeeeeecCCeeEEEEecccCc-hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCC
Q 013750          167 VHRNLLRLIGFCTTPTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA  245 (437)
Q Consensus       167 ~H~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~  245 (437)
                      .||++++. .+-.+.+...+.|+.-+++ ++.. +..       ++...+++++.+|+....+++..     +|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            68888876 4556666666767665432 2222 332       68889999999999988666655     78899999


Q ss_pred             CeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013750          246 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID  318 (437)
Q Consensus       246 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~  318 (437)
                      |++++.++.+++.-.|+-..+                  +|.     ..+...=.-.+=+++..+++++..|+
T Consensus       109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999877764322                  222     11222223367788999999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.33  E-value=0.76  Score=40.50  Aligned_cols=114  Identities=14%  Similarity=0.162  Sum_probs=77.0

Q ss_pred             ccccceeeeeeeecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCceEecCCCCC
Q 013750          167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE-YLHEHCNPKIIHRDVKAA  245 (437)
Q Consensus       167 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~iiH~dlk~~  245 (437)
                      .||++  -..+-.+.+...+.|+.-+++.-...++.       ++...+++++.+|+.... +++..     +|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence            57887  33444667777777776544332223332       678899999999988776 55544     78899999


Q ss_pred             CeeecCCCcEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhh-HHHHHHHHHHHhCCCCCC
Q 013750          246 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDV-FGYGIMLLELVTGQRAID  318 (437)
Q Consensus       246 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv-~s~Gv~l~elltg~~p~~  318 (437)
                      |+++|.++.+++.-.|+-..                  ++|.-+     + ..|. -++=+++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987776432                  233221     1 2233 367778888888877663

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.45  E-value=0.066  Score=53.36  Aligned_cols=60  Identities=10%  Similarity=0.020  Sum_probs=17.2

Q ss_pred             CCeeeecCcEEEEEEEECC-CCEEEE------EEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeee
Q 013750          117 KNVLGQGGFGKVYRGVLAD-GTKVAV------KRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT  179 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~-g~~vAv------K~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  179 (437)
                      .+.||   ||.||+|.+.. ..+|||      |...... +......|.+|..++...+|||+++..++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            45666   99999999864 468888      7765422 2333457888999999999999999987763

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=84.36  E-value=0.1  Score=52.22  Aligned_cols=32  Identities=22%  Similarity=0.081  Sum_probs=26.3

Q ss_pred             cchHHHHHHHHHHHhcccccceeeeeeeecCC
Q 013750          151 GGDAAFQREVEMISVAVHRNLLRLIGFCTTPT  182 (437)
Q Consensus       151 ~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  182 (437)
                      ...++|..|++++.+++|+|+|+++|||.+..
T Consensus       321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          321 QGSETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             ----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             ccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            34678999999999999999999999998765

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=82.71  E-value=0.21  Score=29.89  Aligned_cols=25  Identities=40%  Similarity=0.430  Sum_probs=11.4

Q ss_pred             EEehHHHHHHHHHHHHHHHHHhhhc
Q 013750           50 IIVGIVGGLIVLISGGLLFFLCKGR   74 (437)
Q Consensus        50 ii~~i~~~~~~l~~~~~~~~~~~~r   74 (437)
                      |++++++.++++++++.+.++.|||
T Consensus        10 IaagVvglll~vii~l~~~~~iRRr   34 (35)
T 1iij_A           10 IIATVVGVLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred             eHHHHHHHHHHHHHHHHhheEEeec
Confidence            4455555222233444444555554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	437
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-18

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 4e-63
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 25/278 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           +       LG G FG+V+ G     TKVAVK L   +      AF  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +RL    T      ++  +M+N S+   L+   P    L       +A   A G+ ++ E
Sbjct: 71  VRLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 IHRD++AAN+L+ +     + DFGLA+L++  +       +  +   APE ++ 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
           G  + ++DV+ +GI+L E+VT  R           +  ++ ++++  R  R D   +   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNLERGYRMVRPDNCPEE-- 238

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                      + Q+  LC +  PEDRP    +  +LE
Sbjct: 239 -----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-61
 Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 27/283 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 170
              +    +G G FG VY+G       VAVK L     +P    AF+ EV ++    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +L  +G+ T P    +V  + +  S+ + L  I+      + +    +A   A+G++YLH
Sbjct: 66  ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL 289
                 IIHRD+K+ N+ L ED    +GDFGLA +      ++   Q+ G++  +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 290 STGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
                   S ++DV+ +GI+L EL+TGQ           +   ++  V +      L  +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                         + M ++   C +   ++RP   +++  +E
Sbjct: 235 RS---------NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 7e-60
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 25/278 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
              +    +G G FG V+ G   +  KVA+K +   E    +  F  E E++    H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L G C       LV+ FM++  ++  LR       +    T   + L    G+ YL E
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
            C   +IHRD+ A N L+ E+    V DFG+ + V   +   +T  +  +   +PE  S 
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
            + S ++DV+ +G+++ E+ +  +    +R   E    +++ +    R  +         
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH-- 230

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                      + Q+   C +  PEDRPA S ++R L 
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 25/278 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
           ++   +  LGQG FG+V+ G     T+VA+K L          AF +E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L    +      +V  +M   S              L       +A   A G+ Y+  
Sbjct: 75  VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 +HRD++AAN+L+ E+    V DFGLA+L++  +       +  +   APE    
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
           G+ + ++DV+ +GI+L EL T  R      +  E    +LD V++  R        +   
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                      +  +   C +  PE+RP    +   LE
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 63/290 (21%), Positives = 126/290 (43%), Gaps = 30/290 (10%)

Query: 108 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEM 162
           ++     + + V+G G FG+VY+G+L   +      VA+K L    +      F  E  +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           +    H N++RL G  +     +++  +M+N ++   LRE    +     +    +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGT 280
           A G++YL        +HRD+ A N+L++ +    V DFGL++++  D   T  T+  +  
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 281 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 340
           +   APE +S  K +  +DV+ +GI++ E++T      +     E               
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221

Query: 341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 390
             +   ++        +     + Q+ + C Q     RP  +++V +L+ 
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 3e-59
 Identities = 68/305 (22%), Positives = 130/305 (42%), Gaps = 40/305 (13%)

Query: 102 YSWRELQLATDNFSEK---------NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFE 148
           +++ +   A   F+++          V+G G FG+V  G L    K    VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 149 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 208
           +      F  E  ++    H N++ L G  T  T  +++  FM+N S+   LR+      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 209 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 268
               +    +  G A G++YL +      +HRD+ A N+L++ +    V DFGL++ ++ 
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 269 RKTNVTT----QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 324
             ++ T       +  +   APE +   K +  +DV+ YGI++ E+++      +    +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           +        +  +E++ RL   +D              + Q+ L C Q     RP   ++
Sbjct: 241 D-------VINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 385 VRMLE 389
           V  L+
Sbjct: 284 VNTLD 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (490), Expect = 5e-59
 Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 47/311 (15%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 159
            L+   +N      +G+G FG+V++            T VAVK L +  S    A FQRE
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66

Query: 160 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------- 204
             +++   + N+++L+G C       L++ +M    +   LR +                
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 205 -----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 259
                PG P L    +  +A   A G+ YL E    K +HRD+   N L+ E+    + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183

Query: 260 FGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 318
           FGL++ +               +  + PE +   + +  +DV+ YG++L E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 319 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 378
           +    EE    ++ +V+        +                  +  +  LC    P DR
Sbjct: 244 YGMAHEE----VIYYVRDGNILACPENCPLE-------------LYNLMRLCWSKLPADR 286

Query: 379 PAMSEVVRMLE 389
           P+   + R+L+
Sbjct: 287 PSFCSIHRILQ 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-58
 Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 30/291 (10%)

Query: 105 RELQLATDNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREV 160
           ++L L  DN    ++ LG G FG V +GV         VA+K L             RE 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 161 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 220
           +++    +  ++RLIG C      +LV        +   L   +     +       +  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116

Query: 221 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVR 278
             + G++YL E      +HRD+ A NVLL     A + DFGL+K +    +     +  +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
             +   APE ++  K S R+DV+ YG+ + E ++  +       ++     ++  +++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGK 229

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           R +                     +  +   C     EDRP    V + + 
Sbjct: 230 RMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 9e-58
 Identities = 60/306 (19%), Positives = 121/306 (39%), Gaps = 35/306 (11%)

Query: 107 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           ++L  D+F + + LG G  G V++      G  +A K +     P       RE++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
                ++   G   +  E  +    M   S+   L++       +      +V++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKG 116

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           L YL E    KI+HRDVK +N+L++   E  + DFG++  +     ++     GT  +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL---------------- 329
           PE L     S ++D++  G+ L+E+  G+  I     +E + +                 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 330 ---------LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 380
                     +D    +   + LD IV+    K  +             C   +P +R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 381 MSEVVR 386
           + +++ 
Sbjct: 292 LKQLMV 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 52/278 (18%), Positives = 103/278 (37%), Gaps = 25/278 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
            + +    LG G FG V  G       VA+K +   E    +  F  E +++    H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           ++L G CT      ++  +M N  +   L  ++             +       +EYL  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 291
                 +HRD+ A N L+++     V DFGL++ V   +   +   +  +    PE L  
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 292 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
            K S ++D++ +G+++ E+ +  +   + R    +    +    +L R            
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHLAS------- 227

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                    E +  +   C     ++RP    ++  + 
Sbjct: 228 ---------EKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-57
 Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 41/302 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMIS- 164
           +  S    LG G FGKV                VAVK L          A   E++++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------------IKPGEPVL 210
           +  H N++ L+G CT     L++  +     +   LR               ++  E  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVR 269
           D       +   A+G+ +L        IHRD+ A N+LL       + DFGLA+ + +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
              V    R  +  +APE +     +  +DV+ YGI L EL +   +       +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255

Query: 330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                       +   ++               M  +   C  A P  RP   ++V+++E
Sbjct: 256 ------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 390 GE 391
            +
Sbjct: 304 KQ 305

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 25/291 (8%)

Query: 100 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQR 158
              ++ + ++   + + K+ LG G +G+VY GV       VAVK L   E       F +
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLK 62

Query: 159 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 218
           E  ++    H NL++L+G CT      ++  FM   ++   LRE    E  +  V    +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120

Query: 219 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 278
           A   +  +EYL +      IHRD+ A N L+ E+    V DFGL++L+           +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
             +   APE L+  K S ++DV+ +G++L E+ T   +        +             
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
               +  +++++          E + ++   C Q +P DRP+ +E+ +  E
Sbjct: 225 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-56
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 33/285 (11%)

Query: 113 NFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 168
           +F+E  V+G+G FG VY G L D        AVK L      G  + F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 169 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
            N+L L+G C  +    L+V P+M++  +       +   P           L  A+G+ 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNP--TVKDLIGFGLQVAKGM- 143

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 284
                 + K +HRD+ A N +LDE F   V DFGLA+ +   +    +  T  +  +  +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 285 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
           A E L T K + ++DV+ +G++L EL+T           + +   +  ++ +  R  + +
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRRLLQPE 257

Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              D              + +V L C     E RP+ SE+V  + 
Sbjct: 258 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-56
 Identities = 64/307 (20%), Positives = 111/307 (36%), Gaps = 46/307 (14%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMIS- 164
           +N     VLG G FGKV               +VAVK L +        A   E++M++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 165 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------------------- 205
           +  H N++ L+G CT      L++ +     +   LR  +                    
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 206 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 265
              VL +      A   A+G+E+L        +HRD+ A NVL+       + DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 266 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 324
           +      V     R  +  +APE L  G  + ++DV+ YGI+L E+ +      +  +  
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272

Query: 325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           + +                  ++      +      E +  +   C       RP+   +
Sbjct: 273 DANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

Query: 385 VRMLEGE 391
              L  +
Sbjct: 318 TSFLGCQ 324

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-56
 Identities = 63/294 (21%), Positives = 127/294 (43%), Gaps = 38/294 (12%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 167
           ++   ++V+G+G FG+V +  +         A+KR+ ++ S      F  E+E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP------------VLDWVTR 215
           H N++ L+G C       L   +  + ++   LR+ +  E              L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 216 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 275
              A   ARG++YL +    + IHRD+ A N+L+ E++ A + DFGL++  +V      T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 276 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 335
             R  +  +A E L+    +  +DV+ YG++L E+V+       +         L + + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG----TPYCGMTCAELYEKLP 240

Query: 336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +  R ++     D              +  +   C +  P +RP+ ++++  L 
Sbjct: 241 QGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 31/279 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 171
                   +G+G FG V  G    G KVAVK + +        AF  E  +++   H NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62

Query: 172 LRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++L+G        L +V  +M   S+   LR    G  VL      + +L     +EYL 
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
            +     +HRD+ A NVL+ ED  A V DFGL K       +     +  +   APE L 
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALR 173

Query: 291 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 350
             K S ++DV+ +GI+L E+ +  R        ++    ++  V+K  +    D      
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228

Query: 351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                       + +V   C       RP+  ++   LE
Sbjct: 229 ------------VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 29/294 (9%)

Query: 117 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 176
           +  +G+G FG+V+RG    G +VAVK  +  E        + E+    +  H N+L  I 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64

Query: 177 FCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
                  T T+  LV  + ++ S+   L         +      ++AL  A GL +LH  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 119

Query: 233 C-----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHI 284
                  P I HRD+K+ N+L+ ++    + D GLA   D     +        GT  ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 285 APEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVLLLDHVKK 336
           APE L         +S +R D++  G++  E+             +    D++  D   +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 337 LEREKRLDAIVDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             R+   +  +  N+   + + + +  M ++   C  A+   R     + + L 
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 1e-53
 Identities = 53/281 (18%), Positives = 108/281 (38%), Gaps = 25/281 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +++     +G G +G+  +    +DG  +  K L     +         EV ++    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 170 NLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           N++R        T   L  V  + +   +A  + +       LD     RV       L+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 228 YLHEH--CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
             H        ++HRD+K ANV LD      +GDFGLA++++   T+      GT  +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           PE ++    +E++D++  G +L EL                   L   +++ +  +    
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRR---- 233

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                +   Y+    + + ++           RP++ E++ 
Sbjct: 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-53
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 31/280 (11%)

Query: 116 EKNVLGQGGFGKVYRGVLAD---GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 171
           E   LG G FG V +G          VAVK L  +   P        E  ++    +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 172 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 231
           +R+IG C   +  +LV    +   +   L++ +     +       +    + G++YL E
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 125

Query: 232 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 289
                 +HRD+ A NVLL     A + DFGL+K +  D       T  +  +   APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
           +  K S ++DV+ +G+++ E  +  +   +  ++  +   +L+  +++            
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERMGCPAGCP----- 236

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                        M  +  LC     E+RP  + V   L 
Sbjct: 237 -----------REMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-53
 Identities = 68/309 (22%), Positives = 129/309 (41%), Gaps = 33/309 (10%)

Query: 96  FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFES 149
           F     Y   E ++A +  +    LGQG FG VY GV          T+VA+K + +  S
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 150 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-- 207
                 F  E  ++      +++RL+G  +     L++   M    +   LR ++P    
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 208 ----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 263
                        ++A   A G+ YL+ +   K +HRD+ A N ++ EDF   +GDFG+ 
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 264 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 322
           + + +        +    +  ++PE L  G  +  +DV+ +G++L E+ T          
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---- 236

Query: 323 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 382
           +   +  +L  V +     + D   D              + ++  +C Q +P+ RP+  
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFL 283

Query: 383 EVVRMLEGE 391
           E++  ++ E
Sbjct: 284 EIISSIKEE 292

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-52
 Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 26/278 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           +++     LG+G +G+V   V       VAVK +    +       ++E+ +  +  H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +++  G       + L   +     +  R+         +     +R       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL 289
                 I HRD+K  N+LLDE     + DFGLA +     +  +  ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 290 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
              +  +E  DV+  GI+L  ++ G+   D      ++     +    L   K++D+   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
             L+K                    +P  R  + ++ +
Sbjct: 238 ALLHK----------------ILVENPSARITIPDIKK 259

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 32/277 (11%)

Query: 117 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRL 174
              +G+G F  VY+G+  +   +VA   L D   +      F+ E EM+    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 175 IGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
                +  +     +LV   M + ++   L+  K     +     +       +GL++LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129

Query: 231 EHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
               P IIHRD+K  N+ +        +GD GLA L      +    V GT   +APE  
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
              K  E  DV+ +G+ +LE+ T +        E ++   +   V    +    D +   
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
            +             ++   C + + ++R ++ +++ 
Sbjct: 241 EV------------KEIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-52
 Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           ++F     LG+G FG VY          +A+K L     E  G +   +REVE+ S   H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
            N+LRL G+    T   L+  +    +V   L+++       D           A  L Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
            H     ++IHRD+K  N+LL    E  + DFG +       ++  T + GT+ ++ PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEM 175

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
           +      E+ D++  G++  E + G+   + +  +E                        
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------------------TYK 214

Query: 349 RNLNKNYNIQEV--ETMIQVALLCTQASPEDRPAMSEVVR 386
           R     +   +   E    +     + +P  RP + EV+ 
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 1e-51
 Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 35/282 (12%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 167
              FS+   +G G FG VY    + +   VA+K++  +  +S        +EV  +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H N ++  G         LV  +    +        KP    L  V    V  GA +GL 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YLH H    +IHRDVKA N+LL E     +GDFG A ++            GT   +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPE 181

Query: 288 YLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
            +     G+   + DV+  GI  +EL   +       L   + +  L H+ + E      
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236

Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                           E        C Q  P+DRP    +++
Sbjct: 237 GHWS------------EYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-51
 Identities = 61/304 (20%), Positives = 121/304 (39%), Gaps = 32/304 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVA 166
             F +  VLG G FG VY+G+           VA+K L +  SP  +     E  +++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 226
            + ++ RL+G C T T +L+             L  ++  +  +         +  A+G+
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 227 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIA 285
            YL +    +++HRD+ A NVL+       + DFGLAKL+    K       +  +  +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 286 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
            E +     + ++DV+ YG+ + EL+T      +  +   +   +L+  ++L +      
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPPICT- 239

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 405
                            +  + + C     + RP   E++       +A   + +  ++ 
Sbjct: 240 ---------------IDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQG 282

Query: 406 TRRQ 409
             R 
Sbjct: 283 DERM 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 76/286 (26%), Positives = 107/286 (37%), Gaps = 31/286 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISV 165
            +      LG G FG V RG           VAVK L       P     F REV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
             HRNL+RL G   TP  ++ V       S+  RLR+    +      T  R A+  A G
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGH 283
           + YL        IHRD+ A N+LL       +GDFGL + +     +  +    +     
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 343
            APE L T   S  +D + +G+ L E+ T  +         +   +L    K+ ER  R 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRP 237

Query: 344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +                  +  V + C    PEDRP    +   L 
Sbjct: 238 EDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 40/299 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 165
           D       LG+G FG+V           A    VAVK L +  +     A   E++++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 166 AVHR-NLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKP------------GEPVLD 211
             H  N++ L+G CT P   L ++  F +  +++  LR  +              +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 212 WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 271
                  +   A+G+E+L      K IHRD+ A N+LL E     + DFGLA+ +     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 272 NV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 330
            V     R  +  +APE +     + ++DV+ +G++L E+ +   +        + D   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEF 246

Query: 331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
              +K+  R +  D                  M Q  L C    P  RP  SE+V  L 
Sbjct: 247 CRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 9e-48
 Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 42/300 (14%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMI 163
           D       LG+G FG+V                TKVAVK L    +    +    E+EM+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 164 S-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVL 210
             +  H+N++ L+G CT      ++  +    ++   L+  +P             E  L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 211 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 270
                   A   ARG+EYL      K IHRD+ A NVL+ ED    + DFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 271 TNVTTQV-RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 329
               T   R  +  +APE L     + ++DV+ +G++L E+ T   +       EE    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 330 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           L   +K+  R  +     +              +  +   C  A P  RP   ++V  L+
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 53/282 (18%), Positives = 108/282 (38%), Gaps = 28/282 (9%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV 167
           +       +G+G FG V++G+          VA+K   +  S      F +E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H ++++LIG  T      ++        +   L+  K     LD  +    A   +  L 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALA 122

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           YL      + +HRD+ A NVL+  +    +GDFGL++ ++       ++ +  +  +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 347
            ++  + +  +DV+ +G+ + E++             +    ++  ++  ER        
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC- 234

Query: 348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                         T+  +   C    P  RP  +E+   L 
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-47
 Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 27/277 (9%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
              ++    +GQG  G VY  + +A G +VA++++ + +          E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++  +       E  +V  ++   S+   + E        D      V     + LE+L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 132

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H +   ++IHRD+K+ N+LL  D    + DFG    +   ++  +T V GT   +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
           +      + D++  GIM +E++ G+             ++  +   +L+  ++L AI   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
            LN+                C     E R +  E+++
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKELLQ 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-46
 Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 30/282 (10%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
            D +     LG G FGKVY+          A K + D +S      +  E+++++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+          ++  F    +V   + E++     L     + V       L YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 126

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H++   KIIHRD+KA N+L   D +  + DFG++     R         GT   +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVV 182

Query: 290 STGKS-----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
               S       + DV+  GI L+E+   +              +       L +  R  
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

Query: 345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                                    C + + + R   S++++
Sbjct: 243 ----------------SNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (383), Expect = 9e-43
 Identities = 59/299 (19%), Positives = 111/299 (37%), Gaps = 31/299 (10%)

Query: 93  RIAFGQLKRYSWRELQLAT----DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF 147
              F   K+Y  + +++      D++     LG G FG V+R    A G   A K +   
Sbjct: 3   NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MT 61

Query: 148 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 207
                    ++E++ +SV  H  L+ L        E +++Y FM    +  ++ +     
Sbjct: 62  PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 120

Query: 208 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKL 265
             +             +GL ++HE+     +H D+K  N++       E  + DFGL   
Sbjct: 121 --MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175

Query: 266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 325
           +D +++   T   GT    APE          TD++  G++   L++G           E
Sbjct: 176 LDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGE 228

Query: 326 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
           +D   L +VK  +    +D      ++++                  A P  R  + + 
Sbjct: 229 NDDETLRNVKSCDW--NMDDSAFSGISED--------GKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 58/282 (20%), Positives = 106/282 (37%), Gaps = 30/282 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           ++F    +LG+G F  V     LA   + A+K L               RE +++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
              ++L        +      + +N  +   +R+I       D    +         LEY
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 123

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPE 287
           LH      IIHRD+K  N+LL+ED    + DFG AK++    K        GT  +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 347
            L+   + + +D++  G ++ +LV G            ++ L+   + KLE +       
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYD------- 228

Query: 348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
                + +   +   +++            R    E+     
Sbjct: 229 ---FPEKFF-PKARDLVE---KLLVLDATKRLGCEEMEGYGP 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 22/284 (7%)

Query: 104 WRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEM 162
           W++ +   D +  ++VLG G F +V           VA+K +      G + + + E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 163 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 222
           +    H N++ L     +     L+   +    +  R+ E              R+    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQV 116

Query: 223 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 282
              ++YLH+        +        LDED + ++ DFGL+K+ D    +V +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174

Query: 283 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 342
           ++APE L+    S+  D +  G++   L+ G          +E+D  L + +  L+ E  
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQI--LKAEYE 227

Query: 343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
            D+    +++ +                 +  PE R    + ++
Sbjct: 228 FDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 7e-42
 Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 35/308 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           D +     LG G FG V+R V  A G     K + +   P      + E+ +++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPK 87

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           L+ L        E +L+  F+    +  R+         +           A  GL+++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144

Query: 231 EHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           EH    I+H D+K  N++ +  +     + DFGLA  ++     +      T    APE 
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
           +        TD++  G++   L++G           EDD+  L +VK+ + E   DA   
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWEFDEDAFSS 254

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR 408
            +                     Q  P  R  + +         L   W +  H  +T R
Sbjct: 255 VS----------PEAKDFIKNLLQKEPRKRLTVHDA--------LEHPWLKGDHSNLTSR 296

Query: 409 QEYERLQR 416
               R  +
Sbjct: 297 IPSSRYNK 304

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  148 bits (374), Expect = 3e-41
 Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 21/254 (8%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 167
           ++FS   ++G+GGFG+VY    AD G   A+K L     +   G+     E  M+S+   
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 168 --HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
                ++ +     TP +   +   M    + Y L +             +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 285
           LE++H      +++RD+K AN+LLDE     + D GLA     +K        GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173

Query: 286 PEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 344
           PE L  G +     D F  G ML +L+ G       + +++ ++  +     +E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 345 ----AIVDRNLNKN 354
               ++++  L ++
Sbjct: 234 PELRSLLEGLLQRD 247

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 54/286 (18%), Positives = 113/286 (39%), Gaps = 18/286 (6%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 170
           + +     +G+G +G VY+     G   A+K++  + E  G  +   RE+ ++    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +++L     T    +LV+  +         + +   E  L+ VT K   L    G+ Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 290
           +    +++HRD+K  N+L++ + E  + DFGLA+   +     T ++           + 
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 291 TGKSSERTDVFGYGIMLLELVTGQRAIDFS----------RLEEEDDVLLLDHVKKLERE 340
           + K S   D++  G +  E+V G                 R+    +     +V +L + 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                + +    +++     E+ I +     +  P  R    + + 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 40/289 (13%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--------TDFESPGGDAAFQREVEM 162
           +N+  K +LG+G    V R +      + AVK +        +  E      A  +EV++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 163 IS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           +  V+ H N+++L     T T   LV+  M+   +   L E       L     +++   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
               +  LH+     I+HRD+K  N+LLD+D    + DFG +  +D        +V GT 
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173

Query: 282 GHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 335
            ++APE +            +  D++  G+++  L+ G              +L+L  + 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228

Query: 336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
               +       D +          +T+  +        P+ R    E 
Sbjct: 229 SGNYQFGSPEWDDYS----------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 20/286 (6%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
           +NF +   +G+G +G VY+      G  VA+K++  D E+ G  +   RE+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N+++L+    T  +  LV+ F+      +       G   +     K       +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
           H H    ++HRD+K  N+L++ +    + DFGLA+   V     T +V           L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAID-----------FSRLEEEDDVLLLDHVKKLE 338
                S   D++  G +  E+VT +               F  L   D+V+        +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
            +        ++ +K       E    +        P  R +    
Sbjct: 236 YKPSFPKWARQDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 32/289 (11%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 167
           +D +    +LG GG  +V+    L     VAVK L       P     F+RE +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 168 HRNLLRLIGFCTTPTERL----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           H  ++ +       T       +V  ++  +++   +    P    +       V   A 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 281
           + L + H++    IIHRDVK AN+++       V DFG+A+ +     +V  T  V GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 341
            +++PE         R+DV+  G +L E++TG+         +    +   HV++     
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLE 389
             D I     ++  +      +  V L     +PE+R    +E+   L 
Sbjct: 230 --DPIPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (355), Expect = 4e-39
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 14/207 (6%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
            +F     LG G FG+V+      +G   A+K L                E  M+S+  H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
             ++R+ G      +  ++  +++       L  +            K  A      LEY
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           LH      II+RD+K  N+LLD++    + DFG AK V     +VT  + GT  +IAPE 
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQR 315
           +ST   ++  D + +GI++ E++ G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 6e-39
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 167
           ++F    +LG+G FGKV+           A+K L                E  ++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 168 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           H  L  +     T      V  ++    + Y ++         D       A     GL+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           +LH      I++RD+K  N+LLD+D    + DFG+ K   +      T   GT  +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQR 315
            L   K +   D + +G++L E++ GQ 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 9e-39
 Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 21/291 (7%)

Query: 110 ATDNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREVE---MI 163
           A   +     +G+G +GKV++   +   G  VA+KR+       G   +  REV     +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 164 SVAVHRNLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
               H N++RL   CT         +    +++         K  EP +   T K +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
             RGL++LH H   +++HRD+K  N+L+    +  + DFGLA++   +     T V  T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 341
            + APE L     +   D++  G +  E+   +     S   ++   +L       E + 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQ------VALL--CTQASPEDRPAMSEV 384
             D  + R    + + Q +E  +         LL  C   +P  R +    
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 53/283 (18%), Positives = 118/283 (41%), Gaps = 13/283 (4%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 169
              ++  + +G+G +G V       +  +VA+K+++ FE         RE++++    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++ +      PT   +   ++    +   L ++   +  L             RGL+Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGHIAPE 287
           H      ++HRD+K +N+LL+   +  + DFGLA++ D    +    T+   T  + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 288 YLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 346
            +      ++  D++  G +L E+++ +    F      D +  +  +     ++ L+ I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           ++            +  +    L   A  +   A+  + +ML 
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSK---ALDLLDKMLT 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 5e-38
 Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 33/295 (11%)

Query: 106 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 164
           EL++  + +     +G G FG +Y G  +A G +VA+K                E ++  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57

Query: 165 VAVHRNLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           +      +  I +C    +   +V   +            +         T   +A    
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGDFGLAKLVDVRKTNV------T 274
             +EY+H       IHRDVK  N L     +     + DFGLAK     +T+        
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 334
             + GT  + +       + S R D+   G +L+    G       +   +         
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           KK+             L K Y              C     +D+P  S + ++  
Sbjct: 231 KKMS-------TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 6e-38
 Identities = 49/278 (17%), Positives = 103/278 (37%), Gaps = 28/278 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
           + +     LG+G FG V+R V  +       K +            ++E+ ++++A HRN
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           +L L     +  E ++++ F+  L +  R+         L+              L++LH
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH 119

Query: 231 EHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
            H    I H D++  N++      + +   +FG A+ +     +    +     + APE 
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEV 174

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
                 S  TD++  G ++  L++G           E +  +++++   E         D
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYT------FD 223

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
               K  +  E    +           + R   SE ++
Sbjct: 224 EEAFKEIS-IEAMDFVD---RLLVKERKSRMTASEALQ 257

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 22/278 (7%)

Query: 118 NVLGQGGFGKVYRGV-LADGTKVAVKRL----TDFESPGGDAAFQREVEMISVAVHRNLL 172
           + LG+G F  VY+         VA+K++          G +    RE++++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 173 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
            L+      +   LV+ FM+          IK    VL     K   L   +GLEYLH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 233 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 292
               I+HRD+K  N+LLDE+    + DFGLAK         T QV  T  + APE L   
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 293 KS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 351
           +      D++  G +L EL+          L  + D+  L  + +       +   D   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 352 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
             +Y   +    I +  + + A  +    +  +  +  
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDD---LLDLIQGLFL 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 32/293 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            ++++  V+G G FG VY+  L D G  VA+K++             RE++++    H N
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74

Query: 171 LLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 224
           ++RL  F  +  E+       LV  ++            +  +  L  +  K       R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFR 133

Query: 225 GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
            L Y+H      I HRD+K  N+LLD D     + DFG AK + VR     + +      
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYR 189

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL------------L 331
                      +   DV+  G +L EL+ GQ    F      D ++             +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 332 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 384
             +     E +   I      K +  +     I +     + +P  R    E 
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 40/291 (13%), Positives = 88/291 (30%), Gaps = 34/291 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 170
            ++     +G+G FG ++ G  L +  +VA+K              + E     +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCT 61

Query: 171 LL-RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
            +  +  F       +LV   +            +         T    A      ++ +
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSI 117

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNV------TTQVR 278
           HE     +++RD+K  N L+              DFG+ K      T           + 
Sbjct: 118 HEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 279 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 338
           GT  +++       + S R D+   G + +  + G     +  L+   +    + + + +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKK 232

Query: 339 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 389
           +   L     R L   +     E   +        + +  P    +  +  
Sbjct: 233 QSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-35
 Identities = 53/285 (18%), Positives = 93/285 (32%), Gaps = 34/285 (11%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISV 165
           D +     LG G F  V +    + G + A K     R             +REV ++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 166 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 225
             H N++ L       T+ +L+   +        L +    +  L              G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKLVDVRKTNVTTQVRGTM 281
           + YLH      I H D+K  N++L +         + DFGLA  +D    N    + GT 
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP 180

Query: 282 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 341
             +APE ++        D++  G++   L++G         +E      L +V       
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSA----- 230

Query: 342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                V+      Y                   P+ R  + + ++
Sbjct: 231 -----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-35
 Identities = 50/289 (17%), Positives = 110/289 (38%), Gaps = 22/289 (7%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
             + +   +G+G +G V++         VA+KR+  D +  G  ++  RE+ ++    H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 170 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 229
           N++RL     +  +  LV+ F       Y              +  + V     + L+ L
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGL 114

Query: 230 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
               +  ++HRD+K  N+L++ + E  + +FGLA+   +     + +V            
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
                S   D++  G +  EL    R + F   + +D +  +  +     E++  ++   
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 350 NLNKNYNIQEVETMIQVALL------------CTQASPEDRPAMSEVVR 386
              K Y +    T +   +               + +P  R +  E ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 54/277 (19%), Positives = 96/277 (34%), Gaps = 33/277 (11%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 176
           VLG G  GKV +        K A+K L D          +REVE     +   +++R++ 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD 72

Query: 177 FCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 232
                       L+V   +    +  R++    G+          +       ++YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 233 CNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
               I HRDVK  N+L           + DFG AK      +  T     T  ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 290 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 349
              K  +  D++  G+++  L+ G              + +   +K   R  + +     
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE----- 235

Query: 350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
                   +  E +  +     +  P  R  ++E + 
Sbjct: 236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-33
 Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 11/207 (5%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 168
           ++F    +LG+G FGKV      A G   A+K L      +    A    E  ++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
             L  L     T      V  +     + + L   +         T +R     A  +  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           L    +  +++RD+K  N++LD+D    + DFGL K              GT  ++APE 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQR 315
           L         D +G G+++ E++ G+ 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 44/278 (15%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRL-----TDFESPGGDAAFQREVEMIS--VAVHRN 170
           +LG GGFG VY G+ ++D   VA+K +     +D+           EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 171 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 230
           ++RL+ +   P   +L+    + +   +     +     L     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127

Query: 231 EHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 289
                 ++HRD+K  N+L+D +  E  + DFG   L+   K  V T   GT  +  PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181

Query: 290 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 348
              +       V+  GI+L ++V G    +         V     V           ++ 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-----SECQHLIR 236

Query: 349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 386
             L                       P DRP   E+  
Sbjct: 237 WCLALR--------------------PSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 7e-33
 Identities = 66/302 (21%), Positives = 115/302 (38%), Gaps = 38/302 (12%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
             + +   +GQG FG+V++      G KVA+K++  + E  G      RE++++ +  H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 170 NLLRLIGFCTTPTER--------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 221
           N++ LI  C T             LV+ F ++         +            KRV   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125

Query: 222 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 278
              GL Y+H +   KI+HRD+KAANVL+  D    + DFGLA+   + K    N  T   
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 279 GTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 337
            T+ +  PE L   +      D++G G ++ E+ T           E+  + L+  +   
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGS 240

Query: 338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALL---------------CTQASPEDRPAMS 382
              +    + +  L +   + + +       L                    P  R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 383 EV 384
           + 
Sbjct: 301 DA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (306), Expect = 8e-32
 Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 16/221 (7%)

Query: 98  QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDA 154
           + +  S    QL  D F     LG G FG+V        G   A+K L            
Sbjct: 29  KWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86

Query: 155 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 214
               E  ++       L++L       +   +V  ++    +   LR I           
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPH 142

Query: 215 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 274
            +  A       EYLH      +I+RD+K  N+L+D+     V DFG AK    R    T
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRT 195

Query: 275 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 315
             + GT   +APE + +   ++  D +  G+++ E+  G  
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 32/293 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 169
             + +   +G G +G V   V    G KVA+K+L   F+S        RE+ ++    H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 170 NLLRLIGFCTTP------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
           N++ L+   T        T+  LV PFM       +L + +     L     + +     
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL--GKLMKHEK----LGEDRIQFLVYQML 131

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
           +GL Y+H        HRD+K  N+ ++ED E  + DFGLA+  D   + +T  V      
Sbjct: 132 KGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYR 185

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVLLLDHVKKLEREKR 342
                L+  + ++  D++  G ++ E++TG+        L++  +++ +      E  +R
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 343 LDAIVDRNLNKNYNIQEVETMIQV---------ALL--CTQASPEDRPAMSEV 384
           L +   +N  K     E +    +          LL        E R    E 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-29
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 17/214 (7%)

Query: 112 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRL---TDFESPGGDAAFQREVEMIS 164
           +NF    VLG G +GKV+          G   A+K L   T  +        + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 165 VAVHR-NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 223
                  L+ L     T T+  L+  ++    +   L + +         T   V +   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136

Query: 224 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 283
             +  L       II+RD+K  N+LLD +   V+ DFGL+K     +T       GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 284 IAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 315
           +AP+ +  G S   +  D +  G+++ EL+TG  
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (278), Expect = 4e-28
 Identities = 55/289 (19%), Positives = 106/289 (36%), Gaps = 30/289 (10%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 169
           D++     LG+G + +V+  + + +  KV VK L     P      +RE++ + ++    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90

Query: 170 NLLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           N++ L      P  R   LV+  + N       +        L     +       + L+
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALD 143

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 286
           Y H      I+HRDVK  NV++D +   + + D+GLA+     +         +     P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198

Query: 287 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 345
           E  +         D++  G ML  ++  +    F    +  D L+    K L  E   D 
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRI-AKVLGTEDLYDY 255

Query: 346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSE-----VVRMLE 389
           I   N+  +    ++               E++  +S      + ++L 
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 8/206 (3%)

Query: 111 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 168
            + +   + +G G +G V        G +VAVK+L   F+S        RE+ ++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
            N++ L+   T                +             L     + +     RGL+Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 288
           +H        HRD+K +N+ ++ED E  + DFGLA+  D      T  V           
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 190

Query: 289 LSTGKSSERTDVFGYGIMLLELVTGQ 314
           L+    ++  D++  G ++ EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 8e-27
 Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 12/207 (5%)

Query: 112 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 169
             +     +G G  G V           VA+K+L+  F++        RE+ ++    H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 170 NLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 227
           N++ L+   T     E       +  L  A   + I+             +      G++
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIK 133

Query: 228 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 287
           +LH       IHRD+K +N+++  D    + DFGLA+      + + T    T  + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188

Query: 288 YLSTGKSSERTDVFGYGIMLLELVTGQ 314
            +      E  D++  G ++ E+V  +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 9e-25
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 21/236 (8%)

Query: 119 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-----------VA 166
            LG G F  V+    + + T VA+K +          A + E++++              
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 167 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARG 225
              ++L+L+          +    +  +     L  IK  E      +  K+++     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 226 LEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMGH 283
           L+Y+H  C   IIH D+K  NVL++  D    +    +A L +    +        T  +
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 284 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 339
            +PE L         D++    ++ EL+TG     F   E        DH+ ++  
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.2 bits (197), Expect = 3e-18
 Identities = 22/159 (13%), Positives = 42/159 (26%), Gaps = 20/159 (12%)

Query: 118 NVLGQGGFGKVYRGVLADGTKVAVK---------RLTDFESPGGDAAFQREVEMISVAVH 168
            ++G+G    V+        +  VK         +    +   GD  F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 169 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 228
           R L +L G             +    +              +       V       +  
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 229 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 267
            +      I+H D+   NVL+  +    + DF  +  V 
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	437
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.16
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.76
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.66

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=411.69  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|+..+.||+|+||+||+|.+.+++.||||++...  ....++|.+|++++++++|||||+++|+|..++..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3567888999999999999999988999999999753  34567899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|.+++...   ...+++..+..++.|||.||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999998753   34589999999999999999999999   99999999999999999999999999998765444


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                      ........||+.|+|||.+.+..++.++|||||||++|||+|+..|+....    ........+.   ..          
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~~~i~---~~----------  218 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDIS---TG----------  218 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHHHHHH---HT----------
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHHHHHH---hc----------
Confidence            444444678999999999999999999999999999999999654443211    1111111111   11          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....+..++..+.+++..||+.||++||||+||++.|+.
T Consensus       219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            1111222334688999999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=414.44  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=210.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      +...++|++.+.||+|+||+||+|.+++++.||||++...  ....+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            3445678888999999999999999988899999999753  3446789999999999999999999998864 567999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++....  ...++|..+++++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence            99999999998875432  22389999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ...........||+.|+|||.+.++.++.++|||||||++|||+||..|+.....    ..   .........       
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~---~~~~~i~~~-------  226 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NP---EVIQNLERG-------  226 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HH---HHHHHHHTT-------
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HH---HHHHHHHhc-------
Confidence            5444444556789999999999999999999999999999999997666532211    11   111111111       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .....+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       227 ---~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         227 ---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence               1112223345678999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-55  Score=416.11  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|...+.||+|+||+||+|.++. +   ..||||++.........++|.+|++++++++|||||+++|+|..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345556899999999999999753 2   368999987655556667899999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++...   ...++|..++.++.|||+||+|||++   +++||||||+|||++.++++||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999988753   33489999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCcc----cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          268 VRKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       268 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ......    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......     .+   ......   
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~---~~~i~~---  248 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DV---INAIEQ---  248 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH---HHHHHT---
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HH---HHHHHc---
Confidence            432221    122457899999999999999999999999999999998 89998643211     11   111111   


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ......+.+++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       249 -------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         249 -------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                   11122334456789999999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-55  Score=410.33  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=204.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ...++|...+.||+|+||+||+|+++  ..||||+++... .....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            34578999999999999999999874  369999996433 34556789999999999999999999998865 568999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++...   ...+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999753   23489999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCC-cccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          268 VRKT-NVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       268 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .... .......||+.|||||.+.+   ..++.++|||||||++|||+||+.||.......    .....+..   ... 
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~---~~~-  227 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGR---GYL-  227 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHH---TSC-
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhc---CCC-
Confidence            4322 23345679999999999864   358999999999999999999999996432111    11111111   110 


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .+. ....+.+++..+.+|+.+||+.||++||||.|+++.|+.
T Consensus       228 ----~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         228 ----SPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             ----CCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                010 112233445689999999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=416.86  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=217.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCe
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE  183 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  183 (437)
                      ++++...++|+..+.||+|+||+||+|.+. +|+.||||++...  ....++|.+|++++++++|||||+++|+|.+++.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            444556678888999999999999999986 5889999998753  3456789999999999999999999999999999


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .++||||+++|+|..++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999987642  34589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      +..............|++.|+|||.+.+..++.++|||||||++|||++|..|+......       ....         
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~---------  226 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVY---------  226 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHH---------
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHH---------
Confidence            876654444444556899999999999999999999999999999999987776422111       0111         


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                       +.+........+...+..+.+|+..||+.||++|||+.||++.|+..
T Consensus       227 -~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         227 -ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             11111222233344556899999999999999999999999999863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=400.87  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=213.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      .++|+..+.||+|+||+||+|++++++.||||+++..  ....++|++|++++++++||||++++|+|.+++..++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            4688999999999999999999988899999999753  33467899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|..++....   ..+++..+.+++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          81 MANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             cCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999999876532   3478999999999999999999999   99999999999999999999999999998765544


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+.....     .+.   ......         
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~---~~i~~~---------  217 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETA---EHIAQG---------  217 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH---HHHHTT---------
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHH---HHHHhC---------
Confidence            444445678999999999999999999999999999999998 79898643221     111   111111         


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                       .....+...+..+.+|+.+||+.||++|||++|+++.|.+
T Consensus       218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             1112223344689999999999999999999999998864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=403.20  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357888999999999999999985 6899999999754444455679999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999998643    3489999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CC-cccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          270 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       270 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .. ...+..+||+.|||||.+.+..+ +.++|||||||++|||+||+.||........   ..    ........     
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~----~~~~~~~~-----  224 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EY----SDWKEKKT-----  224 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HH----HHHHTTCT-----
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HH----HHHhcCCC-----
Confidence            32 22345679999999999988776 6789999999999999999999975332110   01    01110000     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ........+..+.+|+.+||+.||++|||++|+++
T Consensus       225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00111122357889999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=405.49  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCC-----CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      .+.|+..++||+|+||+||+|.++++     ..||||++..........+|.+|++++++++|||||+++|+|.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35677889999999999999997542     3799999976555555678999999999999999999999999999999


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+.++++.+++...   ...++|..+.+++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999887653   33489999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCc--ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          266 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       266 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      .......  ......||+.|+|||.+.++.++.++|||||||++|||++|..|+......    ...   ....      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~---~~~i------  226 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEV---MKAI------  226 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH---HHHH------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHH---HHHH------
Confidence            6543222  223356899999999999999999999999999999999977665432111    111   1111      


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          ....+...+.+++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       227 ----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         227 ----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             ----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence                1122223344456789999999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=404.29  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=207.2

Q ss_pred             cCCCCCCe-eeecCcEEEEEEEEC---CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~-lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|...+. ||+|+||+||+|.++   ++..||||++.........++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            44555554 999999999999864   3557999999865555567789999999999999999999999975 468999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|.+++...   ...+++..+.+++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999987643   23489999999999999999999999   99999999999999999999999999999775


Q ss_pred             cCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          268 VRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       268 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ......  .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......     .....   ....    
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~~---i~~~----  228 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAF---IEQG----  228 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHH---HHTT----
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHH---HHcC----
Confidence            433322  223468899999999999999999999999999999998 89999643211     11111   1111    


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            .+...+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus       229 ------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         229 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  1122334455689999999999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=398.10  Aligned_cols=247  Identities=25%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             CeeeecCcEEEEEEEECC---CCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecccC
Q 013750          118 NVLGQGGFGKVYRGVLAD---GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN  193 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  193 (437)
                      +.||+|+||+||+|.+++   ++.||||++.... +....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   4689999996432 33445789999999999999999999999965 457899999999


Q ss_pred             chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCCcc
Q 013750          194 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV  273 (437)
Q Consensus       194 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  273 (437)
                      |+|.+++....    .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999987643    389999999999999999999999   99999999999999999999999999998765433322


Q ss_pred             --cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          274 --TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       274 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                        .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......     .+.   ......          
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~~~---~~i~~~----------  226 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVT---AMLEKG----------  226 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHH---HHHHTT----------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----HHH---HHHHcC----------
Confidence              233568999999999999999999999999999999998 89998643211     111   111111          


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .+...+..++..+.+|+.+||+.||++|||+++|+++|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1122233455689999999999999999999999998864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=408.89  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=209.4

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC-C-----CEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecC
Q 013750          109 LATDNFSEKNVLGQGGFGKVYRGVLAD-G-----TKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP  181 (437)
Q Consensus       109 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  181 (437)
                      ...++|++.+.||+|+||+||+|++.+ +     ..||+|++...........|.+|+.++.++ +|||||+++|+|.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            445788889999999999999999743 2     369999997655556677899999999998 899999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKP-------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV  242 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl  242 (437)
                      +..++||||+++|+|.+++.....                   ....+++..++.++.||++||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999975431                   123589999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 013750          243 KAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFS  320 (437)
Q Consensus       243 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~  320 (437)
                      ||+|||++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543332 2234568999999999999999999999999999999998 89998643


Q ss_pred             cccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 013750          321 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE  389 (437)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  389 (437)
                      ....    .+..             ++........+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus       271 ~~~~----~~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDA----NFYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSH----HHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHH----HHHH-------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2211    1111             11111222333445568999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=402.06  Aligned_cols=256  Identities=20%  Similarity=0.295  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec--CCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  187 (437)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++.... .....+.|.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67888999999999999999975 68999999997543 33445678999999999999999999999864  4567999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998765434456899999999999999999999972  12499999999999999999999999999987


Q ss_pred             cccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          266 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       266 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+..     .+...+.   .. ..  
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----~~~~~i~---~~-~~--  231 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIR---EG-KF--  231 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH---HT-CC--
T ss_pred             cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----HHHHHHH---cC-CC--
Confidence            65322 2234567999999999999999999999999999999999999999643211     1111111   11 11  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   1122234457899999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=392.31  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999996 469999999987533 34467899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|.+++...     .++...+..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++......
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999887652     389999999999999999999999   99999999999999999999999999999765332


Q ss_pred             CcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcccc
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN  350 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  350 (437)
                       .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......     ..   .........        
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~---~~~~~~~~~--------  233 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RA---LYLIATNGT--------  233 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HH---HHHHHHHCS--------
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HH---HHHHHhCCC--------
Confidence             2334457999999999999999999999999999999999999999643211     11   111111110        


Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          351 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       351 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001112233467899999999999999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=401.59  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ..++|++.+.||+|+||+||+|++++++.||||++...  ....+.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            35678889999999999999999988889999999743  3446789999999999999999999999854 56899999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|..++....  ...++|..++.++.||+.||+|||++   +++||||||+|||++.++++||+|||+++.....
T Consensus        92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999998886532  23489999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhccc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR  349 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  349 (437)
                      .........||+.|+|||++..+.++.++||||||+++|||+||..|+......    ......+   ..          
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i---~~----------  229 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQV---ER----------  229 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH---HT----------
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHH---Hh----------
Confidence            444444567899999999999999999999999999999999977765432211    1111111   11          


Q ss_pred             cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          350 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       350 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ......+...++.+.+++.+||+.||++||||.+|+++|+.
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            11122333445689999999999999999999999999987

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=390.99  Aligned_cols=246  Identities=25%  Similarity=0.403  Sum_probs=206.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++....  .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56888999999999999999985 68999999986321  2344677899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++.....    +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999986433    89999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..        ..........       
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~-------  220 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE-------  220 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-------
T ss_pred             C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-------
Confidence            2   233457999999999999999999999999999999999999999743221        1111111110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          ..++...+..+.+|+.+||+.||++|||++|+++
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                1112233457899999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=407.00  Aligned_cols=267  Identities=21%  Similarity=0.280  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ..++|++.+.||+|+||+||+|+.. +|+.||+|++.........+.+.+|+.++++++|||||+++++|.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999975 689999999976545556678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+++  +|+||||||+|||+++++.+||+|||+|+....
T Consensus        84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999997643    3899999999999999999999731  799999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH------------
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK------------  336 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------  336 (437)
                      .   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+....... .......            
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM-FGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH-C------------------
T ss_pred             C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhcCCcccCCcccccc
Confidence            2   22345799999999999999999999999999999999999999975432211000 0000000            


Q ss_pred             ----------HHhccchhhhcccccc---CCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          337 ----------LEREKRLDAIVDRNLN---KNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       337 ----------~~~~~~~~~~~d~~l~---~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                                ........+..+....   ... ....+.++.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                      0000000000000000   000 0112357889999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=394.55  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++... .....+.|.+|++++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46788899999999999999975 6899999999753 355667899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +++|+|..++.+..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            99999999876532   3489999999999999999999999   99999999999999999999999999998654221


Q ss_pred             Cccccccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                       .......||+.|+|||++.     ...|+.++|||||||++|||+||+.||.......     ....+..   .. .. 
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~~i~~---~~-~~-  233 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIAK---SE-PP-  233 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHHH---SC-CC-
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHc---CC-CC-
Confidence             1233467999999999984     4568999999999999999999999996433211     1111111   10 00 


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                            ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       234 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 ------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  01112234468899999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=393.98  Aligned_cols=255  Identities=20%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      .++|+..+.||+|+||.||+|.+..    +..||||++.........+.|.+|++++++++|||||+++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4678888999999999999999743    35799999876555556678999999999999999999999996 467899


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ||||+++|+|..++...   ...+++..++.++.||++||.|||++   +++||||||+||++++++.+||+|||+++..
T Consensus        85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            99999999999987653   33489999999999999999999999   9999999999999999999999999999877


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                      ........+...||+.|+|||.+.+..++.++|||||||++|||+| |..||.......     +...+.   ...    
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~~~~i~---~~~----  226 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE---NGE----  226 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH---TTC----
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----HHHHHH---cCC----
Confidence            6544444555678999999999999999999999999999999998 888886443211     111111   111    


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                            ....+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus       227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  112233455689999999999999999999999998864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-52  Score=399.17  Aligned_cols=266  Identities=24%  Similarity=0.379  Sum_probs=214.5

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      .+++...++|+..+.||+|+||+||+|+++      +++.||||++.........++|.+|++++++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            455556788999999999999999999964      35789999997655455567899999999999999999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKII  238 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii  238 (437)
                      ...+..+++|||+++|+|.+++.....                    ....+++..++.++.|++.||+|||++   +++
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999865321                    123489999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCC-C
Q 013750          239 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR-A  316 (437)
Q Consensus       239 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~-p  316 (437)
                      ||||||+|||+|.++.+||+|||+++....... ...+...+|+.|+|||.+.+..++.++|||||||++|||++|.. |
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999986543322 22334568899999999999999999999999999999999964 5


Q ss_pred             CCCCcccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          317 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                      |.....     ....   .......          ....+...+.++.+|+.+||+.||++||||.||+++|+.+
T Consensus       243 ~~~~~~-----~e~~---~~v~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYGMAH-----EEVI---YYVRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTSCH-----HHHH---HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCH-----HHHH---HHHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            543211     1111   1111111          1122334456889999999999999999999999999863

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=386.43  Aligned_cols=247  Identities=23%  Similarity=0.401  Sum_probs=194.6

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec----CCeeEEEE
Q 013750          115 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY  188 (437)
Q Consensus       115 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~  188 (437)
                      ...+.||+|+||+||+|.+. ++..||+|++.... .....+.|.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34567999999999999975 58899999987533 33445679999999999999999999999854    34578999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec-CCCcEEEeecCCceecc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~  267 (437)
                      ||+++|+|.+++....    .+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999997643    389999999999999999999998 11299999999999996 57899999999998543


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      .   .......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......    ..+   ......... ..  
T Consensus       167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~---~~~i~~~~~-~~--  232 (270)
T d1t4ha_         167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQI---YRRVTSGVK-PA--  232 (270)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHH---HHHHTTTCC-CG--
T ss_pred             C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHH---HHHHHcCCC-Cc--
Confidence            2   22345679999999998865 6999999999999999999999999632211    111   111111111 00  


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        .+    +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 --~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 --SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              11    1112346889999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=395.83  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL  186 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  186 (437)
                      ++|+..+.||+|+||+||+|.+. +|+    +||+|++....+....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46888999999999999999974 343    69999987655566778999999999999999999999999875 5678


Q ss_pred             EEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceec
Q 013750          187 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV  266 (437)
Q Consensus       187 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~  266 (437)
                      ++||+.+|+|.+++...   ...+++..+++++.|||.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            88999999999887763   34589999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchh
Q 013750          267 DVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD  344 (437)
Q Consensus       267 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (437)
                      ....... .....||+.|+|||.+.++.++.++|||||||++|||+| |..||+......     +...+..        
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----~~~~i~~--------  228 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK--------  228 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----HHHHHHH--------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHc--------
Confidence            5433322 233568999999999999999999999999999999999 788886432211     1111111        


Q ss_pred             hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          345 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       345 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                           ..+...+..++..+.+|+.+||+.||++|||+.|+++.|+.
T Consensus       229 -----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         229 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                 11122233455689999999999999999999999998865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-52  Score=396.46  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=191.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .+.|++.+.||+|+||+||+|... +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466888999999999999999975 6899999999754434445678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec---CCCcEEEeecCCceec
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLV  266 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~  266 (437)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++   +++.+||+|||+++..
T Consensus        88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999753    3489999999999999999999999   999999999999994   5789999999999865


Q ss_pred             ccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhh
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI  346 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (437)
                      ...  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ...   .......     
T Consensus       161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~---~~i~~~~-----  225 (307)
T d1a06a_         161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLF---EQILKAE-----  225 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH---HHHHTTC-----
T ss_pred             cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHH---HHHhccC-----
Confidence            432  2233467999999999999999999999999999999999999999643211     111   1111110     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                        .........+.+..+.+|+.+||+.||++|||+.|+++.
T Consensus       226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              011111223345678999999999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-51  Score=392.86  Aligned_cols=246  Identities=26%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCC--CcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++.....  ....+.|.+|++++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34888899999999999999974 688999999875332  233457899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999998766543    2389999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccccccccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhh
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA  345 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (437)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||......        .......... .  
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~-~--  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE-S--  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC-C--
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC-C--
Confidence                 233569999999999864   46899999999999999999999998643211        1111111111 0  


Q ss_pred             hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          346 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       346 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         +.+   .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       232 ---~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 ---PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               011   11223458899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=390.52  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56889999999999999999975 68999999986321  2344577999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999987654    389999999999999999999999   999999999999999999999999999997754


Q ss_pred             CCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          269 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       269 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     ..+...+   ...       
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i---~~~-------  225 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKI---IKL-------  225 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH---HTT-------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHH---HcC-------
Confidence            332 223346799999999999999999999999999999999999999974321     1111111   110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                        .  ..++...+..+.+|+.+||+.||++|||++|+++
T Consensus       226 --~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         226 --E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              0  0122233457899999999999999999999754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=384.81  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e  189 (437)
                      .++|+..+.||+|+||.||+|.++ |+.||||++++   ....+.|.+|++++++++||||++++|+|.+ .+..++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            456777899999999999999995 78999999964   3445789999999999999999999999965 456899999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+++|+|.+++....  ...++|..+++++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999996532  23479999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                          .....+|..|+|||.+.++.++.++||||||+++|||+| |+.|+......     .....+.             
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~i~-------------  214 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE-------------  214 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHT-------------
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH-------------
Confidence                223457899999999999999999999999999999998 67776543221     1111111             


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ...+...+...+..+.+|+.+||+.||++||||.+++++|+.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            112223334445688999999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=379.36  Aligned_cols=252  Identities=19%  Similarity=0.252  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-----CCcchHHHHHHHHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .+.|++.+.||+|+||+||+|+.. +|+.||||++....     .....+.|.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467889999999999999999984 68999999986422     123467899999999999999999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC----cEEEeec
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF  260 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Df  260 (437)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999997653    389999999999999999999999   999999999999998776    4999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..     ..   .......
T Consensus       162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~---~~~i~~~  231 (293)
T d1jksa_         162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ET---LANVSAV  231 (293)
T ss_dssp             TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHTT
T ss_pred             hhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HH---HHHHHhc
Confidence            999876432  2233456899999999999999999999999999999999999999743211     11   1111111


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..       ..........+..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NY-------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC-------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00       0000001123457889999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=389.45  Aligned_cols=268  Identities=25%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeee
Q 013750          103 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLI  175 (437)
Q Consensus       103 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~  175 (437)
                      ...+++...++|++.+.||+|+||.||+|.+.      +++.||||++.........+.+.+|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33555556688999999999999999999963      24689999998655555667888999988877 689999999


Q ss_pred             eeeecC-CeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCC
Q 013750          176 GFCTTP-TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV  242 (437)
Q Consensus       176 g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dl  242 (437)
                      +++... ...++||||+++|+|.+++.....            ....+++..++.++.||++||+|||++   +|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence            998665 468999999999999999975421            123589999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC-CCCCCC
Q 013750          243 KAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFS  320 (437)
Q Consensus       243 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~-~p~~~~  320 (437)
                      ||+|||+++++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999866543332 334467999999999999999999999999999999999975 566533


Q ss_pred             cccccchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          321 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      ....    .+...+.   ..          .....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       241 ~~~~----~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         241 KIDE----EFCRRLK---EG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CCSH----HHHHHHH---HT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH----HHHHHHh---cC----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2211    1111111   11          1112223344578999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-49  Score=387.11  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999975 68999999997533 3456788999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC--CCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~  267 (437)
                      |+++|+|.+++...   ...+++..+..++.||+.||+|||++   +++||||||+|||++.  ++.+||+|||+++...
T Consensus       104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999988642   23489999999999999999999999   9999999999999964  6789999999998765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .......||+.|||||++.+..++.++|||||||++|||++|+.||...+..     .....+...  ....    
T Consensus       178 ~~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~--~~~~----  244 (350)
T d1koaa2         178 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKSC--DWNM----  244 (350)
T ss_dssp             TT--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHT--CCCS----
T ss_pred             cc--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC--CCCC----
Confidence            33  2234457999999999999999999999999999999999999999643211     111111111  0000    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                          ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       245 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 ----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                011112234578999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=391.68  Aligned_cols=266  Identities=23%  Similarity=0.366  Sum_probs=215.7

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeee
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      ++++...++|...+.||+|+||+||+|.+.      +++.||||+++..........|.+|++++++++|||||+++|+|
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            344555678888999999999999999863      25789999998655555566799999999999999999999999


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCC
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED  252 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~  252 (437)
                      ...+..++||||+++|+|.+++....      .....+++..+.+++.|+|+||.|||++   +|+||||||+|||++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence            99999999999999999999986432      2234579999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCceecccCCCcc-cccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCcccccchhhH
Q 013750          253 FEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLL  330 (437)
Q Consensus       253 ~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~  330 (437)
                      +++||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||. .|+.....        
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------  241 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------  241 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------
Confidence            999999999998664433222 33346899999999999999999999999999999999985 55543211        


Q ss_pred             HHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 013750          331 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE  391 (437)
Q Consensus       331 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  391 (437)
                      ...........          ....+...+..+.+++.+||+.||++||||.+|+++|+..
T Consensus       242 ~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         242 EQVLRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHHHhCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11111111111          1112333456899999999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=386.37  Aligned_cols=251  Identities=28%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             CCeeeecCcEEEEEEEECCC----CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeec-CCeeEEEEecc
Q 013750          117 KNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFM  191 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~~g----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~  191 (437)
                      .++||+|+||+||+|++.++    ..||||++.........++|.+|++++++++||||++++|+|.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999997532    36999999765556667889999999999999999999999875 46889999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      ++|+|.+++...   ...+++..+++++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999988753   33478889999999999999999999   999999999999999999999999999987654322


Q ss_pred             c---ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          272 N---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       272 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .   ......||+.|+|||.+..+.++.++||||||+++|||+||+.|+.......    .....   .....       
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~---i~~g~-------  251 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVY---LLQGR-------  251 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH---HHTTC-------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHH---HHcCC-------
Confidence            2   2223568999999999999999999999999999999999888875322111    11111   11111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         ....+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  290 (311)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               111223344688999999999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=387.67  Aligned_cols=263  Identities=25%  Similarity=0.358  Sum_probs=213.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec
Q 013750          108 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT  180 (437)
Q Consensus       108 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  180 (437)
                      +...++|+..+.||+|+||.||+|++.      +++.||||+++..........|.+|+.+++++ +|||||+++|+|.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            344578888999999999999999862      45789999998655555667899999999999 69999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCC
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKP--------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN  246 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~N  246 (437)
                      .+..++||||+++|+|.+++.....              ....+++..+.+++.||++||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            9999999999999999999976432              233589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeecCCceecccCCC-cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCcccc
Q 013750          247 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEE  324 (437)
Q Consensus       247 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~-~p~~~~~~~~  324 (437)
                      |+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+. +|+.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997654333 2233467899999999999999999999999999999999954 4443322111


Q ss_pred             cchhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          325 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                          .+..             +++.......+...+..+.+|+.+||+.||++||||.||+++|+.
T Consensus       256 ----~~~~-------------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         256 ----KFYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ----HHHH-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHH-------------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                0111             111122222233345689999999999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=384.22  Aligned_cols=255  Identities=29%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC--C--CEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD--G--TKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  185 (437)
                      ++|++.+.||+|+||+||+|++..  +  ..||||++....  .....++|.+|++++++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            567888999999999999998642  2  378999986432  23445789999999999999999999999976 4678


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +||||+++|++.+++....   ..+++..+++++.|||+||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            9999999999998876532   3489999999999999999999999   999999999999999999999999999997


Q ss_pred             cccCCCcc--cccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          266 VDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       266 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      ........  .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+..        .........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~--  230 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKE--  230 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTS--
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhC--
Confidence            75443322  223457889999999999999999999999999999998 89998643211        111121111  


Q ss_pred             hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          343 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       343 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                             ......+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       231 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         231 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                   11122233345689999999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=388.46  Aligned_cols=256  Identities=24%  Similarity=0.415  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-CC--EEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|++.+.||+|+||+||+|++++ |.  .||||++.........+.|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            677888999999999999999753 43  57889887655555677899999999998 799999999999999999999


Q ss_pred             EecccCchhhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcE
Q 013750          188 YPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA  255 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~  255 (437)
                      |||+++|+|.+++....            .....+++..+.+++.|||+||.|||++   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999987531            2345689999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCC-CCCCCcccccchhhHHHHH
Q 013750          256 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR-AIDFSRLEEEDDVLLLDHV  334 (437)
Q Consensus       256 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~-p~~~~~~~~~~~~~~~~~~  334 (437)
                      ||+|||+++.......  .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.....        ....
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~~~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY  236 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HHHH
Confidence            9999999986543222  223468999999999999999999999999999999999765 5543211        1111


Q ss_pred             HHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          335 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       335 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....          ..+...+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       237 ~~i~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         237 EKLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HHGGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHh----------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11111          11122334455689999999999999999999999999876

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-49  Score=386.44  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            357899999999999999999974 69999999987533 3345678899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec--CCCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~~~~  267 (437)
                      |+++|+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+++...
T Consensus       107 ~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         107 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999887654   233489999999999999999999999   999999999999998  67899999999999765


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ......+.   ..       
T Consensus       181 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~---~~-------  243 (352)
T d1koba_         181 PD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVK---RC-------  243 (352)
T ss_dssp             TT--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHH---HC-------
T ss_pred             CC--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH---hC-------
Confidence            43  223445689999999999999999999999999999999999999964321     11111111   11       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      +...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0111111222344578999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=383.19  Aligned_cols=260  Identities=28%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC--------CCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec
Q 013750          110 ATDNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT  180 (437)
Q Consensus       110 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  180 (437)
                      ..++|.+.+.||+|+||.||+|+..+        +..||||+++.........++.+|+..+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            45678888999999999999998532        3479999998655555667899999999888 89999999999999


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCee
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL  248 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIl  248 (437)
                      ++..++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   +++||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            9999999999999999999975431            234589999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeecCCceecccCCCc-ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 013750          249 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED  326 (437)
Q Consensus       249 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~ellt-g~~p~~~~~~~~~~  326 (437)
                      ++.++.+||+|||+++........ ......+|+.|+|||.+.++.|+.++||||||+++|||++ |..||......   
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---  244 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  244 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence            999999999999999976543332 2344568999999999999999999999999999999998 67777533211   


Q ss_pred             hhhHHHHHHHHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          327 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                        ....   ...          .......+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus       245 --~~~~---~i~----------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         245 --ELFK---LLK----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             --HHHH---HHH----------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHH---HHH----------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              1111   111          111122233345689999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=382.28  Aligned_cols=249  Identities=22%  Similarity=0.255  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.+..  .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467889999999999999999974 69999999996421  234567789999999999999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|..++.....    ++...+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999886543    78889999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..     .+.   ......       
T Consensus       157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~---~~i~~~-------  220 (337)
T d1o6la_         157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLF---ELILME-------  220 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHHC-------
T ss_pred             cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHH---HHHhcC-------
Confidence            322 2334467999999999999999999999999999999999999999754321     111   111110       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                        .  ..++...+..+.+|+.+||+.||++||+     ++|+++
T Consensus       221 --~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 --E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --C--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              0  1122233457889999999999999995     778775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.9e-49  Score=369.92  Aligned_cols=258  Identities=23%  Similarity=0.275  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHHhcccccceeeeeeeecCC----e
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----E  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~  183 (437)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++....  .....+.|.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467889999999999999999974 69999999997533  2334567999999999999999999999987544    3


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+||||+++++|..++....    .+++..++.++.||+.||+|||++   +|+||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            789999999999999887653    389999999999999999999999   9999999999999999999999999998


Q ss_pred             eecccCCC--cccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          264 KLVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       264 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ........  .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+..        ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~  230 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED  230 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcC
Confidence            76543222  2234467999999999999999999999999999999999999999743211        1111111111


Q ss_pred             chhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhc
Q 013750          342 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEG  390 (437)
Q Consensus       342 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~  390 (437)
                      ...       ......+.+..+.+++.+||+.||++|| |++++++.|..
T Consensus       231 ~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         231 PIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            100       0111122345789999999999999999 89999887754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-48  Score=374.62  Aligned_cols=245  Identities=24%  Similarity=0.289  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++...  ......+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56888999999999999999974 6999999998642  12345678999999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+++|+|..++.....    +++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999998876433    78888899999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .    .....||+.|+|||.+.+..|+.++|||||||++|||+||+.||...+..     ..   .......        
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~---~~~i~~~--------  216 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KT---YEKILNA--------  216 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH---HHHHHHC--------
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----HH---HHHHHcC--------
Confidence            2    23467999999999999999999999999999999999999999743211     11   1111111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                       .  ..+++..+..+.+++.+||+.||.+||     |++++++
T Consensus       217 -~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         217 -E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             0  111223345788999999999999996     8999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=375.83  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHH--HHHhcccccceeeeeeeecCC----eeE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVE--MISVAVHRNLLRLIGFCTTPT----ERL  185 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~--~l~~l~H~niv~l~g~~~~~~----~~~  185 (437)
                      ++|...+.||+|+||+||+|++ +|+.||||++...    ..+.+..|.+  .+.+++|||||+++|+|...+    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            3456678899999999999998 5899999998632    2344444444  556789999999999997654    578


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecCCCCCCeeecCCCcEEEeec
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      +||||+++|+|.++++..     .++|..+++++.|+|.||+|||+.+     .++|+||||||+|||++.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            999999999999999863     3899999999999999999999731     248999999999999999999999999


Q ss_pred             CCceecccCCCc---ccccccccccccccccccCCC------CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchh---
Q 013750          261 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV---  328 (437)
Q Consensus       261 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~---  328 (437)
                      |+++........   ......||+.|+|||++....      ++.++|||||||++|||+||..|+...........   
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            999977543322   223457999999999987543      57799999999999999999988753222111000   


Q ss_pred             ---hHHHHHHHHHhccchhhhccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          329 ---LLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       329 ---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                         .............    ..++.+... .+.+.+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence               0011111111111    111111111 123456789999999999999999999999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-48  Score=364.85  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC--------cchHHHHHHHHHHHhcc-cccceeeeeeeecC
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--------GGDAAFQREVEMISVAV-HRNLLRLIGFCTTP  181 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  181 (437)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++......        ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67888999999999999999974 6899999998643211        12346889999999997 99999999999999


Q ss_pred             CeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecC
Q 013750          182 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG  261 (437)
Q Consensus       182 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg  261 (437)
                      +..++||||+++|+|.+++....    .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999997643    389999999999999999999999   99999999999999999999999999


Q ss_pred             CceecccCCCcccccccccccccccccccC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 013750          262 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK  335 (437)
Q Consensus       262 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  335 (437)
                      +++......  ..+...||..|+|||.+.+      ..++.++||||+||++|||++|+.||......     ....   
T Consensus       156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-----~~~~---  225 (277)
T d1phka_         156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----LMLR---  225 (277)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH---
T ss_pred             heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-----HHHH---
Confidence            999765422  2344679999999999853      35788999999999999999999999743211     1111   


Q ss_pred             HHHhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          336 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       336 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ...... .      ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus       226 ~i~~~~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         226 MIMSGN-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHTC-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhCC-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111111 0      0111112234468999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-48  Score=375.82  Aligned_cols=245  Identities=21%  Similarity=0.257  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccC--CCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  188 (437)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...  ......+.+.+|+++++.++|||||++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57889999999999999999975 6999999998632  12344667899999999999999999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceeccc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV  268 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  268 (437)
                      ||+.+|+|..++....    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999987654    389999999999999999999999   999999999999999999999999999997643


Q ss_pred             CCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc
Q 013750          269 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD  348 (437)
Q Consensus       269 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  348 (437)
                      .    .....||+.|||||++.+..++.++|||||||++|||+||+.||...+.     .....   .....        
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~---~i~~~--------  253 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYE---KIVSG--------  253 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---HHHHC--------
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHHH---HHhcC--------
Confidence            2    2345799999999999999999999999999999999999999964321     11111   11111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 013750          349 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR  386 (437)
Q Consensus       349 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  386 (437)
                       .  ...+...+..+.+++.+||+.||.+|+     |++++++
T Consensus       254 -~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         254 -K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             0  011223345789999999999999994     8888875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=368.82  Aligned_cols=251  Identities=18%  Similarity=0.242  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...  ......+.+|+++++.++|||||++++++.+.+..|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            467888999999999999999975 6889999999753  3345578899999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC--CCcEEEeecCCceecc
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD  267 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~  267 (437)
                      |+++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.  ...+||+|||+++...
T Consensus        82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999998753   23489999999999999999999999   9999999999999985  4589999999998764


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ..  .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......     .....+...  ......-.
T Consensus       156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i~~~--~~~~~~~~  226 (321)
T d1tkia_         156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNA--EYTFDEEA  226 (321)
T ss_dssp             TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHT--CCCCCHHH
T ss_pred             cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC--CCCCChhh
Confidence            32  2233456899999999999999999999999999999999999999753321     111111110  00000000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                              ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 --------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 --------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0112357889999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-48  Score=377.27  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHH---HHHHHhcccccceeeeeeeecCCee
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTER  184 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~  184 (437)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....  .......+.+|   +++++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367889999999999999999975 68999999985321  11223344444   6667777899999999999999999


Q ss_pred             EEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          185 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       185 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                      |+||||+++|+|.+++....    .+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999997643    378899999999999999999999   99999999999999999999999999998


Q ss_pred             ecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL  343 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (437)
                      ......   .....||+.|+|||.+.. ..|+.++|||||||++|||+||+.||........     ......       
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~-------  220 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM-------  220 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHH-------
T ss_pred             ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-------
Confidence            765332   234579999999999975 4689999999999999999999999975432211     000000       


Q ss_pred             hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          344 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       344 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                        ....  ....+...+..+.+|+.+||+.||++|||     ++|+++
T Consensus       221 --~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 --TLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --SSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --cccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              0000  01112223457899999999999999999     688874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=367.17  Aligned_cols=257  Identities=24%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC----cchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEecc
Q 013750          117 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM  191 (437)
Q Consensus       117 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  191 (437)
                      .++||+|+||+||+|++. +|+.||||++......    ...+.+.+|++++++++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999974 6899999998643211    12357889999999999999999999999999999999999


Q ss_pred             cCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCCC
Q 013750          192 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT  271 (437)
Q Consensus       192 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  271 (437)
                      .++++......    ...+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99887766543    33478888999999999999999999   999999999999999999999999999986543322


Q ss_pred             cccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhcc--
Q 013750          272 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--  348 (437)
Q Consensus       272 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  348 (437)
                       ......||+.|+|||.+... .++.++|||||||++|||+||+.||.....     ......+.............+  
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChhhccchh
Confidence             22345689999999998654 579999999999999999999999964332     111111211111000000000  


Q ss_pred             -------ccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          349 -------RNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       349 -------~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                             .......+     ...+..+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                   00000111     122467899999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=371.77  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=197.5

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhc-ccccceeeeeeeec----CCe
Q 013750          111 TDNFSEK-NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT----PTE  183 (437)
Q Consensus       111 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  183 (437)
                      .++|.+. +.||+|+||+||+|++ .+|+.||||++.+      ...+.+|++++.++ +|||||++++++.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            4678766 4699999999999997 4689999999863      24577899987654 89999999999865    456


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC---CCcEEEeec
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF  260 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Df  260 (437)
                      .|+|||||++|+|.+++...  +...+++..+..++.||+.||+|||++   +|+||||||+|||+++   ++.+||+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            89999999999999999753  234589999999999999999999999   9999999999999985   567999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      |+++......  ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.........     .....    
T Consensus       159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----~~~~~----  227 (335)
T d2ozaa1         159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKT----  227 (335)
T ss_dssp             TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred             ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----HHHHH----
Confidence            9998765432  234467999999999999999999999999999999999999999643221110     00000    


Q ss_pred             cchhhhcccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 KRLDAIVDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                          .+......  .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       228 ----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 ----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                00000000  0111234568999999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=372.40  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC--CCcchHHHHHHHHHHH-hcccccceeeeeeeecCCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv  187 (437)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++.+..  .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999985 68999999996421  2334566777877765 68999999999999999999999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecc
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD  267 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~  267 (437)
                      |||+++|+|..++.....    ++...+..++.||+.||+|||++   +++||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999986543    78889999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccchhhhc
Q 013750          268 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV  347 (437)
Q Consensus       268 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (437)
                      ... ...+...||+.|+|||.+.+..++.++|||||||++|||+||+.||...+..     .+...+.   ..       
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i~---~~-------  218 (320)
T d1xjda_         155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHSIR---MD-------  218 (320)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHH---HC-------
T ss_pred             ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHH---cC-------
Confidence            332 2334467999999999999999999999999999999999999999753321     1111111   10       


Q ss_pred             cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 013750          348 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVVR  386 (437)
Q Consensus       348 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl~  386 (437)
                      .+    .++...+..+.+|+.+||+.||++|||+. |+++
T Consensus       219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            01    11223345789999999999999999985 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=361.51  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788999999999999999997 468999999996432 23346789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      |+.++.+......   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9987655444332   233489999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc--hhhh
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR--LDAI  346 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  346 (437)
                      . .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+...    .+............  ....
T Consensus       156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred             c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhcccc
Confidence            2 2333457999999999877665 5899999999999999999999997432111    01111111100000  0000


Q ss_pred             c-cccccCC-----------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          347 V-DRNLNKN-----------YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       347 ~-d~~l~~~-----------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      . .+.....           ..+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0 0000000           011223578999999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=363.34  Aligned_cols=241  Identities=22%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCC-----cchHHHHHHHHHHHhcc--cccceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~  182 (437)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......     .....+.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357888999999999999999974 6899999998642211     11234678999999986  899999999999999


Q ss_pred             eeEEEEecccC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-CCcEEEeec
Q 013750          183 ERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDF  260 (437)
Q Consensus       183 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Df  260 (437)
                      ..++||||+.+ +++.+++....    .+++..+..++.||+.||+|||++   +|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 67777776543    389999999999999999999999   9999999999999985 479999999


Q ss_pred             CCceecccCCCcccccccccccccccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          261 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       261 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      |+++.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+              ....
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~  218 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIR  218 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHH
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhh
Confidence            999865422   2344679999999999987765 677999999999999999999996321              0000


Q ss_pred             ccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..       .    .++...+.++.+|+.+||+.||++|||++|+++
T Consensus       219 ~~-------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 GQ-------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CC-------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc-------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00       0    111123357899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-47  Score=359.55  Aligned_cols=262  Identities=21%  Similarity=0.277  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEec
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF  190 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  190 (437)
                      ++|...+.||+|+||+||+|++++|+.||||++.... .....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999999999999999996432 233467899999999999999999999999999999999999


Q ss_pred             ccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccCC
Q 013750          191 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK  270 (437)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  270 (437)
                      +.++.+..+....    ..++...+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.+.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9988777765532    3489999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc---hhhh
Q 013750          271 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR---LDAI  346 (437)
Q Consensus       271 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  346 (437)
                       .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......     ..............   ....
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTG
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCCCChhhccch
Confidence             223334689999999998754 5799999999999999999999999743221     11111111110000   0000


Q ss_pred             c------------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          347 V------------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       347 ~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      .            .+..........+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0            000001112223457889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=359.40  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-C-CCEEEEEEeccCC-CCcchHHHHHHHHHHHhc---ccccceeeeeeeec----
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTT----  180 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----  180 (437)
                      .++|++.+.||+|+||+||+|++. + ++.||||++.... .......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 5679999986422 223344567888877665   79999999999853    


Q ss_pred             -CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEee
Q 013750          181 -PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD  259 (437)
Q Consensus       181 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D  259 (437)
                       ....++++||++++++......   ....+++.....++.|++.||+|||++   +|+||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3467899999999887655443   233478999999999999999999999   999999999999999999999999


Q ss_pred             cCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHh
Q 013750          260 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER  339 (437)
Q Consensus       260 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  339 (437)
                      ||+++....  ........||+.|+|||.+.+..|+.++||||+||++|||++|+.||...+..     ...........
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~  232 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIG  232 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred             hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhC
Confidence            999986542  22334567999999999999999999999999999999999999999754321     11111111110


Q ss_pred             ccchhh----------hcc---ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          340 EKRLDA----------IVD---RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       340 ~~~~~~----------~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ......          ...   ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000          000   00001112233457889999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-46  Score=355.00  Aligned_cols=258  Identities=18%  Similarity=0.217  Sum_probs=194.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeee-eeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI-GFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lv~e  189 (437)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....   ..+++..|+++++.++|+|++..+ ++....+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            56888999999999999999974 68999999986532   234578999999999888766555 44577788899999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeec---CCCcEEEeecCCceec
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLV  266 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~  266 (437)
                      |+.+ ++...+...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++..
T Consensus        84 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LLGP-SLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CCCC-BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EcCC-chhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9955 555554432   23489999999999999999999999   999999999999875   4567999999999977


Q ss_pred             ccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          267 DVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       267 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..........  ...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~  234 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERISEKKMS  234 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH--HHHHhhcccCC
Confidence            543221      2234579999999999999999999999999999999999999997543322111  11111110000


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .....     +    ....+.++.+++..||+.+|++||++.++.+.|+.
T Consensus       235 ~~~~~-----~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         235 TPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             SCHHH-----H----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CChhH-----h----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            00111     1    11223578999999999999999999999888864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-45  Score=346.28  Aligned_cols=259  Identities=15%  Similarity=0.190  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhccc-ccceeeeeeeecCCeeEEEE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLLVY  188 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~  188 (437)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++....   ....+.+|++.++.++| +|++.+++++......++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            367888999999999999999975 68999999886432   23457789999999875 89999999999999999999


Q ss_pred             ecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecC-----CCcEEEeecCCc
Q 013750          189 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA  263 (437)
Q Consensus       189 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla  263 (437)
                      ||+ +++|.+++....   ..+++.....++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||++
T Consensus        81 e~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            999 678888876532   3489999999999999999999999   9999999999999974     578999999999


Q ss_pred             eecccCCCc------ccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 013750          264 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL  337 (437)
Q Consensus       264 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  337 (437)
                      +........      ......||+.|||||.+.+..++.++|||||||++|||+||+.||..........  ....+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~  231 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEK  231 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhc
Confidence            976533221      2234579999999999999999999999999999999999999997544332211  11111111


Q ss_pred             HhccchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 013750          338 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG  390 (437)
Q Consensus       338 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  390 (437)
                      .......++     ...    .+.++.+++..|++.+|++||+++.+.+.|+.
T Consensus       232 ~~~~~~~~l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         232 KQSTPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HHHSCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             cCCCChHHh-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            111111111     112    23578899999999999999999999888764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=348.31  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec--------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--------  180 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------  180 (437)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.+.+|++++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367888999999999999999974 79999999986432 24456778999999999999999999999855        


Q ss_pred             CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeec
Q 013750          181 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF  260 (437)
Q Consensus       181 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df  260 (437)
                      ....++||||+.++++......    ...++......++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            3457899999998887655443    23378888999999999999999999   9999999999999999999999999


Q ss_pred             CCceecccCCCc---ccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 013750          261 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK  336 (437)
Q Consensus       261 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  336 (437)
                      |+++........   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....     .........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~  236 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQ  236 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHH
Confidence            999876532221   22234689999999998765 689999999999999999999999964321     111111111


Q ss_pred             HHhccc---hhhhccc--------cccCCCCH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          337 LEREKR---LDAIVDR--------NLNKNYNI-------QEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       337 ~~~~~~---~~~~~d~--------~l~~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ......   .......        ........       .....+.+|+.+||+.||++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            111000   0000000        00000111       112466789999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=354.47  Aligned_cols=264  Identities=18%  Similarity=0.285  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecCC----eeE
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----ERL  185 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  185 (437)
                      +++|+..+.||+|+||+||+|+. .+|+.||||++.........+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35688899999999999999997 4799999999976554555678999999999999999999999996543    234


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      ++++|+.+|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            555667799999998753     289999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCc--ccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          266 VDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       266 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .......  ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......     .............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-----~~~~~~~~~~~~~  233 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILGILGSPS  233 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCC
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-----HHHHHhhhccCCC
Confidence            6443222  2334568999999999854 457899999999999999999999997543211     1111111000000


Q ss_pred             hhh-----------hc-cccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          343 LDA-----------IV-DRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       343 ~~~-----------~~-d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      ...           .. ........     .+.....+.+|+.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000           00 00000000     11123468899999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=356.65  Aligned_cols=259  Identities=24%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccceeeeeeeecC------CeeE
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TERL  185 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  185 (437)
                      +|+..++||+|+||+||+|++. +|+.||||++.....     .+.+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4667789999999999999985 699999999975321     234799999999999999999998543      3468


Q ss_pred             EEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCce
Q 013750          186 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK  264 (437)
Q Consensus       186 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~  264 (437)
                      +||||++++.+...... ......+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++
T Consensus        96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            99999987755544332 22344589999999999999999999999   999999999999999775 89999999998


Q ss_pred             ecccCCCcccccccccccccccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH------
Q 013750          265 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL------  337 (437)
Q Consensus       265 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  337 (437)
                      ......  ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.......    .+.......      
T Consensus       172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTRE  245 (350)
T ss_dssp             ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCHH
T ss_pred             hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHhCCChHH
Confidence            765332  2334568999999998865 568999999999999999999999997543211    011111100      


Q ss_pred             -----Hhc---cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          338 -----ERE---KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       338 -----~~~---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                           ...   ...................+.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000   0000000000011112234457899999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=352.85  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccCC---CCcchHHHHHHHHHHHhccc-ccceeeeeeeecCC
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPT  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~  182 (437)
                      .++|++.+.||+|+||+||+|+..    +|+.||||++....   .....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367889999999999999999852    47899999986422   12335678899999999977 89999999999999


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      ..++++||+.+|+|..++.....    +.......++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999999986543    57788889999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE  340 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (437)
                      ++..............|++.|+|||.+.+.  .++.++|||||||++|||++|+.||..........    .........
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~----~i~~~~~~~  251 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRILKS  251 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHHHC
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHhcccC
Confidence            987655444444456799999999999765  46889999999999999999999997554332111    111111000


Q ss_pred             cchhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 013750          341 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR  386 (437)
Q Consensus       341 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  386 (437)
                                 ....+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                       01122334568999999999999999995     788864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=341.31  Aligned_cols=263  Identities=21%  Similarity=0.239  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCCeeEEEEe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP  189 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  189 (437)
                      ++|.+.+.||+|+||+||+|++. +|+.||||+++... .....+.+.+|+.+++.++||||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57888999999999999999974 68999999986433 23456789999999999999999999999999999999999


Q ss_pred             cccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCceecccC
Q 013750          190 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR  269 (437)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  269 (437)
                      ++.++++..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999998877643    2378899999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccch-----
Q 013750          270 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL-----  343 (437)
Q Consensus       270 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  343 (437)
                      .. ......++..|+|||.+.... ++.++|||||||++|||++|+.||.....    .......+.........     
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTT
T ss_pred             Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC----HHHHHHHHHhhcCCCChhhhhh
Confidence            22 233345778999999987665 69999999999999999999999743221    11122222221111000     


Q ss_pred             -hhhcc---------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          344 -DAIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       344 -~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                       ....+         ..-...........+.+|+.+|++.||.+|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000         00011122334467889999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=349.65  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=192.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecCC------
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------  182 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  182 (437)
                      .++|...+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467888999999999999999975 69999999997432 2334567889999999999999999999997654      


Q ss_pred             eeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCC
Q 013750          183 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL  262 (437)
Q Consensus       183 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl  262 (437)
                      +.++||||+ +.+|.......     .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            569999999 55677666542     389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccccccccccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhcc
Q 013750          263 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK  341 (437)
Q Consensus       263 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (437)
                      ++.....    .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+...     ............
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~  238 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-----QLKEIMKVTGTP  238 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCC
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-----HHHHHHhccCCC
Confidence            9865432    2345689999999998764 57899999999999999999999997542211     111111100000


Q ss_pred             c------------------hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          342 R------------------LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       342 ~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                      .                  ........+ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0                  000000000 01112234577899999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-44  Score=347.77  Aligned_cols=259  Identities=18%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeec--CCeeEEE
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT--PTERLLV  187 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv  187 (437)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++..    ...+++.+|++++++++ ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            67999999999999999999974 689999999864    23567899999999995 9999999999874  3568999


Q ss_pred             EecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCC-cEEEeecCCceec
Q 013750          188 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLV  266 (437)
Q Consensus       188 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~  266 (437)
                      |||+++++|..+..       .++...+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            99999999876542       388999999999999999999999   999999999999998654 6999999999876


Q ss_pred             ccCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-----HHHHhc
Q 013750          267 DVRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV-----KKLERE  340 (437)
Q Consensus       267 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~  340 (437)
                      ....  ......+|..|+|||.+.+.. ++.++||||+||++|||++|+.||.................     ......
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5332  234456899999999987654 79999999999999999999999864332211100000000     000000


Q ss_pred             ---c---chhhhccc--------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          341 ---K---RLDAIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       341 ---~---~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                         .   ........        ..........+.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0   00000000        0001111223457889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=342.36  Aligned_cols=260  Identities=20%  Similarity=0.224  Sum_probs=190.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeec------CCe
Q 013750          112 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PTE  183 (437)
Q Consensus       112 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~  183 (437)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67888999999999999999975 69999999997433 23345578899999999999999999999853      367


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .|+||||+.++.+... .      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHHhh-h------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            8999999987766544 2      1278999999999999999999999   9999999999999999999999999998


Q ss_pred             eecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH------
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL------  337 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  337 (437)
                      +....  ........+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+....    ........      
T Consensus       167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~----~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ----WNKVIEQLGTPCPE  240 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCHH
T ss_pred             hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH----HHHHHHhccCCCHH
Confidence            86543  2233445689999999999999999999999999999999999999964331110    00000000      


Q ss_pred             ------------Hhc------cchhhhccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013750          338 ------------ERE------KRLDAIVDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM  387 (437)
Q Consensus       338 ------------~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  387 (437)
                                  ...      ..............   .....+..+.+|+.+|++.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                        000      00011111111111   123456789999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-43  Score=338.93  Aligned_cols=259  Identities=21%  Similarity=0.255  Sum_probs=193.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCC-CCcchHHHHHHHHHHHhcccccceeeeeeeecC-----Ce
Q 013750          111 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE  183 (437)
Q Consensus       111 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  183 (437)
                      +++|++.+.||+|+||+||+|+.. +|+.||||++.... +....+.+.+|++++++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999974 69999999997533 233456788999999999999999999998543     33


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEeecCCc
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA  263 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla  263 (437)
                      .+++++|+.+|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            46677888899999988542     389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccccccccccccccCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHHhccc
Q 013750          264 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR  342 (437)
Q Consensus       264 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (437)
                      .....    ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||...+..     .....+........
T Consensus       169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPG  239 (348)
T ss_dssp             -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCC
T ss_pred             cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCC
Confidence            75432    233456899999999876654 689999999999999999999999754321     11111111100000


Q ss_pred             hh-----------hhccccc-cCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013750          343 LD-----------AIVDRNL-NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR  386 (437)
Q Consensus       343 ~~-----------~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  386 (437)
                      ..           ....... ....     ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00           0000000 0000     0122357889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-38  Score=310.78  Aligned_cols=264  Identities=19%  Similarity=0.213  Sum_probs=189.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-----------cccceeeeeeeec
Q 013750          113 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFCTT  180 (437)
Q Consensus       113 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~  180 (437)
                      +|.+.+.||+|+||+||+|+.. +|+.||||++...  ....+.+.+|+++++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4888999999999999999974 7999999999742  234567788999988775           5789999988754


Q ss_pred             --CCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCC----
Q 013750          181 --PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDF----  253 (437)
Q Consensus       181 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~----  253 (437)
                        ....+++++++..+.......... ....+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              345666666665544333332222 33447888999999999999999998 6   899999999999998654    


Q ss_pred             --cEEEeecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCCcccccch--hh
Q 013750          254 --EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD--VL  329 (437)
Q Consensus       254 --~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l~elltg~~p~~~~~~~~~~~--~~  329 (437)
                        .++++|||.+......    .....||+.|+|||.+....++.++||||+||+++||++|+.||..........  ..
T Consensus       168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              3999999999865432    234568999999999999999999999999999999999999987433221111  01


Q ss_pred             HHHHHHHHHh--------ccchhhhccc-------------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013750          330 LLDHVKKLER--------EKRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMS  382 (437)
Q Consensus       330 ~~~~~~~~~~--------~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  382 (437)
                      +......+..        ........+.                   ..........+..+.+|+.+|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1111111000        0000000000                   001233466778999999999999999999999


Q ss_pred             HHHH
Q 013750          383 EVVR  386 (437)
Q Consensus       383 evl~  386 (437)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=3e-24  Score=189.52  Aligned_cols=169  Identities=11%  Similarity=0.050  Sum_probs=119.2

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCC-----------------cchHHHHHHHHHHHhcccccceeeeeee
Q 013750          116 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-----------------GGDAAFQREVEMISVAVHRNLLRLIGFC  178 (437)
Q Consensus       116 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~H~niv~l~g~~  178 (437)
                      +.+.||+|+||+||+|...+|+.||||+++.....                 .......+|...+.++.|+|++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46789999999999999989999999987531110                 0012345688889999999999887653


Q ss_pred             ecCCeeEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEecCCCCCCeeecCCCcEEEe
Q 013750          179 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG  258 (437)
Q Consensus       179 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~  258 (437)
                          ..+++|||+++..+..           ++......++.|++++++|||++   +|+||||||+|||++++ .++|+
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence                2379999998866533           23334567899999999999999   99999999999999975 58999


Q ss_pred             ecCCceecccCCCcccccccccccccccccccCCCCCCchhhHHHHHHH
Q 013750          259 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML  307 (437)
Q Consensus       259 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gv~l  307 (437)
                      |||+|............  ..+... -.+.+ ...|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            99999865422111100  000000 01111 35678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=3e-07  Score=82.68  Aligned_cols=150  Identities=13%  Similarity=0.092  Sum_probs=98.4

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcc-cccceeeeeeeecCCe
Q 013750          105 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTE  183 (437)
Q Consensus       105 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  183 (437)
                      .++.....+|...+..+.++.+.||+... ++..+.+|+..... ......+.+|...+..+. +--+-+++.++..++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            45666667776655544455578999875 46677888876432 223345678888877664 3334567788888888


Q ss_pred             eEEEEecccCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 013750          184 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------  233 (437)
Q Consensus       184 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------  233 (437)
                      .++||+++++.++.......      .   ....++.++++.++.||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            99999999998875443210      0   11223344444444444311                              


Q ss_pred             --------------------------CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          234 --------------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       234 --------------------------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                                                .+.++|+|+.|.||+++++..+-|.||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                      12489999999999999887778999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.16  E-value=4.1e-06  Score=74.60  Aligned_cols=142  Identities=15%  Similarity=0.096  Sum_probs=85.8

Q ss_pred             eeecC-cEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccc--ceeeeeeeecCCeeEEEEecccCchh
Q 013750          120 LGQGG-FGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQNLSV  196 (437)
Q Consensus       120 lG~G~-fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL  196 (437)
                      +..|. .+.||+...+++..+.+|.-...    ....+..|...++.+....  +-++++++.+++..++||+|+++.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            44444 36899999888888899976532    2334677888887665433  45677888888888999999988765


Q ss_pred             hhh--------------hhhcC---CCCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhcC----
Q 013750          197 AYR--------------LREIK---PGEPVL--DWVTRKRVA--------------------LGAARGLEYLHEHC----  233 (437)
Q Consensus       197 ~~~--------------l~~~~---~~~~~l--~~~~~~~i~--------------------~~ia~~l~yLH~~~----  233 (437)
                      ...              +....   ......  .+.....-.                    ......+..+....    
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            331              11100   000000  111000000                    01122333333321    


Q ss_pred             CCceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          234 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       234 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      .+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            22489999999999999887778999988763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=0.00017  Score=68.45  Aligned_cols=76  Identities=13%  Similarity=0.120  Sum_probs=47.8

Q ss_pred             CeeeecCcEEEEEEEECC-CCEEEEEEeccC------CCCcchHHHHHHHHHHHhcc-c--ccceeeeeeeecCCeeEEE
Q 013750          118 NVLGQGGFGKVYRGVLAD-GTKVAVKRLTDF------ESPGGDAAFQREVEMISVAV-H--RNLLRLIGFCTTPTERLLV  187 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~------~~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv  187 (437)
                      +.||.|....||+....+ ++.++||.-.+.      ..+........|.+.+..+. +  ..+.+++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 678999965421      11223344556888877653 2  234455544  45566899


Q ss_pred             EecccCch
Q 013750          188 YPFMQNLS  195 (437)
Q Consensus       188 ~e~~~~gs  195 (437)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.24  E-value=0.00035  Score=64.28  Aligned_cols=137  Identities=13%  Similarity=0.105  Sum_probs=80.1

Q ss_pred             cEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce--eee-----eeeecCCeeEEEEecccCchhh
Q 013750          125 FGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL--RLI-----GFCTTPTERLLVYPFMQNLSVA  197 (437)
Q Consensus       125 fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~-----g~~~~~~~~~lv~e~~~~gsL~  197 (437)
                      --.||+...++|+.|++|...+..  ...+++..|...+..+...++.  ..+     .........+.+++++++..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            358999999999999999986532  2456788899888877543321  111     1123445678889998764432


Q ss_pred             hh--------------hhh----cC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCC
Q 013750          198 YR--------------LRE----IK-PGEPVLDWVT-------------------RKRVALGAARGLEYLHEH----CNP  235 (437)
Q Consensus       198 ~~--------------l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~~l~yLH~~----~~~  235 (437)
                      ..              ++.    .. ......++..                   +..+...+.+.++.+...    ...
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            10              111    00 1112222221                   111222233333444332    234


Q ss_pred             ceEecCCCCCCeeecCCCcEEEeecCCcee
Q 013750          236 KIIHRDVKAANVLLDEDFEAVVGDFGLAKL  265 (437)
Q Consensus       236 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~  265 (437)
                      +++|+|+.+.|||++++  ..+.||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999754  45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.76  E-value=0.0039  Score=58.62  Aligned_cols=73  Identities=14%  Similarity=0.216  Sum_probs=50.0

Q ss_pred             CeeeecCcEEEEEEEECCC--------CEEEEEEeccCCCCcchHHHHHHHHHHHhcccccce-eeeeeeecCCeeEEEE
Q 013750          118 NVLGQGGFGKVYRGVLADG--------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVY  188 (437)
Q Consensus       118 ~~lG~G~fg~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~  188 (437)
                      +.|+.|-.-.+|+...+++        ..|.+++.-.   .....+..+|..+++.+.-.+++ ++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            5688888899999987543        4566666542   22234566899998888655665 67776643    5889


Q ss_pred             ecccCchhh
Q 013750          189 PFMQNLSVA  197 (437)
Q Consensus       189 e~~~~gsL~  197 (437)
                      ||+++.++.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.66  E-value=0.0042  Score=56.23  Aligned_cols=159  Identities=11%  Similarity=0.030  Sum_probs=82.1

Q ss_pred             cCHHHHHHHhcCCCCCCeee-----ecCcEEEEEEEECCCCEEEEEEeccCCCCcchHHHHHHHHHHHhccccccee--e
Q 013750          102 YSWRELQLATDNFSEKNVLG-----QGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR--L  174 (437)
Q Consensus       102 ~~~~e~~~~~~~~~~~~~lG-----~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~--l  174 (437)
                      .+.+|++....+|...+...     .|---+.|+.+.++| .+++|+.....+   .++...|++++..+.+.++.-  .
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhcccccccc
Confidence            35577888888887755443     455577899888665 488998764322   234455677776665433211  1


Q ss_pred             e----e--eeecCCeeEEEEecccCchhhh--------------hhhhcCC-------CCCCCCHH--------------
Q 013750          175 I----G--FCTTPTERLLVYPFMQNLSVAY--------------RLREIKP-------GEPVLDWV--------------  213 (437)
Q Consensus       175 ~----g--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~-------~~~~l~~~--------------  213 (437)
                      +    |  +.........++.+..+.....              .++....       ......+.              
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            1    0  1122334455666655432211              0110000       00000000              


Q ss_pred             --HHHHHHHHHHHHHHHHHh-cCCCceEecCCCCCCeeecCCCcEEEeecCCce
Q 013750          214 --TRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK  264 (437)
Q Consensus       214 --~~~~i~~~ia~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~  264 (437)
                        .....+..+...+.-.+. ..+.++||+|+.+.||+++.+...-+.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence              011112222222222221 123479999999999999998877999999886